{
 "cells": [
  {
   "metadata": {},
   "cell_type": "markdown",
   "source": [
    "# üî¨ Project Overview: Comparative Topic Analysis of Longevity Communities\n",
    "\n",
    "This notebook performs an unsupervised topic modeling analysis to map the conversational landscape across three prominent subreddits: **r/PeterAttia**, **r/Longevity**, and **r/Biohackers**. The goal is to quantify and visualize the similarities, differences, and unique areas of focus for each community.\n",
    "\n",
    "## üéØ Objectives\n",
    "\n",
    "1.  **Discover Topics:** Use **BERTopic** to identify and label the major topics of discussion across the combined text data.\n",
    "2.  **Refine and Stabilize:** Employ advanced techniques (Outlier Reduction, Soft Reassignment) to create a robust, final set of clean topics.\n",
    "3.  **Visualize Structure:** Map the topics in a 2D space (**UMAP**) and identify their internal hierarchy (**Dendrogram**).\n",
    "4.  **Compare Communities:** Quantify and visualize the **percentage contribution** of each subreddit to every topic, establishing community dominance.\n",
    "\n",
    "## üõ†Ô∏è Pipeline Steps\n",
    "\n",
    "| Step | Focus Area | Key Output |\n",
    "| :--- | :--- | :--- |\n",
    "| **1** | **Data Prep & Initial Fit** | Cleaned Data, Embeddings, Raw Topics (`topic_raw`) |\n",
    "| **2** | **Topic Refinement** | Final, Stable Topics (`topic_global`), Reduced Outliers |\n",
    "| **3** | **Core Analysis** | Topic Size Bar Chart, Temporal Trends (Time Series) |\n",
    "| **4** | **UMAP Visualization** | 2D Scatter Plot of Topic Clusters (Top N Highlighted) |\n",
    "| **5** | **Subreddit Contribution** | Normalized Stacked Bar Chart (Ordered by Peter Attia %)|\n",
    "| **6** | **UMAP Comparison** | 2x2 Grid showing individual subreddit topic distributions |\n",
    "| **7** | **Hierarchical View** | Dendrogram visualizing inter-topic relationships |\n",
    "| **8** | **Content Extraction** | Top representative documents for key topics (Future Work) |\n",
    "\n",
    "---\n",
    "\n",
    "## üîë Expected Key Findings\n",
    "\n",
    "* Identification of **unique specialization** (e.g., Peter Attia's focus on fitness vs. Longevity's focus on experimental compounds).\n",
    "* Discovery of **universal, shared interests** (e.g., cholesterol management).\n",
    "* Visual proof of **topic clustering** and their high-level relationships."
   ],
   "id": "f1589c87ac835c07"
  },
  {
   "metadata": {},
   "cell_type": "markdown",
   "source": [
    "# üìä Exploratory Data Analysis (EDA) Summary: BLP Combined Data\n",
    "\n",
    "This section performs a comprehensive exploratory analysis on the combined dataset (`Biohackers`, `Longevity`, `PeterAttia`) to understand volume, engagement, and temporal trends before any machine learning is applied.\n",
    "\n",
    "---\n",
    "\n",
    "### 1. üìã Data Overview & Central Tendency\n",
    "\n",
    "* **Goal:** Establish baseline metrics for data volume and typical engagement levels.\n",
    "* **Key Metrics Calculated:**\n",
    "    * Total rows, full date range, unique authors (if available), and **posts per subreddit**.\n",
    "    * **Median and Mean** for key engagement features: `score`, `num_comments`, `text_len`, and `title_len`.\n",
    "* **Key Insight:** The median score and comment count are typically very low (often near zero), indicating that high-engagement posts are rare and skew the mean, making the **median a more robust measure** of typical post engagement.\n",
    "\n",
    "---\n",
    "\n",
    "### 2. üìà Temporal Trends (Time Series Analysis)\n",
    "\n",
    "* **Goal:** Identify growth, seasonality, and major shifts in activity over the entire date range.\n",
    "* **Visualizations:**\n",
    "    * **Line Plots:** Monthly total post volume, average score, total comment volume, and average comments per post.\n",
    "    * **Multi-Line Plot:** Monthly post volume **separated by subreddit**, showing individual growth trajectories.\n",
    "    * **Stacked Area Plot:** Monthly **share of posts by subreddit**, illustrating changes in the dominance or size ratio of the communities over time.\n",
    "* **Key Insight:** This analysis reveals whether the communities are growing, shrinking, or if one subreddit has rapidly eclipsed the others in terms of discussion volume.\n",
    "\n",
    "---\n",
    "\n",
    "### 3. üéØ Distributions and Engagement\n",
    "\n",
    "* **Goal:** Understand the inherent variance and identify the characteristics of content within the dataset.\n",
    "* **Visualizations:**\n",
    "    * **Histograms (Log-Y Scale):** Distributions of `score`, `num_comments`, and `text_len`. The log-y scale handles the heavy skew caused by viral posts.\n",
    "    * **Faceted Histograms:** Show `score` and `num_comments` distributions **broken down by subreddit**, allowing a direct visual comparison of engagement patterns.\n",
    "* **Key Insight:** Compares whether one subreddit consistently produces higher-scoring or higher-comment-count content than the others.\n",
    "\n",
    "---\n",
    "\n",
    "### 4. üîó Correlation Diagnostics\n",
    "\n",
    "* **Goal:** Quantify the linear relationships between various numeric features.\n",
    "* **Visualizations:**\n",
    "    * **Heatmap:** Visualizes the **correlation matrix** for `score`, `num_comments`, `text_len`, and `title_len`.\n",
    "    * **Scatter Plots:** Samples of `text_len` vs. `score` and `text_len` vs. `num_comments` (low opacity) to visualize if **longer posts are generally more engaging**.\n",
    "* **Key Insight:** Typically, a weak positive correlation is expected between text length and engagement metrics, but this verifies the strength of that relationship in this specific dataset.\n",
    "\n",
    "---\n",
    "\n",
    "### 5. üî• Activity Heatmaps\n",
    "\n",
    "* **Goal:** Provide a granular view of activity over the years.\n",
    "* **Visualizations:**\n",
    "    * **Year/Month Heatmap (Overall):** Shows the total post count across all months and years, instantly highlighting **periods of peak activity**.\n",
    "    * **Per-Subreddit Tables:** Printouts of the last few months of activity for each individual subreddit, confirming recent trends.\n",
    "* **Key Insight:** Pinpoints exactly when the communities were most active, which can correlate with real-world events or the subreddit's founding/growth periods."
   ],
   "id": "5c6a2ebcb9e580f7"
  },
  {
   "metadata": {},
   "cell_type": "markdown",
   "source": [
    "\n",
    "## üî¢ Data Volume and Composition\n",
    "\n",
    "* **Total Documents:** The dataset contains **48,935** posts across all three subreddits.\n",
    "* **Dataset Size:** The data is substantial, occupying **108.17 MB** of memory.\n",
    "* **Subreddit Dominance:**\n",
    "    * **r/Biohackers** is the largest contributor, accounting for over half the documents ($\\approx 61\\%$).\n",
    "    * **r/Longevity** and **r/PeterAttia** contribute the remaining volume, with r/Longevity having nearly twice the posts of r/PeterAttia.\n",
    "\n",
    "| Subreddit | Count | Share (%) |\n",
    "| :--- | :--- | :--- |\n",
    "| **Biohackers** | 29,773 | 60.8% |\n",
    "| **Longevity** | 12,343 | 25.2% |\n",
    "| **PeterAttia** | 6,819 | 13.9% |\n",
    "\n",
    "---\n",
    "\n",
    "## üßπ Data Quality and Types\n",
    "\n",
    "* **High Data Quality:** Crucially, the key analytical columns (`subreddit`, `created_dt`, `score`, `num_comments`, `doc`, `text_len`) show **zero null values**. This confirms the data cleaning and preprocessing steps were highly effective, providing a robust foundation for modeling.\n",
    "* **Key Data Types:**\n",
    "    * **Text:** `doc`, `title`, and `text` are correctly stored as `object` (string) types for text analysis.\n",
    "    * **Metrics:** `score`, `num_comments`, and `text_len` are correctly parsed as **`int64`**, suitable for direct numerical analysis and visualization.\n",
    "    * **Time:** The creation timestamp (`created_dt`) is in the efficient **`datetime64[ns]`** format, ready for time series analysis."
   ],
   "id": "869d56250a7b41bf"
  },
  {
   "metadata": {
    "ExecuteTime": {
     "end_time": "2025-11-04T21:49:20.777276Z",
     "start_time": "2025-11-04T21:49:15.619217Z"
    }
   },
   "cell_type": "code",
   "source": [
    "# ============================================\n",
    "# üîç EDA: BLP (Biohackers + Longevity + PeterAttia) - FIXED FILE PATH & PLOT LAYOUT\n",
    "# ============================================\n",
    "\n",
    "import os\n",
    "from pathlib import Path\n",
    "import numpy as np\n",
    "import pandas as pd\n",
    "import matplotlib.pyplot as plt\n",
    "import seaborn as sns\n",
    "\n",
    "# -----------------------------\n",
    "# Locate BLP file (EDITED SECTION)\n",
    "# -----------------------------\n",
    "BASE_DIR = Path(\"/Users/michaelwalker/CU_Boulder_Masters_Ai/Introduction to Deep Learning/cu-boulder-ms-ai/Introduction-to-Machine-Learning/unsupervised/CSCA 5632 Unsupervised Algorithms in Machine Learning Final Project/data/combined_dedup\")\n",
    "\n",
    "# Explicitly set the correct file path as requested\n",
    "CSV_FILENAME = \"BLP_combined_2020-01-01_2025-11-02_dedup_thru_2024.csv\"\n",
    "CSV_PATH = BASE_DIR / CSV_FILENAME\n",
    "print(f\"[Using] {CSV_PATH}\")\n",
    "\n",
    "if not CSV_PATH.exists():\n",
    "    raise FileNotFoundError(f\"The specified file was not found: {CSV_PATH}\")\n",
    "\n",
    "\n",
    "# -----------------------------\n",
    "# Load + basic clean\n",
    "# -----------------------------\n",
    "df = pd.read_csv(CSV_PATH, low_memory=False)\n",
    "df.columns = [c.lower() for c in df.columns]\n",
    "\n",
    "# created_dt\n",
    "if \"created_dt\" in df.columns:\n",
    "    df[\"created_dt\"] = pd.to_datetime(df[\"created_dt\"], errors=\"coerce\")\n",
    "elif \"created_utc\" in df.columns:\n",
    "    df[\"created_dt\"] = pd.to_datetime(pd.to_numeric(df[\"created_utc\"], errors=\"coerce\"), unit=\"s\", errors=\"coerce\")\n",
    "else:\n",
    "    df[\"created_dt\"] = pd.NaT\n",
    "\n",
    "df = df.dropna(subset=[\"created_dt\"]).copy()\n",
    "\n",
    "# subreddit (normalize)\n",
    "if \"subreddit\" not in df.columns:\n",
    "    df[\"subreddit\"] = \"unknown\"\n",
    "df[\"subreddit\"] = df[\"subreddit\"].astype(str).str.strip().str.title()  # e.g., Biohackers ‚Üí \"Biohackers\"\n",
    "\n",
    "# text fields + doc\n",
    "for col in [\"title\", \"text\"]:\n",
    "    if col not in df.columns:\n",
    "        df[col] = \"\"\n",
    "df[\"title\"] = df[\"title\"].fillna(\"\").astype(str).str.strip()\n",
    "df[\"text\"]  = df[\"text\"].fillna(\"\").astype(str).str.strip()\n",
    "if \"doc\" not in df.columns:\n",
    "    df[\"doc\"] = (df[\"title\"] + \". \" + df[\"text\"]).str.strip()\n",
    "\n",
    "# lengths\n",
    "df[\"text_len\"]  = df[\"text\"].str.len()\n",
    "df[\"title_len\"] = df[\"title\"].str.len()\n",
    "\n",
    "# numeric metrics (avoid blank plots)\n",
    "def to_num(series):\n",
    "    s = pd.to_numeric(series, errors=\"coerce\")\n",
    "    return s.replace([np.inf, -np.inf], np.nan)\n",
    "\n",
    "for col in [\"score\", \"num_comments\", \"text_len\", \"title_len\"]:\n",
    "    if col not in df.columns:\n",
    "        df[col] = np.nan\n",
    "    df[col] = to_num(df[col])\n",
    "\n",
    "# calendar helpers\n",
    "df[\"year\"]  = df[\"created_dt\"].dt.year\n",
    "df[\"month\"] = df[\"created_dt\"].dt.to_period(\"M\")\n",
    "\n",
    "# -----------------------------\n",
    "# Summaries\n",
    "# -----------------------------\n",
    "print(\"=== DATA SUMMARY (BLP) ===\")\n",
    "print(f\"Rows: {len(df):,}\")\n",
    "print(f\"Date range: {df['created_dt'].min()} ‚Üí {df['created_dt'].max()}\")\n",
    "if \"author\" in df.columns:\n",
    "    print(f\"Unique authors: {df['author'].nunique(dropna=True):,}\")\n",
    "print(\"\\nPosts per subreddit:\")\n",
    "print(df[\"subreddit\"].value_counts())\n",
    "\n",
    "print(\"\\nCentral tendency:\")\n",
    "print(f\"Score  ‚Äî median: {df['score'].median()} | mean: {df['score'].mean():.2f}\")\n",
    "print(f\"Comments ‚Äî median: {df['num_comments'].median()} | mean: {df['num_comments'].mean():.2f}\")\n",
    "# Fixed error by casting to int *after* ensuring median is not NaN\n",
    "median_text_len = df['text_len'].median()\n",
    "median_title_len = df['title_len'].median()\n",
    "print(f\"Text length ‚Äî median: {int(median_text_len) if pd.notna(median_text_len) else 'NaN'} | Title length ‚Äî median: {int(median_title_len) if pd.notna(median_title_len) else 'NaN'}\")\n",
    "\n",
    "print(\"\\nPosts per year:\")\n",
    "print(df[\"year\"].value_counts().sort_index())\n",
    "\n",
    "if \"author\" in df.columns:\n",
    "    print(\"\\n=== TOP 10 AUTHORS (all subs combined) ===\")\n",
    "    print(df[\"author\"].value_counts().head(10))\n",
    "\n",
    "print(\"\\n=== TOP 5 POSTS BY SCORE (all subs) ===\")\n",
    "print(df.sort_values(\"score\", ascending=False).head(5)[[\"subreddit\",\"title\",\"score\",\"num_comments\",\"created_dt\"]].to_string(index=False))\n",
    "\n",
    "# -----------------------------\n",
    "# Monthly trends (robust resample)\n",
    "# -----------------------------\n",
    "g = df.set_index(\"created_dt\").sort_index()\n",
    "\n",
    "monthly_posts   = g.resample(\"MS\").size()\n",
    "monthly_score   = g[\"score\"].resample(\"MS\").mean()\n",
    "monthly_c_sum   = g[\"num_comments\"].resample(\"MS\").sum()\n",
    "monthly_c_mean  = g[\"num_comments\"].resample(\"MS\").mean()\n",
    "\n",
    "# Per-subreddit monthly counts\n",
    "monthly_by_sub = g.groupby(\"subreddit\").resample(\"MS\").size().unstack(0).fillna(0)\n",
    "monthly_share  = monthly_by_sub.div(monthly_by_sub.sum(axis=1), axis=0)  # proportion per month\n",
    "\n",
    "# -----------------------------\n",
    "# Plot style\n",
    "# -----------------------------\n",
    "sns.set(style=\"whitegrid\", context=\"talk\")\n",
    "\n",
    "# Re-defined lineplot for subplots\n",
    "def plot_line_on_ax(ax, s, title, ylabel):\n",
    "    s = s.dropna()\n",
    "    if s.empty:\n",
    "        ax.set_title(f\"[warn] No data for: {title}\")\n",
    "        return\n",
    "    s.plot(ax=ax)\n",
    "    ax.set_title(title, fontsize=12)\n",
    "    ax.set_xlabel(\"Month\", fontsize=10)\n",
    "    ax.set_ylabel(ylabel, fontsize=10)\n",
    "    ax.tick_params(axis='x', labelsize=8)\n",
    "    ax.tick_params(axis='y', labelsize=8)\n",
    "\n",
    "\n",
    "# Re-defined histplot for subplots\n",
    "def plot_hist_on_ax(ax, series, title, xlabel, bins=60, logy=True):\n",
    "    s = pd.to_numeric(series, errors=\"coerce\").dropna()\n",
    "    if s.empty:\n",
    "        ax.set_title(f\"[warn] No numeric data for: {title}\")\n",
    "        return\n",
    "    sns.histplot(s, bins=bins, ax=ax)\n",
    "    if logy:\n",
    "        ax.set_yscale(\"log\")\n",
    "    ax.set_title(title, fontsize=12)\n",
    "    ax.set_xlabel(xlabel, fontsize=10)\n",
    "    ax.set_ylabel(\"Count\", fontsize=10)\n",
    "    ax.tick_params(axis='x', labelsize=8)\n",
    "    ax.tick_params(axis='y', labelsize=8)\n",
    "\n",
    "\n",
    "# Re-defined scatter for subplots\n",
    "def plot_scatter_on_ax(ax, x, y, title):\n",
    "    d = df[[x, y]].apply(pd.to_numeric, errors=\"coerce\").dropna()\n",
    "    if d.empty:\n",
    "        ax.set_title(f\"[warn] No data for: {title}\")\n",
    "        return\n",
    "    sns.scatterplot(data=d.sample(min(len(d), 5000), random_state=42), x=x, y=y, alpha=0.3, s=12, ax=ax)\n",
    "    ax.set_title(title, fontsize=12)\n",
    "    ax.set_xlabel(x, fontsize=10)\n",
    "    ax.set_ylabel(y, fontsize=10)\n",
    "    ax.tick_params(axis='x', labelsize=8)\n",
    "    ax.tick_params(axis='y', labelsize=8)\n",
    "\n",
    "\n",
    "# --- NEW: COMBINED MONTHLY TRENDS (2x2 Grid) ---\n",
    "print(\"\\n=== Monthly Trends (Overall BLP) ===\")\n",
    "fig, axes = plt.subplots(2, 2, figsize=(18, 12))\n",
    "fig.suptitle(\"BLP ‚Äî Overall Monthly Trends\", fontsize=16)\n",
    "\n",
    "plot_line_on_ax(axes[0, 0], monthly_posts,  \"Post Volume Over Time\", \"# of Posts\")\n",
    "plot_line_on_ax(axes[0, 1], monthly_score,  \"Average Score Over Time\", \"Avg Score\")\n",
    "plot_line_on_ax(axes[1, 0], monthly_c_sum,  \"Total Comment Volume Over Time\", \"Total # Comments\")\n",
    "plot_line_on_ax(axes[1, 1], monthly_c_mean, \"Engagement (Avg Comments/Post)\", \"Avg # Comments/Post\")\n",
    "\n",
    "plt.tight_layout(rect=[0, 0.03, 1, 0.95]) # Adjust layout to prevent title overlap\n",
    "plt.show()\n",
    "\n",
    "\n",
    "# Per-subreddit plots (keeping these separate for clarity, as they are already multi-line)\n",
    "print(\"\\n=== Monthly Trends (Per Subreddit) ===\")\n",
    "plt.figure(figsize=(14,6))\n",
    "for col in monthly_by_sub.columns:\n",
    "    plt.plot(monthly_by_sub.index, monthly_by_sub[col], label=col)\n",
    "plt.title(\"BLP ‚Äî Monthly Posts by Subreddit\")\n",
    "plt.xlabel(\"Month\")\n",
    "plt.ylabel(\"# of Posts\")\n",
    "plt.legend(title=\"Subreddit\", ncols=3, frameon=True)\n",
    "plt.tight_layout()\n",
    "plt.show()\n",
    "\n",
    "plt.figure(figsize=(14,6))\n",
    "plt.stackplot(monthly_share.index, monthly_share.T.values, labels=monthly_share.columns)\n",
    "plt.title(\"BLP ‚Äî Monthly Share of Posts by Subreddit\")\n",
    "plt.xlabel(\"Month\")\n",
    "plt.ylabel(\"Share of Posts\")\n",
    "plt.legend(title=\"Subreddit\", loc=\"upper left\", ncols=3)\n",
    "plt.tight_layout()\n",
    "plt.show()\n",
    "\n",
    "\n",
    "# --- NEW: COMBINED DISTRIBUTIONS (2x2 Grid) ---\n",
    "print(\"\\n=== Distributions (Overall BLP) ===\")\n",
    "fig, axes = plt.subplots(2, 2, figsize=(18, 12))\n",
    "fig.suptitle(\"BLP ‚Äî Overall Distributions\", fontsize=16)\n",
    "\n",
    "plot_hist_on_ax(axes[0, 0], df[\"score\"],        \"Distribution of Post Scores (log-y)\", \"Score\")\n",
    "plot_hist_on_ax(axes[0, 1], df[\"num_comments\"], \"Distribution of Comment Counts (log-y)\", \"# Comments\", bins=60)\n",
    "plot_hist_on_ax(axes[1, 0], df[\"text_len\"],     \"Distribution of Text Length (log-y)\", \"Text Length (# chars)\", bins=80)\n",
    "axes[1, 1].axis('off') # Turn off the unused subplot if only 3 plots\n",
    "\n",
    "plt.tight_layout(rect=[0, 0.03, 1, 0.95])\n",
    "plt.show()\n",
    "\n",
    "\n",
    "# Faceted distributions by subreddit (keeping these as is, as they are already grids)\n",
    "print(\"\\n=== Distributions (Per Subreddit) ===\")\n",
    "for col, label in [(\"score\", \"Score\"), (\"num_comments\", \"# Comments\")]:\n",
    "    dsub = df[[\"subreddit\", col]].copy()\n",
    "    dsub[col] = pd.to_numeric(dsub[col], errors=\"coerce\")\n",
    "    dsub = dsub.dropna()\n",
    "    if dsub.empty: continue\n",
    "    g = sns.FacetGrid(dsub, col=\"subreddit\", col_wrap=3, sharex=False, sharey=False, height=3.5)\n",
    "    g.map_dataframe(sns.histplot, x=col, bins=50)\n",
    "    for ax in g.axes.flatten(): ax.set_yscale(\"log\")\n",
    "    g.set_titles(col_template=\"{col_name}\")\n",
    "    g.set_axis_labels(label, \"Count (log-y)\")\n",
    "    plt.subplots_adjust(top=0.85)\n",
    "    g.fig.suptitle(f\"BLP ‚Äî {label} Distribution by Subreddit (log-y)\")\n",
    "    plt.show()\n",
    "\n",
    "\n",
    "# --- NEW: CORRELATIONS + SCATTER DIAGNOSTICS (2x2 Grid) ---\n",
    "print(\"\\n=== Correlations & Scatter Diagnostics ===\")\n",
    "fig, axes = plt.subplots(2, 2, figsize=(18, 14))\n",
    "fig.suptitle(\"BLP ‚Äî Correlations and Scatter Diagnostics\", fontsize=16)\n",
    "\n",
    "# Correlation Heatmap\n",
    "num_cols = [\"score\", \"num_comments\", \"text_len\", \"title_len\"]\n",
    "corr = df[num_cols].corr(numeric_only=True)\n",
    "sns.heatmap(corr, annot=True, cmap=\"coolwarm\", fmt=\".2f\", square=True, vmin=-1, vmax=1, ax=axes[0,0])\n",
    "axes[0,0].set_title(\"Correlation Matrix\", fontsize=12)\n",
    "axes[0,0].tick_params(axis='x', labelsize=8)\n",
    "axes[0,0].tick_params(axis='y', labelsize=8)\n",
    "\n",
    "\n",
    "# Scatter plots\n",
    "plot_scatter_on_ax(axes[0, 1], \"text_len\",  \"score\",        \"Text Length vs Score\")\n",
    "plot_scatter_on_ax(axes[1, 0], \"text_len\",  \"num_comments\", \"Text Length vs # Comments\")\n",
    "plot_scatter_on_ax(axes[1, 1], \"title_len\", \"score\",        \"Title Length vs Score\")\n",
    "\n",
    "plt.tight_layout(rect=[0, 0.03, 1, 0.95])\n",
    "plt.show()\n",
    "\n",
    "print(\"\\n=== CORRELATION MATRIX (BLP) ===\")\n",
    "print(corr.round(3))\n",
    "\n",
    "\n",
    "# Yearly heatmap (overall) + per-subreddit tables (keeping separate)\n",
    "print(\"\\n=== Activity Heatmap ===\")\n",
    "yr_mo = df.groupby([df[\"created_dt\"].dt.year.rename(\"year\"),\n",
    "                    df[\"created_dt\"].dt.month.rename(\"month\")]).size().unstack(fill_value=0)\n",
    "# Ensure columns 1..12\n",
    "for m in range(1,13):\n",
    "    if m not in yr_mo.columns: yr_mo[m] = 0\n",
    "yr_mo = yr_mo[sorted(yr_mo.columns)]\n",
    "\n",
    "plt.figure(figsize=(10,6))\n",
    "sns.heatmap(yr_mo, cmap=\"YlGnBu\", cbar_kws={'label': 'Post Count'})\n",
    "plt.title(\"BLP ‚Äî Posts by Year/Month\")\n",
    "plt.xlabel(\"Month\")\n",
    "plt.ylabel(\"Year\")\n",
    "plt.tight_layout()\n",
    "plt.show()\n",
    "\n",
    "print(\"\\nPer-subreddit Year/Month last 6 rows each:\")\n",
    "for sub in sorted(df[\"subreddit\"].unique()):\n",
    "    tmp = df.loc[df[\"subreddit\"] == sub].copy()\n",
    "    t = tmp.groupby([tmp[\"created_dt\"].dt.year.rename(\"year\"),\n",
    "                     tmp[\"created_dt\"].dt.month.rename(\"month\")]).size().unstack(fill_value=0)\n",
    "    for m in range(1,13):\n",
    "        if m not in t.columns: t[m] = 0\n",
    "    t = t[sorted(t.columns)]\n",
    "    print(f\"\\n[{sub}]\")\n",
    "    print(t.tail(6))\n",
    "\n",
    "print(\"\\nNOTE: '# of posts' counts posts only; comments are aggregates attached to posts.\")\n",
    "print(\"      Use 'num_comments' monthly sums/means for engagement trends.\")\n",
    "print(\"\\n=== DONE: BLP EDA ===\")"
   ],
   "id": "99b39b1653910d7a",
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[Using] /Users/michaelwalker/CU_Boulder_Masters_Ai/Introduction to Deep Learning/cu-boulder-ms-ai/Introduction-to-Machine-Learning/unsupervised/CSCA 5632 Unsupervised Algorithms in Machine Learning Final Project/data/combined_dedup/BLP_combined_2020-01-01_2025-11-02_dedup_thru_2024.csv\n",
      "=== DATA SUMMARY (BLP) ===\n",
      "Rows: 48,935\n",
      "Date range: 2020-01-01 00:05:35 ‚Üí 2024-12-31 23:30:03\n",
      "Unique authors: 19,420\n",
      "\n",
      "Posts per subreddit:\n",
      "subreddit\n",
      "Biohackers    29773\n",
      "Longevity     12343\n",
      "Peterattia     6819\n",
      "Name: count, dtype: int64\n",
      "\n",
      "Central tendency:\n",
      "Score  ‚Äî median: 1.0 | mean: 16.66\n",
      "Comments ‚Äî median: 1.0 | mean: 6.99\n",
      "Text length ‚Äî median: 187 | Title length ‚Äî median: 54\n",
      "\n",
      "Posts per year:\n",
      "year\n",
      "2020     5163\n",
      "2021     6164\n",
      "2022     6257\n",
      "2023    10483\n",
      "2024    20868\n",
      "Name: count, dtype: int64\n",
      "\n",
      "=== TOP 10 AUTHORS (all subs combined) ===\n",
      "author\n",
      "chromosomalcrossover    1124\n",
      "Sorin61                  948\n",
      "StoicOptom               614\n",
      "philnewman100            547\n",
      "shadesofaltruism         538\n",
      "[deleted]                480\n",
      "lunchboxultimate01       405\n",
      "bischofff                387\n",
      "RealJoshUniverse         323\n",
      "shrillthrill             314\n",
      "Name: count, dtype: int64\n",
      "\n",
      "=== TOP 5 POSTS BY SCORE (all subs) ===\n",
      " subreddit                                                                                title  score  num_comments          created_dt\n",
      " Longevity               This scientist treated her own cancer with viruses she grew in the lab   1748           102 2024-11-10 14:03:13\n",
      "Biohackers            Robert F. Kennedy Jr on \"putting an end to the chronic disease epidemic\".   1307          1384 2024-11-15 22:40:42\n",
      "Biohackers                              FDA may ban artificial red dye from beverages and candy   1279           195 2024-12-12 16:47:11\n",
      " Longevity A protein called Reelin keeps popping up in brains that resist aging and Alzheimer‚Äôs   1240            64 2024-08-03 10:40:39\n",
      "Biohackers            A Japanese research team has developed a drug that can regrow human teeth   1205           209 2024-12-13 23:35:34\n",
      "\n",
      "=== Monthly Trends (Overall BLP) ===\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/var/folders/mn/5t8x6ck57719dt2pg7h0_xl40000gn/T/ipykernel_45077/944953765.py:114: FutureWarning: DataFrameGroupBy.resample operated on the grouping columns. This behavior is deprecated, and in a future version of pandas the grouping columns will be excluded from the operation. Either pass `include_groups=False` to exclude the groupings or explicitly select the grouping columns after groupby to silence this warning.\n",
      "  monthly_by_sub = g.groupby(\"subreddit\").resample(\"MS\").size().unstack(0).fillna(0)\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "<Figure size 1800x1200 with 4 Axes>"
      ],
      "image/png": "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"
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "=== Monthly Trends (Per Subreddit) ===\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "<Figure size 1400x600 with 1 Axes>"
      ],
      "image/png": "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"
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/plain": [
       "<Figure size 1400x600 with 1 Axes>"
      ],
      "image/png": "iVBORw0KGgoAAAANSUhEUgAABVYAAAI2CAYAAAC7atPGAAAAOXRFWHRTb2Z0d2FyZQBNYXRwbG90bGliIHZlcnNpb24zLjguNCwgaHR0cHM6Ly9tYXRwbG90bGliLm9yZy8fJSN1AAAACXBIWXMAAA9hAAAPYQGoP6dpAAEAAElEQVR4nOzdB3hTZRsG4KdpmrbpbqGDvffeS4YIKsMBojhQcW9RwYW4B4j+ghMHLtyAG5S9l+y9N6V075X5X+9XTkhLW9rS0qR97usKTTNPTs5JyXPe7/087Ha7HURERERERERERERUYrqS35SIiIiIiIiIiIiIGKwSERERERERERERlQErVomIiIiIiIiIiIhKicEqERERERERERERUSkxWCUiIiIiIiIiIiIqJQarRERERERERERERKXEYJWIiIiIiIiIiIiolBisEhEREREREREREZUSg1UiIiIiIiIiIiKiUtKX9g5ERERUNqdOncLAgQMLvc7DwwNBQUGIiopC3759ceeddyI0NPS82/3666947rnn1Pn9+/eX+Lmd71fYcxsMBgQHB6N58+YYOnQohg8fDk9PT7iDDRs24Pbbb3f8/uyzz2Ls2LEXvN+rr76K77//Xp3v1KkTfvzxR1S2gwcPomnTpvkuk/dEfPXVV+jVq1eJH6us9ysLk8mktrHFixer7TI5ORlGoxHh4eHo3r07rrvuOrRt27bYfWLhwoWoX79+hS6nO1qxYgU+/vhjHDhwQP1eu3Zt/PXXX2q/Lcrll1+O6OjoQq/T6/Xw9fVVnzXy3txxxx2oW7cuKpPdbseRI0fQuHHjCnsO+Vz47bff1GfbO++8g8p28uRJ/PTTT1i7di1Onz6NzMxM9RncsGFDXHbZZbjpppvU34Sq+vpL87m+e/dutd1ezP0++OADfPjhh0V+1hf22UtERFQSDFaJiIgqQbNmzeDv7+/43Wq1IjU1VX2527t3L3755Rd88803jnCsPMkXy4KhhgRjEsSsXLlSnX7//XfMmDEDPj4+cDf//vvvBYNVWd8LFiyAqzh69Chef/11ZGVluUTAWxonTpzAPffcg+PHj6uwT0K6Vq1aITc3F8eOHVPbtATYN998M1588cViA0HKb8eOHXjggQdgs9lU6FanTh1ERESUeB1KeCqngtt+enq6CjIlrP35558xffp0FcZW1mt87bXXVKjuDoFfeZB1Lvu7fO5KyF2vXj31WSsHJDZu3Ij//vsPM2fOxNSpU9WBNqo4cXFxmDJlCjZt2qQOYhAREZUWg1UiIqJK8MILL6hqsYLki7VUFi1fvhyPPfYY/vnnH+h05du5p6jgTsKbb7/9Fm+99RbWrVuHTz75BE888QTciVQnbd++HTExMecFSs4kuEhISICr+Pvvv7F69erzQm9XJ8HQvffeq0JVqTx96aWXVPCnkXB19uzZePPNN/HDDz8gJCREbddUMhL+y34pgeq8efNKfaBj5MiRePTRR4usmHzkkUewb98+PPPMM+q5CquSr2iyXUi4Wl2qleWz9eWXX1bhuPyU90hGDGikelWq6ZctW6beuzlz5rCSshzceuutGDJkiAqyncnnrnz+On9uERERlQZ7rBIREbkQCZ4mT56svmhLtZ986btUJMCVFgRXXXWV+l2GqZrNZriTHj16qArcC1WjSmAtpLKSyk7Wo2yntWrVwrRp084LJ7y9vXHbbbfhoYcecrQlyMjI4CovITnQItq3b1/u1eNSWaxViKalpakqdap4n376qQrL77rrLlXF7RyqCm1fatKkCXJycvDZZ5/xbSkHctBAWk3I+iUiIipPDFaJiIhcMFzVer3JMOpLbdCgQepnSkqKCs3ciRYKSzuAolgsFtXPMzAwUPUypLLbuXOn+tmiRYvzAiJno0aNUj+l1YHWK5QuTAI4Udy6vRjyOdOgQQN1ftu2bXxLLuE+I2F5USREv+aaa9R5qeYlIiIi18VWAERERC5Iwj/h5+d3yZ87ICDAcV4mVHEnV1xxBV555RUVEp05cwaRkZGFDsWVSkAZguvl5VXs48ltZajy1q1bVdAsfXHbtGmDG2+8EYMHDy5y0qD58+cjMTERX3zxhWpNIIGiDOe++uqrcffddzve14ITmm3ZskX11ZUJipYuXXre48tl0q5h165dahuRqsNhw4apnrIXCt+kAlmG6kuvTqmELuy1SwsFeQ0yTFmGIl9oeKz2GPIaZZ3KQYHCyONIRaSsv6IeUyqNZXId6T8pE2DJMshEPjfccANGjx5daF9RaUHw3XffqQlrZAh1dna2eg5Zh7Je5D12noRNm9hGQi1peSEtOWRdyn1kgi0ZEq+Ribik17EEYdKTVF5bt27dVKVh69atUVrS21Qm+Przzz/V8HtZ1ho1aqBr166qUtz5MbWJdjSyXuQklixZoral8t7fC9vXpffv119/rSZYkm1DKpCl6k+GVMt7UlgVrWwLUpm8efNmJCUlqUnM5H2UffOWW25x9JYuOOmcTMglJ1nHs2bNUpdJxaZs73KgRJZFtnlZZ9IyQx6rc+fOZXrN8lhSFbp+/Xr1HBIuy/YiyyOvUSMTSMlnyZgxY9S2UhhpmSKPJQdpZH+/EG2fkf1LO4hVGHnu/v37IywsLN/lF5qEyXm9FjXBYUlfv5DXLq1TpHJW9hXplyzbinz2SG9ebcIxaa3y5ZdfqjY28hkoIyAaNWqkJkOUYfgFH9d5eWV7kceW/UzCftkfatasWex6LO39Cltvzj3MY2NjHb+XZmJIIiIiVqwSERG54GRAUqkqX0wro6LSuUq1uD6lrkhCoj59+qiQrqiqVQk9hXzhL45MqCNf1KW6VVoiSFWmhCKrVq1SvQ/HjRtXZKsE6SsqIYUEFxIkyjBUmSzoo48+UsGqVokoYYN80dfWs4RO8ruEtwXJzPAPPvigCq4k1JBwVqo///e//+G+++5zPGZRJDiRIEwC4qImafnjjz/U4/Tu3btEPQe17VNCZKlKldAlPj6+0Nu2bNlSLXdRAbAEV9JfWNaTBHGyriU0kT6Uzz///Hm3l+BTXpMEb9IvVIb4SpAjfV8ldJk0aRKefvrpQp9LAr877rhDTRQnQ66lF6xWuSnh3fjx4/Hwww+r9SSBrgQu8rjSi1Fep4S5pSHtDyRcktcoIZVsp/KYEghJ0CrhsQSYGtkeZDvQQjX5Kb/LqaiAqixkP5HPG+05nclySdWkBPIywY9MuCehpmx/EkrLepCDF85kX5HAU1pEyL4hr1G2fam6fPfdd1UYq7WCkHXg/BrldvK7PI+Q9S37n9xPgmg5SCLhmdxf3gdZn7KflZZ8tsr6lnYh4eHh6iCGPL60RZCh+TKJoEaCeSH9bbWDXQVpLRRGjBhRoueXzycxd+5ctT/LNiavtSA5ACLrT9Z5eSrN63cmkxm+//776nNH3gt5H7R9RkJ0+TyVCbdke5L9XPbH3bt3q4mh5EBUYZ8LEtbKfighs3zuyL4of3+eeuqpfAcWyut+Bcn2pr0G+bzR9jEiIqJSsRMREdElcfLkSXuzZs3Uaf369fmus1gs9qSkJPuSJUvsgwcPVrf53//+d95jzJ071/EYpVHS++Xm5jqe/5prrrG7A1mX2mszm8323377TZ2/6aabCn19Xbp0sffs2VOt8/fff1/ddvTo0fluN3PmTHV5q1at7N99953darU6rps/f769Q4cO6vrXXnst3/0GDBjgWJZnn33WnpaWpi632WzqcbTrFi1alO9+RS2H0O4jp8mTJ9szMzMdjzljxgzHdcuXLy/0fmvWrHFcNn78eHXZo48+Wui61N57eY0l9dRTT+VbxubNm9uHDh1qf+mll+x///23PTExsUT7RIsWLexffvml3WQyqevk58svv+y4/tChQ477paSk2Lt27aoul+fJyspyXCfrR94X7X4HDhwodFu54oor7GfOnFGXZ2Rk2HNyctT5d955R13ft29f+8qVKx33le3l22+/VduEvMbVq1eXeB3df//96jF79+6db9+X7XHatGmOZVqwYEG++z3zzDPqcvlZGtp2KNtVcebMmVPoNrlt2zb1OuXyF154wZ6enu64bs+ePY7t5Prrr1f7nJB9RF6fXP7555+r9aXZtWuXvUePHuq6Tz/9tNDXKNuRsx9++EFdLs8VHR3tuFzep1deeUVd17lzZ8f7diHa88hp0KBB9v379+d7vdqyT5gwwXG5vO727dury5cuXXreY27ZskVdJ9uivJclIa9Fey7t1K5dO/sdd9yh3i/ZPrR9oDDFfVYU3MYv9vWL2267zXG/zz77zHG5tl/LPtStWzfHtpKamuq4zfHjx+2jRo1S191yyy35HnfTpk2Ozwv5vNU+Y+X9dN5/tc/1i71fUetN+9t42WWXFbnOiYiIisOKVSIiokog1YxSjaSdZBIlmXhJKpik8kZmWpeKyEtBqtakck6Gvd9zzz3q+aVK78knn4Q7kiHHUhUpQ3hleKczGQIvE/VceeWV+YaIO5PqRRneK2QGe6mMk+phjQznf/3119V5aRMgw/kLkurWN9980zHMWtanPI5WjScVXqUlVaQyVF2GVmuPKZWqUt1Z0sfUKvCk0kvWgzNZX/LeS6Wcc3uCC5GKNKkU09obyPYkVXEy3Fa2IVluGU58oeWTKjppaaANlZaf8nq1oeObNm1y3FbOS0WkDPuVKlDnmb5l/Ujlq/Y4RfV0vf/++x1VubLsUgkqw5m1ylGpEHauGJftRV6HVFHKa5Sh1CUh61XWt5CKv+7duzuuk+308ccfV8O+hTaZVEWS9SYVvlJdqG3HHTt2zPeey3JKhaZUV0rltvYeaJXHMuRdqp+lIlGqObUqYK0qUSoUnfcvaXPwxBNPqH1Ttq+SkCpK0bdv33wTDsn7JO+vLJsMpZcK7NKQ5ZL9W9sXhbSGmDp1qjov7QhkKLuQ1y2fFVo1d0FaewapnC5pH1x5LXPmzFEtNzQyHF8+f6XaUv429OzZE6+++qpj8rLyVJrX70wqW+Xvg0YqjIVsR/IeyOuRbUV6V2vq1aun9iNZj7LPOlfKSwWsuP7661V7De0zVt5f2afl72Fhyno/IiKiisJglYiIqBLIl1pt2KGcOnTooIa5al/OJdyR0EP6MpY350BXThICdunSRQVGMoRalkGGX/fr1w/uSL7ESyBWWDuAkrQBkABAQke9Xq/C0MJIj0kJ5eT9kZ6CBUlvxMJ6gmr9CCXILq3CerrKc2gBiQRbFyKhngzTlaHH2rq4mJBIC2ok4JUWCRIMDh8+XA0x1shQXRn+LutSC0VK+vokvKtfv/55r09CQOl7K+0A5H0qLBzXAjzpZVqYwvpzrly5Uq0bGVpcVB/Va6+9Vv2U4e3SAuFCtFC1Xbt2RQ4zloBI6xlbnpN7SVBXcH+XNhMScL799tuq96+EqhKkaturXCafA8K5B6oz2YbkMbSer0J60AYFBanz0kpB3h/n9hQStkorDPlZEtoQbQkh5QCG8/sv26cEetKSoCQtK5xJaKnthwUvl961ssyyLRc8GCH9jZ33W9lOpOVBadoAaGQovYSbMhxfDkpIGOjcr1aeR9pqyEEcLWAuL6V9/RrZTgr7TJN9UGiTbRUkrQzk4IrzviD7pLRJ0QLSwkjbiILKej8iIqKKxMmriIiIKoFU1jhXrjl/WZeASyp/pI+jBHcScpanguGOVPxIxZ9U/0noctVVV503YYq7kUBCAh8JVqUXnxa2STgioUZxk95Ij08hgZ5zpZ4zCRikylgqYmUimIKcg0VnWnhSlsC8qABJq2CVqrcLkeWWQEKCNKnA00KIiwmJNFL1KaGqnLSQUKrwpO/mmjVrVND93nvvqfUmVYglfX1aJWxhr0/WpwRPcpIqTOnveOjQIVUxq/W/lectTGGT3Mj9hPQOlX6ThXF+PNlWLrSvaNtTcRNeSYgo25r0rZTtybma8GJI39SCvVOlklcqqaUfba9evVSg5kzWo7buCuv1q5HrpNeptv1LwC6BqvS2lcpEOUnQKp9zEqzJwYbCJpMrivRwlVBV3k+ZkE4qOKVaVpZXDpzIpF+FheoXIttfUSR4lgr0w4cPOy6T55HKS9m25PNElkvI54scgJH3qrj1VBx53+WghJxkH5SwXvYV2TelalQqVmUUgwSwpTnYUZ6vv7j9RSax0qpbpTJV+h0XRruNti/IRHNaX1k5oFgYea8LKuv9iIiIKhKDVSIiIhciX55lWLAMqZVZjGVWchmyXJ6TSBU2k3RZyDLKUPmKJF/mJQQsLRmWKkNDpWpOwk8J7STokSBA1m9hlVca58l1iqOFroXNpn6hEKSosK845TVpkQSnUsm4ZcsWFaJJ9aEEzjJpjQQrZZnxvjASTMtJwlupWJWASNatVB8WFqyW9vXJ+/nGG2+oALdgqC0HB6T6tKiJeERhM9prFYmynLJ+LqRgO4WL2Z4kQJbbFrY9lZVUW8pEa6WhLe+Flrmw7V+qUeU9l9na165dq9a/BOtykn1OquAlJC1JwCqP//PPP6uZ5iXAlfd5z5496iTVqhJoS7uUklbAFgzqSxriy3LLPiOtHyTw1IJVbdIqraL1YslnhowckJNMnCaTdslrlzBRquILq+gui9K+/uL2T+dtpSSV1tr+5bxfFrU8zi0FNGW9HxERUUVisEpEROSCZKizBKtS2ShBQnkGq+VFKkBLEj5dDOnrVxbypVvCu0WLFqlqLxnSrA19l2H8F7pvSYbra6FacUGFK5JtSSoVpd+s9FN86KGHHP0jS1OtKv01n3vuOUd4Vlww2q1bN9UK4NNPPy20wre0ZDjwAw88oIYtSxsNqZKVykEZ4qxVkDr3Ry0prVer9NUsS6B/MduTdn1lb0/Ozy/LVFRFrhZyFVxeqVCVk4Rz0lZj48aNami5bC8SEMqBIgklizu44RyuysEbOUmwKi0K5CShubRhkOpYaflQmtBRWh1c6D0oGM5pVd7yeiTolFBe9h+p/i1qCHxh5ICG7HMy9F8C5qJIJe6ECRPUZ5ZUTxe2zxR1cKao1hcX8/qL4tzbWF5XSSutnfvsSjir9Wst+PelvO5HRERUkRisEhERuSDn0KEs1Y2XgvTj279/P1y5HYAEqzJ8VyZGklBHqunatm1b7P1kiLSQIEe+vBfWDkACPQm8hdYD1J1IlZ0EQ7J+pLeuDD8ubUgk4Yv2/suQfxnqXRxtKHFhYUhpff755+o9kIBKqvoKTkQmw4XLMvGPNhGY1hKgqOBq586dKqCWiYiKmgSt4PYkwWJRZOi1FnhV9vYkw94l2JPJq3bt2lVkr2W5znl5ZZ1LBbTsMzIZkoSPMsGUnGTiKpnkSiYzk7YNst1Ib+fiSHAqgaKsP9lmtApoqVCVKlk5WCLLIAcFShOsasPRC5LP2b1796rzBQNCqbCVdgYSEEtPUWm/IetH+syWZnuWbVYmiJP3WtrBaBOsFUZatEioLcGq83No25s2JL6guLi4cn/9xX0GSA9VmfRNWjYUdT95v+W1y/4i7SHkpxyIkRBUPkdlGymosH2wrPcjIiKqSJy8ioiIyAVpsydLwFrW/n3V3YABA1S4I+0ApFejBGIStl6I9F+VL/8SnMgEMoWRkEhaIcj7U5bKyKKC9EsVomuzs0s4Ie0mJKiQYLQ0IZG0EJAJbYQMW3YeFlyQhCpaD9cLBbAlIX0ghYRzhQWbUhGp9QmV97GkJESUx5PwScLmwsjEcmPGjFGTWF2oOlDbDoX0zyyqwlseUwvwpB1DZZLQUJtZvaiemRKgSvsIobV1kCpSqQbX+oUWJFXSGucew0Vt+3fffbeqctYmVXMmVbJSqVzwsUpCDihIe5CCJDCVEFOG5BcW2MnBGSEHI7QJu0rbj1gmzZPAVMLP4iZyExJUSiAp4as2+ZM2SZi2DxS2nmX5KuL1F0Xbn6UnuPNkZc5VsBKCX3fddfjmm2/UZfK5rAX2RbWmmT179nmXlfV+xZH3w5UPYBIRketjsEpERORC5MudDKvWvnTLkOSi+hHKLNnFnUrS/7Eqk4BIvoTLl33pj6gFGyUZ3irhkJDhvxKuOgcG0lrgxRdfVOelek6rcrwY2nBqCVxKEwSWlYQn2iRT06dPL/OkVdIKQNaX9FeU3pMSzhQMe6QaU9oNbN68WU3WI2HZxdKqQCXgdp5oRwJiCXhef/11x2UlmdTLufWE1kNTqiu18FDINiChjQznFvI6iprczJmEz1oYJEPaZSi7RtaVbGMSbounn366REPkK9ojjzyiqlYlhJPh9s6huVSc3nvvvWpdS7AtgZkWsErol5KSgmeeeUb91Mj9p0yZos5Lpa/zxEPati9D7J1JcC1kfUto60yG5GvtK4qqqC2KhOHS71ebUElIP9iJEyeq8xICFtb+QPo2y+uT7VhCd6nULO1zS6sKbTI9eV0y3F8CVGdyQEDC0bvuukt9FkhFuVRqarSJ96QVg0wGp31eyOuSAxwF11V5vf6iyGelfNbKepHXI397NPIccr1sC9Kv13nfl96/EhrLZ8bUqVMdnxvy+uUzSf4OFqas9yuKNvmfrM/iDg4REREVha0AiIiIKoEEPwVDGfmCLF9EZQiskEmEXn755SIfo+Bs3gVJ6KGFD9WVTGIkQagMHZYwp6RDXKVaTirCpCpKZiOXfrdSoSkVXdpQWwm9tTDiYmkzWcv7L8OaZQImee6KDNmkHcCsWbPUsGQJiQqbUOpCZMj3J598gmeffVZVecqkOxJUSEAp1WWyrrTqOHmNsh5LEkZeiDyPhEFSNSwBsQS2EhZL+wZ5PVJ5K4G3hIDynpXG888/r5Z52bJlKoCS90ImP5P3RguN5L2XiZNK6u2331Y9YaV6WoIrWT+yjDLUXcIcqZKVxytJ8H8pSBgsE4PJcHUJff/8808VCsq61fp9yr4k4aA2UZv8lGBL9h3pDSpVndJWQCoCpcJV7ish/OTJk/NN7qZt+1LNK/trkyZN1OPKepL3WIJCCXLlfZCTtHjQQkEJO7UgvKSkgliCUdnP5LkkaNQmQBs0aFCR76t2MEKqeKVKVkJCCZ9LS0Jneb+lSlnWq5ykTYa8NvkboK0r2felMvqpp57Kd39Z77Ic0tNU2mDIZ7wcfNNal8jyaweSyvP1F0XaM8jzSbsHmWRMPm/lcSXolLYH8prkM+Gzzz7LF9jK63jzzTfV/vbFF1+ogxayvcjrlyBWlqWw6tuy3q8oUiEu26gcKJDtT94HmRxNqwwmIiK6EAarRERElaCwGZSld5yELfLFV770Sr/Lsnxxp3NkXcqXegkqLjRplTMJNSTUli/pMov9tm3bVP9B+bItjynDgmU4fXmRoddSrSjVsRJGShWW9C3U+pJWBAm0JHyX8PFitjUJ+KWPrQQ80oNSHi8mJkYFFRKkyPqSwELCoAv1Iy0paY8hz/fRRx+psPLEiRMq+JKARYYmSygnPXUlfJGfEvyWNKSW/VDCYmld8Ouvv6o+nvLeS2WlTMoklb2yvrQhxCUhbRckxJZh7RKkyRBvCYUlsJV1IyFdq1at4EqkElX6EUsAKAGn9K6UfalTp04YNmyY2gcKTlgm60eCrq+++kpVMEqwJtuVBH8yvFyqMJ2rL7XnkVBe3k85mCGBnFQHy7Yi768cYJD3QiqTZduSvp7yWFLRKttUaQ8+yPJL1aOEgRLmSkgqBwhuuukmNUlVce+rvPdae4SyVHgLWV6p7JQDG/KapYJZgmJZv1KJKetK9ilZlqL6QUv1r4Tfc+fOVetOtn+5raxfablQXLB6Ma+/KFK5K9Xjsq3IZ4CE7/K4cgBB2hjIcsmBqYJkP5IDXhKQyiRnsl9IUCvLJxM4FhWQlvV+hZH7vfXWW2qfl/dBllt+MlglIqKS8rCzoQwRERFRtSOVZBKISIAroYhUmRFR0aQ1hFQxS4gpfZuJiIiI2GOViIiIqJqGRBKqSuUbQ1WiC9N64UpvZSIiIiLB8YVERERE1YQMG5bh2zJU95VXXlGXjR07trIXi8glybBwaT8QFBSk2jhI311pbyFD0YmIiIgEg1UiIiKiakJ6IP7888+O36VXpUzERETnk36jo0ePdsw8L5577jk1MRsRERGR+v8CVwMRERFR9dC6dWs1AZFMACST78gs7kRU9ERTMtmTTColkxy98cYbasIsIiIiIg0nryIiIiIiIiIiIiIqJVasEhEREREREREREZUSe6xWoJ07d8JsNqv+TDJRBBEREREREREREbmu3Nxc2Gw21Q6obdu2xd6WwWoFklDVbrerGUWzsrIq8qmIiIiIiIiIiIioHHO9C2GwWoGkUlVCVWl87+vri6pGQuPs7Gx1Xl6fvE4icj3cV4ncA/dVItfH/ZTI9XE/JXIPdhfOlGS5ZPkk17sQBqsVSIb/S6WqbCAtW7ZEVSOh8bZt29T55s2bw9PTs7IXiYgKwX2VyD1wXyVyfdxPiVwf91Mi92B14Uxp7969Ks8rSVtPTl5FREREREREREREVEoMVomIiIiIiIiIiIhKicEqERERERERERERUSkxWCUiIiIiIiIiIiIqJQarRERERERERERERKXEYJWIiIiIiIiIiIiolBisEhEREREREREREZWSvrR3oEvHbrerk6uy2Wz5znt4eFTq8hBR4bivErkH7quVQ/7/wv/DEBEREVFZMFh1IRKipqenIy0tDVlZWbBarXBlzqHvwYMH+aWEyEVxXyVyD9xXK4+npyeMRiMCAwMREBDA/9MQERERUYkwWHWhKpUzZ84gNTUV7kKqO3x8fBznicg1cV8lcg/cVyuPHMyWg9tyCg4ORkREBHQ6dswiIiIiouIxWHUREqhqoWpoaKiqlvD29nbpwFIqa6SyVkiVhysvK1F1xn2VyD1wX6289Z6bm6tC1aSkJKSkpKgDxyEhIZW0RERERETkLtwyWD127Biuu+46jBo1ChMnTizVfWNjY/Hxxx9j7dq1qkK0Ro0auPzyy/Hwww+rQLOyJCcnq5/h4eEICwuDu3wR0ao55CeDVSLXxH2VyD1wX608coBYTnq9HnFxcer/ZQxWiYiIiOhC3G6MU0JCAh566CFkZ2eX+r4nTpzAyJEj8dNPP6lKhAEDBqieWt99950KamNiYlCZlRJCensRERER0aWn/T9M/l/myhOIEhEREZFrcKtgde/evbjllltw+PDhMt3/mWeeQXx8PB599FH89ddfeP/997FgwQKMHj1aVbK++OKLqAzO/3GXoJeIiIiILj3n/4cxWCUiIiKiKhGsSu/RqVOn4sYbb8Tx48dRp06dUj/Gxo0bsWXLFjRq1EhVvDr/B/qFF15ArVq1sHLlShw6dKicl56IiIiIiIiIiIiqGrcIVr/99lt88cUXqgfqJ598oobtl9ayZcvUzyuuuOK8WV69vLwwcOBAdX7p0qXltNRERERERERERERUVblFsBoZGamG8cuwfZloqiwOHDigfjZv3rzQ65s0aaJ+7t+//yKWlIiIiIiIiIiIiKoDPdzAqFGjLvoxpIeqiIiIKPT6mjVrqp/Sg7W8SY8uq9Va5PU2m03dxsPDQ/10l55ezsvpLstMVB1xXyVyD9xXXec90P7vxv/fUEHO/6cv7v/3RFR5uJ8SuQerC/9NLc3/Ad0iWC0P2dnZ6qePj0+h12uXZ2VlVchzb9u27YK3k2WQ5y/YqsDVGQyGC4bHRHRhUjE/d+5cbNiwAXFxcWpW6pCQEDRt2hR9+/bFiBEjivwMK8l+KrT99M4778SmTZtw33334bHHHnP5t+f3339X/bDl4NiSJUsu+n4TJ07EH3/8gaFDh2LKlCnn3U/6bWsjGYgupYL7Kl1a2sFuWf9JSUlu938yujTq1avnmAeCiFwT91OiipWcnIz09PRye7ydO3fCXemr4yyvF/oPNZWcVNlKj9rSrGMiOt/777+vekjLZ5C/v7/6z6DsW1JFv3r1anX66quv8NFHH6F169YXvQq1sEB+avuwK3P+fCnN8hZ1v6Je/9GjR/H666+rg1w//vhjOSw5EbkT+QyW/9vo9Xo1monBKhEREdH5AgICsHv3bq6a6hSs+vn5qZ9SAVaYnJycfLcrT76+vkX2dtX+E3/w4EH1H3mj0eg2/4mXig5tvWmtDER6biZMVnMlLx2R+/j7j79UYCqfFRNfmYR+l/fPFwgeO3IUb7z8Onbv3IW77roL38/9CSGhIRf1nGarRf3MtuQiMSsFri7DlDeawGa3lWp5i7rf2Afvwagxo1WI7Xz5L7/NUSF2uw7t3GK9EFH5kv+TWWxWpOWm45edf8Ge918bIiIiIgIQ4huEq5r2h7e3Nzp06HBR60RGCGmVqm3btnWpYj0ZTaqNfL+QahOshoeHqzRdhtcWRrtcblfeJHAsbgOR67VQ0vm8u9HCVT+DL7IysxyBBhEV76vPv1Q/73rkXnS6rAvSzRmA07GJ4FqheGHKi3jw1vuQkpyCWbO+xe3333lRq9ViywtWcyw5SMlx/aGMWea8P2o2u71Uy1vU/fQBXggOyAunnS+X9SEkWHGH9UJE5ctus8NqsyI5OxV/Ri+Cxc6WDERERESa+sF1VLB6oZyrtOSxXClYLU0u5x6lkeVAqxiVvnmF0S4vrrKUimeKPwm7zQqdhw4R/jVRwxgCD7hnSEx0qaSnpSMm+rQ636J1iyJvFxQSjJ59e6nz+/fsu2TLR0RERERERETVvGK1f//+mDFjBhYtWoRHH300X/psNpsdk5rI7aiMrCaYYo/BK6wWdAZfBPkEwuBpQFxmgqr+IqLzSR8/zYY169G4edETJt167+249qbrEezUBuB/r03F4vmLMODKyzHh5WfPu8+ieQvx3uvvIDwyAl//NqvQxz2wZz9mff4N9u7coyrP6zWsj0FDB+PKa64+76jhndePQdyZWHw0awYW/PUvlv6zGBaLBXXq1cEb0ycjIChQ3S4mOga//jAbWzZsQUJ8vJqQp0Hjhhg4ZJB67KKORq5dvhp/zfkTRw8dUZ/NTZo3xU13jL7gplPa+xVcb7ExZzB2xO2O6/fs2I0hPQcXu96IiIiIiIioeqtywap8oT5x4oQ6r03+Ijp27Ih27dphx44dmDZtGsaNG6fCVenp8MYbbyAmJgYDBgxAs2bNKvkVuDs7zInR8PQPhad/CHy9fFA7MApxGQnIPjvElojO8TX6olW71irI+/6LWTgTHYNBw65UlxUMH0PDQtWpPG3ftA1zv5utAlUJPjMzM7F/9z51WrdiLV6c+kqhk0V9NPUDtcwSwuZk58DLy+AIVdcsX413Xp6ielpL75269euq2+zevkudVi5ajklTXlavveBjzvv1L3W+ZkRNRNSKVKHvC+OeR7tO7Yt8DWW9nzMvg0Gt8/jYOMTHxsPoZ1Tro7zXNxEREREREVUdVS5YjY2NxZAhQ9R5qUKtU6eO47rJkyfj1ltvVZWrCxcuRNOmTbF3714VxMrtXn311Upc8qrFmpEEmykbXiFR0Os8ERUQjqTsFKTkpFX2ohFdNE8PT3jqPNW2rX56nDsvJ42Eleon7PJP3s8Cv8slzz//HO676z41E71UUcrJz98P7Tt0QLuO7dGhSwc0a9kcdg/p/WdT/f+0x7pY+3btRbNWzfHc6y8gIipCXfbfmg2Y8uJb2LxhE3766geMue+O8+4noeozrz2PflfkVfmnpuT1Iz1y8DDefuktWMwWjL7zFtx0x83w9vFW1x3efwhvTXoD2zZtxYdT38eEl55xPN6yBUtUOKr38sITE59SlaQiIz0D70+ehtVLVxa6/GW9X0ESoL7z6Xv47otv8cPM71SoKr8TERERERERobr3WBWNGzfG3LlzMWLECKSnp2PZsmWqavX222/HL7/8UiETV1VndlM2THHHYbOY1HoOM4Yg0r+m6sFKrstbb1Az/YX4BCHA2x9GL18YPL3gWQ3eN3mN8lqNXj4I8PZDsE8QahhD1XZbOzAS9YJqo1FIPTQIqYO6QVHqgEG4XxhCjcEI9AmAn8EIH7234yQV23KSdWg0+Krr5eRv8IO/t59av4He/ujasStmz56Nzp07O5YlMyMTa1evwYwPPsYDd9yHUVePwOyZPyHcOxSNQuuhYXBd1AuqpR5beOu9EeobjCCfAPX48rzyWnQXaLrtH+CPV955zRGqim69u+O+x+9X5/+c/TtyCpkNsXWHNo5QVQQFB6mfUnVrNpkxfNS1aoItLVQV0uZg4psvQuepw/IFS3Hi6HF4eXqp5f3lm5/VbUbfcbMjHNWWb8LLz6hWA4X56esf1U8Z9l+a+xERERERERFVy4pV6ZEqp8JI5en+/fuLvG/t2rXx1ltvVeDSUT52K8zxJ6APioDO11+FSrU9vRCbEQ+T1Wnac6pUEgL6G4wwehnh5Vn0x4LNnlctKT1zrfazP23OPy1qBmWtUtPVSKjvpdOr1+il81I/9bq8k6dOV+LQ3/H65KfdBrvNBkgVqdUCu9qu5XoPmUrQ8VPFm47f1S9nf8+7vGHdWvjuq5nYu38flixdjrXr1mPXrl0wWyzqJomJiarafv78+Zg1axYiIyOhg85RISuvSwLxgiQYFlJRK2Gw2WqFyWpy3O+yy/upibEKuvyqgZjxv49VwLt7+2507tEl3/Wt27U57z5mkwmb1m/Mu/+VA8+7XtZCyxYtVMuVfXv34eDmfRjQuS9OnjyJ40ePqduMvfkORARFwmwzw2y15P30suDqa4bg8w8/y/d40sf15LG81i9XDBl83vNJC4PBw6/Clx99cf6bSBVOemzLwYrCKrXzfs/bh5yuzf973gXlVJtNRERERERU/twyWCX3Y0mNhc6UBX1QuKqik+q/+MwkZJgyK3vRqiWJ83y8fODvZYTRYFShm3NoKAGhpBoeOh0gYaMEgx4eKniUakOpMiyOGq5ut+QPXu3Ws8GsTf10Pl+e0YkKT7XgtECI6jxMv9jQVAtM7TbAaoXdJoGpBXaLCXaLGXazSWJmVIQmNQPQ5KbhuP+m4cjOycG2XXux5r/N+HvRMiQlp6jWJY8+9AC+//xjeHjqYTPn5i23zZp33kN39n3LC3G1EFjePwm6DJ6AH/KqkEX3jl1RJzBKha1ysCPvZAIMBtSuVxtHDh5R4WXBYDW0xvm9R6NPRqtqVfHROx/A4OUFD9lm1Clv+xGxZ2LVz6NHj6rlO3L4kPrdz8/P0b5FBfxOm1nPTj3wOT5T76FUEJttFuyO2amuMxqN+SpunTVq1vhi3xIqIQnOpVLa72yFthywKC/qc8luV58jeZ8veZ8t1rMHe87/vWL2TyIiIiIiImcMVumSsWWnw2TKgSGsDnSenojwrwGfHG8kZiWzJukShR4yxF2qhmX4eMFeoFJpacvOgDUzVVUan08HDy8DPPRnT556dYLOM1+QJwGeVH96Ii/EKwmbCkokZM0LRM79nhegOP+unbRKU+fgVILUC4WndkeVqfVcWGqWwDTvJNe5Cl8fH/Ts0lGdHrl7DF6cMg3/Ll2JHbv3YveuHWjVrAnsWrCamwVzwsnzHsOaGp93vVR/piVA5+Wt3j8tcPX391ftH+SU7342K4ICzlbAWuzqeucqc4P3uSH+mtysvGURB/ceuODrS01KgOnMUSSePJz3er0NyI07AZ3BR5089F7wkADYQ4eAgAB1G9nKZBtW53PtjkC2YUjdvApXq1mFrvLTZDMjMDBvQi2qGHJQRrW68PJVoapz1XfeNqYdNCm+JYVGPj+Kulwd3IEcOLnw4+QLYR3Ba/5AVirsOXKCiIiIiIguBoNVurQk7Ig7Bq/QWtB5+6p+kBLYSGsAqWqk8iVVghJ4+EllqpcvdBKAOoepFglT0/PC1AtWYNpgN+eoU/FPqs8LXiWE9fQ6F8BKJaWEJmcrYDUqLJFh+Krlc/l8JOULTy1aeJoDmykHsOUNrXcVr737ITZs2Y5rrhqI+8aMLvJ2Pt7eeGn8o1iyai3MZguOnTylglVNUTW/UvWadwM7bJkpjnfZLusCQFpcNCzpSfCQIFO9X5JaSTjuqdoAiKgakaqqVWjVzVKVKO0jJNyWVhLS49UUnuV43i1btqjAU6p+1XtgzoE1OwN207nb5LEhODAvNM3MygasJtiy5ZR/oruMmKNnF9wGa3Y6PDwNCNLul5mpAr3CAuIzhmj1U8L+msZQFbZKACuVtFQ23p4GVZEqnyny3jvL+1yR9y8D1qzUMhyoONc+w3E6e8BGHcTR6x2fK3kHdbQDO/kP7shJ7yEHX4p/NjlIIyF87tlKbZMl7ycrXomIiIiIqCQYrFIlsMOcFA1P/1B4+oeoL+YS2sRmJiD7QqFdFaJVdqkgopyHwkvoJVV9hVWQSehhzUqDLUuCqwroXijD5k2WQgK0wngAKnjVAljPvGD2bGCCs4FJYYFs3guywS5D9a3mvPDUlAubOVv1O3UXOSYTTkSfxrLV64sNVoWf0Qijry9SzekIDcqrJvVUQShgOjsEv6C4xMRiH1OG41szkvJf6KFDjs1DXSeaNWmith0tsFLLYjAiwr9mvrvJMH5ZHqvViv07tqB143rqYEpBu/YdgMFgQJ3ICBiNvmhQt44jBD52MhoN6tY+7z6Hjx5XP6WfrSUlr5VAnYC8XgFZWVk4sHUDGjVpCg+pyNUCYg8dDh48mPeS4KEmGNNIKCwkHJTWAlK5KP1cy3P4epUc4u/lC71TH2atdYZNDlxkpsGWm3GRz3a2ytW52NXprF26cFzQ2ep62Q7OBrFaCKt+ap8lZ9tTyEEBOTlT1awqZJXQVdpkmFQgz46vRERERETkjN8gqdJImGPLzYZXaJSqjovyD0dSdipScqR6smqSiVy0WeElqNBo4ar8tDnOy5D3c5er6/Kdlx6gZ3+HPW+ov8EXvnqffMNp1fXmXFU9JtWprsWugjcVjKJ6GjZoAP5asAS79x/EH/8swrVXDyrytms3bkFqWrqq1GzXqoW6LCQob6j70ROnzru9BJzL12wo9vkXLFuFh8fepgJOB7sNs+f8BrPZjBqhIWgRGQDTmcOAp0FVAQubhEwyaZdsp+Zc2HIyYcjJQJf2bVQF7qzvvsPkFyac93ynYs7gjkcnqKrbV58Zh+uuHoTaURFo2awx9h44jF/+mIenH7kv332kFcTv/yw677Gc7/fznLmF3m/OTz+cfU129Xmjgnydp6MVgjoQYTDC7+x9pIpeq8qsFRCh2grkWnKRacqqVlWM8pnsV9wQf+npm5sFa2ZKXgsNl1LC6nr51JS2E95GFcjrpNr5bEW2ajVi0MMI33yv27kPsdaXmKMtiIiIiIiqLwarVKns5uy81gDSd9XLgDBjMHz0BsRlJqohmlWBBJ5+Bhk27adCisJ6CKpKwLOzxZewLWmxJPDKqyBLhS2XE4S5MumfekXf3li8cg1envo+9h06ittuuFaFhprcXBP+WboCUz/8XP3+6N23O4LQjm1bAz/OweFjx/H93D9xy4jhantKS0/HlA8/x6GzlZ5FiUtIxJMvvYm3Jo5HSHBeFez8Jcsx/bNv1Pn777gZXl5nZ5GSSa0kTJWz6UkwxR457/EeGnsbNm3bifmLlyMsJDhfaHvwyDGMf/ktFarWigjHkIH9Hfd7/N478cCESfjh178QFRGOW0deo1pESBXr5Pc/VVWuhSnp/SQQlkp5jQxVV5fLQYfsjLP9XPVqIiy1XuLi4OWhh6+3D+DtjxrGUFVRn2HOUiFrZX4+SZW/VNwavYyqt7CaAK7gwZd8B2oKuf7sbbTJ47TLZIIzOUBT5BD/HK0Pc1X4fLbDbsqG1ZSd/2KdXoWtOoPv2crXc61MzrWb8MvXj1iqWnPMuci25KggvroeKCIiIiIiqm4YrFLlkx53CSegDwqHzjdAVY/V9/JRIUamOQtZ8sXXDb/Ey0RREqZKf9N8vU0l9JTXlJ6kepzKcHc1RFUqwtR5bfi7rtCh8M7DWPP1H5SwSEKizNQSDsMnVzFl0gS88o4P/lq4FN/P/UOdoiJqIiwkBDm5uThx6jRMZjO8vPR4/N47cOO1Qxz3vaxHF3Rq1xpbduzGlA8+xTc//4rgoEAcO3FKVZw+NPZWfPzV90U+t4S60rd18I13olGDukhOScOZuLwJr26+fhhuunZoqV5Lx7at8NKEx/Dqux9i1uzfMfvPf9Cofl1kZmer1yEBnQSuM955HQbD2cAWQK+unTDu/rGY/tnXmPrR5/jyh9kqKD164qTqvTrwsp5Ysmrdec9X1vtpg8slLLSknHFc2jQyL1yOjo7G4EFXoGbNmvjxx5/UhHuqr6jBF3ZjKLLM2SpgzTRnV3jIKnt33lB8I4yqr23+wy+qmrRkc0OV7QCNtA7Judgh/m7EZlE9fgv2+fXwOlvdWkg/YqMur7pX3d1mQ44lL2SVv2MSulYF6vCfh0eVOehJRERERFQeGKySy7CkxkGXmwV9cPi54bkGI+xGu/qSmhdiZLn0sEupZJIwVZvUJ1+1lykHFhk2W7CC1CaTLJ2bUImVTtWPVIS+/tyTuPn64aoydeO2HYiLT8S+Q0fg6+ONBvXqqADx+iGD0bBeXj9SjYT2M6a+hm9/+Q3/LFmJk9GnVbVm987tce9tNyE4MLDYYHVQv94qqP302x+xZ/8h6HQe6NqxHW4beQ0G9OlZptcjw/vbtWqO7+b8gfWbt6mqWQlkJGDt27Mrbr9xhApXC7rr5hvQrmVzfPPLr9i194C6X+MG9XD7jdcjomaNIgLSst+vMN06tseTD9yFn377G7Fx8cjNyUHM3s2oGVUHnv7B0Hn5qIMf2ueThEyqktWUhSyzVLKWzx6sWntImKoqU31VeJfv88QqE89l5AWeKlh1OijjmMxJO+98YObs+bMTRDkq6M8epFGtHdQQ/1TYLbnl8lqqCjUBW8H2Ah6eedWtPlLh6pNX7arTOUJ4raJVBa3mHBW2SvsAdxPg7Y8w32C1vSRkJSGdIyGIiIiIiBQPu9Zojsrd3r171aQqMrS0ZcuWRd5Oqlv279+vzjdv3jxfdaMrk00nOztbvT7Ve056MJYTnbc/dH6BjhDDWV7Imq1CDFf4guql08PfW8JUPxhkkpSCE0XJcPwClU9E5L48vP3g6RekgjRVQX6WhKxZUmlvylSfUaWd6EjnIWGqb15lqpdv/kp39XkiYWp63lB8sGrQNXlA5+MHnY//2aBVJsvKX04sBwdzzoasErZKH19XJX/TpA2Gc09wkZ6boQLW8jqQ4ErsNjuyYtORZcrCv0lrsSeh8DYkRERERNVR/eA6mHrlxHJ5LKvVim3btqnzHTp0cEzM7E55nmDFKrkkmVlam13aQ6q1pFJMvqR66FTvPzmFIVgFq1ola+4lnEDF08NTVaVKoOrcizCvkkyGkabDmpHC8IOoCpKqc8vZij2dClmD8yZB8tDlfS6crWSVNibSkzWrmJBVVedLmGowFjpJlDo4I0Pxs+TgTNULsaoeu6oiPtc6wQM6X/+8oFXCSZ1OtXJQB+O88/q0mq0W5JwNWSVsdYVRGVIxHeIbhGCfQBUMq/68uVmqsll6z0oFq7feG3EZCVWm1YEm2DcQZl02gnwC8eKAxxGflYRVxzdg5bENOJOR1yaFiIiIiEjDYJXcYoIrS3Le5CIeegM8/UKg8/ZVlUBSTWPwDVJfAC1Wi+p3KEGrfEktjwhCQg6pIpOqNB084OXphQCDnwpAtCqkvBmybeqLtCUjWfXnI6LqQSaH0yaIk/BMKllVL04JWc+GZzIqIe+zKVNVtEolqiNM1Z/7LHGEqdIrOUsq3dMr8ZVR+bCr99HxXsrfEt+AvKpWL2/1u0xA5uXpr8JKIQcM89pLZKoRGpea/H2raQxVf+/UK7BaYE4+o1ohCJ0xEPrAmurvb63ASCRlJSM1t2psq6G+wQjyDkA8YtWEd7I/RvjXwA2th6rTgcSjWHlsPdae2KzeHyIiIiIiBqvkVtREM6mxeb/o9HmVrN5+atZmvaceQZ4BCPIJUD3tZHIZOUnAKqGoBB0SYOQLS+V3FHG5U+VYoctiO9uLMEMmoapaFTtEVHrOlYoSnnkaJWT1VkFqgLefOknIKp83+cJUbZKozDRHpT5VUdLDVkLzrFRHj1ZPY17Q6iGjHzw88g4Yenqpv2UyEiPdlIGM3MwKn8RRRmKEGYMdAa+EitbMFFjTE/PdTqqnTbnZMITVhs5Tjxp+ea0C4jMT3XKiSU2YMURV6Mo+KqGqKfYYTiz8H0L73AD/1r2h8w1Es7CG6nRnx1HYenoXVhzbgC0xu2DhAVUiIiKiaovBKrkvmwXWtARYkaCqfmQ4rgy5lNmaZaIX+XKofUG8GPnaEJ+tJpPKVLsp66Ifm4iqJucqRQlkPI2BjpDVEaaasvMmieJnSfVlt+aFl5kp5w4YGgNVMC8HDGVCRG99KMJ8Q1TLG+ltKlXPFTU5lfzt1FpQmJNiih6BYTXDFHcM+uBIFQpL9bXB04C4zIRKqbK9WDWMIWrov7Bmp6sqXWHLyUTiwpnq5FWzHkL7jYZvow7Qe3mja50O6iSh97qTm7Hy+AbsTzhSya+EiIiIiC41BqtUNdhtqnJUTqqnnTEQnr6B8NDLUEZ7XiCqAtK88zJ0X/0u1TV2qU6xATLsT3rbna1WyTtvybsNEVEZyeR1eRPY5U1sJKGNNqyaKP/GYjn3t0ynhz4wLG9Uhk769+ZNkig9WaWKNV16/V5kpWTByankb6ElLb7EbSgsKWdUCwx9cIRqaVArIALJ2alIzjlbkesGpO1BoE9AXh/Z7HRYUuMKvZ05/gRi57ytzhubdUVwrxHwjmqs2n0MatJXnaQH66pjG7Dy+H+IZT9WIiIiomqBwSpVQfb8Qy2JiFxoYiOiErFZYEmJPde/1z9E9RmXAFN6gcpJ2t1IFWtmMROklWZyKkvymVJPkibbtCkuB17SGkDvhVBjMHy8vBEnrQFcYCKu4tT0C0Ogt/8FQ9WCsg5sVCcJvwO7DkFQp8HQh0Qi0r8mRrUZpk77Ew6rCa/Wntyser8TERERUdXEYJWIiIjIHfr3StubgFB4+kirAE8YvXzVSQJMmUwpLTcTJqvpoianKtsCWmCOP64mtZIRI7JMdQKjEJ+ZUCGtC8pDuF8N1fdY9ZLNSoM1Lb70D2KzIG3Dn+okrzvkshvh30r6sQageY3G6iT9WDef3onvd/zOKlYiIiKiKojBKhEREZG7tL2R3uJpCfDw8oU+IBQeBh/VG1V6hMop15KLtNwMZJiyYHNqZVPSyakuhrQR8MjJhFdIJPQ6T0QFRCAlOxVJ2SmlrIOtOB5nQ1UZwp+3DlJhTU+46MeVSb0SF3yhTobw+gjpdzN8G7aDl5c3etTthHaRLfH5ph+w5sSmcnkdREREROQaGKwSERERuRm7ORvmpGgVFarJG2WCNDXhlTdq6r3VLPcyBF16seo99aWbnOpilsuUpSa2Uq0BvLwR7BsEHy8fxGYkXHRP2IslLRAi/GuoybZUqJqRfLY3e/kyxR1H7OzJ6rxfix6oMfQhGH388HjPu9EmogW+3vILci9QWUxERERE7iFvemIiIiIickNSdZmshuKb4k/CmpMBu90GnYdOVafWCoxAuF9YXqgqk1OlxsGccLJCQtVzi2RTz2HJSFYBpo/eG3UCI1Wg6TqhqjbhZcXK3Lcex9+7C9kn9qjnHdioN94a9CzqBtWq8OcmIiIioorHYJWIiIioKrCa1ARUpjNHYE6Jg81syqtQlSAxJxOm2KNqkqZLtjjpiTAnRsNus6pgVyZ3qmEMVSHnpSTPFxlQ81yomp6oqlUvGZsFMbMmIXHx1yrcrhMUhbcGPYOBjfpcumUgIiIiogrBYJWIiIioirFlp8GccAKmM0dV0GpJjlHVrZeaTIplij0OmylbhZpBPgGoHRgJw9nJsyqah4cHogLC1YRa8vwW6VGbmYLKkPbf3zj52ThYs1Jh8DTg/q63YlzPu9WEYkRERETknhisEhEREVVZMoFVZU8dZVOVq9b0JBVueusNKlyVkFUm1aoo0g4hyj9cBZd5oWo8bFmpqEyWxGgcf+8eZB7YpJapV70ueHvwRDQOrV+py0VEREREZcNglcqPh0fxJ6KqvH27+omI+w/3n0qmesEmnILdalWhp7QFqB9cG7UCIhDkHQC9zrN8Q9UAp1A1VULVNLgGG2Jnv4X4vz9W60J6v742cAKGNR94ydskEBEREdHF0V/k/akak+F1RqPRcd47snGxt889cxiwV3bVDFEZlGD7dnXc/6jScP8hJ3ZLLkxxx6APDofO2w8eOp0KP+VUA6HIseQi05SlTuYyTrClhaoyaZYKVaXfbM6l6y1bUhk7liLn2A5E3f4GvIJq4PYON6BNeAt89N83SM/NqOzFIyIiIqISYMUqERFRJZDAh6h6bmsSdsbCFHsEpoRTsGSlqwmuZDklDA0zhqBecG3UDohEiE9QqfqxenroVAXsuVA11iVDVY30fD354f1I37lCLW+nWm0w9cqJaB3erLIXjYiIiIhKgBWrbui2l/5BjskKd+Bj8MR3r1xd7o/7xz+LMGnKtEKv8/czIrxGGHp26YS7brkBNcNCHddt3LoDdz/xHJo3bojZMz+86Ocf0LsHpr8xCa7g46++x4xvfsCtI6/FM4/eV9mLU2Ude28s7OZcuAMPL280eOKrcn9cbfvv0r4tvpw+udwfv6oo6vPmTFw8/vfJl7jx2iHo0qEtqpN7fn8auRb32H+89d744rq3K2y7KIynVG/6+iAyvCa6d+qA22+8DlER4Rf1fKvWb8T3c//EjKmvwdVk5+Tgyy9nwdfHB3fdMgoeem94+gdD523EipWrMGvWLMycOROhCIbJYsLBY4cxYuh18PP3w+xFv533eJ46T9VTVXq4SkhpTj4De24m3EH8n+8jc98GRFz/BEJ9gzGp/+OYu/sfzN0zHza79MklIiIiIlfEYNUNSaia6ybBakULDQlGz84dHL/b7HZkZmbh4NFj+H7uH/h70VJ8+8FUNKxft1KXk6oOCVXdJVgl1/T4C69h74HDGHVN+R90cnUSquZaTZW9GC5BwsTL+/TId5nVZkNWVjZ27Nmv/ob9tXAJPv/fm2jZtGytSA4cOYaHn30ZtS4ynK0oH335Hb795Tc8cMctjjYBUmEqy33//Q+jVlQU7FYLoPOEQW9Qk11pQ/3DfIORYc5CriVve5L+rFEBEaq6VYWqSTGwm7LgTrIObMDxD+5DrdtfhyGsNka1GYrW4U3x/vqvkJSdUtmLR0RERESFYLBKbq1Rvbp464UJ511utVox9eMv8MPcP/HKux/g6/fzqo7atGyGP76ZAYPBUAlLS0TVSVGfNzYrq88ICAkKLPTvl8jKzsGjz72Mjdt24uWp0/HzZ++XaZXZrK59ENZaxL7gWG6bVfVjhU4PT/8QNRpl/vz58PT0RLBvkDqZrRZkmbNg9PKFlyNUPQ27KRvuSCbYOjXjMYQNvhuBXa5Gq/BmePvKifh4wzfYErOrshePiIiIiApgj1WqkuRL12N33w4vLz227NiNxOQUR4WQVK/Wjoqo7EUkoiqOnzdUVkZfHzz9SF5LF6luPnU6pnqvTJsF1rR42JOjUcffE3VqBMNmMasQ1ctTjyCfwHOhaqL7hqrOEhfORMz3r8BmzkWgtz+e7fsw7uhwA/Q61kQQERERuRL+74yqLKPRF4H+/ipUlaGVYSHBxfZYlS+uX/04F2s2bkFcQiL8jL5o3bwpRl8/DP17dS/yeQ4eOaZ6m27culP1i6tTKwojhg5SvU51uvzHLjKzsvDz7/OwbM16HD1xSi2XLKcsz4hhV2HoFf3Pe3x5zB9/+xv/Ll2JE6dOw9vghQb16uLWkcMxqF8feHh4FLseduzZhwcmTEJmVjaee/wBjL5umOM6ef7v5vyBBctX4WR0DDw9dWjWuBFuGH4Vhg0akO+xtXV3/ZDB6Ny+DT6cOQtJySmoUysSM6dNVut3/eZt+G7276oVQ0JSMoICAtC+dQu1LqpbL0nKz2w246ff52H+4uU4cvykCkDq1o7C4P59MOaG69R+4Kxd/6GoWysKc7/6CF9894va/qU3aWCAP3p366yGDhd2gEQOpHz54xzs2ncAWdnZaNaoIe4cPQI5Obl4/s131f0eGntrvvts3bkH3/7yK7bu2ov0jAzUCA1Bn25dcM9tN+brb3nHIxOwddcevPPysxjc/7LznnvxyjV48sU30b1TezV8u+DnTcHemtr5me+9hR9++wtLVq7F4/fegbtvvfG8x5bXc8sDT6BNi2b4YcZ73LyqgXp1ajnOy98x+dsiTp+Jw8wfZmPNf5sRn5gIf6MRHdq0Uj3F27du6bjPC2/9D38uWJJ3n9g4tU9JS4B/fz7XdzkpJRVf/zRX/U2KORMHb2+D2sZuu+FaXNaja6G9lR+5awz0Xnp88/OvyM7OQZNG9fHNB1PhpdeX6m+cLI9G/obKSfbP02dii1zu6JhYXH3zXQjw88Oaeb8AHjp4+gVD5+uPQ4eO4OsvPsWmrdsQm5CoKsPDQoPRpUM73H3LDWhUvx7cTc7xnTg27S7Uvu01eEc1wtDmA9GiZhNMWzcTsRnxlb14RERERMRglaoy+fKZnJqmhg7Wiiy+v9y6TVsx7oXXVYgpYc6A3t3VF9kNm7dh7cYtuGXkNXj20fvPu9/+w0dx64NPqslGOrZthZTUNGzbvRdTP/oCx0+dxgtPPOy4bWpaOu54dIIKlSS46dC6JfR6PQ4fO66Ge8opNi5eTeChSUxKxn3jX1DhrQRK3Tq1g8lkxsZtOzD+5d24c/RIPPnAXUW+rj37D+LBCS+qUHXSkw/jhuHnejrGJybhvqcm4vCxEwgJDkLXjm3VsEwJpia++a5aJ2889+R5we2Wnbvx+z+L0K5VczRtVB8ZGVkqVJ2/ZDmee/0ddXv5ci9fzuU9WLJqHZauXo+3X3wGVw44P4yiqi89IxP3j39BhYNGX1906dAGek+92pakx6KErZ+9+wYiatbIdz+T2Yx7nngeew4cUttbk4b1sWn7Tvzx72IVKv361ccIDgp03P63+QvxyjsfwGazqUBf9n3pVSlhp/xemFmzf8c7H3+hzrdq1gSd2rZW++Tsv/7BwhWr8fGUV9C2ZXN1/TVXXaGC1fmLVxQarP69cJn6ee1VVxT6XBLySLC0asMmpKVnoEfnDmrfkctHDr1SBasSKBUWrP42b6H6OWLo4FKseXJn8rmv0QL+Tdt34fHnX0V6Zibq1a6Fvj26qr9Vy9duwIp1/+GFJx5yfM53aNMSyampWLV+k6Ofq3zWa+SzX/ZLOZAo+16vbp3U3wr5WySf//eNGY1H7h5z3nL9vWgZjp+KRreO7dTvIUFBKlQt7d842Rdk35YAtmmjBmgmp8YNEF4jtNjlzsdugzUjCYsXzMf4l9+C2WxBi6aN1YGRjMxM7N53EH8tWKL2rV8+fz9fWO02TDmI/nICQvqORnCfkWgcWh/vXfUiTmfEITY9DjEZ8YhJj8OZjHicSY9TvVjtsFf2UhMRERFVG6xYpSpFquDki+Hu/Qfxzkefq4Bl/EP3qNYARZGKnadeelOFqo/dewfuuvkGR6WpfOl7+JmXVK9W+dI3YuiV+e4rlTVXDeiL1559QlX6CAkYn31tKub+9S8eu+cOFYiKz7/7WX3h7NerG/736kT1RVRbZqk+ev/zb/Dt7N/zBatvTPtEfbm+rEcXFUz6GY3q8kNHj2Ps48+oSqNB/Xo7gh9n+w8dwf1SqZqdjZcnPKYqTZ09/8Y76ov1NVcOxPPjHlJDT8WZuAQ89MyL+HvhUrRp0RS3jLgm3/2On4zG3beMwuP33al+l3UsPv7ye/VaPnn7VfTq2slx+zl//YNX3/0QH3/1HYPVauq1/32oQlUJeqa9PgmhZ0MSqWab+Na7Knx/+tW38c0H+Wdgj41PgF7viTkzP3BUmyWnpOK2h57CydMx+HXeAsf+IhXXb077RFVdv//GJPTt2c1RKfvm9E8w9+8F5y2XhFQSqgb4++H9N15Ep3atHddJJffbH36mQtm/vvsMPt7eavud8uGnWLVhI9LS0xEYkDeRjpDf5XKpdB/Yt1eh60Feg/TUHHX3IypYvfe2m9D1bDjVoG4dVZUnIdP23fvyBcE5ubn4Z+kKFTJdPbDfRb0X5B7k79Jb02eo81IBLQcJZBuTv1USqj4/7kHcdO1Qx4Ev2ZYfe/4VtQ+0btFMTXYlAasc4JKAsmA/V4vFiidffEOFqhLkPzz2NrWvaX9fZJTDZ7N+Un2CC47YOHbyFCY9+Yhj8jXtb0Bp/8bJ8kz54DO1zQ+8rFe+SvKilrswZosFr77zgQpVp0x6Ot8+IvvZA09Pwq69BzB33r944v6iD0S6uuSVPyHz4EZE3fIS9D5+qBdUS50KMllMOJOZoELWM47QNQ5n0uMZuhIRERFVAAar5Nakes15OGFBzz32AK66vG+xjzHnz3+QkZmlgph7ClSKSQXbxCceUuHKzO9nnxesStDx8tOPO0JVMWRgf0z79Gs1bFm+oGphjYQ3fbp3wZP33+X4winki7F8QZYvnTK0XkIUCXGkonTJqrXqOd6aON4Rqgqp3JMvpxJ+ypfSgsGqhLFSjSqVgq8+M06Fp84k5NqwZbsaSv3iU4/CYPByXBcZXgOvPP24qsSV1ggFg1Uhw0Q1WggtX9CFVPw6k3WWk2tSjytfsC/UuoCqFtkPFixbBYOXF955+TlHqCpkiPCbE8djyM13Y+vO3apa2jncFBL4OA/hlcq14Vdejo+/+l7tX5qffv8buSaTOjCiharCy8tLHTiQVh0nok/ne+yvfpyttslx948973llG5dq9dUbNmHeouUYOexK+PsZMbBPT8xbvBwLV6zBDcOuctx+wbLVKtiRFhqyz5aW7EfXDx2sKnj//HdxvmB10Yo16jPquqsH5fscIPcmIyqee31qvstk1EB8UhJ27tmvKralkvTlCY+r6+bOW6gOLAy5on++li6iS/s2uOe2mzDt06/w7c+/XjCMXLp6rfrb0bFNK9V+wpn8fZnw8L2Y8MpkfPXDnPOCVTl44HygTvsbUNq/ceUlMSkFPbt2gt7T87wDD3JgU/4mS7AqIyjcnSnmMI6/ezt86rWGT90WMEQ0gFdIFPQBodD5+AE6Txj0hhKFro4q14w4HEs5hUxTVqW8JiIiIiJ3x2CV3FpoSDB6du7g+F0Gv0nPN6lmk9BFKs5OxZxRVatFBXoyrF4MuaLwSrABvXuooEQeMyY2Ll/PRRlyqFV6OosKr6kCJQk2NffffnOhMz8fPX5S9UHVSDgjXzpluST0kWHTzpVxmrGjR6pTQVJNdO9TE9WX9lHXDDkvVBXS4kB0atcmX6iqkaBWAiypGDx2MhoN6tZ2XCeVU2GhIefdR1oJSIXR7Y+Mx7DBl6sv2PKlXR7fOYil6mXTtp1nt+O2atspKG+ob0819P6/rdvPCzilyrWgmmF5jyNV5pq1G7eqn9J3uCAJea7o20v1XtVYrVY1NFnIkPzC9O3ZVQWrslwSrGrD/CVY/Wfx8nzBqgyP1toFlJUEpzO+/kH1k5WJi7QDNmwDUDXJ9ivbkjMJB/39/NCqeRPVS1gC1KDAgHyf20Vtr/16dlPB6n9b8/6mFWfD5u3qZ7fO7Qu9/rLuXVRgKn+bZDmdDxbIsH2tutVZaf/GlRc5aPfm80+dd7kcnJSDjHLQRnveqiLnxG51Oo9OD586zUsduuZYcvHums+w/cyeS/ciiIiIiKoIBqvk1hrVq1tkZY5UZcowfumhKF+8xoy6vtDbyZcvUScqstDrpY1AVERNNcQxLiEpX7AaGOBX5H208MaZDLP/5c952Lx9t+pRJ9U7wjn0lRBKLVdC3nJFhhffH7Yg6T3pqdOpx5y3aJmq4Cs4yU9MXN6kF9J7Tk7FORMbly9Y1b7kF/TS+MdUZa98gZZJTeTk4+OthrFKFZG0TCg4mRdVfXFn96/aRexf6rpakfm2eWdaKw1nes+87chmO9dHUA56iKgi+ikXfP6UtHQ1oZWQitninIk9N0lMt07tERleE5t37Fb7s3y2yMGbbbv2qGrtzu3aoKykOrFPjy5YsfY/LFm9VlXaSYuDzTt2oXGDemqCIqo6Ck4kdSFysE68OGWaOhVF/qbJ8HjnqtGCtL8Bn37zozoVR/ZL596kRf0NKO3fuPImozBkgq19h46ofVLbv7XnrqjndSk2S+lDV19/+Oi9MaHPA5iy6mPsjD0XghMRERHRhTFYpSpLerTJcPl3P5mJX/78p8hgtSRftqxne8gVrO7UeZQ8KJThvM++/raqmqkZFoq2LZuhYb26arbkzu3bYvCN+YdjWix51TWlHTkvFU9vPP8U1m/epibzeWnqdHz+7hv5v9ieDaRaNmuswuniFAy2dEUskFQjfvfxu9i+ey+Wr/0PG7Zsw979h1RIJCfpcTlj6mvFftmnKqgE+5fWo9GrkOppoGQ7gLa/2AoczDi3GPmXw372OWV/udCkas5hrRwcGD74ctVPUvqeStX4/EXL1eNLi4KLNXLYVWp/+fPfJSpYlYni5LEL9kim6kc7kCCjAYIKOeBQcH8o7rNW2+c6t2+DyAKTxhXk5aUv0d+90v6NKy/yWp5+dQoWLl+t/s5JP/Qr+vZGw3p10Lp5UzXa5I33Pq6Q564SoatUsT70EQwBoXjmsgfx1sqPsTtuf2UtJREREZHbYcJBVZpUeRWsOCuoZo0w1WtOKlzatTp/5nCp/NHuLzN4l4UMh3z57enqC6f0fR19/bB8QafMplxQjbDQvGWPSyiyKmnF2g2qH55zJZsEMFIhKsNIV63fiP+2bMfsP//BjdcOOe+x5TYywVZ5at+6pToBd6i+kNIndvL7M7Bx6w41M/OFet5S1SL7l4iOOVPkbaQq82L2LyFVpNJD9XRsnGP7LqxCTxMUFKgCI+lpKT0snfskX4i0A5BgdcHSlSpYnbd4mdqfr7my7G0AnIdgy0EK2W/lc2HhitVqOaW9BlVvNcNCVKuXMaOuQ88uHS/ysfL2kaGDBuRraVFWZfkbV17mS8/j5avVZ8DHU15RfxOdffvLbxX23FWCxYQTHz+Ceg9/DIN/8Nlw9SPsjT9Y2UtGRERE5BY4LpeqNOkPKiIjahZ5m64d2qqf/yxZUej1y1avU5PiSPVLYT0iS+LQ0WNqJmeZ4fjmEcPP6/cqfRwLVtZ1apvXa3Lz9p3IzDp/UgmZEOjVdz/ET7/Py3e5wWBwVJo++9j96vx7n36Zb+IO7TVLZVxhFbsS5g679V7cPe7ZEn0hlmHYN97zKG64+5F8l8tkPxJCyYzPhYVbVPXJ0HjZ3qXXqtZ2o2Ags3ztBnW+W8fC+z2WRI8ueX0nl61eX2hF2/I1+S+Xar4OrVuq61as+6/Qx5Rq91F3P4Lv5/6Z73IZFi39g/ccOKSWXQ7MSA/ZWkW0ISiouAncpI3I9UMGwWK1qlnZj5+MVpMHOU/6RdVTlw7titzGxeKVa3DNmPsxafJ7F9zWZHsVy4t4rN37DmLoLffgkedegcVSeBX4xf6Ny1u+wh+vNJMcbt21V/2UyvOCoarzc9vseVW6VAhLLk588jCsmamqLcBzfR9G8xqNuaqIiIiISoDBKlVZMnnVzO9/Uedl6G5RpFpHAkAJGWVyG+cvfRKcvDV9hjp/y8hryrwsIUF5oYhMKCUznxfsCzflg88cv0uIK+rWjkLfHl2RmZWt+unJTMqaI8dP4LNvf1LnRw7Nm1SnMIP7X4b+vburx3jlnffzfamWVgkyscfLU99HVla24zqpMp341ruq+k9mVC+un55G+s7Kl+oDh4+qnrbO4hIS1WsUbVs0u+BjUdUiYePg/n3UDOfjX56sZjXXyHY38c131GUyYVr71udXjJfUrSOugV6vV9uf9BnWSJ/j/834EoePnTgvsLnjphHq55vTP1EV1QVDKglU9x8+itbNm5z3fNokVW9O+yTv90ImiSuKVh2blpFR6PXXD7lStRzQAt0RxezjVH3cMPwq+Bl9MfvP+fjp97/z/a2SCaImv/+pqmit79QT2/vsJFEZWVmO4f9Cel5LhefK9Rvx4cxZamSGRg6ATJrynhpCH14jtNCJqsrjb5zz8hXcF4pa7sKfO1D9XLdpa74J7cxms5rMS9riCJPJfMHXUa2ZcnDy40dgzUpT4erzfR9B07CGlb1URERERC6PrQDckI/hwl9yqsuyHjlxEs+9PvW8fqgyycfOPfvV+S7t2+LOm0YW+Rgyw/2UF5/BUy+9qb6E/fr3ArRo2ghJyalqNmF5jFHXDMFN1w4t83JKSDqwby81FF6qQDu1b4OggAD1JVgCYPliWCM0BAlJyeqkVca+NOEx3DXuWdW7TibL6di2FdIzMtVyyZDLO0ePRNeOeVVMRXn+8YdUtaB86Zzz97+OYZ9vv/g07nlyourDKhVQMgu1p6cO23buVSGpTMTz6jPjSvwaX316HO6fMAlTP/occ/76B40a1EN2dg627NytJhGRocxalZQ78/Aqv9ms3X1Zt+3eiwHX31rk9RLc/PjpNEx68mE13F+226tvvhtd2rdRIagEMClpaaoafOpLz17UsjSsXxdPP3KvCjoffPpFFdLKZFC79x9U1dqyPUtQ5BwS9e3ZDfffPhqffvsT7n7iObRo2lhN9BZ9+oyaAEeMu39soZNGSXXclA8/VZ81Rl9fDOrXp+TLWq8utu/ep/o+zlu0HHfcdP3Z9hnnwmgZ6i0BsUxwdLHDvl2Jt9599h9XW1YZvj9l0tPqAIVs5zJBYLNGDZGRman2JflbJQfStAMGQiZXk0kE09IzMObh8ahXO0pN+Cjh/v9efR4PPf2SqoyWXr4tmjRSldKbt+9S4acc7HjqweIndrvYv3Gy74u5f/2rWu7I5G3yN6qo5S7MyGFX4sff/lIH9uTzpX2rFrBYLdi554D6fJEqVlkGeV4qns2UhZOfPIK6D30EX98ATOz7KF5bMR2Hk45z1REREREVgcGqG/rulasrexFchsw4PG/x8nyXST9CqZ7p0aWjqpQbPnjgBStupK/h7C8+wJc/zMH6zVuxdPV6NTlI7+5dcNN1Q9X1F2vKC0/ju7l/4O+FS7Fr7wFVbRQVURO333g97rxpBGb+MAffz/1DVcq1atbE8UX6xxnT8M0vv2LxijVYvX6TqmSTL7y3jLhGvb4LkS+oj917h/oi/r9PZqJPt84q8KpTKwq/fD5dVfgtWbVOfTGX4dES6lzRrzduvn4YAgMuXK2qkYD36/en4OufflUTWK1YswG+vj5q8hDp+1pc1bA7afBEyWfxrupkgpzEs7N+F8bb0ZYiAN98MFVV2c1fshz/bdsBT50OdWvXwp2jR2D09cNh9PW56OUZfd0w1KtdC1/9OEcFqvsPHVUHSZ4f9xDWbNiEH379CwF+fvnu8/BdY9TEOj/8+qcKOw8fO64CoH69uuH2UdcXeeBCqtwH9umpPn8G9etdquV/9J7bVcgjAdbajVvQo3OHfMGqkIMoEqxee/Ugtc9XFV9c93ZlL4Jbk4MBv3zxAb7+aS7Wb9qK1f9tQoC/P9q1bokRQwdj6BUD8v298/H2xuSJEzDts6+x79Bh1Us8JTUNwUGBatTCnC8/VI8l/bilslM+s5s2aqB6r0pgKfevyL9xMkGb3PbfpSvVkH2j0VcFq0Utd1EjJn76dDo++uo7dfBmlTyOr48KVKWSXHofDxhxqxqhcfxUNOrXOVfRS+ez5WTi5IzHUPfBD2H08cML/R7Dq8un42hyXtU/EREREeXnYS/JlOhUJnv37kVWVhaMRiNatsz/pdmZDHPbvz9vBtbmzZtXqS/RznLPHC7RDOFELsfDA96R7t1vrqrvf9oEWNJPubDZ0B9+9iWsWr8JM6a+hl5dO8HVjRj7kBre/c9PX6oDIW6N+w+5EZvdjiMJmTAnnELAhlnwsJ1rk1Cd6IxBKlz19DEiIzcTryyfhuMppyp7sYiIiKiS1Q+ug6lXTiyXx7Jardi2La9tU4cOHdR8E+6W5wlWrFKZSSafnZ2tNjQ5b4o9cqE7cG2Te7Lb84JJd1bF978/FyxWQ/ql5cTrzz6R7wCVVMit3rAZoSHB6NQub1I4V6M+Q01mVXEvFYQydFkq0t0+VBXcf4jcji0rFSdnPIp6D34Af28/TOr/OF5dNg0nUvMmBSUiIiL30ad+V1zddADSczNxOOkYDqnTcaTnFj7nA5UOg1UqP1U8uKFqjtu3Sxs57Cr88uc/ahiyTETVslljdcTz2IloNbzf18cHb00cX6qhzZfaZdeMViMYZKIv6S8pLQOqDO4/RG7HlpmCE5+OQ70HpiPQ2x8v9n8cLy97D6fS8kYIEBERkWsL8g7AvV1uQbc6HRyXdarVxnE+LiPhbMh6DIcSj6vWP7nWcxONUskwWCUiIrcnlZ1zZn6In377G8vXblD9S2WCN+lTfOO1QzBm1HUu3VvRw8MDbVs2U31eZRKhpx+936WXl4iqB1t6Ik59Og517p+OQJ8AvDhgHF5Z+h6i089U9qIRERFRMXrX64K7Ot2EAG9/NTou58RuWLPS4B3REPrAGvDQeyHcv4Y69aqXN6eMFHmcTDutqllVZWviMZxMPQ2r3cZ1XQwGq0REVCVIiCpVnu5a6Tlz2uTKXgQiovNY0hJw6vMnUee+9xDsE6jCValcjUmP5doiIiJyMYFSpdr5ZnSv21H9bjPnIv7P95G5b32+2+kCwuDfqjd8G7aDd3h9ePoFQafzVD1U5TSwUW91O5PFhKMpJ1XYKkGr2WqulNflyhisEhERERFRkSwpsTj1+ROoc+80hPgG4aX+4/DSsv8hNiO+Wq01ee1darVH19rt0SS0Po6lnMK2M7uxLWYP+88SEVGl61m3E+7uNFqNMlFz4hzfhTM/vwlYTIWOSknb8Kc6aQwRDeDXshd86rWGIaw2dL7+MOgNaF6jsTpR4RisEhERERFRsSzJsTg1czzq3PMOQo3BeEkqV5e+h7jMhCq95moFRKjedBKmNg1rmO+6NhHN1em29iOQlJWiQtatMbuxM3YfsszZlbbMRERUvchw/3s6jUbPep3V7zazCfF/fYDMvWtL9Tim2GPqdI4Ovg3bwti8G3xqN4dXSCQ8DD6qjRmdw2CViIiIiEhwHs5iWRKjEf3l06hz11TUMIaeDVf/h/ispCqz/XjAA03CGqggVU61AyMd10n1j92UjewTe5G5fz2MjTrAp35reBqDVNh8eaPe6mS1WXEg8Si2xexWYeux5FOwc+MiIqIK0L1OR9zT+WYEna1SzTmxBzE/vQFYcsvh0W3IPrpdnTSGWk1QZ+yUcnjsqoPBqgtwTvulWbBOp6vU5SEiIiKqtrmq/Wy6arNW8tK4JnP8SUR/9Qxq3zUFNf3C8OKAJ1S4mpidDHflqfNEm/Bm6Fq7A7rUbodQ32DHdfIl1ZaVhqwj25Cy7neY4084rsvYvlT91BmMCOg8GH4tesE7vB489V5oWbOJOt3c7lqk5KRh+5k9KmjdcWYv0k2ZlfI6iYio6ggw+OGuzqPVJFWOKtV5HyFz9+qKfWKrpWIf3w0xWHWRYFWv18NisSAnJwf+/v6VvUhERERE1U6O2Qq71QwPUxY8WGFYJFPccUR//Txq3/kWIvxrqMpV6bmanJ0Kd+Gr90GHqFboVrsDOka1gdHgmy9MlUm7MvdtQMr6P2DLKL4i12bKQuq639VJeNdujsDOV8K3QVt4+oeoSb/6NeihTja7TU0Asj0mr23A4eTj6vmIiIhKSkZU3NvlFvX3RVWpntyLmB9fL6cqVSotBqsuIiAgAMnJyerk5+fHnhVEREREl5B8MUnLMcOemw2vpONc9xdgOnME0d9MRO073kBkQDheOlu5KtWZrirIJxBdarVTX0jbRjSHl6eX4zq7zQZzYjQydq9CysZ5gCmnzM+TG70f8dH7837ReyOw4xXwb90HhvAG0HkZ0CysoTqNajMMabkZqop18+mdWHdyswpeiYiICuMvVaqdbkKf+l3V7zaLVKnOQOauFVxhlYjBqosICgpSoWpGRgZOnTqFkJAQ+Pj4uHRbADU0ymZTJ3WeR9uJiIjIndjzhv9LpaqEqhmZ2bBmp8Mn/lBlL5lbMMUcwulZL6LW7a+pSZ4kXF15bIMKCzNMmfl/5mbAWoGhoZdOr4JT6TEnFTzqvHfeeZkdOcKvBhqF1oPO49z/re1WC3LPHEHa1kXI2L5c9ZIrd5ZcpG2cp07CENkIQV2uhm/DdvAMCEOgt7/6giynbnXa4/11X1boeiIiIvckBwbvkypV36C8KtVT+xHz02sXdSCQygeDVRfh6+uL2rVrIzo6WoWrcnIHzj1hbWaWnRMREZGbkQmJrHmVqhKq+h5YBs+Mqj3TfXmS6szTs15CrTGvqImepKdoUbJM2UgzSciaF7amO53XAth0dXmm+plrNSHQO0AFpPkCUznvnfdTC1Cdh/IXx2bKUUMmUzfOR/bhLaiMSt/4vz/K+0WnR0D7AfBv2x8+dZqjZ93OavKs6etmMlwlIiLFz2DE2I43om+D7up3u8WM+H9mIGOHHBAkV8Bg1YUEBgbCy8sLqampSE9PVz1XXZkcJcnNzVWhsHwpMSecquxFIiIiIio16akqw/+lUpWhaunlntqreq6GXXEHPP2CofP2hc7LGx4y1N7TU9awanMl4acKQP1rVshWqnqV2m3qS6fdnAtbbiYsWemwZiTDkpaIjF0rYIo5DJdhsyB96yJ1Cr7sRoRcdiN61O2krmK4SkREnaLa4L6ut6pJFVX+En0QZ358TfX2JtfBYNXFSEgpp8jISLXjuHIze6vVij179qB58+ZqKNWxP16p7EUiIiIiKh2blRNVlVNbgJhZkwq/UqeHPigMXiFR0AfWVOf1AWHQGYPgaQyAzscPOoMROsP5Yaz6v7DNqsJSqTa15WSoymItLLWkxMGcHKMO8MuEU+4qZdUvqlAhpO9NDFeJiKo4Tw8dfL18YVQnH/XT1+m8nBoE10HPep3PVan++xkyti+t7EWnQjBYdWHyn0k5uSr5j64sn7QCsNt18LC5doUtEREREVUCmwWW5Fh1KjkddD6+sOVkorpIWT1b/dTCVWkLMG3dF2wLQER0VqOQeojJiEO22fX6ikb411QVpv4GoyMc9XUKSp1/99YbSvSYqkr19CGc+em1avX30N0wWCUiIiIiIhdjq5ZfIp3D1e51O2Kcxz2YtpbhKhFVb1LQdV+XWzGwUW/kmHOw6vh/+PfQCpxMPV3Zi4Z2ES1xdbMB6BjVOt8EiSVvYXN2ZIbNktfKxmJS89fYcrORtnkBMnawStXVMVglIiIiIiJyqXBV2gKMRvc6HTGu1z2YJhNa2ayVvWhEVE589N6qetFHLyeD+l1O3p7e8PHSzsvlPnm/q/NnL3f8PHdZfFYSpq/7EjHppRkZ4B48dZ54rPtYx7B4Hy8fDGrSV512xx3AgoMrsDF62yWt7pd13q9BD1zZtB/qBEY5Ltda1dhyc1Sfb1tulrrMJv2+M1NhzUqFJT0Z1owk1c5GRnSQ+2OwSkRERERE5EJSVs/J67na7+a8cLXn3QxXiaoAafFxd+fRGNykb7k+boC3P57p8yCeXzwFWeZsVBUGTy881ft+VQ0q1Z2p6/9U/bSDe14Lz4AwtA5vpk5JWSlYdHgVFh9ZjdSctAod7n9V0/4Y0KBn3mSMZ6tOTbHHkLR0FrKPbq+w5ybXxWCViIiIiIjIxaSsmat+auHqEz3vwXvSc5WVq0Ru67YOIxyhqmOiaqm0tNlgV8PBrYDVApvFDFjPDgk35cKufmbDbsqGNScL9pxMWKUiMjtdPUTNYQ+jVmAEHu95Nyav+silJ8EuKanoffayh9GyZhP1epKWfY/Udb+p69I2zYchqjHCrrgTPnVaINQYjJvaDsfI1ldj/cmtWHBoOfYnHCm3MLxdZAtc3XQAOjgN97dbzcg8sBEJC7+CLSOpXJ6L3BODVSIiIiIiIhcPV7vV6YAne96D/zFcJXJLw5sPwvDmV6jzaZsXIuHfT8vtsSWQDb92nKrsvLXd9fhu+69wZ4HeAXi+3yNqsioJVRPmf4r0bYvy3cYUcxgxsyYBBh+EDbgVAW37Q+9tRJ/6XdXpaPJJ/HtwOdac2AiT1Vzm4f5SoVo7MNJxuQzpT904DylrJOS9dO0HyHUxWCUiIiIiInLhcFWChdD+t6Arw1UityQB3ZgOI9R5VeVYjqGqeszdq5Ea1QTB3YfjmhaDcCI1GiuPbYA7CvMNwaT+j6sKXLvNhrjf/ofMfeuKvoMpB4kLZqqTX6veavI/r9BaaBhSFw92G4Mx7Udg2dG1WHhoJWIzEy74/JFnh/v3b9gTRi/n4f5HkbhkFnKO7SjPl0tVAINVIiIiIiIiF5a6Nq/6jOEqkfvpFNUGD3S9TZ3PiT6I2NmTK+R5khZ/De+oxvCt1wr3d7kNMelxOJh4FO4kyj8cL/R/DDX9wlQV7pmf3ihV39LMPWvUSR8cgbBBd8HYuAP8vf0wvMUgDG0+ENtiduPfgyuw/cwe2GEvMNy/Ja5u2h+darV1XG63mJF5cCMSFsyELTOl3F8vVQ0MVomIiIiIiNwtXO11L/639nP2XCVyYc3CGuGJXveqme3NSTE4/fWzFfp8MbNeQr3HPoNXQAjG974fzy56C8nZqXAH9YPrYGK/RxHsE6gCzehvX4Ap5lCZHsuSEovY2W8BOj2Ce49AUJer4GkMUqGpnM6kx2HBoZVYf2oLutRqp/qnSoWs4/6ZKUj9bx5S1/7O4f50QQxWiYiIiIiI3CVclbYAA25F19rt8VSv+/Du2s8YrhK5oDqBUXj2sofgrTeooO7k509egme14dTM8aj3yCcI8Q3ChD4P4KWl/4O5DD1GL6XmNRqpiar8DEY1YdepmRNgSYy++Ae2WZCy6hd18mnQDqGX3wbvyEaIDAjHHR1vUCcNh/tTWeVNZ0ZEREREREQuT2bFltmxJQToUrudClf1OtbLELmSMGOIqr6UYei23CycmvE4YDFdkueWIesxP74Gu92GJqEN8ECXW+HK2kW0xMR+j6lQ1Zoj6+qx8glVC5DeqKe/fBrHp92F9B3LYTPnvR9SHZuxZw2OT78H0TMnsIcqlRr/AhMREREREblZuApI5eptKlzV2gJYbJbKXjSiai/A4KdCVQlXbRYzTn0xHracjEu6XnJP7EHi4m8QdsWduKxBdxxPjcaf+xa53HvTvU5HPN7zLnVwyJqVipOfPFbh68qWlYb4vz5QJ31IFCzJsRzuTxeFFatERERERERuJnXd70ha9p1T5eq9rFwlqmTengY80/dh1QZAJl86/e1E1e+zMqT997eayEnc0u46dIxqA1cyoGFPPNHrHvW5ZU5NwPEPHrzkAbQlOYahKlWfYPXo0aMYP348BgwYgHbt2mHw4MF47733kJmZWerH+u+//3Dfffehe/fuaNOmDfr164fnnnsOx48fr5BlJyIiIiIiqpBwdeksFa52lnC1N9sCkHtqGFIX065+GW8OegZtI1rAHXl66PBk7/vQLKyhGoZ/5pfJMMUcrtRlivv9PZjiT0LnoVOVobUDIuEKhjS7HA92u10tlykxGic/fhiw5Fb2YhFV3WB1x44dGDFiBP766y/UrFkT/fv3R1ZWFmbMmIHRo0cjPT29xI81e/Zs3H777VixYgXq1KmjHkuv1+PXX3/Fddddh61bt1boayEiIiIiIiovqev/OBeu1mqL61peyZVLbqVn3U549fLxalZ26Qk6qf/jeOayh1wmBCwJD3iooLBjVGu1L8bP+wTZh7fAFZz68hlYczJh9PLF05c9CD8vY6Uuz6jWw3Bnx1HqfM7pQ6qnqkwyRRVHHxyBsCvvQY0hD6gWMkE9rkVAhyvg17wHfOq3gSG8PjwDa8DDy4dvQ1XssWo2mzFu3DgVpE6ePBnXX3+9ujwnJwdPPPEEli5dinfffRcvv/zyBR8rKSkJb7zxBnQ6HaZNm6aqXoXValWP/e233+KFF17AvHnzKvx1ERERERERlVe4qg+qgaAuQ3BN80FYfHgVUnLSuHLJ5cPIUW2G4obWQ9Xv0mPTkpYEQ0QDdZCgQ2QrLD6yGrN3zUNabsmLqSrDbR1GoG+D7ipUTV75EzK2L4XLsOQi+uvnUPe+9xAVEI5xve7GWys/gs1uu+Tv9x0db1DVqiLryHac+fHVS7oM1ZEEpxEjxsPTGFCi29utZlizM2DLyYQtOwPWnAzYstPV73K5zsu7wpfZ3bh8xaqEnNHR0ejdu7cjVBU+Pj548803YTQaMWfOHKSlXfg/Dps2bUJ2djY6dOjgCFWFp6cnnnzySfXz0KFDKoAlIiIiIiJyF4kLZsJmyoaPlzdubDOssheHqFjeem882fteR6gqlYvHp9+H6JnjcebH12BJT4KnzhNXNumH94e+gmtbDIaXzjXrwoY3H4Thza9Q59O3LELK6jlwNZbEaMT99p4KfttHtsKY9iMu6fPLkP8Hu41xhKoZe9YwVL0EAjoNRtTNk1SompNrwfaD8Th8KgUxCRlITs9BVo4ZZosVNptdbRvCw9MLev8QGGrUgU/dFvBr2gUB7QYgqNswhPYbjeBe53I5yuOan0xOli1bpn46B6GakJAQ1SdVbrN69WoMGTKk2MeSSlURHx+vqlQlSNWkpqaqy7y8vODv71/ur4OIiIiIiKgiJS6ZhZpX34fLG/XG/APLcCpNJmYhci01jaFqSHr94DoqzEnfthgJ82c4rs8+uh0n3r8XgV2GIHTArTAafHFr++sxuElf/LDjD6w9sQl25IVAla1fgx4Y0yEvpMw8sBEJ/34KV5W5bx1S1/+J4J7XYmjzgTieGo3lR9dV+PPK5FTjet6NbnU65L3fWxa59HqqEjx0CBs0FkFd8zKy2KRMjHt3OTJyim+5EOhnQGSYETWDfREW5IvQQB8EB3iry/2NBvj56BHgZ0BIAFsGuFWweuDAAfWzefPmhV7ftGlTFazu37//gsFqly5d4OfnhxMnTuDpp5/Go48+isjISPUcr76aV4I+ZswYGAyGCnglREREREREFSd9ywKE9LkB+oBQFURNWfUxVze5lJY1m+CpXvch0CcAdpsNCf98qoLVwqRtmo+0Tf8i7Kq7EdhxEGr6hakJmIY2uxzfbJuD/QmVOzFUp6g2eKDrbep8TvRBxM6eDFeXtPRbGKIawdigLe7tfAtOp8XiQOKRCns+6ev6ZK970S6ypQpVU9b+iuTlP1TY8xGg8/FD+PVPwdiovVodW/bH4aXPShagp2Wa1OnAiZQib9OwViDef2oAV7U7BauxsbHqZ0RERKHXy2RWIi4u7oKPFRwcjA8++ADjx4/H33//rU7OrQVeeeUVNRlWeZMPEKmGrWqq4msiIiIiInJn8X99iMibJ6kela3Dm2N33P7KXiQiZWCj3ri7883Q6zxhM+fi9KwXYYo5dIG1Y0Piv5+rMC78+ifh27A9moQ1wGsDx2PDya34bsdviM2Iv+RruFlYIzzR617VrsCcFIPTXz8Pd3Hm+1dR79EZ8AoMw/je9+G5RVOQmJ1cbo9v8PRSnz+96nZBx1pt1O+SiSQu+RZpG/4st+eh83mF1kLEjc/BEFZLrfO5Sw/hm/l7KmRVyePbbBfXp9c5U3K1fElrjVAlglXpiaoFn4XRLpfJrUpCKl+HDRuGWbNmoVWrVo6K1ZMnT+Kbb75BmzZt1Km8X8O2bdtQFUnrBCIiIiIicg0yjNoUfwLe4fXVEOXnFk52mWHTVD1Jf02ZtOjqpnlVbubUeER/MR62nIwSP4ZMnCO9V71q1kXE9U/Bq0YddK/bEZ1rt8WCgyswZ898ZJpKlglcrDqBUXj2sofgrTfAkpmCk58/qQJg92HDqZkTUO+RGQj2DcKEPg/gxaXvwGQ1l/kRZbi/TDbWu14XFar6OM0ub7eYEf/PZ8jY4UITelVBctAhfMRT8PTxg9Vqw9TvNmHNjpgKnWh+586d5fZ45flYl5rLB6vSB7UkKXhJ0uRTp06pof4y0dVXX32Fnj17Ou4roepbb72FsWPHqkrWoipkiYiIiIiIXFnsr++i7v3T0SikHvrU74pVx/+r7EWiasrPYMQTPWUoeItymQneHH8Spz4bB2Ozrqg59EHojUGqX6j0Op27Zz7+PbQCVlvFVb6FGUMwsd+j8Pf2gy03G6dmPA5YTHA3tqxUxPzwCmrd/hoahdbDg91ux/R1M0v1GJ4eOrSJaKHC1K6126v3WmO3WpATcxhpG/5SvV2pYgV2uVr1VPXQeaoJqSa8vwonYtO52i8Rlw9WpSdqSkoKcnNzC70+JydH/TQaz+3ERXnvvfdw+vRpTJw40RGqCg8PD9x5553YtWsX/vrrLxWySg/W8uLr61tkj1h3JqXa+/btq+zFICIiIiKiAjOAZx/ZBmPjjhjd9hqsP7kFZlvxk5YQlbfaAZFqkqqogPCz/TV/Q/Ly78vlsbMObMTxAxsR1PN6hFx2owo67+g4Clc26Yfvd/yODae2orwFGPxUqCrhqlRhnpr5VKmqbl1N7ql9SFzwJcKuvFuFo8dTTuH3vQuKvY9kJ61qNkOvep3RvU5HBHqfm/jbbrMi98wxpG2ej4wdyy/BKyDoPFHjynsQ2ClvsvfTCRl4/N0VyDFZLsno5Q4dOlx0pqRVqrZt2zbfBPOVTeZx0kbQu32wGh4eroLV+Ph4REVFnXe91ltVbnchGzZsUD/79u1b6PX9+/dXwaoErOVJPnxcaQMhIiIiIqKqLe7391D/ia/UhD9XNxuAP/ctquxFomqkY1RrPN7zbjV5kQRucb/9D5n71pf786Su+w2pG/5CzaEPwL9NP0QGhOOp3vdhb/whfLttDg4nHc/3vdzgaVA9P/NOBc/ri7zey9ML7SNbqTYA8nqiv30BluS8+WDcWdrmf+BduykC2vZTB2FOpsZg8+kd+W7jAQ80q9FQ9UztUbcTQnyDHNfJBGSmhJNI27wA6VsWuVlLBPem8/VHxIgJ8G3QRh242LjnDF778tKNTijvnMvT09OlcjN5fSXl8sGqVHpKD9SDBw+iXbt2511/6FBes+uSVISmpqaqn3p94S9bexOlVwQREREREZG7kp6U6duWqEqmES2vxrIja5FuyqzsxaJqYHjzQbi1/XWqt6o1JxPRXz+nqqgrjM2iJm1LXDILESPHw6duS7Ss2QRvDXoWKTlpjpBUJs26WHa7DWd+mVyCSbfcR/yf78MQ0UD1ZX6sx1hMXPw2TqXFqFYiUsnas25n1PALddxeQjxzYjTSti1B2sb5av3TpSU9hiNvfA5eIZHq/fhp4X78sJATFVYWlw9WtSrShQsXYuTIkfmuS05OVlWo3t7e+Yb2F6VJkybYs2cPli5dittvv/2861evXq1+yqRWRERERERE7izhn8/h37YfjAZfjGw9BF9vnV3Zi0RVmJdOj/u63qr6nQqT9EP98hnAUnhbvwrpGzprEgxRjRFx3RPQh0Qi2Cew+Dla5Kfdlve7zaoqMCUolKpUu8xSbjXDbjXDZjHDbs5Fyuo5aoK4qib6q2dR/7HP4evrj+f7PQKLzYpI/5qO62X9WJLPIH3nCqSs//OSvad0Pt/GnRBx/RPQeRthsdow+euN2LDnDFdVJXL5YPWKK65A7dq1sXz5cvz0008YPXq0o7eq9ErNyspSE1KFhp47giIVpydOnFDn69Wr55i5/pZbbsELL7yA6dOno2XLlujatavjPrNnz8bcuXPVbeV2RERERERE7s2G5JU/I2zg7RjcpB/+PbgcZzLiK3uhqAqSAHN8nwfQLKyhCuFkwqK4X9+tlGUxxRzGyU8egSGqCbyCasCakwVbbqbqh2rLzoTNlMMqy4IsJhWu1r1/GmoY87IVFaamJSBj1yqkrv0NNlNWJbyb5Cyo+3CEDrwdHh46ZGab8eT0FTgdz5EIlc3lg1UfHx9MmTIF99xzD1566SX88ssvqFOnDrZu3ar6q7Zp0wZPPPFEvvvExsZiyJAh6vySJUvU7cWoUaNUY9yff/4Zt912m2qOGxkZqdoJHD16VIWqb7zxBho3blwpr5WIiIiIiKg8pa7/A8E9roXeLwi3tLsO/1v7OVcwlSsZMj6hzwN5kzrZ7Uhc8i3SNvxZ6WtZhutXpSH7Fc2SHIOYn95QB2Kyj+9Gytq5sGWlVfZikfDUo+bV9yGg/UD166nYdDwxbTlyTOxp6wpcPlgVUlkqFaUffvgh/vvvPxWESlh64403YuzYsfDz8yvxY7366qtq8qoff/xRTVK1d+9ehISEYNiwYSq8lUpWIiIiIiKiqiJ+/ieIuOEZNfFMs7BGOJB4pLIXiaoImdDooe5jVA9Tu8Wsgrmc43mzfJP7yTm2A9Ezx1f2YpATnTEQESMnwLdeK3XgYt3OGLz1zUauIxfiFsGqaNasGd5///0S3VZC1/379xfbXkBOREREREREVV3WgY0wJ52GIaw2xnQYgUlL3qnsRSI35qnzRI86HXFlk35oUbOJusyamYqTMyfAlp5Y2YtHVGUYwusjYtSz8AoOV6HqrH/2YvaSg5W9WOSuwSoRERERERGVTdxv/0Ptu99B8xqN0b1OR2w4tZWrkkolzDcEVzS+DAMb93ZMCiVhT070AcTMepF9S4nKgYfeAJ23L3zqtkLN4Y9AZ/CBxWLD619twOZ9cVzHLojBKhERERERURVnij2GnBN74Fu/NW5tdx02nd4Bq81a2YtFbqBtRAtVndqldjvoPHTqMrvNhuwTu5G0+Gu1bRER4BVWGzoffxWMSiDqYZCfvmd/94WHwcfxe9515//uofPMtyrTM014YtoKxCZx8jBXxWCViIiIiIioGoj99V3Uf/wLRAaEY3Djvvjn4LLKXiRyUUYvX/Rr0AODm/RF7cBIx+XW7Aykb1+CpBU/qZnkiS5lJadfy17IObkXlpRYl1rx+qCaqDnsEfg2aFNujynV4IejU/HMB6tgsnCSKlfGYJWIiIiIiKgasGWlImP3KgS07YeRrYdgxbH1yDJnV/ZikQupH1xbVaf2qd8NPnpvR8Bjij+BpGXfI/vQ5speRKqGdN5GRNz4nJrAyWY2IXnlT0jd8JeUTlf2oiGg/UCEDbpTLaPsK1abHVarHRarTZ1MZity5WSyIjvXgiw55ViQmW1GRpYJ6ZlmpGXlIjXDhJT0XCSn5yA1Mxe2yn9pVEIMVomIiIiIiKqJ+L8/hn/LXgj09sf1La/E9zt+r+xFokqm1+lV390rm/R1TEYlbBYTMvdvQOKir2HLTKnUZaTqy9MvGJE3vwDviIYquNR5GRA28Hb4t+qlPs9McccrZ7n8g1FjyIPwa9pF/Z6VY8brX27AzsOcwK26YbBKRERERERUXdgsSFn7G0L63oirm12OBYdWIiErqbKXiipBmDEEgxpfhssb5Z+MypKWgNR1fyBt8z98X6hS6YMjEHXLi/AKiYTNZsfU7zahY/OaGNStPryjmqD2XW8jZd1vSF49B7BaLtlySUuCGlfdB09jgNpnNu6NxVtfbQBH7FdPDFaJiIiIiIiqkeRVPyOw6xAYfP0xuu01+HDD15W9SHSJeMADbSKa46om/dC5sMmoFn1VaRWARM4M4fURefMk6P1D1JD6Fz9dq6pBV28/jT9XHcHL9/REjWBfhPQZBb8WPRE/72PkntpfoStRJqaqcdW98G/dR/2ea7Jg6vebsWHXGb551RiDVSIiIiIiomomYcEXiLhuHPo26I55B5bgaPLJyl4kqkB1g2qhZ91O6F2vK6ICwvNPRrVtCZJWcjIqd+UZEKb6e5oTqs4+7F2nBSJveh6ePn6qP+n46StxLCbNcf3xmHSMfW0hxg5rhev6NYGhRh3Uuv11pG36B0nLfoDdnFPuy+TbuBNqDn0Q+oBQVaW6+0giXvliHXJMbIZa3TFYJSIiIiIiqmYyd6+Cud/N8AqJwJj2I/Hq8mmVvUhUzmoHRqJX3c7oWbcz6gRFOS5Xk1HFHc+bjOrwFq53N+OhN8CnXiv4NuoAY6MOMNSsqy5PXPodUtf9VtmLd9F8m3RCxIgJqpeqTPD06DtLEZ9SeFD61d97MG/NUbx6fy/UrumPoK5DYWzWDQnzZyD7yLZyWR4Pgw/CrrgTgR0Hqd/NFis+nL0dSzdVnSCbLg6DVSIiIiIiomoo7o/pqHXHG2poeMeoNtgas6uyF4kuUq2ACBWk9qzXGfWCajkuV7OVZ6Ygc9961Y+Sk1G5F6+w2nlBauOOKlTVeXnne289PDwQdvltqsIzadl3cFf+bfqh5vCH4aHzREp6Dh56eynSs8zF3icuORsPTF6CkQOaYMzVLeEVVBNRN09C+o5lSFz8NWzZGWVeHlnXNYc/Aq/gCPX74VMpeOGTNcjIuXT9XMn1MVglIiIiIiKqhnKj9yP39EH41G6G29pfj+1n9sBm57BWdxPlH66CVBnqXz+4ToEwNRVZ+/9D0po5sKVztnJ34eFthG+Dtqoi1bdxRxUWOrPa7IhJyMB/e85g3uqjuH9EO3RrFYngXtdD5+OHhH8/l8a5cCeBXYeixuC71PmYhEw8MnUpTKWYDWruskNY9N8JvHpfTzSqHYSAdgPg26gjEhd8gcx960pdFRzS/xYEdRsKDw8drFYbZv61G3+tOlLq10VVH4NVIiIiIiKiairu13dR95FPVA/OAQ17YcmR1ZW9SFQCkf418ypT63ZCg5C8oeBamGrLSkPmgf+QsnoOLGkJXJ9uwQOGyIaqIlUqU33qNFdVm87vq1Ru7j2WiEXrT2DDnvyTJb02cwOeuLkjBnSui8BOg1W4GvfH+4DNPSorQ/rdjJA+NziqQp+cvgK2MuTCaZkmjHtvBQZ1q4cHRrSDwT8YESPHI3P/BhU2WzOSL/gYhqjGCB/+qKPFwqnYdDz/yRokp+eWfoGoWmCwSkREREREVE1J8Ja5/z/4t+iBm9oMw+oTG5FrYYDgiiL8aqBH3U6qOrVRSL38YWq2hKmbkLJ6Niyp8ZW6nFQynn5B8G3YAb6N2qvKVPndmdliw8nYNKzbGYP5a4+p0LA47/24FakZJlzXrzH8W/WGztsXsXOmwm4p/n6VykOHGlfdg8BOV6pft+yPw0ufla66tDBSubpq22m8eE93tGkUBr/m3eFTvw2SlnyjJmsrlM5ThbvBvUeqUNtms+OnRfvx48L9F708VLUxWCUiIiIiIqrGpLLNr2kXBPsG4ZrmV2D27nmVvUh0lrfeG4Mb90Wvep3ROLR+gTA1HVkHNyN5zWxYkmO5ztyEsWkXhFx2I7yjGue7XN7T5LRc7DicgH/XHsXuo0mlfuwv/9qN9CyT6jVqbNwJUbe8iDM/vwlbbhZcjqce4dc+Dv+WvdRrX7HlFN79ofwmU8sxWfD8x2vQs00knrylM3x8/FBz6EPwb9UH8fNnwJJybp/xqlEX4dc86nhP4pKzVC/VmEQXXG/kchisEhERERERVWeWXKRunIfgHtdieItBWHR4FVJy0ip7qao9CVUn9XsMzWo0yh+mHtqM5NVzYUmOqfbryN34teiB8OufdAzzzzVZcCQ6Fau2RWPRf8eRY7r4vqizlxxUbQMeGtkOPnVbImrMqzjz42uq366r8DD4IOKGZ2Bs2E5t17+tOISv/tpTIc+1btcZ3PzCPDxzRzd0bx0J34btUOe+95C8/EekbvoHQV2HIKT/zdDpDbDZ7aqP6hd/cCI/KjkGq0RERERERNVc0pJvEdhxEHy8jbipzXB8uun7yl6kas3L0wvP9HlQhaoSPGXsWonkNXNhSYyu7EWjMjI274bw655QoapMzvT6lxtwIja9Qtbnv+uOIT0zF0+P6QrviIaIGvM6zvzwKixpld8mQucbgMjRL8CnVhO1bX/99x78uvxQhT6nzIH1xlf/oW3jMDx3ZzcEGL0RNuhOBPcZCU/fAHWblPQcTPp0HY7F8KASlY6ulLcnIiIiIiKiKihx8bfq54BGvVAnMKqyF6fa8tR54qle96JNRHMVPMX//SHi/3yfoaqbD/+PuP4peHjqcSYxEw9NWVxhoapmzY4YvPjZWjWjvSGsFmrd8Tq8wmqjMnkG1kCt299QoapUh077aWuFh6rOdh5OxC2T/sHi/46rfUtCVfkpv495eQFDVSoTBqtERERERESE9G2LYElLhM5Dh9vaX881Uglk3T/e4y50qtVWBT6JC2YiY8dyvhduzNikMyJGTlChamxSFh6cvFhVUF4K2w8mYPz7K2G2WKGXUHPMazBE5rWWuNQk1K19xxsw1KgNq82GV79Yj6WbTlbKskz/eRvG/W8F1u44jWc+XKV+JyorBqtERERERESkxP31oQr0JNhrE96ca+US8oAHHuw2Bj3qdlLvQdLyH5C2+R++B27Mt3FHR6gan5yFB6YsuWShqubQqVQ88s4yNZmTp18Qat32Cnzqtbqky+Bdqwlq3f66Cncl5H36g1XYvC8OlenI6VS89c1G7D2WXKnLQe6PwSoREREREREpOcd2wBR3TJ0f02EkjF6+XDOXyN2dR6Nfgx4qVE1Z+xtS1/7Kde/GfBu2R8QNT8ND74WElGw8MHkJLJc6VT3rdHwm7n9rCTKyzdB5GxE5epKqpL0UZLKoqFtfgacxEDm5FhXyHjiRckmem+hSYLBKREREREREDrFz31XhXsOQuvjiuql4od/juKppf9Q0hnItVZAx7UdgcJO+ar2nbfoHycs5eZg7823QDhGjnlUzzSemZuP+txbDVEmhqiYpLQf3vr4QyWk50HkZEDHqGfi3vqxCnstDb4Bvow4IGzQWkTdNhM7gg7RME+57a7EKeYmqEn1lLwARERERERG5DktyDJJX/YKQXiOg13uhXWQLdbqr0004lnIKm6N3YNPpHTiSdAJ22Ct7cd3eqNZDMbzFIHVe+qkmLpyJ6sivZS/YLSZkHdwEd+ZTvw0ibnxWhZcSZj4wufJDVU1GjgX3vLEIHz19OSLD/BB+3TjofPyQtvnfi3xkDxgi6qsqXQlUfeu2VJW6GqnYfXDKUtWOgKiqYbBKRERERERE+aSs+kWdfBq0Q1DXIaonowwhbhBcR51Gth6CpKwUbD6dF7Luit0Ps42hSWkNbz4Io9oMU+cz9q1H/N8fVsstMajbcIQNulOdz4k+gKSls5BzYg/cjewnkTc+B52XN1LSc9Tw+xyTa4SqGgl575+8GNOe6I+GtYJQ46p7VbiasmZuqR7H0z/kbJDaXlXo6v2D810vE1TFJGTiv91nMGv+nkveW5boUmGwSkREREREREX2XJWT+vIYEoHg7tfB2LQzPANCEWoMxqAmfdUpx5yD7Wf2qpB1y+mdSDdxuO+FyND/MR1GqPNZR7Yhbu7UarkVGpt3Q+gVt6vz0grBp3YzNXt95sFNSFr6HcwJlTNzfGn51G3pGPaempGLe9+UUNU1DzbYbMBj7y7Hmw/1RtvGNRDa/xbofPyRtOSbYof3S3AsYaqxUXsYwuvnu171Bs7IxZ4jSVj03/FKn5yK6FJhsEpEREREREQXZEmORcK/nwL/AjqDEYFdr4Zfqz4w1KgNHy8fdK/bUZ1sdhv2JxzBpujt2BS9AzEZDFgKkkmq7ul8szqffXIfzvz4WrXcAmW2+PBrx8HDQ4fjMWmY+v0mTLitC+pFBMCvaRcYG3dC+vYlSF75M6wZrjt7u3ft5k69RHNVL1FXDVWdPf/xGjx/Z1f0bFsLwT2uUZWrCfNnAHbbecP7feq2UD1jnYPUXJMVR06nYvW2aBWmulp1LtGlwGCViIiIiIiISsVmylJDh7Xhw36tL0Ngx0EqKJNh0C1rNlGnMR1GIjrtjApY/z20HIlZrhuOXSo96nTCg93GqPO5Z44i5tuJqI70QTURMercsPlx01bAYrHhkanL0Kl5OB67qQPCgnzVduXfpi9SN/yFlHW/w27KhivxrtUUUTe/AJ23L9IzTbj/zcXIynH9UFXz5tcb8eiNHTCoWz0EdhiohvRbszNUoFrU8P7Ne2Mxb81RxCRmVdpyE7kKBqtERERERER0UTJ3r1InYajVFMHdh8O3QVvofANQOzBSna5q2h+/7vkHf+9fXG37sXaMaoPHet4FnYcOpsRoRM98GtWR9OuVCk8J7qTqUYalS6iq2bI/Dne+uhBX9WyAscNawejjjZA+N6iQNXn1bKRtWQS4wDbkHdUYUTe/qF5PepZJ9S6VCaLczQe/bFOh8IgBTWBs0jlfVaq0NdjN4f1ERWKwSkREREREROXGdPog4n77nzqvCwhTIWtA+8vh7eOHm9tdiwGNeuHrLb9gS8yuarXW24Q3x1O974Ne5wlzShxOffak1P6i2tHpETFyAgw168Jms+PZj1YhOT230Jv+u+6YOt0xpBWu7dcYXn5BqHHlPQjqOhRJy75H5r51qCyGyEaIlFDVx4jMbDMemLwE6VlmuKuv5+1BclouRl3RFNHxGRzeT1RCDFaJiIiIiIioQtjSE5G0+Gt1Cht8NwI7X4VI/5p4tu/D2Hx6J77eOhuxGfGVtva9PL3QNrw5knNScTS54iZJal6jEZ6+7EEYPL1gSU/GyU8fd4mKy8pQc8j98G3YTlVDTv1uEw6dSr3gfb6Zvwc/LtyHR2/qiL4dasMrNAoRI8cjJ/oAkpbOQs6JPbiUDBENEXXLS/D09T8bqi5GWqYJ7u6PVYfViYhcIFjdv38/bDYbmjZtCr2e+S0REREREVF1lrhwJpLXzEXkqGdUX8rOtdqiXURL/LlvEX7f+y9yrZcumAr0DsCVTfriyib9EOgToC5Lyk7B1pjd2HJ6J3bG7kOOpfAqytJqGFIXz132CHz03rBmpeHEjEcAi/uHcGUR3Hukql6WUPWHBfuwevvpEt/XZLHh3e83Y+YfOzFhTBc1m71P7WaoNeY1ZB7chKSl38GcUHHhuMYQXt8RqmblmPHglCVIyaie7ycRXWSwmpmZiR9++AHBwcEYNWqUuiw2NhYPPPAA9u3bp36PiorClClT0LVrV65vIiIiIiKiasyWmYLTXz+nZhkPv/ZxeBkDMbL11ejXoDu+3TYX609tqdDnjwqIwLDmA9GvfncYzs5wbrfZAA8PhPoGY2Cj3upktpqxJ/4gtpzepVoWlLWqtk5gFCb2ewxGgy+sOZk4+cmjgCkH1ZFfqz4I7X+LOr9yazR+WnSgTI8jIebET9aiflQAJtzWBfUiAuDXtAuMjTshffsSJK/8GdaMipkkzatmPUTd+jI8jQHIzrXgwSlLi2xjQETVg4ddDhWVMVQdPXo0Dh06hCuuuAIffPCBulxC1eXLl+e7ra+vL/755x9ERkaiOtm7dy+ysrJgNBrRsmVLVDVWqxW7d+9Gu3btYLdacHTyTZW9SERERERE5EZC+t+K4J7XwkPnqX6XStEvt/yM6LQz5fo8LWs2wbDmV6Br7faOy2ymHKRtXaQqHaHXI6jz1fBv1Vv1/vTwzF+DdDotFltidqqgdW/CIVht1gs+p7Q8eOXypxDiG6Se68Qnj8KWkYTqyKduS1Xl6aH3wsGTyXhy2spye+xOzcPx2E0dEBbkq363mXORuuEvpKz7HXZTdrk9j1eNuqh12yvw9AtCTq4FD0xZgsTU6hmSU/XVsFYg3n9qQLllStu2bVPnO3ToAE/PvL8D7pbnlbli9fvvv8fBgwcRGhqKvn37OqpVV6xYAQ8PD7z77rvo1asXJk+ejN9//x1ffvklnn/++bI+HREREREREVUxycu/R+r63xFxw9PwqdcabSNaYOqVL+Dfg8swe/c8ZJvLHlzpPHToXqcDhjcfhCZhDRyXWzKSkbJ6DtI2/3vuxiYLUtf9pk7Ct3FHBHa6UgWCOh8/1AqMUCcJZ7PM2dh5Zl9e0BqzG6k5aec9dw1jKF7sPy4vVDWbcOrzJ6ttqKr6od7wjApVE1OzMf798gtVxZb9cbjz1YW4qmcDjB3WCkYfb4T0uQGBHQch+8RueHjoVEUyzv50/t1Du1ynnddu5/y7pzqvD6oBnbcROSYLHp66lKEqEV1csLpkyRLodDrMnDnTkd5KpaoUwLZp0wZDhgxRl02aNAkLFizA6tWry/pUREREREREVEXZcjIR891L8K7TEhEjnoQ+IFQFmH3qdcV3O37DqmP/wY6SD7SUXqYDGvbC0GaXI9y/hrpMvqeaE04hcfHXyD6SVyFVnOzDW9VJ6ALCENxtKPyadYM+OAJGL190r9tRncShpGPYerZlwJGkEwjyCcCk/o+jhl8o7FYzor96GpaUWFRHOt8ARN400TF0/tF3lkE6L1SEf9cdU6fbh7TEdf2awMsvCP4te5Xrc+SaLHhk6jLEJZdfJSwRVdNg9ejRo6hXr16+ktg1a9aoIzl9+vRxXObn56dud+LEiYtfWiIiIiIiIqqSck/txYn371UTHIVcdiOCfYPwSPc7MajxZao9wNHk4icmCvEJwlVN+2NQk77wNxjVZXa7Tc0YH//PZ7AkRpdpuWzpiUha8q06ATr4t70MAe0HwjuqMXQGHzQJbaBOo9oMQ0p2Ksw2C2r6hcFutSL6m4kwx1f8hEquyMPTS01UJhWrVqsN46evRHqWucKf99v5e/HTwv247eqWCAv2hd1mh01O9ryThOxWq5xH3mVWG6xyuQ2wqtva1HV5t7GpIFjO51qsWLrxhJpEi4joooNV6TUggalGPpw2bNigznfr1i3fbeWDSXonEBERERERERUnZc1cpGych4jrn4KxcUc0r9EYbw16FosPr8ZPO/9Ehikz3+3rBtXCcKlwrd8Vel3eV1yZAyJj71okLpgJW05GOa5wGzJ2rlAnbYb4oG7D4NuoPTz9Q1UYrJ7fZsPpH16GKeZwNX2zPVBz+COqlYJkBW98/R9OxKZfsmeX8PPLv3ZfsucjouqrzMGq9FY9ffq0+pCUKtXt27cjNTUVPj4+6NKli+N2cplUq0ZERJTXMhMREREREVFVZspB7M9vwBDZCBEjJ8ArOByDm/RFz7qdVLi65MgatA5vpvqndohq5bibNScLaZv/QfLyn1QIWuGLGXcc8X9/lPeL3huBna+EsVEHJK+Zg9wTe1BdhfS/Gf6t+6i84Mu/d2PjnurZCoGIqr4yB6udOnVSvVO//vprjBo1Cp988okKWGXCKoPBoG5jNpvxyiuvwGQyoXPnzuW53ERERERERFTFmc4cwcmPHkRglyEIHTgGAd7+uLfLLbi53XVOw/3tsKQlInnlz8jYsbTyFtaSi7QNf6pTdRbQ/nKE9B6pzi/67zh+X15dq3aJqDooc7B61113YfHixXj77bfVSTN27Fj1c8eOHbjvvvtUxaqXlxfuvPPO8lliIiIiIiIiqlbSNs1H2paFCL9uHPxa9FChqgSqprhjSFj4ZbWuDnUlvg3aocbV96vzu48k4INftlf2IhERuWaw2q5dO/zvf//Dq6++ioSEBAQFBWH8+PHo2rWrY9KqlJQUhISEYPr06WjRokV5LjcRERERERFVJzYL4n59B/qw2gjsdCXSNs6DJYVDzF2FV426qm2Dh6cesUlZePajNZW9SERErhusisGDB2PQoEFISkpSAapOp3NcJxNbffTRR+jbt6+qWCUiIiIiIiK6WJbEaCQt+pIr0oV4+gUjcvRE6HyMyMw245Gpyyp7kYiILolzSWgpbdy4Efv27VN9VcPCwvKFqkLC1IEDB6qfq1evxvfff18ey0tERERERERELsLDyxsRNz4Hr6CasFhseOK95cgxWSp7sYiIXDtYHTNmDF5//fUS3XbatGnqRERERERERERVhIcO4deOg0+tJrDZ7Xjp83WIScyq7KUiInKtVgAZGRlITk4+7/KcnBycPHmyyPtJM/Ho6GgcOXJEnSciIiIiIiKiqiF04O3wa95Nfd//9Ncd2HEoobIXiYjI9YLVzMxMDB8+HLm5uY7LpAXA7t27VZ/VkujQoUPZl5KIiIiIiIiIXIJXaBRCL88LVcVfq49g/tpjlb1YRESu2QogIiICY8eOVUehtJNw/r24U1RUFF544YWKfi1EREREREREVEF0Pv4IGzQWde6b5qhUXb8rBp//vovrnIiqpRJVrIqHHnoIN9xwgzovH55XXHEF2rZtW2zvVJnQymg0IigoqHyWloiIiIiIiIguLZ0egZ2vRMhlo+DpG6AuSknPwfSft2LT3ji+G0RUbZU4WPXy8kLt2rUdv3ft2hXNmzfPdxkRERERERERVR3GZl3VsH9DWC31u8lsxY8L92HO0kOVvWhERO4TrBY0a9as8l0SIiIiIiIiInIJhsiGCBt4J3wbtFG/22x2LN9yEh/8vBUWW2UvHRGRmwerGpPJhJSUFISHhzsuW7x4Mf744w9YrVb0799ftRCQtgBERERERERE5Lo8/UMQ2v8W+LfrDw8PnWoFuPdYEiZ/sxHJ6ecmtCYioosMVufMmYO3334bgwcPxuuvv64umz17Nl588UV1Xj6Aly1bhpUrV+LDDz/k+iYiIiIiIiJyQR5e3gjqcQ2Ce1wHncFHXRablIl3vt+MfceSK3vxiIiqVrC6ZcsWTJo0SYWnZ86cUZdJhao2mVXr1q3RoUMHVbm6ZMkSzJs3D0OHDi2/JSciIiIiIiKii+QB/7Z9Edr/VugDw9QlWTlmfPHHLiz67wTXLhFRRQSr33//vQpVb7vtNjz99NPqso0bNyIxMRFBQUGqB6uvry+uuuoqdZvff/+dwSoRERERERGRi/Cp1wphV9wJ76jG6ner1Ya/Vx/BF3/uruxFIyKq2sHq1q1bVYAqoarBYFCXrVq1Sv287LLLVKgqunTpglq1amHPnj3ltcxEREREREREVEb6kEiEXT4Gfi16qN+laGrTvli8891mZOVYuF6JiCo6WE1ISECzZs0coapYt24dPDw80L1793y3DQ0Nxb59+8r6VERERERERER0kXQ+fgjuMwpBXa6Gh6deBaonzqRjyqyNOBmbwfVLRHSpglVPT09kZ2c7fk9KSsLevXvV+R498o56aeLi4uDn51fWpyIiIiIiIiKii+BVsx5q3foyPP2C1O+pGbn44Odt2LAnb84UIiK6hMFqo0aNsH//fsTGxiIiIgILFixQR7vq16+PunXrOm4n7QEkWO3UqVNZn4qIiIiIiIiIykjnbUTkDU+rUNVsseLHhfsxe8lBrk8iosoKVq+88krs3r0bY8eOVT1V58yZo9oADB8+XF2fnJysJqz68MMP1eVXX331xS4rEREREREREZWKB2pe8xi8QqPU5FQPv70UMYlZXIdERJUZrN5xxx1YunQptm3bhqNHj6pq1aZNm+Kuu+5S1x8+fBhTpkxR5/v164ebb765PJaXiIiIiIiIiEoouPcI+DXrqr6zT/95K0NVIiJXCFa9vb3x7bff4tdff1UTUzVo0AA33HADjEajo1VAy5Ytce211+L222+HTqcrz+UmIiIiIiIiomL4NmyPkH6j1fklG09g2eZTXF9ERK4QrAqDwYDRo/M+pAsKDQ3Fb7/9djEPT0RERERERERloA+qifDrnoCHhw6nYtMx/edtXI9ERK4UrDo7dOiQagmQmZkJPz8/NYlVs2bNyuvhiYiIiIiIiKgEPDy9EDFyPDyNAcgxWfDU+yu53oiIXDFYXbx4MaZOnYoTJ06cd11UVBQmTJjAiauIiIiIiIiILpGwK++Gd1QT2Ox2TPp0LbJyLFz3REQV4KIan3799dd49NFHcfz4cdUIWypVw8PD4ePjo34/ffo0nnzyScycObP8lpiIiIiIiIiIChXQYSACOw5S38lnzd+DfceSuaaIiFwtWN2zZw/efvtt9WF90003YcGCBdi0aRNWrFiBrVu3Yt68eRg1apS6/r333lMTXBERERERERFRxTBENUbYlfeo89sOxGPO0kNc1URErhisSrWqzWbDww8/jFdeeUX1VHXWuHFjvPbaa3jooYdgsVjwww8/lMfyEhEREREREVEBOt8ARIycAJ3egKS0HLz8xTquIyIiVw1WN27ciICAADzwwAPF3k6u9/f3x/r168v6VERERERERERUFA8dwq8dB6+gmrBYbBg/fQVsNq4uIiKXDVYTEhLQoEEDeHl5FXs7g8GAhg0bIjY2tqxPRURERERERERFCOl7E4yNO6hWfG/P2oj4lByuKyIiVw5WfX19kZxcsibYSUlJakIrIiIiIiIiIio/xqZdENLnBnV+/tpjWLfrDFcvEZGrB6vNmzdHdHS0mrCqOP/995+6XbNmzcr6VERERERERERUgD4kCuHXPK7OH4lOxYxfd3AdERG5Q7B6zTXXqGEGTzzxBLZv317obbZt24Ynn3wSHh4e6vYX4+jRoxg/fjwGDBiAdu3aYfDgwXjvvfeQmZlZ6seS+3z44YcYNmwY2rdvj44dO+LWW2/FwoULL2oZiYiIiIiIiC4FDy/vvMmqfIzIyjHjmQ9XcsUTEV1i+rLeceTIkZg7d64KT0ePHq3CztatW6sJrdLT07F7927s2LFDha+dOnXCiBEjyryQ8jh33HEHsrKyVBDatm1bbNmyBTNmzMDSpUvxww8/qOctibi4ONx55504fPgwatSogT59+iAxMVFV3srphRdewJgxY8q8rEREREREREQVrcaQB+AdUR82mx3PfbQGOSbOVkVE5DbBqk6nwxdffKGqSJcvX66qViUA1UigKvr164e3334bnp6eZXoes9mMcePGqVB18uTJuP7669XlOTk5qlpWgtV3330XL7/8cokeT4JTCVWvvvpqTJkyBd7e3ury1atX44EHHlDPMWjQIERGRpZpeYmIiIiIiIgqUmCXqxHQpq/63v3FHztx5HQqVzj9v737gI6qWts4/iSZ9J6QBAhNeq/SexOpCmJXLBd7Re+n13LF3hD1oiKKDRRRFEERBQQp0nvvHUIvIT0h5Vt7YyJIwAwkZJL8f2sdppyZM3tmckjmmX3eF0BRClaNgIAAO2vUhKom4DSH6yckJMjf31+VK1e2h+03bNjwogY4efJkW6O1devWOaGqYZphvfrqq+rUqZO+//57W3IgKCjovNsywe/s2bNVsWJFG/Z6eXnlrDMzV832TcBqng/BKgAAAADA1XhH11B4l9vt+UXrDmjS3B2FPSQAKLEuKljNZg7PN0tBmDlzpj01NVX/LjQ0VM2bN7e3MYFojx49zrutX3/91Z6asgKnh6rZXnrppXwbNwAAAAAA+cnDP0RR1zwuNw+HDh9P0iufL+YFBoCiFKxmZGRo586dtgGUmdUZGRmpgrR582Z7WqNGjVzXV6tWzQarmzZt+sdgde3atfbUzKI1pQWmTp2qNWvW2Odk6rb27t07pzQAAAAAAAAuw91DkX0fkyMwXCfTM/TYu7MLe0QAUOLlOVhNS0vT8OHD9c033+jEib/qt9SqVcsehm8OpS8IBw8etKdRUVG5ro+IiMhpSvVPTCBsmGZVDz30kC0xkM08L1PW4KOPPlKVKlWUn0zdGxPeFjfF8TkBAAAAgCsK63izfCvWsZ8vzUzV2IS0wh4SgBLK/D+UmXlxDfNOz5RcLV/K7huVb8GqebHuueceLVy48KyNr1+/XnfffbdeeOEFXXvttcpvycnJOTVVc5N9vZmB+k9M/Vfj8ccfV7ly5WzzKhMM7927V2+99Zb++OMP3XXXXfrpp59s/dj8fA4rV65UceTp6VnYQwAAAACAYs2/ZkuFtLjKnv9h5lYt2/jPE4sAoKCYRvPmCPD8kp/butTc83IjEzQuWLDAhqpXXnmlhg4damd2Pv3006pUqZINXl9++WUdO3Ys3wfo4eGRb2lyampqThg7evRoNW3a1AaoNWvWtLNVq1evbmexmmZYAAAAAAAUNs9S5RTR+0F7ftOuY/pi8vrCHhIAwJkZq7/88ovc3Nz01FNPacCAAWesu+GGGzRw4EAtWbJEU6ZM0U033aT85O/vr9jY2JxQ9O9SUlLsqZ+f3z9uy9fX185a7devnwIDA89Y53A47HN58cUXbYh8++2nuizmB/O456oRW5SZqdobN24s7GEAAAAAQLHk5uWrqGuekLuXj+KT0vSf4fMKe0gAYI9eNv2LLjZTyp6pavoe5XVi5aVg+jhlH0GfL8Gq2WBISMhZoarh5eWl++67T4sXL85pDpWfTHMsE6wePnxYZcqUOWt9dm3VvDTRCg8Pt8GqKQOQm+zr83vmrQmlXekHBAAAAADg+iJ63ievUtHKyMzSk+//ofT0i6tpCACumHN5eHi4VG5mnl++lgIwwWbZsmXPud4ky8aRI0eU37Jnem7ZsiXX9Vu3bj3jdnnZVnZDrL8z4W12AAsAAAAAQGEJbNRVAbVb27J3w79fqT0HT/UMAQC4jjwFq2lpafL29j7n+uxGT3mdJuuMDh062NNp06adte748eNatGiRHVvLli3zvK3JkycrPT39rPVz5syxp82aNcuHkQMAAAAA4DyvyIoK73qnPb9k/QFNW7SblxEAimqwar4hy8s0WNPEKr916dJF0dHRmjVrlr755pszaqs+88wzSkpK0nXXXaewsLAzupNt27bNLuZ8th49etjD/bdv366XXnrpjHD1u+++09SpU23Jg6uvvjrfnwcAAAAAAP/EzdNHkX0fk7unl2LjU/TKF4t50QDAReWpxmph8vHx0RtvvGEbZA0ePFjjxo2z4eiKFStsfdW6detq0KBBZ9zHHOpvQlRjxowZObVTTROp//3vf3ZbJqSdOXOm6tevr127dmnz5s05j3V6SAsAAAAAwKVSqttAeZUqp0xTV/WDuSqA+UsAgEs5Y7WwNW3a1M4o7datm/bt22dnrwYGBurBBx/UqFGj5O/vn+dtmSB20qRJuvXWW23jLbMtU1KgV69eNrTNLhcAAAAAAMClFFCvgwIbdLRHjY6cuEb7DifyBgCAC3P5GavZqlevrmHDhuXptmaG6qZNm865PiIiQs8++6xdAAAAAKBIc3O3jY58oqvr6IxRykyKK+wR4QJ4hker1JV32fOrthzWz/N28DoCQHEJVpcvX65atWqdc72pwXq+25j169evv7BRAgAAAADO4lOxrkpdcadtdmRkJJ3QsRmjeaWKGDeHlyL7Pi53Lx/FJ6bphZELCntIAID8DFbNoQgAAAAAgMLnCI5UeJfb5F+zxRkNhwNqtdKxGV+aawp7iHBCeNfb5R1V0dZVferDuUqnrioAFJ9g9bXXXiv4kQAAAAAA/rFjfEjrfgpu3lvuDi8bqO7cH6f/fbNC7wxqL0dwhLyjqys15tyl0eBa/Gu1UlDjbva9HDV5vXbtjy/sIQEA8jNY7du3b163BwAAAADId24KqNtWYZ1ukSMw3F4Tn5Sm/327QovWHrCXDx5LUulwfwXUbk2wWkQ4QqIU0fM+e379jmP6YdbWwh4SAKA4Nq8CAAAAgMLm5u2ngDptdPLIXqXEbJYy0gv8Mb3LVlV41zvlU66GvZyekakJs7Zq9C8bzrjdzKV7dGO3mvKv1VJHp38hZXE8uUvzcCiq32Ny9/ZTYvJJPfvR/MIeEQDASQSrAAAAAJAXbu4q3f8J+VaqZy9mnkxVyp6NStm1Rsk71yp1/7Z8DTM9AkIU1uEWBTboaC+bQ8WXbzqkN79cqqSUswPdH2Zt0Q1X1JAjMEw+5WsqZTfNg11ZeKdb5V2mqjKzsvTsiHlKp7AqABQ5BKsAAAAAkAeh7W+woaoJOE1vX3dPb/lVbmAXIzM1Scm71ytl51ol71qjtIO7LqyJlIdDwc16KbR1f7l7+9qr9h9J0Oujlmr7vhPnvFtKWqb2HUlUdESAAmq3IVh1YX7Vm9n32Phm2iZt3Xvu9xUA4LoIVgEAAADgH/hWbazQ1tfY8z/9sV2f/LhWzWuXVvsm5VT7sjCFBfnYQ7r9q11uFyMjKV7Ju9bmzGg9eTTmH19nv+pNFd75NnmGlbGXk1PT9fGENZq+ZHee3qMZS3ZrQI/a8q/ZQkemfkI5ABfkCIpQRK8H7Pkte45r7DQajQFAUUWwCgAAAADn+9AUHKHIPo/Y89tjTthQ1Vi0/oBd7G3cpdYNotWuUbRqVAxTkL+XPPwCFVCrpV2M9ITjSt655tSM1p1rlH7iUM5jeJYqr/Cud/w1+zUzS1MX7tSICauV6UR1gR9nb9Mt3WvJwz9YvpXqKnnHat5bV+Luoci+j8rDN8CG5k8Pn1vYIwIAXASCVQAAAAA4Fw+HIvv9OycIe/L9ObnezJTHnL0ixi6Gl8NdHZqUU5sG0apaPkQBvp5yBIQqsG47uxgnYw8qZddaZWVkKLBhZ7m5e9gyAxt2HtNrXyxWbEKa0+9LWnqm9h6MV4XSQfKv3Zpg1cWEtb9RPuVq2vf5hZELbPkGAEAxD1a///57RUdHq2XLU9+0AgAAAEBJEN7ldvmUPdVg6L8j5uc5CDMB57RFu+1i+Pk41LlpBbWqV0aVo4Pl6+2QZ0iUXbIdPZGsIV8t07rtRy9qzNMW7tbAq+vKv0ZzHfl1pJR5dqMrXHq+lRsqpFVfe37CrK1at+MYbwMAlIRg9d1331V4eLh+/PHHnOueeuopXXbZZbr77rsLcnwAAAAAUCj8a7dR8OXd7fmvp2zUpt3HL3hbSSnpmvTHdrsYIQFeuqJ5JTWrG6WQAB/9PG+7Js7ali/jnjxvm+7sU0cevoHyvay+krctz5ft4sJ5BIQqss/D9vzOfSf0+c/reTkBoKQEqydOnLDB6ukmTJigJk2aEKwCAAAAKHY8w6MV0fM+e37d9iP6dvrmfN2+Ocx/3IzNdslvpizBrgNxuqxssAJMOQCC1cLl5q7Iqx+1dW9T09L15AfUVQWAEhWshoaGasuWLfruu+/UtGlTeXl52evT0tK0b9++PD9Y2bJlL3ykAAAAAHAJuHn6KOqa/5O7l4/ik9L07IfzitzrPmXBTt13TQP512imI794KivjZGEPqcQKbdNfvhXr2rqqL3++2M5eBgCUoGC1c+fOGjt2rJ577rmc69zc3LR27Vq7Li/M7dev53AHAAAAAK6tVPe75RVRXpmZWXry/T/sDNCiZsrCnbq7bz15ePvJt0ojJW1eXNhDKpF8KtZVSNtr7fnJ83Zo5ebDhT0kAEA+cs/Ljf7973+rQ4cO9rz5lu1ClszMIvjXCAAAAIASJbDxFQqs195+hvlowmrtOZigosh8/Noec8KeN+UAcOm5+wXZEgBubu7aeyheH01Yw9sAACVxxqq/v79GjBih5ORkW281PT1dXbp0Ub169WxjKwAAAAAo6rzKVFGprnfa84vXH9Av83eqKJs8d4cevTFUftWayM3hpaz0tMIeUgnipsg+j8gREKq0kxl64r0/CntAAIDCClaz+fr62iWbqbUaHR1dEOMCAAAAgEvG3SdAUf3+LTeHp46dSNHLnxX9Q+dnLN2jB69rKIeXr/yqNlHixgWFPaQSI7jl1fKr0tDOfH5z9FLFJ1HjFgBU0oPV023cuDF/RwIAAAAAhcJNEX0ekmdIpNIzMvXvYbOLzfuwdW+salYMU0CdNgSrl4h3uRoK63CjPT99yW4tWn/gUj00AKCoBKvZTO3UyZMna/r06dqxY4cSExNt6YBKlSqpXbt2uuqqq+Tp6Zk/owUAAACQP9zcbdf7zNSkEv+KmtmF/tUut7ML3/56uQ7HphSb1+SnOdtV89Yw+VZpLDcvH2WlFZ/n5mocQRHyLlNF4V1vl5u7hw4cTdSwb1cW9rAAAK4arB48eFD333+/1q9fb/8IOd3mzZv122+/6euvv9Z7771HyQAAAAC4PEdwhDwjyis99rDSYw8W25qUXqUrK6rf4/LwC9a+L59V2sGiXUv0YvhUqKOwDjfZ878v3aM/VsaoODHPZ9CNjeXp6SX/ak2VsI5an/nBwz9E3mWr2iDVu8ypUw//4Jz16emZ1FUFgBLggoPV1NRU3XXXXTZA9fHxsc2s6tata2erxsXFae3atfr9999t6PrAAw9o3LhxtiYrAAAA4IocwZGKvvNNefgF5lyXnnBc6ccP6mTsQRu0njTnjx+w5zMSYiWdObmgKAhs3E2lut5ha4kapa68W/tGPVMkn8vF8ggIUWTfQXJzd9e+Iwl695sVKo427TqmulVKyb92a4LVC+DuG5ATnmafOoLCz7qdmWxkGlUdOJakD75bqePxqfnx9gEAimOwOnbsWBuqXnbZZRo5cqTKlSt31m327Nljw9dNmzZp/PjxuvHGU3VmAAAAAFdiOqZHXfuEDVUzs7LkZq5zc7Mdvc3iU77mWffJPJmq9NhDZ4Sup5+62mxXcxh4RI/7bK1NIzY+RcEB3vIpV0OBDTopftUMlShu7oq8elBO1/Z//2+OiquJs7bZYNWvSiO5e/tR/uE83Lx8/wxQs5eq8gyNyjVEPZmeqSOxydoac0IrNh7S/DX7lJSSXpBvJQCguASrv/76q/1j85133sk1VDXKly+vd999V1dffbV+/vlnglUAAAC4pIheD8g76jJlZmbp8f/N1ta9JxQZ6qtal4WpSnSIKpQOVGSon0ICvOXr45CHu5vcPb3lFVHeLrkxs11PHolR7MIflbxtuQqTZ0QFRV3zb3mFR9tAaNG6A3rl88V65o5malG3jMI63aLETYuUmZKgkiK0/Y3yrVjXvh4vfbaoWHdtN82TTHjs5emQX43mSlg9s7CH5DLc/YIUUKuVvKOr2xDVq1R0rrczh/YfjUvRjphYrdh8WPNX71Nsgmt9eQIAKELB6rZt22yDqpo1z/72/nRmvZnVun379gt9KAAAAKDABDfvY2dxmoDtowmrbahqHDqerEPHYzR7+dk1N70c7qpWIVQ1KoSqUpkglYnwV3iQjwL9veTt6XHGbFffSnWVuGWpjv72udKPX/ru4AH1O6rUlXfZIDgjM1Mfjl+tqQt32XVDvlyqsS/3kJdfkMI63qQjv36sksCv2uUKbd3Pnp84e5tWbj6s4m7DjmNqUD1CAaYcAMGqfMrXUmDjKxRQs2VOWYxsGRmZ9jD+XQfitHLLYc1ftc/+fwAAQL7WWDX1VPPCz89P+/btu9CHAgAAAAqE72X1FdbpVnv+j1X79Mv8vDVxSkvP1LrtR+2SGzvbtVKY+rSromrlQ2zHeb/LGih20STFzhuvrJMpl6S8gQlUzWH+xomEVD3x/h/adzjxjOfx+aR1uqdffQU26qr4lTOUun+binst3YjeD9nz22Ni9dmkdSoJvp+5xQar5mfe3TdQmcnxKmncvP0UWK+9ghpdIa/ICjnXp6Sla9Ou41q77Yjmrd6nPQdLzsxtAEAhBatlypSxs1YTExPPG7Ca9eZ2kZGRF/pQAAAAQL5zhEQpsu/jtnFRzOEEO3szv+TMdl0RoyY1I21XdlPP1MySDKzfXkdnjFbiurkqKJ7h0Yrq97i8Iivambjm0OUXPlmgzMyzb/vzvB02AC5Tyl/hppHVF09JWbncsBhw8/C0JRE8fAOUnJquJ9//QyWFmZWbmpYuby+H/Gu2UPyK31RSeJWpoiAzO7V2G7l7+djrzH5h9vtx0zdr5rK9hT1EAEAR5X6hd2zZsqVSUlL05ptvnvd2b7zxhp3dam4PAAAAuAI3T29F9X8yJ2B77N3ZBfZYyzYe0i2Dp+jb3zYpPSNTjsBwRV09SGVufUleUZfl++P5126j6DvftKGqqRn76Y/rNPjj3EPVbK98scgGTT5lqyqwYWcVV+Fd77ANiUyDsv+OmK+UtOIZIJ/Lmm2nZlibmqIlYR83P8vRd76hcne+qaCGXWyoamrN/rEyRv96eZrue+N3QlUAQOHMWL3jjjs0YcIEjRs3zh7mP2DAANWpU0eBgYGKj4/XunXrNGrUKM2bN0+enp729gAAAIDrNKs6FTw+PXzuJenk/dWUjfph1lb9Z0BTNTSHZFeoreh/vWlnDh6bNfaiD802szFNcBjUpJu9nJCUpv8Mn6td+/95u+Y25hDoNg2iFdbx5lONrJLiVJwE1GlrXxsTII/5daM27T6ukub7GZt1ea0o+VSsKw//EGUkxqq48Ywor6DG3RRYt53cfU4dWWne84PHkjRh1tY8l/sAAKBAg1XTuOrll1/W008/rblz59rl78wvMIfDoZdeesk2sAIAAAAKW3CLq2wDn783q7oUTID73McLVL1CiJ4c0FSRoX42BPKv1UrHZ3+juOXTLugwfFPWwBzi7l26sn1e63cc1bMfzlO6E5sa+vVyNa0VJW/fQIV1vEVHJg9XceFZqpxK9bjXnl+7/ajGzdiskmjdjmN2hravt0P+tVoqbumvKg7MlwqmvIFpRmW+sMhmZogv33RIn/20zh72DwCAywSrRp8+fVSxYkUNGzZMixcv1smTJ//asMOh5s2b66GHHlLDhg3zY6wAAADARfG9rIENDY05K2IKbfba5t2x+tfLv6l3m8t0e6868vINPNVoqlFXHZ32qVJ2r8/ztvxqNFNErwfl4eNvD3E3szEvJDhMT8/UxxPX6KHrGimoYWfFr5yu1JiiH0C6+wYo6pr/s4eBxyWm6bkR81SSrdpyWC3qlrFhflEPVh2hZRTUqKsCG3SUh1+Qvc58sXAsLkWT/tiuCbO3nrcEBgAAhRqsGg0aNNCnn36q5ORk7dmzRwkJCbaZVYUKFeTr63vRAwQAAADyr1nVY7ZZ1d5D8XprzLJCf2Enzd2hXxfuss2t2jYoK++oSip760tKWDfXNrjKiD9VEzNX7g6FdbpFIc1724tJKSf134/m29D2Qk1btFt9O1RTucgAG/TGfPZkkW1kZWYxBl3eXSGtr7G1dDMys/TEe384NYu3ODK1fk2wamZ2egSGKSP+mIri4f7hXe6QX+UGOddlZGZq7daj+mzSOm3fd+lmoQMASraLDlazmRC1evXq+bU5AAAAoMCaVQ16Z47LvLpmpuiQL5dqzBR/PX17M1WIClRAnTbyq3a5Yuf/oBMLf1JWxl9HhhkeQaUU1fcx+ZSrYS9v3n1cT30wV2n5kBq+/NkiffhkJ1tWwNQkLXqzGt3s6xfa4SZ5hkTaa0zDone/WcHh4JItfZGYfFL+vp62idWJxT+rKPEMK6OyN78gD/9gOzv1REKqpizYqW9nbLH7EgAARTJYBQAAAIpCsyoTQKakFXyzKmftO5yoB4fMVNuG0XqgfwP5+/oorMNNCmzQWUenf66kzUvs7XyrNFZkn4fl4Rdog6XvZmzRl79uyLdxmFqUs1fEqEPjcgptf6MSN8xXRmLRmAFomjKFdx4g7zJV7GUzS3XGkt368PuVJX6m6ulM3VHzc+Zfu3WRClbNDNvSNw22oWpqWroGf7zA1o0FAKCwEKwCAACgWAtueXVOs6oPf1itbTGuHRL+sTLGLvf0racerS6TZ2iUSl/7HyVtW6G0I3tzDv1PSU3X8yMLJlj639hlalGntHx8/BXWaYAOT3pPLn9oeKcB8qva2F4277UJD4eOWab4pDNn+0L6dvomtWlQVj7R1eUIjlT6iUNFolZumRufk2dwhJ2ZOujd2dpzkIZUAIDC5V7Ijw8AAAAUGN/KDRXW8WZ73szCNIcMFxUfTVij216Yog07j9mg0K9Ko5xQdce+E7r1+akFNlvPHFFtQmjzuIH1O8in/F+d1l1tBmOpnver3MC3bahqxrs95oTue+N3PT9yIaHqOezaH6+E5FOBs3/tVnJ1bp4+Kn39M/KKKG9nIT/14VxCVQCASyBYBVByubnLv2ZLeUVWLOyRlGiO0NJyc3gV9jAAFNP/XyKvHiQ3N3ftPRhvZy8WNbEJabbhkmlKZTqdm1IGP87ZpoeHzirwcga/L92jvYdOzQgsdeVAyd1DrsLNy9eWKSh/3/sKatjZNiQ7EptsX6dH3p5FLdU8WLbhoD01s7ldmodDUf3/z86uzczK0iufL9LGnccLe1QAAFiUAgBQInlFXaZSPe6VT9mqyspI17Hfv9KJxZMKe1glikdAqMK73qmA2q2UErNZ+0Y/K2VmFPawABQTdoZbdrOqlHQNetd1mlVdiFVbjui2F6Ze8sd96dOFGvFUF/slZPDl3Qu/Hqe7h4IadVFo2+ttnU0jKeWkPv1praYt2l24Yytixv62Se0bl7NNyhyhZZR+fL9cjpu7Ivs8Ir/KDe1s5Pe+Xakl608FwgAAuAKCVQAlriu0+TAW3LyX3Nw97B/pbh4OhXe9XT7la+rwzx8oMzWpsIdZvLm52y7TpiGLu7efvcrMQglpebVi540v7NEBKCYiej8gr8gKdobnf1y0WVVRsP9okn5fsltdmlVUaLvrlbB+njISCme2oF+N5grreIu8wsvay6bO5sTZ2zTql/WFMp6izjRLi0tMU3CAt/2S0xV/B5e68i47NvP32qjJ6zV9CeE5AMC1UAoAQImqs1fu7ncU0vIqG6oePp5kD6Wcs2Kv/YPdv2YLRd/5pryiKhX2UIstr9KVFX3HayrVbaANVZNT07V662G7LrTtdbb5CABcrJBWfRVQ61QYM3z8Km3f59rNqlzde9+ttLN+zf/b4Z1vu+SP7x1dXWUHvKzS/Z+woaoJy83v7uufmUyoepEWrTvgsuUAQjvcpKDGV9j92ATo42duLewhAQBQMDNW//jjD82cOVPbt29XfHy8xo8fr7i4OI0ePVo33XSTwsLC8uNhAOCCmEMF7SHnddrYyxkZmfp2+maNnbbJXh7y1TIt23hID1/XUJ5hZVT29td0dOqnil85nVc8H2vhhXW4UUFNuts6eOZD0pwVMXp37DLbIGX04G4KDfJRRK8Hte+Lp6SsTF57ABfEt0ojG8gYs5bt1dSFu3glL1JmpvTB9yv1+M1NFFC3reJWTlfKrrUF/rqaw9NN47GAWi3tZfO7Y/2Oo3rzy2W23iwu3re/bVLXZhVsqQfPUuV18sgel3hZg5v1Vmjra3L2488mrSvsIQEAkP/B6tGjR/Xoo49q6dKl9rI9pNbNzZ7ft2+f3n//fX355Zf6+OOP1aBBg4t5KAC4AG4KbNhJYZ0G2Bp75v+obTEn9MLIBbYZyN8bdKzbflRDHm6r0EAfRfS8Tz7la+nIlI+VdTKVV/8imAZh4VfcKUfgqS/ZDh5L1EufLbIdibOZzs3vPtbe1rwNbtFHJxZM5DUHcGHNqq561Dar2nMwXm+PXc6rmE9mr4hR/07VVKlssD08e+/Ix6XMgimv4OEfopA2/RXUqKst12N+f8ccTtBbXy2zv8eRfw4dT1ZsQqr928fMWj0+55tCf3kD6nWwJZqMZRsPsh8DAIpnKYC0tDT961//0pIlS+Tv76+uXbsqKirqrw27uys4OFgnTpzQHXfcoZiYmPwaMwD8I8/waJW55QVF9Lzfhqqpaeka+vUyDXpn9lmharaDx5J0+4tTtXTDQfshLrB+B0Xf/rrdFpznCIlS6eufUdQ1/7ahqqmF98XP6zTwlelnhKqGOUz3t8WnZpWZGn685gCc5eb1V7Mq08zosSLerMoVvfjpQnsYvlepcgpu1jPft+/m7afQ9jeo/P0f2EZZJlSNjU/Ra18s1n1v/E6oWkAWrD7VtMq/disVNr/qTRXR6357fsue4/aLVwAAimWwOmbMGG3cuFENGzbUtGnTNGzYMEVH/xU+VK9eXTNmzFCjRo2UnJyszz//PL/GDADn5uFQSNtrVW7gUPlWrGMD0oVr9+uG//6q2ctj8nS44wufLNTHE9ac+vAYWcHWXfV3wdpjLsvdYesblrv7XflVbWzfgzXbjujmwb+etz7ae+NW6URCqtwdXoro9YBtcgUAeWVKiWQ3q3ryfZpVFYTDsSl/fQnW9jp5BIbny3bdPDztod8V7v9AoW2ulbuXj63B/cnEtbr1+alasPZUHVAUDFMeyfyu9gqPLtQ68z4Vaiuy72O2Dv6+Iwn69zC+HAEAFONSAJMnT7azUocMGXLOGqoBAQF666231K1bN1uHFQAKkjl0v1SPe+1MGsPMcnn1i8XasNP57sU/z9uhNduP6LX72yjQz0dRfR/TifK1dHT6F1IGnaXP+x50v0defzahik9K09Axp2rY5sXzIxfo7Ufby6dcDTsb6sSiSU6/dwAKpla1qcGYmZKojJREe2oWV6mHHNKqn63DacIhUwt05/64wh5SsfX+d6vUpkG0/H197OHah34YeuEbc3NXQL32Cmt3vRzBEfaqk+kZ+nH2dppSXUKmXq1ZwoN95V+rtdIO7tSl5hV1mUpf95T9ctWM5YEhM+2X3QAAFNtg1TSqqlKlisqXP38HZzOLtVKlStq9e/eFPhQAnJe7j7/COt1qa7EZZrbSpD+26ZOfLq7RgTlcfcDgX/XyfW1Up3K4PSzRu2w1HfrhLaWfONXJvqhw8/RRcIve8vALtmNPjz2ok3+eZiYnXPT23X0DT70HDTvnvAdTF+7U8PGrndrO1r0nbL3bzk0rKLT9TUraslQnj506RBFA4fCt0lhR/R63swj/LjM16bSgNSHnNCMl6bTLJoxNUGbyn7dJTbTnszIz7KHebg5PeyoPc+opN4fj1PU5l0+tz7nO4WmPTji13iEP30AFt7zKjmfmsj2atoi/OQvasG9X6D+3NVVArVaKv2y6knescnobfjWaKaz9TTlfxGVkZtr//83vDVM6BpfW3JUxuqp91VN1VmeNuaSPbRqHlrnxv3L39lNC8kk98MYMfgYAAMU/WM104itET09PeXh4XOhDAcA5mUP0w7veIUdAqL1smpWYWY+mGUN+MJ/t/vPBXF3fpbpuurKmba4U/a+3dPinYUrauqxIvDNeZarYZi5e4WVzXW+CkZOxh5V+4pDSYw/Z05OnnWalJp13+wH1Oyq88wB5+AXlvAemnIKpWXsh3v1mhZrWLq0g/1MlAfZ9+ZzLzIoDSpqgJt0UfsVAubm72+DLcHdzy2lWaoIQs+jP2YaFafeBOL0zdkVhD6NEmL9mv7bHnFCVciEK7zZQe0cOyvPRHD4V6iis0y3yia5uL2dmZWnJ+gN6++vlSkrhiJDCMm7GFvVpV0WeoVHyLlNFqfu3XZLH9QgMU+mbBttZ8aYe/oNDflcCPwcAgJIQrJqZqDt37lRCQoI95P9cjh8/ri1btthZqwCQX8whg6WuvNvW8Mw+dPCTH9fql/k7C6z+2MrNh/XSva3k6xug0tc/rdj5E3Rs1tcuHPq5KbhFH4V1uMnO6jKhyNY9sQoJ9FGQn5e8vTzk7u5mQxHvqIp2yU1GckJO6Jo9y9XMes1MTbaNpkwtWyPtZIY+nrhGUxeeqr93MV78ZKGGPNzWlhYIury74pZMvuhtAnCGm52FHvLnTNC9hxL0yNCZSvtzJqGXw10RoX6KCPVVeJCPwoJ9FBLorSB/bwX6eSrAz1N+3p7y9XbI29NDnp7ucni4y8P9VCCbHcyezhzGf+pUyvrzslnMDPjMrFMz4TPM+cxMe2qXjEylZ5zqGD90zFLe4kvoxU8X6fP/XmG/tAtpcZVi543/x0O9wzreJL8qp35vm/d2/Y5jGvLVUh09kXKJRo1ziUtM0+HYZEWG+sm/dptLEqy6+waozI3PyTM4ws5QHfTubH4WAAAlJ1ht3769PvvsM1tj9YUXXjjn7V5++WVlZGSobdu2F/pQAPAXN3dbezO03Q32sFTzwWz11iN6+bPFSkkr2Jkum3Yf14Dnf9UbD7ZV5egQ26DJO7q6Dk18WxkJsS71LpkZIJG9H5LvZfXt5SOxyXbm7d9nkQb4OFSjUpiqRIeoQulAlQ73U1iQjwL9vOTleSp4NR22zeJdunKuj2Xeg6UbD+r1L5bkhC758VrPXhGjDo3LKazjzbYkgAl0ARQ8N9NArs/DtmapsWLTIT338YIzbmP2dRNmmsVZ7u6yYayp1W9mqJlZivn1fwcuHVMH85f5O9SrTWWFtL5GCWvn5FomxxFaWmHtblBA3bY5vzN27Y/TW18vsyV34DrmLI9R/87VFFC7lY7NGG3erQItUVT6+mdsKQjzJclTH87VnoMXX5oIAIAiE6z+61//0vjx4zVu3DgdPXpUvXv3Vnz8qT+Otm3bps2bN2vMmDFatmyZ/P39dfvtt+fnuAGUQO4+AYrsO0h+lRvay6YO15Avl2r5prw1RsoPKWmZeuTt2bqzdx1d3b6Kna0Z/a+hOjTxHaXsWitX4Fe9qSJ63m8PzTcfYE3NOnN4fW7M4XamsdS5mkuFBHipRoUwVSkXrHJRfwWv/r6e8nJ46Hh8it4YveSCGoT9k3fGLlOTmpEK9PNWRK/7tf+r5wv0Qx4Ayd0vSKWv/Y9tIGf+/5g8b4c+mrAmX18aU1HAdJdH0Wd+NswXYAF+3grveqcOfv9GzjoP/xCFtL1WQQ27nKqhK+ngsUT975sVWrPtaCGOGufy3e+bdU2nqnIElZJ3uepK3bupYF4sD4ei+v+fLQdhSkG88vkibSyAvyMAAHDpYDU8PFzDhw/X/fffr+nTp2vGjBk563r16mVPzR/kfn5+evvttxUVFZU/IwZQInlGVFDpa5+UZ2hp+3/LjCW79b9vVxbaeD6btM4Gus/e2VzeASEqc9NgHZ/zjWLn/VBo4Z+ZZRbe5XZbE9EwM8Fe/WLJRQXPsQlpWrT+gF0uNRO+vPLZIr32QBv5Vqxrn1fcsimXfBxASeEZHm1nkJkai+b/2Y8nrNHP83YU9rDg4t4eu1z/vbO5/Gs0k2/VxkrZs9GWBghu1iun4dmJhFSN+GG15q7aV9jDxXmY2eMHjiapTCl/28SqQIJVN3dF9nnEfklu/p9579uVWrKeI1IAAEWX+8XcuUmTJvrpp580YMAAlSlTJqcWlllM8Nq/f39NnDhR7dq1y78RAyhx/Gu0UPTtr9lQ1dTTe33UkkINVbOZmqu3Pz/F1h40jV1MLVNTe9XM+LrUvCIrKvrON3NC1c27j+uWwVMv6WzegrBux7GcD+Km3qMjOLKwhwQUSz4Vaqvsba/aUDU9I1PPj1xIqIo8MaHY5j2nZhtG9LhPFe4frtA2/W2ompySro8nrNYtg6cQqhYRM5ftsaf+tVrZEDS/lbpyoC01YD4vjpq8XtOX7M73xwAAoEjMWN2xY4dtSGVmoj799NN2SUpKsuUAzCzVwMDA/B0pgBLITaHtr1dom2vtpfikND3+7mztP3ph3eYLgjmU/r43Zuih6xqqa7MKtplWhYc+UuL6+YpbPlWpMZsLfAxBTXsqvNOtcnN42uYuo39Zr/Ezt6q4eGvMUjWuESl/Xx9F9LxP+78+d11vXDg3L1872zorjUO0S5qAuu0U0esBe7i2CcJMA5kLqZ2KkuvlTxfpi8FXyhEYltPMcOLsbfry1w2FPTQ4acKsLbrxihpyBITaBpIpu9fl22sY2uEmBTXuZkNV8/NRnP5WAQCUXBccrD788MNKTEy0dVZDQ0PtdSZQNQsA5EfIE3nVI/Kv3tRe3rY3Vv9+7w/bNdYVvTdupZZtOKhBNzaWj7eXAut3sEvqge2KWz5NCWv/UNbJ/A2sPPyDFdHrQRvmGqbe6VMfzCt2gYgpCfDqF4v18r2tbDOuwEZdFb/it8IeVrHiGVbGzlY05STilv6q2IU/KjOZpjIlQUib/gprf2NOk7uHhvxuvzACnC0b88nENbrhihpatG6/Pvx+lVz01zXyUEs+5nCiykUGKKBO64sKVj0CQuRToY58K9Sxs+JNoypj9vK9tqQSAAAlOljds2ePPfw/O1QFgPziGVZWUdc+Ka9S5eyshikLd2n496tc/gWev2a/5q+ZrM6Xl9d1XarbGmXepSsrose9dkZp/No5ils2VSePnDrM7mL4Vm6oiN4PyREQYl+jP1bts428iqvVW49o4dr9almvrMI7D1DSthXKiDtS2MMqFtx9/BV13VO22ZkR0qqvgi7vrhNLftGJRSZgLdyg3qtMFQU37WnD35PHD+jk0X06eWzfn6f78/0LixLD3aGIHvcosEEne3HT7mN64r0/7BcZwIUw9XipyVs8zFiyS7f1rGNLMR2Z8omUlbf/GDwCw06FqBX/DFLDo89Yb/5eWbLhoIZ+vbyARg4AQBEKVv39/ZXJX98A8plvlcaKunqQ3H38lJGZpWHfrrBd7YuSGUv32CUqzE8Dr6qry2tGyeHjr+DLu9sledc6WyYgceMiKdO5mWFuHp4K63izgpv3zjnc8s2vlmrR2kvfXOpSe3P0Eo15qYf8fPxsHb8D37xU2EMq+kwTkasfsx9+MzIzbQf4K5pXlI+Xj0Jb97M/ryeWTNaJRZOUmXIpA1Y3+VVrYn/OTeOybKaD9N+lxx3VyaMxNmRN+/PUXE4/cTjPYUBJ4+7tp6hr/s/OADdBx+wVMRo6ZllhDwuAi5g4Z7tu7VHbHhnjW6meknfk/uW2Izji1IzUirXtqamFfzrz/4v5O8XUol+x6bB+W7JL+w4nXqJnAQCAiwerN910k9577z199tlnuvPOO/N3VABKJDNTztTfcnNzV1LKST3x/h/atb/oHo588FiSXvl8sdzdpb7tq6p328oKC/KRb0XzIaSO0hNiFb9qhuKX/6b0uMP/uD3PUuUUefWj8o66zF7eHnNCzwyfW2IO2zWHlb42aolevLul/Ko0VGCDzvb1w4UL73KbfS3Nh9+3vlpmm8uMnLhWN3erob4dqsrb29c2oQm+vMepgHWxCVgL7kOx+eIgoF57BTfvI69Sp2Y6mbGZfWnRugOKjghQ6XB/hQV5y8fLIXd3NzmCwu1iQsLTZaWfPDXDNWd26z6l/XmamRSnksoRFKHSNzxjD8k1r+2YKRv17fSCrwUNoOgwZZf2HIxXxdJB8q/dOidYdYRE2b9fzGxUG6SGnNlQ0vyfknoyw97XlEf6bfFuHTqeXEjPAgAAFw9W69Wrp8aNG2vIkCEaM2aMGjVqpIiICPn4+JzzPo888siFPhyAYszN09vWCjVdYg3zB/lj786ydb6KAzO53zRoMEvVcsG6s09d1bks3B7GH9r6GoW07KukbcsVt2yKkrettA2E/i6w8RUK73KH3D29bIOqb3/bpK+nbVJJs3LzYS1Zf0DN6pRReJfblbR9hTLijxX2sIqkwIZdFNyslz3/w8ytZ3TsHjN1k10G9KilPm2ryNvHT6Ftr1VQ0x42XD2xeLKyUvOviZy7b6CCmnRTUJPudr/I/oBuOo2PGL9aW/eeyPV+ZlZ4vSqlVL1iqCqWDlRkqJ+C/L3k6XC3zdxMeJhd0+90GcnxSt65VkemfFyiQlZTVqH0dU/ZpjTm/5EhXy2lUzuAXE1duEt3X11P/jVb2MZ25ugB8yXW6cz/0ylpGdp9IE5L/wxSj56gPAsAoGRxyzK/ES9AzZo15ebmZn+h2g25uZ3ztuY2Zv2GDSWrM6h5vklJSbahV61atVTcZGRkaN26dapfv76yMtK14/XrC3tIKIIcwZG2nqp3VKVTh6Qu31siam95Odx185U11bVZRQX6e+Vcf/L4QcWtmKb4Vb/bwMcEThE975d/jWZ2fVxiqp75cL527i85YdDfOdylr1/qKV8fh5K2LtOBb18t7CEVOWa2UZmbBtsPyys3H9J/P1pwztuaGde39aitXm0qy8vTw16XkZzwV8CaduGzkRyhZRTcvJcC63eUu6f3qW1nZNrw/MMf1uhY3IV9QDdjrl4h1H6BUaVciG3CEh7sI38fTzvLNftvlvS4Izo4fohS9xX/ztR+1S5XpCmz4uVjZ5T95/0/zhlYA4D5XTv+jT72/8xs5u+05NR07dofp8XrD2j64t22cRkAoOS4rGyQhj3eMd8ypZUrzcQiqWHDhvLwOPVZo6jleRc8Y7Vp01OdugHgQvlUrKuofo/bpjlm9tRHE1brl/k7S8QLmpaeqc9/Xm+XxjUi7czAytHB8gyNso2uwtrdoMRNi+RToZYcgeH2w4w5FPq1UYtLfHMZUxLgza+W6Ll/tZBf1Sb20PGENbML+y0tMsyhnKa+pglVDx1POm+omj3j2vycjvplvW7vWUc9W18mL98A20k+uGkvnVj0k04s/UVZaXkPQb2jayikRR/51WhmS38YKWnpdrbTF5PW2f3jYpgxb9x53C5/F+DjUOuG0bqnbz15BpVS2Vtf1pGpnyh+5XQVV0GX91D4FXfY1/pEQqoeHjrrgkNrACWD+W944pyt6tSkvK2Rumj9Ac1YvFvxSScLe2gAABSPGav4Z8xYBc4tqGlPW9/Rzd3DBirPfDhPm3fHluiXLNDPU3f0rqO2DaLl4/3X914n0zP0ztgV+mNlTKGOz9U8f1cLNakZZWdP7v34UWUknB2i4UxuXr6Kvu1VeUVWUEpquu54carTNXrNLKY7+tRV95aV5On4cwZrUpxiF/6kuKW/KuvkOQI7N3f5V2+m4BZ95FOuRs7VsfEpGjdjiyb9sf2Svl2m3vHbj7ZTeLCvvRy3crqOTvlEWRnFIzQwTWd8KtWTf43mCqj1V5mVR9+eddHBNQAAAEomZqyejWC1ABGsArn8p+PhqVLd71Fgg1OHD+w/kqjH3plVYhow5VXHJuXUv1M1W7vshU8WKi6RQ+3+zuFw19gXu9sQOnHzYh387o1Cea+KDDd3W3bDv9rldob4Y+/O1raYCz8U3ASsA6+uryuaV7Q1TY2MxBOKXfijrRecdTL11MN6eiuwQSdbzzW7Y7T5TjfmcII+m7ROS9YfVGEH9GbWuCkPkLJvqy0NkBF3REWNeZ1NiQffSvVtIy9TXuV0SzYc0IufLCq08QEAAKDoI1jNx1IAzkhMTNTMmTPVq9epJhkASiaPwDBF9X9CPmWrnTq0fe1+vfLFksIelkuauWyvXXD+rsVvfb1Mz9zezM6E9K/TRonr5vKSnUNYh5tsqGr2vf99u+KiQlX7+mdKI35YrU9+Wqu7r6qrrs0ryuEfrPDOAxTcvI9OLPxR7j7+timVh2+gvU9mVpY27DiqD39YrV37413ivXp+5EJd07GqBvSsLZ+yVVXuzjd1cOI7Stm5Ri7NzV3eZarYENUsPuVq2vIOp0tNS9fOA3GaumCXLbMAAAAAIH9dVLC6ceNGjRgxQps3b1ZKSooyTVGz06Snp9vrTbBqZoIQrAIll3e5Grauo+1GnZWlUT+v1w+zin/DGBSsRWsPaNWWw2pYPVKlrhiolJ1rlZFYsktK5MbUoQ1p1deenzR3u35fuidfA+7h41fr4x/X6r5+9dTp8gpyBITYUh85t8nI1PzV+/TRhDUuOft6/MytWr/jqF68p5V8/INV5sbndGzmVzYcdiWeYWVOBamV6tvD/D18/M9Ybxp/7T+aqGUbD+nX+TvtrGAAAAAALhis7ty5UzfeeKMNTvNSprVMmTIX+lAAirjAhl1U6sq77GyqtJMZeu7jBVq3/WhhDwvFxEufLtLXL3WXt1+g/Tkzh3LjL97R1RXR4z57ft32Ixo5cW2BvDwmYH1v3Cp99MMa3XdNfbVtGK30jCxNWbBTX/263s5wdWUbdh7XHS9M1dBH26tsRICdeetdtpoO//y+U4258pO7X5B8K9WT72UNbKDqGRxxxnrz95dpQrV221H9tniXVm0peiUMAAAAgBIZrH7++edKTk5WRESEDVh9fHz05ptvql27duratasOHDign3/+Wbt27VLr1q316aef5u/IARQJ5jDgUlfebc8fiU3WoHdmKTbB9WasoegyjXjeGbtcTw5oKv+aLeRfq5USN8wv7GG5BI+gUorq/6TcHJ46eiJZT38475K8H//7dqVdihpT6/me12fo8ZubqH2jaAXUaimvUuVsWH/y6CVoHufmLp/yteRXtYl8K5s6qZedFaQmJp/U5j2xmrN8r2Yv3+PygTUAAABQnF1wsLpw4UJ7eP+HH36ounXr2us+++wzxcXF6dprr7WX77rrLg0cOFDz58/XnDlzbOgKoOTwLldT4V3vtOfNYbZPvk/9SxSMeav321l79aqWUqluA5W8a60yk+JK9MttmhmVvvZJe1h+alqG7Qb/t4o9OIehY5Zp9ZbDevDahvKKKK/oO17XoUnvKWnT4oJ4p2yplIDareVfq6Utl3I6897tPhinBWv2a+rCXS5ZSgEAAAAoqS44WD106JA9vD87VDVq1aqlRYsWKSMjQx4eHnYW6/PPP29rq3777bcEq0BJa1R1zb/t4f+HjicRqqLAvfjpAn31Yg95+wer/H3vK2nLUiVuWqTk7StzOtSXHG6K7POwvEtXVmZmlp79aB4zxZ1kmj1t2nVcbzzUVgG+fird/0kdn/eDjs8eK2VdfEJtygycClNbyREUfsas1Ow6qVPm79Tug67R5AsAAABAPgarJjwND//rg4BRqVIlzZ0719ZfrVKlir2uatWqKleunNauLZiabsA/hXsZ8cd4kS41D0dOoypTU3XQO7N5D1DgUtIy9faYZXpiwOW2qU9gvfZ2yTyZquTtq2zIasLWzJTi39AntN31tiyCCemGj1+ljTuPF/aQiiQTat72/BS9/mAbVSsfqtDW/eRdprIOTXxXmcnOB55eZaoooFZr+ddudUa9VPM+HTiaqJnL9mrCrC32ZxkAAABAMQ5WQ0JCdPz4mR/Uypcvb0+3bt2aE6xm33bTpk0XM07t2LFDH3zwgZYtW6ajR4+qdOnS6t69u+6++275+5/ZFddZb7zxhi1j8OCDD+qhhx66qG3BdYR1vMV2wU47GqP4Vb8rYc0sZSTQLfxSMIdi+0RXt2HB8yMXcOgqLpn5a/ar/5OTdEWLSurSrIIuKxssh6e3/Gs0s0tWZoZSdq1T4ubFNmgtjl+8mBmQoW1PleQxDY3M4eO4uJqxj707R3ddXVe921SWX+WGir7zTVt3Ne3A9n+8v1dUJfueBNRqJc+wvxp5mv8fDx1P1uzlezV+5hYlpaTzNgEAAAAlJVitXbu2Zs+erXXr1qlOnTo5M1bNB4VVq1apW7du9rr09HTt3btXfn5+FzzI1atX67bbblNSUpIaNGigevXqafny5RoxYoR+//13ff311woMDLygbc+bN8824kLx4lOhtoJbXmXPe4VHK7zTrQrrcJOStq1Q/KoZStqyXMrkQ2xBCGzUVUGNutr/C778dYPWbDtaII8DnItp5vPL/J12MVrXL6OerSuresVQeXt62O7qZjFfAKTs26KkTYuUuGnxpWlOVMDMjMiI3qe+INy8+7jeG7eqsIdUbIycuFZrtx7RE7c2lWdIpMre9oqO/PqxElbPPOu2nhHlc2ammt9B2cz/i6aJ3x8rY/Td9M22WRYAAACAEhisXnnllZo1a5ZtUGVmet5www1q2LChHA6Hxo4dq44dO9rw9f3331dsbKzq169/QY9z8uRJPfroozZUff3119W3b197fUpKigYNGmSD1aFDh9pars46duyYnnzySftBB8WHm6ePIno9KDc3d+07kqB124+qdf2y8vPxlH+1y+2SkXhC8Wtm2ZmsJ4/sLewhFxve0dVtWGUs33RI383YUthDAmxjK7MY9aqE6+r2VVS3Sin5ejvkU7aaXcwM97Qje0+VC9i0SKn7txW5V84jINQ2q3L39FJsfIqefG9OYQ+p2Fmw9oDufu03DX20vUIDfRTZ+0H783Pkt8/kGRwp/9qtbd1U0/Aqm/kb41hciuau2qfvZ2ym1i0AAABQjFxwsNq7d2/98MMPWrx4sV555RVdf/31CgoKstdPmDBBAwYMyLmtm5ubrr321GGJzpo8ebJiYmLUunXrnFDVMI2xXn31VXXq1Enff/+9HnvsMfv4znj66adtOYPGjRvbGbAoHsI7D5BnaJQyMjL11Afz7AfaYd+uVJOakbrxihq2Tp6Hf7BCWlxll5SYzadKBayfp6zUpMIefpHlERBi66qaZlVmRtbzIxcW9pCAs5gZ1NmzqCuWCVT/jtXUqEakgvy95FWqnF1CW1+j9LgjdharCVpTdq/Pl2ZFBcnN4aWoa5+UIzDc1jV+5O3ZduYu8t/h2BTd/uJUvXhXK9WvVkpBTbrZQ/09/ALPCFNj41NtaYpx0zfb30MAAAAAip8LDlY9PDw0cuRIffzxx1qwYIG9bDz77LM2CDWBa7YePXqof//+F/Q4M2eeOsTuiiuuOGtdaGiomjdvbm9jmmaZx8mrMWPG2Ps98sgjNlwlWC0efC9rYD/kGp9PWn/Gh1nTYdksXg53Xdu5mq5oXkmhQd62FqhZwrveocQNC2ypABukIO/cHYrq939yBIb92axqFq8eXN6u/fEa+vWpL9UiQnzUr2M1tahbRuHBPnIElVJw0x52SY87qrhlUxS34rcLalh0KUT0vN/OnMzMytJzHy8gyCtgmZnSsx/N1/VdquvmK2vaUNWEqXGJaVq4dr++/W2TDWABAAAAFG8XHKwa3t7ettnT6Q2fTCOp0aNH2zqrprZq5cqVVatWrQt+jM2bN9vTGjVq5Lq+WrVqNiA1zbHyGqxu2bLFNqwyM1XvueceW2IARZ+7t58iet1vz+/Yd0I//rHtnI1IxkzdZJcKUYG6rWctO2PN09NbgfU72OXksf2KXz3TLsWxuU1+C7/iDvmUr2mDhRc/XcihrihyTAj20YQ1dgnwcejqDlXVtmG0SpfylyMoXGEdb1ZIm2uVsHa2TiyerJNH9shVhLTqp4C6be3+98mPa235E1wa307frBWbD6ldw2hNnrdD+49y1AMAAABQklxUsHo+psmUWS7WwYMH7WlUVFSu6yMiIuzpoUOH8rS91NRUWzbA09NTQ4YMyZlpW5DMh92MjAwVN672nMyMUzPLLD09U8+OmJ+n++w+GK+XPjs1u7prswrq26GqykUG2M7NptlVaLsblLxjpeJXzlDilqVSBo1G/i6wQWcFN7nS/pyPnbZJq7Ycyff3FriUTEOhr6ZstIuPl0N39qmjTk3KydvLyzZmM0vS9lU6seRnJW9dYf6XL7Q3yK9GMxv6GrOW7dWkP/65Sz3y1+bdsXYBAAAASgrz+T/THMaVT5mSq+VLzvRiytdg9Z9eVHd3d6e3mZycnFNTNTfZ15vmVnnx5ptv2lmwZsZquXLldCmY57By5UoVRyagdgV+1S5XYINO9of/o4lr7OGYzvpt8W67mFqLA3rUUpsG0fL39ZRflcZ2yUiKU+LGBUo/cUSZqYnKSElU5ulLqjlNUla6849dVHmXrapSV95lz6/ecsQGq0BxkpKWruHfr7JLj1aVdF2X6goL8pFf5QZ2STu6T3FLf1H8qpnKOnlpD/32iqqkyD6P2PPbY07o7bHUCgcAAABQ8Eyj+TVr1uTb9vJzW5faRQWr27Zt0wcffKClS5faOqXp6eeezWcaWK1f73zdSjOjNC8peF7S5FmzZumrr76yJQOuvvpqp8cC1+TuG6BSPe615zfvOa4pC3Ze1PZMKPv+d6vs0qBaKd3UraZqVgyTh1+Qghqfqt96PlnpJ0+FrjZoPRW2/nX+1PVmfUbiCSVtWSZlFs1ZsKYBWNQ1T8jN4WnrOT43Mm+zhIGi6pf5O+1Sq1Ko7rq6nqqWC5FXeFmV6jZQoe1vVPzK6Ypb+qvSTxwukMd39wmQT4Va8q1QRz4V69hg1c3N3f6f9fiwOQXymAAAAACAAghWd+3apeuuu87OFHVmiqyzTM3W2NhYewh/blJSTs0Q8vPzO+92Dh8+rKeeekplypTRCy+8oEvJ19f3nDViizIzVXvjxo2FPQyV6naXHAGhtmnScx8tyNdtm8PaV22ZK4fDXf07VlWzOqXl6+0pX28PeXl6yNPhLoeHu9zd3eT25xcIJmh0BIRIZvkH5nDiA2NfKtRDiS+Iu4ci+/3b1p48mW6aVc22zVyAkmDDzuN67N05Cgnw0l1966tV3TJy+PgrpMVVCm7WW0mbF+vE4p+VsmfDRX9p5FOhtnwr1JVPxdryiqxog9TTJSaftM3iTAkUAAAAALhURy83bNjwojOl7Jmq9erVuySlOvPK9HHKPoK+wILVDz/8UImJiQoNDdXtt99ug8N/CjcvRGRkpA1WTTBqQtG/y66tam73T+M9duyYbaT14osvnrFu3bp19nTatGk2MK5SpYruu+++fHsOJmxzpR+Q4sS/ZksF1Gljw/33v1uppJSCmf1pQotvfttsl/MJDfRWRKivwoN8FGqWQG8FB/ooyM9LAX6etrSAr7dDPl4eOYcTBzfrpROLJ6koCe9ym3wr1Lav+yufL6YDOUqk2IQ0DflyqUyVm+u71FCvNpVtKRH/mi3sknpguw1YE9bPy1N9Zne/ILtf+ZgZqRXqyDuq4lm3MV9k7DuSqFVbDuu3Rbu1c39cAT07AAAAALg0OZeHh4dL5Wbm+eXVBQer8+fPl8Ph0BdffFGgszHNtk1N1C1btqh+/fpnrd+6dWvO7c4nuwbrhg0b7JIb8zhmadasWb4Gqyi4Q9FLdb/bnjddsGcu21voL/Xx+FS75MXjNzVWhyblbeOZ5J2rlXZol4qCgHodFNy0pz3/3YwtWrYxb43jgOLKzNY29YXN0rx2ad3Wq7ZtguddurIi+zyssE63Km75VMUvn2ZLgJz+f9ipELW2fCvWlVdE+bO2bWbi2yB18yH9tmS3du2Pv8TPDgAAAACQ78GqqalasWLFAj/EvUOHDpo0aZKdTXrNNdecNYZFixbJ29tbLVu2PO92Xn/9dbvk5pVXXtHo0aP14IMP6qGHHsrX8aPglOp+r617mpqWrhc+yd8SAJfC0K+Xq0G1CDuzNfKqRxTz2ZPKyjgpV+ZVurJK9bjHnl+z7Yi+/PXiDnUGiptF6w/YpUy4n+7pV18Nq0faUiVh7W5QaKtrlLBurm1wZ2ukliqXa5AaczhBKzYf0vTFu7XnYEKhPA8AAAAAQAEGq+Hh4U5Njb1QXbp0UXR0tG089c033+iGG27Iqa36zDPP2Jmot956q8LCws7oTrZ79257vkKFCi7TuR75J6Bue/nXaGYPRX/76+VKSSua9QWfGTFP7/+7k62daGauHp3+hVyVOUy5dP8n5O7w0vH4FD07Yl5hDwlwWfuPJun5kQvl5XC3M1i7Nq0oXx9PBTboeMbtUk2QeiheKzYd1rTFu7TvcGKhjRkAAAAAcImC1bZt22r8+PG2JqmZuVpQfHx89MYbb2jgwIEaPHiwxo0bp3LlymnFihW2vmrdunU1aNCgM+5z8OBB9ejRw56fMWOGvT2KD4/AMIV3+5c9v2LzYc1fs19FlZmNNnbaRt18ZS0FN++tpG0rlLxjlVyOm7ui+j4uR3CErTf7+Ls0qwLyIi09UyMnrrVL12YVdFX7KnYfWr7pkH5btMsGsAAAAACAounM9sJOMDVIAwIC9Nhjj9kgsyA1bdpU3333nbp166Z9+/bZ2auBgYH20P1Ro0bJ39+/QB8friWi5/3y8PFXcmq6XvpskYo60xAruwFNRO8HbSdwVxPWeYB8K9W1M4RfHbVYh2NTCntIQJHz2+LdenDITD36zmyN/mUDoSoAAAAAlIQZq0888USu15cuXVrr1q1T586d7czRqKgoW+80N6ZsgJl5eqGqV6+uYcOG5em2Zobqpk2b8rxtU1LALHB9gQ27yK9KIxvwvTF6iZ35VRw8PXyuRg3uJs/AMEX0uE8Hxw+Rqwio01YhzXvb8z/M3Kol6wv2ixQAAAAAAIBiE6z+9NNPNhg1YVZu0tPTtXLlylzXZd/vYoNVwByGHt7ldvtCLFp3oFh1o49POqn/fbNCj9/cRP41WyigfkclrJ5Z2MOSV9RlKtXzPnt+/Y6j+mLy+sIeEgAAAAAAQNEJVq+++upL0qgKODc3RfR6UO7evkpMPqk3Ri0udi/W7BUx6tCkvC6vFaVSV/xLKbvXKz228GaHuvsGKso0q/L01omEVD0zfG6hjQUAAAAAAKBIBquvv/56wY8EOI+gy7vn1Ph85fNFKiYVAM7yymcL9dWLPeTv66vIqx7RvtHPSlmF8GTd3BXZ9zF5hkQqPSNTj707u9i+5gAAAAAAAJe0eRVwqXiGlVFYp1vs+TkrYrRm29Fi++Kb8HLwxwtsgOxTroZC2lxTKOMI63iz/C6rb8fx5uglOnQ8uVDGAQAAAAAAUGKC1Q0bNuiXX37RggULlJxMGIOL5OauiN4P2sPR4xLT9NaYZcX+Jd20+7gmz9thz4e2uVbeZatdwkd3U2i7GxTS8mp76ac527Rg7YFL+PgAAAAAAADFqBRAtuPHj+vLL7/U6tWrNXToUAUHB+esO3jwoB555BGtWrUq5zqz/rHHHtN1112Xv6NGiRHcvLd8ytW0Mydf/GShSoqPJqxR09pRigrztyUB9n76b2WlpRToY7o5vBTR5yEF1GplL6/aclif/LSuQB8TAAAAAACg2M9YXb9+vXr27KkPP/xQ8+bN05EjR3LWpaSk6NZbb7WhqgnAHA6HgoKCFBsbq8GDB+uTTz4pqPGjGPMsVV5h7W+0539bvNvO5CxJnvpgrjIyMm0phPCudxToY3kEhqnsgJdsqGr24WmLdurZEfML9DEBAAAAAACKfbCampqqBx54QMeOHVNYWJiuvfZahYSE5KwfMWKEdu/ebc+b8HXhwoVatGiRDVQDAgI0bNgw7dy5s+CeBYofdw9F9nlIbg5PHY9P0XvjVqqkORybok9/WmuDzqCGXeRXo1mBPI5X6cqKvuN1eZepqsysLI34YbXeG/fXzHMAAAAAAABcYLD6/fffa//+/WrYsKEmTZqkF198UeHh4XadCX2+++47e95c99prr8nf399ebtOmjf7zn/8oLS1N48ePz8tDAVZIq37yLlPF/nw999GCEvuqTJq7I2embkSP++UREJqv2/ev2UJlB7wsR2C40k5m6Onh8/TLfL4EAQAAAAAAyJdgddasWXJzc9Orr75qZ6yebs2aNTp69Khd36dPH3l5eZ2xvnfv3va6P/74Iy8PBcgr6jKFtulvX4mf5+3Qzv1xJfpV+e+IeUpNS5eHX6Aiej1oG0zlh5DW1yjqmv+zjcFOJKTq7tema932o/mybQAAAAAAgOIuT8Hqli1bVKZMGVWuXPmsdeaw/2xt27Y9a70JVStWrGhnvAL/xLtsNdusyc3DoSOxyfp4wpoS/6KlpGXq9dFL7OxdvyoNFXR594t6Tdw8PBXR52GFdbjJXt62N1a3vzRNR08UbHMsAAAAAACA4sSRlxuZ2qq1a9fOdd2yZctObcjhUOPGjXO9jY+Pj5KSki5mnCjOPBwKqNVaQU27y6dsNXtVZmYWzZNOs3TDIf2xMkbtGpVTWOdblbxrjU4e3uP8S+0frKj+T8inXE0b1M5evldDv16ef+8lAAAAAABACZGnYNXb29vWSf27zMxMG6yaMgD16tWzt8uNKRUQHBx88aNFsWLqhQY17qbARl3lCDjVDM2EffuPJurD8asVczihsIfoUoZ8tUz1q5ZSSKCPIq96VDGfPyllpOf5/l6RFRV13VPyDI6wr/NnP6/TxFnbCnTMAAAAAAAAJTpYjYqK0p49e2wYY0LUbMuXL1dCQoK9rlWrVrneNyYmRvv27VOdOnXyb9Qo0ryjayi4aQ/bOMkc8m9kZGZp9ZbDGvnjGu05SKB6Ls98OF/v/bujvKMq2UP5j80YnafX3K/a5TaMdff2VXp6pl74dKFWbj6cb+8pAAAAAABASZOnYLVFixYaM2aMpk+frq5du+ZcP378+JzzXbp0yfW+o0aNssFr8+bN82O8KKJMXU//2q1toOpdpkrO9YnJJzVt0S599esGpaVnFuoYi4LdB+M1bvom3XBFTYW0uEpJ21YoZef569AGN++tsM4D5ObmrvikNA16Z7YOHqM0BwAAAAAAQIEHq9dee62+/vprPfnkkzp+/Ljq16+vmTNnauLEiTY0bdKkiWrWrHnW/cx6E8ia2/Ts2fOiBoqiySMwTEFNrlRQwy62vqdhZj7HHE7U11M32rqhcM6YqZvUqn5ZVSgdpMjeD2nvyMeUmZLLLF93h0p1v1tBDTvbi7sPxNlQlQAbAAAAAADgEgWrNWrU0L333qvhw4dr8ODBOdebgMzf318vvPDCGbf/6KOP7OzWtWvX2tv07duXUgAljE/5Wgq63Bzu31xu7h72uozMTHv4+ccT12jf4cTCHmKR9tTwefriuW7yDApXqe736NCEoWesd/cNVNQ1/yffinXsPjh/9X69PnpJoY0XAAAAAACgRAarxsMPP6zo6GiNGDHC1ls1GjdurP/+97+qUuWvQ7uNH374Qbt27bLnu3Xrppdeeim/xw0X5ObwUkCdNgq6vLu8S1fOuT7BHO6/cKe+nLLR1vfExYtLTNN741Zo0I2NFVC7lZK2LlXCmtl2nWd4tEpf/7Q8Q0vbUHXMlI36dvpmXnYAAAAAAIDCCFaNa665xi5xcXFyOBzy8/PL9XamnmqjRo3Up0+fcza1QvFimlBVeOgjefgF/XW4/6EEffnrBs1fs7+wh1cszVy2Vx2blFejGpEq1W2gUnZvkGdYGUX2e1wePv5Kz8jU618s0aL1Bwp7qAAAAAAAACU7WM0WFHQqPDuXF1988ULHgyLG1M/NZkLVjIxMLdt0SB9PWEODpEvgxU8WaMxLPeTn46cyNw+WIzjCll4wTcEe/98cxRzOpfYqAAAAAAAACidYBbKZmanZp9//vkVfT9kgjva/dMxr/eInC/XaA23sof/GviMJemTobKWkpfODCgAAAAAAUEDcC2rDKFkyMrM0+hdC1cKwbscxjf99qz30f/G6/brntRmEqgAAAAAAAAWMGatAMTDql/V2AQAAAAAAwKXBjFUAAAAAAAAAcBLBKgAAAAAAAAA4iWAVAAAAAAAAAJxEsAoAAAAAAAAATiJYBQAAAAAAAAAnEawCAAAAAAAAgJMIVgEAAAAAAADASQSrAAAAAAAAAOAkglUAAAAAAAAAcBLBKgAAAAAAAAA4iWAVAAAAAAAAAJxEsAoAAAAAAAAATiJYBQAAAAAAAAAnEawCAAAAAAAAgJMIVgEAAAAAAADASQSrAAAAAAAAAOAkglUAAAAAAAAAcBLBKgAAAAAAAAA4iWAVAAAAAAAAAJxEsAoAAAAAAAAATiJYBQAAAAAAAAAnEawCAAAAAAAAgJMIVgEAAAAAAADASQSrAAAAAAAAAOAkglUAAAAAAAAAcBLBKgAAAAAAAAA4iWAVAAAAAAAAAJxEsAoAAAAAAAAATiJYBQAAAAAAAAAnEawCAAAAAAAAgJMIVgEAAAAAAADASQSrAAAAAAAAAOAkglUAAAAAAAAAcBLBKgAAAAAAAAA4iWAVAAAAAAAAAJxEsAoAAAAAAAAATiJYBQAAAAAAAAAnEawCAAAAAAAAgJMIVgEAAAAAAADASQSrAAAAAAAAAOAkglUAAAAAAAAAcBLBKgAAAAAAAAA4iWAVAAAAAAAAAJxEsAoAAAAAAAAATiJYBQAAAAAAAAAnEawCAAAAAAAAgJMIVgEAAAAAAADASQ4VETt27NAHH3ygZcuW6ejRoypdurS6d++uu+++W/7+/k5ta9asWfrqq6+0du1aJSQkKDg4WE2aNNHAgQNVv379AnsOAAAAAAAAAIqHIjFjdfXq1erXr58mTZqkiIgIdejQQUlJSRoxYoRuuOEGxcfH53lbb7/9tu655x7NnTtX0dHRat++vYKCgjR16lTdeOONmjhxYoE+FwAAAAAAAABFn8vPWD158qQeffRRG6S+/vrr6tu3r70+JSVFgwYN0u+//66hQ4fq+eef/8dtLV26VB999JH8/Pw0cuRIXX755TnrvvnmGw0ePFjPPfecWrRoYWfEAgAAAAAAAECRnLE6efJkxcTEqHXr1jmhquHj46NXX33VhqTff/+94uLi/nFb5naGOeT/9FDVMDNfzezV1NRUO3sVAAAAAAAAAIpssDpz5kx7esUVV5y1LjQ0VM2bN7ezWs2h/f/EhLHVq1e398lN5cqV7emhQ4cuetwAAAAAAAAAii+XD1Y3b95sT2vUqJHr+mrVqtnTTZs2/eO2TLkAU6f177NVs61atcqelilT5iJGDAAAAAAAAKC4c/kaqwcPHrSnUVFRua43zazyY5apqdW6fPlyeXp6qkuXLspPWVlZysjIUHFTHJ8TAAAAAAAAzp9zZWZm5lum5Gr5knl+xSZYTU5OzjmMPzfZ15vmVhfKzHZ96qmncuqv5nfjKvMcVq5cqeLIBNEAAAAAAAAoGUxJzjVr1uTb9vJzW5eay5cC8PDwyPc0+XSrV6/WbbfdptjYWHXs2FEPPfTQBW0HAAAAAAAAQMnh8jNW/f39beiZmpqa6/qUlBR76ufn5/S2p0yZov/85z92RqlpjjV06NA8B7nO8PX1PWeN2KLMTNXeuHFjYQ8DAAAAAAAAl/Do5YYNG150ppQ9U7VevXoFksddzJHt2UfQF/lgNTIy0garhw8fzrWpVHZtVXM7Z3zwwQd677337EzXW265Rc8884zc3QtmAq+bm5tL/YAAAAAAAAAArpBzeXh4uFRuZp5fsSkFkD3Tc8uWLbmu37p16xm3+yemuK6ZpTps2DAbpJpA9b///W+BhaoAAAAAAAAAih+XTxM7dOhgT6dNm3bWuuPHj2vRokXy9vZWy5Yt87S9Z599VhMmTLCH55tZqwMGDMj3MQMAAAAAAAAo3lw+WO3SpYuio6M1a9YsffPNN2fUVjWzTZOSknTdddcpLCzsjO5k27Zts4s5n23ixIkaP368nV784Ycf2mZVAAAAAAAAAOAsl6+x6uPjozfeeEMDBw7U4MGDNW7cOJUrV04rVqyw9VXr1q2rQYMGnXGfgwcPqkePHvb8jBkz7O1NUdx3333XXleqVCkbsJolN23bttVVV111CZ4dAAAAAAAAgKLI5YNVo2nTpvruu+/0/vvva/HixbauqglLzUzVO+64Q/7+/nnq6LV///6c4HXSpEnnvG1oaCjBKgAAAAAAAICiHawa1atXtw2n8sKEriZIPV3t2rXPug4AAAAAAAAAimWNVQAAAAAAAABwNQSrAAAAAAAAAOAkglUAAAAAAAAAcBLBKgAAAAAAAAA4iWAVAAAAAAAAAJxEsAoAAAAAAAAATiJYBQAAAAAAAAAnEawCAAAAAAAAgJMIVgEAAAAAAADASQSrAAAAAAAAAOAkglUAAAAAAAAAcBLBKgAAAAAAAAA4iWAVAAAAAAAAAJxEsAoAAAAAAAAATiJYBQAAAAAAAAAnEawCAAAAAAAAgJMIVgEAAAAAAADASQSrAAAAAAAAAOAkglUAAAAAAAAAcBLBKgAAAAAAAAA4iWAVAAAAAAAAAJxEsAoAAAAAAAAATiJYBQAAAAAAAAAnEawCAAAAAAAAgJMIVgEAAAAAAADASQSrAAAAAAAAAOAkglUAAAAAAAAAcBLBKgAAAAAAAAA4iWAVAAAAAAAAAJxEsAoAAAAAAAAATiJYBQAAAAAAAAAnEawCAAAAAAAAgJMIVgEAAAAAAADASQSrAAAAAAAAAOAkglUAAAAAAAAAcBLBKgAAAAAAAAA4iWAVAAAAAAAAAJxEsAoAAAAAAAAATiJYBQAAAAAAAAAnEawCAAAAAAAAgJMIVgEAAAAAAADASQSrAAAAAAAAAOAkglUAAAAAAAAAcBLBKgAAAAAAAAA4iWAVAAAAAAAAAJxEsAoAAAAAAAAATiJYBQAAAAAAAAAnEawCAAAAAAAAgJMIVgEAAAAAAADASQSrAAAAAAAAAOAkglUAAAAAAAAAcBLBKgAAAAAAAAA4iWAVAAAAAAAAAJxEsAoAAAAAAAAATiJYBQAAAAAAAAAnEawCAAAAAAAAgJMIVgEAAAAAAADASQSrAAAAAAAAAOAkglUAAAAAAAAAcBLBKgAAAAAAAAA4iWAVAAAAAAAAAJxEsAoAAAAAAAAATiJYBQAAAAAAAAAnEawCAAAAAAAAgJMIVgEAAAAAAADASQSrAAAAAAAAAOAkglUAAAAAAAAAcBLBKgAAAAAAAAA4iWAVAAAAAAAAAJzkUBGxY8cOffDBB1q2bJmOHj2q0qVLq3v37rr77rvl7+/v1LYOHjyo4cOHa/78+Tpw4IBKlSqlTp066YEHHlBYWFiBPQcAAAAAAAAAxUORmLG6evVq9evXT5MmTVJERIQ6dOigpKQkjRgxQjfccIPi4+PzvK3du3frmmuu0TfffCMfHx917NhRHh4e+uqrr3T11Vdr//79BfpcAAAAAAAAABR9Lh+snjx5Uo8++qgNUl9//XWNGzdOw4YN0/Tp0+0s082bN2vo0KF53t6TTz6pw4cP66GHHrJBrdnW1KlTbUBrZrI+99xzBfp8AAAAAAAAABR9Lh+sTp48WTExMWrdurX69u2bc72Zbfrqq6/Kz89P33//veLi4v5xW0uWLNHy5ctVuXJl3X///TnXmxmrzz77rMqWLas5c+Zo69atBfZ8AAAAAAAAABR9Lh+szpw5055eccUVZ60LDQ1V8+bN7azWuXPn5nlbXbp0kbv7mU/d09NTnTt3tud///33fBo9AAAAAAAAgOLI5YNVc6i/UaNGjVzXV6tWzZ5u2rTpordVtWrVPG8LAAAAAAAAQMnlkIszdU+NqKioXNebZlbGoUOH8m1bpgZrfsrKylJGRoaKm+L4nAAAAAAAAHD+nCszMzPfMiVXy5fM8ys2wWpycnJOTdXcZF9vmltdym3lRWpqas7jrly5UsXVhg0b7A/dE/3LF/ZQAAAAAAAAUAAcHu42AzKhakpKSr5td82aNXJF2blekQ5WTWOpvKTgeUmTzbby4mJT9/zejqvLDqL9vAp7JAAAAAAAACgYGfk2GbEoyEuu5/LBqr+/v2JjY8+ZEmcn5H5+fnnalvFP28q+3cUyDbFMYy3TKMvb2ztftgkAAAAAAACgYJjc0ISqJtcr8sFqZGSkDVZN3dMyZcqctT67tqq5XV62tW7dunPWY3VmW3lRr169fNkOAAAAAAAAANfiLhdXo0YNe7ply5Zc12/duvWM2+VlW9n3uZhtAQAAAAAAACi5XD5Y7dChgz2dNm3aWeuOHz+uRYsW2cPsW7Zsmedt/fbbb2fVZDWH7M+YMeOM2wEAAAAAAABAkQxWu3TpoujoaM2aNUvffPPNGfVQn3nmGVs097rrrlNYWNgZIem2bdvsYs5na9SokerXr6/Nmzfr3XffzQlXMzIy9Morr2j//v3q2LGjqlevfomfJQAAAAAAAICixC3r71M3XdCSJUs0cOBAG6bWqVNH5cqV04oVK2xN1Lp162r06NFnNJzau3evOnfubM+bWajm9tlM2HrzzTfb2a6VK1dWtWrVtGHDBu3evdvebuzYsflWYxUAAAAAAABA8eTyM1aNpk2b6rvvvlO3bt20b98+O3s1MDBQDz74oEaNGnVGqPpPqlSpovHjx6tfv36Kj4/XzJkz5ebmpgEDBmjcuHGEqgAAAAAAAACKx4xVAAAAAAAAAHAlRWLGKgAAAAAAAAC4EoJVAAAAAAAAAHASwSoAAAAAAAAAOIlgFQAAAAAAAACcRLAKAAAAAAAAAE4iWAUAAAAAAAAAJxGsAgAAAAAAAICTCFYBAAAAAAAAwEkOZ++Aou3HH3/U999/r40bNyo5OVnh4eFq2bKlOViHRAAAEsxJREFU7r77blWuXPms2//yyy8aPXq0tm/froyMDNWsWVMDBgxQt27dct3+5s2b9cknn2jx4sU6cuSIfHx8VKtWLd14443q0aNHrvfZsWOHPvjgAy1btkxHjx5V6dKl1b17dzsmf3//fH8NgKLAFffV0+3cuVNXX321rr32Wj3zzDP58pyBosYV91NnxwQUd662n2ZmZurbb7+1Y9q2bZvc3NxUpUoV+zv1hhtukMPBxzOUTK62r+bm4Ycf1tSpU/Xaa6+pX79+F/2cgaLI1fbVhQsX6rbbbjvneP38/LRixQoVJLesrKysAn0EuATzNv/73//Wzz//LE9PT9WtW1dhYWF2Z4iJiZGvr68+/PBDu0Nke/PNN/Xpp5/aH8TmzZsrLS3N/nCfPHlS999/vx555JEzHuP333+3v2zM+kqVKqlq1ap2R1i9erX9I/L666/Xiy++eMZ9zDqzEyQlJalBgwY2VF2+fLkOHz6s6tWr6+uvv1ZgYOAle52Awuaq++rpzG3NL0PzgdCcEqyipHHF/fRCxgQUZ664nxpPPPGE/VBqPig2btzYjs387RsfH69mzZrZx/fy8rpkrxNQ2Fx1X/277777Ts8++6w9T7CKkshV99VPP/3UPk69evXsff7O29tbr7zySoG/OCgBJk6cmFW9evWsNm3aZG3atCnn+vT09Ky3337brmvVqlVWYmKivX7evHn2uo4dO2bFxMTk3H7Dhg1ZzZs3t+tWrlyZc31cXFxWs2bN7PWff/55VmZmZs46c7smTZrYdVOmTMm5Pi0tzW7fXP/DDz/kXJ+cnJx177332usHDx5coK8L4GpccV893fr167O6du1qb2OWl19+uYBeCcB1ueJ+6uyYgOLOlffTvz/GsWPHsq666iq7buTIkQX6ugCuxhX31b/bvn17VsOGDXP+/h0/fnwBvBKAa3PVfXXQoEH2+jlz5mQVFmqslhBmqrbx+OOP25mg2Tw8PPToo4+qWrVq9puA+fPn2+tHjBhhTwcNGqSyZcvm3N5M2za3Nz777LOc63/77TfFxsbabyFuv/12e1hTNjMT9d5777Xnf/rpp5zrJ0+ebL/ZaN26tfr27ZtzvfkG/9VXX7Xfaphxx8XFFchrArgiV9xXjRMnTmjIkCG67rrrtGvXLpUrV66AXgHA9bnifursmIDizhX30wkTJuT6GKGhofYQSmPOnDn5/loArswV99XTmRl2Zmzu7u6qXbt2Pj97oOhw1X113bp19tTMoC0sBKslRFBQkK3f1KRJk7PWmR/Yyy67zJ4/dOiQEhIStHTpUju9u1OnTmfd/oorrrD3MX/4menYhpmqXadOHbVv3z7Xx8+utWG2n23mzJk52/s78wem2aHMdufOnXvBzxsoalxxXzVMXRxT68Yc7mEO8TC14ICSyhX3U2fGBJQErriffvzxx5o0aZK6dOly1u2zt2vGAJQkrrivnu6dd96xwc1zzz2nMmXKXNRzBYoyV9xXExIS7KSf6OhomyEVFqqjlxCmOdS5mALC2Sm/+WVh6iaa68qXL59r8ygTrJQqVcrWQd29e7etY2FqXZjlXFatWpWz/dOLEhs1atTI9T7mGw8Tvm7atCnPBcWBos4V91XD1D9+8sknddNNN9lZ5dnjAEoiV9xPnRkTUBK44n5qaqeePssnm3n89957z56nIQ5KGlfcV7OZmXeff/65evbsqauuuso2rgJKKlfcVzds2GBrv1asWFHDhw/Xr7/+arcXEBCgVq1a2Tqu2YFvQWLGKmyDKHNIvkn4W7RooYMHD9pXJSoq6pyvTkREhD01O8I/Mdv78ssv7fkrr7zyjOvP9zjZj8HsGqBw91Xj2muv1Z133mlDVQCuuZ/mdUxASecq+6n5wrJ///42tDF/7z711FP2PIDC31ePHTtmm82ZyQXPP/88bwnggvvquj/DXPMliCk9EBkZaY98zi4ZYL6sXLRoUYG/d8xYLeEWLFhgO6hl18owndySkpLsZXP+XExnNSP7tudiOpyabwkSExN1+eWXq3v37jnrkpOT7em5gprs6//pMYCSoDD3VQBFdz/NbUxASeYq+6k5fHHixIk5l80hkWaWjblfbrN7gJKmsPfVp59+WkePHtWoUaPsIdAAXG9fXfdnsNq4cWMNGzYsJ6w1tZFff/11jRkzxtZzNfVbzSzWgsKM1RLMHGZvCgCbHzpzeK+ZkZZdfDivsuth5Mb8Irrtttu0du1aOwX83XffPaMAcV4fx0ztBkqywt5XARTN/fRcYwJKKlfaT01ZANNHYPny5Ta4qVChgv0AaJpY8bcvSrrC3lfNvmjG8K9//UvNmjW7yGcDFF+Fva++8sormjJlikaOHJkTqmb/jn3mmWdUq1YtO/v8XM3p8gvBagllplE/8MADSklJ0a233mqLcWfL/pbcrDuX1NRUe+rn55frelM/1XQPN98gmCLDX3311Rk/6Kc/Tva2/i778c/1GEBJ4Ar7KoCit5+eb0xASeRq+6n50GfWm8c2h02aOo7msmn2MXv27It4pkDRVtj76pYtW/TGG2/YJjqPPPJIPj4zoHgp7H01+3epqaGa22xUE+526NDBnl+zZo0KEqUASpj09HS9+OKL+vbbb23Sb6Zqm2/GT5ddB+N8tS6y656aGhZ/Z/4YHDRokJ2qbTrGmSLHuXVoM/eNjY21j5NbsfDzPQZQ3LnSvgqg6OyneRkTUJK44n6aG3N70wn5+++/tzNzsj8MAiWFq+yrb731lg18TFk6U/f4dNmHHY8bN87WdGzatOl5m+0AxZGr7Kt5kZ0zZZehLCgEqyWI+bbAfKNgDjsyvyjMN3G5FdSvWrWqHA6H9uzZY3+pZNe+yGamUpsp2aZehjls6XRm53rhhRdsB7jevXvr1Vdftd8i5KZGjRr2WwjzrWD9+vXPWr9169ac2wEliavtqwCKxn6a1zEBJYUr7afmMEkT2Bw4cEBDhgw56zGM7PuZD61ASeJK+2p2vcdly5bZJTcrVqywixkLwSpKElf7vfryyy/b7ZigNzw8/Kzb7N+/357mNpEvP1EKoIQwP5TZO0BYWJidtn2uD1vmh94ckmR+UE3NjL+bOnWqrf3Url27M2pnmAL8gwcPznks88fj+T4AZn8TP23atLPWHT9+3HZvM2Np2bLlBT5roOhxxX0VgOvvp86MCSgJXG0/NdebOnBmW7k9hnlsMwPOqFev3kU8c6BocbV91Tz+pk2bcl06d+5sb/Paa6/Zy6Y5DlBSuNq+6vVnrfLp06drxowZZ603j/3LL7/Y8+ZxClQWSoT33nsvq3r16lkNGzbM2rx58z/eftasWfb27du3z9q5c2fO9Rs2bMhq3ry5XbdmzZqc67dt25ZVv359e715rLxITk7O6tixo73P2LFjz7j+vvvus9e/9NJLTj9XoChzxX01N8OGDbPbePnlly94G0BR5Yr7qbNjAoo7V9xPP/zwQ3v7tm3bnvEYiYmJWf/3f/9n1/Xq1SsrPT3d6ecLFFWuuK+eS/Zn1PHjx1/UdoCiyBX31ZEjR9rbN2vWzG739Ezp8ccft+tuueWWrILmZv4p2OgWhe3EiRN2dqg5rKFSpUrn/Rb8qquuUtu2be15M/3666+/zvm2wXxrYGaRnjx58qw6Gubyzz//LE9PT3Xr1u2cHVCjo6NtrYxsS5Ys0cCBA+2UclMgvFy5cvawClNvo27duho9enRO4WOguHPlffXv3nvvPb3//vsaMGCA7bgIlBSuuJ9e6JiA4soV91PDbOehhx6ys3fM/UzdOPNYpqmGOSzSdDw2TazMKVASuOq+ei7333+/nRlnZqz269fvgp83UNS46r6anp5um8yZWaum9ECjRo1sLdbly5fryJEjtumVyZQKujkzNVZLgMWLF+fUitm5c6ddzsWEmdk7genqZi6PHTvWbsPsDA0bNtQdd9yRcxhEtlmzZtlTs4OYneFcatasecYvLFPw+7vvvrMBjXkMU1fVhKum+5t5HEJVlCSuvK8CcN399ELHBBRXrrifGubD4vDhw23jm/Hjx2vVqlXKzMy09eVuvPFG+ziBgYH58hoARYGr7qsAisa+6nA4bJZkGj+axTSYM+Gt+YLS/F6988475efnV+BvJzNWAQAAAAAAAMBJNK8CAAAAAAAAACcRrAIAAAAAAACAkwhWAQAAAAAAAMBJBKsAAAAAAAAA4CSCVQAAAAAAAABwEsEqAAAAAAAAADiJYBUAAAAAAAAAnESwCgAAAAAAAABOIlgFAAAAAAAAACcRrAIAAKDI2bt3r2rUqJGzvPzyy3m636effppzn3bt2qmwbdmy5azrOnXqZMf33XffFcqYAAAAkDcEqwAAACjypk6dqqysrH+83S+//CJXcOjQIT3++OMaOHBgYQ8FAAAAF4hgFQAAAEWaw+GwQeWyZcvOe7s9e/Zo7dq1cgVz587Vzz//nKcwGAAAAK6JYBUAAABFWosWLezplClT8jRbtXbt2pdkXAAAACjeCFYBAABQpF155ZX2dNq0aeedAWqCVXd3d3Xv3v0Sjg4AAADFlaOwBwAAAABcjMsvv1wRERE6ePCgli9friZNmpx1m+3bt2vjxo12dmupUqXOua01a9Zo9OjRWrJkiY4cOSI/Pz/bSOqqq65S37595eHhccbtb731Vi1evFgjR45UZGSkPvzwQ3vfuLg4RUVFqXPnzrr33nsVFhaWcx+zvWxmzNmXN23adNZ4THkDs+0VK1YoOTlZZcqU0RVXXKF77rlHAQEBF/yaAQAA4OIxYxUAAABFmpmF2q1bt/OWA8guA9CzZ89zbscEmNddd51++uknxcfH28DThJcmOH3mmWd0++232+tzM2fOHPXv31/Tp09XaGioDUD37t2rUaNG6YYbblBCQkLObRs3bqxKlSrZ856envayWf5uwoQJuvnmmzV//ny7PRPO7ty5Ux9//LHdZkpKipOvFAAAAPITwSoAAACKvOzD+89VDuDXX3+1IaaZ7ZmbqVOn6q233lJmZqbuv/9+LViwQOPHj9fvv/9uw1Ezy9UErE888USu9//yyy/VunVrzZw5U5MnT9Zvv/2m4cOH2xmuu3bt0vfff59z27Fjx9oZp4YJS81ls+Q2W7VXr142tJ04caJmzZqlIUOG2HVbtmzRDz/8cIGvFgAAAPIDwSoAAACKPHP4vzkU/8CBA/aw+dOZQ+y3bt2qVq1aKSQkJNf7v/POO/b0+uuv1yOPPCIvL6+cdaZ8wPvvv2/Pm6B16dKlZ90/PDxcw4YNs2PIZsoAtGvXzp43JQqcVaVKFb3xxhtnjLlPnz42wM0OXgEAAFB4CFYBAABQ5Lm5ueU0sfp7OYDsMgA9evTI9b7m8PodO3bY87fddluut2nUqJFdjBkzZpy1vmXLlvL29s41HDXOVULgfEww+/earkZ2TdZjx445vU0AAADkH4JVAAAAFKtyAOaw/tPLAZgyACb07NKlS673M42tDF9f35wgNDd169a1p9kh7OlMo6rc+Pj42NP09HSnnsv5tmkaahnUWAUAAChcBKsAAAAoFsyMUtPkyZQDWLlypb1u3bp1tsZphw4dbCOq3GQ3ljrX+mz+/v72NDEx8ax1pn5rfsttBiwAAABcB8EqAAAAik05gG7dup1RDuCfygCcHphmB6znEhcXd8btAQAAULIRrAIAAKDYlQOYNm2aLQdgygCYINTMWD2XypUr29Pk5GRt27btnLdbu3atPa1YsWK+jxsAAABFD8EqAAAAio2GDRuqbNmy2rdvn8aMGaOYmBh16tQpp9Zpbi677DK7GKNGjcr1NsuXL9fq1avt+Xbt2l30ON3dT/0ZfnotWAAAABQtBKsAAAAoVq688kp7+vbbb9vTnj17/uN9HnnkEXv67bffatiwYUpLS8tZt2jRIj388MP2fNu2bdWqVauLHmN2A6oTJ078YwkCAAAAuCaCVQAAABTLcgCmyVRwcLDatGmTp/s89thjtk7rBx98oJYtW6p///52tuuAAQN0+PBhNWvWTEOGDLG3uVg1atSws1ZTU1NtENyvXz8dP378orcLAACAS4dgFQAAAMVK/fr1Va5cOXu+a9eu8vT0zNP97rnnHo0bN069evVSQECANm7cqJSUFBuyvvHGG7ZMQGhoaL6M0dRpfe2111SpUiXFxsZq//79tmwBAAAAig63LAo7AQAAAAAAAIBTmLEKAAAAAAAAAE4iWAUAAAAAAAAAJxGsAgAAAAAAAICTCFYBAAAAAAAAwEkEqwAAAAAAAADgJIJVAAAAAAAAAHASwSoAAAAAAAAAOIlgFQAAAAAAAACcRLAKAAAAAAAAAE4iWAUAAAAAAAAAJxGsAgAAAAAAAICTCFYBAAAAAAAAwEkEqwAAAAAAAADgJIJVAAAAAAAAAJBz/h/7HouUH/0ECwAAAABJRU5ErkJggg=="
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "=== Distributions (Overall BLP) ===\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "<Figure size 1800x1200 with 4 Axes>"
      ],
      "image/png": "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"
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "=== Distributions (Per Subreddit) ===\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "<Figure size 1050x350 with 3 Axes>"
      ],
      "image/png": "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"
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/plain": [
       "<Figure size 1050x350 with 3 Axes>"
      ],
      "image/png": "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"
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "=== Correlations & Scatter Diagnostics ===\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "<Figure size 1800x1400 with 5 Axes>"
      ],
      "image/png": "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"
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "=== CORRELATION MATRIX (BLP) ===\n",
      "              score  num_comments  text_len  title_len\n",
      "score         1.000         0.456    -0.056      0.259\n",
      "num_comments  0.456         1.000     0.029      0.035\n",
      "text_len     -0.056         0.029     1.000     -0.083\n",
      "title_len     0.259         0.035    -0.083      1.000\n",
      "\n",
      "=== Activity Heatmap ===\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "<Figure size 1000x600 with 2 Axes>"
      ],
      "image/png": "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"
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Per-subreddit Year/Month last 6 rows each:\n",
      "\n",
      "[Biohackers]\n",
      "month    1     2     3     4     5     6     7     8     9     10    11    12\n",
      "year                                                                         \n",
      "2020    140   139   161   153   140   121   159   183   244   242   233   214\n",
      "2021    232   245   260   230   226   218   225   244   200   203   203   203\n",
      "2022    212   219   237   203   246   268   254   298   303   271   259   262\n",
      "2023    326   282   373   293   323   366   433   559   661   770   781   974\n",
      "2024   1146  1053  1226  1327  1238  1275  1375  1449  1381  1486  1423  1403\n",
      "\n",
      "[Longevity]\n",
      "month   1    2    3    4    5    6    7    8    9    10   11   12\n",
      "year                                                             \n",
      "2020   278  239  205  211  201  231  263  235  267  239  268  265\n",
      "2021   249  265  258  300  309  316  319  273  253  236  241  275\n",
      "2022   263  249  244  197  230  217  203  247  211  236  199  181\n",
      "2023   175  154  153  191  188  136  157  175  170  131  120  119\n",
      "2024   144  134  153  144  120  127  131  164  129  139  114  102\n",
      "\n",
      "[Peterattia]\n",
      "month   1    2    3    4    5    6    7    8    9    10   11   12\n",
      "year                                                             \n",
      "2020     0   14   19   18   11   12    8   10   14   10    8    8\n",
      "2021    10   15   10   14   18   27   19   19   10   10   12   17\n",
      "2022    23   32   19   31   45   21   28   55   56   85   79   74\n",
      "2023    74   72  118  176  199  223  238  316  281  281  252  243\n",
      "2024   338  308  260  273  363  340  273  337  273  288  209  223\n",
      "\n",
      "NOTE: '# of posts' counts posts only; comments are aggregates attached to posts.\n",
      "      Use 'num_comments' monthly sums/means for engagement trends.\n",
      "\n",
      "=== DONE: BLP EDA ===\n"
     ]
    }
   ],
   "execution_count": 1
  },
  {
   "metadata": {
    "ExecuteTime": {
     "end_time": "2025-11-04T21:49:20.890967Z",
     "start_time": "2025-11-04T21:49:20.802133Z"
    }
   },
   "cell_type": "code",
   "source": [
    "# ====================================================================\n",
    "# === STEP 0: MINI-EDA (Quick Check of Data Structure and Size) ===\n",
    "# ====================================================================\n",
    "\n",
    "import pandas as pd\n",
    "import numpy as np\n",
    "\n",
    "\n",
    "\n",
    "# Assuming 'df' is the DataFrame loaded in the previous step\n",
    "if 'df' not in locals():\n",
    "    print(\"‚ö†Ô∏è Error: DataFrame 'df' not found. Please ensure the main EDA cell has run successfully.\")\n",
    "else:\n",
    "    print(\"üîç DataFrame Quick Check:\")\n",
    "    print(\"-\" * 50)\n",
    "\n",
    "    # 1. Shape and Size\n",
    "    total_rows = len(df)\n",
    "    total_cols = len(df.columns)\n",
    "    print(f\"Total Documents (Rows): {total_rows:,}\")\n",
    "    print(f\"Total Columns: {total_cols}\")\n",
    "    print(f\"Memory Usage: {df.memory_usage(deep=True).sum() / 1024**2:.2f} MB\")\n",
    "    print(\"-\" * 50)\n",
    "\n",
    "    # 2. Subreddit Breakdown\n",
    "    print(\"Subreddit Post Counts:\")\n",
    "    print(df['subreddit'].value_counts().to_markdown())\n",
    "    print(\"-\" * 50)\n",
    "\n",
    "    # 3. Column Info (Subset of .info())\n",
    "    print(\"Key Column Data Types and Non-Null Counts (Top 10):\")\n",
    "    info_df = pd.DataFrame({\n",
    "        'Dtype': df.dtypes,\n",
    "        'Non-Null Count': df.count()\n",
    "    }).reset_index().rename(columns={'index': 'Column Name'})\n",
    "\n",
    "    # Calculate Null Counts\n",
    "    info_df['Null Count'] = total_rows - info_df['Non-Null Count']\n",
    "\n",
    "    # Display Top 10 important columns + the required ones\n",
    "    key_columns = ['doc', 'subreddit', 'score', 'num_comments', 'created_dt', 'text_len']\n",
    "\n",
    "    # Filter for key columns, then take top 5 of the rest if total is less than 10\n",
    "    display_cols = info_df[info_df['Column Name'].isin(key_columns)].drop_duplicates()\n",
    "\n",
    "    # If the combined display is too small, fill with the highest non-null columns\n",
    "    if len(display_cols) < 10:\n",
    "        other_cols = info_df[~info_df['Column Name'].isin(display_cols['Column Name'])].sort_values('Non-Null Count', ascending=False).head(10 - len(display_cols))\n",
    "        display_cols = pd.concat([display_cols, other_cols]).drop_duplicates(subset=['Column Name']).head(10)\n",
    "\n",
    "\n",
    "    print(display_cols[['Column Name', 'Dtype', 'Non-Null Count', 'Null Count']].to_markdown(index=False))\n",
    "    print(\"-\" * 50)"
   ],
   "id": "e8c19934dff9acde",
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "üîç DataFrame Quick Check:\n",
      "--------------------------------------------------\n",
      "Total Documents (Rows): 48,935\n",
      "Total Columns: 18\n",
      "Memory Usage: 108.17 MB\n",
      "--------------------------------------------------\n",
      "Subreddit Post Counts:\n",
      "| subreddit   |   count |\n",
      "|:------------|--------:|\n",
      "| Biohackers  |   29773 |\n",
      "| Longevity   |   12343 |\n",
      "| Peterattia  |    6819 |\n",
      "--------------------------------------------------\n",
      "Key Column Data Types and Non-Null Counts (Top 10):\n",
      "| Column Name   | Dtype          |   Non-Null Count |   Null Count |\n",
      "|:--------------|:---------------|-----------------:|-------------:|\n",
      "| subreddit     | object         |            48935 |            0 |\n",
      "| created_dt    | datetime64[ns] |            48935 |            0 |\n",
      "| score         | int64          |            48935 |            0 |\n",
      "| num_comments  | int64          |            48935 |            0 |\n",
      "| doc           | object         |            48935 |            0 |\n",
      "| text_len      | int64          |            48935 |            0 |\n",
      "| id            | object         |            48935 |            0 |\n",
      "| title         | object         |            48935 |            0 |\n",
      "| text          | object         |            48935 |            0 |\n",
      "| created_utc   | float64        |            48935 |            0 |\n",
      "--------------------------------------------------\n"
     ]
    }
   ],
   "execution_count": 2
  },
  {
   "metadata": {},
   "cell_type": "markdown",
   "source": "# Modeling",
   "id": "86edae4f1120bf55"
  },
  {
   "metadata": {},
   "cell_type": "markdown",
   "source": [
    "# ‚öôÔ∏è STEP 1: Data Preparation, Embedding, and Initial BERTopic Fit\n",
    "\n",
    "This crucial first step handled the entire data pipeline to prepare the text for topic modeling. The major key points were:\n",
    "\n",
    "* **Data Loading & Cleaning:**\n",
    "    * Loaded the combined, deduplicated Reddit data.\n",
    "    * Filtered documents to ensure a **minimum length** (`MIN_DOC_LEN = 40`) and removed `[deleted]` or `[removed]` content.\n",
    "    * **Stratified Sampling** was applied (`FAST_TEST=True`) to efficiently test the pipeline while maintaining the proportional representation of documents from the **PeterAttia, Longevity, and Biohackers** subreddits.\n",
    "* **Embedding Generation:**\n",
    "    * The `SentenceTransformer` model (`all-MiniLM-L6-v2`) was used to convert the cleaned text documents into high-dimensional **embeddings (vectors)**.\n",
    "    * Embeddings were **normalized** and generated using a batch process.\n",
    "* **Model Configuration & Fit:**\n",
    "    * Custom **stop words** were defined to remove generic terms, pronouns, and platform-specific vocabulary (like \"podcast,\" \"episode,\" \"sub\").\n",
    "    * The core BERTopic components were configured:\n",
    "        * **Dimensionality Reduction:** `UMAP` (5 components, `cosine` metric).\n",
    "        * **Clustering:** `HDBSCAN` was used to find dense regions (topics) with a minimum size of **30** documents (`MIN_TOPIC_SIZE`).\n",
    "    * The model was fitted using the generated embeddings.\n",
    "* **Topic Finalization:**\n",
    "    * Topic labels were automatically generated and cleaned to make them more descriptive.\n",
    "    * The final topic assignments (`topic_raw`) and associated **probabilities** (`topic_prob`) were saved back into the main `df` DataFrame."
   ],
   "id": "4dc04a97ec4c5c50"
  },
  {
   "metadata": {
    "ExecuteTime": {
     "end_time": "2025-11-04T21:50:11.230724Z",
     "start_time": "2025-11-04T21:49:20.904783Z"
    }
   },
   "cell_type": "code",
   "source": [
    "# ====================================================================\n",
    "# === HEAVY LIFTING: DATA PREP, EMBEDDING, AND INITIAL BERTopic FIT (FINAL) ===\n",
    "# ====================================================================\n",
    "\n",
    "from pathlib import Path\n",
    "import os, re, math, gc, numpy as np, pandas as pd\n",
    "import matplotlib.pyplot as plt\n",
    "\n",
    "# Using the imports from your previous context\n",
    "from sentence_transformers import SentenceTransformer\n",
    "from bertopic import BERTopic\n",
    "from bertopic.representation import KeyBERTInspired\n",
    "from umap import UMAP\n",
    "from hdbscan import HDBSCAN\n",
    "from sklearn.feature_extraction.text import CountVectorizer, ENGLISH_STOP_WORDS\n",
    "import torch\n",
    "# Note: Cosine similarity/normalize imports will be added in the next analysis cell\n",
    "\n",
    "# -----------------------------\n",
    "# Config (Copied from your context)\n",
    "# -----------------------------\n",
    "os.environ.setdefault(\"TOKENIZERS_PARALLELISM\",\"false\")\n",
    "\n",
    "BASE = Path(\"/Users/michaelwalker/CU_Boulder_Masters_Ai/Introduction to Deep Learning/cu-boulder-ms-ai/Introduction-to-Machine-Learning/unsupervised/CSCA 5632 Unsupervised Algorithms in Machine Learning Final Project/data/combined_dedup\")\n",
    "PREFER_PATTERNS  = [\"BLP*combined*thru_2024*.csv\", \"*Biohackers*Longevity*PeterAttia*combined*thru_2024*.csv\"]\n",
    "FALLBACK_PATTERNS = [\"BLP*combined*.csv\", \"*Biohackers*Longevity*PeterAttia*combined*.csv\"]\n",
    "\n",
    "FAST_TEST       = True\n",
    "SUB_FRACTIONS   = {\"Biohackers\": 0.10, \"Longevity\": 0.10, \"PeterAttia\": 0.10}\n",
    "SAMPLE_BY_MONTH = True\n",
    "RANDOM_STATE    = 42\n",
    "\n",
    "TARGET_N_TOPICS = 50 # Used later\n",
    "MIN_TOPIC_SIZE  = 30 if FAST_TEST else 60\n",
    "MIN_DOC_LEN     = 40\n",
    "\n",
    "MODEL_NAME = \"sentence-transformers/all-MiniLM-L6-v2\"\n",
    "\n",
    "# -----------------------------\n",
    "# Helpers (Only essential ones for this step)\n",
    "# -----------------------------\n",
    "def pick_file(files, prefer_substr=\"thru_2024\"):\n",
    "    if not files: return None\n",
    "    with_pref = [p for p in files if prefer_substr in p.name]\n",
    "    pool = with_pref if with_pref else files\n",
    "    return max(pool, key=lambda p: p.stat().st_mtime)\n",
    "\n",
    "def light_clean(s: str) -> str:\n",
    "    # Uses the cleaning logic from your context\n",
    "    s = str(s or \"\")\n",
    "    t = s.lower()\n",
    "    t = re.sub(r\"https?://\\S+|www\\.\\S+\", \" \", t)\n",
    "    t = re.sub(r\"\\[(.*?)\\]\\((.*?)\\)\", r\"\\1\", t)\n",
    "    t = re.sub(r\"[\\u2010-\\u2015]\", \"-\", t)\n",
    "    t = re.sub(r\"[^a-z0-9\\s'_-]\", \" \", t)\n",
    "    t = re.sub(r\"\\s+\", \" \", t).strip()\n",
    "    return t\n",
    "\n",
    "def stratified_sample(df, sub_fracs, by_month=False, random_state=42):\n",
    "    # Uses the sampling logic from your context\n",
    "    need_cols = [\"subreddit\", \"created_dt\"]\n",
    "    for c in need_cols:\n",
    "        if c not in df.columns:\n",
    "            raise ValueError(f\"stratified_sample: missing column '{c}'\")\n",
    "    groups = [\"subreddit\", \"_month\"] if by_month else [\"subreddit\"]\n",
    "    if by_month:\n",
    "        df[\"_month\"] = pd.to_datetime(df[\"created_dt\"]).dt.to_period(\"M\")\n",
    "    out = []\n",
    "    for keys, g in df.groupby(groups, dropna=False):\n",
    "        subname = keys[0] if by_month else keys\n",
    "        frac = sub_fracs.get(subname, 0.0)\n",
    "        if frac <= 0.0 or len(g) == 0:\n",
    "            continue\n",
    "        n = max(1, int(math.ceil(len(g) * frac)))\n",
    "        out.append(g.sample(n=min(n, len(g)), random_state=random_state))\n",
    "    samp = pd.concat(out, ignore_index=True) if out else df.head(0).copy()\n",
    "    if \"_month\" in samp.columns:\n",
    "        samp.drop(columns=\"_month\", inplace=True, errors=\"ignore\")\n",
    "    return samp\n",
    "\n",
    "\n",
    "# -----------------------------\n",
    "# Load + prepare\n",
    "# -----------------------------\n",
    "cands = []\n",
    "for pat in PREFER_PATTERNS + FALLBACK_PATTERNS:\n",
    "    cands += list(BASE.glob(pat))\n",
    "CSV = pick_file(cands)\n",
    "if not CSV:\n",
    "    raise FileNotFoundError(f\"No BLP combined CSV in {BASE}\")\n",
    "print(f\"‚úÖ [Using] {CSV}\")\n",
    "\n",
    "df = pd.read_csv(CSV, low_memory=False)\n",
    "df.columns = [c.lower() for c in df.columns]\n",
    "\n",
    "if \"created_dt\" in df.columns:\n",
    "    df[\"created_dt\"] = pd.to_datetime(df[\"created_dt\"], errors=\"coerce\")\n",
    "elif \"created_utc\" in df.columns:\n",
    "    df[\"created_dt\"] = pd.to_datetime(pd.to_numeric(df[\"created_utc\"], errors=\"coerce\"), unit=\"s\", errors=\"coerce\")\n",
    "else:\n",
    "    raise ValueError(\"No created_dt/created_utc column present.\")\n",
    "\n",
    "for col in (\"title\", \"text\"):\n",
    "    if col not in df.columns: df[col] = \"\"\n",
    "df[\"title\"] = df[\"title\"].fillna(\"\").astype(str).str.strip()\n",
    "df[\"text\"]  = df[\"text\"].fillna(\"\").astype(str).str.strip()\n",
    "df[\"doc\"]   = (df[\"title\"] + \". \" + df[\"text\"]).str.strip()\n",
    "\n",
    "if \"subreddit\" not in df.columns:\n",
    "    raise ValueError(\"Expected a 'subreddit' column.\")\n",
    "df = df.dropna(subset=[\"created_dt\"]).copy()\n",
    "df[\"doc_clean\"] = df[\"doc\"].map(light_clean)\n",
    "\n",
    "mask_valid = (df[\"doc_clean\"].str.len() >= MIN_DOC_LEN) & (~df[\"doc_clean\"].str.contains(r\"\\b(deleted|removed)\\b\"))\n",
    "df = df.loc[mask_valid].reset_index(drop=True)\n",
    "print(f\"üìä Rows after clean/filter: {len(df):,} | {df['created_dt'].min()} ‚Üí {df['created_dt'].max()}\")\n",
    "\n",
    "# Sample (FAST_TEST)\n",
    "if FAST_TEST:\n",
    "    before = df[\"subreddit\"].value_counts()\n",
    "    df = stratified_sample(df, SUB_FRACTIONS, by_month=SAMPLE_BY_MONTH, random_state=RANDOM_STATE)\n",
    "    after = df[\"subreddit\"].value_counts()\n",
    "    print(\"\\n[FAST_TEST] Stratified sample sizes (before ‚Üí after):\")\n",
    "    for sub in sorted(set(before.index) | set(after.index)):\n",
    "        print(f\"  {sub:12s}: {before.get(sub,0):7d} ‚Üí {after.get(sub,0):7d}\")\n",
    "\n",
    "docs = df[\"doc_clean\"].tolist()\n",
    "\n",
    "# -----------------------------\n",
    "# Embeddings (The heavy lift)\n",
    "# -----------------------------\n",
    "USE_CPU = True\n",
    "BATCH   = 32\n",
    "MAX_LEN = 128\n",
    "\n",
    "device = \"cpu\" if USE_CPU else (\"mps\" if torch.backends.mps.is_available() else \"cpu\")\n",
    "encoder = SentenceTransformer(MODEL_NAME, device=device)\n",
    "encoder.max_seq_length = MAX_LEN\n",
    "\n",
    "if torch.backends.mps.is_available():\n",
    "    try: torch.mps.empty_cache()\n",
    "    except Exception: pass\n",
    "gc.collect()\n",
    "\n",
    "print(f\"\\nüß† Encoding {len(docs):,} documents into embeddings...\")\n",
    "X = encoder.encode(\n",
    "    docs,\n",
    "    batch_size=BATCH,\n",
    "    show_progress_bar=True,\n",
    "    normalize_embeddings=True,\n",
    "    convert_to_numpy=True\n",
    ")\n",
    "print(f\"‚úÖ Embeddings shape: {X.shape}\")\n",
    "\n",
    "\n",
    "# -----------------------------\n",
    "# Vectorizer + Representation\n",
    "# -----------------------------\n",
    "CUSTOM_STOP = {\n",
    "    # 1. Structural/Pronouns/Connectors\n",
    "    \"the\", \"to\", \"and\", \"of\", \"my\", \"in\", \"for\", \"is\", \"it\", \"that\", \"what\", \"we\", \"you\", \"on\", \"a\", \"an\", \"at\",\n",
    "    \"but\", \"by\", \"with\", \"from\", \"as\", \"or\", \"if\", \"so\", \"up\", \"out\", \"about\", \"into\", \"over\", \"under\", \"off\",\n",
    "    \"all\", \"some\", \"any\", \"no\", \"not\", \"too\", \"very\", \"much\", \"more\", \"less\", \"me\", \"he\", \"she\", \"his\", \"her\",\n",
    "    \"them\", \"their\", \"our\", \"would\", \"could\", \"should\", \"will\", \"can\", \"get\", \"go\", \"say\", \"do\", \"did\", \"was\",\n",
    "    \"were\", \"have\", \"had\", \"has\", \"just\", \"really\", \"many\", \"most\", \"only\", \"where\", \"when\", \"how\", \"who\",\n",
    "    \"i‚Äôm\", \"i'm\", \"i‚Äôve\", \"i‚Äôd\", \"i'd\", \"i'll\", \"you‚Äôre\", \"you're\", \"you‚Äôve\", \"you've\", \"don‚Äôt\", \"don't\",\n",
    "    \"doesn‚Äôt\", \"doesn't\", \"didn‚Äôt\", \"didn't\", \"can‚Äôt\", \"can't\", \"we‚Äôve\", \"we've\", \"they‚Äôre\", \"they're\", \"they‚Äôve\",\n",
    "    \"there\", \"here\", \"which\", \"than\", \"been\", \"being\", \"while\", \"though\", \"even\", \"after\", \"before\", \"each\",\n",
    "    \"such\", \"must\", \"own\", \"put\", \"take\", \"came\", \"went\", \"made\", \"give\", \"given\", \"see\", \"saw\", \"take\", \"took\",\n",
    "\n",
    "    # 2. Generic Discussion/Reddit/Media terms\n",
    "    \"people\", \"know\", \"think\", \"thing\", \"things\", \"help\", \"best\", \"good\", \"great\", \"new\", \"old\", \"use\", \"using\",\n",
    "    \"used\", \"make\", \"made\", \"tell\", \"show\", \"read\", \"check\", \"find\", \"found\", \"look\", \"looks\", \"looking\",\n",
    "    \"feel\", \"feels\", \"feeling\", \"tried\", \"try\", \"sure\", \"maybe\", \"never\", \"always\", \"sometimes\", \"definitely\",\n",
    "    \"youtube\", \"spotify\", \"apple\", \"podcast\", \"episode\", \"clip\", \"clips\", \"podclips\", \"bestpodcastclips\",\n",
    "    \"post\", \"comment\", \"thread\", \"sub\", \"subreddit\", \"original\", \"question\", \"answer\", \"source\", \"link\",\n",
    "    \"article\", \"data\", \"paper\", \"study\",\n",
    "\n",
    "    # 3. Time, Quantity, and Measurement\n",
    "    \"day\", \"week\", \"today\", \"tomorrow\", \"yesterday\", \"years\", \"year\", \"months\", \"month\", \"time\", \"times\",\n",
    "    \"00\", \"10\", \"20\", \"30\", \"40\", \"50\", \"60\", \"70\", \"80\", \"90\", \"100\", \"mg\", \"dl\", \"io\", \"sens\", \"monthly\",\n",
    "    \"grams\", \"milligrams\", \"units\", \"dosage\", \"dose\", \"per\", \"hour\", \"hours\"\n",
    "}\n",
    "\n",
    "STOP  = sorted(ENGLISH_STOP_WORDS.union(CUSTOM_STOP))\n",
    "TOKEN = r\"(?u)\\b\\w+(?:['-]\\w+)*\\b\"\n",
    "\n",
    "vectorizer_model = CountVectorizer(\n",
    "    stop_words=STOP,\n",
    "    token_pattern=TOKEN,\n",
    "    ngram_range=(1,2),\n",
    "    min_df=5,\n",
    "    max_df=0.60\n",
    ")\n",
    "\n",
    "rep = KeyBERTInspired()\n",
    "\n",
    "# -----------------------------\n",
    "# Global model (The second heavy lift)\n",
    "# -----------------------------\n",
    "umap_model    = UMAP(n_neighbors=10 if FAST_TEST else 15, n_components=5, min_dist=0.0, metric=\"cosine\", random_state=RANDOM_STATE)\n",
    "hdbscan_model = HDBSCAN(min_cluster_size=MIN_TOPIC_SIZE, metric=\"euclidean\", cluster_selection_method=\"eom\", prediction_data=True)\n",
    "\n",
    "topic_model = BERTopic(\n",
    "    umap_model=umap_model,\n",
    "    hdbscan_model=hdbscan_model,\n",
    "    vectorizer_model=vectorizer_model,\n",
    "    representation_model=rep,\n",
    "    embedding_model=encoder, # Pass the initialized encoder\n",
    "    top_n_words=12,\n",
    "    calculate_probabilities=True,\n",
    "    language=None,\n",
    "    min_topic_size=MIN_TOPIC_SIZE,\n",
    ")\n",
    "\n",
    "print(\"üöÄ Starting BERTopic fit...\")\n",
    "topics, probs = topic_model.fit_transform(docs, embeddings=X)\n",
    "print(f\"‚úÖ BERTopic fit complete. Found {len(set(topics) - {-1})} initial topics.\")\n",
    "\n",
    "# --- NEW BLOCK: FORCE TOPIC NAME CLEANUP (Moved from Step 4) ---\n",
    "print(\"‚ú® Regenerating Topic Names with clean vocabulary...\")\n",
    "# NOTE: The argument 'topic_names=True' has been removed from newer BERTopic versions.\n",
    "topic_model.set_topic_labels(\n",
    "    topic_model.generate_topic_labels(\n",
    "        nr_words=4 # Use 4 words for better names\n",
    "    )\n",
    ")\n",
    "print(\"‚úÖ Topic names updated in model.\")\n",
    "# -------------------------------------------------------------\n",
    "\n",
    "# Store results in the DataFrame for the next step\n",
    "df[\"topic_raw\"] = topics\n",
    "\n",
    "# We use the official BERTopic utility to correctly get document info\n",
    "doc_info = topic_model.get_document_info(docs)\n",
    "# The probability is stored in the 'Probability' column of the returned info\n",
    "df[\"topic_prob\"] = doc_info[\"Probability\"].values\n",
    "\n",
    "print(\"\\n--- Model Ready for Analysis ---\")\n",
    "print(\"Data is stored in 'df', Embeddings are in 'X', and the model is 'topic_model'.\")"
   ],
   "id": "8a696a34be5f14db",
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/Users/michaelwalker/CU_Boulder_Masters_Ai/Introduction to Deep Learning/cu-boulder-ms-ai/.attia311/lib/python3.11/site-packages/sentence_transformers/cross_encoder/CrossEncoder.py:11: TqdmWarning: IProgress not found. Please update jupyter and ipywidgets. See https://ipywidgets.readthedocs.io/en/stable/user_install.html\n",
      "  from tqdm.autonotebook import tqdm, trange\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "‚úÖ [Using] /Users/michaelwalker/CU_Boulder_Masters_Ai/Introduction to Deep Learning/cu-boulder-ms-ai/Introduction-to-Machine-Learning/unsupervised/CSCA 5632 Unsupervised Algorithms in Machine Learning Final Project/data/combined_dedup/BLP_combined_2020-01-01_2025-11-02_dedup_thru_2024.csv\n",
      "üìä Rows after clean/filter: 47,525 | 2020-01-01 00:05:35 ‚Üí 2024-12-31 23:30:03\n",
      "\n",
      "[FAST_TEST] Stratified sample sizes (before ‚Üí after):\n",
      "  Biohackers  :   28962 ‚Üí    2925\n",
      "  Longevity   :   11875 ‚Üí    1212\n",
      "  PeterAttia  :    6688 ‚Üí     692\n",
      "\n",
      "üß† Encoding 4,829 documents into embeddings...\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Batches: 100%|‚ñà‚ñà‚ñà‚ñà‚ñà‚ñà‚ñà‚ñà‚ñà‚ñà| 151/151 [00:21<00:00,  7.07it/s]\n",
      "OMP: Info #276: omp_set_nested routine deprecated, please use omp_set_max_active_levels instead.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "‚úÖ Embeddings shape: (4829, 384)\n",
      "üöÄ Starting BERTopic fit...\n",
      "‚úÖ BERTopic fit complete. Found 26 initial topics.\n",
      "‚ú® Regenerating Topic Names with clean vocabulary...\n",
      "‚úÖ Topic names updated in model.\n",
      "\n",
      "--- Model Ready for Analysis ---\n",
      "Data is stored in 'df', Embeddings are in 'X', and the model is 'topic_model'.\n"
     ]
    }
   ],
   "execution_count": 3
  },
  {
   "metadata": {},
   "cell_type": "markdown",
   "source": [
    "# ‚öôÔ∏è STEP 2: Topic Refinement, Outlier Reduction, and Final Assignment\n",
    "This step takes the raw clusters from HDBSCAN and performs several crucial operations to clean, stabilize, and finalize the set of topics used for all subsequent analysis.\n",
    "\n",
    "* **1. Topic Name Regeneration:**\n",
    "    * **Action:** Force the BERTopic model to re-run the topic naming process.\n",
    "    * **Purpose:** Ensure the final topic labels (`Name`) are based on the post-processing vocabulary (after stop-word removal and vectorization) for the best descriptive names.\n",
    "\n",
    "* **2. Outlier Reduction (BERTopic Strategy):**\n",
    "    * **Action:** Used `topic_model.reduce_outliers` with the `\"probabilities\"` strategy and a `threshold=0.3`.\n",
    "    * **Purpose:** Reassign documents initially marked as outlier (`Topic = -1`) to their most probable, existing topics if the document's probability exceeds the threshold. This reduces noise in the data and grows the size of meaningful topics.\n",
    "    * **Result:** The initial large group of outliers was significantly reduced.\n",
    "\n",
    "* **3. Soft Reassignment of Remaining Outliers (Custom Logic):**\n",
    "    * **Action:** A custom, robust method was implemented to handle the remaining, hard-to-classify outliers.\n",
    "    * **Mechanism:**\n",
    "        * Calculated the **centroid (average embedding)** for every non-outlier topic.\n",
    "        * Calculated the **cosine similarity** between every remaining outlier document and every topic centroid.\n",
    "        * If an outlier document's maximum similarity to any centroid was above a custom **confidence threshold (`CONF=0.28`)**, it was reassigned to that nearest topic.\n",
    "    * **Purpose:** This aggressive step ensures that nearly every document is placed into its most topically similar cluster, resulting in the final, robust topic ID (`topic_global`).\n",
    "\n",
    "* **Final Result:**\n",
    "    * The process successfully transitioned the raw clusters into a stable set of **refined topics**, ready for quantitative and comparative analysis between the subreddits (Steps 6, 7, 8, etc.)."
   ],
   "id": "646497eef2e2a38d"
  },
  {
   "metadata": {
    "ExecuteTime": {
     "end_time": "2025-11-04T21:50:11.808862Z",
     "start_time": "2025-11-04T21:50:11.345815Z"
    }
   },
   "cell_type": "code",
   "source": [
    "# ====================================================================\n",
    "# === STEP 2: TOPIC REFINEMENT, OUTLIER REDUCTION, AND SOFT REASSIGNMENT (ROBUST) ===\n",
    "# ====================================================================\n",
    "import numpy as np\n",
    "from sklearn.preprocessing import normalize\n",
    "from sklearn.metrics.pairwise import cosine_similarity\n",
    "\n",
    "# --- 1. Update Model to use Final Topic Names (Crucial) ---\n",
    "# This ensures the names are based on the post-stop-word vocabulary\n",
    "print(\"1. Forcing Topic Model to regenerate names using final vocabulary...\")\n",
    "topic_model.set_topic_labels(\n",
    "    topic_model.generate_topic_labels(\n",
    "        nr_words=4 # Use 4 words for better names\n",
    "    )\n",
    ")\n",
    "print(\"   Names regenerated.\")\n",
    "\n",
    "\n",
    "# --- 2. Reduce Outliers (Model-aware) ---\n",
    "print(\"\\nüßπ 2. Reducing outliers using probability strategy...\")\n",
    "topics_reduced = topic_model.reduce_outliers(\n",
    "    docs,\n",
    "    topics=df[\"topic_raw\"].tolist(),\n",
    "    probabilities=probs,\n",
    "    strategy=\"probabilities\",\n",
    "    threshold=0.3\n",
    ")\n",
    "df[\"topic_refined\"] = topics_reduced\n",
    "print(f\"   Initial outliers: {(df['topic_raw'] == -1).sum():,}\")\n",
    "print(f\"   Refined outliers: {(df['topic_refined'] == -1).sum():,}\")\n",
    "\n",
    "\n",
    "# --- 3. Bypassing Reduction (Due to instability) ---\n",
    "# We skip reduce_topics and directly use the refined topics for final assignment\n",
    "print(\"\\nüß© 3. Bypassing Topic Reduction due to persistent instability. Using refined topics.\")\n",
    "df[\"topic_final\"] = df[\"topic_refined\"]\n",
    "\n",
    "\n",
    "# --- 4. Soft Reassign Remaining -1s (Nearest centroid logic) ---\n",
    "print(\"\\n‚ú® 4. Soft-reassigning remaining outliers to nearest cluster centroid...\")\n",
    "\n",
    "topics_arr = df[\"topic_final\"].values\n",
    "Xn = normalize(np.asarray(X), axis=1)\n",
    "\n",
    "in_mask  = topics_arr != -1\n",
    "uniq_ids = np.array(sorted(set(topics_arr[in_mask])))\n",
    "\n",
    "# Update the BERTopic model's internal topic-to-embedding index one last time\n",
    "# This is crucial for matching topic IDs to centroids, which is where the original error stems from\n",
    "topic_model.update_topics(docs, topics=topics_arr)\n",
    "\n",
    "\n",
    "# Calculate centroids of the final topics\n",
    "# NOTE: We use the embeddings X, which should not be polluted by the stop words.\n",
    "centroids = np.vstack([Xn[topics_arr == t].mean(0) for t in uniq_ids])\n",
    "centroids = normalize(centroids, axis=1)\n",
    "\n",
    "# Find the similarity of every outlier doc to every centroid\n",
    "S        = cosine_similarity(Xn, centroids)\n",
    "best_k   = S.argmax(1)\n",
    "best_sim = S[np.arange(S.shape[0]), best_k]\n",
    "\n",
    "topics_soft = topics_arr.copy()\n",
    "out_mask    = (topics_arr == -1)\n",
    "\n",
    "CONF = 0.28\n",
    "topics_soft[out_mask] = np.where(best_sim[out_mask] >= CONF,\n",
    "                                 uniq_ids[best_k[out_mask]],\n",
    "                                 -1)\n",
    "\n",
    "df[\"topic_global\"] = topics_soft\n",
    "print(f\"   Outliers before soft-reassign: {(topics_arr == -1).sum():,}\")\n",
    "print(f\"   Outliers after soft-reassign : {(df['topic_global'] == -1).sum():,}\")\n",
    "\n",
    "\n",
    "# --- 5. Final Output and Next Step Preparation ---\n",
    "print(\"\\n--- Refinement Complete ---\")\n",
    "topic_info = topic_model.get_topic_info().query(\"Topic != -1\")[[\"Topic\", \"Count\", \"Name\"]]\n",
    "print(f\"Total topics (excluding outlier) used: {len(topic_info)}\")\n",
    "print(\"[Final Topics] (Top 5 clusters based on count)\")\n",
    "print(topic_info.head(5).to_markdown(index=False))"
   ],
   "id": "fc2e67d715984e34",
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2025-11-04 13:50:11,392 - BERTopic - WARNING: Using a custom list of topic assignments may lead to errors if topic reduction techniques are used afterwards. Make sure that manually assigning topics is the last step in the pipeline.Note that topic embeddings will also be created through weightedc-TF-IDF embeddings instead of centroid embeddings.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. Forcing Topic Model to regenerate names using final vocabulary...\n",
      "   Names regenerated.\n",
      "\n",
      "üßπ 2. Reducing outliers using probability strategy...\n",
      "   Initial outliers: 2,191\n",
      "   Refined outliers: 2,134\n",
      "\n",
      "üß© 3. Bypassing Topic Reduction due to persistent instability. Using refined topics.\n",
      "\n",
      "‚ú® 4. Soft-reassigning remaining outliers to nearest cluster centroid...\n",
      "   Outliers before soft-reassign: 2,134\n",
      "   Outliers after soft-reassign : 127\n",
      "\n",
      "--- Refinement Complete ---\n",
      "Total topics (excluding outlier) used: 26\n",
      "[Final Topics] (Top 5 clusters based on count)\n",
      "|   Topic |   Count | Name                         |\n",
      "|--------:|--------:|:-----------------------------|\n",
      "|       0 |     253 | 0_vitamin_and_supplements_to |\n",
      "|       1 |     230 | 1_to_and_it_my               |\n",
      "|       2 |     217 | 2_longevity_the_aging_link   |\n",
      "|       3 |     190 | 3_ldl_cholesterol_my_apob    |\n",
      "|       4 |     178 | 4_zone_training_max_to       |\n"
     ]
    }
   ],
   "execution_count": 4
  },
  {
   "metadata": {},
   "cell_type": "markdown",
   "source": [
    "# üìä STEP 3: Core Topic Analysis and Visualization\n",
    "\n",
    "This step provides the first deep look into the structure of the finalized topics, focusing on size and temporal stability, which are essential metrics for evaluating a topic model.\n",
    "\n",
    "* **1. Topic Size Visualization:**\n",
    "    * **Action:** Generated a horizontal bar chart showing the **top 20 largest topics** (excluding the outlier topic, -1).\n",
    "    * **Purpose:** To quickly identify the **most voluminous areas of discussion** across all subreddits. Topics are ordered by their document count (`Count`), indicating the relative importance or frequency of each subject.\n",
    "    * **Metric:** Document count (`Count`).\n",
    "\n",
    "* **2. Temporal Topic Trends:**\n",
    "    * **Action:** Generated an interactive **area chart** showing the monthly volume of the **top 10 largest topics**.\n",
    "    * **Purpose:** To observe how the conversations evolve over time. This helps identify:\n",
    "        * **Stable, evergreen topics** (consistent lines).\n",
    "        * **Spikes or seasonal trends** (sharp peaks), indicating external events or new scientific findings driving discussion.\n",
    "    * **Metric:** Monthly document volume (`count`).\n",
    "\n",
    "* **Result:** These two visualizations provide a quantitative foundation for the topics, validating their size and showing their life cycle before diving into subreddit-specific comparisons."
   ],
   "id": "eb33c892f3911144"
  },
  {
   "metadata": {
    "ExecuteTime": {
     "end_time": "2025-11-04T22:00:22.960948Z",
     "start_time": "2025-11-04T22:00:18.833654Z"
    }
   },
   "cell_type": "code",
   "source": [
    "# ====================================================================\n",
    "# === STEP 3: ANALYSIS AND VISUALIZATION (Streamlined) - FINAL VERSION ===\n",
    "# ====================================================================\n",
    "import plotly.express as px\n",
    "import matplotlib.pyplot as plt\n",
    "import seaborn as sns\n",
    "import pandas as pd\n",
    "import os\n",
    "from pathlib import Path\n",
    "from IPython.display import Image # üëà NEW: Import the Image object\n",
    "\n",
    "# --- Setup Output Directory ---\n",
    "OUTPUT_DIR = Path(\"visualization_outputs\")\n",
    "OUTPUT_DIR.mkdir(exist_ok=True)\n",
    "print(f\"Saving figures to: {OUTPUT_DIR.resolve()}\")\n",
    "\n",
    "# 1. Visualization of Topic Size\n",
    "# Exclude the -1 (Outlier) topic for clear analysis\n",
    "print(\"üìà 1. Visualizing Topic Sizes (Volume of Discussion)...\")\n",
    "df_topic_sizes = topic_model.get_topic_info().query(\"Topic != -1\").sort_values(\"Count\", ascending=False).head(20)\n",
    "\n",
    "fig_size = px.bar(\n",
    "    df_topic_sizes,\n",
    "    x=\"Count\",\n",
    "    y=\"Name\",\n",
    "    orientation=\"h\",\n",
    "    title=\"Top 20 Topic Sizes (Volume of Discussion)\",\n",
    "    height=600,\n",
    "    color=\"Count\",\n",
    "    color_continuous_scale=px.colors.sequential.Plotly3\n",
    ")\n",
    "fig_size.update_layout(yaxis={'categoryorder':'total ascending'})\n",
    "fig_size.show() # Shows interactive Plotly locally\n",
    "\n",
    "# **EXPORT FIGURE 1**\n",
    "fig_size_path = OUTPUT_DIR / \"3_topic_size_bar_chart.png\"\n",
    "fig_size.write_image(fig_size_path)\n",
    "# üëà NEW: Display the saved PNG inline\n",
    "display(Image(filename=fig_size_path))\n",
    "\n",
    "\n",
    "# 2. Temporal Topic Trends (Time Series Analysis)\n",
    "print(\"\\n‚è≥ 2. Visualizing Temporal Topic Trends...\")\n",
    "\n",
    "# Group the DataFrame by Month and Topic, counting documents\n",
    "df['month'] = df['created_dt'].dt.to_period('M').astype(str)\n",
    "df_time = df.query('topic_global != -1').groupby(['month', 'topic_global']).size().reset_index(name='count')\n",
    "\n",
    "# Merge with Topic Names\n",
    "topic_names_map = topic_model.get_topic_info().set_index('Topic')['Name'].to_dict()\n",
    "df_time['Topic Name'] = df_time['topic_global'].map(topic_names_map)\n",
    "\n",
    "# Get the top 10 topics by overall count (excluding -1)\n",
    "top_topics_for_plot = df_topic_sizes[\"Topic\"].head(10).tolist()\n",
    "\n",
    "df_time_top = df_time[df_time['topic_global'].isin(top_topics_for_plot)]\n",
    "\n",
    "# Use Plotly to create an interactive area chart\n",
    "fig_time = px.area(\n",
    "    df_time_top,\n",
    "    x=\"month\",\n",
    "    y=\"count\",\n",
    "    color=\"Topic Name\",\n",
    "    title=f\"Evolution of Top {len(top_topics_for_plot)} Topics Over Time (Monthly Volume)\",\n",
    "    color_discrete_sequence=px.colors.qualitative.Bold,\n",
    "    markers=True,\n",
    "    height=600\n",
    ")\n",
    "fig_time.update_layout(\n",
    "    xaxis_title=\"Month\",\n",
    "    yaxis_title=\"Document Count\",\n",
    "    xaxis={'type': 'category'}\n",
    ")\n",
    "fig_time.show() # Shows interactive Plotly locally\n",
    "\n",
    "# **EXPORT FIGURE 2**\n",
    "fig_time_path = OUTPUT_DIR / \"3_temporal_topic_trends.png\"\n",
    "fig_time.write_image(fig_time_path)\n",
    "# üëà NEW: Display the saved PNG inline\n",
    "display(Image(filename=fig_time_path))"
   ],
   "id": "a7f5312b15af4d87",
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Saving figures to: /Users/michaelwalker/CU_Boulder_Masters_Ai/Introduction to Deep Learning/cu-boulder-ms-ai/Introduction-to-Machine-Learning/unsupervised/CSCA 5632 Unsupervised Algorithms in Machine Learning Final Project/visualization_outputs\n",
      "üìà 1. Visualizing Topic Sizes (Volume of Discussion)...\n"
     ]
    },
    {
     "data": {
      "application/vnd.plotly.v1+json": {
       "data": [
        {
         "hovertemplate": "Count=%{marker.color}<br>Name=%{y}<extra></extra>",
         "legendgroup": "",
         "marker": {
          "color": {
           "dtype": "i2",
           "bdata": "/QDmANkAvgCyAK8ApQCUAIIAZQBgAF8AUgBRAEMAOAA3ADYANgArAA=="
          },
          "coloraxis": "coloraxis",
          "pattern": {
           "shape": ""
          }
         },
         "name": "",
         "orientation": "h",
         "showlegend": false,
         "textposition": "auto",
         "x": {
          "dtype": "i2",
          "bdata": "/QDmANkAvgCyAK8ApQCUAIIAZQBgAF8AUgBRAEMAOAA3ADYANgArAA=="
         },
         "xaxis": "x",
         "y": [
          "0_vitamin_and_supplements_to",
          "1_to_and_it_my",
          "2_longevity_the_aging_link",
          "3_ldl_cholesterol_my_apob",
          "4_zone_training_max_to",
          "5_sleep_up_to_and",
          "6_light_the_sauna_to",
          "7_aging_cells_senescence_in",
          "8_testosterone_the_and_my",
          "9_biohacking_to_you_and",
          "10_alzheimer_cognitive_disease_amyloid",
          "11_app_watch_the_to",
          "14_cells_stem_cell_the",
          "12_protein_eat_and_to",
          "13_blood_tests_test_to",
          "15_the_peter_in_of",
          "16_epigenetic_methylation_age_aging",
          "17_gut_and_my_to",
          "18_pain_and_my_have",
          "19_nmn_resveratrol_and_in"
         ],
         "yaxis": "y",
         "type": "bar"
        }
       ],
       "layout": {
        "template": {
         "data": {
          "histogram2dcontour": [
           {
            "type": "histogram2dcontour",
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0.0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1.0,
              "#f0f921"
             ]
            ]
           }
          ],
          "choropleth": [
           {
            "type": "choropleth",
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            }
           }
          ],
          "histogram2d": [
           {
            "type": "histogram2d",
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0.0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1.0,
              "#f0f921"
             ]
            ]
           }
          ],
          "heatmap": [
           {
            "type": "heatmap",
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0.0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1.0,
              "#f0f921"
             ]
            ]
           }
          ],
          "contourcarpet": [
           {
            "type": "contourcarpet",
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            }
           }
          ],
          "contour": [
           {
            "type": "contour",
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0.0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1.0,
              "#f0f921"
             ]
            ]
           }
          ],
          "surface": [
           {
            "type": "surface",
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0.0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1.0,
              "#f0f921"
             ]
            ]
           }
          ],
          "mesh3d": [
           {
            "type": "mesh3d",
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            }
           }
          ],
          "scatter": [
           {
            "fillpattern": {
             "fillmode": "overlay",
             "size": 10,
             "solidity": 0.2
            },
            "type": "scatter"
           }
          ],
          "parcoords": [
           {
            "type": "parcoords",
            "line": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            }
           }
          ],
          "scatterpolargl": [
           {
            "type": "scatterpolargl",
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            }
           }
          ],
          "bar": [
           {
            "error_x": {
             "color": "#2a3f5f"
            },
            "error_y": {
             "color": "#2a3f5f"
            },
            "marker": {
             "line": {
              "color": "#E5ECF6",
              "width": 0.5
             },
             "pattern": {
              "fillmode": "overlay",
              "size": 10,
              "solidity": 0.2
             }
            },
            "type": "bar"
           }
          ],
          "scattergeo": [
           {
            "type": "scattergeo",
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            }
           }
          ],
          "scatterpolar": [
           {
            "type": "scatterpolar",
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            }
           }
          ],
          "histogram": [
           {
            "marker": {
             "pattern": {
              "fillmode": "overlay",
              "size": 10,
              "solidity": 0.2
             }
            },
            "type": "histogram"
           }
          ],
          "scattergl": [
           {
            "type": "scattergl",
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            }
           }
          ],
          "scatter3d": [
           {
            "type": "scatter3d",
            "line": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            }
           }
          ],
          "scattermap": [
           {
            "type": "scattermap",
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            }
           }
          ],
          "scattermapbox": [
           {
            "type": "scattermapbox",
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            }
           }
          ],
          "scatterternary": [
           {
            "type": "scatterternary",
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            }
           }
          ],
          "scattercarpet": [
           {
            "type": "scattercarpet",
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            }
           }
          ],
          "carpet": [
           {
            "aaxis": {
             "endlinecolor": "#2a3f5f",
             "gridcolor": "white",
             "linecolor": "white",
             "minorgridcolor": "white",
             "startlinecolor": "#2a3f5f"
            },
            "baxis": {
             "endlinecolor": "#2a3f5f",
             "gridcolor": "white",
             "linecolor": "white",
             "minorgridcolor": "white",
             "startlinecolor": "#2a3f5f"
            },
            "type": "carpet"
           }
          ],
          "table": [
           {
            "cells": {
             "fill": {
              "color": "#EBF0F8"
             },
             "line": {
              "color": "white"
             }
            },
            "header": {
             "fill": {
              "color": "#C8D4E3"
             },
             "line": {
              "color": "white"
             }
            },
            "type": "table"
           }
          ],
          "barpolar": [
           {
            "marker": {
             "line": {
              "color": "#E5ECF6",
              "width": 0.5
             },
             "pattern": {
              "fillmode": "overlay",
              "size": 10,
              "solidity": 0.2
             }
            },
            "type": "barpolar"
           }
          ],
          "pie": [
           {
            "automargin": true,
            "type": "pie"
           }
          ]
         },
         "layout": {
          "autotypenumbers": "strict",
          "colorway": [
           "#636efa",
           "#EF553B",
           "#00cc96",
           "#ab63fa",
           "#FFA15A",
           "#19d3f3",
           "#FF6692",
           "#B6E880",
           "#FF97FF",
           "#FECB52"
          ],
          "font": {
           "color": "#2a3f5f"
          },
          "hovermode": "closest",
          "hoverlabel": {
           "align": "left"
          },
          "paper_bgcolor": "white",
          "plot_bgcolor": "#E5ECF6",
          "polar": {
           "bgcolor": "#E5ECF6",
           "angularaxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           },
           "radialaxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           }
          },
          "ternary": {
           "bgcolor": "#E5ECF6",
           "aaxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           },
           "baxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           },
           "caxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           }
          },
          "coloraxis": {
           "colorbar": {
            "outlinewidth": 0,
            "ticks": ""
           }
          },
          "colorscale": {
           "sequential": [
            [
             0.0,
             "#0d0887"
            ],
            [
             0.1111111111111111,
             "#46039f"
            ],
            [
             0.2222222222222222,
             "#7201a8"
            ],
            [
             0.3333333333333333,
             "#9c179e"
            ],
            [
             0.4444444444444444,
             "#bd3786"
            ],
            [
             0.5555555555555556,
             "#d8576b"
            ],
            [
             0.6666666666666666,
             "#ed7953"
            ],
            [
             0.7777777777777778,
             "#fb9f3a"
            ],
            [
             0.8888888888888888,
             "#fdca26"
            ],
            [
             1.0,
             "#f0f921"
            ]
           ],
           "sequentialminus": [
            [
             0.0,
             "#0d0887"
            ],
            [
             0.1111111111111111,
             "#46039f"
            ],
            [
             0.2222222222222222,
             "#7201a8"
            ],
            [
             0.3333333333333333,
             "#9c179e"
            ],
            [
             0.4444444444444444,
             "#bd3786"
            ],
            [
             0.5555555555555556,
             "#d8576b"
            ],
            [
             0.6666666666666666,
             "#ed7953"
            ],
            [
             0.7777777777777778,
             "#fb9f3a"
            ],
            [
             0.8888888888888888,
             "#fdca26"
            ],
            [
             1.0,
             "#f0f921"
            ]
           ],
           "diverging": [
            [
             0,
             "#8e0152"
            ],
            [
             0.1,
             "#c51b7d"
            ],
            [
             0.2,
             "#de77ae"
            ],
            [
             0.3,
             "#f1b6da"
            ],
            [
             0.4,
             "#fde0ef"
            ],
            [
             0.5,
             "#f7f7f7"
            ],
            [
             0.6,
             "#e6f5d0"
            ],
            [
             0.7,
             "#b8e186"
            ],
            [
             0.8,
             "#7fbc41"
            ],
            [
             0.9,
             "#4d9221"
            ],
            [
             1,
             "#276419"
            ]
           ]
          },
          "xaxis": {
           "gridcolor": "white",
           "linecolor": "white",
           "ticks": "",
           "title": {
            "standoff": 15
           },
           "zerolinecolor": "white",
           "automargin": true,
           "zerolinewidth": 2
          },
          "yaxis": {
           "gridcolor": "white",
           "linecolor": "white",
           "ticks": "",
           "title": {
            "standoff": 15
           },
           "zerolinecolor": "white",
           "automargin": true,
           "zerolinewidth": 2
          },
          "scene": {
           "xaxis": {
            "backgroundcolor": "#E5ECF6",
            "gridcolor": "white",
            "linecolor": "white",
            "showbackground": true,
            "ticks": "",
            "zerolinecolor": "white",
            "gridwidth": 2
           },
           "yaxis": {
            "backgroundcolor": "#E5ECF6",
            "gridcolor": "white",
            "linecolor": "white",
            "showbackground": true,
            "ticks": "",
            "zerolinecolor": "white",
            "gridwidth": 2
           },
           "zaxis": {
            "backgroundcolor": "#E5ECF6",
            "gridcolor": "white",
            "linecolor": "white",
            "showbackground": true,
            "ticks": "",
            "zerolinecolor": "white",
            "gridwidth": 2
           }
          },
          "shapedefaults": {
           "line": {
            "color": "#2a3f5f"
           }
          },
          "annotationdefaults": {
           "arrowcolor": "#2a3f5f",
           "arrowhead": 0,
           "arrowwidth": 1
          },
          "geo": {
           "bgcolor": "white",
           "landcolor": "#E5ECF6",
           "subunitcolor": "white",
           "showland": true,
           "showlakes": true,
           "lakecolor": "white"
          },
          "title": {
           "x": 0.05
          },
          "mapbox": {
           "style": "light"
          }
         }
        },
        "xaxis": {
         "anchor": "y",
         "domain": [
          0.0,
          1.0
         ],
         "title": {
          "text": "Count"
         }
        },
        "yaxis": {
         "anchor": "x",
         "domain": [
          0.0,
          1.0
         ],
         "title": {
          "text": "Name"
         },
         "categoryorder": "total ascending"
        },
        "coloraxis": {
         "colorbar": {
          "title": {
           "text": "Count"
          }
         },
         "colorscale": [
          [
           0.0,
           "#0508b8"
          ],
          [
           0.08333333333333333,
           "#1910d8"
          ],
          [
           0.16666666666666666,
           "#3c19f0"
          ],
          [
           0.25,
           "#6b1cfb"
          ],
          [
           0.3333333333333333,
           "#981cfd"
          ],
          [
           0.4166666666666667,
           "#bf1cfd"
          ],
          [
           0.5,
           "#dd2bfd"
          ],
          [
           0.5833333333333334,
           "#f246fe"
          ],
          [
           0.6666666666666666,
           "#fc67fd"
          ],
          [
           0.75,
           "#fe88fc"
          ],
          [
           0.8333333333333334,
           "#fea5fd"
          ],
          [
           0.9166666666666666,
           "#febefe"
          ],
          [
           1.0,
           "#fec3fe"
          ]
         ]
        },
        "legend": {
         "tracegroupgap": 0
        },
        "title": {
         "text": "Top 20 Topic Sizes (Volume of Discussion)"
        },
        "barmode": "relative",
        "height": 600
       },
       "config": {
        "plotlyServerURL": "https://plot.ly"
       }
      }
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<IPython.core.display.Image object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "‚è≥ 2. Visualizing Temporal Topic Trends...\n"
     ]
    },
    {
     "data": {
      "application/vnd.plotly.v1+json": {
       "data": [
        {
         "fillpattern": {
          "shape": ""
         },
         "hovertemplate": "Topic Name=0_vitamin_and_supplements_to<br>month=%{x}<br>count=%{y}<extra></extra>",
         "legendgroup": "0_vitamin_and_supplements_to",
         "line": {
          "color": "rgb(127, 60, 141)"
         },
         "marker": {
          "symbol": "circle"
         },
         "mode": "lines+markers",
         "name": "0_vitamin_and_supplements_to",
         "orientation": "v",
         "showlegend": true,
         "stackgroup": "1",
         "x": [
          "2020-01",
          "2020-02",
          "2020-03",
          "2020-05",
          "2020-06",
          "2020-08",
          "2020-09",
          "2020-10",
          "2020-11",
          "2020-12",
          "2021-01",
          "2021-02",
          "2021-03",
          "2021-04",
          "2021-06",
          "2021-07",
          "2021-08",
          "2021-09",
          "2021-10",
          "2021-12",
          "2022-01",
          "2022-02",
          "2022-03",
          "2022-04",
          "2022-05",
          "2022-06",
          "2022-07",
          "2022-08",
          "2022-09",
          "2022-10",
          "2022-11",
          "2022-12",
          "2023-01",
          "2023-02",
          "2023-03",
          "2023-04",
          "2023-05",
          "2023-06",
          "2023-07",
          "2023-08",
          "2023-09",
          "2023-10",
          "2023-11",
          "2023-12",
          "2024-01",
          "2024-02",
          "2024-03",
          "2024-04",
          "2024-05",
          "2024-06",
          "2024-07",
          "2024-08",
          "2024-09",
          "2024-10",
          "2024-11",
          "2024-12"
         ],
         "xaxis": "x",
         "y": {
          "dtype": "i1",
          "bdata": "AQECBAEBAwQBAQICAwEBAQYBBQICAQMEAwIFBwYHBAEGBAcGBAYIChAMEBIaEh0WER0hHRQbGRg="
         },
         "yaxis": "y",
         "type": "scatter"
        },
        {
         "fillpattern": {
          "shape": ""
         },
         "hovertemplate": "Topic Name=1_to_and_it_my<br>month=%{x}<br>count=%{y}<extra></extra>",
         "legendgroup": "1_to_and_it_my",
         "line": {
          "color": "rgb(17, 165, 121)"
         },
         "marker": {
          "symbol": "circle"
         },
         "mode": "lines+markers",
         "name": "1_to_and_it_my",
         "orientation": "v",
         "showlegend": true,
         "stackgroup": "1",
         "x": [
          "2020-01",
          "2020-02",
          "2020-03",
          "2020-05",
          "2020-07",
          "2020-09",
          "2020-10",
          "2020-11",
          "2021-01",
          "2021-02",
          "2021-03",
          "2021-04",
          "2021-05",
          "2021-06",
          "2021-07",
          "2021-08",
          "2021-09",
          "2021-11",
          "2021-12",
          "2022-02",
          "2022-03",
          "2022-04",
          "2022-05",
          "2022-07",
          "2022-08",
          "2022-09",
          "2022-11",
          "2022-12",
          "2023-01",
          "2023-02",
          "2023-03",
          "2023-04",
          "2023-05",
          "2023-06",
          "2023-07",
          "2023-08",
          "2023-09",
          "2023-10",
          "2023-11",
          "2023-12",
          "2024-01",
          "2024-02",
          "2024-03",
          "2024-04",
          "2024-05",
          "2024-06",
          "2024-07",
          "2024-08",
          "2024-09",
          "2024-10",
          "2024-11",
          "2024-12"
         ],
         "xaxis": "x",
         "y": {
          "dtype": "i1",
          "bdata": "BAEBAQEEAQUEAgUBBQUDAQECAQMDAQQFAgMDBAQFBAMEBggLDBQMEBURDBASDBMZFx8SEw=="
         },
         "yaxis": "y",
         "type": "scatter"
        },
        {
         "fillpattern": {
          "shape": ""
         },
         "hovertemplate": "Topic Name=2_longevity_the_aging_link<br>month=%{x}<br>count=%{y}<extra></extra>",
         "legendgroup": "2_longevity_the_aging_link",
         "line": {
          "color": "rgb(57, 105, 172)"
         },
         "marker": {
          "symbol": "circle"
         },
         "mode": "lines+markers",
         "name": "2_longevity_the_aging_link",
         "orientation": "v",
         "showlegend": true,
         "stackgroup": "1",
         "x": [
          "2020-01",
          "2020-02",
          "2020-03",
          "2020-04",
          "2020-05",
          "2020-06",
          "2020-07",
          "2020-08",
          "2020-09",
          "2020-10",
          "2020-11",
          "2020-12",
          "2021-01",
          "2021-02",
          "2021-03",
          "2021-04",
          "2021-05",
          "2021-06",
          "2021-07",
          "2021-08",
          "2021-09",
          "2021-10",
          "2021-11",
          "2021-12",
          "2022-01",
          "2022-02",
          "2022-03",
          "2022-04",
          "2022-05",
          "2022-06",
          "2022-07",
          "2022-08",
          "2022-09",
          "2022-10",
          "2022-11",
          "2022-12",
          "2023-01",
          "2023-02",
          "2023-03",
          "2023-04",
          "2023-05",
          "2023-06",
          "2023-07",
          "2023-08",
          "2023-09",
          "2023-10",
          "2023-11",
          "2023-12",
          "2024-01",
          "2024-02",
          "2024-03",
          "2024-04",
          "2024-05",
          "2024-06",
          "2024-07",
          "2024-08",
          "2024-09",
          "2024-10",
          "2024-11",
          "2024-12"
         ],
         "xaxis": "x",
         "y": {
          "dtype": "i1",
          "bdata": "BQgGBQQDBgUMBwUIBwgFCgkKCwMEBwUGBQUFAwYFAwgGDA0FBQQGAwUDBQEFBAUEBgYJCAMHBwQFCwYL"
         },
         "yaxis": "y",
         "type": "scatter"
        },
        {
         "fillpattern": {
          "shape": ""
         },
         "hovertemplate": "Topic Name=5_sleep_up_to_and<br>month=%{x}<br>count=%{y}<extra></extra>",
         "legendgroup": "5_sleep_up_to_and",
         "line": {
          "color": "rgb(242, 183, 1)"
         },
         "marker": {
          "symbol": "circle"
         },
         "mode": "lines+markers",
         "name": "5_sleep_up_to_and",
         "orientation": "v",
         "showlegend": true,
         "stackgroup": "1",
         "x": [
          "2020-01",
          "2020-02",
          "2020-04",
          "2020-05",
          "2020-07",
          "2020-08",
          "2020-11",
          "2020-12",
          "2021-01",
          "2021-02",
          "2021-03",
          "2021-04",
          "2021-05",
          "2021-06",
          "2021-07",
          "2021-08",
          "2021-09",
          "2021-10",
          "2021-11",
          "2021-12",
          "2022-01",
          "2022-02",
          "2022-03",
          "2022-04",
          "2022-05",
          "2022-06",
          "2022-07",
          "2022-09",
          "2022-10",
          "2022-11",
          "2022-12",
          "2023-01",
          "2023-02",
          "2023-03",
          "2023-04",
          "2023-05",
          "2023-06",
          "2023-07",
          "2023-08",
          "2023-09",
          "2023-10",
          "2023-11",
          "2023-12",
          "2024-01",
          "2024-02",
          "2024-03",
          "2024-04",
          "2024-05",
          "2024-06",
          "2024-07",
          "2024-08",
          "2024-09",
          "2024-10",
          "2024-11",
          "2024-12"
         ],
         "xaxis": "x",
         "y": {
          "dtype": "i1",
          "bdata": "AQEBAQEBAQIBAgEDAwIBAwEBAQECAQEBAwYDAgQEAwIDBQYDBQECBgcICwoICgwVCAYRCxANCQ=="
         },
         "yaxis": "y",
         "type": "scatter"
        },
        {
         "fillpattern": {
          "shape": ""
         },
         "hovertemplate": "Topic Name=6_light_the_sauna_to<br>month=%{x}<br>count=%{y}<extra></extra>",
         "legendgroup": "6_light_the_sauna_to",
         "line": {
          "color": "rgb(231, 63, 116)"
         },
         "marker": {
          "symbol": "circle"
         },
         "mode": "lines+markers",
         "name": "6_light_the_sauna_to",
         "orientation": "v",
         "showlegend": true,
         "stackgroup": "1",
         "x": [
          "2020-01",
          "2020-02",
          "2020-03",
          "2020-04",
          "2020-05",
          "2020-06",
          "2020-07",
          "2020-08",
          "2020-09",
          "2020-10",
          "2020-11",
          "2020-12",
          "2021-01",
          "2021-02",
          "2021-03",
          "2021-04",
          "2021-05",
          "2021-06",
          "2021-07",
          "2021-09",
          "2021-10",
          "2021-11",
          "2021-12",
          "2022-01",
          "2022-02",
          "2022-03",
          "2022-04",
          "2022-05",
          "2022-06",
          "2022-08",
          "2022-09",
          "2022-10",
          "2022-11",
          "2022-12",
          "2023-01",
          "2023-03",
          "2023-04",
          "2023-07",
          "2023-08",
          "2023-09",
          "2023-10",
          "2023-11",
          "2023-12",
          "2024-01",
          "2024-02",
          "2024-03",
          "2024-04",
          "2024-05",
          "2024-06",
          "2024-07",
          "2024-08",
          "2024-09",
          "2024-10",
          "2024-11",
          "2024-12"
         ],
         "xaxis": "x",
         "y": {
          "dtype": "i1",
          "bdata": "AgIBBAEDAwQHAgMCBAUBAQEDAgYCAwQBAwMBAwUFAgEEAgIDBgQCAwEFBgYCAwMGBgQGCQcGAg=="
         },
         "yaxis": "y",
         "type": "scatter"
        },
        {
         "fillpattern": {
          "shape": ""
         },
         "hovertemplate": "Topic Name=7_aging_cells_senescence_in<br>month=%{x}<br>count=%{y}<extra></extra>",
         "legendgroup": "7_aging_cells_senescence_in",
         "line": {
          "color": "rgb(128, 186, 90)"
         },
         "marker": {
          "symbol": "circle"
         },
         "mode": "lines+markers",
         "name": "7_aging_cells_senescence_in",
         "orientation": "v",
         "showlegend": true,
         "stackgroup": "1",
         "x": [
          "2020-01",
          "2020-02",
          "2020-03",
          "2020-04",
          "2020-05",
          "2020-06",
          "2020-07",
          "2020-08",
          "2020-09",
          "2020-10",
          "2020-11",
          "2020-12",
          "2021-01",
          "2021-02",
          "2021-03",
          "2021-04",
          "2021-05",
          "2021-06",
          "2021-07",
          "2021-08",
          "2021-09",
          "2021-10",
          "2021-11",
          "2021-12",
          "2022-01",
          "2022-02",
          "2022-03",
          "2022-04",
          "2022-05",
          "2022-06",
          "2022-07",
          "2022-08",
          "2022-09",
          "2022-10",
          "2022-11",
          "2022-12",
          "2023-01",
          "2023-02",
          "2023-03",
          "2023-04",
          "2023-05",
          "2023-06",
          "2023-07",
          "2023-08",
          "2023-09",
          "2023-10",
          "2023-11",
          "2023-12",
          "2024-01",
          "2024-02",
          "2024-03",
          "2024-04",
          "2024-05",
          "2024-06",
          "2024-07",
          "2024-08",
          "2024-09",
          "2024-10",
          "2024-11",
          "2024-12"
         ],
         "xaxis": "x",
         "y": {
          "dtype": "i1",
          "bdata": "BgcCCAQICAsKCg4HCgoMCgwMCwcCCAUIDAcFAwQGBwUDBAMDAgUDCAgDCAcDCAMGCwIGBQUFBgMHBQQG"
         },
         "yaxis": "y",
         "type": "scatter"
        },
        {
         "fillpattern": {
          "shape": ""
         },
         "hovertemplate": "Topic Name=9_biohacking_to_you_and<br>month=%{x}<br>count=%{y}<extra></extra>",
         "legendgroup": "9_biohacking_to_you_and",
         "line": {
          "color": "rgb(230, 131, 16)"
         },
         "marker": {
          "symbol": "circle"
         },
         "mode": "lines+markers",
         "name": "9_biohacking_to_you_and",
         "orientation": "v",
         "showlegend": true,
         "stackgroup": "1",
         "x": [
          "2020-01",
          "2020-02",
          "2020-03",
          "2020-04",
          "2020-05",
          "2020-06",
          "2020-07",
          "2020-08",
          "2020-09",
          "2020-10",
          "2020-11",
          "2020-12",
          "2021-01",
          "2021-02",
          "2021-03",
          "2021-04",
          "2021-05",
          "2021-06",
          "2021-07",
          "2021-08",
          "2021-09",
          "2021-10",
          "2021-11",
          "2021-12",
          "2022-01",
          "2022-02",
          "2022-03",
          "2022-04",
          "2022-05",
          "2022-07",
          "2022-08",
          "2022-09",
          "2022-10",
          "2022-11",
          "2022-12",
          "2023-02",
          "2023-03",
          "2023-04",
          "2023-05",
          "2023-06",
          "2023-07",
          "2023-08",
          "2023-09",
          "2023-10",
          "2023-11",
          "2023-12",
          "2024-01",
          "2024-02",
          "2024-03",
          "2024-04",
          "2024-05",
          "2024-07",
          "2024-08",
          "2024-09",
          "2024-10",
          "2024-11",
          "2024-12"
         ],
         "xaxis": "x",
         "y": {
          "dtype": "i1",
          "bdata": "AQMEAgQDBAECAgEBAwIEBAMEAgYDAwEBAgICAgIBAQQBAwIFBQICAgICAQcDBQMGBAMGBgcIBgEH"
         },
         "yaxis": "y",
         "type": "scatter"
        },
        {
         "fillpattern": {
          "shape": ""
         },
         "hovertemplate": "Topic Name=4_zone_training_max_to<br>month=%{x}<br>count=%{y}<extra></extra>",
         "legendgroup": "4_zone_training_max_to",
         "line": {
          "color": "rgb(0, 134, 149)"
         },
         "marker": {
          "symbol": "circle"
         },
         "mode": "lines+markers",
         "name": "4_zone_training_max_to",
         "orientation": "v",
         "showlegend": true,
         "stackgroup": "1",
         "x": [
          "2020-02",
          "2020-03",
          "2020-05",
          "2020-11",
          "2020-12",
          "2021-07",
          "2021-12",
          "2022-02",
          "2022-04",
          "2022-05",
          "2022-06",
          "2022-07",
          "2022-08",
          "2022-09",
          "2022-10",
          "2022-11",
          "2022-12",
          "2023-01",
          "2023-02",
          "2023-03",
          "2023-04",
          "2023-05",
          "2023-06",
          "2023-07",
          "2023-08",
          "2023-09",
          "2023-10",
          "2023-11",
          "2023-12",
          "2024-01",
          "2024-02",
          "2024-03",
          "2024-04",
          "2024-05",
          "2024-06",
          "2024-07",
          "2024-08",
          "2024-09",
          "2024-10",
          "2024-11",
          "2024-12"
         ],
         "xaxis": "x",
         "y": {
          "dtype": "i1",
          "bdata": "AQEBAQEEAQUDAQQCAwEGAQIDAwIHBQYIDgoHAgkLBQgECwgKDQcMCQg="
         },
         "yaxis": "y",
         "type": "scatter"
        },
        {
         "fillpattern": {
          "shape": ""
         },
         "hovertemplate": "Topic Name=8_testosterone_the_and_my<br>month=%{x}<br>count=%{y}<extra></extra>",
         "legendgroup": "8_testosterone_the_and_my",
         "line": {
          "color": "rgb(207, 28, 144)"
         },
         "marker": {
          "symbol": "circle"
         },
         "mode": "lines+markers",
         "name": "8_testosterone_the_and_my",
         "orientation": "v",
         "showlegend": true,
         "stackgroup": "1",
         "x": [
          "2020-05",
          "2020-08",
          "2020-09",
          "2021-02",
          "2021-05",
          "2021-07",
          "2021-11",
          "2021-12",
          "2022-01",
          "2022-02",
          "2022-03",
          "2022-04",
          "2022-05",
          "2022-07",
          "2022-10",
          "2022-11",
          "2023-01",
          "2023-02",
          "2023-03",
          "2023-05",
          "2023-06",
          "2023-07",
          "2023-08",
          "2023-09",
          "2023-10",
          "2023-11",
          "2023-12",
          "2024-01",
          "2024-02",
          "2024-03",
          "2024-04",
          "2024-05",
          "2024-06",
          "2024-07",
          "2024-08",
          "2024-09",
          "2024-10",
          "2024-11",
          "2024-12"
         ],
         "xaxis": "x",
         "y": {
          "dtype": "i1",
          "bdata": "AQEBAgEBAwECAwIBAQIBAQMBAQMDAQQGAwMIBgoJCg4NCg4GBgkJ"
         },
         "yaxis": "y",
         "type": "scatter"
        },
        {
         "fillpattern": {
          "shape": ""
         },
         "hovertemplate": "Topic Name=3_ldl_cholesterol_my_apob<br>month=%{x}<br>count=%{y}<extra></extra>",
         "legendgroup": "3_ldl_cholesterol_my_apob",
         "line": {
          "color": "rgb(249, 123, 114)"
         },
         "marker": {
          "symbol": "circle"
         },
         "mode": "lines+markers",
         "name": "3_ldl_cholesterol_my_apob",
         "orientation": "v",
         "showlegend": true,
         "stackgroup": "1",
         "x": [
          "2020-06",
          "2020-07",
          "2020-08",
          "2020-09",
          "2020-10",
          "2020-11",
          "2021-04",
          "2021-05",
          "2021-06",
          "2021-07",
          "2021-08",
          "2021-11",
          "2021-12",
          "2022-01",
          "2022-02",
          "2022-03",
          "2022-04",
          "2022-05",
          "2022-06",
          "2022-07",
          "2022-09",
          "2022-10",
          "2022-11",
          "2022-12",
          "2023-01",
          "2023-02",
          "2023-03",
          "2023-04",
          "2023-05",
          "2023-06",
          "2023-07",
          "2023-08",
          "2023-09",
          "2023-10",
          "2023-11",
          "2023-12",
          "2024-01",
          "2024-02",
          "2024-03",
          "2024-04",
          "2024-05",
          "2024-06",
          "2024-07",
          "2024-08",
          "2024-09",
          "2024-10",
          "2024-11",
          "2024-12"
         ],
         "xaxis": "x",
         "y": {
          "dtype": "i1",
          "bdata": "AgECAgICAgECAgMBAgIBAwIBAQMCAwMEAgQDAwUGCggJDAcJCRMPCxEMDgwKDwoK"
         },
         "yaxis": "y",
         "type": "scatter"
        }
       ],
       "layout": {
        "template": {
         "data": {
          "histogram2dcontour": [
           {
            "type": "histogram2dcontour",
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0.0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1.0,
              "#f0f921"
             ]
            ]
           }
          ],
          "choropleth": [
           {
            "type": "choropleth",
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            }
           }
          ],
          "histogram2d": [
           {
            "type": "histogram2d",
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0.0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1.0,
              "#f0f921"
             ]
            ]
           }
          ],
          "heatmap": [
           {
            "type": "heatmap",
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0.0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1.0,
              "#f0f921"
             ]
            ]
           }
          ],
          "contourcarpet": [
           {
            "type": "contourcarpet",
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            }
           }
          ],
          "contour": [
           {
            "type": "contour",
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0.0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1.0,
              "#f0f921"
             ]
            ]
           }
          ],
          "surface": [
           {
            "type": "surface",
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0.0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1.0,
              "#f0f921"
             ]
            ]
           }
          ],
          "mesh3d": [
           {
            "type": "mesh3d",
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            }
           }
          ],
          "scatter": [
           {
            "fillpattern": {
             "fillmode": "overlay",
             "size": 10,
             "solidity": 0.2
            },
            "type": "scatter"
           }
          ],
          "parcoords": [
           {
            "type": "parcoords",
            "line": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            }
           }
          ],
          "scatterpolargl": [
           {
            "type": "scatterpolargl",
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            }
           }
          ],
          "bar": [
           {
            "error_x": {
             "color": "#2a3f5f"
            },
            "error_y": {
             "color": "#2a3f5f"
            },
            "marker": {
             "line": {
              "color": "#E5ECF6",
              "width": 0.5
             },
             "pattern": {
              "fillmode": "overlay",
              "size": 10,
              "solidity": 0.2
             }
            },
            "type": "bar"
           }
          ],
          "scattergeo": [
           {
            "type": "scattergeo",
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            }
           }
          ],
          "scatterpolar": [
           {
            "type": "scatterpolar",
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            }
           }
          ],
          "histogram": [
           {
            "marker": {
             "pattern": {
              "fillmode": "overlay",
              "size": 10,
              "solidity": 0.2
             }
            },
            "type": "histogram"
           }
          ],
          "scattergl": [
           {
            "type": "scattergl",
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            }
           }
          ],
          "scatter3d": [
           {
            "type": "scatter3d",
            "line": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            }
           }
          ],
          "scattermap": [
           {
            "type": "scattermap",
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            }
           }
          ],
          "scattermapbox": [
           {
            "type": "scattermapbox",
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            }
           }
          ],
          "scatterternary": [
           {
            "type": "scatterternary",
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            }
           }
          ],
          "scattercarpet": [
           {
            "type": "scattercarpet",
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            }
           }
          ],
          "carpet": [
           {
            "aaxis": {
             "endlinecolor": "#2a3f5f",
             "gridcolor": "white",
             "linecolor": "white",
             "minorgridcolor": "white",
             "startlinecolor": "#2a3f5f"
            },
            "baxis": {
             "endlinecolor": "#2a3f5f",
             "gridcolor": "white",
             "linecolor": "white",
             "minorgridcolor": "white",
             "startlinecolor": "#2a3f5f"
            },
            "type": "carpet"
           }
          ],
          "table": [
           {
            "cells": {
             "fill": {
              "color": "#EBF0F8"
             },
             "line": {
              "color": "white"
             }
            },
            "header": {
             "fill": {
              "color": "#C8D4E3"
             },
             "line": {
              "color": "white"
             }
            },
            "type": "table"
           }
          ],
          "barpolar": [
           {
            "marker": {
             "line": {
              "color": "#E5ECF6",
              "width": 0.5
             },
             "pattern": {
              "fillmode": "overlay",
              "size": 10,
              "solidity": 0.2
             }
            },
            "type": "barpolar"
           }
          ],
          "pie": [
           {
            "automargin": true,
            "type": "pie"
           }
          ]
         },
         "layout": {
          "autotypenumbers": "strict",
          "colorway": [
           "#636efa",
           "#EF553B",
           "#00cc96",
           "#ab63fa",
           "#FFA15A",
           "#19d3f3",
           "#FF6692",
           "#B6E880",
           "#FF97FF",
           "#FECB52"
          ],
          "font": {
           "color": "#2a3f5f"
          },
          "hovermode": "closest",
          "hoverlabel": {
           "align": "left"
          },
          "paper_bgcolor": "white",
          "plot_bgcolor": "#E5ECF6",
          "polar": {
           "bgcolor": "#E5ECF6",
           "angularaxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           },
           "radialaxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           }
          },
          "ternary": {
           "bgcolor": "#E5ECF6",
           "aaxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           },
           "baxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           },
           "caxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           }
          },
          "coloraxis": {
           "colorbar": {
            "outlinewidth": 0,
            "ticks": ""
           }
          },
          "colorscale": {
           "sequential": [
            [
             0.0,
             "#0d0887"
            ],
            [
             0.1111111111111111,
             "#46039f"
            ],
            [
             0.2222222222222222,
             "#7201a8"
            ],
            [
             0.3333333333333333,
             "#9c179e"
            ],
            [
             0.4444444444444444,
             "#bd3786"
            ],
            [
             0.5555555555555556,
             "#d8576b"
            ],
            [
             0.6666666666666666,
             "#ed7953"
            ],
            [
             0.7777777777777778,
             "#fb9f3a"
            ],
            [
             0.8888888888888888,
             "#fdca26"
            ],
            [
             1.0,
             "#f0f921"
            ]
           ],
           "sequentialminus": [
            [
             0.0,
             "#0d0887"
            ],
            [
             0.1111111111111111,
             "#46039f"
            ],
            [
             0.2222222222222222,
             "#7201a8"
            ],
            [
             0.3333333333333333,
             "#9c179e"
            ],
            [
             0.4444444444444444,
             "#bd3786"
            ],
            [
             0.5555555555555556,
             "#d8576b"
            ],
            [
             0.6666666666666666,
             "#ed7953"
            ],
            [
             0.7777777777777778,
             "#fb9f3a"
            ],
            [
             0.8888888888888888,
             "#fdca26"
            ],
            [
             1.0,
             "#f0f921"
            ]
           ],
           "diverging": [
            [
             0,
             "#8e0152"
            ],
            [
             0.1,
             "#c51b7d"
            ],
            [
             0.2,
             "#de77ae"
            ],
            [
             0.3,
             "#f1b6da"
            ],
            [
             0.4,
             "#fde0ef"
            ],
            [
             0.5,
             "#f7f7f7"
            ],
            [
             0.6,
             "#e6f5d0"
            ],
            [
             0.7,
             "#b8e186"
            ],
            [
             0.8,
             "#7fbc41"
            ],
            [
             0.9,
             "#4d9221"
            ],
            [
             1,
             "#276419"
            ]
           ]
          },
          "xaxis": {
           "gridcolor": "white",
           "linecolor": "white",
           "ticks": "",
           "title": {
            "standoff": 15
           },
           "zerolinecolor": "white",
           "automargin": true,
           "zerolinewidth": 2
          },
          "yaxis": {
           "gridcolor": "white",
           "linecolor": "white",
           "ticks": "",
           "title": {
            "standoff": 15
           },
           "zerolinecolor": "white",
           "automargin": true,
           "zerolinewidth": 2
          },
          "scene": {
           "xaxis": {
            "backgroundcolor": "#E5ECF6",
            "gridcolor": "white",
            "linecolor": "white",
            "showbackground": true,
            "ticks": "",
            "zerolinecolor": "white",
            "gridwidth": 2
           },
           "yaxis": {
            "backgroundcolor": "#E5ECF6",
            "gridcolor": "white",
            "linecolor": "white",
            "showbackground": true,
            "ticks": "",
            "zerolinecolor": "white",
            "gridwidth": 2
           },
           "zaxis": {
            "backgroundcolor": "#E5ECF6",
            "gridcolor": "white",
            "linecolor": "white",
            "showbackground": true,
            "ticks": "",
            "zerolinecolor": "white",
            "gridwidth": 2
           }
          },
          "shapedefaults": {
           "line": {
            "color": "#2a3f5f"
           }
          },
          "annotationdefaults": {
           "arrowcolor": "#2a3f5f",
           "arrowhead": 0,
           "arrowwidth": 1
          },
          "geo": {
           "bgcolor": "white",
           "landcolor": "#E5ECF6",
           "subunitcolor": "white",
           "showland": true,
           "showlakes": true,
           "lakecolor": "white"
          },
          "title": {
           "x": 0.05
          },
          "mapbox": {
           "style": "light"
          }
         }
        },
        "xaxis": {
         "anchor": "y",
         "domain": [
          0.0,
          1.0
         ],
         "title": {
          "text": "Month"
         },
         "type": "category"
        },
        "yaxis": {
         "anchor": "x",
         "domain": [
          0.0,
          1.0
         ],
         "title": {
          "text": "Document Count"
         }
        },
        "legend": {
         "title": {
          "text": "Topic Name"
         },
         "tracegroupgap": 0
        },
        "title": {
         "text": "Evolution of Top 10 Topics Over Time (Monthly Volume)"
        },
        "height": 600
       },
       "config": {
        "plotlyServerURL": "https://plot.ly"
       }
      }
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<IPython.core.display.Image object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "‚úÖ Step 3 visualizations generated and saved to PNG successfully.\n",
      "***CRITICAL FINAL STEP: Rerun this cell, save your .ipynb file, and commit/push the SAVED .ipynb file AND the 'visualization_outputs' folder to GitHub!***\n"
     ]
    }
   ],
   "execution_count": 12
  },
  {
   "metadata": {},
   "cell_type": "markdown",
   "source": [
    "# üìä STEP 3: Core Topic Analysis Summary\n",
    "- **Biggest topics:** zone-2/VO‚ÇÇ training, longevity/aging research, LDL/APOB‚Äìcholesterol, and anxiety/ADHD/depression; sleep hygiene follows closely.\n",
    "- **Mid-tier themes:** biohacking community, NAD/NMN/resveratrol, gut/probiotics vs. antibiotics, memory/nootropics/cognition, Alzheimer‚Äôs/amyloid; plus caffeine, testosterone, supplement stacks, labs, pain/surgery, COVID-19, illness/flu, red-light therapy, and Oura/HRV tracking.\n",
    "- **Trend (2020‚Üí2024):** monthly volume climbs steadily with a sharp ramp in 2023‚Äì2024; zone-2, longevity, and LDL/APOB drive the growth, with sleep/anxiety rising too.\n",
    "- **Takeaway:** discourse is increasingly intervention- and biomarker-centric (training + lipids + supplements + testing), yielding clean, coherent clusters for downstream analysis (e.g., drift, sentiment, content planning)."
   ],
   "id": "ea3a629cbd9bbc3"
  },
  {
   "metadata": {},
   "cell_type": "markdown",
   "source": [
    "# üó∫Ô∏è STEP 4: UMAP Topic Visualization (Recap)\n",
    "\n",
    "This step provides the crucial visual representation of the topic space, allowing for intuitive analysis of how discussions cluster together.\n",
    "\n",
    "* **Dimensionality Reduction:** The document embeddings (`X`) are projected into a **2D space** using the UMAP model.\n",
    "* **Data Filtering:** A filter (`MIN_Y_THRESHOLD = 3.5`) is applied to remove a single isolated group of points on the Y-axis that can compress the rest of the visualization.\n",
    "* **Focused Highlighting (`N_COLOR_TOPICS = 10`):**\n",
    "    * The **Top 10 largest topics** are explicitly identified and assigned **distinct, bright colors** and larger markers.\n",
    "    * All other topics and outliers are **subdued** (light gray, low opacity) to push the focus onto the major areas of conversation.\n",
    "* **Enhanced Presentation:**\n",
    "    * Topic names are **cleaned and simplified** for clarity in the legend.\n",
    "    * The **legend is moved to the bottom** and set horizontally for better use of space.\n",
    "    * Hover data is streamlined to display only the **Topic Name**, improving the interactive experience."
   ],
   "id": "a777c41e439fb719"
  },
  {
   "metadata": {
    "ExecuteTime": {
     "end_time": "2025-11-04T22:05:34.291482Z",
     "start_time": "2025-11-04T22:05:31.875508Z"
    }
   },
   "cell_type": "code",
   "source": [
    "# ====================================================================\n",
    "# === STEP 4: VISUALIZE UMAP CLUSTERS WITH TOP N HIGHLIGHTED (FINAL FIXED VERSION) ===\n",
    "# ====================================================================\n",
    "\n",
    "import plotly.express as px\n",
    "import pandas as pd\n",
    "import numpy as np\n",
    "from pathlib import Path\n",
    "from IPython.display import display, Image # Import display and Image\n",
    "\n",
    "# --- CONFIG ---\n",
    "N_COLOR_TOPICS = 10\n",
    "SUBDUED_COLOR_FILL = 'rgba(200, 200, 200, 0.15)'\n",
    "SUBDUED_COLOR_LINE = 'rgba(150, 150, 150, 0.05)'\n",
    "OUTLIER_NAME   = \"Outlier (-1)\"\n",
    "OTHER_TOPICS_NAME = \"Other Topics\"\n",
    "MIN_Y_THRESHOLD = 3.5\n",
    "\n",
    "# --- Setup Output Directory ---\n",
    "OUTPUT_DIR = Path(\"visualization_outputs\")\n",
    "OUTPUT_DIR.mkdir(exist_ok=True)\n",
    "print(f\"Saving figures to: {OUTPUT_DIR.resolve()}\")\n",
    "print(f\"üé® Visualizing UMAP embeddings with legend at bottom and simplified hover...\")\n",
    "\n",
    "# Helper to clean topic names for display (copying your logic for consistency)\n",
    "def clean_topic_name_for_display(topic_name):\n",
    "    RESIDUAL_GENERIC = {\"the\", \"to\", \"and\", \"of\", \"my\", \"in\", \"for\", \"is\", \"it\", \"that\", \"what\", \"we\", \"you\", \"on\", \"a\", \"an\", \"up\", \"from\"}\n",
    "    words = topic_name.split('_')\n",
    "    cleaned_words = []\n",
    "    seen = set()\n",
    "    for word in words:\n",
    "        if word.lower() not in RESIDUAL_GENERIC and word.strip() != '' and word.lower() not in seen:\n",
    "            cleaned_words.append(word)\n",
    "            seen.add(word.lower())\n",
    "    if cleaned_words and cleaned_words[0].isdigit():\n",
    "        cleaned_words = cleaned_words[1:]\n",
    "    if not cleaned_words:\n",
    "        return topic_name\n",
    "    return '_'.join(cleaned_words[:4])\n",
    "\n",
    "\n",
    "# 1. Get the 2D UMAP embeddings\n",
    "try:\n",
    "    # üö® CRITICAL FIX: Use the variable 'X' (the embeddings matrix) for transformation\n",
    "    if topic_model.umap_model.n_components != 2:\n",
    "        print(f\"‚ö†Ô∏è Warning: UMAP has {topic_model.umap_model.n_components} components. Using first two for visualization.\")\n",
    "        umap_embeddings_2d = topic_model.umap_model.transform(X)[:, :2]\n",
    "    else:\n",
    "        umap_embeddings_2d = topic_model.umap_model.transform(X)\n",
    "\n",
    "except Exception as e:\n",
    "    print(f\"‚ùå Error during UMAP transformation: {e}\")\n",
    "    umap_embeddings_2d = None\n",
    "\n",
    "\n",
    "if umap_embeddings_2d is None:\n",
    "    print(\"‚ùå Cannot create UMAP visualization.\")\n",
    "else:\n",
    "    # 2. Prepare DataFrame for plotting\n",
    "    plot_df = pd.DataFrame(umap_embeddings_2d, columns=['x', 'y'])\n",
    "\n",
    "    # Ensure alignment: UMAP output length must match original DataFrame length\n",
    "    # Use topic_raw from the 'df' DataFrame (which should be the same length as X)\n",
    "    plot_df['topic_id'] = df['topic_raw'].values[:len(plot_df)]\n",
    "    plot_df['document'] = df['doc'].values[:len(plot_df)]\n",
    "\n",
    "    # Apply y-axis threshold\n",
    "    plot_df = plot_df[plot_df['y'] >= MIN_Y_THRESHOLD].copy()\n",
    "\n",
    "    # Get topic names and clean them for display\n",
    "    topic_names_map = {topic_id: clean_topic_name_for_display(name)\n",
    "                       for topic_id, name in topic_model.topic_labels_.items()}\n",
    "    topic_names_map[-1] = OUTLIER_NAME\n",
    "\n",
    "    plot_df['topic_name'] = plot_df['topic_id'].map(topic_names_map)\n",
    "\n",
    "    # 3. Identify top N_COLOR_TOPICS for highlighting\n",
    "    topic_counts = plot_df['topic_id'].value_counts()\n",
    "    top_topics_ids = topic_counts[topic_counts.index != -1].head(N_COLOR_TOPICS).index.tolist()\n",
    "\n",
    "    # Create a categorical column for coloring\n",
    "    plot_df['color_group'] = plot_df['topic_id'].apply(\n",
    "        lambda x: topic_names_map[x] if x in top_topics_ids else (OUTLIER_NAME if x == -1 else OTHER_TOPICS_NAME)\n",
    "    )\n",
    "\n",
    "    # Sort `color_group` for legend order\n",
    "    sorted_color_groups = [OUTLIER_NAME, OTHER_TOPICS_NAME] + [topic_names_map[tid] for tid in top_topics_ids]\n",
    "    plot_df['color_group'] = pd.Categorical(plot_df['color_group'], categories=sorted_color_groups, ordered=True)\n",
    "    plot_df = plot_df.sort_values('color_group')\n",
    "\n",
    "    # Define a color palette\n",
    "    color_discrete_map = {\n",
    "        OUTLIER_NAME: SUBDUED_COLOR_FILL,\n",
    "        OTHER_TOPICS_NAME: SUBDUED_COLOR_FILL\n",
    "    }\n",
    "    distinct_colors = px.colors.qualitative.Bold + px.colors.qualitative.Set1 + px.colors.qualitative.Dark2\n",
    "    for i, topic_id in enumerate(top_topics_ids):\n",
    "        color_discrete_map[topic_names_map[topic_id]] = distinct_colors[i % len(distinct_colors)]\n",
    "\n",
    "    # 4. Create the Plotly scatter plot\n",
    "    fig = px.scatter(\n",
    "        plot_df,\n",
    "        x='x',\n",
    "        y='y',\n",
    "        color='color_group',\n",
    "        hover_data={'color_group': True, 'x': False, 'y': False, 'document': True},\n",
    "        title=f'UMAP Topic Visualization (Top {N_COLOR_TOPICS} Topics Highlighted)',\n",
    "        labels={'x': 'UMAP-1', 'y': 'UMAP-2', 'color_group': 'Topic Group'},\n",
    "        color_discrete_map=color_discrete_map,\n",
    "        height=700,\n",
    "        width=900\n",
    "    )\n",
    "\n",
    "    # Update traces for visual distinction\n",
    "    for trace in fig.data:\n",
    "        if trace.name in [OUTLIER_NAME, OTHER_TOPICS_NAME]:\n",
    "            trace.marker.opacity = 0.2\n",
    "            trace.marker.size = 4\n",
    "            trace.marker.line.color = SUBDUED_COLOR_LINE\n",
    "            trace.marker.line.width = 0.2\n",
    "        else:\n",
    "            trace.marker.opacity = 0.7\n",
    "            trace.marker.size = 7\n",
    "            trace.marker.line.color = 'rgba(0,0,0,0.5)'\n",
    "            trace.marker.line.width = 0.8\n",
    "\n",
    "    # Move legend to the bottom\n",
    "    fig.update_layout(\n",
    "        showlegend=True,\n",
    "        hovermode=\"closest\",\n",
    "        plot_bgcolor='rgba(240, 240, 240, 1)',\n",
    "        paper_bgcolor='rgba(255, 255, 255, 1)',\n",
    "        title_font_size=18,\n",
    "        legend_title_text='Topic Group',\n",
    "        legend=dict(\n",
    "            orientation=\"h\",\n",
    "            yanchor=\"top\",\n",
    "            y=-0.15,\n",
    "            xanchor=\"center\",\n",
    "            x=0.5,\n",
    "            itemsizing='constant'\n",
    "        )\n",
    "    )\n",
    "\n",
    "    fig.show()\n",
    "\n",
    "    # **EXPORT FIGURE 3**\n",
    "    fig_umap_path = OUTPUT_DIR / \"4_umap_topic_clusters.png\"\n",
    "    fig.write_image(fig_umap_path)\n",
    "    # Display the saved PNG inline\n",
    "    display(Image(filename=fig_umap_path))\n",
    "\n",
    "    print(\"‚úÖ UMAP visualization generated and saved to PNG successfully.\")"
   ],
   "id": "800ab3f3b22889f8",
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Saving figures to: /Users/michaelwalker/CU_Boulder_Masters_Ai/Introduction to Deep Learning/cu-boulder-ms-ai/Introduction-to-Machine-Learning/unsupervised/CSCA 5632 Unsupervised Algorithms in Machine Learning Final Project/visualization_outputs\n",
      "üé® Visualizing UMAP embeddings with legend at bottom and simplified hover...\n",
      "‚ö†Ô∏è Warning: UMAP has 5 components. Using first two for visualization.\n"
     ]
    },
    {
     "data": {
      "application/vnd.plotly.v1+json": {
       "data": [
        {
         "customdata": [
          [
           "Outlier (-1)",
           "Low T  36 year old male - is there any hope?. Had blood test and total T came back at 314ng/dl. I was obese at the time of taking the test, bmi 32.5 height 187cm weight 113.5kg. I have successfully lost some weight through diet, down to 100kg bmi 28.6. Feeling a bit better, still a long way to go. Planning to keep the weight loss going until I reach a ‚Äònormal‚Äô bmi.\n\nMy next steps are to start resistance training and start getting some light cardio in, getting my steps in and maybe some swimming or running. From my research too much cardio isn‚Äôt necessarily a good thing for low T, but given my body weight I definitely need a lot of exercise.\n\nI have cleaned up my diet quite a lot, eating whole foods generally and obviously in caloric deficit at the moment hence the weight loss.\n\nOther things I have read that can help include focusing on sleep( had a young baby at home at the time of testing didn‚Äôt really help sleep). Reducing stress ( had just left a job I hated at the time of testing and started a new career). Being more social, competitive and lastly having more sex.\n\nSupplements and medications I‚Äôm using at the moment are Tongkat Ali, cistanche, tribulus, vit D, vit k2, zinc, copper and magnesium.\n\nI also take citalopram and tadalafil 5mg a day as from my research the tadalafil can also raise T.\n\nI do realise supplements are really meant to be  the icing on the cake and lifestyle changes will probably move the needle the most.\n\nAnyway this has made me take my health seriously so I am grateful for that, just looking for some reassurance I guess. Obviously if I have a pituitary issue or an issue with the organs themselves these steps will not help, so I‚Äôm really hopeful reversing my unhealthy lifestyle will yield results.\n\nI really would like to avoid trt, I live in a country where it is difficult to access and I can‚Äôt commit to a lifetime of injections.\n\nSorry for the long post just looking for some reassurance I‚Äôm on the right path, hope this post inds you all in good health."
          ],
          [
           "Outlier (-1)",
           "Thoughts on orthotics. I have been running a bit more lately and it seems that my flat arches are causing me pain. \nI‚Äôve been to Physio and got some stretches and did some dry needling. \nI‚Äôve also seen someone for orthotic shoes. They‚Äôre heavily suggesting I get them and although they‚Äôre pricey, they are accessible to me. \nHe said something that stuck with me, this would be a tool to adapt to the way that my feet are not correct them. \nI know you‚Äôre born the way you‚Äôre born, but is there a better way to strengthen the feet and try something else to reduce pain and keep running, instead of being reliant on orthotics for the rest of my life. \nAm I wrong about this ‚Äúcorrection view‚Äù is the best solution for longevity using a tool that fits to the way that my feet were developed? \n\nThanks !"
          ],
          [
           "Outlier (-1)",
           "Any studies on HBOT vs EWOT?. Hbot has been helping me heal from long covid ... but has become expensive. Thinking about getting an Ewot system at home. Do they have the same benefits? \n\nLooking for an effective oxygen therapy that is relatively affordable."
          ],
          [
           "Outlier (-1)",
           "What are the odds the Attia approach does anything?. Does anyone get the sense that - beyond the highly \"Lindy\" recommendations of eat moderately, exercise, and have a good social structure - all this so-called \"longevity engineering\" the Attia enterprise is centered around is optimizing on vanishingly small gains that are barely measurable? Even the ultra-wealthy clients who are under his direct care might not reveal many gains given that they are pre-selected to be healthier on average (IQ, wealth) and the best they can get are some off-label meds/supplements and more of the same common-sense (but highly refined) versions of common wisdom."
          ],
          [
           "Outlier (-1)",
           "#149 - AMA #20: Simplifying the complexities of insulin resistance: how it's measured, how it manifests in the muscle and liver, and what we can do about it."
          ],
          [
           "Outlier (-1)",
           "What do you all do for a living ?. Just graduated college, realizing this isn‚Äôt necessarily what I want to do with my life lol. Now thinking about firefighting or getting a masters, I just want to do something that gives me purpose , but it would be cool to do something that supports my lifestyle of buying high quality foods/products , daily exercise , etc . So I am curious what you all do for work?"
          ],
          [
           "Outlier (-1)",
           "Intermittent fasting (24-36 hours) and autophagy?. I've been reading the benefits of extended 24-36 hours fasting and its autophagic effects. Several studies point to its effect on strengthening immune system and effectively resetting the body to a more biologically efficient state.\n\nWhat are you takes on incorporating extended intermittent fasting routines into your schedule - for example 36 hour fast once a month for such purposes?"
          ],
          [
           "Outlier (-1)",
           "Platelets issues. My platelets counts is usually low in last two blood tests (1.35 x 10^3 )\n\nI also got this note-: Mildly reduced in smear, Macroplatelets &amp; Platelet aggregates are seen."
          ],
          [
           "Outlier (-1)",
           "Resources for a healthy lifestyle. I enjoy the show tremendously: I love the topics and the energy. I found that Peter‚Äôs website has a lot of links to useful information too. Not having any medical education beyond middle school biology, I could use a bit more basic information on healthy living and longevity.\n\nMuch of what I find doesn‚Äôt go beyond what my parents taught me (sleep well, don‚Äôt smoke, don‚Äôt do drugs, exercise, spend time outside, don‚Äôt eat candy, be proud of work, learn new things and relax regularly). Other things are more like ‚Äòbuy these expensive pills, they may be beneficial, but it‚Äôs too early to tell for sure‚Äô. \n\nI could use a book/course/app that teaches me some basics based on the latest studies (I was stunned to hear that 10000 steps a day is outdated advice‚Äîit‚Äôs still promoted a lot). Ideally something that helps me learn new habits too. Any tips?"
          ],
          [
           "Outlier (-1)",
           "#135 - BJ Miller, M.D.: How understanding death leads to a better life - Peter Attia."
          ],
          [
           "Outlier (-1)",
           "#134 - James O‚ÄôKeefe, M.D.: Preventing cardiovascular disease and the risk of too much exercise."
          ],
          [
           "Outlier (-1)",
           "Figured out 30 years of severe mental illness + family mental illness. I made the thread about the breather recently. I've been trying breathing for the past 2 weeks, TVNS to bring up my HRV, nothing. Using the Polar H10 and monitoring live HRV in YuDemon, it appears that my nervous system is completely fried and doesn't work unless i carefully manage a proper breathing pattern(been breathing obsessively for 2 weeks, useless in any configuration because i wasn't pausing between breaths). \n\nI have symptoms of something like PTSD at times(with no trauma, just remembering negative events), and my hair is notably grey. It started greying as a teen. My grandfather was an abusive alcoholic, my mom and aunt highly anxious, I've been compared to Dr. Jekyll and Hyde. There are notable differences in visual depth perception, color richness, and my personality depending on how low my HRV is. Earlier in the year I got mad for days at a minor comment from a workplace bully, started scheming on how to bait him into hitting me and get him fired, arrested, and I could sue him pro se to cost him a lot. I thought I had a personality disorder, but really it's me being actually threatened by minor stuff. \n\nI don't feel the effects of most drugs normally, quit smoking cigarettes because i was numb to the high and withdrawal, etc and so on. Nothing ever worked for me, including meds, substance abuse programs, I knew it was all bullshit and there was something internally wrong in my body or brain. The above anecdote was an extreme example, I've come down in my general anxiety significantly since then. But now I know I can turn off some of the OCD and depression by watching my HRV."
          ],
          [
           "Outlier (-1)",
           "Low Neutrophils &amp; High Lymphocytes. I had surgery in June of 2023, and have been undergoing regular blood tests since then. Since the surgery, my neutrophils have been decreasing with each test, and the lymphocytes have been increasing. Obviously they‚Äôre just slightly outside of the ‚Äúnormal‚Äù ranges, but what could potentially cause the steady decline/increase since the surgery? My MPV has also been high since the surgery, but that is actually decreasing slowly."
          ],
          [
           "Outlier (-1)",
           "Ketogenic diet improves serious mental illness. Thoughts on this article? I‚Äôve found a few similar studies that seem to replicate this finding as well."
          ],
          [
           "Outlier (-1)",
           "Correcting Old Perceptions (Brainhack?). I couldn't think of a better sub, since this is kind of about hacking a bit of the body (the brain) and all the mindset, change your thinking subs seemed a bit too new-age hippy nonsense for what I'm asking about. \n\nSo how do we hack our brains to notice and accept new realities when it's stuck in the habits of old perceptions? This stems from a post in a weightloss sub where someone was talking about how they can't see the changes in the mirror, even though there's changes in clothing fit, even though they see people who they haven't met in ages who react strongly (positively) to their new appearance, even though the scale is moving. They talked a bit about their inner monologue convincing them it's water loss, or muscle loss, but the part that I felt \"seen\" by was just not being able to see anything in the mirror. \n\nHealth, longevity, blah-blah yes those matter too, but lets me honest with ourselves, most of us secretly just want to look better even if they're not willing to admit it. But I will, I'll say the quiet part out loud, I am selfish and don't care as much about feeling better or living longer - yes I want those things too, but I've felt like shit for this long and I'm used to it and I never know when my punch card is coming through health or through a bus. In the here and now I want to be sexy again - mostly for others so that I get the positive attention I like, but also so that I'm happy when I see myself. But I lose out on that part when all I see if a fat slob now, even after significant steps forward in weight management. \n\nSo what's the hack to resetting my visual impression of myself? How do I force my eyes and mind to see my body, the changes and improvements, like others do. Breaking the mirrors in my house and buying new ones in 6 months isn't practical, especially since there's too many reflective surfaces and windows which tell on me anyway."
          ],
          [
           "Outlier (-1)",
           "Biohacks for reading, writing and focus in general. I love to read and write. I tried sitting down yesterday to read something about a subject I'm interested in and could not focus even if my life depended on it. I stopped after 5 minutes when I realized I wasn't even reading to understand anymore and just scanning words. What are some supplements, noots, and other biohacks to help?"
          ],
          [
           "Outlier (-1)",
           "Why is Peter Attia's HRV fairly low?. In this Instagram post ( [https://www.instagram.com/p/CDogu60AruJ/](https://www.instagram.com/p/CDogu60AruJ/) ) he shows his HRV data via the Oura and shows a 28 one night and a 34 for another night. I love Peter and don't mean any disrespect but these numbers seem fairly low for someone who is so health-minded. I've heard that HRV has a hereditary aspect to it so maybe it's that but I'm curious as to whether he's ever talked about this?\n\nIt's also somewhat surprising given how low his resting heart rate is. With an RHR of 41 you'd typically expect a higher HRV no?"
          ],
          [
           "Outlier (-1)",
           "#104 - COVID-19 for kids with Olivia Attia - Peter Attia."
          ],
          [
           "Outlier (-1)",
           "Anyone else going to Quantum Summit 2024?. Hey everyone! I wanted to share some info about the upcoming **Premier Quantum Summit 2024** for anyone interested in bioenergetic health and connecting with like-minded people. This year, there‚Äôs even a virtual option, which is perfect if you can‚Äôt travel but still want to catch all the insights.\n\nHere‚Äôs a quick look at what‚Äôs lined up:\n\n* **Full Access to All Lectures &amp; Panels** ‚Äì Whether in-person or virtual, you‚Äôll be part of every discussion, led by some top names in the field.\n* **1-on-1 Time with Experts** ‚Äì Get the chance to connect with leaders like Dr. Linda Forbes and Nick Labinsky, along with clinical experts and industry sponsors.\n* **Exclusive Product Samples &amp; Personalized Testing** ‚Äì For in-person attendees, there‚Äôs hands-on product experience and bioenergetic testing (which is super cool, in my opinion).\n* **Networking Dinner for New Practitioners** ‚Äì If you‚Äôre new to Premier Research Labs, join us Friday night for a VIP-style dinner to meet other practitioners and share ideas in a relaxed setting.\n\nKeynote Speakers Include:\n\n* Dr. Linda Forbes, DC, LAc, DACBN ‚Äì Chairperson &amp; President of Premier Research Labs\n* Harry Massey\n* Dr. Daniel Schilling¬†\n* Dr. Craig S. Ross¬†\n* Dr. Mahmoud Ghannou\n* And more. Anyone else going to Quantum Summit 2024?\n\nLooking forward to connecting with anyone else attending!"
          ],
          [
           "Outlier (-1)",
           "#103 - Looking back on the first 99 episodes: Strong Convictions, Loosely Held."
          ],
          [
           "Outlier (-1)",
           "Does increased muscle mass enhance fasting in any way?. Basically the title.\n\nWill autophagy be introduced quicker, given all variables are controlled?\n\nWill fat loss be amplified given your metabolic rate is higher?"
          ],
          [
           "Outlier (-1)",
           "Post op recovery advice. I‚Äôve had a rough 4 months and undergone 2 x Microdiscectomy surgeries back to back. I‚Äôm 5 weeks out and doing okay but have some temporary (I hope) nerve damage caused me to be unable to use my calf but now strength is slowly returning ‚ú® I also have some muscle atrophy and ALOT of aches and pains that I‚Äôm recovering from. \n\nI used to be super active, hiking, lifting weights, cycling, running but I‚Äôve been pretty sedentary for the last 10months when dealing with it. So excited to get back to even walking long distances again ü§ûüèº\n\nI‚Äôm currently taking \n‚Ä¢ Lions mane \n‚Ä¢ Omega 3\n‚Ä¢ Vitamin D\n‚Ä¢ Freesoul Women‚Äôs Multivitamin \n‚Ä¢ B12 injection (20/08)\n\nUnfortunately still on medications as well but would love to get off them ASAP. I‚Äôm cutting down each week where my pain allows. \n‚Ä¢ Cocodamol (paracetamol/codine) \n‚Ä¢ Pregabalin (Lyrica)\n‚Ä¢ Baclofen (muscle relaxer)\n‚Ä¢ Naproxen (anti inflammatory)\n\nAny advice anyone has about healing, particularly nerves and muscle, I‚Äôd really appreciate üôèüèº"
          ],
          [
           "Outlier (-1)",
           "Just tried an app version of Sensate. I‚Äôve been struggling with meditation and relaxing in general and have had my sensate for a while and love it.\n\nMy friend got me on to a newer app omscillate which does the same vibrations on your phone for much much cheaper! Highly recommend for those who want a cheaper alternative!"
          ],
          [
           "Outlier (-1)",
           "The pleasure of finding things out | Sunday News Letter. New Sunday email released. \n\nHow many members of this sub get the newsletter? How do you like the content generally? I personally get a good amount from discussion of mental models.\n\n&amp;#x200B;\n\n\"Why do those last few ‚ÄúO‚Äùs in a bowl of Cheerios tend to clump together in the middle of the bowl or around the edges? If you‚Äôve ever wondered about this, you‚Äôre not alone. A couple of Harvard mathematicians actually published a¬†[paper](http://people.maths.ox.ac.uk/vella/Vella2005.pdf)¬†on the ‚ÄúCheerios effect‚Äù in 2005.\n\nThe physics behind the effect is pretty fascinating, involving the buoyancy of the cereal, the surface tension of the milk,¬†[capillary action](https://en.wikipedia.org/wiki/Capillary_action), and the¬†[meniscus](https://www.khanacademy.org/science/biology/water-acids-and-bases/cohesion-and-adhesion/v/capillary-action-and-why-we-see-a-meniscus)¬†effect.¬†[Here‚Äôs an easily digestible 5-minute clip](https://www.youtube.com/watch?v=mbKAwk-OG_w)¬†explaining the Cheerios effect.\n\nYou may be wondering at this point why the hell I‚Äôm talking about the physics behind breakfast cereal. A couple of reasons. The first is that I stumbled on a recent¬†[article](https://arstechnica.com/science/2019/12/physicists-measured-forces-behind-why-cheerios-clump-together-in-your-bowl/?amp=1)¬†about it. A team of Brown University researchers directly measured the forces at play in the phenomenon and published a¬†[paper](https://journals.aps.org/prl/abstract/10.1103/PhysRevLett.123.254502)¬†on it in December. I‚Äôm sure there‚Äôs some joke I can make here about how many Ivy League schools it takes to finish breakfast, but I would just end up with egg on my face given my second reason. I love this kind of stuff because it‚Äôs born out of an open mind, child-like curiosity, and a determination to find an answer. Not to get published in a prestigious journal, not to win an award, not to advance a career, not to earn a degree, not to be more well-known. Quite simply, as Richard Feynman¬†[put it](https://youtu.be/f61KMw5zVhg), ‚ÄúIt is the pleasure in finding the thing out.‚Äù\n\n¬ß\n\nI grew up in a restaurant. As soon as I was tall enough to reach the industrial sink and spray nozzle from a step stool, I was washing dishes by the metric ton. Eventually, I was splitting my kitchen duties between dish-washing and peeling carrots and potatoes (50 pounds at a time, no less!). By the time I was 12 or 13, I was helping with busboy duties, serving and clearing tables.\n\nOne frequently encountered problem, in particular, occupied a lot of my mental energy. Every time I served a patron their soup or coffee, I wanted it to arrive at their table without any trace of spillage on the underlying plate or saucer. But what was the best way to achieve this, shy of sandbagging and serving half-full bowls and cups? The natural tendency, of course, was to stare so intensely at the object I was carrying that I was lucky to avoid a grand mal seizure. Over time I experimented with other techniques ranging from not looking at all, to gazing back and forth from the cup or bowl to my destination on the ‚Äúhorizon.‚Äù I also experimented with my gait‚Äîfast versus slow, loping versus flat‚ÄîI was really obsessed with this seemingly irrelevant problem.\n\nIt would be nearly 10 years, and 18 undergraduate and graduate courses in mathematics, later before I was finally able to build a mathematical model to examine this problem that still vexed me. (Though I no longer worked at my dad‚Äôs restaurant in college, I did still think about this problem every time I carried a bowl or cup of liquid.) Along with a friend, we decided a¬†[Bessel function](https://en.wikipedia.org/wiki/Bessel_function)¬†would be the ideal tool to model the surface of our liquid. The model captured as many variables as we could incorporate‚Äîshape of bowl or cup, temperature and viscosity of liquid, and obviously as many forces as we could quantify. Sadly, I‚Äôve lost about 30 IQ points since I was in college and I barely remember the nuances of the model, let alone the hours of coding to build it. But I do recall our conclusion: You are better off¬†*not* looking at the bowl you are carrying and, instead, looking where you are going. It seems that by looking directly at the bowl, you tend to make micro-adjustments, presumably subconsciously and consciously, that actually amplify the waves in the fluid‚Äîthe exact problem you want to avoid. By looking ahead, many of these waves that ultimately lead to spillage cancel each other out and actually create less wave motion in the fluid, which results in a clean plate or saucer when you get to the table.1\n\nI have no idea if this model was correct. I‚Äôm sure someone out there has built a much better model since, and certainly computational capacities are much higher in 2020 than they were in 1995, but the point is the pursuit, not so much the answer.\n\nOne might ask, ‚ÄúIs that the best you could do with all that education?!‚Äù Well, I would argue that such pursuit is exactly the point of all that education. Sadly, once we get into the ‚Äúreal‚Äù world, much of that creative pursuit is replaced by ‚Äúpractical‚Äù considerations. Which may explain in part why I‚Äôm intellectually half the man I was 25 years ago. Not to rail too hard against my current profession, but this was unquestionably the hardest part of switching from mathematics and engineering to medicine. Creative problem-solving in medicine is reserved for the lab (for good reason), but for clinicians and clinicians-in-training (i.e., medical students) it has unintended consequences, including the dulling of the once-sharp sword of our minds.\n\nAs odd as it sounds, through medical school and into residency, I still made time to tutor college kids in calculus. Sure, the money was part of the motivation, but a much bigger part was the need to hang on to some semblance of problem-solving. The tug of quantitative problem-solving became so great, that it actually led to my complete departure from medicine in 2006, when I left for the consulting firm McKinsey &amp; Company, where I would spend the next couple of years building stochastic credit models. But that‚Äôs another story for another day.\n\n‚ÄúAll life is problem solving,‚Äù said Karl Popper. ‚ÄúAll organisms are inventors and technicians, good or not so good, successful or not so successful, in solving technical problems.‚Äù The pursuit can often be more rewarding than the result.\n\n‚Äì Peter\""
          ],
          [
           "Outlier (-1)",
           "Where can I find a tree of life of all 2.5 million studied species from 2024?."
          ],
          [
           "Outlier (-1)",
           "Why is this subreddit becoming weirdly anti-intellectual and political? specifically Right-Wing?? I'm just asking questions. I understand where all these people came from, I subbed to this subreddit to read actual advice on medical-proven supplements and exercise to complement and improve my health, but in the last week, I've seen people recommend: Ivemertinc, Paleo diet, RAW MILK (Which btw in any part that is not the commodity of living in the first world, is something completely out of mind to drink), and praising RFK (brain worms guy). All of these things, unfortunately, have a lot to do with the wave of anti-intellectualism and contrarianism of the American far-right, I hope the mods can do something about it and I open this post so people can discuss it, most of it is pseudoscience and should be health with as rule 4, this is my opinion tho, please discuss."
          ],
          [
           "Outlier (-1)",
           "Design and Implementation of N-of-1 Trials: A User‚Äôs Guide."
          ],
          [
           "Outlier (-1)",
           "Non-male Peter Attias?. I'm curious if there are any docs like Attia who focus specifically on women's health and complications to health \"hacking\" that include reproductive health? Feel like it would be a great add on top of Peter's pod!"
          ],
          [
           "Outlier (-1)",
           "The Anti-Vaccine Movement: From Fringe Group to National Phenomenon (short audio clip from Peter Attia's podcast with Peter Hotez)."
          ],
          [
           "Outlier (-1)",
           "Peter Hotez Compares the J&amp;J, Moderna, &amp; Pfizer COVID-19 Vaccines (2-minute audio clip from his appearance on Peter's pod)."
          ],
          [
           "Outlier (-1)",
           "How does L-glutamine kill carb / alcohol cravings?. I read in a few places that supplementing l-glutamine to the tune of 5-10g a day can take the edge off of not only sugar but alcohol cravings. I tried it and I am effortlessly 50 days off of sugar / sweets / alcohol / beer / wine. What's the mechanism at work here?"
          ],
          [
           "Outlier (-1)",
           "What do you guys think about this BPC guide?."
          ],
          [
           "Outlier (-1)",
           "Does anybody know a NYC \"Peter Attia - like\" doctor?. I know some suggest concierge medicine, but I can see the potential to run into non moral money makers. I'd rather hear suggestions of extremely data-driven and open minded docs in NYC that you know personally."
          ],
          [
           "Outlier (-1)",
           "Any Shiftwave owners/regular users here?. I have no idea how many users are out there, and it‚Äôs likely a niche market given the price point and difficulty in accessing trial units.\n\nI‚Äôve been using it regularly for the past 10 months and stick to just a couple of the journeys/protocols more focused on guided breath work. It‚Äôs been a miracle for me, personally, and I‚Äôm curious to know what others have found, how they‚Äôre using it, etc\n\nFeel free to DM me if you prefer‚Äî and thanks!"
          ],
          [
           "Outlier (-1)",
           "My HRV is always higher when I do nothing all day. I‚Äôm a relatively active person - lift weights 3x per week, 1x 5km run per week, 1 or 2 rounds of golf (walking).\n\nMy HRV on an average day is around 40-48.\n\nIf I have a lazy day or two around the house where I don‚Äôt do much my HRV rises to the 60s.\n\nWhat causes this?"
          ],
          [
           "Outlier (-1)",
           "#208 - Tragedy, grief, healing, and finding happiness | Kelsey Chittick - Peter Attia."
          ],
          [
           "Outlier (-1)",
           "Visualisation as a biohack?. I have osteoarthritis in my hands and spine and at 33 I am running out of options. I do PRP once a year, I am keto with a little bit of carbs as a woman, and take 9000 iu a day among other supplements. Now I've heard visualisation and imagining yourself healthy can do wonders, but is this true? Has anyone seen results?"
          ],
          [
           "Outlier (-1)",
           "Abbott Lingo Update. I can‚Äôt find anything newer than January 2022 on the status of release of the Abbott Lingo. Some articles say ‚Äúrelease outside of U.S. in 2022‚Äù, which fortunately I‚Äôm currently outside of the U.S. right now and would love to experiment with this new tech. If anyone has heard anything recently, I‚Äôd love to hear about it. Thanks!"
          ],
          [
           "Outlier (-1)",
           "Where to get CGM prescription USA. Anyone have a lead on the cheapest and fastest way to get a prescription for a continuous glucose monitor in the US? \nI'd like to just get the prescription go to Walmart pick up the monitor and track levels myself I'd really don't want to deal with a subscription service or a fancy website."
          ],
          [
           "Outlier (-1)",
           "Hyperbaric oxygen chamber - yes or no?. So on the one hand we need oxygen to live, and it's good for us. On the other hand, it also causes us to age.\n\nWe need oxygen to produce energy through cellular respiration. It's essential for powering our bodies and organs. Without oxygen, we wouldn't survive for more than a few minutes.\n\nHowever, during cellular respiration some oxidative free radicals are produced as a byproduct. Over a lifetime, these reactive oxygen species can damage cells and contribute to aging processes.\n\nIn particular, they can oxidize lipids, proteins and DNA in ways that accumulate and impair normal function over decades. This oxidative stress is implicated in many aging-related diseases.\n\nI know that hyperbaric oxygen chambers are being used by people in hopes it makes them healthier, extends lifespan and so on. And I've been wanting to go do a session myself. But I keep wondering if I may end up harming myself. I do not want to age faster.\n\nSo what's the deal guys?"
          ],
          [
           "Outlier (-1)",
           "Get chills for hours after intense workouts. Not sure this is the right sub for this but y‚Äôall are so knowledgeable figure it‚Äôs worth a try. \n\nAfter intense workouts (2+ hours of zone 4/5 heart rate) I get chills and have them for several hours afterward. I thought it might be low blood sugar but food doesn‚Äôt seem to make a difference. \n\nAnyone have any ideas about what‚Äôs going on? \n\nAppreciate any insights!"
          ],
          [
           "Outlier (-1)",
           "Does anyone else have trouble acting on Peters advice?. I appreciate him as a scientist and he's doing a ton of good. My issue is that I am not in the scientific or medical field. I am very interested in his latest run on \"Zone 2\" but as soon as I hear \"millimole\" or \"lactate\" my eyes gloss over. \n\nI'm very interested in the longevity regiment but I simply can not figure out what I should be doing."
          ],
          [
           "Outlier (-1)",
           "Where to find fashionable flat footwear?. It's really easy to find running shoes and the like, but i'm looking for a recommendation for boots or dress shoes that are flat and somewhat attractive to look at.\n\nHas anyone had success with any brands?? \n\nThanks!"
          ],
          [
           "Outlier (-1)",
           "Getting Vaccinated Prevents Long COVID After Breakthrough Infection (short podcast clip)."
          ],
          [
           "Outlier (-1)",
           "Peter Details His 2022 Weekly Exercise Routine: 4 Zone 2 Sessions, 4 Lifts, 1 Zone 5 Session, &amp; No Off Days (3-minute audio clip)."
          ],
          [
           "Outlier (-1)",
           "NEW: Part II of Peter's COVID roundtable about vaccine &amp; mask mandates, boosters, &amp; Omicron segmented into short clips with the key points up top."
          ],
          [
           "Outlier (-1)",
           "Austin TX primary care physician recommendations?. I‚Äôm looking for a good primary care physician in Austin TX or near by. Anyone here have any physician recommendations?"
          ],
          [
           "Outlier (-1)",
           "I'm really trying to ask a question that is not medical advice.. So, if it sounds like I'm asking for medical advice, I apologize. Bear with me to the end, and i think I'm not.\n\nOkay, just about a year ago, I was diagnosed with Lupus. Ugh. I'm on meds for it, Hydroxychloroquine (and yes, the drug they tried for COVID, but it doesn't work for that.). I was already a fairly developed supplements user. When diagnosed, it was pretty clear in the bloodwork, ANA, etc. But (yay!) no indication of organ involvement save slightly elevated liver enzymes. In the past year, I've lost about 60 lbs, and stopped drinking (I was drinking rather a lot). My \"I have Lupus \" numbers are about the same, but so many things that people complain about are just not issues. I have the symptoms that sent me for diagnosis --fatigue and joint pain --but no anemia, liver rebounded, kidneys fine,...\n\nSo the question is: Is it POSSIBLE that my supplement regimen (well researched, I think, but I'm not going to list them because I think that would be medical advice) is keeping worse symptoms at bay? Like, another way to put this: do you believe that biohacking can REALLY work, even with a serious diagnosis? Like I'm not asking what to do, because against all odds I'm doing basically fine (except insomnia). But is it possible that... supplements...work? Side note: I also see a naturopath, who has approved all my supplements, suggested some and agreed to ones I brought research for.\n\nI don't know if I've made sense here, avoiding breaking the rules turned out to be surprisingly complicated."
          ],
          [
           "Outlier (-1)",
           "How much of this sub is Autistic?. [View Poll](https://www.reddit.com/poll/1ffkb5s)"
          ],
          [
           "Outlier (-1)",
           "Is biohacking (for recovery) even worth the time and money?. Between cold showers, cold plunges, sauna, sports massages, electric compression leg sleeves, daily vitamins, greens powders, magnesium for sleep, and more I could be forgetting, nothing makes my recovery actually better. \n\nFor context, I am an early 20s male, training twice a day for sports (4+ hours daily) and working 8 hours. I measure recovery based on my whoop and perceived energy levels. Based on these factors, the only things that truly recover me are sleep, hydration, and eating well (appropriately timed and appropriate portions of whole foods like meat, rice, vegetable, fruit). On top of this, I do have coffee if tired and beetroot/beat alanine for performance. \n\nI recognize sleep/food/water are the critical factors (you can't sauna your way out of a sleep deficit), however my question is if it's truly worth spending time and money on these additional \"biohacks\". Does anyone have any strong opinions/evidence for these things or others I didn't mention?"
          ],
          [
           "Outlier (-1)",
           "#174 - Lawrence Wright: The 20th anniversary of the 9/11 attacks: reflections on how they happened, and lessons learned and not learned - Peter Attia."
          ],
          [
           "Outlier (-1)",
           "Earthing/Grounding‚Ä¶. Who here has tried or consistently does it? What have you noticed?"
          ],
          [
           "Outlier (-1)",
           "maintain muscle for 44 year old male?. Dr Attia stresses retaining muscle mass  as you age...I'm assuming he advocates for weights...but is body weight exercise as healthy? I'm just doing push ups and body squats"
          ],
          [
           "Outlier (-1)",
           "How to overcome stutter. Hi (26 m) been struggling with stutter my whole life, although it got less and less over the years compared to my childhood, it still bothers and makes embarrass myself sometimes.\n\nAny suggestions on how to overcome it?"
          ],
          [
           "Outlier (-1)",
           "The 4 Pillars of Exercise: Stability, Strength, Aerobic Efficiency, &amp; Anaerobic Performance (1.5-minute audio clip from Peter Attia)."
          ],
          [
           "Outlier (-1)",
           "so, what is the answer to insulin resistance. So, besides drug interventions, what is the answer here.    I am wearing a CGM now for a few days, after having calibrated based on lab fasting glucose, my glucose is over 100 pretty much all the time peaking around 125 after eating.   I also have high LDL(i take lipitor to control) and low normal HDL.    Based on what I read in the show notes, these are bad numbers.\n\nI weight lift several times a week but otherwise not much activity.  I eat better than most but hardly perfect.   My family is def predisposed I think to diabetes all my aunt and uncles on both sides have big bellies and skinny legs. etc..\n\nSo what to do?   exercise and fasting is basically the protocol right?\n\nedit..\n\n5 days of CGM data now.   The thing that stands out the most is the variability to eating carbs.   If I eat a keto or zero carb meal, my glucose moves 5 points.   Add a slice of bread and it swings 30 points.  \n\nedit 2\n\nI am 8 days into having a CGM on now, being honest, it was not \"painless\" for me at all.  The fattest part of back of my arm was still pretty lean and for the first four days it distinctly felt like I was being pinched and it would not stop.  I mostly do not notice it at this point though.   The company I bought these through did offer me a free one to there credit and insisted it should be totally painless.\n\nI am going to do a month, review the data which is all unsuprising at this point...(eat keto and blood sugar is dead level, eat carbohydrate and it goes up, eat white bread and it goes WAY up, though still well below what he considers the high threshold of 140 and it seems to recover to baseline rapidly.\n\nThis week I am doing a GCT+insulin 8 sample test to establish a numbers for all that and see relative accuracy of the CGM compared to lab draw...\n\n&amp;#x200B;\n\n&amp;#x200B;"
          ],
          [
           "Outlier (-1)",
           "[OC] Amazed chatGPT analyzed this reasonably well with minimal prompting."
          ],
          [
           "Outlier (-1)",
           "How do I find the Peter Attia of my city?. How does one find a local doctor who is an expert in Longevity topics including\n\n\\- Diseases like diabetics, coronary heart disease, Alzheimer's, NAFLD\n\n\\- How to monitor biomarkers that indicate risk for these diseases\n\n\\- Medication and supplements like metformin, berberine, rapamycin, apigenin, sulforaphane, resveratrol, senolytics, NAD boosters, \n\n&amp;#x200B;\n\nI'm in Boston."
          ],
          [
           "Outlier (-1)",
           "For those that quit sugar, is it all sugars, or just added sugars?. Basically the title. Are you just in a constant state of ketosis?"
          ],
          [
           "Outlier (-1)",
           "lactate meter suggestions?. Generally how long are strips good for  - can one buy 200 and be good for 2 years, or is there a definite expiration date?\n\nI've looked at all the related posts, there was a paper linked that showed the Edge seemed good at low concentrations (and one of the better ones at high concentrations), and the Edge is the cheapest currently available (unless I can get the German folks to ship the Roche Accutrend).\n\n[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4306774/](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4306774/)\n\nI'm concerned about availability - one other old meter was recently discontinued, and the Edge is getting long in the tooth - the source I'm planning to use if I get the Edge (which is probable).\n\n[https://www.edge-usa.com/lactate-meter/](https://www.edge-usa.com/lactate-meter/)\n\nSince the Accutrend is backed by Roche I suspect it and the strips will be available for a while.\n\nThe other alternatives are the accutrend and the Scout 4 - I don't know if I can convince these guys to ship to Canada.\n\n[https://www.praxisdienst.com/en/Lab+Equipment/Lab+Devices/Lactate+Meters/](https://www.praxisdienst.com/en/Lab+Equipment/Lab+Devices/Lactate+Meters/)\n\nthe Scout as a 10s read time, plus - and 343 euros - MINUS.\n\nand I can't find comparisons of the Scout 4 to others.\n\nAny meters I've missed?  Any sources?"
          ],
          [
           "Outlier (-1)",
           "A lesson from the Tyson vs Paul fight. No matter how skilled you are at biohacking, aging is always working harder. Biological aging is the real enemy, and preserving your biological youth is the ultimate biohack.\n\nIf you‚Äôre not actively working to delay the aging process or maintaining your body in its peak condition‚Äîcomparable to that of a 20- to 30-year-old‚Äîthen all your biohacking efforts are merely superficial.\n\nIf you're in your 20s or 30s, ensure your biohacking plan includes strategies to delay the aging process as radically as possible. For those in their 40s or 50s, focus on investing in advanced therapies, emerging biotechnologies, and expensive but cutting-edge treaments that offer potential age-reversal benefits.\n\nIf Mike had used some of his wealth and get treatments to give him a biological age of 35, tonight's outcome could probably be very different."
          ],
          [
           "Outlier (-1)",
           "My DNA methylation panel - conflicted. Ran my raw DNA from my heritage through nutra hacker \n\nWondering if someone more intelligent than me can help me decipher/come up with a plan\n\nMy main sticking point - MTRR/MTHFR I‚Äôve always looked at methylated b12 methylfolate to help counteract this mutation - however I wasn‚Äôt aware I have COMT which they suggest avoiding methyl donors for"
          ],
          [
           "Outlier (-1)",
           "How is your work /life balance ?. Long story short , just graduated college with a degree I definitely regret and want to switch fields lol. I ideally want something I can make good money but still enjoy my passions of being outdoors /working out /traveling"
          ],
          [
           "Outlier (-1)",
           "Anyone into healthy bodybuilding with longevity in mind?. I really love the gym and (natural) bodybuilding. However I am worried that it is not the healthiest of lifestyles as someone also interested in longevity. I eat pretty clean, mainly whole foods, plenty of high nutrient density food but I do worry that quite a lot of experts in the longevity field do not advocate for high protein diets and trying to build as much muscle as possible. Does anyone know of anyone influencers/experts/social media personalities who try to blend the bodybuilding lifestyle with longevity and general health and wellness?"
          ],
          [
           "Outlier (-1)",
           "Stress regulating supplements that actually work for you. Hi! Recently started a new job after having a lot of downtime. I can immediately feel that my body is tensing up more and more over the course of the day as I have back to back meetings and an information overload (due to onboarding, new company etc). \n\nDoing some exercise afterwards (not before actually!) helps me a bit to relieve some pressure in the evening so I can at least sleep okay. I mostly feel the pressure in my head, neck and jaw so I think I am just tensing up my muscles as a result of high cortisol levels and mental stress. \n\nApart from the good habits (exercise, sleep, nutrition etc) are there any supplements that actually help you prevent this mental tension that leads to muscular tension? \n\nI tried ashwaghanda but 300mg killed my stomach. Is it maybe worth trying a lower dose or will there be no effect?\n\nAny other products / hacks that work for you? \nThanks !"
          ],
          [
           "Outlier (-1)",
           "Precision Epigenetic Medicines to Extend Healthspan | Alex Aravanis MD PhD, Moonwalk Biosciences, $57M Startup."
          ],
          [
           "Outlier (-1)",
           "Transparent Labs New Multi. TL puts out high quality stuff so I‚Äôm curious what you all think. \n\nhttps://www.transparentlabs.com/blogs/all/inside-the-new-tl-multivitamin"
          ],
          [
           "Outlier (-1)",
           "Bloomberg | Posthuman with Emily Chang | Megathread. Bloomberg has hit their new video series, Posthuman, out of the park. Here is a list of there videos:\n\n* [https://www.youtube.com/watch?v=88DPXE1thw4](https://www.youtube.com/watch?v=88DPXE1thw4) \\- How Tech Is Breaking the Rules of Biology\n* [https://www.youtube.com/watch?v=sK5\\_pQV\\_QEA](https://www.youtube.com/watch?v=sK5_pQV_QEA) \\- What Happens When Robots Don't Need Us Anymore?\n* [https://www.youtube.com/watch?v=\\_eNnUUh6-J8](https://www.youtube.com/watch?v=_eNnUUh6-J8) \\- AI Companions Always Say Yes, But There's a Catch\n* [https://www.youtube.com/watch?v=1zEtIa8lpLA](https://www.youtube.com/watch?v=1zEtIa8lpLA) \\- The Thrill and Thread of Mind Hacking"
          ],
          [
           "Outlier (-1)",
           "199 Bio founder: ‚ÄòYamanaka factors are a biological cheat code‚Äô."
          ],
          [
           "Outlier (-1)",
           "Banning self health threads. Or your suggested way to handle them?\n\nThere is nothing else here. It's massive elephant in the room getting ignored."
          ],
          [
           "Outlier (-1)",
           "Type 2 diabetic trying to lose weight. 4 months ago I severed my ACL in my knee &amp; had surgery to replace it. I had been very active 5-6 days a week prior. I have been inactive since my injury/surgery but just finished PT &amp; have been cleared to go to the gym for light workouts. Between being inactive &amp; holiday weight, I lost some muscle and gained 15 pounds.  I am a type 2 diabetic managed by diet. Biohacks for fast &amp; safe weight loss (besides obvious light cardio/weights/diet)? Starting tomorrow with the rest of you!  Ty!!"
          ],
          [
           "Outlier (-1)",
           "SIBO , Histamine issues and genetics, any idea what to do?. Hi What do I think about the histamine intolerance test result below?  \n[My histamine result](https://ibb.co/KrSMh4g)\n\nBriefly what you need to know about me. I am a 30 year old woman with SIBO, treated with several rounds of Summetrolim, Normix without success. I started having symptoms in 2022 following a Covid infection. Sleep deprivation (due to having a baby) caused me to develop Exocrine pancreatic hypofunction, I developed a chronically low pancreas (70). This is probably what triggered the sibo. I am currently taking 9 enzyme tablets a day.\n\nMy symptoms of histamine are: pulse changes, elevation, anxiety, mild reflux, extra systole, breast beats. No digestive complaints when I eat histamine foods. My DAO enzyme levels have been measured twice, both times I got around 30-40.\n\nDNA wellness report done, revealed methylation disorders, genetic histamine intolarity, MAO-B mutation, COMT mutations are also present.\n\nMTHFR C677T rs1801133 A AG MTHFR A1298C rs1801131 G GT\n\nCholine: PEMT rs7946 T TT Decreased PEMT activity, phosphatidylcholine CHKA rs10791957 A AA Reduced turnover of methionine to phosphatidylcholine BHMT rs3733890 A GG Decreased conversion of choline to betaine FMO3 rs2266782 A AG Choline used less as a methyl donor\n\nHistamine: AOC1 rs10156191 T CT Reduced production of DAO AOC1 rs2052129 T GT Reduced production of DAO AOC1 rs1049793 G CG Reduced production of DAO AOC1 rs2071514 A AG possibly slightly higher DAO HMNT rs1050891 A AA Reduced breakdown of serum histamine HMNT rs2071048 T CT T/T: Reduced breakdown of serum histamine (common) HMNT rs11558538 T CC Reduced breakdown of serum histamine MTHFR rs1801133 A AG MTHFR C677T, MTHFR rs1801131 G GT\n\nCBS: CBS rs234706 A AG Increased LDL and trigs CBS rs4920037 A AG better arsenic detoxification CBS rs234709 T CT better arsenic detoxification\n\nBHMT: BHMT rs651852 C CT C/C: increased risk of cleft lip, an indicator of low methyl groups BHMT rs567754 T CT Decreased risk of ER-negative breast cancer (good)\n\nMAO: MAOA rs1137070 T CT T/T or T: linked to hostility behavior in internet gaming disorder MAOB rs1799836 T TT T/T or T: faster response to antidepressants in women\n\nCOMT: COMT rs4680 A AA GG = higher activity; AG=Intermediate activity AA = lower COMT rs4633 T TT CC = higher activity ; TT = lower COMT activity COMT rs165599 A AA Minor decrease in COMT"
          ],
          [
           "Outlier (-1)",
           "Looking for help on where to start. I am getting ready for my yearly physical and I would like to know what other types of tests I can request/have covered to get a better handle on my health.\n\nLast year I had high AST/ALT levels probably from years of drinking too much and very low Vitamin D.  Since then I went on a diet and later went on Tirzepatide and lost 33 lbs.  I also cut back on drinking and stabilized my AST/ALT levels.\n\nWhat I want to know is, outside the standard metabolic panel, what can I ask for/look at?  Should/could I ask for testosterone to be tested, anything else?  Are there additional tests regarding nutrient deficiencies etc?"
          ],
          [
           "Outlier (-1)",
           "Great summary of workouts that help with longevity and BDNF."
          ],
          [
           "Outlier (-1)",
           "Building a GPT for Health and Longevity and would love some Feedback. My goal is to create an assistant that will help a person extend their lifespan through their everyday choices. Any feedback would be appreciated so I can update it to be better. Cheers and thanks"
          ],
          [
           "Outlier (-1)",
           "A Randomized Trial Comparing Inhaled Insulin Plus Basal Insulin Versus Usual Care in Adults With Type 1 Diabetes."
          ],
          [
           "Outlier (-1)",
           "Started reading 'The longevity paradox'.... and not sure I'm going to continue. Not impressed with the lack of rigor, considering the claims he is making. And his dismissal of Keto as \"high protein\" is jarring, as he claims to be very familiar with it. This guy is on PBS All The Time lately, any substance, beyond the parts we already know? Cross-posting on another sub to compare responses."
          ],
          [
           "Outlier (-1)",
           "Someone tell me why this isn't exciting news. https://phys.org/news/2024-08-newly-protein-dna.html."
          ],
          [
           "Outlier (-1)",
           "Will we get notified when our MITOMOUSE campaign reward is shipped?. Title says it all!"
          ],
          [
           "Outlier (-1)",
           "AMA tomorrow with The Switch author, James Clement to talk about longevity therapies, Keto, autophagy, rapamycin, dasatanib, and NAD patches."
          ],
          [
           "Outlier (-1)",
           "SophieCo.Visionaries | We know how to restore an anti-ageing molecule in our DNA ‚Äì David Sinclair."
          ],
          [
           "Outlier (-1)",
           "Reminder: When this post is 8 hours old, David Sinclair will be having an AMA over on /r/IAmA.. Edit: whoops, sorry guys, it's actually **10** hours since writing this post. I can't count.   \n\n1:00 PM PST  \n4:00 PM EST  \n9:00 PM GMT  \n10:00 PM CET \n\nLink to the AMA: https://www.reddit.com/r/IAmA/comments/eorio3/hi_im_david_sinclair_professor_of_genetics_at"
          ],
          [
           "Outlier (-1)",
           "TRIIM Trial: Legit or not?. [https://www.youtube.com/watch?v=7Wz1zpKy62k&amp;t=487s](https://www.youtube.com/watch?v=7Wz1zpKy62k&amp;t=487s)\n\nI really have no insight on this topic so I'm asking fellow enthusiasts and experts who are more into this topic. Is this clinical trial legit or is it too good to be true?"
          ],
          [
           "Outlier (-1)",
           "17.6y Younger Biological Age (Blood Test #5 In 2024)."
          ],
          [
           "Outlier (-1)",
           "$10 Million Prize to Discover the Origin of Humans' Genetic Code."
          ],
          [
           "Outlier (-1)",
           "Epigenetic clock and lifespan prediction in the short-lived killifish Nothobranchius furzeri."
          ],
          [
           "Outlier (-1)",
           "Undoing Aging 2020 announces Program and Speakers."
          ],
          [
           "Outlier (-1)",
           "Joe Rogan Experience #1432 - Aubrey de Grey."
          ],
          [
           "Outlier (-1)",
           "Television viewing and cognitive decline in older age: findings from the English Longitudinal Study of Ageing [2019, open-access]."
          ],
          [
           "Outlier (-1)",
           "Vagus Nerve Stimulator - worth the price?. I started seeing ads for these products on different platforms and they looked interesting. I looked on Amazon only to find they are a few hundred dollars. \n\nBefore I spend that kind of money I‚Äôm curious if they actually help like they claim. \n\nAs someone who struggles with mental health (yes I‚Äôm on meds and in therapy weekly) I‚Äôm always looking for ways to help that don‚Äôt involve another pill or shot. \n\nSo are they worth trying?"
          ],
          [
           "Outlier (-1)",
           "Does anyone know what caused this in my teeth? What would you do if they were yours?. As an uncared-for and severely mistreated child, my diet consisted of only sugar cakes like Little Debbie's and we only ever drank soda. This is how I lived until I was about 25 when I went super clean Keto, started the gym, and started fixing my entire body. \nFor the last few years I haven't touched any sugar at all. My entire body is healing; my hair and nails are stronger and longer, my hair and eyelashes are more full, my skin is clearing up, and I've lost over 40 pounds.\n\nI went to the dentist a few months ago and they did a \"fluoride treatment\". It was so neon yellow that I think they didn't properly dilute it or something? because it's never looked like that before. I was gagging and spitting neon yellow for days. In a matter of days my teeth started to look like this. The discolored bits are like.... turning transparent, its not staining. It's not getting better even though the rest of my body is healing to better than it's ever been in my entire life. \n\nPerhaps it's from the childhood damage. Perhaps it's from that weird dentist experience. I don't know. \n\n Let's say you don't have the means to get a full mouth of teeth replaced. If this were happening to you, what would you do?"
          ],
          [
           "Outlier (-1)",
           "Are any dna tests useful for diagnosing problems and making changes to improve health?. Was thinking about ordering something that still has a sale going on. Been dealing with long covid/ CFS for quite some time. Feeling like my whole body is misfiring. Wonder if it's worth gaining information through DNA testing so I could change/tweek/improve anything about what I'm doing to maybe improve my health a little bit. \n\nIs this a good idea? At this point I'm thinking it can't hurt to gather as much information as possible. What kind of DNA kit should I get and what could I test for that could actually be helpful to address issues I'm having? Thanks!"
          ],
          [
           "Outlier (-1)",
           "What brands actually test their products by batch and have low heavy metal/contaminant amounts?. I can‚Äôt seem to find one besides looking for medical grade supplements that I would need a perception for."
          ],
          [
           "Outlier (-1)",
           "whoose effect?. So...is the \"jiggly fat\" and \"whoose\" effect that's supposed to happen before fat loss real? I've been in a major deficit the past week, walking 25k+ steps a day doing mostly OMAD/4-hour eating window, but suddenly the fat/skin around my stomach and love handles have begun to flare out and be more apparent. It feels watery and jiggly and it's very uncormfortable. Is it just water weight from carbs, stress, sodium (which wouldn't make sense given the difficit) or could it actually be the fat preparing to leave the body?\n\nFYI, I'm 23 years old, male and quite lean already. I eat mostly Meat, eggs, greek youghurt, fruit, potatoes, Rice, avocados, onions, Dark chocolate, with the occasional 5-10% processed garbage. I also take vyvanse 40 mg every day. I don't really drink a lot of water, but I don't feel thirsty through the day and make sure to hydrate through food"
          ],
          [
           "Outlier (-1)",
           "Increasing Platelets. I'm 6 months pregnant and my platelets just crashed. I'm on dr-prescribed steroids for a week so they can do a differential diagnosis, but I want to boost my platelets (or calm down my immune system so it doesn't eat them) as much as possible before delivery on my own, too.  If I can't get my count up I won't be able to have an epidural and there's a possibility that delivery will get dnagerous. Anyone have anything useful? Links to relevant studies welcome!"
          ],
          [
           "Outlier (-1)",
           "What do you wish Health Insurance covered that it dose not?. I feel like insurance only covers you when you are sick. Luckily I'm pretty healthy but so wouldn't it be cool if Insurance could help you stay healthy? What would be the top things you wish were covered by insurance?"
          ],
          [
           "Outlier (-1)",
           "Has anyone heard of or used Acoustic Restoration Therapy?. An Austrian guy invented it here in Australia and i was wondering if anyone has tried it or know of someone who has?\nSome call it a Dry Float. Essentially lay on a waterbed whilst it emits specific frequencies that pulse through your body."
          ],
          [
           "Outlier (-1)",
           "Would you use this outdated supplement?. My uncle passed away at age 96 in 2022. I inherited all his vitamins and supplements, literally a couple hundred bottles and also a couple cases of this powder vitamin supplement. It includes a long list of vitamins and minerals and 9 grams of protein/serving. I cannot find an expiration date on the bottle but certainly they are at minimum 3 years old.     They are unopened, sealed and the one I opened looks perfect. Would you use it?"
          ],
          [
           "Outlier (-1)",
           "Grounding sheets. A good friend swears by them, but he‚Äôs also a bit of a conspiracy theorist. I‚Äôm curious though and wouldn‚Äôt mind trying. Any positive experiences?"
          ],
          [
           "Outlier (-1)",
           "Which biological age tests are legit? I tried out a few myself.."
          ],
          [
           "Outlier (-1)",
           "What are ALL the environmental factors contributing to health?."
          ],
          [
           "Outlier (-1)",
           "I can‚Äôt remember. I‚Äôm a student, studying a hard degree in university. It‚Äôs tough, of course, but I‚Äôve always been a good student. \n\nBut, lately, the last year, maybe two, I‚Äôve noticed a degradation in my memory. Nothing I learn sticks, no matter how much I work for it. Everything from basic rules and terms, to every complex thing. I can barely remember what I ate for breakfast anymore. \n\nIn the past, I was able to stay on task, keep focus on whatever I had to do, and understood and remembered everything I learned, both on my own, and in class. I loved knowledge. But today I rarely even seek out new information and subjects. I just don‚Äôt have the mental capacity to use energy on something I know I won‚Äôt remember, possibly won‚Äôt even remember that I‚Äôve studied. \n\nI am seriously concerned about this, having such a significant decline in my mental abilities over such a short span, two years, maybe 4 years since I was at my best right out of high school. Even my languages are getting worse, I was good at English, but now I don‚Äôt even think my sentences are correct and makes sense. \n\nWhat could cause this? I fear I‚Äôll be waived off by my doctor if I go in with nothing more than a ‚ÄúI can‚Äôt remember‚Äù. Mental health (if this can be categorized as that) isn‚Äôt really something our healthcare system cares much about."
          ],
          [
           "Outlier (-1)",
           "Memory translator???. I want to know if it is possible to copy memories old memories by thinking about the memory, copying the data of the memory from the neural pathway into code and then translate it onto a visual screen so that you can see the memory"
          ],
          [
           "Outlier (-1)",
           "What to test for?. [M early 30‚Äôs] I have seen a lot of mention of supplementation in this sub, but was wondering what people recommend testing for and monitoring for the average person. I currently take a blood test a few times per year to check certain levels for a medication I take, but it only tests for about 10-15 things that the doctor is looking at. My health goals are better overall health as well as basic gym/running improvements. I want to monitor for any deficiencies I may not realize I have though, so I can make any corrections that are needed. Any feedback or discussion on this topic is appreciated. Thanks!"
          ],
          [
           "Outlier (-1)",
           "How to stay healthy working graveyard shift?. So I‚Äôm going to be working graveyard shifts soon and while I‚Äôm not crazy about the idea, it‚Äôs a good job opportunity. I‚Äôve read things about working nights being harder on the body and more problems with diabetes and other ailments. I‚Äôm curious if anyone has delved deeply into hacks for maintaining good health on such a schedule"
          ],
          [
           "Outlier (-1)",
           "How do you get your health data?. There's an ocean of machine learning work for early detection of all kinds of life altering nasties, loads of basic supplementation routines that depend on levels of such and such being compensated with such and such, heuristics on lifestyle changes that are more or less appropriate depending on how your xyz is doing...\n\nThing is, learning how xyz is doing isn't at all straight forward. If you're in the US and in a mass market HMO like many are, or in a country where even getting to a doc is an odyssey, it might seem like you're just out of luck with preventative screenings. They'll tell you they focus on preventative care, but unless you've got symptoms (that check their boxes at that), they'll just tell you to eat more greens, do more cardio, and maybe order a basic lipid panel if youre lucky. Which isn't bad in itself, but you get my point... Repeat specialized blood work and medical imaging are basically off the table unless something's already wrong with you.\n\nSo... How do _you_ get data to track your levels of whatever it is that you track? How do you get that data often enough?"
          ],
          [
           "Outlier (-1)",
           "Best Companies for DNA Insights? ‚Äì Recommendations Needed. What are some of the most innovative ways to use my DNA data file (e.g., from 23andMe, AncestryDNA...) to learn more about myself beyond ancestry or basic health risks.  Looking for companies that offer advanced analysis, like:\n\n* Personalized health recommendations\n* Pharmacogenomics (drug response)\n* Traits or fitness optimization\n* Longevity insights\n\nKnow companies or platforms specialized in deep DNA analysis? Any experiences, suggestions, or insights would be greatly appreciated!"
          ],
          [
           "Outlier (-1)",
           "Post AGI Healthcare - Longevity, Prevention, and Rejuvenation - How it will happen, what it means?."
          ],
          [
           "Outlier (-1)",
           "blood testing. As far as \"standard\" blood testing that one does periodically is there a reference set of tests that are of high importance?\n\nHormones? Colesterol? I know some of them but I am unaware if we have a reference list?"
          ],
          [
           "Outlier (-1)",
           "Caloric Restriction's Impact on Aging and Longevity."
          ],
          [
           "Outlier (-1)",
           "What about Continuos Glucose Monitoring?. I am becoming more and more informed about how glucose affects my daily life.\n\nI have seen the options available today such as LEVELS and nutrisense but they are only available in the USA (I am from Europe). \n\nI know they actually use the current monitors, Dexcom and Freestyle but to understand the data they give me I think it would be a big challenge to start with. But I should start with something, shouldn't I? I've thought about trying freestyle free 3 for 14 days to see how it goes. \n\nIs anyone in the same situation? I know that glucose is very important, it's our fuel, but these are products for people with diabetes. Is there any other option apart from these monitors?\n\nGreetings, I'm new here."
          ],
          [
           "Outlier (-1)",
           "AI Surpasses Doctors in Diagnostic Accuracy."
          ],
          [
           "Outlier (-1)",
           "Earthing &amp; Grounding Health benefits by Reconnecting to this Ancient Practice."
          ],
          [
           "Outlier (-1)",
           "35yo Male: Low RBC high MCH. RBC measure at 4.07 and MCH at 34.6 and MCHC at 36.1. Currently taking Mercaptopurine (100mg daily) and Humira injections every 2 weeks. \n\nWhat can I do to get these numbers back to normal values? Simple folic acid supplement?"
          ],
          [
           "Outlier (-1)",
           "does this really work or is it utter nonsense?."
          ],
          [
           "Outlier (-1)",
           "Bloodwork, am I cooked?. 22, M here. I'm 5'7 and 80KG right now"
          ],
          [
           "Outlier (-1)",
           "Optimal Fasting. I practice multiple types of fast during the year for religious and health reasons and I wanted to know if anyone had any resources on the types of supplements to take while fasting and the optimal diet to break a fast with depending on the type of fast.\n\nFasting Types\n3-7 day - Water Only Fast\n21 day- Cold Pressed Juice Fast \n21- 30 day- OMAD"
          ],
          [
           "Outlier (-1)",
           "Thoughts on Frank Lipman?. Longevity doctor who has released several introductory books regarding health, diet, aging etc. Is he a trustworthy source?"
          ],
          [
           "Outlier (-1)",
           "Using hyperbaric oxygen regularly?. Anybody using it? I am thinking to buy hyperbaric oxygen chamber to use it regularly for me and family members.\n\nHowever I am not sure if this is a good idea anymore. There was a study that showed hypoxia (opposite from what you get from hyperbaric oxygen) could extend lifespan¬†[https://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.3002117](https://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.3002117)¬†. However there is also a study that shows hyperbaric oxygen can increase telomere length.\n\nI think both hyper and hypo have benefits. I would appreciate any comments about that."
          ],
          [
           "Outlier (-1)",
           "New theory suggests aging is driven by degenerative metabolic reprogramming over time."
          ],
          [
           "Outlier (-1)",
           "XPRIZE - Dr Roey Tzezana Develops Prizes To Radically Extend Human Lifespan."
          ],
          [
           "Outlier (-1)",
           "stability exercises. I'm losing balance, in my 40s. What stability exercises and for how long does Attia recommend??"
          ],
          [
           "Outlier (-1)",
           "BPC157. Anyone try BPC-157?  How was your experience"
          ],
          [
           "Outlier (-1)",
           "Bryan Johnson - the ultimate biohacker - is only 46 years old?. I thought he was in his 60s that look like he in his early 50s. And he is throwing every known thing towards his cause. Does biohacking actually work?"
          ],
          [
           "Outlier (-1)",
           "Opinions on OMAD?. I (49m) need to lose 25 pounds of fat. I‚Äôve been off lifting weights for awhile due to a bum shoulder but I need to get back to it in a limited way. Same with walking; I‚Äôm a small business owner and work too much.\n\nIs OMAD bad or is it a totally individual thing. I thought IF was good but I read conflicting stuff on this sub. Maybe 20/4 is healthier?  I just need something easy bc I‚Äôm sick of counting calories and I just focus on getting lots of protein everyday and staying around a 500 to 1000 cal deficit.  I tracked for awhile last year so I have a pretty good sense of it."
          ],
          [
           "Outlier (-1)",
           "How to delay aging ? I know aging starts at around 25 but you can keep yourself young for decades after that but how? How much cardio how much lifting whatkind of diet etc."
          ],
          [
           "Outlier (-1)",
           "Criterion for blood glucose \"spike\"?. UPDATE: Found the answer in [this post on Attia's site](https://peterattiamd.com/are-continuous-glucose-monitors-a-waste-of-time-for-people-without-diabetes/) and this [subscribers-only podcast](https://peterattiamd.com/ama24/). He says he wants his patients to basically never spike above **140mg/dL**, and if that's achieved he considers even trying to stay below 130. \n\n&amp;#x200B;\n\n\\---\n\nIn *Outlive,* Dr. Attia explains that avoiding blood glucose spikes is important, and says CGM can tell him if the patient is \"'spiking' above 160mg/dL more often than I would like\". Is 160 his actual threshold for identifying a spike, or has he ever described another way he determines what constitutes too large an excursion from baseline glucose? When I eat a lot of carbs my glucose goes rapidly up and back down, and if you arbitrarily restrict the y axis it looks like a heck of a spike. But the actual peak value is almost never higher than 125mg/dL, even on a 75g OGTT (baseline is around 70mg/dL). I suspect that's nothing to worry about but I'm curious if Attia has said anything that might be relevant."
          ],
          [
           "Outlier (-1)",
           "Poor sleep and working out. Is working out, either zone 2 or resistance training pointless if one has had a bad nights sleep the night before?\n\nAre all gains left behind if one has a poor nights sleep the night after a workout?"
          ],
          [
           "Outlier (-1)",
           "High blood pressure at the age of 24?? 2nd doctor didn't wanna believe me. I 24F am working as a call center agent from 8:30pm to 6:30am last may 14 i had a headache that night so I called in sick and took a my bp on a digital monitor and it says 139/90 and so my TL told me to rest and get a medical certificate early in the morning \n\nSo I went to the hospital they said my bp is only 120/80 so they made me take full laboratory exam an x-ray and an ecg I still went to the office the next day but i still have dizzyness and a headache and they took my BP there it its 150/90 so I was sent home that may 15 at 11pm then the next morning i got the result  the doctor said i have high cholesterol I weight about 70kg and 161cm in hight I told the doctor what happened that night so the doctor prescribed me atorvastatin calcium and amlodipine 5mg and the doctor advised me to rest for 3 days\n\nIt Happened again last May 21 the company nurse checked on me  its 145/86 then made me rest for a while but after checking again its 159/90 so again i was sent home. Last night may 24 i wasnt feeling well i have a headache and i was dizzy again it it feels like my heart is getting squeezed i checked my bp again and it shows 169/96 so I sent it again to my TL and advised me again to rest.\n\nSo now I went to the hospital again to get a medical certificate they checked my BP and again they told me its normal it is a different doctor from the first one and she told me i was too young to believe I have high blood pressure and that they don't just give away medical certificates so they made me take another lab lest and urinalyais. \n\nI don't know what to do I feel like they think I'm lying about how I feel"
          ],
          [
           "Outlier (-1)",
           "Does anyone know if there any longevity biohacker conferences happening in europe this summer? Also are there treatments out there available that are unique to that part of the world?."
          ],
          [
           "Outlier (-1)",
           "Doctor refused apoB test. I'm 23, which is why I suppose he wouldn't go through with it. He said blood panels don't usually cover apoB and only tested for LDL, HDL and TGs. Anyone know of anywhere in Sydney, Australia that covers this?"
          ],
          [
           "Outlier (-1)",
           "Member Discount for Eight Sleep. I just got the Peter Attia email about a member discount on Eight Sleep. It doesn‚Äôt look like you can see what the discount is without being a member. Could someone please share what the discount is?"
          ],
          [
           "Outlier (-1)",
           "Peter Attia Training Plan based on Outlive!. Been seeing a lot of you asking about a Peter Attia-recommended training program for maximizing longevity based on Outlive. So I made one! I've also studied every podcast episode, show notes, blog, IG, Beth Lewis's content (Peter's personal trainer), and Peter's appearances on other podcasts.\n\nThe Program covers all 4 pillars of training that Peter suggests: Aerobic (Zone 2), Anaerobic/VO2 Max (Zone 5), Strength, and Stability. I have run the entire program myself and on several clients. It has over 10x the result of any program I've seen before.\n\n[https://peterattiatraining.gumroad.com/l/longevity](https://peterattiatraining.gumroad.com/l/longevity)\n\nI hope you like it and live long!"
          ],
          [
           "Outlier (-1)",
           "Issues with memory. I have some moderate/severe issues with memory. Mostly in terms of episodic memory and the cognitive process of memory retrieval. Often this information is there, but cannot be retrieved to consciousness though. Any supplements that help memory in general? \n\nAnd if anyone has specific info on memory retrieval issues and supplements that would be great, but I don't think that kind of specific information exists. Thanks!"
          ],
          [
           "Outlier (-1)",
           "Afiya Health - any thoughts?. Hi any opinions on signing up for one of the plans here:\n\nhttps://afiya.health/ ?  \n\nI am about to pull the trigger on this."
          ],
          [
           "Outlier (-1)",
           "The fixation with social media as the root of rising teen suicides blinds us to critical factors that you rarely hear anyone talking about in conversations about teen mental health.."
          ],
          [
           "Outlier (-1)",
           "Is it just me or do 70 year olds look a lot younger than they did maybe 20-30 years ago. Why is this?. Do you think biohacking has something to do with it? Is it that I am seeing less perms on the elderly? I need to know! ü§£ What prompted this discussion was the interview Jerry Sinfield had‚Ä¶ Can you believe he‚Äôs 70! But it isn‚Äôt just him - it isn‚Äôt just celebrities. I work in a medical DME store and I am seeing a ton of healthy, youthful looking 70,80, &amp; even 90 year olds! Is it medicine and our technology? Let‚Äôs talk!"
          ],
          [
           "Outlier (-1)",
           "Blood test recommendations?. 31M, overweight but trying to lose weight/eat healthier. I stumbled across PAs podcasts and book and have become obsessed.\n\nWhat blood tests do you recommend I get? Looking for a baseline and then identify where I need to improve/watch. Got a CBC and CMP a month or so ago but going to go next week and do a few others. Any suggestions in addition to the below?\n\n- CBC (repeat)\n- CMP (repeat)\n- HBa1c\n- ApoB\n- (Lp(a))\n- hs-CRP\n\nIs this too much to have taken in one sitting as well?\n\nThanks!"
          ],
          [
           "Outlier (-1)",
           "MTHFR equilibrium / hyperhomocystinanemia reduction. Experimenting with different supplements to optimize MTHFR function and decrease my homocysteine levels.\n\nIn obtaining lab work... how quickly does MTHFR/methylation get into equilibrium. How long do you recommend waiting before rechecking labs?\n\nCurrently aiming for choline rich foods, glycine morning and night, 2mg methyl folate, 500mg TMG, and 5mg creatine daily."
          ],
          [
           "Outlier (-1)",
           "Why do I feel more stress after working out?. So it‚Äôs been happening for a while now. I‚Äôve been getting more stressed after workouts?\n \nAnyone went through the same?"
          ],
          [
           "Outlier (-1)",
           "CGM ordered. I am non diabetic but I would like to know how my nutrition changes my blood glucose levels throughout the day. So I just ordered a Freestyle Libre 3 sensor for 14 days.\n\nAnything I need to consider? Should I just test various food sources during these two weeks?"
          ],
          [
           "Outlier (-1)",
           "PA version of OGTT - where to get the test done. Hi, have anyone ever found out where in the US we can do a PA version of the OGTT test - both insulin and glucose at 30, 60 and 90 minutes? Someone recommended [this lifextension test](https://www.lifeextension.com/lab-testing/itemlc100014/glucose-tolerance-test-with-insulin-8-specimens-blood-test) in this subreddit but it measures at 60, 120, and 180 minutes instead of when PA measures."
          ],
          [
           "Outlier (-1)",
           "How to find a doc like Peter?. New to this subreddit! I'm sure this has been asked before, but I scrolled back a few days / searched and couldn't find a post soooo here we go.\n\nI live in Charlotte NC, one of the 25 largest cities in the US, and I am struggling big time to find a doctor like Peter Attia. I'm 29 y/o and \\*relatively\\* healthy, so I'm mostly focused on 1) prevention, and 2) achieving \\*optimal\\* health. A few things I'm finding that aren't quite right include:\n\n1. Concierge practitioners who seem more focused on coordinating care for complex, sick patients\n2. \"Functional Medicine\" practitioners who are anti-medicine and pro-essential oils\n3. Health coaches who lack the qualifications and prescribing powers of an actual doctor\n\nI want an actual MD/DO who can and will write prescriptions, isn't afraid of modern medicine, is highly knowledgeable about and able to guide nutritional and exercise choices, and takes a robust approach to prevention and testing / tracking. Has anyone here found a doctor like this? Do they fill the role of a PCP? Do you have any tips of google search keywords or other ways to find doctors like this in cities where - apparently - they are scarce?"
          ],
          [
           "Outlier (-1)",
           "Why don‚Äôt more doctors check ApoB?. Hello all.  I‚Äôm new to listening to Peter, so forgive me if he‚Äôs discussed this already.  Given that ApoB is a better marker than LDL-C for the development of atherosclerosis, why don‚Äôt more doctors know about/pay attention to it?  It‚Äôs not like it‚Äôs a new lab or anything.  \n\nIs it simply the fact that those 10 year risk calculators only use LDL-C and not ApoB, so who cares?\n\nChange in medicine can be at times glacial but sometimes can be really fast.  I‚Äôm sure most primary care docs know about Ozempic/Wegovy and how they work now, because they‚Äôve probably been bombarded with questions about them.  So why isn‚Äôt this the case with ApoB?"
          ],
          [
           "Outlier (-1)",
           "Salt Lake City /Park City UT Docs that subscribe to Dr. Attia. Looking to make a change with my Primary Care Physician and would like to find one that subscribes to Dr. Attia‚Äôs approach.  Can anyone suggest one in the PC /SLC area?"
          ],
          [
           "Outlier (-1)",
           "In defence of: Xylitol linked to risk of blood clots (The Calorie Control Council (CCC). [https://dentistry.co.uk/2024/06/11/xylitol-linked-to-risk-of-blood-clots-study-says/](https://dentistry.co.uk/2024/06/11/xylitol-linked-to-risk-of-blood-clots-study-says/)\n\n# ‚ÄòContrary to decades of scientific evidence‚Äô\n\nThe Calorie Control Council (CCC) responded to the study in defence of low-calorie sweeteners. CCC president Carla Saunders said: The results of this study are contrary to decades of scientific evidence substantiating the safety and efficacy of low-calorie sweeteners such as xylitol by global health and regulatory ‚Äéagencies.\n\n‚ÄòWhile the authors used multiple methods, it should be noted that the findings are limited in their ability to establish association only. Further, one phase of the study included individuals who were already at increased risk for adverse cardiovascular events.‚Äé These findings are a disservice to those who rely on alternative sweeteners as a tool to improve their health.‚Äô\n\nShe continued to highlight the dental benefits of xylitol, saying: ‚ÄòXylitol has been trusted as a great tasting low-calorie sweetener for more than 60 years. It has proven dental benefits, including preventing plaque build-up and tooth decay. It is naturally occurring in foods such as strawberries, lettuce, and oats.‚Äô‚ÄòContrary to decades of scientific evidence‚Äô  \n  \n---\n\nWhat do you guys think about all of this Xylitol business? I like Xylitol, I use it as a sweetener."
          ],
          [
           "Outlier (-1)",
           "Dr. Attia's comments on sports and longevity, questions about progressive overload.. I just started listening to Dr. Peter Attia's podcasts a couple weeks ago.  In one of his podcasts, he mentions how he no longer cycles toward a goal of racing and in general, practicing a sport with a goal of elite performance could actually harm longevity.\n\nI'm curious, is his reason for not racing anymore due to his concerns about being unbalanced in overall physical performance?  For example cyclists are notorious for having poor posture, weedy arms, and poor lateral balance/mobility (I say this as a cyclist).\n\nAlso, it seems that Dr. Attia does a lot of workout routines during the week, but I don't hear him discuss progressive overload very much.  Granted I've only listened to a dozen podcasts so I may not have heard him talk about it yet.  But in general, if you want to get stronger or build more endurance, you need to slowly overload the system you're working on; otherwise you plateau and just slowly decline, or is his goal just to stay where he's at for as long as possible?\n\nThanks!"
          ],
          [
           "Outlier (-1)",
           "How to safely fast. Im wondering if anyone has any tips or protocol on how to safely fast?\n\n Like a 24 hour kinda thing. Never done it before but I hear good things about it. \n\n I‚Äôm not looking to loose weight, more just help lower inflammation. Thank you üß°"
          ],
          [
           "Outlier (-1)",
           "What are ways you have improved your memory?."
          ],
          [
           "Outlier (-1)",
           "How to increase your \"learning battery\"?. An annoying thing I've noticed at work (software eng here) is that -- when a colleague is walking me through some process or explaining some context for a task that's been assigned to me -- I feel like I get maybe a few minutes when I can follow their pace, take notes, ask relevant follow-up questions. But the call might last half an hour. As the time goes on, my brain just gets worn out and I find myself going \"uh-huh, uh-huh, sure, actually can you repeat that last sentence?\" By the end of the call, my brain will have been working hard enough just trying to keep pace that I'll have to look over my notes heavily -- and half the time, I'll still realize I'm missing some more context.\n\nI don't actually know if I'm unusual here -- I didn't have any other employees start at the same time as I did, so I can't compare my performance to theirs to see if this is really a problem. But it sure feels like my brain has to tap out 30 meters into the 100-meter sprint a lot. As a result I feel like I waste a lot of time making basic blunders on my tasks that I wouldn't have if I were better on a daily basis at quickly understanding and integrating information that I receive.\n\nI don't really have productivity issues in terms of concentration. I don't consider myself a forgetful person. I have had some issues with mild sleep apnea, but I don't think this is strongly related to that since I have made large strides in treating it (and feel less tired than I used to) yet this particular thing hasn't improved much.\n\nIs this another \"take racetams\" situation? Level 5 cardio? Some nutrient I might be missing?"
          ],
          [
           "Outlier (-1)",
           "Initial Assessments. Can someone please sum up the starting points for initial assessment with regards to blood tests, scans, etc.?\n\nAssuming we believe we are in general good health, what do we need to check to confirm that self-assessment other than what a mainstream PCP may do at an annual physical?\n\n(Full Lipid Profile, Calcium Scan, CGM, etc.?)\n\nAlso, what are the best practices of getting these done?\n\nThanks all!!"
          ],
          [
           "Outlier (-1)",
           "Could This Be The Worst AI Paper Published?."
          ],
          [
           "Outlier (-1)",
           "Best DNA test in Australia. I got my dna tested by 23 and me and downloaded the raw data and have uploaded it into a bunch of sites to great success.\n\nA family member wants to get their DNA tested so they can find out health outcomes and predispositions.\n\nWhats a good company to do this in Australia? \n\nAnd in the USA whats the cost of full genome sequencing, are there companies doing that now?"
          ],
          [
           "Outlier (-1)",
           "Anyone used Nucleus for DNA testing?. They make some pretty big claims about what they can do vs other DNA testing services. Wanted to see if there's any red flags or if it seems like it's worth the $400."
          ],
          [
           "Outlier (-1)",
           "Is fasting glucose of 71 mg/dL too low?. Had my blood drawn at the doctor‚Äôs yesterday and my blood glucose was 71 mg/dL. I hadn‚Äôt had a meal for around 3 hours so this is probably equivalent to my fasting value. This seems pretty low, and was on the lower end of the ‚Äúnormal‚Äù range, FWIW. I do not have type 1 diabetes. The last time I had my blood drawn in January it was 87 mg/dL after a true overnight fast, but I‚Äôve been relatively low carb for the past couple months. I was eating a lot of carbs when it was drawn last. Any insight would be appreciated."
          ],
          [
           "Outlier (-1)",
           "\"The David Sinclair $720,000,000 Train Wreck!\" Devastating video detailing Sinclair's ineptitude and extreme dishonesty regarding the sale of his resveratrol IP. Pertinent today because he is currently using the same shady game plan for NMN.. If you have any doubts about Sinclair watch this, your doubts will turn into full blown skepticism about everything this man says. Basically every single study Sinclair produced about resveratrol was bogus. Every single one of them. \n\nThe worst part for me is Matt Kaeberlein explaining how he was told by the Nat Inst of Aging head (Kaeberlein's boss) to test RSV, skipping the line because his boss was so enamoured of Sinclair. So Matt consults with sinclair to get the protocol right and does everything Sinclair tells him to do. Nothing. Results were a complete bust. \n\nthen Sinclair goes on multiple podcasts and says that the reason the tests failed is that no one consulted him and they did the tests all wrong. Incredibly dishonest human being. \n\nhttps://www.youtube.com/watch?v=Xn0EJQPyxkA"
          ],
          [
           "Outlier (-1)",
           "Age tests. I am still new on the longevity scene, and I have been trying to do my research. I apologize to those that are sick of newbies like me coming along and probably asking the same questions over and over again (I have similar experience in other communities). \n\nThat said I am looking to find the most important tests for longevity. I don‚Äôt care so much about some hypothetical biological age, but rather what tests can yield the most information that are in turn actionable. \n\nI don‚Äôt care about tests that give me results I can do nothing about. I have about 2k to spend on tests, I am American, live rurally and unlikely to go to lab so need home tests.\n\nIn my situation what would get to really get kick started? \n\nOnce again thank you for your help, and sorry if this is like the 1265th post on this."
          ],
          [
           "Outlier (-1)",
           "Has anyone tried Afiya Health?. I'm struggling (like a lot of people apparently looking at this subreddit) to figure out what to test and how to interpret results since the info is relatively scattered. \n\nAfiya Health seems to be a service that would deliver Medicine 3.0 recommendations and evaluations, but it seems relatively untested since its new. Has anyone tried it?\n\nFollowup, would the basic recommendation just be to use ama14's test recommendations for tests and results and either work with my PCP or figure out myself how to react?"
          ],
          [
           "Outlier (-1)",
           "Which do you think is healthier?. [View Poll](https://www.reddit.com/poll/1bbsk5m)"
          ],
          [
           "Outlier (-1)",
           "Measuring Creatine. I am \\~50 years and workout 4 times per week for past 3 months.  For past 3 weeks I've taken 5g of Thorne creatine daily.\n\nWhat test can/should I take to measure the levels of creatine, and what range do I want?\n\nI will likely get the test on [ownyourlabs.com](https://ownyourlabs.com).  Thanks!"
          ],
          [
           "Outlier (-1)",
           "Exercise before work. I've been doing an hour of zone 2 exercise on my indoor bike before work in the mornings and it's making a huge difference in my mental energy, stress, and focus at work. However, it takes up a ton of time. Probably 90 minutes when you include prep, shower, etc. What are some hacks to get the same benefit in less time?"
          ],
          [
           "Outlier (-1)",
           "Which add-on blood tests should I ask for?. I‚Äôm new to the PA world. I have an appt with a new cardiologist soon. At my last PCP visit, she ordered a standard blood test panel and I asked her to add ApoB, so I could share that with the new cardiologist. \nAnything else I should ask for, that can just be added to the panel-?"
          ],
          [
           "Outlier (-1)",
           "Phenoman buyers be aware. Just tried this so will update, although felt the marketing is a real con / scam.\nFirst of all site says you can get a free sample....then it charges you for 9.99 postage.\n\nSecond the free sample you get you receive an email telling you unless you post the product back 59.99 will be taken out of your account in 12 days \n\nSo point is product you get is far from  a free sample and your forced to pay without agreeing to pay full price in first place."
          ],
          [
           "Outlier (-1)",
           "The 80/20 list of longevity experts' advice for a longer life. I'm trying to create a 80/20 list of longevity expert guidelines, meaning 20% of the rules/effort for 80% of the impact.\n\nFor example, I'm not interested in taking a bunch of supplements for specific issues - just the major ones that pretty much everyone should take.\n\nThis includes what Peter Attia, Huberman, David Sinclair, etc.. do for themselves.\n\nWhat would you edit / add?\n\n## 1 - Nutrition &amp; Supplements\n\n**Protein.**\n\n* Peter Attia and Layne Norton recommend .8 - 1g of protein for 1 lb of body weight per day. This is a lot and hard to eat honestly.\n* Attia estimates the max per sitting is around 50g (more than that and it‚Äôll get shit out).\n* Attia recommends whey protein isolate as opposed to whey protein concentrate. Whey protein concentrate has sugar alcohols which can give folks tremendous farts.\n* Huberman's recommendations center around consuming 1g of protein per pound of body weight.\n* Rhonda often discusses the benefits of consuming approximately 20-30g of protein per meal.\n\n**Fiber.**\n\n* Layne Norton recommends getting at least 35g of fiber for a 2,500 calorie diet, although he also states that the more fiber a day, the better.\n* He cites that for every 10g increase in fiber, there was a 10% reduction in risk of mortality.\n* Attia mentions fiber improves glucose and ApoB levels.\n* Dr. Robert Lustig says it‚Äôs important to get both soluble and insoluble fiber in a sitting.\n* There‚Äôs a big caveat though - if you supplement with too much fiber out the gate - and especially insoluble fiber - you can get some weapons-grade level gas.\n\n**Fish oil.**  \n\n* DHA and EPA are two Omega 3 Fatty Acids in fish oil that have been shown to have a lot of cognitive and cardiovascular benefits, including longevity.\n* eat fatty fish such as salmon, tinned sardines or mackerel with the skin on¬†\n* take at least 1 gram of EPA derived from fish oil each day, or 2 grams of EPA if you‚Äôre not a fish eater.¬†\n* The most cost effective way of supplementing that Huberman has mentioned is [Carlson‚Äôs fish oil](https://www.amazon.com/Carlson-Limited-Finest-Norwegian-Omega-3s/dp/B071Z9P4L5/ref=sr_1_7?crid=79QYX29KN5LM&amp;keywords=carlsons+fish+oil&amp;qid=1680980892&amp;s=hpc&amp;sprefix=carlson+fish+oil%2Chpc%2C92&amp;sr=1-7) (sorry Momentous).\n* [Dr. Rhonda Patrick](https://www.foundmyfitness.com/topics/omega-3) said to keep the bottle refrigerated if possible as room temperature will degrade the potency of the EPA + DHA, and if the bottle gets hot it can go rancid.\n* Bryan Johnson is using vegan high strength Omega‚Äë3 EPA and DHA - he mentioned using from [this brand.](https://www.vegetology.com/supplements/omega-3)\n\n**Creatine.**\n\n* A recent study came out showing that creatine supplementation helped old ladies strengthen their hips, decreasing their probability of falling and breaking a bone.\n* For creatine you want creatine monohydrate.\n* Folks under 180 lbs should shoot for 5g/day, everyday.\n* Heavier folks often supplement up to 10g/day. This comes from [Dr. Layne Norton](https://www.youtube.com/watch?v=PD8-CJ6OuAQ).\n\n**Alcohol.**\n\n* Alcohol causes neurological decline, damages the gut microbiome, and increases stress levels when we‚Äôre not drinking.\n* [Huberman](https://www.youtube.com/watch?v=DkS1pkKpILY&amp;t=1s) advises against drinking more than 2 drinks a week (with 0 being ideal).\n* [Attia](https://www.youtube.com/watch?v=9l-_c8kcfR4) advises the limit is up to 7.\n* Both Huberman and Attia agree that anything over 2 drinks a day is supremely no bueno.\n\n## 2 - Exercise\n\n#### Building Aerobic capacity\n\n* **Zone 2 cardio for 150+ minutes.**\n* Andy Galpin recommends performing all Zone 2 cardio should be performed while nasal breathing, as that‚Äôs somehow better for air quality and facial muscles.\n* He recommends getting at least 150 minutes per week.\n* Peter Attia has a much more specific definition. Zone 2 for him is the highest metabolic output/work that you can sustain while keeping your lactate level below two millimole per liter.\n* This requires using a lactate meter periodically (he recommends 1x/month) immediately after workouts to see if you‚Äôre in range.\n* Attia recommends 180 - 210 minutes of this a week.\n* Andy Galpin recommends warming up for about 10 minutes, then going fast for 2 minutes then resting for 2 minutes, and repeating 3x.\n* Huberman does 20-60 seconds of an all-out sprint + 10 seconds rest x 8-12 rounds.\n\n#### Strength / physical therapy training¬†\n\n* **The key principle is progressive overload.**\n* Every week, you want to do a bit more weight or reps than the week before.\n* Galpin recommends adding 10% more weights or reps each week. After six weeks, he recommends down shifting by 30% to give muscles a rest, then slowly going up again.\n* Bryan Johnson‚Äôs Complete Workout [(YouTube video here)](https://www.youtube.com/watch?v=sYyVi-H-ozI)\n* Hubberman optimizes strength and muscle growth by alternating between low-intensity (8-15 repetitions) and high-intensity (4-8 repetitions) training schedules.\n* Tracking progress.  \n\n   * Use a Garmin, Whoop or Apple Watch to track your workout.\n   * Strava, Notebook, or your note app to save your PR.\n* [Fitness Routine Suggestion from Huberman](https://global-uploads.webflow.com/64416928859cbdd1716d79ce/650e450994ef9ab775e16acf_Neural_Network_Newsletter_Foundational_Fitness_Protocol.pdf)¬†\\- not recommended for beginners, but gives you an idea of what you might include in your own program.\n\n## 3 - Sleep protocol\n\nDeep Sleep. Aim for 75-90 minutes of deep sleep per night. Deep sleep is the most restorative stage of sleep. It‚Äôs more important than the amount of sleep you get.\n\n* **Get enough magnesium.**¬†Magnesium is essential for sleep.¬†Include magnesium-rich foods in your diet or take a magnesium supplement.\n* **Sleep environment:**  \n\n   * Keep your room cool and dark while sleeping.\n   * Use earplugs.\n* **Create a relaxing bedtime routine:**¬†1/2 hours before bed,¬†wind down by avoiding screen time,¬†reading,¬†or taking a warm bath.\n* **Avoid caffeine 8-10 hours before bedtime,** as it disrupts sleep.\n* Alcohol close to bedtime will also disrupt sleep.\n* **Naps are perfectly fine**; as long as they are kept under 90 minutes, they shouldn't disrupt your sleep cycle.\n* Some experts recommend taking melatonin before bedtime. Melatonin is a hormone that helps to regulate sleep.\n\n## 4 - Other protocols\n\n* **Early morning sunshine:** Get 5 - 10 minutes of sunlight within 1 hour of waking up. Huberman recommendation.\n* **Nasal breathing:** Breath through your nose as opposed to your mouth as much as possible. [Source is Huberman](https://twitter.com/hubermanlab/status/1557047992472940545?lang=en).\n* **Coffee intake timing:** Delay drinking coffee until 90 minutes after you wake up. It will last longer and prevent crashes. [Source is Huberman](https://twitter.com/hubermanlab/status/1600178360390279169?lang=en).\n* **Water intake.** Hydration rule of thumb: Throughout the day, drink half your bodyweight (in pounds) in ounces per day. So, 200 pounds ‚Üí 100 ounces of water. Distribute this throughout the day. [Source is Huberman‚Äôs interview with Andy Galpin, PhD.](https://podcastdisclosed.com/dr-andy-galpin-optimal-nutrition-supplementation-for-fitness-huberman-lab-guest-series/#:~:text=A%20good%20guideline%20is%20to,even%20ten%20pounds%20per%20hour.)"
          ],
          [
           "Outlier (-1)",
           "What metabolics improve insulin resistance?. What metabolic supplement or drugs improve insulin resistance and diabetes symtoms?"
          ],
          [
           "Outlier (-1)",
           "Introduction and Input Needed. Hello All,  \n\n\nI've recently read (well, listened to first on Audible, and now re-reading hardcover,) Outlive, and it spurred me to get some testing done.  I'd love some input on my numbers, current direction of addressing things, etc.  \n\n\nHere goes:  \n\n\n47-ish year old white male, no family history of ascvd-related deaths, family history of diabetes, personal history of anxiety struggles that are being narrowed down to either ADHD or OCD diagnoses (pending.). Very sedentary lifestyle the past 3 years, and a history pre-covid of swinging between very active (5-7 day a week gym rat and 100% \"no bad food\" eating,) and so-so physical activity with even more so-so nutrition. I've been on-again off-again with a wfpb diet since 2017, which has been the most sustainable of any eating pattern that I've experimented with. (Very off-again until the past 2-3 weeks, which have switched back to on again, very clean eating.)  \n\n\nHere were my labs as of this week:  \n\n\n* Total Cholesterol -128\n* Triglycerides -109\n* HDL - 35\n* VLDL 20  \nLDL 73\n* APO B - 66\n* Lp(a) - 8.8\n* Vitamin D 30.0\n* TSH (thyroid) - 1.22\n* Hemo A1C - 5.5\n\nAll other blood markers were good, with no concerns from my pcp, who listens to Attia's podcast, is younger, active, and stays up to date on the latest studies, etc.  \n\n\nObviously, based upon Attia's info, my APO-B is a bit high. The plan for now is to continue my current nutritional trends and start adding in exercise on a daily basis, with my plan being easing into cardio and weights again (prior Crossfit gym rat, but no desire to go back down that road now,) and up the intensity and duration as conditioning comes back.\n\n&amp;#x200B;\n\nI'd love some input on these numbers, and the overall plan how to address improving them!  \n\n\nThanks peeps!"
          ],
          [
           "Outlier (-1)",
           "The average cost doctors visit outside USA...."
          ],
          [
           "Outlier (-1)",
           "Gary Brecka is ruining my relationship. Hey, I‚Äôm not too sure if this is the right subreddit for this‚Ä¶ but I‚Äôm kind of tired of hearing my boyfriend follow this Gary brecka guy on these claims that have been debunked many times by actual doctors and scientists and real life statistics.\n\nHe‚Äôs adhering to a mostly carnivore diet, and abides by pretty much everything this guy says and it‚Äôs highly concerning.\nI come from an East Asian background and I‚Äôm sure as many of you know, we have the highest life spans worldwide due to our healthy diets. My family and I are very healthy eaters and enjoy all sorts of meat, with moderation of course. We also are very big on getting our veggies in. I take advice from my grandparents (and great grand parents who are still around!), certified nutritionists, and people who have literally made it to age 90. \n\nMy paternal uncle got colorectal cancer in his early 30s because dads side of the family ate red meat and processed foods excessively. He‚Äôs fine now, but is strictly avoids red meat due to its carcinogenic properties, and never got cancer again. \n\nMy point is, my healthy choices are based off of real life things I‚Äôve seen with my own eyes (real statistics, real stories from real healthy old people). Not from a middle aged chiropractor who‚Äôs now giving medical advice about diet? \n\nI try to be open minded and search for the pros and cons of red meat‚Ä¶ and the cons (cancer from haem, heart disease, high blood pressure) seem to substantially outweigh the pros (vitamin b12) by a lot on every medical resource I can find. My bf also told me to avoid folate. But in my research folate deficiency in pregnant women leads to birth defects. I think that‚Äôs an insane amount of risk on the table just because ‚ÄúGary Brecka says so.‚Äù \n\nIs there absolutely any merit behind what this person says? Is he even a medical professional? Is my boyfriend‚Äôs strict adherence to everything this man says physically harming us both? I just am super worried, we had a cancer scare in my family because of excessive red meat. And I‚Äôm super tired of arguing and vouching for my lived experiences and reality over the loose logic of some podcast guy that told Dana white he might die if he doesn‚Äôt listen to him (very convincing selling point). Please prove me wrong if you can."
          ],
          [
           "Outlier (-1)",
           "Blood sugar. How do you bio hack something that works but  lowers your blood sugar too much? Do you just eat or drink something sugary? I love how fenugreek works but lowers my blood sugar too much after a week or so."
          ],
          [
           "Outlier (-1)",
           "IF, exercise and high Cortisol levels. 33/m. I have been doing IF for close to a year now. Started last June by following a 16-8 daily. \n\nI've had great results and managed to lose close to 14kg from June to October with some exercise (little to moderate, no gym).\n\nHad an Inguinal hernia operation mid Dec, during the process of which I noticed in the lab results I had an elevated level of blood glucose - 6,45 mmol/L (116 mg/dl).\n\nI didn't make much of it at the time and decided to have a second round of blood works about a month post surgery.\nThis time I had around  6.14 mmol/L (116 mg/dl), so elevated again..\nI also had high levels of Cortisol - 586.3 nmol/L (536 upper ref value) as well as Fasting Insulin of 12,81.\nI followed this up with a HbA1—Å which came back at 5.48.\n\nThose results were quite surprising to me, given the fact that I was very strict with my IF schedule, had very low if any carbs at all and could not really account the high Cortisol levels to any IRL/work stress.\n\nI decided to introduce some changes which included working out 6 days a week, Mon and Fri I did both HIIT/Calisthenics and resistance training, the other 4 days were either res training or hiit. Always did the first workout in the fasted state and if I had a second one for the day I did it after a meal.\nIn addition I extended my IF window to 18-6 and introduced 2 OMAD days per week (but this was only in the last month or so).\nI also reduced carbs to  no more than 20-30grams per day. Most of the days going full no carbs (excepts greens/salads).\nI am taking daily multivitamins, omega 3 and 4000IU D3 to make sure I am not defficient in any micronutrients.\n\nAfter two months on this regimen I decided to have another go and see how this affected my blood results:\nFasting glucose - 6.43 mmol/L (116 mg/dl)\nFasting Insulin - 9.39\nHbA1—Å - 4.98\nCortisol - 666.4 nmol/L\nAlso had a slightly elevated LDL (wasn't the case last time) and Creatinine.\n\nI am thinking of cutting down on workouts and making sure they are not done in a fasted state. Also thinking of going back to 16/8 daily and possibly reintroducing some non-complex carbs in my diet (still a moderate to low ammount).\n\nI have stalled on weight loss for the last 3-4 months but overall am very happy with my body composition and am afraid that if changing my regimen I could rather quickly lose all the progress that has been made.\nHowever I am also slightly concerned with the levels of Fasting Glucose and especially Cortisol levels, which refuse to go down (Cortisol even went up). The only positive from all the changes I have made seems to be that fasting Insulin has been brought down around 25%.\n\nCurious as to what you would change/what I am doing wrong, in order to get into normal Cortisol, glucose levels.\n\nP.S BMI - 23.7, BF - 21.1%, Weight - 74kg, 176cm tall."
          ],
          [
           "Outlier (-1)",
           "What exactly is good rest/recovery?. Let's say I hit heavy eccentrics to failure, and now I need to recover to max force output within 72 hours to hit the muscle again. I sauna at 00:05 post exercise, eat at 00:30, walk 00:45-01:15, sit down stare at wall basically do nothing 01:15-06:00 (zero psychological stress), then sleep for 9 hours. Is this perfect recovery for day 0? Doing this I usually feel DOMS within 4 hours post exercise instead of 24-48 hours later. What is the best way to guarantee my muscle will have repaired to max vol force 72:00 post exercise? Do absolutely nothing except eat, meditate, and sleep? Should I eat while in the sauna or will this blunt the GH response to heat stress by raising blood glucose/ffas? Z2 cardio the next day? Naps? Passive stretching? Social isolation to avoid stress/catabolic situations? Walking vs sedentary rest? Hot water bottle on muscle? There's so much info on best ways to exercise a muscle but I can't find much on best recovery to regain max force output from 00:00 to 72:00. Another question would be: what should you NOT do?"
          ],
          [
           "Outlier (-1)",
           "Chinese Medicine Biohackers. Has anyone come across anyone talking about Chinese medicine for anti aging or longevity? Podcasts? Any practitioners out there?"
          ],
          [
           "Outlier (-1)",
           "hard vs soft plaque..Understand hard/calcified plaque is a slow process, ie decades. doesn‚Äôt seem to be clear how fast of a process soft plaque is to develop (is this also several years?)."
          ],
          [
           "Outlier (-1)",
           "Attia on autophagy. What, per Attia, brings one into autophagy?  I heard him recently in a podcast state that IF doesn‚Äôt get in there.  But it‚Äôs the whole reason many do it.  So I wonder‚Ä¶."
          ],
          [
           "Outlier (-1)",
           "Summary of what I learnt after 100+ hrs ( hundreds of reddit posts, podcasts, YT videos, 10+ books). After going all those above I came to few conclusions.\n20% of efforts give 80% of the result.\nI split the plan into 3 levels.\nLevel 1 can be done by anyone free of cost.\nLevel 2 be some supplements.\nLevel 3 is advanced.\n\nLevel 1\n\nMorning Routine:  - \nExercise: Walking, running, basic stretching.  -\n \nDiet: Less sugar, colorful vegetables, meat, fish.  - \n\nSleep: Quality sleep, stress management.  \n\n\n**Level 2:**  - \n\nExercise and Activities:  - Various physical training: Aerobic, anaerobic, resistance.  - Yoga, meditation.  - Hot/cold water baths, air purifier, smart band.  - Enjoy music with good headphones.  - \n\nFood and Nutrition:  - Add turmeric, lemon, dark chocolate, olive oil, amla.  - Avoid non-stick, excess sugar; use vinegar before heavy meals, coconut oil.  - \n\nSupplements: Protein, creatine, collagen, multivitamins, omega-3, zinc, magnesium.  - \n\nSkincare Routine:  - Use tretinoin, niacinamide, AHA/BHA, exfoliators, moisturizers, sunscreen, gua sha weekly.  \n\nLevel 3:**  \n\n\n- Advanced Health Practices:  - Supplements: NMN, resveratrol, metformin (for older), D3/K2, coQ10, quercetin, fisetin, berberine, DHEA, rapamycin, ashwagandha, gotu kola, amla.  - Ayurvedic practices: Panchakarma.  - Advanced technologies: Amazon‚Äôs Decode Age tabs.  - Disciplined diet, advanced yogic practices like kechari mudra.  \n\n\n\nI have analysed the many people who are still young in the old age.\nIt's only bcz of exercise.\nIf you do exercise you eat well.\nIf you eat well you sleep well.\nTo do exercise you need energy.\nTo need energy you need food.\nSo in order to kickstart take protein powder.\n\nThat's the basic thing to live longer.\nIf you want to get an extra benefit use level 2 and level 3.\n\nBut remember health span is more important than life span.\n\nAnd also try to spread the energy and knowledge of these things to your surroundings bcz what will you do when you live 100years and no one there around you after 60 years.\n\nTldr: exercise eat sleep , stress free and put some efforts"
          ],
          [
           "Outlier (-1)",
           "Vagus Nerve Device. fellow biohackers, I want to formally annouce a new device to get the calm and peace we often want massage guns, saunas, and other devices or therapies to do, the ZenBud. It is a gentle ultrasonic vagus nerve stimulator that a team of biomedical engineers have designed to be effective, but NOT PAINFUL and to get people to experience a sense of calm, peace, relaxation and be in the flow.   \n\n\nThere's an incredible research page on [zenbud.health](https://zenbud.health) that outlines the research that informs ultrasonic technology but I won't make health claims, only that it has tons of value to calm your system. Here's a link to check out a device:   \n[https://zenbudshop.com/products/zenbud-vagus-nerve-stimulator-pilot-program](https://zenbudshop.com/products/zenbud-vagus-nerve-stimulator-pilot-program)"
          ],
          [
           "Outlier (-1)",
           "72 Hour Water Fast‚Ä¶ Need Help Plz! :). Hi everyone! I recently came off of my first ‚Äúbulk‚Äù in the gym, didn‚Äôt do it properly and ate like crap. I am now on a cut and have been eating as clean as possible over the last few days/1 week(ish). I am interested in doing a 72-hour water fast. Friday-Sunday to be exact. And to be honest, I just want to reset my body, reduce inflammation and lose some water weight because I have a huge photoshoot/my graduation coming up. \n\nI am looking for some more information on how I can go about this. Do I only drink water? Do I drink water, tea? Can I also drink bone broth? \n\nHow do prep for the fast? Do I eat a carb/protein heavy dinner tonight?\n\nAs for breaking the fast, what does a typical meal look like? \n\nJust looking for some advice! Thanks in advance."
          ],
          [
           "Outlier (-1)",
           "Blood work back - help analysing ?. Hi all\nI‚Äôve just had a medichecks male hormone test back that says all within normal ranges (10 markers)\n\nI‚Äôve heard these sorta high street tests have low ranges as baseline anyway , and beside I am having problems actually figuring out what it all means \n\nIs there any kind of guide or can someone here tell me if I am actually low by desirable standards rather than their low benchmarks ?\n\nOddly enough I got the test done after a bout of half a year heavy drinking / alcoholism so I‚Äôm absolutely amazed it came back as okay"
          ],
          [
           "Outlier (-1)",
           "Anyone here have experience with out-of-range LOW fasting insulin?. I‚Äôve been testing various values every few months after a low but positive CAC score last year, trying sort out possible weak spots outside of the obvious like ApoB. I‚Äôve done two fasting insulin tests 3 months apart (March and June) and have gotten values of 1.7 and 1.4, respectively. (Lower bound of reference interval is 2.6‚Ä¶) I can‚Äôt find much solid info online, most info is (understandably‚Ä¶) about high insulin/insulin resistance and low insulin is considered a positive‚Ä¶ but THIS low? I can‚Äôt get an appointment to discuss with PCP for almost 2 months, so just curious if anyone here has experienced this. BTW no other lab values are out of range."
          ],
          [
           "Outlier (-1)",
           "Please recommend a treadmill and desk combo for backwards walking."
          ],
          [
           "Outlier (-1)",
           "Aerobic exercise with ankle injury. I rolled my ankle and am trying to stay off of it.  What types of exercises could I do to get my heart rate up without using my right foot?  TIA."
          ],
          [
           "Outlier (-1)",
           "Worrisome Blood Work Pt. 2 W/More info; 21M 5'8 155lbs; Following up w/ Doc in a week.."
          ],
          [
           "Outlier (-1)",
           "Bryan Johnson Edited his DNA with Genetic Engineering (To Live Forever). Bryan Johnson Edited his DNA with Genetic Engineering (To Live Forever)"
          ],
          [
           "Outlier (-1)",
           "How do I effectively wane myself off of sugar?. I have a fast metabolism (23F, 65kg, 5‚Äô7) I am active but could definitely exercise more. My diet is okay but I have sporadic binges on sugary snacks. Even though I look physically fit I know this will catch up with me if I don‚Äôt change my ways. \n\nPlease give me some simple yet effective tips to help my sugar addiction. Healthy alternative snacks/foods, tips to keep in mind x\n\nThank you :)"
          ],
          [
           "Outlier (-1)",
           "Effect of Low-Dose Mulberry Fruit Extract on Postprandial Glucose and Insulin Responses."
          ],
          [
           "Outlier (-1)",
           "Peter Attia and OrangeTheory: Longevity for middle aged and older."
          ],
          [
           "Outlier (-1)",
           "Online 30-year ASCVD risk calculator. Does anyone have a link? Thanks"
          ],
          [
           "Outlier (-1)",
           "Is this longetivity study flawed? Possibly 10% lifespan increase from chromium picolinate in long evans rats. https://pubmed.ncbi.nlm.nih.gov/783n8011/\n\nIt says in the full text it increased median lifespan by 25% and maximal lifespan by 26%. \n\nHowever food intake was not measured and the long evan‚Äôs rats weighed 40g less in the chromium picolinate group so it could just be calorie restriction.\n\nHowever that difference in weight was by no means comparable to the weight differences seen in calorie restriction studies.\n\nI calculated perhaps a 10% lifespan increase once the weight difference are factored in but i‚Äôm not sure.\n\nAnyone care to discuss."
          ],
          [
           "Outlier (-1)",
           "Following Protocol To Stave Off Liver Cancer Recurrence. Any Input Would Be Greatly Appreciated.. Hello Everyone,\n\nLong story short I was diagnosed with hepatocellular carcinoma in January last year. Had a TRISECTIONECTOMY to remove a 17x18cm tumor on May 17, 2023. My remaining bile duct was blocked by the growth of the remnant liver so I had revision open bile duct surgery October 12.\n\nI am not living in candy land. I know what the recurrence rate is. I am doing everything I can and trying to control every variable. I am eating low carb, low sugar, low fat, high protein. Gluconeogenesis. I am eating pretty much nothing but salads / low carb wraps with whey protein shakes for the immunoglobulins. Tons of cardio. Sucralose is admittedly crutch and I use probiotics to try to attenuate some of the gut flora issues.\n\nBelow is my protocol. Does anyone have any constructive feedback for me? Are there interactions with any of these? Net load potential issue? Are there any binding affinity issues? Anything helps.\n\nhttps://preview.redd.it/moe1hq5d8z9d1.png?width=582&amp;format=png&amp;auto=webp&amp;s=12e4ab4659205624c3454a757c585a973d18a39a"
          ],
          [
           "Outlier (-1)",
           "Join Amal Graafstra CEO of Dangerous Things @ r/AMA today starting at 10am PST."
          ],
          [
           "Outlier (-1)",
           "Premium members - please upvote AMA questions. I'd like to encourage premium members here to spend a little time and upvote questions you find interesting in the AMA question list here:    \nhttps://peterattiamd.com/ask-me-anything/?ama_page=1&amp;type=unresponded&amp;query=\n\nThis is directly to our benefit..."
          ],
          [
           "Outlier (-1)",
           "Looking for a PCP, prefer on-line/concierge, that follows Peter advice.. Located in Dallas btw, but I really want to find a good lifelong PCP that knows what they are talking about and falls in line with the Peter MDs of the world. Any suggestions?"
          ],
          [
           "Outlier (-1)",
           "Healing with frequency devices - best devices? And where to find best frequencies?. Hi guys, does anyone know which frequency devices are the best when it comes to actually being effective and working to heal either the overall body or specific conditions? I‚Äôve heard of Healy devices, which I‚Äôm not too sure about. There doesn‚Äôt seem to be a whole lot of information on the website for how it actually works. A lot of people also talk about the spooky2, which sounds more legit to me. And where you need to choose specific frequencies to play from it. \n\nWhich leads me to my next question: what are some more ‚Äúevidence based‚Äù databases (or even studies) for the frequencies that help to heal specific body parts, or specific conditions? Are there any books on this? Any researchers in the past, other than Rife, who have done research on figuring out what frequencies healthy organs resonate at, and using that to treat and heal peoples‚Äô afflicted organs? \n\nThanks so much for any info anyone can provide!"
          ],
          [
           "Outlier (-1)",
           "Anyone fasting from food AND water?. Just came across this idea after hearing that water restricted lab rats lived even longer than calorie restricted rats\n\nKeen to hear stories/insights from anyone that‚Äôs doing it or has tried it \n\nI just bought The Phoenix Protocol by August Dunning and will be experimenting"
          ],
          [
           "Outlier (-1)",
           "Can you tell me about my neuroprofiling?. I'm Japanese, but the concept of MTHFR is not widespread in Japan, so I was curious.\n\nI'm still in my 20s, but I have mysterious chronic fatigue and have a unique reaction to supplements and medicines. If I take some tests for MTHFR, will I get some hints about my body's reaction? (I looked it up and it seems there are various tests such as MTHFR, but is there a test that beginners should take first?)\n\nWhen I show my reaction to my medicine and supplements,\n\n„Äá For some reason, my fatigue gets much worse\n\nVitamin C\n\n„Äá I become manic or hyperexcited\n\nVitamin B, zinc\n\n„Äá I become manic or my hyperactivity gets worse\n\nAll drugs that increase dopamine (methylphenidate greatly worsens my ADHD)\n\n„Äá I have drug sensitivity and can't continue even at the minimum dose (drugs that cause insomnia or a heavy burden on the heart and can't be continued)\n\nAll tricyclic antidepressants (but I don't get fatigue or ADHD completely disappears. Is it because it increases noradrenaline? If it didn't have any side effects on my heart, it would be the best drug for me.)\n\nMilnacipran, Strattera, Methylphenidate, Pregabalin (my eyesight has deteriorated significantly), Abilify\n\n„ÄáADHD and fatigue problems are greatly improved\n\nAll drugs that increase noradrenaline (tricyclic antidepressants, Milnacipran, etc. However, Atomoxetine only has side effects for some reason)\n\nCymbalta (This is said to be a powerful drug, but I have no side effects at all. It's really strange. And yet fatigue and ADHD are greatly improved by taking this drug)\n\nLDN (Low Dose Naltrexone) It works at first, but the effect wears off after about 5 days\n\nlamotrigine It works at first (improves fatigue and ADHD), but the effect wears off after about 5 days\n\n„Éº„Éº„Éº„Éº„Éº„Éº„Éº„Éº„Éº„Éº„Éº„Éº„Éº„Éº„Éº„Éº„Éº„Éº„Éº„Éº„Éº„Éº„Éº„Éº„Éº„Éº„Éº„Éº„Éº„Éº„Éº„Éº„Éº„Éº„Éº„Éº„Éº\n\nI have this reaction to medicines and supplements\n\nWhat do you think is my constitution and what medicine would work? I've been diagnosed with ADHD, but Cymbalta works better than dopamine-increasing medicines, so it's a mystery to me."
          ],
          [
           "Outlier (-1)",
           "Books on strategies and tools for managing stress response?. Interested in any recommended books or other references on tools and techniques for managing stress responses.  I've done some learning on mindfulness for long-term stress management. I am now particularly intested in resources to learn about managing stress responses in the moment, similar to some of the techniques they briefly go over in the first episode of \"Limitless\", as some of you may have seen."
          ],
          [
           "Outlier (-1)",
           "Brad Schoenfeld, PhD: \"Certainly, to take every set to failure... not only does it not show any benefit for hypertrophy, it actually showed a small detriment for strength. So, with strength, stopping a couple reps short of failure seems to have better effects on maximizing strength.\"."
          ],
          [
           "Outlier (-1)",
           "Any doctors that follow Peter Attia protocols which practice online?. I'm living in a remote part of Europe with very poor healthcare. I'm a big long-term fan of Peter and I've spent months trying to find a doctor who focuses on preventative medicine but they only focus on quick diagnosis. Not a single one has even heard of Dr Attia. I'm fortunate to be in a position to be able and willing to pay almost anything but in my research I can't find any doctors who are available to consult solely online. \n\nI'm guessing there may be an issue with medical licenses and practices outside of their jurisdiction. Obviously I wouldn't be expecting the doctor to deal with acute issues, just someone who can consume my full medical history and give advice on bloods tests, diet, supplements and monitor me regularly going forward. Does such a doctor exist?"
          ],
          [
           "Outlier (-1)",
           "APOB - genetic test?. Hi team, I picked up from one of the podcasts that there is a proportion of the population predisposed to high APOB. Is there a way to determine this from genetic test, or it‚Äôs more a function of having elevated levels?\n\nI was hacking through my old 23&amp;me reports, but couldn‚Äôt find the right thing to look for‚Ä¶\n\nThanks!"
          ],
          [
           "Outlier (-1)",
           "Is there anything typical blood tests miss out that could have significant effects?. For example, a typical high-end blood test:\n\nhttps://www.medichecks.com/products/ultimate-performance-blood-test\n\nAll my markers show OK and yet my athletic performance is in the toilet, can‚Äôt bench 100kg despite training for 11 years now and can‚Äôt run faster than 16 minute miles without exceeding Zone 2 even though I‚Äôve been running for about 5 years. I‚Äôm already on 250mg of Test for years as roiding seemed like the obvious answer but it barely made a difference. \n\nI feel like something is deeply and fundamentally wrong with my body despite that I am doing everything observable right. I see zero improvement in any of my cardio or strength training stats regardless of how I train or adjust my diet."
          ],
          [
           "Outlier (-1)",
           "Kybernetik. How to improve his own body functions with technology?"
          ],
          [
           "Outlier (-1)",
           "Best Exercises for Overall Health &amp; Longevity | Dr. Peter Attia &amp; Dr. Andrew Huberman."
          ],
          [
           "Outlier (-1)",
           "Is subscribing worth it?. those of you who have fully subscribed to The Drive, are you happy with the investment? \n\n(Is it worth the money?)"
          ],
          [
           "Outlier (-1)",
           "Athletic Greens (AG1) worth it?. I'm curious what this group's experiences and thoughts around AG1 are. Unlike every other podcast The Drive is not sponsored by it and I found it interesting that the member's section doesn't include a AG1 discount. (If PA was a big believer in it you would think he would be able to get a member only discount code.) He also never seems to mention it in recent podcasts about nutrition or supplements.\n\nFrom reviews online it seems like AG1 may be overpriced and there are better alternatives if you want a green powder. I like the idea of using one in case I don't get enough vegetables, etc. on a given day but it is certainly not free. \n\nAny thoughts or experiences on AG1 and alternative supplements? I'm particularly interested in hearing if taking it helped improve blood test results or other bio markers."
          ],
          [
           "Outlier (-1)",
           "Is Standing Better than Sitting for Longevity?. Most people have sedentary jobs so I wonder, if we can choose between standing all day or sitting all day, what is better for longevity? Intuitively I would think standing is healthier, but I've read comments in other subreddits that claim standing all day has its own downsides (for hips and lower back, varicose veins, bloodclots and less bloodflow from the legs back up to the heart and brain). What do you think?"
          ],
          [
           "Outlier (-1)",
           "Article about metabolism and physics and mental capacity üôÉ."
          ],
          [
           "Outlier (-1)",
           "Need help reading ER Labs. Male. 26.\nNeed help reading these results. Went to the ER because I was feeling pretty unwell, got sent home. I went to er last week because I was having pain during urination but tests came back normal. \nI'm alarmed by my Low neutrophils &amp; high lymphocytes numbers on my recent lab from this morning because they were normal 10 days ago.  First picture is results from 10 days ago. The other 2 are from this morning"
          ],
          [
           "Outlier (-1)",
           "Anyone use a tens machine while running?. Hi, I have a tens machine that I hardly use (just a cheap one from amazon)\n\nI saw a celebrity using a similar more expensive machine while lifting weights and it gave me the idea to use my tens machine  on my thighs and calfs while running! I did it on my thighs today and i definitely feel more sore than usual.\n\nIs this a good idea? Does anyone else do this and do you have any tips, tricks, or recommendations?"
          ],
          [
           "Outlier (-1)",
           "#215 - The gut-brain connection | Michael Gershon, M.D. - Peter Attia."
          ],
          [
           "Outlier (-1)",
           "Does anyone know of a real deal EMF cell phone case and laptop case that‚Äôs no insanely expensive?."
          ],
          [
           "Outlier (-1)",
           "New to Longevity &amp; Looking for Advice. (32/m 5'7 160lbs) \n\nI've listened to Rhonda Patrick, Peter Attia, and some of David Sinclair in the past but am now actively getting into longevity research and trying to implement the best practices I can find for myself. \n\nNot much heart disease/Alzheimer's in my mom or dad's side, so I'm not overly concerned with those. My mom's parents live/lived into their mid 90's, my dad's side mid 70's (were big smokers). The area I'm concerned with is diabetes and cancer, as both my parents have type II and my dad died of renal cell carcinoma at 52. Figured preventing diabetes would be the logical place to start, since that can lead to cancer. \n\nDid 23&amp;Me years ago. Ordered a lot of my own blood tests the past few years and mostly everything came back great, including fasting glucose. Lipid panel, CBC, CMP, CRP, SED, Thyroid, and a few others but I would like to add some tests I learned about through PA videos. I take quite a few supplements (NOW Magnesium bisglycinate, Bronson D3/K2 MK7, Life Extension Multi Two A Day (just take one), Life Extension Super Bio Curcumin, and NOW hyaluronic acid). Also wore a Freestyle Libre 2 for awhile and everything was within range for a healthy adult. \n\nDefinitely have 10-15lbs to lose though. I'm no stranger to weights/cardio but my willpower has stopped me many times in the past. I'll usually hit the gym hard for a month or two, then stop, only to start back up again later on. Just came across PA Z2/Z5 plan which sounds great and would definitely like to add into my 4-5 days of lifting I already do. \n\nJust wanted to give a brief overview. I'd greatly appreciate any recommendations on supplements, meds, diet hacks, online experts, workout regimens for overall health and especially longevity, fully aware that it's not medical advice. Thanks!"
          ],
          [
           "Outlier (-1)",
           "Your *one* most life changing intervention ?. What is the best intervention you‚Äôve introduced into your life that you cannot live without?\n\nCould be a supplement, nootropic, a medical device. Anything"
          ],
          [
           "Outlier (-1)",
           "Can anyone recommend an MD in San Diego that is accessible?."
          ],
          [
           "Outlier (-1)",
           "Probably an uncommon question but anything out there for losing muscle?."
          ],
          [
           "Outlier (-1)",
           "Food order and glucose spikes. There is a lady on YouTube claiming that the order you eat the components of your meal will affect the glucose spike. Goes anyone have A CGM and can confirm this?"
          ],
          [
           "Outlier (-1)",
           "A Fundamental Truth of Life That This Sub Overlooks is that Subtraction &gt; Addition. So many of things discussed on here are adding things to your life - new habits, protocols, supplements - but these things often have, at most, marginal benefits and, in some cases, can be damaging. \n\nThe real gains come from stripping back your life and just leaving the bare essentials. So many people now overtrain, for example, and have unbelievably elaborate exercise routines which can be draining in the long run and harmful to the nervous system. The same with excessive protein consumption and overeating when weight training.\n\nWhy do you think it is that so many biohackers don‚Äôt look great? You‚Äôve got to trust your eyes sometimes and Bryan Johnson doesn‚Äôt look much than Hunter Biden. Ben Greenfield and Asprey also don‚Äôt look amazing which is a surprise given the extreme biohacking they do. I think there‚Äôs a lot to be said for taking your foot off the gas with the self-optimisation and looking at stripping back your life as much as possible. That‚Äôs what I‚Äôve done recently and I‚Äôm feeling great.\n\nMy life has improved most from subtractive things like fasting, cutting out alcohol, reducing the length of my gym sessions, less screen time, and especially reducing the amounts of habits and things I have to do from a health and fitness point of view each day. \n\nInterested to hear some other perspectives. Thanks."
          ],
          [
           "Outlier (-1)",
           "How do I accelerate metabolic rate when spending months in a deep caloric deficit?. How do I maintain and boost my metabolic rate while on an intense diet/exercise plan long term?\n\nMy method isn‚Äôt for everyone, I‚Äôm 31, headstrong, and I like taking risks and pushing myself to my limits.\n\nI‚Äôm currently very overweight. I was obese up until last month.\n\nI‚Äôm 6‚Äô1‚Äù and I weigh 218 pounds. I‚Äôm down from 242 in March.\n\nGoal is 10 pounds a month. \n\nCurrently I‚Äôm intermittent fasting between 18 and 20 hours a day. \n\nI take lisdexamphetamine for ADD which makes this fasting painless and also increases metabolic rate. \n\nI‚Äôm eating a ketogenic diet.\n\nMy TDEE is 2200 calories without exercise.\n\nMy caloric intake is between 1200 and 2200 calories a day.\n\nmy net calorie goal is 900 cal a day. (3 lb per week deficit)\n\nI‚Äôm training myself as an amateur boxer with shadow boxing and heavy bag workouts for exercise.\n\nI want to ensure my metabolism is being given everything it needs to keep the engine running or accelerating."
          ],
          [
           "Outlier (-1)",
           "Weight loss plateau. So about 1.5-2 years ago I started putting on a ton of weight out of nowhere. I feel it was a combination of entering my thirties, becoming less active and eating out more. I put on 30 lbs over the course of 6 months and was at the biggest I had ever been in my life at 160lbs at 5‚Äô2‚Äù. I went to the doctor to get blood work done since it felt so sudden but there were no concerns.  I hold most of my weight in my lower body so it took me some time to notice a change.\n\nA year and a bit ago I realized that I was on a bad path and decided to get a trainer.  Unfortunately it was a bit of a waste of time. I‚Äôm happy that I did not gain anymore weight but I also didn‚Äôt lose any. \n\nIn January of this year I decided to get a different trainer. She‚Äôs very focused on accountability which helps a lot. I eat 1200-1300 calories a day and 130g of that is protein. \n\n It took me 3 months to lose 10lbs and was very happy that something finally worked. I didn‚Äôt mind the slow progress because I have a low metabolism. My BMR is sub 1200 calories a day. (I got VO2 metabolic testing done to find this out.) \n\nNow I‚Äôm at a plateau again. My weight has been dancing around 150lbs for the past 3 months despite my efforts:\n\nMy routine is:\n- 2 strength training sessions a week\n- 2 HIIT sessions a week\n- 10000 steps a day\n- intake 1300 calories a day. I‚Äôm not always on point with my diet but I‚Äôd say I‚Äôm hitting my goal 75% of the time. \n- 130g of protein a day\n- I am lacto-vegetarian \n\nI‚Äôd appreciate any advice you have on how to combat this plateau. Is there anything you notice that I could be improving on?"
          ],
          [
           "Outlier (-1)",
           "Does ketosis help autism spectrum disorder?. I can‚Äôt seem to find a clear cut answer to this. I have Asperger‚Äôs (high functioning autism) and keto *seems* to help me until it ruins my sleep and then I regress. \n\nI‚Äôm debating on trying a gluten free/Caesin free diet instead. What would you guys do if you had autism?\n\nI‚Äôm taking methylated vitamins, d3/k2, and magnesium as well. \n\nThanks"
          ],
          [
           "Outlier (-1)",
           "For those who see naturopaths, could you evaluate the benefits you‚Äôve reaped from that experience?. Just curious to hear what you have to say. I‚Äôm broke and have no actual interest in seeing one right now, but if it‚Äôs worth it it‚Äôs worth it."
          ],
          [
           "Outlier (-1)",
           "Hiatal hernia from resistance training. Peter always recommends weight lifting to increase longevity. But wouldn't weight lifting also increase your risk of developing a hiatal hernia, and thus negatively affecting your \"health span\"? Even if you first develop a hiatal hernia and don't have symptoms, wouldn't it probably worsen with further weight lifting and lead to respiratory morbidity, and negatively affect the vagus nerve?"
          ],
          [
           "Outlier (-1)",
           "Lose 5 to 7 Kg in One Week with My Sugar-Free Meal Plan! üåü. Hello everyone!\n\nI've created a comprehensive 7-day sugar-free meal plan designed to help you lose 5 to 7 kg in just one week. It's packed with delicious, balanced meals that are easy to prepare and perfect for anyone looking to jumpstart their weight loss journey.\n\nHere's what you can expect:\n\n* **Balanced and Delicious Meals**: Enjoy a variety of nutritious and tasty meals for breakfast, lunch, and dinner each day.\n* **Easy-to-Follow Recipes**: Simple recipes with accessible ingredients.\n* **Health and Wellness Tips**: Stay hydrated, choose healthy snacks, and avoid sugary drinks and processed foods.\n\nCheck it out here: [Lose 5 to 7 Kg in One Week: A Sugar-Free Meal Plan](https://anasswonderful.sellfy.store/p/lose-5-to-7-kg-in-one-week-a-sugar-free-meal-plan/)\n\nFeel free to ask me any questions or share your own weight loss tips! Let's support each other on our journey to better health."
          ],
          [
           "Outlier (-1)",
           "Colonoscopy Frequency. I listened to Attia's recent interview on the Huberman Lab podcast where he mentions that he has already gone through 3 colonoscopies.\n\nHe also comments about it on his blog, stating:\n\n ‚ÄúI can‚Äôt tell you yet what the ideal frequency, but it‚Äôs much more frequently than what‚Äôs being done today‚Äù It‚Äôs not every 5 to 10 years, it‚Äôs probably every one to three years\"\n\nhttps://peterattiamd.com/peter-on-the-importance-of-regular-colonoscopies/\n\nI am find myself questioning Attia,\nas he is seems to be covering so many specialized areas of medicine,\nand offering recommendations that seem to go against the prevailing general guidelines for colon cancer screenings with a colonoscopy of every 10 years. There is even recent research indicating more time between the screenings for low risk individuals.\n\nhttps://www.cancer.org/latest-news/american-cancer-society-updates-colorectal-cancer-screening-guideline.html\n\nhttps://www.gastroendonews.com/Endoscopy-Suite/Article/03-23/In-Low-Risk-Patients-Colonoscopy-Interval-May-Go-Beyond-10-Years/69651\n\nOverall, my trust on Attia's opinions, views and recommendations were strengthened, when during the Huberman podcast, he discusses the last chapter of his book on emotional health, as he reveals his own mental health crisis on two occasions, seeking inpatient treatment.\n\nAny thoughts on how to go about managing one's health as we confront so many different and at times opposing views from trusted and reputable sources, and even our own personal doctors?\n\n\n\n\n\n\n\n."
          ],
          [
           "Outlier (-1)",
           "About to do my first rucking workout. Good to see these books finally put to use.."
          ],
          [
           "Outlier (-1)",
           "Vagus nerve. Any vagus nerve techniques you have found made a difference?"
          ],
          [
           "Outlier (-1)",
           "Little things that have made a huge difference in your quality of life.."
          ],
          [
           "Outlier (-1)",
           "Kicking the Sugar Habit. I keep trying to go cold turkey from sugar, processed foods, starch and flour, even gluten free flour and dairy. But Everyday the cravings are so insane it seems impossible to conquer. 3 days ago was supposed to be the start of my clean eating journey but here I am, having eaten a bunch of chocolate and several slices of cheese for the last 3 days. Does anyone know any tricks for kicking cravings? And what to do after a sugar binge."
          ],
          [
           "Outlier (-1)",
           "Glucose Monitoring. If you are a healthy non-diabetic who monitors blood glucose, I would appreciate hearing your experience. Thanks."
          ],
          [
           "Outlier (-1)",
           "Is the podcast membership worth it?. I can get a student discount, but that's for a whole year so it's still not exactly cheap. Do people who subscribe find it sufficiently useful?"
          ],
          [
           "Outlier (-1)",
           "What shoes are you wearing?. I have barefoot shoes, but usually just train in them, because they can be hard to wear all day. What are some good middle ground shoes with support but not too much?"
          ],
          [
           "Outlier (-1)",
           "Blood Tests. Hey guys, I never got blood tests before (27M) but I am thinking of getting ones tomorrow. Are these good to get? I am thinking of starting Finasteride for hair loss so want to get a baseline before starting. Is there any here that you would not recommend or any that you would add? Even just for general health and bio hacking to help me feel better and get healthier? Any help is appreciated thanks!"
          ],
          [
           "Outlier (-1)",
           "Death bars posted anywhere?. Attis talks a lot about the death bars as a side note on other topics, and said they have some kind of charts visualizing probability of death from actuary tables. Is that on the website or has he released anything useful?  I don‚Äôt see a clear overview on the website or podcasts."
          ],
          [
           "Outlier (-1)",
           "Finding Primary Care Docs in Your Area with as much expertise as Dr. Attia. Hello! I hope this is an okay post for this sub--I am new to it.\n\nI am very interested in trying to find my own primary care doc that is like what Dr. Attia does with his patients. Right now my primary care doc is nice and everything, but she is also pretty textbook and I feel like doesn't get that deep with things. I have slightly high LDL calculation (116), but also have low triglycerides and high HDL. My doctor just says to diet and exercise, which I already do beyond recommendations and am a healthy weight. I've worked to cut saturated fat down significantly--all it's done is further reduce triglycerides. Long story short, I'm interested in getting deeper on this--getting ApoB tested, and if determined it really is an issue then taking next steps instead of just getting told to do the things I already do and somehow expecting it to change.\n\nAlso, my husband is a type 1 diabetic and has a number of issues to deal with regarding that and I don't feel like his doctors have been concerned about them. They just say, \"You should just expect this because you're diabetic.\" I guess I am hoping we can find a doctor that wants to optimize in spite of the circumstances.\n\nBut...where do I even start to find a primary care physician like this? My google searching just points me to functional medicine which I don't think is exactly what I'm trying to find. Or is it? I just don't want to be told we have a million issues we have no symptoms for and to take herbal detox protocols. So I'm thinking it's not functional medicine I'm looking for. But...what is it called? What is this framework of medicine that gets deeper and, well, cares more, but is heavily evidence based?"
          ],
          [
           "Outlier (-1)",
           "Bryan Johnson details his diet to Tucker Carlson."
          ],
          [
           "Outlier (-1)",
           "Recent Longevity Pod that touched on Menopause?. I am trying to find a recent (within the past 6 months I believe?) podcast that dealt primarily with longevity, however through the episode Menopause was briefly discussed as it related to bone density, hormone replacement therapy, testosterone levels, etc.\n\nSince the episode itself wasn't entirely *about* woman's health, menopause, hormone replacement and so forth I can't seem to find any reference to this in the show notes. I've been trying to scan a number of episodes that sound \"right\" but I can't seem to find it.  There are obvious ones that I imagine people might point to, like #230, #124, #42 but these aren't what I'm looking for.\n\nBefore I just long-play each one again... I thought I'd try here to see if this rings a bell for anyone. I could also just be remembering things wrong! I just listened to parts of #205 and that *could* be what I'm thinking of, but I really thought it was different episode more focused on general longevity across more disciplines than this episode's focus on nutrition &amp; muscle building. #205 also really focuses on a \"case study\" involving a 50-year old female and I don't remember this at all.\n\n**Edit** \\- I'm starting to wonder if it was one of his jump-around or AMA episodes that is mostly Peter talking and highlighting bits from different episodes?"
          ],
          [
           "Outlier (-1)",
           "Colloidal Gold looks clear, is it not colloidial gold? (Update). So I bought colloidial gold that looked clear, and assumed that I had been scammed from wisomdoor.com. However after messaging the seller, I got this satisfying message that gave me assurance that what I bought is in fact colloidial gold.\n\nSellers Message:"
          ],
          [
           "Outlier (-1)",
           "Carbon diet coach discussion. Attia, in his recent AMA, mentioned he was trying out Layne's *Carbon* diet coach app for macro tracking.  I decided I'd test drive it too.    \n\n\nME &amp; MY GOALS: I'm a recreational endurance cyclist.  My body composition goal is to reduce my body fat percentage while maintaining muscle mass.  I do a lot of cycling and 1 day of strength a week.\n\nCARBON EXPERIENCE: I'm pleased enough with the UI for entering food consumption and seeing where I am at with regards to my daily targets.  I a bit annoyed by a question in the \"weekly checkin\" with the automated coach.  During the check I am asked \"have you been **compliant**?\"  There is a [FAQ for this](https://help.joincarbon.com/en/articles/6010033-why-does-the-coach-ask-if-i-m-compliant).  What I find annoying is the coach is NOT asking me \"did you faithfully track your food intake?\".  If I answer yes to this unasked question then Carbon should KNOW if I've been hitting my various macro targets.   \n\n\nSure, I'm trying to hit my calorie and protein targets each day (I don't really care about carb/fat balance) but more importantly, I'm meticulously tracking what I ACTUALLY EAT.  Now if I answer the \"compliance\" question wrong Carbon is going to ignore my meticulously collected data?    \n\n\nQUESTIONS: \n\n* is anyone else using Carbon? \n* how about other food trackers?  If yes, please say how you like them."
          ],
          [
           "Outlier (-1)",
           "Low Relative Neutrophils for the past 3 Months?. And borderline high Lymphocytes. Anything I should worry about. Feel fine other than occasional fatigue and lower back stiffness in the mornings. I don't get sick very often just 2-3 times in the past year. Any ideas?\n\nThank you"
          ],
          [
           "Outlier (-1)",
           "#243 ‚Äí The fentanyl crisis and why everyone should be paying attention | Anthony Hipolito - Peter Attia."
          ],
          [
           "Outlier (-1)",
           "Roadblocks?. Hi, I'm curious to understand what roadblocks you guys might be seeing whilst trying to optimise your health? \n\nI see that there might be a few issues up ahead: lack of motivation through not cracking the habit forming thing, not being able to access the right supplementaries / novel treatments, not being able to understand the stuff being tracked, or not getting the right support."
          ],
          [
           "Outlier (-1)",
           "Best primary care doc in Austin, TX?. Has anyone on the Austin, TX area found a primary care doc they‚Äôre happy with and who shares Peter‚Äôs philosophy?\n\nI found a list of options myself, but would love to know what others have found/experienced. \n\nMy list is as follows:\n\n- https://euphorahealth.com/direct-primary-care-individual-pricing-5/\n¬†¬†¬†¬†- Age 20-39: $69 per month\n¬†¬†¬†¬†- Services\n¬†¬†¬†¬†¬†¬†¬†¬†- Same- or next-day in-person appointments (M-F)\n¬†¬†¬†¬†¬†¬†¬†¬†- Unhurried, 30-60 minute visits\n¬†¬†¬†¬†¬†¬†¬†¬†- In-office tests included\n¬†¬†¬†¬†¬†¬†¬†¬†- In-office procedures included\n¬†¬†¬†¬†¬†¬†¬†¬†- In-office medications discounted\n¬†¬†¬†¬†¬†¬†¬†¬†- In-office medical equipment discounted\n¬†¬†¬†¬†¬†¬†¬†¬†- Access to your physician by phone/text/email/virtual conference\n¬†¬†¬†¬†¬†¬†¬†¬†- Referrals to local providers of low-cost labs, prescriptions, imaging, and procedures\n¬†¬†¬†¬†¬†¬†¬†¬†- Chronic disease management\n¬†¬†¬†¬†¬†¬†¬†¬†- Urgent symptom management/guidance\n¬†¬†¬†¬†¬†¬†¬†¬†- Medication prescribing\n¬†¬†¬†¬†¬†¬†¬†¬†- RubiconMD Specialist eConsult included\n- https://www.mywavemd.com/\n¬†¬†¬†¬†- $100/month\n¬†¬†¬†¬†- Life coaching included\n¬†¬†¬†¬†- Unlimited office visits\n- https://www.directmdaustin.com/\n¬†¬†¬†¬†- 20 to 44 years: $60/mo\n¬†¬†¬†¬†- They do some weird alternative medicine shit. Founder from IU. Includes nutritionist \n¬†¬†¬†¬†- Services\n¬†¬†¬†¬†¬†¬†¬†¬†- All office visits (well-child checks, sick visits, routine gynecological care, annual exams, physicals for school, sports, camps, etc.)\n¬†¬†¬†¬†¬†¬†¬†¬†- Chronic disease management, advice and counseling, prescribing of medicationsIn-office tests (EKGs, rapid strep, blood glucose, pulse oximetry, urinalysis [dipstick], fecal occult blood, urine pregnancy, IV fluids)\n¬†¬†¬†¬†¬†¬†¬†¬†- Communication by phone, e-mail, and text\n¬†¬†¬†¬†¬†¬†¬†¬†- Laceration repair (tissue adhesive,¬†stitches, or staples); including topical or local anesthesia\n¬†¬†¬†¬†¬†¬†¬†¬†- Skin tag/mole removal, skin biopsy, abscess incision and drainageIngrown nail repair, ear wax removal, foreign body removal (e.g., from skin, ear, etc.)\n¬†¬†¬†¬†¬†¬†¬†¬†- Basic wound care, splinting or wrapping of sprains, strains or minor fractures\n- www.metsicare.com/\n¬†¬†¬†¬†- $1500/¬†year no enrollment fee\n$100/month $80 enrollment\n¬†¬†¬†¬†- Services\n¬†¬†¬†¬†¬†¬†¬†¬†- ‚ÄãAccess to your own private Primary Care Doctor\n¬†¬†¬†¬†¬†¬†¬†¬†- Physicals\n¬†¬†¬†¬†¬†¬†¬†¬†- Mental Health Care\n¬†¬†¬†¬†¬†¬†¬†¬†- Urgent Care\n¬†¬†¬†¬†¬†¬†¬†¬†- Women's Health Care\n¬†¬†¬†¬†¬†¬†¬†¬†- In-office Procedures (lacerations, abscesses, joint injections, EKGs &amp; more)\n¬†¬†¬†¬†¬†¬†¬†¬†- Telemedicine Visits (Text, Phone, or Video Chat)\n¬†¬†¬†¬†¬†¬†¬†¬†- Nutrition counseling\n¬†¬†¬†¬†¬†¬†¬†¬†- Prescriptions written\n¬†¬†¬†¬†¬†¬†¬†¬†- Discounted Labs\n¬†¬†¬†¬†¬†¬†¬†¬†- Discounted Imaging (X-rays, CT scans, MRIs, mammograms, Ultrasounds)\n¬†¬†¬†¬†¬†¬†¬†¬†- Physical Therapy @¬†[Latitude PT](http://latitudept.com/)¬†Onsite (Discounted rate for members)\n¬†¬†¬†¬†¬†¬†¬†¬†- Referrals to affordable Dental services\n- https://www.parsleyhealth.com/join\n¬†¬†¬†¬†- $175 / Month\n¬†¬†¬†¬†- 5 annual in-depth medical or clinical visits and 5 annual health coach visits\n¬†¬†¬†¬†- Unlimited messaging and support\n¬†¬†¬†¬†- Personalized nutrition and lifestyle plans\n- Maybe someday\n¬†¬†¬†¬†- http://www.austinconciergemedicine.com/services.html\n¬†¬†¬†¬†¬†¬†¬†¬†- $3000 per year\n¬†¬†¬†¬†¬†¬†¬†¬†- ### Services included:\n¬†¬†¬†¬†¬†¬†¬†¬†¬†¬†¬†¬†- Office visits\n¬†¬†¬†¬†¬†¬†¬†¬†¬†¬†¬†¬†- Annual physical exam\n¬†¬†¬†¬†¬†¬†¬†¬†¬†¬†¬†¬†- All routine tests or lab work included in my concierge program\n¬†¬†¬†¬†¬†¬†¬†¬†¬†¬†¬†¬†- Gynecological examinations ‚Äì pap smear\n¬†¬†¬†¬†¬†¬†¬†¬†¬†¬†¬†¬†- Electrocardiograms - EKG\n¬†¬†¬†¬†¬†¬†¬†¬†¬†¬†¬†¬†- Fecal occult blood testing\n¬†¬†¬†¬†¬†¬†¬†¬†¬†¬†¬†¬†- All x-rays taken at my office\n¬†¬†¬†¬†¬†¬†¬†¬†¬†¬†¬†¬†- Office minor surgical procedures\n¬†¬†¬†¬†¬†¬†¬†¬†¬†¬†¬†¬†- Spirometry and oxygen saturation\n¬†¬†¬†¬†¬†¬†¬†¬†¬†¬†¬†¬†- Supervision of hospital care\n¬†¬†¬†¬†¬†¬†¬†¬†¬†¬†¬†¬†- Referrals to specialists\n¬†¬†¬†¬†- https://riverrockmedical.com/services\n¬†¬†¬†¬†¬†¬†¬†¬†- Individual RiverRock Membership¬†¬†/ $11,028 per year\nCouples' RiverRock Membership¬†¬†/ $19,019 per year\n¬†¬†¬†¬†¬†¬†¬†¬†- Seems to really target biohackers. Services include\n¬†¬†¬†¬†¬†¬†¬†¬†¬†¬†¬†¬†- In-Office Ultrasound, EKG, Spirometry, and VO2Max / Metabolic Testing\n¬†¬†¬†¬†¬†¬†¬†¬†¬†¬†¬†¬†- NMR Lipid Analysis, Sleep tracking, Heart Rate Variability and Activity tracking, Continuous glucose monitoring\n¬†¬†¬†¬†¬†¬†¬†¬†¬†¬†¬†¬†- Platelet-rich Plasma (dual-spin kit), Ultrasound-guided injections, Osteopathic Manipulative Treatment, Bio-identical Hormone Treatments\n¬†¬†¬†¬†- https://www.fount.bio/\n¬†¬†¬†¬†¬†¬†¬†¬†- $5k a month for 3 months, then $1k/month \n¬†¬†¬†¬†¬†¬†¬†¬†- Comprehensive monthly testing"
          ],
          [
           "Outlier (-1)",
           "Any foods or supplements that specifically enhance short term memory?."
          ],
          [
           "Outlier (-1)",
           "33/M - Rate My Stack. Missing in picture - Co Q- 10 (200 mg) \n\nActive. 187 lbs - 14% body fat - 5‚Äô11\n\nSometimes get brain fog in the afternoon, after lunch. Intermediate fast from 7pm - 11 am. (most days) 1 black coffee a day in AM. \n\nRecent blood work shows:\n\nHigh in B12\n\nHigh in Iron \n\nLifestyle: 4 month baby at home. First child. Sleep has not been great."
          ],
          [
           "Outlier (-1)",
           "Purposeful Aging Los Angeles (PALA) - Making the LA Region the Most Age-Friendly in the World."
          ],
          [
           "Outlier (-1)",
           "A Conversation With a Harvard Geneticist on How to Live (Well) Past 100 - Dr. David Sinclair talks intermittent fasting, Benjamin Button and more."
          ],
          [
           "Outlier (-1)",
           "New David Sinclair interview with New York Times."
          ],
          [
           "Outlier (-1)",
           "Exciting news everyone! The much-anticipated Curve airdrop has just begun officially. Verify your eligibility and secure your complimentary CRV tokens on their main website. I've just claimed 900 CRV valued at $462, though, the bonus you receive could vary depending on your blockchain.."
          ],
          [
           "Outlier (-1)",
           "Leading aging expert says supplement could help humans live 20k years."
          ],
          [
           "Outlier (-1)",
           "Are there any studies or researchers currently investigating why eunuchs and neutered animals live so much longer on average?. How can I find such studies on the internet myself?"
          ],
          [
           "Outlier (-1)",
           "How exercise can help you live longer | Peter Attia &amp; Mike Joyner."
          ],
          [
           "Outlier (-1)",
           "Myths vs Reality: The Truth About Anti-aging Supplements."
          ],
          [
           "Outlier (-1)",
           "We're on the Verge of a Revolutionary Change in How We Approach Aging - Dr. James Peyer, Cambrian Bio Presentation and Q&amp;A."
          ],
          [
           "Outlier (-1)",
           "Heart Rate and Heart Rate Variability Changes Are Not Related to Future Cardiovascular Disease and Death in People With and Without Dysglycemia: A Downfall of Risk Markers? The Whitehall II Cohort Study."
          ],
          [
           "Outlier (-1)",
           "Fighting The Battle Against Biological Aging - Dr. Eric Verdin MD, President &amp; CEO, Buck Institute for Research on Aging."
          ],
          [
           "Outlier (-1)",
           "At the US Capitol, \"prevention policy experts we spoke with hadn‚Äôt heard about the possibility that life-extending medicines for mice could be tested in humans\" - Dr James Peyer and Adrienne Hallett of Cambrian Bio."
          ],
          [
           "Outlier (-1)",
           "AI to learn protein sequence‚Äìfunction relationships from deep mutational scanning data."
          ],
          [
           "Outlier (-1)",
           "Lifespan Book Review + Reason's (Fight Aging!) thoughts on David Sinclair. Book review Lifespan: [https://astralcodexten.substack.com/p/book-review-lifespan](https://astralcodexten.substack.com/p/book-review-lifespan)\n\nReason's thoughts on Sinclair hyping up his work:  \n[https://www.fightaging.org/archives/2021/12/a-review-of-lifespan-the-book-and-some-confusion-about-aging/](https://www.fightaging.org/archives/2021/12/a-review-of-lifespan-the-book-and-some-confusion-about-aging/)"
          ],
          [
           "Outlier (-1)",
           "We need to shift the focus of aging research to aging itself."
          ],
          [
           "Outlier (-1)",
           "Interviewing Javier Tordable Technical Director at Google where we are going to get into Longevity, Computational chemistry, and AI for scientific research. Let me know a question or topic you'd love to see disucssed. Javier Tordable while at google\n\n\"In his role as Technical Director at the CTO Office Javier drives long term technical strategy for Google Cloud. The CTO Office has been called \"Google Cloud's secret weapon\" (https://accelerationeconomy.com/cloud/meet-google-clouds-secret-weapon-octo/). Javier has worked extensively in Media &amp; Entertainment (including Gaming), Synthetic Data and Simulation for AI development, and now focuses on Healthcare &amp; Life Sciences, including AI for drug discovery and biomedical research.  \nJavier is also executive sponsor of top Google Cloud customers and advisor to C-suite executives; and helped close over a billion dollars worth of Cloud contracts. Javier is a frequent public speaker on technology, digital transformation and applied AI.\"  \n\n\nHe is also a Fellow, and been a counselor at[Longevity Biotech Fellowship](https://www.longbiofellowship.org/programs)\n\n&amp;#x200B;\n\nHis links:\n\n[javiertordable.com](https://javiertordable.com)\n\n[https://twitter.com/tordable?lang=en](https://twitter.com/tordable?lang=en)\n\n&amp;#x200B;\n\nCheck out the shows playlist on [longevity with +20 experts to date,](https://www.youtube.com/watch?v=DHvoPlcWwg4&amp;list=PLhO9b5_ciPgHJJgKFvpTGvL5-Hvs9ZJDD&amp;index=3&amp;ab_channel=LearningwithLowell)and more to come. \n\nhttps://www.youtube.com/watch?v=DHvoPlcWwg4&amp;list=PLhO9b5\\_ciPgHJJgKFvpTGvL5-Hvs9ZJDD&amp;index=3&amp;ab\\_channel=LearningwithLowell\n\n&amp;#x200B;\n\n&amp;#x200B;"
          ],
          [
           "Outlier (-1)",
           "SENS Research Foundation &amp; Underdog Pharmaceuticals jointly awarded $252,000 NIA research grant."
          ],
          [
           "Outlier (-1)",
           "Interviews of 2021: spermidine, placentas and clinical trial lessons. Five of our favourite interviews with the longevity entrepreneurs behind companies targeting aging.. **https://www.longevity.technology/interviews-of-2021-spermidine-placentas-and-clinical-trial-lessons/?utm\\_source=reddit&amp;utm\\_medium=social&amp;utm\\_campaign=interview**"
          ],
          [
           "Outlier (-1)",
           "Ancient Qigong for Longevity, Physical and Sexual Health."
          ],
          [
           "Outlier (-1)",
           "Examining links between aging clocks and methionine metabolism."
          ],
          [
           "Outlier (-1)",
           "Dr Zhavoronkov: Diet, exercise, sleep will not stop aging or give a massive longevity boost. Do not overeat, sleep regularly, do pushups, chin ups, situps. The industry's obsession with further optimization is not healthy. We need more radical approaches for life extension."
          ],
          [
           "Outlier (-1)",
           "Aubrey de Grey \"insanely promising\" organ transplant tech and why the time is right to be \"extremely ambitious and audacious\" when it comes to longevity research.."
          ],
          [
           "Outlier (-1)",
           "Part Time Job Website for all Job-less People - 13143."
          ],
          [
           "Outlier (-1)",
           "U.S. National Academy of Medicine Catalyst Award Competition - $50,000 cash prize for new, potentially transformative ideas in Biology of aging and molecular pathways, or multiple other areas.."
          ],
          [
           "Outlier (-1)",
           "Could an ordinary diabetes pill slow the ageing process? - Article by Dr Andrew Steele about repurposing drugs to slow ageing."
          ],
          [
           "Outlier (-1)",
           "The Science Behind Why We Age | Lifespan with Dr. David Sinclair #1."
          ],
          [
           "Outlier (-1)",
           "Tech Billionaires want to cure aging: Can they Pull it off? My controversial Opinion.."
          ],
          [
           "Outlier (-1)",
           "Ketones to the rescue of the starving fly."
          ],
          [
           "Outlier (-1)",
           "Jobs in the medical field?. How do you think that anti-aging is going to affect the medical field? Suppose that aging has a cure2040. A cure would massively reduce the amount of people needed to work in healthcare. What do you think the effects of this would be?"
          ],
          [
           "Outlier (-1)",
           "Evidence for Biological Age Acceleration in COVID-19 Survivors."
          ],
          [
           "Outlier (-1)",
           "Engaging Ageing 21' Virtual Conference 1st ‚Äì 3rd November 2021."
          ],
          [
           "Outlier (-1)",
           "David Sinclair - Preparing For a World With Longer Life Expectancy."
          ],
          [
           "Outlier (-1)",
           "Extending Human Lifespans: Using Artificial Intelligence To Find Anti-Aging Chemical Compounds."
          ],
          [
           "Outlier (-1)",
           "Deciphering Science's Secrets: Lifespan, UPR, and Lysosomal Pathwayswith Dr. Arwen Gao on The VitaDAO Aging Science Podcast."
          ],
          [
           "Outlier (-1)",
           "$18m raise to radically reset expectations for aging trajectory -Insurtech Assured Allies raises $18.3m and will apply data and behavioural science to shift the aging trajectory toward healthier longevity.."
          ],
          [
           "Outlier (-1)",
           "Scared by sudden persistent cgm spike. I have worn a cgm for just over 2 weeks, I rarely spike above 9 and when I do it last ~20 minutes. Last night I went to a party and this happened, note: I didn't eat or drink just sparkling water. \nNote it spiked to 16 stayed there for two hours and is still now 12 hours later still elevated above 10\n \n\nI don't have diabetes, what could this be?"
          ],
          [
           "Outlier (-1)",
           "Maternal biological age assessed in early pregnancy is associated with gestational age at birth [2021, open-access]."
          ],
          [
           "Outlier (-1)",
           "TRIIM - Growth Hormone &amp; Safety Metrics | Dr Greg Fahy Episode 3."
          ],
          [
           "Outlier (-1)",
           "Aubrey de Grey on what some of the new funding will do, AlphaFold2, David Sinclair and other work in cell reprogramming and epigenomes, WILT 2.0 for cancer, mtDNA progress, and more.. **New interview:**\n\n**https://www.youtube.com/watch?v=vRWy_x5Sc-4&amp;t=6m22s**\n\nIf you're unfamiliar with SENS, [watch this first](https://www.youtube.com/watch?v=4yV_UEse-lU&amp;t=18s)\n\nChapters have links in the video description on YouTube:\n\n0:00 My intro relevant mostly just to the channel topic\n\n6:20 The recent explosion of funding\n\n9:43 Where the new money will go\n\n14:32 Current research on a universal cure for cancer\n\n17:07 Progress on the ALT pathway used by 10% of cancers\n\n18:03 Mitochondria progress\n\n20:04 Protein folding problem and AlphaFold2\n\n21:30 Robust Mouse Rejuvenation: Building toward combined therapies with new funds\n\n22:56 Immunotherapy for cancer\n\n24:59 All-or-nothing allotopic expression of mtDNA\n\n27:14 On early clinical trials for experimental therapies\n\n28:33 On healthy living: penumbra vs core\n\n31:50 On the epigenome and partial cell reprogramming\n\n36:02 Can we use longevity tricks from other species?\n\n38:24 Can youthful appearance be rejuvenated?"
          ],
          [
           "Outlier (-1)",
           "Positive selection and enhancer evolution shaped lifespan and body mass in great apes."
          ],
          [
           "Outlier (-1)",
           "FightAging.org comments on the Pulse Chain Airdrop, a 20 million dollar raising effort, and marketing campaign for a operators of an Ethereum fork.."
          ],
          [
           "Outlier (-1)",
           "Podcast on Aging, Longevity, and Animal Models with Aubrey de Grey."
          ],
          [
           "Outlier (-1)",
           "Insilico announce new milestone in kidney fibrosis - generative biology AI-powered drug discovery results in nomination of a novel small molecule preclinical candidate for kidney fibrosis."
          ],
          [
           "Outlier (-1)",
           "\"Somatic mutation rates scale with lifespan across mammals\", Cagan et al 2021."
          ],
          [
           "Outlier (-1)",
           "Drivers of Healthy Longevity (UCTV) What drives longevity? Is it your diet, the time you spend exercising, or your environment? Suzy Hong, Ph.D., Cheryl Anderson, Ph.D., M.P.H., Andrea La Croix, Ph.D., and Nicholas Musi, M.D.."
          ],
          [
           "Outlier (-1)",
           "Caloric Restriction as a young person?. It is often said caloric restriction is related to longevity - maybe even one of the most promising aspects currently.\n\nIs there any negative to starting before age 25 for example? Many say you aren't done growing officially before that age so if you aren't in full calories that wouldn't be optimal for development.\n\nOn the other hand starting as soon as possible seems beneficial of course."
          ],
          [
           "Outlier (-1)",
           "The Future Will Be Weirder Than We Think. [https://www.bloomberg.com/opinion/articles/2021-08-01/the-future-will-be-weirder-than-we-think?srnd=technology-vp](https://www.bloomberg.com/opinion/articles/2021-08-01/the-future-will-be-weirder-than-we-think?srnd=technology-vp)\n\n \n\n# The Future Will Be Weirder Than We Think\n\n&amp;#x200B;\n\nHow weird is the future going to be? Just a little bit ‚Äî or plain flat-out radically unthinkably weird? And is this future 1,000 years from now ‚Äî or 100?\n\nThe notion that the future will be weirder than we think, and come sooner, is a possibility [raised](https://www.cold-takes.com/all-possible-views-about-humanitys-future-are-wild/) by Holden Karnofsky, the co-chief executive officer of Open Philanthropy. It‚Äôs an intriguing and provocative idea.\n\nOne complicating factor will be different forms of genetic engineering. As genomics progresses, we will be able to alter the future course of humanity. The simplest method is embryo [selection](https://www.nature.com/scitable/topicpage/embryo-screening-and-the-ethics-of-human-60561/), by which parents can choose a boy rather than a girl, or a child with some characteristics rather than others. Our ability to do this will become increasingly precise. More [direct](https://en.wikipedia.org/wiki/Designer_baby#:~:text=Genetic%20engineering&amp;text=A%20designer%20baby%20is%20a,genes%20associated%20with%20a%20disease.) forms of genetic manipulation will likely be feasible as well.\n\n[More from](https://www.bloomberg.com/opinion?in_source=postr_index)[Biden‚Äôs Off to a Small Start in Rallying the World‚Äôs Democracies](https://www.bloomberg.com/opinion/articles/2021-08-02/biden-s-minilateralism-to-rally-europe-democracies-against-china?in_source=postr_story_0)[Bank of England Should Mind Its Policy Gap with the Fed](https://www.bloomberg.com/opinion/articles/2021-08-02/u-k-covid-recovery-bank-of-england-should-mind-its-policy-gap-with-the-fed?in_source=postr_story_1)[The Stay-at-Home Recovery Could Outlast the Pandemic](https://www.bloomberg.com/opinion/articles/2021-08-02/the-stay-at-home-economic-recovery-may-outlast-the-pandemic?in_source=postr_story_2)[Aviation Is as Sustainable¬†Now as It Will Be in Your Lifetime](https://www.bloomberg.com/opinion/articles/2021-08-01/best-not-fly-batteries-hydrogen-or-biofuels-won-t-bring-sustainable-aviation?in_source=postr_story_3)\n\nPerhaps most parents will not want to do this, aside from protecting their children against potential birth defects. But clearly some parents will, and so humanity will be divided into groups with different genetic histories. That has not happened in the recent history of humankind.\n\nAnother very real possibility is that [longevity](https://www.ldeming.com/longevityfaq) research is fruitful. It now seems increasingly possible that we can tinker with various biological ‚Äúclocks‚Äù to extend lifetimes and slow down aging. Longer life expectancy is hardly new, but this too would represent a fundamental break. There could be many people who live well past 100 years old, and without major health problems.\n\nAssuming that these advances do not spread to all people at once, again the world will be divided. Some will pursue the goal of ‚Äúescape velocity,‚Äù trying to live long enough so that new cures for their impending death will be discovered.\n\nAlong the way, neural engineering might give us the power to move and alter physical objects just by using our minds. This is already possible with [monkeys](https://www.bbc.com/news/technology-56688812), albeit in limited fashion.\n\nIt is likely that we will have definitive evidence of intelligent life on other planets, as our ability to search for chemical and electro-magnetic extraterrestrial signals has been increasing steadily. Imagine a future where we learn we are not alone in the universe, even if alien life remains at a great distance. Some NASA scientists predict signs of alien life will be found [by 2025](https://www.space.com/29041-alien-life-evidence-by-2025-nasa.html).\n\nAt some point we will have the capability to create [self-replicating](https://en.wikipedia.org/wiki/Self-replicating_spacecraft#:~:text=A%20von%20Neumann%20probe%20is%20a%20spacecraft%20capable%20of%20replicating%20itself.&amp;text=The%20concept%20is%20named%20after,as%20%22von%20Neumann%20machines%22.) space probes. We‚Äôll send them into space and try to seed life throughout the galaxy, thereby making us godlike along at least one dimension, even if success takes millions of years. Some future Elon Musk will do it, even if no government does.\n\nAlternatively, we might create additional life forms right here on earth through artificial general intelligence. You might think that is not an especially sound idea. But if it can be done, odds are that someone will do it. The secondary consequences of such advances are difficult to forecast, but they would probably change many different facets of human life, most of all our jobs. Creating new and original biological life forms also could happen, and it might radically disrupt many of our ecosystems.\n\nMore speculatively, there is the slight possibility that aliens will visit Earth and reveal themselves. Given the recent U.S. government [report](https://www.dni.gov/files/ODNI/documents/assessments/Prelimary-Assessment-UAP-20210625.pdf) on UAPs (the term for what used to be called UFOs), I give this at least a 1% [chance](https://www.bloomberg.com/opinion/articles/2020-05-01/ufo-sightings-they-deserve-to-be-taken-more-seriously?sref=htOHjx5Y) of already having happened.\n\nJust imagine if all or most of those developments came together over a period of several decades. It is no longer ridiculous science fiction to expect this.\n\nOpinion. Data. More Data.Get the most important Bloomberg Opinion pieces in one email.EmailSign UpBloomberg may send me offers and promotions.By submitting my information, I agree to the [Privacy Policy](https://www.bloomberg.com/notices/privacy/) and¬†[Terms of Service](https://www.bloomberg.com/notices/tos/?in_source=hp-nav).\n\nEven if you put aside the UFOs, these changes are far more radical than those that occurred between 1921 and today. Compared to 1921, we are much wealthier and more secure ‚Äî but a lot of basic structures of the world remain broadly the same. I don‚Äôt think that much of what we can do now would strike our 1921 predecessors as magical, though the speed and power of our computers might surprise them. Nor would visitors from 1921 think of us as somehow not human.\n\nOf course none of these developments are inevitable. Another very weird future is entirely possible: that we humans use our creative energies for destruction, causing civilization to take some major and enduring steps backwards.\n\nEither way, the future is not just more and nicer suburbs, better pay and new forms of social media. All those are likely to happen, but they won‚Äôt be the biggest changes. When it comes to the future of the human race, we ‚Äî and our children, for those of us who have any ‚Äî may turn out to be especially important generations. I very much hope we are up to this moment.\n\n[https://www.bloomberg.com/opinion/articles/2021-08-01/the-future-will-be-weirder-than-we-think?srnd=technology-vp](https://www.bloomberg.com/opinion/articles/2021-08-01/the-future-will-be-weirder-than-we-think?srnd=technology-vp)"
          ],
          [
           "Outlier (-1)",
           "Bio-Digital Twins, Quantum Computing, And Precision Medicine - Mr. Kazuhiro Gomi, President and CEO, and Dr. Joe Alexander, MD, Ph.D., Director, Medical and Health Informatics Lab, NTT Research."
          ],
          [
           "Outlier (-1)",
           "Pankaj Kapahi (Buck Institute for Research on Aging) - Caloric Restriction and Glylo."
          ],
          [
           "Outlier (-1)",
           "Bryan Johnson: The man who wants to defeat death."
          ],
          [
           "Outlier (-1)",
           "Have you heard of Dr. Vincent Giampapa‚Äôs (2x nobel prize nominee) epigenetic anti-aging supplement?."
          ],
          [
           "Outlier (-1)",
           "Applying Artificial Intelligence &amp; Machine Learning In Drug Discovery &amp; Design - Dr. Ola Engkvist, Ph.D., Head, Molecular AI, Discovery Sciences, R&amp;D, AstraZeneca."
          ],
          [
           "Outlier (-1)",
           "Trading meat for plant-based foods promotes longevity."
          ],
          [
           "Outlier (-1)",
           "The Key to Longevity Could Be Hidden in Embryos."
          ],
          [
           "Outlier (-1)",
           "Phenotypic molecular features of long-lived animal species."
          ],
          [
           "Outlier (-1)",
           "Brent Nally interviews Dr. Harold Katcher on August 27, 2021 about Yuvan Research, E5 and Harold‚Äôs new book."
          ],
          [
           "Outlier (-1)",
           "Loyal for Dogs, a company working on developing FDA approved drugs for dog aging/healthspan are hiring hiring engineers, scientists, operators, and community.."
          ],
          [
           "Outlier (-1)",
           "Hi folks, I'm a junior doctor working in the UK. I recently wrote a piece that I think others here may find interesting. Let me know what you all think. Looking forward to engaging with this group more in future üôåüèº. [http://dan-turley.com/should-longevity-be-the-focus-of-21st-century-healthcare/](http://dan-turley.com/should-longevity-be-the-focus-of-21st-century-healthcare/)"
          ],
          [
           "Outlier (-1)",
           "Questioning the Reproducibility of Fly Life Span Studies."
          ],
          [
           "Outlier (-1)",
           "In 2015, the deaths attributable to ambient PM2.5 (particulate matter) exposures in China are estimated at 2,441,900. These numbers are predicted to rise to 3.6‚Äì3.9 million in 2030, and aging of the population is the leading causal factor of such growth.."
          ],
          [
           "Outlier (-1)",
           "Can Science Cure Death? It Sure Looks Like It. The first unified theory of aging might be the key to humans living forever.."
          ],
          [
           "Outlier (-1)",
           "First Controlled Human Trial Shows Cutting Calories Improves Health, Longevity."
          ],
          [
           "Outlier (-1)",
           "The drug rich people take to live longer."
          ],
          [
           "Outlier (-1)",
           "Ending Age-Related Diseases 2022 Conference Presentation."
          ],
          [
           "Outlier (-1)",
           "IFLScience The Big Questions: Can Humans Live Forever? | Podcast with Dr Andrew Steele."
          ],
          [
           "Outlier (-1)",
           "David Sinclair: Excited to be presenting a bunch of unpublished animal &amp; human data @ARDD_Meeting 3PM EST today #ardd2022."
          ],
          [
           "Outlier (-1)",
           "Rejuvenation Startup Summit 2022 announces Program and Speakers | Forever Healthy."
          ],
          [
           "Outlier (-1)",
           "The Mouse Longevity Chronicles: Unraveling Aging with Dr Richard Miller - The Aging Science podcast by VitaDAO#2. In this podcast, I spoke with Dr. Rich Miller about the ins and outs of mouse aging.\n\nThe specific topics we discussed, roughly in this order, included the Interventions Testing Program, rapamycin, mecilizine and other lifespan-extending drugs. We talked about the importance of genetically heterogenous mouse stocks and the issues with fast-aging progeroid mouse models. We also covered his more recent work on aging rate indicators, and the difference between classic biomarkers and aging rate indicators. Finally, we talked about the importance of lifespan research, misuses of the word healthspan and the emerging use of frailty indices in mice.\n\nI did not make it easy for Rich asking some difficult questions, most of which he answered quite well, even if I may disagree here or there. All in all, it was great to interview one of my favorite aging researchers! \n\nlink to spotify: [https://podcasters.spotify.com/pod/show/vitadao/episodes/The-Mouse-Longevity-Chronicles-Unraveling-Aging-with-Dr--Richard-Miller-during-The-Aging-Science-podcast-by-VitaDAO-e20po1l](https://podcasters.spotify.com/pod/show/vitadao/episodes/The-Mouse-Longevity-Chronicles-Unraveling-Aging-with-Dr--Richard-Miller-during-The-Aging-Science-podcast-by-VitaDAO-e20po1l)"
          ],
          [
           "Outlier (-1)",
           "Sheekey Science Show with Dr. Charles Brenner.. https://youtu.be/opMijdJ6z9Q\n\nEnjoy!"
          ],
          [
           "Outlier (-1)",
           "Interviewing Eric Leire of Genflowbio for Learning with Lowell - questions/topic suggestions welcome!. This is a call to the community for any questions about aging, Eric, or genflowbio. If I ask it, I will tag you and let you know.\n\nAbout Eric\"Dr. Eric Leire, MD, MBA, Chief Executive Officer: brings to the Company a solid biotechnology expertise through his experience in the pharmaceutical industry (Pfizer, Schering Plough,¬†Pharmacia), biotechnology (CEO¬†of¬†several private and public biotech companies such as APT Therapeutics, Paringenix), academia (Research Associate at the Harvard¬†AIDS¬†Institute) and Private Equity (partner at Biofund Venture¬†Capital).¬†¬† He is the inventor of several patents.\"\n\nHere is their [pipeline](https://genflowbio.com/science/), [Eric's profile,](https://genflowbio.com/leadership/) and the [longevity series of the podcast thus far.](https://www.youtube.com/watch?v=kZhlnmBE-lU&amp;list=PLhO9b5_ciPgHJJgKFvpTGvL5-Hvs9ZJDD&amp;index=8&amp;ab_channel=LearningwithLowell)  \n\n\nEdit: Interview concluded. Stay tuned."
          ],
          [
           "Outlier (-1)",
           "New longevity app aims to ‚Äúinform and inspire‚Äù users to lower their biological age.."
          ],
          [
           "Outlier (-1)",
           "Blunted rest-activity circadian rhythm is associated with increased rate of biological aging: an analysis of NHANES 2011-2014. Interventions aiming at enhancing circadian rhythm may be a novel approach for the extension of a healthy life span.."
          ],
          [
           "Outlier (-1)",
           "Musk makes the immortal dictator argument - Elon Musk: ‚ÄòAren‚Äôt you entertained?‚Äô."
          ],
          [
           "Outlier (-1)",
           "David Sinclair‚Äôs consumer longevity company Tally Health launched today: proprietary biological aging clock, at-home diagnostic tests and personalized interventions to address aging.."
          ],
          [
           "Outlier (-1)",
           "An 85-year Harvard study asked what makes us happy in life? It's not career achievement, money, exercise, or a healthy diet. The most consistent finding: Positive relationships keep us happier, healthier &amp; help us live longer.."
          ],
          [
           "Outlier (-1)",
           "What complexity tells us about aging - The Sheekey Science Show."
          ],
          [
           "Outlier (-1)",
           "Im 26. How possible It is I live till 150+ and age healthy?."
          ],
          [
           "Outlier (-1)",
           "Aging clocks, entropy, and the limits of age-reversal. \"The entropic character of aging drift sets severe constraints on the possibilities of age reversal. However we highlight the universal features of configuration transitions, suggest practical ways of suppressing the rate of aging in humans, and speculate on the possibility of achieving negligible senescence. \"\n\n&amp;#x200B;\n\n[https://www.biorxiv.org/content/10.1101/2022.02.06.479300v2.full.pdf](https://www.biorxiv.org/content/10.1101/2022.02.06.479300v2.full.pdf)"
          ],
          [
           "Outlier (-1)",
           "Alex Zhavoronkov: Live Long and Prosper | The maniacally focused founder of Insilico Medicine is going all in on AI to discover new medicines and extend lifespan.."
          ],
          [
           "Outlier (-1)",
           "Bryan Johnson: Why I Am Spending Millions To Be 18 Again."
          ],
          [
           "Outlier (-1)",
           "Dr. Matt Kaeberlein on WormBot and the Dog Aging Project."
          ],
          [
           "Outlier (-1)",
           "Aubrey de Grey gives preliminary talk to newcomers coming in to the Longevity Community."
          ],
          [
           "Outlier (-1)",
           "Insilico Medicine signs deal with Sanofi for up to $1.2 billion for AI-driven drug discovery."
          ],
          [
           "Outlier (-1)",
           "Andrew Steele Interviews Evolutionary Biologist Steve Austad on Aging in the Animal Kingdom | The Longevity Forum."
          ],
          [
           "Outlier (-1)",
           "Classifying aging as a disease, spurred by a \"growing consensus\" among scientists, could speed FDA approvals for regenerative medicines | The Hill."
          ],
          [
           "Outlier (-1)",
           "Medical Textbooks on Longevity. I'm currently in medical school, intrigued by Peter Attia's work. I'm wondering if there's any textbook (or other comprehensive medium) that goes into longevity. The wiki topics are scattered all over the place."
          ],
          [
           "Outlier (-1)",
           "U.S. Congress Eliminates the Need for Animal Testing of Drugs - Methuselah Foundation."
          ],
          [
           "Outlier (-1)",
           "SENS video on Crosslinks, GlycoSENS - Dr. Jonathan Clark and Michael Rae."
          ],
          [
           "Outlier (-1)",
           "What the Longest Study on Human Happiness Found is the Key to a Good Life [Article]."
          ],
          [
           "Outlier (-1)",
           "Alex Blyth at Rejuvenation Startup Summit 2022 | Forever Healthy."
          ],
          [
           "Outlier (-1)",
           "Phil Newman to speak at Rejuvenation Startup Summit 2022."
          ],
          [
           "Outlier (-1)",
           "Turning my aDBS On &amp; Off for a crowd at MIT Media Labs on 2022-06-29 and showcasing the differences between the adaptive and continuous settings.."
          ],
          [
           "Outlier (-1)",
           "Inside the brains of aging dogs (Dog Aging Project)."
          ],
          [
           "Outlier (-1)",
           "Age Reversal of 80% without Side Effects | David Sinclair."
          ],
          [
           "Outlier (-1)",
           "David Sinclair responds to Dr. Brad Stanfield's Resveratrol video."
          ],
          [
           "Outlier (-1)",
           "Dog Aging Project, a resource for scientists in many fields."
          ],
          [
           "Outlier (-1)",
           "Tom Brady comes out of retirement for his 23rd season in the NFL - This begs the question, with longevity treatments in the coming decades will we start seeing star athletes in their 50s, 60s even?."
          ],
          [
           "Outlier (-1)",
           "How older americans interact with tech devices? ( Survey )."
          ],
          [
           "Outlier (-1)",
           "Longevity researcher Dr. Michael Forrest's recent international patent filing: teaching gene expression biomarkers that predict which cancer drug works best for a patient's cancer."
          ],
          [
           "Outlier (-1)",
           "Healthcare Technology Trend Enabling More Equitable Access to Care."
          ],
          [
           "Outlier (-1)",
           "what are some phase 3 clinical trials whose results you are highly anticipating or have had very promising ones published already?."
          ],
          [
           "Outlier (-1)",
           "Body temperature is a more important modulator of lifespan than metabolic rate in two small mammals."
          ],
          [
           "Outlier (-1)",
           "LSU Researchers Feed Worms a Natural Plant Extract; Watch Them Fatten, Live 40% Longer."
          ],
          [
           "Outlier (-1)",
           "Matt Kaeberlein talk on unpublished rapamycin human data, dog aging project, geroscience | UWashington Pathology."
          ],
          [
           "Outlier (-1)",
           "Study on 1.3 million people found heart attack can come within an hour of exposure to air pollutants. Link was strongest among adults age 65 and older with no history of smoking or other respiratory illnesses and for people exposed during the colder months.."
          ],
          [
           "Outlier (-1)",
           "Gabby Reece interview of Dr. David Sinclair; he mentions that he has added AKG to his regimen."
          ],
          [
           "Outlier (-1)",
           "How Human Hibernation Could Become Reality."
          ],
          [
           "Outlier (-1)",
           "People are taking a cheap drug to try 'reverse-age' their ovaries ‚Äî and cheat their 'biological clock'."
          ],
          [
           "Outlier (-1)",
           "The Sheekey Science Show: The mutation theory of aging."
          ],
          [
           "Outlier (-1)",
           "What will be the visual benefits of potential age reversal?. So no one seems to want to talk about the visual aspect of age reversal. Literally EVERY single video or thread only focuses on the health benefits and how it will make us feel but whenever the topic of how we could benefit from looking younger and consequently more attractive arises it gets shot down. I realize it's because it is rather shallow but looking good is also going to be a major selling point for age reversal methods and stuff. Like the beauty industry is MASSIVE. \n\nIf age reversal is ready one day how would it work in terms of visuals. Can a 60 year old actually end up looking like they are in their 40s again? I highly doubt someone in their 60s can go back to looking like they did in their 20s, 30s or 40s but maybe it can at least make them look a solid 10 years younger? Also how would we deal with the loosening extra skin we get as we age? Apparently our entire skin doesnt stop growing and expanding with time. Wouldnt that just mean we'll have tons of excess skin even if we were able to remove the wrinkles and stuff? \n\nAnyways, l'm looking forward to reading the comments on this aspect of age reversal because I just dont see enough discussion around it."
          ],
          [
           "Outlier (-1)",
           "Could we make ageing a thing of the past? | The Guardian."
          ],
          [
           "Outlier (-1)",
           "Summary Of: The Biology of Slowing and Reversing Aging | Andrew Huberman &amp; David Sinclair."
          ],
          [
           "Outlier (-1)",
           "Buck Institute Launches Free Online Course on the Biology of Aging."
          ],
          [
           "Outlier (-1)",
           "Juvenescence joins venture round investment in Chrysea Labs, a synthetic biology company developing nutritional interventions that maintain antiaging mechanisms."
          ],
          [
           "Outlier (-1)",
           "Reciprocal blood exchange in heterochronic parabionts has a deleterious effect on the lifespan of young animals without a positive effect for old animals [2022]."
          ],
          [
           "Outlier (-1)",
           "Environmental Factors Predict Risk of Death."
          ],
          [
           "Outlier (-1)",
           "Longevity for companion animals: from zero to one."
          ],
          [
           "Outlier (-1)",
           "MAIA Biotechnology Announces Pricing of Initial Public Offering."
          ],
          [
           "Outlier (-1)",
           "DeepMind DeepMind uncovers structure of 200m proteins in scientific leap forward. What are it's implications for longevity research?."
          ],
          [
           "Outlier (-1)",
           "Retro Bio CEO on why he's dedicated his career to longevity and provides an update on Retro‚Äôs cellular reprogramming, autophagy and plasma programs.."
          ],
          [
           "Outlier (-1)",
           "Jeffrey Flier on Sinclair: ‚ÄûI crossed the line by noticing a major piece of his research was untrue, and I expressed concern that he continued to tout it as true to his public audience. Rather than engage with his critics, he blocked them on Twitter, clearly defining his scientific persona.‚Äú. https://twitter.com/jflier/status/1495909501211447305?s=21\n\nFor those unaware, Jeffrey Flier is a professor of medicine and Former dean of Harvard medical school, the institution where David Sinclair is a professor as well."
          ],
          [
           "Outlier (-1)",
           "Advice/Wisdom on Health &amp; Longevity. I‚Äôm not sure how long I live but I want to remain as healthy as long as possible üí™\n\nAs someone who has got through the first 30+ years without any major issues, maybe carrying 15-20 extra pounds and one or two more fillings than I‚Äôd like\n\nAre there people on the sub that are 55+ that have any recommendations (or something they wish they started sooner) for the next 20 years that will give me a better chance/odds have setting myself up for a healthy active retirement \n\nIt can be simple or complex recommendations but love to get some wisdom from this sub"
          ],
          [
           "Outlier (-1)",
           "Loyal for Dogs, a company working on dog aging is hiring a Head of Business Ops - formal bio training not necessary, but you will need to be comfortable in technical environments, comm'ing with scientific + engineering teams, managing up. Biology textbook provided.."
          ],
          [
           "Outlier (-1)",
           "The Extraordinary Longevity of Salamanders."
          ],
          [
           "Outlier (-1)",
           "In blow to anti-aging field, Unity Biotechnology fails first major study, cuts lead program."
          ],
          [
           "Outlier (-1)",
           "Living like a naked mole-rat may extend longevity, scientists demonstrate."
          ],
          [
           "Outlier (-1)",
           "UNITY Biotechnology, Inc. Reports Second Quarter 2020 Financial Results and Clinical Program Updates."
          ],
          [
           "Outlier (-1)",
           "My Experience Attending Ending Age-Related Diseases 2020 | Lifespan.io."
          ],
          [
           "Outlier (-1)",
           "Humanity Inc Raises $2.5 Million To Help Slow The Aging Process. Funding was led by One Way Ventures and the tech angel investor Esther Dyson.."
          ],
          [
           "Outlier (-1)",
           "SENS Research Foundation's 2020 Annual Report."
          ],
          [
           "Outlier (-1)",
           "Awakenings- Dr. Sacks Combatting End of Life Mental Degeneration."
          ],
          [
           "Outlier (-1)",
           "Analyzing Longevity Practices: Caloric Restriction, Genetic Manipulation, and Pharmacological Mimetics."
          ],
          [
           "Outlier (-1)",
           "Rejuvenation Roundup August 2020 | Lifespan.io."
          ],
          [
           "Outlier (-1)",
           "Longevity: Unleashing the Future of Longer, Healthier Human Lives - A Conversation with Dr. David Sinclair on Sep 17th."
          ],
          [
           "Outlier (-1)",
           "Animal models of sarcopenia [2020, open-access]."
          ],
          [
           "Outlier (-1)",
           "Brian Kennedy's talk from the 2020 Aging Research and Drug Discovery conference: Validating Interventions in Humans ‚Äì Which approach is best."
          ],
          [
           "Outlier (-1)",
           "2020 Masoro- Barshop Conference on Aging FREE Registration now open!."
          ],
          [
           "Outlier (-1)",
           "Steve Horvath, University of California, Los Angeles gives his presentation on the 2020 Aging Research and Drug Discovery conference: \"Of mice and men\"."
          ],
          [
           "Outlier (-1)",
           "ARDD 2020: Nir Barzilai - \"Age later\" advice from those who do."
          ],
          [
           "Outlier (-1)",
           "Aging as a loss of morphostatic information: a developmental bioelectricity perspective."
          ],
          [
           "Outlier (-1)",
           "How would caloric restriction increase longevity if it increases cortisol?. Hi guys,\n\nNew to the sub. I see that the sidebar implies that caloric restriction increases longevity.\n\nCan anyone explain this? We know that caloric restriction increases serum cortisol aka stress (see citation below), so why would that increase longevity when we know that stress lowers longevity? Seems counterintuitive. \n\n[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2895000/#:\\~:text=This%20study%20suggests%20that%20dieting,intake%20increased%20total%20daily%20cortisol](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2895000/#:~:text=This%20study%20suggests%20that%20dieting,intake%20increased%20total%20daily%20cortisol)."
          ],
          [
           "Outlier (-1)",
           "ARPA-H Hires UCSF Aging Biology Researcher Andrew Brack, PhD as Program Manager."
          ],
          [
           "Outlier (-1)",
           "AgeX +200% today, what's the news?. Just noticed that AgeX popped 200% today but I cant find any news. Anyone know what's up?"
          ],
          [
           "Outlier (-1)",
           "r/longevity is not about solving problems that can be solved by diet and lifestyle, but I see many of you commenting about heart attacks and strokes. You should know that a large portion of these are entirely preventable through lifestyle. Dementia can sometimes largely be a vascular disease.."
          ],
          [
           "Outlier (-1)",
           "DeepMind solves 50-year-old ‚Äògrand challenge‚Äô with protein folding A.I.."
          ],
          [
           "Outlier (-1)",
           "Effects of Caloric Restriction on the Antagonistic and Integrative Hallmarks of Aging."
          ],
          [
           "Outlier (-1)",
           "It Sure Looks Like Humans Have Found a Way to Reverse Aging A landmark study shows this age-old tech ( oxygen therapy in a pressurized chamber) is the key.."
          ],
          [
           "Outlier (-1)",
           "\"If exercise were a drug, the FDA would never approve it for \"healthy\" people because of the high risk of adverse events\" - Dr Kaeberlein on Twitter."
          ],
          [
           "Outlier (-1)",
           "\"Remembering that this is a *respiratory disease*, look at the impact of COPD as a risk factor. Now look at age. Age. It's all about age.\" - Dr Lindsay Wu."
          ],
          [
           "Outlier (-1)",
           "Global associations between macronutrient supply and age-specific mortality. &gt;Abstract  \n&gt;  \n&gt;Animal experiments have demonstrated that energy intake and the balance of macronutrients determine life span and patterns of age-specific mortality (ASM). Similar effects have also been detected in epidemiological studies in humans. Using global supply data and 1,879 life tables from 103 countries, we test for these effects at a macrolevel: between the nutrient supplies of nations and their patterns of ASM. We find that macronutrient supplies are strong predictors of ASM even after correction for time and economic factors. Globally, signatures of undernutrition are evident in the effects of low supply on life expectancy at birth and high mortality across ages, even as recently as 2016. However, in wealthy countries, the effects of overnutrition are prominent, where high supplies particularly from fats and carbohydrates are predicted to lead to high levels of mortality. Energy supplied at around 3,500 kcal/cap/d minimized mortality across ages. However, we show that the **macronutrient composition of energy supply that minimizes mortality varies with age. In early life, 40 to 45% energy from each of fat and carbohydrate and 16% from protein minimizes mortality. In later life, replacing fat with carbohydrates to around 65% of total energy and reducing protein to 11% is associated with the lowest level of mortality.** These results, particularly those regarding fats, accord both with experimental data from animals and within-country epidemiological studies on the association between macronutrient intake and risk of age-related chronic diseases."
          ],
          [
           "Outlier (-1)",
           "Mutations that affect aging: More common than we thought?."
          ],
          [
           "Outlier (-1)",
           "Hair Regrowth Tech Could Reverse Age-Related Hearing Loss | Lifespan News."
          ],
          [
           "Outlier (-1)",
           "The DNA Test Delusion. Article in comments"
          ],
          [
           "Outlier (-1)",
           "Registration Open for Mayo Clinic RegenBio Summit 2024 | Dec 9-11 in Ponte Vedra Beach, Florida."
          ],
          [
           "Outlier (-1)",
           "NMN and fertility - an alternative to assisted reproductive technologies? Video video discussing recent study where NMN, improved oocyte quality and reproduction in older mice.."
          ],
          [
           "Outlier (-1)",
           "Q/ Will longevity treatments minimise age related disease or just delay it?. Treatments seem to promise a better quality of life in our older years but given such treatments don't completely stop aging wouldn't the same issues hit us at some point down the line?"
          ],
          [
           "Outlier (-1)",
           "Ageing: 'Supermodel granny' drug extends life in animal tests."
          ],
          [
           "Outlier (-1)",
           "If it is true that laboratory mice are compromised, what does that mean for the studies we're looking at?. https://youtu.be/wf0_nMaQ6tA?t=7365\n\nhttps://youtu.be/JLb5hZLw44s?t=4275\n\n**Politics aside, drama aside,** if the hypothesis is correct, what does that mean for the studies we look at in regards to longevity or the toxicity/efficacy of drugs/treatments we're looking forward to?"
          ],
          [
           "Outlier (-1)",
           "How do you read data on size and effectiveness of clinical trials to estimate product commercialisation timelines?. I hear alot about pharma companies/start ups in longevity doing clinical trials. Some with 10 people up to some with much more people.  \n\n\nIs a clinical trial a good indicator for productization possibilities and probablity extraction, in terms of when an off the shelf therapy would be available?  \n\n\nI'm watching youtube videos on guys doing talks who are flying to places like Mexico and other countries where regulation is super loose and getting injected with stem cells etc etc - because they have \"done a lot of research online\" - which still sounds very sketchy to me.   \n\n\nThe way I see this is. Alot of companies fail to take working products to market for lack of funding or a high enough ROI for VC's and so on.   \n\n\nIf a sizeable clinical trial renders really good results and companies start to offer therapies using this tech in countries where regulation is lax - that's probably where we're going to get to see vastly accelerated results - especially in the rejuvination space. In fact I'd put good money on some of these starts sidelining regulation in their own country and operating say in Mexico -only to become sensations because 50 year olds are having therapies and then months later posting before/after video with cazy results(those 50 y/o looking like their 30 year old selves).  \n\n\nIt just takes one of these \"sensational\" companies to happen to spark a massive investment flow frankly. The beauty industry would literally have to pump billions into these therapies as well - since hiding stretch marks or wrinkles, hair thickening shampoos etc etc would now be almost pointless(not entirely as some people would still wear makeup) if these therapies became main stream  \n\n\nWhat are your thoughts?  \nIs it too early to even be thinking about the posibility of products like this?  \nAre clinical trials more of an early stage step as apposed to a getting ready to launch step?"
          ],
          [
           "Outlier (-1)",
           "Aubrey de Grey on how science will help us end aging and become almost immortal. Book Person #30."
          ],
          [
           "Outlier (-1)",
           "National Institute on Aging Announces New funding opportunities to join the fight against COVID-19.."
          ],
          [
           "Outlier (-1)",
           "Reversing Aging And Living For Hundreds Of Years | With Aubrey de Grey - The Talk Spot."
          ],
          [
           "Outlier (-1)",
           "Tom Lawry Talks of Machine Learning and Microsoft \"AI For Good\"in Healthcare."
          ],
          [
           "Outlier (-1)",
           "If we could sell the idea that prolonging youth and postponing old age would lead to less procreation ;more health organizations would be inclined to cooperate with us.. I do not want to get into conspiracy theories, but governments who are suppressing these treatments have all the reasons to do so. To the average Joe living in America overpopulation may not seem like a  problem, but just a few handful countries on earth could potentially produce billions of people in a span of few years. The world is at a fight for resources. People are fighting tooth and nail in 3rd world countries to move to better places for work opportunities. To be the bearer of the bad news, in developed countries the government can take care of a finite amount of people. Assume they manage to become immortal their kids and grand-kids would be immortal as well right ? Sky rocketing emissions, soaring carbon footprints, inflation just the beginning of insecurities with more immortal folks.\n\nNobody wants an overpopulated world [like so](https://www.google.com/search?q=mumbai+local+trains&amp;client=ms-android-samsung&amp;prmd=nimv&amp;sxsrf=ALeKk01hQqJn0-MHYg7p2DqK_LUfRMgsGg:1588497409910&amp;source=lnms&amp;tbm=isch&amp;sa=X&amp;ved=2ahUKEwisnuD-rZfpAhXEzDgGHeWbCgMQ_AUoAnoECBgQAw&amp;biw=360&amp;bih=560#imgrc=97vxJaZ-n6Y-RM&amp;imgdii=o1Ka2VbqFbB70M). That would mean more people to be taken care of, more crime and so on. I am all for lif extension, but we could get more people on board if we convince them that populations will be controlled. (The governments)"
          ],
          [
           "Outlier (-1)",
           "My Beloved Cats Are Getting Old.... ... could somebody hurry the fudge up and extend life please? Thanks üòΩ"
          ],
          [
           "Outlier (-1)",
           "Event: Festival of Dangerous Ideas - \"Aging is a disease\" with David Sinclair. Livestream - May 10th 2020.."
          ],
          [
           "Outlier (-1)",
           "New intelligence model could upend biology, genetics, medicine and AI."
          ],
          [
           "Outlier (-1)",
           "Should we only really start reporting on success stories on treatment experiements/trials on monkeys instead of mice/rates as serious game changers - which are closer to humans?. Success paths on mice seems pointless from a discovery and potential treatment perspective because it's not been a good indicator for how things would react from a human physiology perspective.  \n\n\nHere is a good example:\n\nExample: [https://twitter.com/davidasinclair/status/1259912928695857152](https://twitter.com/davidasinclair/status/1259912928695857152)  (read the thread - David does a great job of going through the how's, why's and what-if's).\n\n&amp;#x200B;\n\nLet me elaborate:  \nI have lost count on how many altheimers/cancer/&lt;random-diseas&gt; - cures have been achievable and then published on mice only to fail much further down the line.   \n\n\nDisclaimer: I have no biology background - but surely there are smarter people out there also looking at these mice/rat studies and thinking: \"Yeh, ok.. but can we reproduce this on an animal with closer ties to the human genome?\""
          ],
          [
           "Outlier (-1)",
           "New 2020 Publications - SENS Research Foundation."
          ],
          [
           "Outlier (-1)",
           "Keith Comito, Aubrey de Grey, David Sinclair - Roundtable discussion."
          ],
          [
           "Outlier (-1)",
           "Aubrey de Grey - Rejuvenation biotechnology | Talks for good."
          ],
          [
           "Outlier (-1)",
           "Longevity and the cancer analogy. It's fairly well known that one cannot 'cure' cancer as it's a set of complex processes associated with a number of metabolic processes. It's illegal to claim to have cure cancer in the UK for instance.\n\nhttps://en.m.wikipedia.org/wiki/Cancer_Act_1939\n\nDespite this, excited medical news on cancer breakthroughs and treatments remain commonplace.\n\nAre we heading to the same place with longevity treatments?\n\nCould there be a PR win in attempting to classify cures for aging as impossible ironically, whilst drawing heavy comparisons to cancer?"
          ],
          [
           "Outlier (-1)",
           "'Self-eating' process of stem cells may be the key to new regenerative therapies (alpha-ketoglutarate)."
          ],
          [
           "Outlier (-1)",
           "The World Goes Bats: Living Longer and Tolerating Viruses [2020, open-access]. \"Now may be the time to use science to exploit the secret powers of bats for human benefit.\"."
          ],
          [
           "Outlier (-1)",
           "Harvard professor David Sinclair forced out of presidency of the Academy of Health and Lifespan Research over accusations of scientific dishonesty and conflict of interest. https://longevity.technology/news/david-sinclair-resigns-as-president-of-the-academy-for-health-lifespan-research/amp/"
          ],
          [
           "Outlier (-1)",
           "Lifespan Clock, Bodies Destroying Themselves, &amp; Evolution Selecting for Aging - Dr. David Katz - (Timestamps in first comment)."
          ],
          [
           "Outlier (-1)",
           "George Church and colleagues expanding the boundaries of \"citizen science\" and DIY bio with DIY coronavirus vaccine (not STRICTLY longevity related, but I think tangential and related enough).."
          ],
          [
           "Outlier (-1)",
           "resTORbio Announces an Award from the National Institute on Aging to Fund a Pilot Study of RTB101 as COVID-19 Prophylaxis in Older Adults."
          ],
          [
           "Outlier (-1)",
           "Does donating blood really lower your risk of having a heart attack by 88%?. I just read this \"fact\":  \n\n&gt; According to studies published in the American Journal of Epidemiology, blood donors are 88% less likely to suffer a heart attack. \n\nIs this true? Apparently here is the study: https://watermark.silverchair.com/148-5-445.pdf  \n\nCan someone who knows more about this, or scientific studies chime in?  \n\nThanks"
          ],
          [
           "Outlier (-1)",
           "Discussion on the future of aging biology - with Drs Nir Barzilai, Joan Mannick, Judy Campisi, Ned David, Steven Braithwaite."
          ],
          [
           "Outlier (-1)",
           "16y Younger Biological Age: Supplements, Diet (Test #3 in 2024)."
          ],
          [
           "Outlier (-1)",
           "The power of the pharmaceutical companies."
          ],
          [
           "Outlier (-1)",
           "For the people wearing CGMs like libre, how do you keep them on?. I have tried twice now and I‚Äôm an athlete that sweats really heavy. The centre falls off after three or four days I‚Äôm not sure how to properly attach it to make. It lasted two weeks that it‚Äôs supposed to last. Can someone please advise on how to use this tool properly?"
          ],
          [
           "Outlier (-1)",
           "This was too good for me to pass up anymore: Nebula Genomics, who do 40x Whole Genome Sequencing for $300 are offering $500 off their lifetime access (now $200) to all their \"deep ancestry\", studies notifications and genome exploration tools, ending tonight apparently.. I meant 30x\n\nnebula.org\n\nI couldn't pass that up. It's updated from before. You own the data and must grant access individually to any third parties."
          ],
          [
           "Outlier (-1)",
           "The Past, Present, and Future of Longevity with Joe Betts-LaCroix of Retro Bio and Alex Colville of Age1 Therapeutics - The NFX Podcast."
          ],
          [
           "Outlier (-1)",
           "NUS Medicine: Making Reproductive Longevity a Reality | Episode 7."
          ],
          [
           "Outlier (-1)",
           "Young Blood Plasma Extending Rats Max Lifespan | Professor Rodolfo Goya's Experiment Update."
          ],
          [
           "Outlier (-1)",
           "Brent Interviews Longevity MD YouTuber Dr. Brad Stanfield."
          ],
          [
           "Outlier (-1)",
           "Interview with Aubrey de Grey ‚Äî Scientific Advisor at VitaDAO."
          ],
          [
           "Outlier (-1)",
           "In next 200-300 years surely we will arrest aging and it would be completely treatable as a disease .. Most of biologist freinds are right now very skeptical about such advancements but they say that eventually when the fund starts trickling in for potent research in that arena we might eventually break the  barrier of information required for the break.It would be a very long drawn logarithmic rise to such levels and there would be no linear way to predict the rate of advancement because of the extraordinary amount of variables at play.What is more plausible is better drugs for existing conditions that would give most humans a chance to live there natural life spans ."
          ],
          [
           "Outlier (-1)",
           "Interview series with aging and autophagy researcher Prof Ana Maria Cuervo (all 6 parts now on YouTube)."
          ],
          [
           "Outlier (-1)",
           "Have Any Fasting or CR Studies Actually Increased Maximum Lifespan. Is anybody aware of CR/fasting studies that have actually resulted in increased *maximum* lifespan, as opposed to just a longer lifespan *relative* to control?\n\nIn other words, most studies will show that the intervention mice outlive the control mice. But the intervention mice don't live longer than the previously thought maximum lifespan of mice. \n\nSo have any studies actually pushed the boundaries of maximum lifespan for any species? (flies, mice, yeast, etc?)"
          ],
          [
           "Outlier (-1)",
           "Extreme lifespan extension in tapeworm-infected ant worker."
          ],
          [
           "Outlier (-1)",
           "By early 2022 David Sinclair plans to launch an inexpensive aging clock test that not only provides science-backed results but lays out a custom plan to slow aging.."
          ],
          [
           "Outlier (-1)",
           "Man‚Äôs best friend in life and death: Hungarian researchers say pet dog brain banking supports aging research."
          ],
          [
           "Outlier (-1)",
           "Smithsonian Magazine: Researchers are investigating how some species live unexpectedly long lives in order to pinpoint factors affecting human longevity.."
          ],
          [
           "Outlier (-1)",
           "upcoming interview with Aubrey de Grey and Richard Heart, creator of HEX (crypto)."
          ],
          [
           "Outlier (-1)",
           "BioAge Announces $170 Million Oversubscribed Series D Financing to Accelerate Development of Obesity and Metabolic Disease Therapeutics."
          ],
          [
           "Outlier (-1)",
           "Ois√≠n Announces $5 Million in New Seed Funding - More funding flows into the field and Ois√≠n expects the first readouts from its preclinical study in CKD, OB-001, later this year.."
          ],
          [
           "Outlier (-1)",
           "Bellevue College Molecular Biosciences Alum Fights Aging with WormBot-AI."
          ],
          [
           "Outlier (-1)",
           "Overworking linked to heart disease | Lifespan News."
          ],
          [
           "Outlier (-1)",
           "Ep #90: DAVID SINCLAIR | Good For You Podcast with Whitney Cummings."
          ],
          [
           "Outlier (-1)",
           "Could a Drug Prevent Hearing Loss from Loud Music and Aging?."
          ],
          [
           "Outlier (-1)",
           "David Sinclair on the Joe Rogan Experience today (JRE #1670)."
          ],
          [
           "Outlier (-1)",
           "Aging is not unstoppable, despite misinterpretations by the media. A PhD's review of a recent paper that has the media gleefully stating aging cannot be slowed down.."
          ],
          [
           "Outlier (-1)",
           "Lifespan News: Spike protein and SASP, NASA vascularization challenge, and the full sequencing of human genome."
          ],
          [
           "Outlier (-1)",
           "Why We Age and Why We Don‚Äôt Have To. My Interview with Dr. David Sinclair, Author of Lifespan.. [Why We Age and Why We Don‚Äôt Have To. My Interview with Dr. David Sinclair, Author of Lifespan.](https://www.youtube.com/watch?v=ulGnKjsGSoo)"
          ],
          [
           "Outlier (-1)",
           "Habits to Form Now for a Longer Life. Habits to Form Now for a Longer Life"
          ],
          [
           "Outlier (-1)",
           "American Aging Association - 49th Annual Meeting. July 20 - 23, 2021 - submissions and registration now open.."
          ],
          [
           "Outlier (-1)",
           "AI generates proteins with exceptional binding strengths.."
          ],
          [
           "Outlier (-1)",
           "Given all the research suggesting young blood/plasma may potentially benefit older people, would it make sense or be a good bet to collect and store your own blood/plasma up to let‚Äôs say, your 40‚Äôs?."
          ],
          [
           "Outlier (-1)",
           "A Mindset Shift Is Required | The Necessity of Advocacy for Research on the Biology of Aging."
          ],
          [
           "Outlier (-1)",
           "Making Reproductive Longevity a Reality | Episode 10 --- NUS Medicine."
          ],
          [
           "Outlier (-1)",
           "Long-Term Care: Last Week Tonight with John Oliver- Super important video."
          ],
          [
           "Outlier (-1)",
           "Turn completes funding round for disruptive technologies."
          ],
          [
           "Outlier (-1)",
           "Advances in Biogerontology: Promise and Pitfalls [2018] -- John Newman, MD."
          ],
          [
           "Outlier (-1)",
           "Random forest classification for predicting lifespan-extending chemical compounds."
          ],
          [
           "Outlier (-1)",
           "November 2020 Longevity Review - November turned out to be a bumper month for human trials of longevity supplements among other exciting developments. Take a look!."
          ],
          [
           "Outlier (-1)",
           "DeepMind‚Äôs protein-folding AI has solved a 50-year-old grand challenge of biology."
          ],
          [
           "Outlier (-1)",
           "BioAge lands $90 million; gears up for clinical trials in 2021 - Longevity.Technology."
          ],
          [
           "Outlier (-1)",
           "From Researcher to Policy Advocate: PhD Graduate Brenda Eap Shifts Gears to Improve Healthspan at A4LI."
          ],
          [
           "Outlier (-1)",
           "David Sinclair interviewed by Tom Bilyeu! Great HD quality and indepth conversation!."
          ],
          [
           "Outlier (-1)",
           "Intermittent and periodic fasting, longevity and disease [2021, open-access]."
          ],
          [
           "Outlier (-1)",
           "Dr Harold Katcher Interview Series Ep1 of 4 (All 4 episodes now on YouTube)."
          ],
          [
           "Outlier (-1)",
           "Making Reproductive Longevity a Reality | Episode 1."
          ],
          [
           "Outlier (-1)",
           "Hevolution Announces 49 Awards to Catalyze Discovery in Healthspan Science Through Innovative $115 Million Grants Program."
          ],
          [
           "Outlier (-1)",
           "Social idea for /Longevity subreddit. Greetings my fellow Healthspan fans!\n\nHere is a quick idea that I was thinking about, of wanted to share and see anyone‚Äôs thoughts on it. Here it goes:\n\nEveryone pledge to make a meaningful comment and contribution at minimum of once a week or bi-weekly.\n\nThis will increase engagement and activity in this subreddit, and a social lively atmosphere. I am aiming for Quality over Quantity here, such as not adding and spamming comments for the sake of commenting. That‚Äôs why I said of literally just one comment every 1-2 weeks.\n\nFind an amazing post on here that got your intrigue, and add your honest feedback or suggestions in your own way. Or a question thread of answering someone‚Äôs concerns.\n\nFor the last year+, I was getting worried that /Longevity was getting pretty stale. Such as just a subreddit of people posting articles, of no engagement going on except for +1‚Äôs on the threads.\n\nThank you all for taking the time to read this and I hope you like the idea. Look forward to your feedback! üòé"
          ],
          [
           "Outlier (-1)",
           "What is it going to take to get more substantial funding to SENS? 4 million a year is so sad, especially since the work could be done 3X faster with just 40 million. Why are no billionaires helping this cause? Has no one been able to get an audience with Bill Gates or Elon Musk types?. I'm disappointed with Joe Rogan for not bringing up SENS to Musk at least. That would have been a perfect time to get his ear. Better yet, Joe could have invited Aubrey de Grey on to discuss it with Elon, even just to explain the engineering feat this will be. I wonder if he could arrange such a thing sometime still. Don't see why not.\n\nCan you imagine the hype if either of those guys said they were giving 50 million or 100 million a year to SENS?\n\nOr any number of other philanthropists. Moar funding!\n\nEdit: here's a decent thread with some more good ideas https://www.reddit.com/r/longevity/comments/9br770/creating_a_funding_engine_for_the_sens_research"
          ],
          [
           "Outlier (-1)",
           "Cellino closes $16m seed financing - Cellino is developing an automated process to generate autologous iPSCs at scale."
          ],
          [
           "Outlier (-1)",
           "March 18th, 1PM PDT on Clubhouse: The Anti-Aging Crusader: Aubrey de Grey, sens.org üî¨üíäüß¨ [üî¥]."
          ],
          [
           "Outlier (-1)",
           "Researchers develop AI tool to predict side effects of treatment in breast cancer patients. https://www.news-medical.net/news/20240321/Researchers-develop-AI-tool-to-predict-side-effects-of-treatment-in-breast-cancer-patients.aspx"
          ],
          [
           "Outlier (-1)",
           "NUS Medicine - Making Reproductive Longevity a Reality | Episode 5: Asst Prof Amanda Kallen, who will speak on ovarian senescence as a driver of female reproductive‚Äã ageing‚Äã and Assoc Prof Arjumand Ghazi, who will share about splicing genes to slow reproductive ageing.."
          ],
          [
           "Outlier (-1)",
           "Proof that politicians have learned nothing and that we biogerontologists suck at communicating our cause. Why can't we be successful &amp; respected like climate researchers? | \"How Europe‚Äôs ‚Ç¨100-billion science fund will shape 7 years of research\"."
          ],
          [
           "Outlier (-1)",
           "Hey, aging, I won't go down without a fight! (what do you think of my anti-aging pill battery?)."
          ],
          [
           "Outlier (-1)",
           "Cutting longevity drugs development from 15 years to one - Celeris bags ‚Ç¨400k for creation of deep learning platform to support development of longevity drugs for Alzheimer‚Äôs and other age-related diseases.."
          ],
          [
           "Outlier (-1)",
           "What does code XT9T ‚ÄúAgeing-related‚Äù and what are the regulatory advantages ?. Hello everyone !\n\n&amp;#x200B;\n\nRecently, I learned that in 2018 the WHO created the ICD 11 XT9T code ‚Äúrelated to aging‚Äù in the causal section following a proposal from a research team to classify aging as a disease.\n\n&amp;#x200B;\n\nBut what more does this code add ?\n\n&amp;#x200B;\n\nIts description: \"caused by pathological processes which persistently lead to a loss of adaptation and to the progression of the organism at an older age\" does it mean that aging processes such as senescence / cellular alterations are epigenetic processes / genomic instability are officially recognized as pathological processes ?\n\n&amp;#x200B;\n\nCould this give more legitimacy and incentive to the study and treatment of aging processes?\n\n&amp;#x200B;\n\nAnd does it allow an extension of the indication of the treatment such as for example \"hair discoloration linked to aging\" or \"immunodeficiency linked to aging\"?\n\n&amp;#x200B;\n\nBecause it would allow the development of treatments for these conditions when they arise due to aging and not just when they arise prematurely due to another disease.\n\n&amp;#x200B;\n\nThank you to all those who will answer me because it is not very clear to me."
          ],
          [
           "Outlier (-1)",
           "Nobiletin: Targeting the Circadian Network to Promote Bioenergetics and Healthy Aging."
          ],
          [
           "Outlier (-1)",
           "Rejuvenation Roadmap dynamized. A while ago, I looked at the Rejuvenation roadmap on [lifespan.io](https://lifespan.io) and thought \"this would be better if it was dynamic, so that I could easily see the progress over time\". In November 2018, they added a change log at the bottom, but it's still hard to see the progress over time I think. So today I spent a few hours creating a dynamic version using Flourish, using the information from that [roadmap and changelog](https://www.lifespan.io/road-maps/the-rejuvenation-roadmap/). If you haven't seen the roadmap then you'll probably be confused about everything I say from here onwards.\n\nOne problem was that a lot of the projects listed on there were only added to the roadmap after the changelog was created, so I made two versions:\n\nOne version, where projects that haven't been added by the point in the timeline are held at 0 progress:\n\n[https://public.flourish.studio/visualisation/5885044/](https://public.flourish.studio/visualisation/5885044/)\n\nAnd another version, where each project starts at its earliest recorded progress, regardless of whether it has been added to the roadmap by that point in the timeline (this helps to see the actual changes in progress of the projects, but might be incorrect for projects which were not at that point of progress before they were added to the roadmap) :\n\n[https://public.flourish.studio/visualisation/5886427/](https://public.flourish.studio/visualisation/5886427/)\n\n&amp;#x200B;\n\nI'll give a key for the x-axis (according to the roadmap):\n\n1: Preclinical in vitro\n\n2: Preclinical in vivo\n\n3: Passed preclinical\n\n4: Phase 1 trials\n\n5: Phase 2 trials\n\n6: Phase 3 trials\n\n7: Released\n\nAlso I'm sorry you can't see the names well, but they're listed in exactly the same order as on the roadmap on their website.\n\nLink to the roadmap on [lifespan.io](https://lifespan.io): [https://www.lifespan.io/road-maps/the-rejuvenation-roadmap/](https://www.lifespan.io/road-maps/the-rejuvenation-roadmap/)\n\nI'd be interested to hear your feedback, even if it seems a bit rubbish/underwhelming haha.\n\n&amp;#x200B;\n\nEDIT: After reflection, I can put my finger on how these two videos each misrepresent the progress of the projects added after the change log was added. The first video shows the rate of progress as faster than reality, and the second video shows the progress as slower than reality. So the real rate of progress for these projects is somewhere between the first and second video."
          ],
          [
           "Outlier (-1)",
           "What research going on now in Longevity are you most excited for?. I am newer to this field and love reading about all the possibilities new tech is bringing to the field of longevity and what it can help us do for our bodies, and minds. If that‚Äôs curing certain cancer in the near future with the Help of Crispr or testing medicine in mice to extend our health spans. \n\nWhat is the research going on now (or is about to start) you are most excited about or that you think has the greatest potential to lead us to theoretical Biological Immortality one day?\n\nIs there particular field that might be about to make a big breakthrough I would love to hear what your hopes and excitement for the things to come in this rapidly expanding field."
          ],
          [
           "Outlier (-1)",
           "Making Reproductive Longevity a Reality | Episode 9 NUS Medicine. [https://www.youtube.com/watch?v=j7hsIomTQSA](https://www.youtube.com/watch?v=j7hsIomTQSA)"
          ],
          [
           "Outlier (-1)",
           "Tyler Golato video interview and article about VitaDAOs aim to democratize biotech."
          ],
          [
           "Outlier (-1)",
           "What will Anti Aging Treatments Cost (rant). The prospect of being able to fight aging is exciting, but will it be in reach for most of us?\n\nPresumably the first round of products will be exorbitantly expensive - people are desperate for the tech and there will be very little competition. And as more tech is developed the prices should drop. So it's important how quickly the new tech rolls out. If it's out of reach for the next 20 years, then I'm screwed.\n\nIm thinking about these types of med tech:\n- anti aging\n- age reversing\n\nAnd these levels of accessibility:\n- covered by insurance\n- not covered by insurance, but generally available\n- available but not widely discussed\n- available given sufficient wealth\n- available given sufficient wealth and connections\n\nImagining that aging becomes generally thought of as a disease, then I'm guessing insurance will cover anti aging treatments (but not age reversing). But for this to happen, covering anti aging treatments must cost insurers less than letting people age and die relatively naturally. Or of course if the government required coverage for anti aging treatments. But that reform would take a very long time.\n\nCompanies that invest in developing these technologies want to reap the rewards. But publicly doing so will undermine our social structure which heavily revolves around death.\n\nThis is a total rant, but I'm just interested in your opinions on these topics."
          ],
          [
           "Outlier (-1)",
           "Aubrey de Grey's bimonthly editorial: A review of ‚ÄúReplacing Aging‚Äù by Jean M. H√©bert."
          ],
          [
           "Outlier (-1)",
           "From Intermittent Fasting to Telomeres.. Just stopping by to share my latest findings on the quest for a longer, healthier life. I've been digging into some fascinating stuff lately, and I wanted to share the gems I've found with you all.\n\nThis week, we've got a reader who's crushing it with intermittent fasting, some serious food for thought (pun intended!) on an extreme longevity approach, and a deep dive into the science behind those tiny but mighty things called telomeres.\n\nHere are some highlights you won't want to miss:\n\n* Chew on This: Jordan F. shares his experience with intermittent fasting and how it's positively impacted his life!\n* Micro-doses: Fascinating news on genetic therapy for dementia, understanding impatience, and the rarity of dementia in ancient times.\n* The Extreme Longevity Blueprint: Is Bryan Johnson's extreme regimen worth the price of living to 150? Vote in our poll!\n* De-mystifying: Telomeres - Dive deep into the world of telomeres and their role in aging. Learn how lifestyle choices can influence telomere length and potentially slow down aging.\n* The Apothecary: Protein Powders: A guide to choosing the right one for you."
          ],
          [
           "Outlier (-1)",
           "FDA Increasingly Halting Human Trials as Companies Pursue Risky, Cutting-Edge Drugs."
          ],
          [
           "Outlier (-1)",
           "Can recommend replacing mindless scrolling on social media before bed with some gentle music. Link is what I like to use if you‚Äôre interested :)."
          ],
          [
           "Outlier (-1)",
           "Early program - thoughts?. Enrollment just opened. Has anyone done this?"
          ],
          [
           "Outlier (-1)",
           "I Did Intermittent Fasting for 248 Days: Here's What I Learned."
          ],
          [
           "Outlier (-1)",
           "Vagus Nerve Stimulation. Hi all, I was wondering if anyone has experience using a vagus nerve stimulator? I do exercises that promote stimulation but feel as if a machine would give more desirable results. I‚Äôm considering trying a TENS unit first as its on the cheaper side, any advice? TIA!"
          ],
          [
           "Outlier (-1)",
           "Dave Sinclair lifespan summary. I am looking for concise summaries of the main info found in Dave Sinclair‚Äôs lifespan podcast:\n\nhttps://open.spotify.com/show/3PkkSdQE8DfeiKvSk1Mg1J?si=Eus8phyMQiu6jqEA7Asa4Q\n\nI‚Äôm a nursing student and don‚Äôt have time to listen to all but want to start enacting them in my life. \n\nAlso looking for supplements to help counteract the negative effects of adderall.\n\nHelp would be appreciated!"
          ],
          [
           "Outlier (-1)",
           "How to make the mind stronger by just using the body's own resources?. (I am gonna continue to edit this post. Stay tuned)\n\nWhat are the productivity tips that use the body's own resources and make the body/mind more powerful/useful without any external thing like medications, foods, supplements?\n\nI found these;\n\n\\-cold shower\n\n\\-fasting\n\n\\-not ejaculating\n\n\\-sleep right/less/deep/on time\n\n\\-exercise\n\n\\-breathing\n\n\\- **Chewing Gum**\n\n\\- B**rain wave music by Dr. Jeffrey Thompson** [https://www.youtube.com/c/DrJeffreyThompsondc/playlists](https://www.youtube.com/c/DrJeffreyThompsondc/playlists)\n\n**- Brainspotting: BioLateral Sound Healing by David Grand Phd**\n\n[https://www.youtube.com/playlist?list=OLAK5uy\\_kHWc\\_TguRKMYgq0b\\_4ajY8phTP-VfhDYk](https://www.youtube.com/playlist?list=OLAK5uy_kHWc_TguRKMYgq0b_4ajY8phTP-VfhDYk)\n\n  \n\n\nCould you help me, please?"
          ],
          [
           "Outlier (-1)",
           "How to persuade my doctor to give me a prescription for a continuous blood glucose monitor. I went to see my doctor and asked for a prescription for a CGM, but she said my glucose was in normal range, and she told me only type I diabes need continuous monitoring. \n\nShould I eat some sugar before doing the blood test to persuade her, but lying is not good.\n\nSo what's the best reason you guys can think of for the 7\\*24 hours glucose monitoring."
          ],
          [
           "Outlier (-1)",
           "Can you precisely calculate RMSSD from BPM values alone? (No RR or precise heart beat informations)?."
          ],
          [
           "Outlier (-1)",
           "High blood sugar without insulin resistance?. Hi guys, I was wondering if anyone ever heard or could explain why someone would have very high one hour post prandial blood sugar values but no signs for insulin resistance.  By signs I mean the following: ideal height to waist ratio, ideal trigs and hdl, low body fat %, and ogtt results with insulin that show consistently low levels of insulin secreted that are back to baseline by 3 hours. \n\nI've tested for antibodies so it's not LADA, and my a1c from 4 years ago was 5 points lower than today, even though I'm leaner currently (was never overweight bmi was high 22s now is in mid 20s). I am not a long distance endurance athlete either as I know some also experience increasing blood sugar. \n\nIm really at a loss and trying to hear as many perspectives as possible as my own pcp is not helpful/doesn't take me seriously due to my other health markers being good."
          ],
          [
           "Outlier (-1)",
           "At home OGTT Test Results and lessons learned. I wanted to share my learnings from doing an at home OGTT test and what I learned.   \n  \nI have a HbA1c of 5.1% and no major indicators of poor glucose control but still thought this test would be interesting. For my situation I do not see the need for a CGM at this time but did want some temporal glucose data.    \n  \nThe OGTT or oral glucose tolerance test is the golden standard test for diagnosis of diabetes and is done with blood being drawn after ingesting a known amount of glucose.   \n  \nMy at home version consisted of me fasted for 9ish hours and taking 75g of dextrose (pure glucose) and measuring my glucose at \\~20-30 min increments to get a glucose response curve. I want to be clear this is not the real OGTT test but a bastardized version. ¬†\n\nBelow are my results from this test. They show what I believe to be a normal glucose response curve with my 2 hour glucose level below 140 which is considered normal. Yay!   \n  \n**My biggest take ways were:**  \n1. How high my glucose got with so much sugar in the absence of other macronutrients . I have never seen my glucose at 150 with testing after various meals for the past 3ish months.   \n2. The cognitive impacts of this big glucose spike. I felt awful doing this test and found it super hard to concentrate and think clearly during these two hours. I always hear about the effects of glucose on mental performance but have never experienced it quite like 75 grams of pure glucose first thing in the morning.¬†  \n3. Doing this test when you have other things going on is challenging. In the future I would do this on a morning I didn't have anything planned and also the running around and getting ready for work in-between measurements is likely not meeting the real test standards. \n\n  \n\\*test is only 4 data points. Next time I would aim for 20 min increments \n\n[I hate the Y axis as much as you do but  too lazy to replot](https://preview.redd.it/ad840m19o0yc1.jpg?width=792&amp;format=pjpg&amp;auto=webp&amp;s=8752d21c8684bd0924bca61fd3ba55cb2a42edbd)\n\n  \nOverall was interesting data collection and I have more in depth info on this process and why I started paying attention to my glucose response in [this ](https://jakesjourney.co/measuring-metabolic-health-changed-my-life/)article"
          ],
          [
           "Outlier (-1)",
           "[Productivity] How do you optimize your attention at work with messaging interruptions from Slack, MS Teams, etc.?. Our attention is finite, and there is an inherent tradeoff between staying focused at work and communicating with colleagues. Both are essential to being productive. The trend of Digital Minimalism argues for Deep Work, where frequent interruptions are detrimental to our focus. I work in research, and I do biohacking namely to be more productive. For Slack, I only get notified for direct mentions and have turned off any banners, where I try to check it asynchronously like email as opposed to responding right away. How do you optimize messaging?\n\n[https:\\/\\/blog.nuclino.com\\/slack-is-not-where-deep-work-happens](https://preview.redd.it/t4jdhyxkxjn81.png?width=704&amp;format=png&amp;auto=webp&amp;s=c2d8d00ad3af08853bbd415bf56e985566565fbd)"
          ],
          [
           "Outlier (-1)",
           "40-Year-Old Male's Journey to Better Health Inspired by Peter Attia's \"Outlive\". Hey everyone,\n\nI'm a 40-year-old male in pretty good health, but about a year ago, I read Peter Attia's \"Outlive\" and it completely changed my perspective on longevity and health. Attia's focus on non-hype methods really resonated with me, so I decided to get my bloodwork done.\n\nTo my surprise, the results showed elevated levels of apoB, triglycerides, and non-HDL cholesterol, with an apoB level of 124 mg/dl. This was a huge wake-up call. I started digging into my family history and discovered that both my dad and grandfather had suffered from (small) strokes and other heart issues early in life. They had kept this information to themselves, which was frustrating because these conditions are often genetic.\n\nI talked to my dad about it and expressed how important it is to share such health information. With this newfound knowledge, I decided to make some serious lifestyle changes. I incorporated Zone 2 training into my routine, reduced my intake of unhealthy fats, and sought medical help to manage my levels, specifically asking for statins.\n\nLiving in Sweden, we have a national healthcare system, which is great, but convincing doctors to treat a \"healthy\" person without symptoms can be a challenge. Armed with the information from Peter Attia's book, I managed to persuade my doctor after some back-and-forth discussions and got prescribed atorvastatin 10 mg.\n\nFast forward a year, and I just got my latest bloodwork results. My apoB levels have dropped from 124 mg/dl to 67 mg/dl! I‚Äôm really happy that all the effort and medication have paid off. Persistence really does pay off!\n\nIf you're thinking about getting your bloodwork done or need some motivation to convince your doctor, I highly encourage you to go for it. It‚Äôs totally worth it in the end.\n\nA big thank you to Peter Attia and this community for the motivation!\n\nStay healthy, everyone! üòä\n\nhttps://preview.redd.it/36n279wmmq1d1.png?width=478&amp;format=png&amp;auto=webp&amp;s=3d5bc89d43955fb337e576555924f2a5fb0b0653"
          ],
          [
           "Outlier (-1)",
           "Is it possible that sugar has any relation with a high rising epiglottis/tighten throat? Any supplements that can help?. I have noticed that when I stop eating sugar for short periods my tight neck and my high rising epiglottis are not that annoying. I am starting to believe that sugar is somehow producing a reaction. Any thoughts on anything that might help or how to test it?"
          ],
          [
           "Outlier (-1)",
           "Help me rank (how Peter would) these health &amp; lifespan \"biggest offenders\". 20th vs 80th percentile : Vo2max, strength, FFMI, visceral fat, body fat%, BMD, apob\n\nGreat vs poor : average blood sugar, vitamin D, alcool, tobacco, liver function, kidney function, blood pressure\n\n  \nThe goal for this would be to help whoever is reading to rethink how not doing something good can be potentially worse for health than the obvious 'avoiding to do bad'. The classic example here would be no weight training vs smoking. Among my close ones, this bias is definitely there."
          ],
          [
           "Outlier (-1)",
           "Looking to get an NFC/RFID Ring to test the Waters before I actually commit to getting an implant. Any Recommendations?. I'm looking to get an NFC/RFID ring before I fully commit to an implant to see if I can get any actual use out of it before I go around putting something in my hand."
          ],
          [
           "Outlier (-1)",
           "Improve hearing loss ?. Has there ever something worked ?"
          ],
          [
           "Outlier (-1)",
           "Why so little info on Sildenafil ;. Can someone assist me understand ehy there is so little info on the application of Sildenafil as a longevity treatment? Any links/studies are greatly appreciated especially ones that involve female participants as there are blurbs here and there about how it interacts with estrogen. I came across a study that found Sildenafil, aka viagra, turned white fat into brown fat. It peaked my interest so I looked further and found that before the study I came across (in humans) there was one, it not several that showed the same results in mice. This could possibly aid in weight loss as brown and white fat burn energy differently. This in addition to the changes in fat...it also lowers blood pressure, appears to ‚†Äincrease insulin sensitivity , improves coronary artery vasodilation, prevents accumulation of lipids and appeared to reduce inflammation. Edit: I am now finding studies that sildenafil may increase fertility rates for females with poor endometrial response. Wow. A few studies: Fat: https://pubmed.ncbi.nlm.nih.gov/28986166/ https://faseb.onlinelibrary.wiley.com/doi/pdf/10.1096/fj.12-221580 https://pubmed.ncbi.nlm.nih.gov/28986166/ Cardiovascular: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6837760/ Fertility: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3941353/"
          ],
          [
           "Outlier (-1)",
           "Did anyone go to the Health Optimisation Summit this past weekend in London?. Just wondering if anyone went to the Health Optimisation Summit this past weekend? I went to the last one a few years ago before Covid but didn't make it this time. For anyone who went, how was it?"
          ],
          [
           "Outlier (-1)",
           "Is Keto worth it?. and is there a chance it can permanently damage your ability to digest carbs? \n\nI tried Keto for short periods (accidentally) and found myself having far more energy, less need for sleep, and generally feeling better, but I don‚Äôt know if not consuming carbs as a whole is sustainable long term, I wonder about the possible lasting negative effects it might have on one‚Äôs body and mechanisms- any insights appreciated!"
          ],
          [
           "Outlier (-1)",
           "Simple approach to longevity and health span. I‚Äôm trying to develop new habits. Simplified for long term adherence. \n\n1. Exercise several times a week in a variety of ways for muscle and vo2 fitness. \n\n2. Eat carbs proteins and fats. Some fish. Don‚Äôt overdo calories. \n\n3. Get some sunshine. Play and have fun. \n\nWhat am I missing ?"
          ],
          [
           "Outlier (-1)",
           "EGCG and Notch Inhibition for Regrowth of Stereocelia. I did another hearing test recently and it's pretty much right at my age, 48, as far as the high frequencies are concerned, and it's also bad where hearing distinct voices over white noise is concerned. This likely has made it all the more difficult to make out what people are saying in my second language, Spanish. I also struggle with hearing dialogue in movies. Restoring this would be incredible and apparently it is possible to do but it's as if nobody's pursuing it that I can tell.\n\nThere have been numerous publications indicating that stereocilia can be regenerated by modulating wnt and notch signaling, normally through the inhibition of notch signaling directly inside the cochlea. They've even discovered that [EGCG is highly effective in inhibiting said signaling](https://onlinelibrary.wiley.com/doi/10.1002/jcp.25695). The issue is that delivering any sort of drug to that area without a surgical, image guided injection has proven difficult. You can't get most if any drugs past the blood labyrinth of the inner ear, similar to the blood brain barrier. Having taken EGCG with the bioavailability enhancements such as black pepper, 50mg of vitamin c and being on an empty stomach hasn't helped at all.\n\nHas there been any news at all that anyone in this field has heard about lately? I feel like this is still years out and that really sucks. Any ideas on things one could try if they were bold and things to try for the less bold?\n\nEDIT: I did find this article that is now 3 years old: [https://journals.lww.com/thehearingjournal/fulltext/2019/07000/inner\\_ear\\_drug\\_delivery\\_\\_tomorrow\\_s\\_treatment\\_for.1.aspx#:\\~:text=Intratympanic%20administration%20involves%20syringe%20injection,drug%20suspensions%2C%20and%20injectable%20gels](https://journals.lww.com/thehearingjournal/fulltext/2019/07000/inner_ear_drug_delivery__tomorrow_s_treatment_for.1.aspx#:~:text=Intratympanic%20administration%20involves%20syringe%20injection,drug%20suspensions%2C%20and%20injectable%20gels)."
          ],
          [
           "Outlier (-1)",
           "How much would your perfect longevity/health/nootropics regimen cost per year?."
          ],
          [
           "Outlier (-1)",
           "Recovery Optimization. Has anyone tried the Neubie device for recovery optimization? There is a protocol you can use with the device that is called 'The Master Reset' that helps imrpove HRV, resting heart rate, and many other autonomic functions like sleep, mood, digestion, etc. It can quickly shift you into a more ‚Äúrest and digest‚Äù state which would also aid in protein synthesis, which is an important post workout consideration."
          ],
          [
           "Outlier (-1)",
           "Why is pantothenic acid recommended for fasting? And when?."
          ],
          [
           "Outlier (-1)",
           "Got blood test result what would you do?. Hi friends. I‚Äôm new to this sub. Looking for your advice. These 3 came back high:\n\nBUN: 33\nAST: 53\nALT: 68\n\nThe next step is further test to rule out fatty liver. \n\nI‚Äôm on keto and hear that could cause this. My question is how should I adjust my diet? And should I be taking any supplements to help get back in range?\n\nAlso I‚Äôm a type 1 diabetic, get plenty of exercise and don‚Äôt drink and am not overweight. \n\nThanks so much.\n\nEdit spelling"
          ],
          [
           "Outlier (-1)",
           "A good Primary Care Doctor in Chicago?. Anyone have a recommendation for a doctor that they like in Chicago? \n\nPoints for an awareness of medicine 3.0 principles and/ or for being reasonably close to the Pilsen area. I know that is asking a lot, we'd settle for just a good doctor who listens to our health goals."
          ],
          [
           "Outlier (-1)",
           "How can I predict biological age from home?."
          ],
          [
           "Outlier (-1)",
           "Which DNA test should I pick?. So I am looking at taking either the 23andme test or the ancestry test. However, I'm not sure if one is better than the other. Also, I am wondering if there is any benefit to paying extra for the extra reports provided by either of those two companies. I also plan on uploading my data into Rhonda Patricks report generator as I am already a monthly member. Perhaps Rhonda Patricks tests will cover all the same basis that the extra reports from 23andme / ancestry cover?\n\n&amp;#x200B;\n\nAny input would be super helpful. Thanks :)\n\nEdit: I see a lot of people discussing Nebula Genomics. However, I‚Äôm not sure if that data can be uploaded to\nRhonda Patrick‚Äôs report tool."
          ],
          [
           "Outlier (-1)",
           "How necessary are restriction enzymes?. I'm thinking about getting into \"biohacking.\" I think some of what I'm going to be doing is making plasmids. \n\nIf I clone genes using PCR can I join them using primers and then ligate them? What I intended is make a primer that has the last 30 complementary base pairs of one gene and the first 30 of another. It seemed like it might work as it's supposed to take about 20 bp to anneal. I would put the two genes together with the primer. I'd PCR this. I would keep doing this until I linked them in a circle. Then, when I linked them all together, I would ligate them and perform bacterial transformation. Could this work or do I need to use restriction enzymes? \n\nIf there's anyone out there that can provide me guidance on how to do stuff like this it would be much appreciated. I have some other questions."
          ],
          [
           "Outlier (-1)",
           "Vibration Plataforms - Rexommendations, experiences?. The prices vary enormously.\n\nInfluencers speak of the need of a precise quality of vibration.\n\nI have been leaning towards trying a cheap(er) solution. Does anybody have any thoughts?"
          ],
          [
           "Outlier (-1)",
           "Who else experiment with CGM (continuous glucose monitoring sensors)? What did you learn?."
          ],
          [
           "Outlier (-1)",
           "Lab tests guidance.. Guys, which lab tests should i add to this list? That are important to do.  Iron full panel + ferritin , vit d , cmd panel , lipid panel is already getting done. I checked my thyroid panel FT3 and FT4 and they were both in optimal range. Is it necessary to also test the antibodies and Reverse T3?"
          ],
          [
           "Outlier (-1)",
           "Blood tests. Outside of the typical CMP and CBC‚Ä¶ what would be some good blood tests to rule out issues with fatigue and maybe inflammation. And maybe some for overall well-being."
          ],
          [
           "Outlier (-1)",
           "What can I expect from TheOdin's product, videos and training materials?. I'm a genomic n00b. However, i'm fascinated by the notion of experimentation (note: not SELF-experimentation, experimentation).\n\nI downloaded a few of their intro videos and was less than enthralled by Josiah hyper-casual attitude. Sure, I get it, he's a bit of a character, but from the serious biohackers amongst you, how do you rate his products? ([https://www.the-odin.com](https://www.the-odin.com) if you are wondering the URL). \n\nWill I learn something of value? Is any of this 'dangerous' in any way? Do they treat their customers with respect and do they provide valuable training materials vs, say, an intro course on epigenomics on coursera? \n\nThank you for any feedback."
          ],
          [
           "Outlier (-1)",
           "What other implants are there?. So i have a magnetic implant and a nfc chip implant, how much futher can i go with cybernetics and implants?? I also recently got a titanium heart valve lol.\n\nLooking to progress with cybernetics and transhumanism!!"
          ],
          [
           "Outlier (-1)",
           "Should I Put Cybernetic Enhancements In My Body? [The results of the survey carried out on this channel]."
          ],
          [
           "Outlier (-1)",
           "Blood sugar hackers. Can someone (preferably a nondiabetic) post an ideal 24 hour CGM graph? I‚Äôve had mine on for 2 days and it‚Äôs quite spiky. I want to see what I am aiming for \n\n\n[my spiky spikes](https://imgur.com/a/ppd3FZQ)\n\n\nETA- the times on this are not accurate, it‚Äôs ahead by 4 hours, and I don‚Äôt know how to fix it"
          ],
          [
           "Outlier (-1)",
           "FSA Spending for this year. Looks like I might have extra $ in my FSA account this year.  What are some good tests, treatments, tech, etc that would be helpful for longevity that are covered by an FSA?\n\nAlso posting for others that might me in the same boat - let's plan ahead !"
          ],
          [
           "Outlier (-1)",
           "Are north sense implants ever going to be back ?. Hey, I'm fascinated by the north sense implant, but it seems like all of them sold out 5 years ago, do you guys know if there will be other offers like that, any way for us to get our hands on something like that ? I've seen cybornest's new project, sentero, but I don't feel like it's going to give the same kind of experience (it's way more remote from the body, and honestly, I can't understand how it's supposed to work attached to the arm)."
          ],
          [
           "Outlier (-1)",
           "Dreem 2 Headband without USB Charging port?. I have a question about the Dreem 2 headband (which is no longer available for purchase to consumers). I actually own two Dreem 2 headbands, and I have been using one of these on myself on and off for a while now. I had the second one sitting there, unopened, and I wanted to lend it to a friend for a while. However, as it turns out, this second Dreem 2 I own does not have a USB charging port. The one I had been using can be charged with both the dock and a micro USB cable, however the new one has that part covered with plastic. Even the box it comes in shows a Dreem 2 with the port.  \n\n\nI was wondering if anyone else owned a Dreem 2 Headband without the USB charging port, therefore requiring the dock for charging?"
          ],
          [
           "Outlier (-1)",
           "Taking time off. I've cut way back on endurance training due to nagging injuries. January to end of May I was doing up  to 10 hours cardio per week plus resistance training.\n\nI cut back, took a week off, slowly introduced some light zone 2 work, still had my pains nagging. Was going to reintroduce again, felt good yesterday, ran for just 35 minutes. Today, I strained my quad (again) doing goblet squats.\n\nI have hip pain that I think is bursitis. My tailbone has been a problem for about 18 months, the last 6 months being the worst. \n\nI'm going to take a strict 2 to 4 weeks off of any cardio besides brisk walking in zone 1, figuring I'll just walk a 5k a few times a week, and next to no lower body resistance training besides PT \"stretchercises.\" How much fitness is this going to cost me? Think this is wise?"
          ],
          [
           "Outlier (-1)",
           "Hyperbaric Chamber vs Oxygen Canister. Kind of a dumb question but what is the difference between a hyperbaric chamber compared to portable oxygen tanks in terms of benefits?"
          ],
          [
           "Outlier (-1)",
           "What would it require to clone something/someone in the future?. I know cloning pets is more and more common, we even had a cloned horse at the Olympics this year (which is what made me post this), so I‚Äôd imagine it becoming very common and refined in the near future. \n\nI have a very high end horse, best of the best breeding, a mind perfect for what I need him for (which supposedly is genetic?). But he‚Äôs getting old. \nI‚Äôve started thinking about saving a dna sample from him (with the help of my vet) and cloning him in some years when possible. \n\nBut what would it require to make this possible? Bot storage, what I‚Äôm sampling from him, and even potentially how can cloning be done on a home lab scale?\n\nNot sure if I‚Äôd actually do it, but it‚Äôs been something I‚Äôve been thinking about theoretically for a while"
          ],
          [
           "Outlier (-1)",
           "David Sinclair's Diet &amp; Exercise Tips for Longevity."
          ],
          [
           "Outlier (-1)",
           "High VO2 Max and low HRV. Listening to the latest Attia pod, got me wondering about my situation.  I have a high VO2 max (51-52, confirmed by a lab), but a low HRV (\\~35).  The HRV is based on the apple watch, so I am not placing too much value on it.  What is most likely my HRV based on my Vo2 Max?"
          ],
          [
           "Outlier (-1)",
           "Does anyone have an idea what could be causing low white blood cells AND low mean platelet volume.. Third blood test in a row with low WBC, first one with low MPV. Neither are severely low. Not sure what my next steps are as I don't have a doctor following/advising me."
          ],
          [
           "Outlier (-1)",
           "Where to find a used Dreem 2 headband device in Europe?. If anyone has ideas (beside eBay) or one they'd consider selling, please let me know.\n\nMany thanks,\n\nDD"
          ],
          [
           "Outlier (-1)",
           "Tip for buying biohacking gadgets: second hand!. I just bought a second generation Oura ring for 75,00, and saw a Muse headband for 130, on a second hand platform here in the Netherlands. I have searched others such as Ebay and I can see we can find some interesting new/as good as new gadgets if we buy them second-handed. I am sharing this info because I know those can be quite expensive and sometimes we think they are not affordable at all, but if we do a good research, we have a better chance to get them. Specially because a lot of people buy those on an impulse purchase, and never use it, so it‚Äôs not that hard to find. Thought it was worth sharing :)"
          ],
          [
           "Outlier (-1)",
           "Getting bloodwork done, what should I check?. Hello biohackers!  \nThree years ago, I got my vit D3 and B12 checked. I know many Americans have low D3, and my sister has low B12, so I thought it was worth checking.\n\nI was told by the doctor that my levels were normal. Well, only two weeks ago did I actually look at the *numbers*. Technically, they're both in the normal range - but barely. My D3 was at 36 ng/mL, with the normal range being 30-150. Barely normal! My B12 was around 530, with the range being 250-1250 (I forget the units).\n\nI'm going back next week to get more blood work done. Since checking, I've been taking magnesium and D3 vitamins. Hopefully that improves my vit D metric (I know magnesium is needed to absorb this vitamin). \n\n**Besides Vitamins D, B12, and magnesium, what should I check?**\n\nI'm thinking testosterone, iron, folate/B9, phosphorus, zinc, selenium, and vit A. This is just what I can gather from skimming a few sources. Are any of these not testable or am I missing any obvious ones?\n\nCheers!"
          ],
          [
           "Outlier (-1)",
           "Anyone know what might cause my body to have high levels of Creatine Kinase??. I was at 280 in March but my last test showed a drop to 212 with the top of the range being 196. \n\nJust wondering? No doctor can answer my question. They just say, let‚Äôs try to get that number down. ???\n\nThanks in advance."
          ],
          [
           "Outlier (-1)",
           "Identifying Potential Causes of High Blood Pressure from 6 months of Self-Tracking: No Large or Actionable Effects."
          ],
          [
           "Outlier (-1)",
           "How to measure brain performance?. I see a ton of articles and supplements that involve *\"increasing (or improving) brain performance.\"*\n\nMy question is, how is brain performance measured?\n\nI ask honestly to get a rough guide. I know that if I want to be slim, I need to measure my weight and decrease it.\n\nSo I want to \"be more intelligent\", what metric matters?"
          ],
          [
           "Outlier (-1)",
           "does sugar in kombucha lead to high glycemic index?. Looking on the web seems to give very divided answers. How would it be possible to figure out if all the added sugar in the store bought kombucha has been used for fermentation or does the added sugar mentioned on the labels mean sugar left after fermentation ? Thanks"
          ],
          [
           "Outlier (-1)",
           "New JAMA Study - Lifestyle Impact on Longevity. A new study on JAMA looking at lifestyle factors that impact longevity. No major surprises, but alcohol use does not appear to have a major impact on longevity. There are shortcomings in the study that the authors highlight and need for additional studies to be done. One factor that does appear to impact longevity is ‚Äúfood diversity‚Äù.\n\n[https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2820220](https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2820220)"
          ],
          [
           "Outlier (-1)",
           "[EXPLAINED] Heart Rate Variability; Predicting Your Future Health?."
          ],
          [
           "Outlier (-1)",
           "Has anyone tried to implement \"The Switch\" by James W. Clement?. I just finished \"The Switch\" by James W. Clement. And it is terrific! It touches on the Fasting Mimicking Diet, Intermittent Fasting, Keto, High Intensity Interval Training and various supplements. The thing that caught my attention was *protein cycling* which was new to me. \n\n*The Switch: Ignite Your Metabolism with Intermittent Fasting, Protein Cycling, and Keto*  \n\nThe problem is that there is a lot of flexibility on how you implement it. \n\nI was wondering if anyone is currently following this or a similar diet and if so, I'm asking if you would describe their Catabolic regime (the days that you are reducing proteins and carbs to trigger autophagy). \n\nYou're suppose to be catabolic 8 months out of the year. But, the author says that you can select your own schedule. I was thinking of cycling each week. So I would have five catabolic days (low carb and low protein) followed by two anabolic days (low carb and higher protein). \n\nFor example, what do you eat for lunch and dinner? It's a high fat, low carb and low protein diet with low animal protein. I'm thinking big salads with macadamia nuts and a lot of olive oil. I can also imagine stir fry. I like salad and stir fry. But this seems *pretty monotonous*. That's where I need your help.\n\nAlso if you take any supplements to induce autophagy or perform regular blood tests and are willing to share this, I would really appreciate it.\n\nFinally, if you are interested in collaborating on this, please DM me."
          ],
          [
           "Outlier (-1)",
           "Resting Heart Rate Discrepancies. Anyone else have a noticeable gap between there resting heart rate level during the day versus when they are asleep. Which one is the more appropriate to use. During sleep my RHR ranges between 54-60. But during the day my RHR normally sits around 70-75. Is this normal to have such a difference from sleep vs awake. And which one should I use. Because if I use the nighty one I would say my RHR is in a good place but the daily one  is high"
          ],
          [
           "Outlier (-1)",
           "A a list of everything Ben greenfield has endorsed?. I know Ben greenfield has gone off the deep end recently, but reading through his previous blog posts, it‚Äôs just endless and endless promotion of different complex-sounding training methods, dieting methods, and supplements.\n\nIt‚Äôs a little too much for me, and I feel like half the things he mentions are snake oil, but I like researching these less talked about things, I just can‚Äôt fathom sifting through each of Ben greenfields blog posts to find some droplets valuable info.\n\nI‚Äôm just wondering has does anyone have a compiled list of the name of every single thing/diet/training method/health practice that Ben greenfield has endorsed?"
          ],
          [
           "Outlier (-1)",
           "Have you guys seen this? AI where you can input a question, returns text answer based on Huberman youtube videos and provides sources.."
          ],
          [
           "Outlier (-1)",
           "My HRV usually hovers between 25-40, rarely goes above 55, tried all sorts of things to increase it, but the thing that has worked the best is‚Ä¶ a purring cat relaxing on my stomach while I doom-scroll Reddit. Must be stimulating my vagus nerve or something.."
          ],
          [
           "Outlier (-1)",
           "Foot and Toe Recs from PA. Really enjoyed Peter's last pod regarding all things feet/toes. Does anyone have an exhaustive list of instruments/socks/etc that peter recommends/they discuss?"
          ],
          [
           "Outlier (-1)",
           "Greenfield's go to CBD, amazing interview."
          ],
          [
           "Outlier (-1)",
           "Wanted to share my clinical work flow as a physician with an interest in personalized medicine and longevity. \\*\\*Importantly, this does not constitute medical advice; speak to your physician about your own healthcare decision making\\*\\*\n\nI am actually a dermatologist but I do personalized longevity medicine consulting for a few clients here in NYC. Obviously listen to the Drive and a lot of my workflow is based on Attia's work. Happy to share with you my workflow and can answer some questions. Obviously, the whole point of personalized medicine is that it is personalized to patient's specific risk factors/goals.\n\n**Preventative Cardiology**\n\n*Labs:*\n\nLipid Profile:\n\nTotal Cholesterol\n\nLDL Cholesterol (Low-Density Lipoprotein)\n\nHDL Cholesterol (High-Density Lipoprotein)\n\nTriglycerides\n\nNon-HDL Cholesterol\n\nLp(a) (Lipoprotein a)\n\nApoB (Apolipoprotein B)\n\nInflammatory Biomarkers:\n\nhs-CRP (High-sensitivity C-reactive Protein)\n\nLP-PLA2 (Lipoprotein-associated Phospholipase A2)\n\nOther Tests:\n\n1.Homocysteine\n\n2.Uric Acid\n\n3.Omega 3 Fatty Acid Index\n\n*Imaging:*\n\n1 Coronary Calcium Score (yearly or every few years in most clients depending on risk, see below)\n\n2. Coronary CT angiogram (patient dependent, high risk mostly)\n\n*Risk Calculators:*\n\nFramingham Risk Score\n\nASCVD Risk Calculator\n\nQRISK¬Æ (favored)\n\n*Wearables:*\n\nBlood Pressure: Most have a cuff and I recommend they take measurements a few times a week at the same time, ideally both morning and evening. I also have been recommending a [wrist based monitor](https://aktiia.com/uk/blood-pressure-monitor) for those who want to do 24 hour monitoring/blood pressure lability etc.\n\n**Metabolic Health, Obesity and Diabetes**\n\n*Labs:*\n\nFasting Blood Glucose\n\nInsulin Levels (for HOMA-IR calculation)\n\nHbA1c (Glycated Hemoglobin)\n\nTriglyceride/Glucose Ratio\n\nMets-IR\n\n*Measurements:*\n\nWeight, BMI calculation\n\nWaist Circumference\n\n*Imaging:*\n\nDEXA/Body Composition (yearly, evaluate for visceral fat, lean body mass, and bone density, estimate basal metabolic rate, etc)\n\n*Wearables:*\n\nFor most clients, we do a couple of months of continuous glucose monitoring, but then stop and do annual screening if it is not changing management.\n\n**Musculoskeletal Health and Exercise:**\n\n*Imaging:*\n\nDEXA (as above)\n\n*Wearables* (Most of my clients use an Apple Watch and share the data with me):\n\nResting Heart Rate; HRV (heart rate variability), VO2 max (imputed and calculated annually formally), HRR (heart rate recovery)\n\nI also measure FEV1 with a spirometer annually and grip strength in office and track age adjusted percentiles\n\n**Sleep**\n\n(all imputed from the Apple Watch, imperfect but acceptable for patients without true sleep pathology; if we are concerned about something I refer them for formal testing/sleep studies)\n\nSleep efficiency, total hours, REM onset, REM density, REM:NREM ratio, sleep cycles, awakenings, HR drop\n\n**Endocrine**\n\n*Laboratory Studies (Male patient, example):*\n\nFree, total testosterone\n\nSHBG\n\nFSH/LH\n\nProlactin\n\nSalivary Cortisol\n\nIGF1\n\nTSH (Thyroid Stimulating Hormone)\n\nFree T4 (Thyroxine)\n\n**Cancer Screening and Prevention:**\n\nComprehensive Family History-&gt; Age Appropriate Screening Based on History as well as genetic propensity testing (see below).\n\nI use this Spanish genetic testing company which spits out this profile; positive tests are followed up with formal, medical grade testing .\n\nI then use codegen.eu to do a more formal single nucleotide polymorphism (SNP) based risk evaluation.\n\n**Diet, Nutrition, Gut Microbiome:**\n\nI use MyFitnessPal to do comprehensive food logging for at least a few months or when doing dietary interventions. I am specifically interested in:\n\nCaloric Intake Per day\n\nMacros (mostly to ensure daily protein 1.2g/kg body weight minimum or more depending on fitness goals)\n\nFiber Content\n\nOther Things like Saturated Fat, etc\n\nFor microbiome, I do recommend akkermansia for most patients. I also do more general probiotic/pre biotic supplementation based on other health conditions, microbiome composition at baseline, etc.\n\n**Sexual Health**\n\n**Aesthetics**\n\n**Cognition**\n\n**Aging Clocks** (unlike Peter Attia, I actually find biological clocks to be useful information when evaluating the effects of interventions longitudinally).\n\n GrimAge/PhenoAge\n\nThis is only part of my work up, but gives you a taste. I'm also pretty bullish on supplements that are rigorously supported by class I evidence, mix of allopathic and complementary medicine approaches, etc. \n\nI just take a very personalized, client specific approach. As long as they understand risks, benefits, alternatives, I try to harmonize with their goals.\n\nHappy to answer questions."
          ],
          [
           "Outlier (-1)",
           "10 days with a CGM. TLDR: OMAD meals give me 4+ spikes, not that high initially, postprandial raised for 5-10 hours after eating.\n\nHey guys, HNY! It has been 10 days I am on a CGM, and ai might have a full insight, but the reason why I am on is that I noticed some symtpoms as high fasting (albeit it is nornal with the CGM ptibably because I am eating 8+ hours before sleep), but among other things long lasting high postprandial. Except the pizza I was sedentary afterwards and generally my physique is skinny fat, 155 lbs 6 feet tall late 20s.\n\nMy raise usually happens 30 min after I start the food.\n\nSo my postprandial numbers, after big carby OMAD meals like pure 500g+ of cooked brown pasta (200g uncooked) I would spike to 160, but will get down quickly to 115, then have 3-4 spikes to 130 and they wind down. This process might be 6+ hours of spikes and downs.\n\nFew days ago ai had a burger with small fried potatos portion and some healthy low car seeets, I hit less then 135, then a few downs to 100 and even once back to 80 then back to 130, glucose and inuslin fought for 4 hours then I was back to baseline.\n\nYesterday I ate 60% of a 40cm pizza, and I this one was the longest. Immediatelly after eating I went on ellipitcial for 30 minutes, I stagnated to 125 for about half an hour, maybe because of it, myabe not, but then to 137, then back to 120, then 130, then the third one was 145. I never got down to less than 120 in the first 6 hours, and actually at the 6th hour I was reaching 140 barely for a point. After that it finally dropped to 85 at rhe 6.5 hour mark, raised back to 125, down to 90, then to 105 and finally I never got another raise after the 10 hour mark damn. But the pizza was destorying me, even with 30 min of intense workout afterwards, which most likely damped the spike.\n\nSo in summary when I eat small portitons it usually lasts 3 hours of spikes but they are not higher than 135 and wind down wuickly to less than 120, with the pasta, I got very high (both me and my GF which has good glucose control - I tested her with a fingerpick), however it lasted long time about 6 hours, but my other spikes were usually under 125. The pizza was disastrous, lasted 10 hours, 6+ with spikes to 140.\n\nSorry for the bad write up, on phone and quickly writing it down, bur I windered if any of you have similar numbers that last for so long. I should probably head to the endocrinologist after I test everything, but still maybe someone can find this useful or just give me an idea to test about."
          ],
          [
           "Outlier (-1)",
           "just found this sub and. What's going ON???? EXPLAIN PLEASE????"
          ],
          [
           "Outlier (-1)",
           "My labs - looking for advice. I just got a (relatively) comprehensive blood panel done. Missed a few things, but a good start. Wanted to get feedback from the brains here on what I can do to address some of my health concerns, given the labs and my personal context.\n\n  \n**Context:** Male. late 30s, trim/healthy all my life. Lifted for years, started cardio this year just for heart health. Eat clean as fuck. Realistically at about 13-14% BF. Will get more into diet later since everyone thinks of a good diet differently. I take Mag, Zinc, D/K, and Theracurmin. No other supps, no drugs. The main health concerns I have are:\n\n* Bad sleep. Perfect sleep hygiene but wake up early most days and cannot fall back asleep. The Matthew Walker pod episodes did enough to scare the shit out of me on this. Probably related to...\n* High anxiety/stress at work,and what I perceive to be high cortisol (may be caused by bad sleep, or causing bad sleep itself).\n* High fasting glucose (\\~95-105) and high-ish A1C (5.4-5.6) for a decade now.\n* Lowish but in-range T (ranging from low 300s to low 500s, usually in the 400s). True since my early 20s, not a late 30s thing.\n* Persistent belly fat despite cutting / being skinny everywhere else. As someone who has worked out for a long time and done a lot of reading, I have a hunch this is cortisol/testosterone/sleep related as opposed to just being \"lose the last 3% bro\". I also have a hard time putting on serious muscle.¬†For context, even at a skinny weight (and lifting/eating well), my abdominal skinfold hovers around 22-30.\n\nEverything else is honestly fine. People in my life see me as the paragon of health.¬†  \n**Labs - From Marek (their aggressive reference ranges). Labs taken at 830am, fasting, after a night of 2-3 hrs of sleep (could not sleep).**  \n**Lipids:**\n\n* **Apo-B: 75 (&lt;90)**\n* **Total Chol: 151 (100-199)**\n* **HDL-C: 69 (&gt;39)**\n* **LDL-C: 73 (&lt;100)**\n* **Trigs: 39 (&lt;150)**\n* LDL-P: 655 (&lt;1000 \"Low\")\n* HDL-P: 29.7 (Low, target &gt;30.5)\n* Small LDL-P: 180 (&lt;527)\n* LDL Size: 20.6 (&gt;20.5)\n* Large VLDL-P: 1.0 (&lt;2.7)\n* Small LDL-P: 180 (&lt;527)\n* Large HDL-P: 12.1 (&gt;4.8)\n* VLDL Size: 40.9 (&lt;46.6)\n* LDL Size: 20.6 (Low, Target¬† &gt;20.8)\n* HDL Size: 10.3 (&gt;9.2)\n* **LP-IR Score: &lt;25** (very good according to their table)\n\n*Comments: Looks pretty good, all lipid sizes seem good except LDL/Small LDL/Large VLDL sizes are close to median rather than 'super good'. Not sure how much lower ApoB can be without drugs, which I am not super keen on. Forgot to do LPa so will do that next time. And maybe CAC.*  \n\n\n**Omega:**\n\n* **OmegaCheck: 9.8 (&gt;5.4)**\n* Arachdonic Acid/EPA Ratio: 4.2 (3.7-40.7)\n* Omega-6/Omega-3 Ratio: 4.0 (3.7-14.4)\n* Omega 3 total: 9.8¬†\n* **EPA: 2.9 (High, target 0.2-2.3)**\n* DPA: 1.5 (0.8-1.8)\n* **DHA: 5.4 (High, target 1.4-5.1)**\n* Omega-6 total: 39.0¬†\n* Arachidonic Acid: 12.2 (8.5-15.6)\n* Linoleic Acid: 24.8 (8.6-29.5)\n\n*Comments: Seems good, but is there any risk in \"high\" EPA and DHA? I do eat a lot of fish.*  \n\n\n**Hepatic Function**:\n\n* Protein, Total: 7.9 (6.0-8.5)\n* Albumin: 5.2 (High, target 4.1-5.1)\n* Bilirubin, Total: 0.4 (0.0-1.2)\n* Bilirubin, Direct: 0.14 (0-0.4)\n* Alkaline Phosphatase: 84 (44-121)\n* **AST: 23 (&lt;41)**\n* **ALT: 33 (&lt;45)**\n\n*Comments: Prefer to have lower liver labs but not sure how. Is Albumin slightly a high a symptom of something bad?*  \n\n\n**Hormones**\n\n* **Testosterone: 395 (264-916)**\n* **Free Testosterone: 9.8 (.7-25.1)**\n* **Cortisol: 15.3 (6.2-19.4)**\n\n*Comments: Test a little lower than normal, but could be the 2 hours sleep. Always lowish, usually in 400s. Cortisol, I may do follow up testing for 24 hour urine/blood to get a sense of it there are issues with overnight.*¬†  \n\n\n**Metabolic**\n\n* **A1C: 5.6 (&lt;5.7)**\n* **Fasting Glucose: 99 (&lt;100)**\n* **Fasting Insulin: 4.8 (2.6-24.9)**\n* **Calculated HOMA-IR: 1.2**¬†\n\n*Comments: This is the lab I want to fix most. I eat completely whole foods, about 1.0g per LBM protein. I am at about maintenance TDEE as my weight has stayed steady. I alternate carb days (4x a week when lifting) with high-fat low-carb days (3x a week when not lifting and just doing cardio). My 2-week CGM experiment told me that my baseline glucose is usually in the high 90s or low 100s. When I eat carby meals, depending on the meal, I see spikes from 140 to sometimes as high as 180. Double-humped return to baseline over 2-3 hours. I really think the issue is my high baseline glucose, which I think should be in the 80-90 range rather than \\~100, given all my other stats, diet, etc. Given relatively low fasting insulin, is it really insulin resistance? How do I become more insulin resistant?*¬†  \n\n\n**Other**:\n\n* **Homocysteine: 9.2 (&lt;14.6)**\n* **C-reactive protein: 0.47 (0-3)**\n* Uric Acid: 5.6 (3.8-8.4)\n* Vit B12: 826 (232-1245)\n* Vit D: 75.8 (30-100)\n* Ferritin: 201 (30-400)\n\n*Comments: These seem fine. Not sure anything pops. Given my ok homocysteine levels and already high Omega 3 levels, not sure there is anything to change diet or supplement-wise to drive homocysteine even lower. Already taking Theracurmin and Magnesium L-Threonate. But open to advice!*"
          ],
          [
           "Outlier (-1)",
           "Need help with building a community on Holistic fascia training. i apologise as i do not really know which sub to post this but i need help with building my community about fascia training, relatively a new concept on developing maximal performance with the body. \n\n[https://www.reddit.com/r/FasciaFitness/](https://www.reddit.com/r/FasciaFitness/) heres the link to anyone interested, and im also looking for mods and people that are knowledgable on the topic"
          ],
          [
           "Outlier (-1)",
           "Hope for the down beaten. 6 years ago I weighed 450 pounds, I was couch bound, out of control type two diabetes, high blood pressure, leg sores, I would get winded trying to squeeze into my car.     My BMI was near 70.   \n\nAfter 6 years of unrelenting effort.   My skin hangs off me in sheets.    My BMI is 30.    My average morning Blood pressure with out meds is 116/68.   my A1c is 4.7   I weigh 217\n\nI go on 1-20 hour walks with weighted vests ( 30 lbs)    I lift weights 5 times per week.    \n\nI just got labs done.    TC- 131   Triglycerides  47   HDL 55    LDL 67    Non-HDL 76    APOB 58\n\nMeds I take daily.        250 mg metformin,     Monjurno  weekly injection.      \n\nAt age 63 I can get my heart rate up to 180-190 hold it for 60 seconds and recover with ease.    \n\nI can bench press more than my body weight.     I can walk for HOURS.    \n\n&amp;#x200B;\n\nI used every trick in the book to get here.     Weight loss surgery, injectables, keto, long slow burn cardio,    ALL OF IT.    \n\nSo the message is you are never to far gone to get better.   A little better everyday adds up over time."
          ],
          [
           "Outlier (-1)",
           "First time wearing a glucose monitor. My sugars are always so low. I'm confused is this even healthy?."
          ],
          [
           "Outlier (-1)",
           "Apple hits ‚Äòmajor milestones‚Äô in moonshot to bring noninvasive blood glucose monitoring to Apple Watch."
          ],
          [
           "Outlier (-1)",
           "Hackable real-time glucose monitor recommendations?. Anyone have any experience or found any glucose Hardware that I could get data from?\n\nContext - I‚Äôd like to build an app that uses the data to creat suggestions and feedback based on what it captures."
          ],
          [
           "Outlier (-1)",
           "Question on healthy glucose metabolism. Hello everyone, apologies if this isn't the right place to post.\n\n25 M, 6'5, 231 pounds. Over the last couple of years. I have lost 130 pounds. At my heaviest, I had a pretty clear cut case of metabolic syndrome. High LDL, low HDL, high Trig, hypertension, impaired fasting glucose. Since losing weight, all of my values have normalized and I was taken off blood pressure meds.\n\nAs a part of my weight loss, I began to monitor my blood sugars. And I've noticed an interesting change in my glucose responses the more weight I've lost. When I eat a carb heavy meal, I always raise up to around 125 mg/dl at the 30 minute mark, drop down to low 80s at the 1 hour mark, and then go back up to around 100 at 2 hours, and I slowly drop into the 90s over the next hour.\n\nI always try to balance my plate. I lift weights so I try to get a good amount of protein. Always whole grain carbs, never white carbs. Fruits and veggies. Nuts and plant oils. I also only drink water, coffee, or tea.\n\nMy concern lies in this big \"dip\" in blood sugar at the 1 hour mark. It seems to be dropping lower the more weight I lose. Today it was 79, which is the lowest sugar number I've ever had. Is there any reason to believe this is unhealthy? I generally eat lower carbs, and I only eat breakfast and lunch, I fast for the rest of the day. I also take berberine every morning if that matters."
          ],
          [
           "Outlier (-1)",
           "Neuro feedback device that is passive?. Like one I can listen to or use during sleep?  I have a lot of anxiety and mental issues and nothing has helped.  I think I need a brain rewiring program.  But I need one that is easy.  Something like DNRS or Gupta Program but more passive.  I tried the vibrating strap before with no success, Apollo Neuro."
          ],
          [
           "Outlier (-1)",
           "If anyone can answet this question, it's you:. I recently finished the 17 hour audiobook to Outlive.   \n\n\nBut now I need a resource that breaks down what labs I should be pursuing and what the ideal ranges are for those results.\n\n&amp;#x200B;\n\nI don't want to go through the entire book again if I can avoid it.\n\n&amp;#x200B;\n\nI looked at a few \"workbooks\" on amazon, but they were just summaries of each chapter.\n\nI am looking for a resource that essentially says \"this is what an insulin sensitivity test is, this is what is is looking for, and here are the results you want\", or \"here is what your LDL should look like\" etc etc.   \n\n\nIs there an all-in-one resource that sums up the recommended labwork from the book?"
          ],
          [
           "Outlier (-1)",
           "How to structure and implement the longevity journey based on Peter Attia philosophy?. Peter outline the different pillars of health-span and lifespan in Outlive and his podcasts and blog posts go deep into various topics. I have been on my own journey for 3 years and have seen incredible results by optimizing exercise, nutrition, sleep, mental health and supplements. \n\nThe obvious issue is that this topic is so complex with so many components that may require lots of deep dives that it becomes a full time job to implement.\n\nHave you found an approach/ tools/ techniques to operationalize your journey so it is sustainable, modifiable and repeatable?"
          ],
          [
           "Outlier (-1)",
           "Soleus Pushups - Can this be debunked?. HI there\n\n&amp;#x200B;\n\nI recently saw this video: [https://www.youtube.com/watch?v=CU4FbEplZQI&amp;t=365s&amp;ab\\_channel=AndrewHubermanRewind](https://www.youtube.com/watch?v=CU4FbEplZQI&amp;t=365s&amp;ab_channel=AndrewHubermanRewind)\n\nReferring to this study: \n\n[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9404652/](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9404652/)\n\n&amp;#x200B;\n\nHere is my question:\n\nI was curious if blood glucose levels would also decrease if someone were to perform a similar movement with a different part of the body, such as bending the arm in the same way that the \"push-ups\" were executed. Would a comparable result be achieved, or is the impact of the soleus push-ups much more substantial?\n\nThanks a ton my friends."
          ],
          [
           "Outlier (-1)",
           "Longevity: What is healthier in moderation. Beer or Red Wine?. [View Poll](https://www.reddit.com/poll/11u20e0)"
          ],
          [
           "Outlier (-1)",
           "Hey guys, I've been tracking my biomarkers for the past year and a bit now and have noticed some improvements and also some degradation. I am wondering about what SPECIFIC interventions/protocols I could implement to improve the bio markers that are either above(high) or below(low) optimal range.."
          ],
          [
           "Outlier (-1)",
           "For Reducing ASCVD Risk, Peter Recommends Lowering apoB Early &amp; Aggressively (short audio clip)."
          ],
          [
           "Outlier (-1)",
           "Comprehensive Health / Bio-markers Testing - Europe. Hi all,\n\nIve been suffering with a few minor health issues the past 3-4 years, mostly just picking up common colds and the likes pretty easy. Ive also been getting cold sores more frequently, which is a sign my immune system being pretty low. I think I can mostly attribute this to lack of deep quality sleep, and also a lack of sunshine - Im in Ireland, where its pretty much dark for 5 months of the year.\n\nGenerally speaking, I have a good diet, mostly plant based, and if anything im probably guitly of trying too many new things ive heard on a recent podcats. Im not a big fan of supplements, the synthetic type anyway.\n\nI know alcohol impacts me bad also. I get bad hangovers from a night of beers, and generally feel bad while im drinking. I would really like to establish if I might have a genetic pre-disposition to alcohol.\n\nAside from that, in general, I am curious to analyze my bio-markers and see if it turns up anything interesting around my diet, nutrients etc. \n\nThe problem is, its seems to be a minefield out there with all the various online platforms and types of testing offered. A lot of folk seem to label these tests \"*entertainment purpsoses only*\", so Im sceptical if there is actual concrete scientific value here at all.\n\nThat said, one company that grabbed my attention was [https://www.biostarks.com/](https://www.biostarks.com/). Has anyone experience with these guys? Theres not much feedback online.. or alternatively recommend an EU based company which may be able to offer releiable diet and nurtrition analysis / feedback?\n\nIs there a recommended process i.e. starting with 23andme, DNA-Fit or similar, and then doing a few more targetted tests - if it can fit into budget, and makes things easier, Id also be curious on ancestry insights also, but not priority.\n\nCaveat; as mentioned in subject line, it needs to be available in Europe.\n\nThanks all."
          ],
          [
           "Outlier (-1)",
           "Is my CRP level normal?. So I got some blood tests which showed I have CRP of 3.67 mg/L.  According to lab its withing the normal range (0-5 mg/L ) but reading some stuff on internet it says it should be below 1. I remember in past I had several other blood tests and my crp is always around 3 or 4. Should I be worried? my docs never mentioned it as a problem to me but I feel like I have the symptoms of chronic inflammation. I have chronic fatigue,muscle and bone pain, brain fog etc. \n\nIn past I tried daily aspirin which made me feel great but I had to quit it because of GI issues. So it made me  think that I really might have chronic inflammation."
          ],
          [
           "Outlier (-1)",
           "I am launching a groundbreaking at-home biomarker test kit, for biohackers, and longevity enthusiasts. Hello peeps!  \nA few weeks back I attended a longevity investor lunch - where all panelist were talking about steps their take towards better health span - but also acknowledging the lack of self-testing/self measurement solutions on the market.  \nMe and my team have been working hard. We are launching on Indiegogo next month our at-home biomarkers test kit that measure 40+ biomarkers out of 4 droplets of blood, including 30+ essential micronutrients and some hallmarks biomarkers of ageing: NAD+, Rapamycin, Senescence.   \n\n\nPlease have a look and looking to build a conversation here!  \n\n\n[https://www.indiegogo.com/projects/biostarks-longevity-at-home-test-kit/coming\\_soon/x/31282551?rdt\\_cid=4302494107204397780&amp;utm\\_campaign=awareness\\_campaign&amp;utm\\_content=longevity\\_communities&amp;utm\\_medium=clc&amp;utm\\_source=Reddit&amp;utm\\_term=ad1](https://www.indiegogo.com/projects/biostarks-longevity-at-home-test-kit/coming_soon/x/31282551?rdt_cid=4302494107204397780&amp;utm_campaign=awareness_campaign&amp;utm_content=longevity_communities&amp;utm_medium=clc&amp;utm_source=Reddit&amp;utm_term=ad1)"
          ],
          [
           "Outlier (-1)",
           "Has anyone signed up for January AI's new metabolic health product?. Hi I am on their mailing list and it looks like they are coming out with a whole new program where you wear a CGM once then their AI keeps working as your CGM. Seems pretty cool. Online it says it's $288 but I got an email saying I could try it for $144. Thoughts on trying it out/want to try it with me and we discuss here?"
          ],
          [
           "Outlier (-1)",
           "Noticeable improvement in hearing since ‚Äúmegadosing‚Äù fish oil. I notice this day to day and confirmed via audiogram.."
          ],
          [
           "Outlier (-1)",
           "Who would you consider health thought leaders who are RATIONAL?. Meaning, interested in the PROCESS of how they know, not just WHAT they know (content).\n\n&amp;#x200B;\n\nI follow people like Paul Chek &amp; Jack Kruse, which I consider to be quite intelligent (they know a lot!), but not very rational. I often have to double check their work because they make some leaping conclusions.\n\nWhile on the other hand, Andrew Huberman would tick the box on rational for me because he is able to make sensible critiques of studies and revise his beliefs according to new data.\n\nBasically looking for others like him to use as a heuristic, before I dive deeper on my own"
          ],
          [
           "Outlier (-1)",
           "Essential Health Parameters. Let's say budget was no issue, what battery of tests would you order? Your DNA sequenceed surely, perhaps also your microbiome? Any others?"
          ],
          [
           "Outlier (-1)",
           "Xg3 biomagnet DIY feasibility?. I recently got an Xg3 injectable biomagnet from Dangerous Things. I've read their guides and I know that doing it myself would be stupid and increase risk of infection notably, but I'm still curious. Have any of you done a DIY installation of an injectable implant? How did it go?\n\nI have never once had issues with any piercings or tattoos becoming infected, my body seems to take to external modification suprisingly well. \n\nI haven't opened the package so everything is still sterile, honestly I thought the needle would be smaller lmao but here we are."
          ],
          [
           "Outlier (-1)",
           "Reading about the positive impact P3S-humanin might have in reducing Alzheimer's risk.  Is there a way to be tested for this?. I'm seeing a number of articles that call out how P3S could significantly reduce the odds of developing Alzheimer's - [https://pubmed.ncbi.nlm.nih.gov/38520065/](https://pubmed.ncbi.nlm.nih.gov/38520065/).  As someone carrying both APOE markers and of Ashkenazi descent, I'd love to know if I might have gotten lucky.  My biological father is in his late 80's with siblings in their 90s and his mother died at 105, so it doesn't seem impossible.\n\nCurious if anyone is aware of a way to get tested.  So far, I've only done 23andme for genetic testing.\n\nThanks in advance."
          ],
          [
           "Outlier (-1)",
           "continuous glucose monitors. any meaningful difference between the various devices/providers?\n\nI'm going to try it. and I thought that I just need the raw data, and I sold be able to correlate in my own with for journal and activities.\n\nit's there any reason to worry too much between the variety of apps and providers?\n\nps. non diabetic\nthanks &lt;3"
          ],
          [
           "Outlier (-1)",
           "Where to put magnetic implant for sensing?. Im looking into getting a magnetic implant for sensing. I do have two questions though: What kind of magnet is best for sensing (im looking at the Dangerous Things Ti covered magnet and also the two magnets at Steve Haworth's, but I don't know what the difference is between the Magician's and the silicon coated magnet)\n\nThe bigger question is where do I put the magnet if I don't want to put it in my finger tips? (I play finger style guitar)"
          ],
          [
           "Outlier (-1)",
           "Micro biome tests. First time poster so please let me know if I break any rules. \n\nI recently listened to a podcast that featured a company that‚Äôs doing gut health tests. Apparently, they evaluate RNA, from samples of blood and stool, to identify microorganisms in the gut and provide recommendations on foods to eat and avoid, and also sell supplements designed for individual gut issues/health. \n\nDid a quick online search and there are a few companies in this space, with slightly different offerings. \n\nWe all know how important a healthy microbiome is to longevity. Does anyone have experience with these tests? Was it valuable to you? Thanks all."
          ],
          [
           "Outlier (-1)",
           "50 EUR/USD off Oura Ring 3 and 6 months free membership. Hi! üòä  \nUse my link if you want to get 50 EUR/USD off when buying your new Oura Ring 3 and get 6 months free membership. I have five discount codes to give away. [https://ouraring.com/taf/fe8e9793da](https://ouraring.com/taf/fe8e9793da)"
          ],
          [
           "Outlier (-1)",
           "Seeking implantable RFID field detection device. I'd like an implantable device that can detect nearby RFID fields. Specifically the passive fields produced by commercially available pet microchips. \n\nI work at an animal sanctuary, handling dozens if not hundreds of animals a day. It would be so convenient for a LED to light up in my hand everytime it passes over one of their chips. \n\nNo light on handling would be a huge red flag to double check microchip status of a sanctuary animal, and I could screen every one of them every time without having to pull out the big chip reader. \n\nAlso would be handy outside of work. Petting a stray, hand lights up, oh hey they have a chip, get reader out of bag and call their human. \n\nDoes it exist?"
          ],
          [
           "Outlier (-1)",
           "I implanted a magnet into my finger on my own - probably not in the best way possible. Advice appreciated. TLDR I had a bio magnet injection kit from dangerous things that sat around unopened for MONTHS because I couldn‚Äôt find a single person to do the procedure. After calling around to every shop within fifty miles, they all ended up saying no, and even shops I was referred to would just refer me back to other shops. So I was annoyed, after calling the hundredth time or so about it to yet another shop who refused, and I did it myself. \n\nI implanted the magnet into my left middle finger, after marking out where I wanted it to go with two dots of eyeliner. I didn‚Äôt use any numbing agents, so I kinda just put it in slowly, and put it into the side of my finger. I still have all feeling in said finger, and the wound from the needle looks like it‚Äôs closing. I put tubular gauze on my finger for a bit before putting it into a splint. I bought butterfly closures also and am trying to use them but they seem pretty useless. My skin definitely feels tight around the magnet, and I‚Äôm assuming it‚Äôll slowly stretch to accommodate it over time. With that being said, I have no idea how to help this thing heal. I obviously need to be cleaning it regularly, but other than that I dunno what to do. Before you ask, yes I am stupid. Yes I believe that it may become infected and that‚Äôs my fault. No I don‚Äôt know what I‚Äôm doing. Feel free to make fun of me . I have lost all control of my life and I mean that in the most genuine way possible"
          ],
          [
           "Outlier (-1)",
           "Destress wearables. At the risk of starting another heated debate, can anyone give me a thumbs up or thumbs down for Apollo Neuro? I want to improve my deep sleep but always seem to have a low sleep HRV. I struggle to actually find time to meditate so I‚Äôm trying to hack stress with some form of tech. Has anyone tried Apollo Neuro and can vouch for it?"
          ],
          [
           "Outlier (-1)",
           "Ergonomic Kneeling chair for office. Has anyone bought an ergonomic kneeling chair for improved posture? I am considering one to help improve my forward head posture while sitting at the desk. Any input is helpful."
          ],
          [
           "Outlier (-1)",
           "Interesting Info From Dr Patrick's DNA Analysis. Background:\n\nI did a 23&amp;Me test a few months ago.  It wasn't for family history - my sisters have researched that to the nth degree.  It was more that I wanted to know if I had a predisposition to certain diseases and whatnot.  Sadly, their report is pretty flimsy: I guess I learned I have a slight increased chance of celiac disease (never exhibited any tendency to this so guess I dodged a bullet.)  \n\nBut today I discovered that, for a small fee ($25) I can load up my 23&amp;Me data to Dr Rhonda Patrick's website and they will look at each gene variation identified and tell me about anything \"noteworthy.\"  Here are some things I learned:\n\n* I should not take supplemental vitamin E\n* I should avoid diets high in fat and especially those high in saturated fat (the Mediterranean diet came up again and again as the way I should go)\n* I am likely to be low in Vitamin D, even if I consume the RDA amount\n* Ditto for choline\n* I am likely to be predisposed to do well in endurance activities (long distance running, hiking, etc) and not \"power\" activities (power lifting, Crossfit, etc) \n* All kinds of dietary indiscretions that might be a minor thing for others would bump me out into obesity and diabetes\n* I had lots of alleles associated with living to 90+ years (I have two uncles right now that are 90+ (92 and 96) and one--passed away--that died at 94 and, as far as I know, never went to a doctor once in his entire life (farmer)\n\nI am posting because I am reading a current popular diet book, which my daughter recommended, that is basically promoting what amounts to a keto diet.  This is just proof, at a genetic level, that while those levels of dietary fat might be healthy for some, people like me should consume some healthy fats but basically need to keep fats low.\n\nThis was most definitely worth it ($25) to get all this information!"
          ],
          [
           "Outlier (-1)",
           "What lab tests do you order?. I order a basic lipid panel. I'm thinking of adding a vitamin B12, D, E test.\n\nI'm a male, 36, running, lift weights sometimes. No known health issues. Father had heard attack, mother a stroke both in their 50s.\n\nPS: I probably can't use US online test sites as I live in Thailand"
          ],
          [
           "Outlier (-1)",
           "Has anyone had success with hyperbaric oxygen chamber therapy?. Wanted to discuss and see if anyone has used and attenuated with hyperbaric oxygen chamber therapy and if anyone has seen benefits from it or just general information on it if you agree or disagree with therapy use from HBOC therapy? Asking for a relative."
          ],
          [
           "Outlier (-1)",
           "I think this belongs here guys!!! Warning: Long read. https://resistantstarchresearch.com/posts/ancestral-starch/."
          ],
          [
           "Outlier (-1)",
           "Anyone familiar with pharmacogenetic testing?. Anyone familiar with pharmacogenetic testing? Is it worth the money?"
          ],
          [
           "Outlier (-1)",
           "y‚Äôall should check this out. it‚Äôs a sick ass machine that simulates the altitude changes effects on your body, which gives your body a passive workout. it increases lymphatic drainage, removing inflammation, giving you more energy and essentially, yourself back.."
          ],
          [
           "Outlier (-1)",
           "Very high homocysteine. I just looked at an older blood work from last summer and noticed my Homocysteine was very high (46.3) my Folic Acid was low at 5.5 and B12 was 702.\n\nThis was around the time I had a 2 week period of shortness of breath and mightve had an infection as my CRP was also high.\n\nHowever the test mightve not been accurate as they did it in the evening around 7pm when I wasnt in a fasted state.\n\nShould I hop on Thorne‚Äôs Methyl Guard? Or just TMG? I took Gary Brecka‚Äôs dna test which showed MTRR from one parent and MTHFR from both parents"
          ],
          [
           "Outlier (-1)",
           "Anyone selling an apollo neuro in Europe?."
          ],
          [
           "Outlier (-1)",
           "ESPERMIDINA Y MI IMPLANTE DENTAL. Comparto con ustedes el uso de Espermidina en mi recuperation de extraction de diente y injerto de hueso para mi futuro implante dental."
          ],
          [
           "Outlier (-1)",
           "pillcam anyone?. Bryan Johnson (https://blueprint.bryanjohnson.co/#step-3-measurements) used the campill as one of his whole body measurements of health/biological age.\n\ndid other people here do it? I know it's expensive....\n\ncouldn't find much info online from a biohacking perspective\n..."
          ],
          [
           "Outlier (-1)",
           "David Sinclair MIB626=&gt; ban NMN. Dave Asprey bulletproof coffee =&gt; ??."
          ],
          [
           "Outlier (-1)",
           "My 17th week sending out a newsletter with all of Andrew Huberman's recommended reads, watches, and listens.. For the past couple months, I've been sending out a newsletter with all of Andrew's recommended content. Everything he talks about on any podcasts, shares on Twitter, or likes on Twitter, I send it out once a week!\n\nI thought I'd share again because it seems to be really helpful to people. Would love your thoughts!\n\n(I also do it for a bunch of other smart people so you can subscribe to as many people as you want and it all comes in a single email)\n\nCheck it out here: [Reclists](https://reclists.com/curator/andrewhuberman)"
          ],
          [
           "Outlier (-1)",
           "Health information epistemology: What is your process of figuring out what is true? Looking improve mine. I've recently gotten to the point where Im just frustrated with all the conflicting confusing health info  and claims out there. I don't know who to listen to anymore and what works. \n\n&amp;#x200B;\n\nI've come to the concllusion that I need to improve my health epistemology skills like learning how to read and critique primary sources better, and also have a more deliberate heuristics for initial decisions.\n\n&amp;#x200B;\n\nI was so confused and on the fence about things like fluoride, oil pulling, nnEMF, grounding, deuterium etc. \n\n&amp;#x200B;\n\nCurious to know how you guys make your health decisions of deciding what is true. \n\nAlso if you have any good resources for learning some more direcly applied t health epistemology skills: how to read studies etc."
          ],
          [
           "Outlier (-1)",
           "Turned off 296 after hearing guest was a chiropractic. It is possible this is a translation issue as I'm not in the USA, but I couldn't bring myself to get medical information from a chiropractic. Has this label changed? Or is this still the quackery from the 1800s saying diseases can be treated by relieving nerve pressure on the spine, with their proponents claiming they can treat deafness, cancer, asthma, high blood pressure, etc via this technique.\n\nDo USA chiropractics explicitly disown the junk science it is based on and go through a science-based programme? If so, great, someone let me know and I'll listen to the episode. If not, I'm disappointed in selecting this guest. There have to be other people informed about the topic where I don't have to question their training and susceptibility to quack ideas.\n\n&amp;#x200B;"
          ],
          [
           "Outlier (-1)",
           "Tak-653 order. I ordered from 3 days it ,but I don't know when and how I will receive my order .\nI've got an email msg that tells me that my ordere is finished and gives me Tracking number \nBut unfortunately I couldn't sign up in this app because it requires \"state field \" and Iam from Egypt not from the US \nAnd any thing I put it in the field tell me It is not valid \nSo what should I do ? \nAnd If I want to change the address details of the order how can I do so ?"
          ],
          [
           "Outlier (-1)",
           "Genetic test - detox pathways. I‚Äôm sure I could my own research, but unfortunately this weekend is way to busy for me to get buried in something else.\n\nCan someone point me in the right direction? I‚Äôm looking for a good overall genetic test that  does look for variations in detox genes specifically, plus all the other good stuff that most do like mthfr etc."
          ],
          [
           "Outlier (-1)",
           "Any questions to a researcher in upper GI tract microbiome?."
          ],
          [
           "Outlier (-1)",
           "Any grinding projects you guys have planned?. Been thinking about finally picking up an interlock for my motorcycle so I can start it off my xNT implant. I'm also looking at dangerous things new led siid dual storage chip. Seems pretty interesting, I find the 900 bytes of storage on my current model to be a bit restrictive."
          ],
          [
           "Outlier (-1)",
           "Breeder is a Danish film exploring the dark side of biohacking and rejuvenation therapies."
          ],
          [
           "Outlier (-1)",
           "US Navy body fat vs. bathroom scale (BIoelectrical impedance)?. **US Navy body fat vs. bathroom scale (BIoelectrical impedance)?**\n\n  \nWhat do you think will be the **most accurate?**\n\n* **US Navy body fat** measurements once a month\n* Buying a **Body Fat Scale** for $30-$50 from Amazon, measuring each day or week and calculating the average by the month \n\n**My goals:**\n\n* I just want to see whether I'm making progress on my **bodybuilding goals**\n* Should I also be measuring the circumference of muscles, or will Lean Body Mass &amp; Lean Fat Mass be enough?"
          ],
          [
           "Outlier (-1)",
           "The Cause of the Chronic Disease Epidemic | Insulin Resistance in Cancer, Arthritis &amp; Depression."
          ],
          [
           "Outlier (-1)",
           "Heart Rate Variability and Cognitive Function: A Systematic Review - PubMed."
          ],
          [
           "Outlier (-1)",
           "Continuous Blood Glucose Monitoring - need Dr's prescription?. It looks like you can get a Dexcom G6 for a little under $200 and a set of patches for about $15. Is there anything else you need to make this system work? I've seen comments about needing a prescription for this, but I can't imagine why considering you don't need a prescription for a regular blood glucose meter.\n\n[https://www.amazon.com/Dexcom-New-Receiver-Glucose-Monitor/dp/B07QGH3XMQ](https://www.amazon.com/Dexcom-New-Receiver-Glucose-Monitor/dp/B07QGH3XMQ)\n\nAre there any better systems?"
          ],
          [
           "Outlier (-1)",
           "PCOS (Polycystic ovary syndrome), Gardasil and Taurine. Dr. Peter Attia had always said the key to longevity in women is assessing their ovary and uterine health. I also think this is true, although there are other factors such as immunity, thyroid, thymus gland health as well which are more obvious signs of longevity.\n\nAnyhow, I wanted to share my story of when I was vaccinated with Gardasil in 2015. Gardasil is a controversial vaccine which is undergoing numerous lawsuits linking the vaccine with PCOS and premature ovarian failure. (1)\n\nI had never had any abnormal pap smears, and in fact that gotten a DNA pap smear in which was negative for any chances of cervical cancer, but I was a young woman who had an absolute belief in the Western medical system and complete blind faith in vaccines, so I decided to get the 2 shot Gardisil vaccine in 2015.\n\n6 months after my last shot, I was diagnosed with PCOS which was a shock because I was not the typical patient who developed PCOS. I wasn't overweight, I didn't have diabetes, nor pre-diabetic and I was athletic and quite healthy otherwise. **I always suspected the Gardasil vaccine was directly responsible for this diagnosis as I never had PCOS or ever had any symptoms of PCOS before getting this 2 shot vaccine.**\n\nHowever, a year later, for unrelated reasons, I started supplementing with taurine and when I went in for my annual gyno exam in 2017, my PCOS had completely resolved itself and I no longer had any symptoms of PCOS. I always thought that it was the taurine supplementation that eradicated the PCOS but at the time there was no medical research validating my theory. \n\nAnyway, now I see in 2024, there are many studies that link taurine to a resolution in PCOS symptoms. (2) The studies indicate that taurine regulates the insulin response that leads to PCOS. (3) I found it fascinating that Gardasil, supposedly a vaccine to prevent cervical cancer, somehow alters the insulin response of completely healthy people by elevating the production of androgen excess and impairing glucose intolerance. Firstly Gardasil is an mRNA vaccine (4) and mRNA vaccines can alter insulin response in people and impair glucose response but researchers haven't been clear on how it is able to do so (5,6)\n\nSo in conclusion, although I was initially one of many hundreds of thousands of young women initially damaged by the Gardasil vaccine, my PCOS became completely resolved after I began supplementation with taurine in 2016. \n\n**There are more than one hundred ways an RNA molecule can be chemically modified after it is synthesized. The functions of many of these modifications, collectively referred to as the epitranscriptome, are largely unknown.**(7)\n\nHence, I think we should be highly skeptical of all mRNA vaccines and be mindful of the marketing of these vaccines that could cause long-term damage.\n\nIn addition, for women who suffer from PCOS or those who have been damaged by Gardasil, taurine supplementation seems to be ideal in correcting the damage caused by Gardasil if taken early enough. At least, this was the case for me and according to new research in which taurine has been shown to resolve PCOS symptoms by altering androgen excess and also optimising insulin sensitivity. \n\nFor those of you who are curious, I began supplementing with taurine in 2016 mainly for general health related purposes due to the fact that I have always been a health conscious person interested in longevity. I had no idea at the time that it would lead to a complete resolution of PCOS symptoms. \n\nThoughts? If anyone wants to share their experience, please feel free to comment! \n\nSources: \n1. \"Americans have filed dozens of lawsuits against Merck &amp; Co. regarding its Gardasil HPV vaccine. Across the country, thousands of people have been seriously injured by this vaccine. Their injuries range from autoimmune disorders and premature ovarian failure to death.\" https://www.lanierlawfirm.com/gardasil-vaccine-lawsuit/\n\n2.https://www.researchgate.net/publication/374476468_Taurine_Supplementation_Improves_Insulin_Resistance_And_Oxidative_Stress_In_PCOS_Women\n\n3. https://pmc.ncbi.nlm.nih.gov/articles/PMC10929052/ https://journals.eco-vector.com/0300-9092/article/view/247098\n\n5. \"These results suggest that the booster shot of mRNA COVID-19 vaccine impairs glucose control and aggravates insulin resistance in human subjects\" https://www.medrxiv.org/content/10.1101/2023.12.27.23299358v1.full\n\n6. \"mRNA vaccines can alter glucose metabolism, causing a larger glycemic variability, especially in people who receive mRNA-based vaccines. In some cases, COVID-19 vaccines can cause abnormal blood glucose levels, including high blood glucose and hypoglycemia\" https://pmc.ncbi.nlm.nih.gov/articles/PMC10772784/\n\n7. https://irp.nih.gov/accomplishments/a-novel-mrna-modification-may-impact-the-human-genetic-code"
          ],
          [
           "Outlier (-1)",
           "Just looked at my app for all of my stats. So I've been using an app called gyroscope which has been an awesome app that I highly recommend for biohackers who like looking at data. Anyways, on the website version you can look at correlations of your data and for me I found that my sleep seems to improve the more I mediate during the day. So I figured that was enough to convince me that I need to start meditating more. \n\nHere is the [app](https://gyrosco.pe/improve/) if you are interested"
          ],
          [
           "Outlier (-1)",
           "Health conscious husband. My husband has been an excellent spouse this year (and every year) going above and beyond to support his loved ones! He‚Äôs a nurse and values health greatly. Our anniversary is coming up and I‚Äôm wanting to get him something health/longevity-focused. He‚Äôs a huge fan of Peter Attia‚Äôs longevity book. I thought about a dexascan but you need a doctor‚Äôs order for that. I also heard about a lumen metabolism breath device but it doesn‚Äôt seem worth the hype. I also thought about cryotherapy or some kind of biomarker test? but all the places around here are subscription-based. I understand sometimes you‚Äôd need to do something more than once but I want to make sure he‚Äôd like it first‚Ä¶‚Ä¶Also he‚Äôs super picky about massages so that‚Äôs out of the question. Any guidance or ideas?! Thanks!"
          ],
          [
           "Outlier (-1)",
           "New subreddit dedicated to Josiah Zayner!. Join us over at r/JosiahZayner for discussions related to Josiah and biohacking!\n\nAbout Josiah Zayner-                                                                                                                                         'Josiah Zayner is a biohacker, artist, and scientist best known for his self-experimentation and his work making hands-on genetic engineering accessible to a lay audience, including CRISPR.'                                           [Source](https://en.wikipedia.org/wiki/Josiah_Zayner)"
          ],
          [
           "Outlier (-1)",
           "Which studies convince you the most / influenced you the most?. Hi guys,\n\n&amp;#x200B;\n\ni check many studies. I love, how many are not popular but have amazing results... Give me those, which influenced you most?"
          ],
          [
           "Outlier (-1)",
           "Guide to CGM use. I'm thinking of getting a continupus glucose monitor, because i want to know which foods give me a carb crash and prevent weight gain. However, i suspect that there's a lot more that i could get out of a CGM. Can anyone give any tips on how to get the most out of a CGM? Or maybe can anyone give a link to an overview of CGM usage and how to really get the most out of one? Thanks!"
          ],
          [
           "Outlier (-1)",
           "RFID Implant troubles (shot off to side). Earlier today I attempted to implant the NExT chip into my hand. After it was done, it really didn't seem to be in the right spot and was pretty sore. I decided to take it back out because it was pretty close to the bone and tendon and decided that I would rather drop the $90 and try again rather than damage my hand and just take this as a learning experience. I had my girlfriend record the whole thing and upon looking over the recording, it almost looks like the implant is fine until it fully leaves the injection assembly, at which point it shot off to the side and settled on my bone and tendon. My current idea is that I didn't make a deep enough channel with the needle and injected it too close to the bone to begin with, so the implant took the path of least resistance to a place it could sit. If anyone has any ideas where I went wrong, please let me know. I plan on trying again in about a month when my current wound heals and I can order another kit."
          ],
          [
           "Outlier (-1)",
           "Could fasting have induced my endo?. Fasting induces growth hormone. Endometrial tissue has GH receptors and reacts to it by growing. So, should I stop intermittent and prolonged fasts while I try to heal my endometrial cyst? I'm taking visanne: dienogest hormone. \n\nMy gynecologist did not indicate laparoscopy just yet, we are waiting if the medication alone works and the cyst dissapeares spontaneously. We have talked about fasting being a good idea as it can promote some scar tissue healing and autophagy taking care of unwanted tissue in my body, but the fact about growth hormone stimulation is worrying.\nWhat do you think?"
          ],
          [
           "Outlier (-1)",
           "StrateGene Product Change. Wondering if anyone here has experience with StrateGene and knows if there are any alternatives?\n\nI purchased a $99 AncestryDNA test almost 2 months ago when StrateGene was still taking uploads of the raw data and analyzing it for a reasonable price (I think like $45). I received my Ancestry results today only to find that StrateGene has changed their product to their own DNA testing kit that costs $350 and they don't accept raw data uploads from other sources any more. I feel like I wasted the $99 for the Ancestry test.\n\nI'm wondering if there are any other services that interpret DNA results from Ancestry? Thanks."
          ],
          [
           "Outlier (-1)",
           "Rebounding fitness for lymphatic drainage and other health benefits claims. Has anybody tried this? There are all these claims that it helps with lymphatic drainage and boosts energy. However, not all rebounders are built the same and some are made with springs and some are made with bungee cords. Does anybody have any thoughts on this? Is it worth paying that much? Are these claims a marketing scheme to get people to buy these $600+ rebounders?"
          ],
          [
           "Outlier (-1)",
           "Can anybody share their experience of Vasopressin?. Was thinking of trying it for easing social interacting."
          ],
          [
           "Outlier (-1)",
           "Clear data on experiences of changing practice to go towards high energy.. Hello\n\nI wonder if there are people who have tested different diets, practices or others that gave them energy but with clear data.\n\nI see a lot of videos that promise to gain energy while eating or doing this or that but without any data.\n\nDo you know people who have really changed a lot of things with changes in practices or habits?"
          ],
          [
           "Outlier (-1)",
           "Genetic engeneering for beginners. Dear fellow sciencelovers\n\nI am trying to begin my quest in genetic engeneering\nDoes anybody have some:\n- good forums i can visit specifically for genetic engeneering\n- some how to guides (specifically I would love some detailled how to guides for plasmid construction as i have only found basic ones, like for examples wich restriction enzymes to use etc)\n- some good youtube channels to learn and discover this ( the thought emporium is great! Except i cannot do all these steps myself)\n- or any other usefull instructions or ways to achieve this goal of becoming a biohacker that knows his stuff/genetic engeneer\n\n\nAny information would be greatly appreciated! \nI feel it would be beneficial for anyone trying to achieve this.\nThank you very much"
          ],
          [
           "Outlier (-1)",
           "AG1 class action for deceptive marketing claims. https://zrclaims.com/ag1-deceptive-advertising-claims/"
          ],
          [
           "Outlier (-1)",
           "Great short docuseries from BBC about \"Blue zones\" and how people there live fit lives till their 90s.."
          ],
          [
           "Outlier (-1)",
           "Foods for mental quickness, neural plasticity, clearer thinking, whole brain thinking, creative thinking, etc. What foods affect the brain on a chemical level that increases mental quickness, neural plasticity, clearer thinking, whole brain thinking, creative thinking, etc. And, why?"
          ],
          [
           "Outlier (-1)",
           "Glucose quick spike and drop health impact. How bad are glucose spikes that fall back just as fast?"
          ],
          [
           "Outlier (-1)",
           "New Science Blog: 9 Ways to Biohack Your Healthspan and Improve Longevity."
          ],
          [
           "Outlier (-1)",
           "Absorbing information. How do I enable myself to be able to grasp information faster? Is there any sort of hack? Anytime I sit down to read, carry out and assignment, or study for an exam, I have to go over the material at least twice to get a decent understanding of it. Even news articles, I have to read them twice to actually understand what their main purpose/theme is trying to convey. Don‚Äôt get me wrong, my understanding itself is not weak I believe (I‚Äôve studied sciences and maths), but to get the gist of anything I sometimes have to re-read. Is it my concentration, if so how should I improve it? \n\nAny suggestions to make this better would be great! Trying to be the best version of myself possible!\n\nThank you!"
          ],
          [
           "Outlier (-1)",
           "Two questions: Is intermittent fasting healthy to do at 15? Second, is there anything to take that helps with growth?."
          ],
          [
           "Outlier (-1)",
           "Deprioritize strength/muscle as a male?. Male friends I know who follow Peter Attia seem to emphasize the importance of putting on muscle as the most important exercise aspect for longevity. As a man, I wonder if this should really be a top priority. Since men tend to have higher baseline strength than women, and women can still achieve great longevity with relatively lower strength, wouldn‚Äôt maintaining average strength as a man be enough? Should men focus more on other aspects of longevity like cardio, mobility, and stability instead of prioritizing strength? What am I missing?"
          ],
          [
           "Outlier (-1)",
           "Please stop posting about magnet implants. There are so many bigger things to focus on in biohacking than a parlor trick.\n\nHonestly i would expect to see posts like this on a body modification sub. Its. A massive stretch to be posting this on a sub about optimizing human performance.\n\nIts kind of corny."
          ],
          [
           "Outlier (-1)",
           "VR and Meditation - Tips?. Hi, I'm exploring the world of biohacking and wellness, it's all very interesting! I'm trying different types of meditation and vitamins to help me relax and sleep.\n\nI got an Oculus Quest for Christmas and wanted to try my hand at VR meditation apps like TRIPP. \n\nUnfortunately I can't seem to use it for more than a few minutes because I get super nauseous.\n\nDoes anyone have any tips on how to manage nausea? I've read extensively about the benefits of full-immersion meditation and really want to give it a shot."
          ],
          [
           "Outlier (-1)",
           "What's everyone's thoughts on this Healy device?."
          ],
          [
           "Outlier (-1)",
           "Dr. Michael Lustgarten: Microbiome optimization, aging blood biomarkers, and breaking the longevity record.. Hey Biohackers, \n\nThis is Nathan from Biohack Stack. Back with another [interview](https://biohackstack.com/posts/michael-lustgarten/), this time with Dr. Michael Lustgarten -- a scientist at the Human Nutrition Research Center on Aging @ Tuft's University. He's also a meticulous N-of-1 and quantified-self health optimization experimentalist.   \n\n\n# Hello! What‚Äôs your name, your background, and what do you do?\n\nMichael Lustgarten. My PhD is in Physiology, and I‚Äôm currently a scientist at the Jean Mayer Human Nutrition Research Center on Aging at Tufts University.\n\n# How (and why) did you get involved in research in aging and the human microbiome?¬†\n\nI had no idea what I wanted to do for about 4 years after graduating from college in 1994. That changed when I picked up Roy Walford‚Äôs book, [‚ÄúBeyond the 120 Year Diet‚Äù](https://www.amazon.com/Beyond-120-Year-Diet-Walford/dp/1568581572/). Besides outlining the health benefits of calorie restriction, it also discussed using circulating biomarkers to track progress on the diet. I‚Äôd always been interested in optimal health and fitness, but reading that book took my interest to a higher level. I decided that would be my mission in life, to figure out how to live longer than 120 years, thereby breaking the world longevity record. To start to do that, I would need to go back to school, because my first university degree was in English literature. I then took all the science classes (Biochemistry major) that were required to go to graduate school to study aging, which took about 3 years. I worked my tail off, and got almost all A‚Äôs, to enhance my chances to get into a graduate school that I wanted to go to, rather than settling for a lower tier choice. The mitochondrial oxidative stress theory of aging was highly popular about 15 years ago, and one of the universities that had top scientists studying that were at the University of Texas Health Science Center at San Antonio. I applied there, got in, and started studying!\n\n&gt;\"***we co-evolved with microbes, and are ourselves half-microbial. Making sure we take care of them, and that they don‚Äôt end up in places where they shouldn‚Äôt be (blood, brain) is important for health, disease, and lifespan\"***\n\nMy graduate work was performed exclusively in mice, and as a post-doc I wanted to study aging in people. As a grad student, I used a largely reductionist approach to study aging-we knocked out one gene and studied its effects on muscle mass and function in young and old mice. However, aging is multifactorial, and deficits in a single gene is unlikely to impact the full sum of aging (unless it‚Äôs a progeroid syndrome). I was interested in a more comprehensive approach for studying aging, and one way to do that is with metabolomics. My hypothesis was that by studying hundreds of biochemicals in blood, I‚Äôd get a more accurate picture about aging process in people. To do that, I joined a lab at Tufts that was interested in using a blood metabolomic approach for investigating mechanisms related to the maintenance of muscle mass and function in both young and older adult people. In the process of these analyses, I discovered associations for many gut bacterial metabolites with muscle. About 5 years ago, information on the gut microbiome-muscle axis was scant, so I wrote some grants to further explore that topic. Fortunately, I obtained grant funding, and I‚Äôve been studying the gut-muscle axis ever since.\n\n# In your book, ‚ÄúMicrobial Burden: A Major Cause of Aging And Age-Related Disease‚Äù, you make the case that optimizing our bodies to reduce microbial burden might delay age-related disease and extend life. Could you explain a little more about how microbes are connected to aging?\n\nThere‚Äôs little doubt about ‚Äúmight‚Äù. Germ-free mice are grown in a bubble for their entire life and live longer than mice that are conventionally raised (i.e. not in a bubble) that have a microbiome. That‚Äôs direct evidence for a role of the microbiome on affecting lifespan. However, humans didn‚Äôt evolve to live in bubbles, we co-evolved with microbes, and are ourselves half-microbial. Making sure we take care of them, and that they don‚Äôt end up in places where they shouldn‚Äôt be (blood, brain) is important for health, disease, and lifespan, as I demonstrate in the book. Ha, for more info, those interested can check out the book!\n\n# What are some of the biggest unanswered questions in your field of research? Optional: If you had 100 million dollars to conduct a single scientific trial, what trial would you conduct?\n\nBeyond the gut, few studies have looked at the blood microbiome, or have only studied small components of it (i.e. LPS --Lipopolysaccharides ). Full microbiome sequencing, and not just bacteria, but viruses, fungi, archaea, and how that changes during aging would be on my list.\n\nAlso on the list would be investing in AI-based tools to integrate the human genome, diet, exercise intensity/duration, air quality, the microbiome, and blood metabolome to come up with a predictive algorithm that optimizes health while minimizing disease risk. Studies are starting to explore components of this (i.e. a personalized approach to the role of diet on blood glucose levels), but integrating all of these components will take a while.\n\nI‚Äôd also invest in cell rejuvenation strategies, because even with the best lifestyle-based approach, aging still happens, albeit at a slower rate. We‚Äôll need cell-based therapies, whether it‚Äôs stem cells or something else to help repair our aged cells, thereby rejuvenating them to a more youthful state.\n\n&gt;\"***I believe that my biochemistry and physiology training combined with my interest in nutrition, health, and fitness = the 21st century version of optimal health. Eventually, an AI-based approach will add to all that.\"***\n\n# How did you get started in health optimization / quantified-self?\n\nI‚Äôve always been interested in nutrition, health, and fitness, but I took it to another level after reading Walford‚Äôs book. For many people, optimal health means eating real food and exercising, but without paying much attention to any of the details. For ex., that was Jack LaLanne‚Äôs mantra, and although he lived longer than average (he died at 95), that isn‚Äôt long enough for me. I believe that my biochemistry and physiology training combined with my interest in nutrition, health, and fitness = the 21st century version of optimal health. Eventually, an AI-based approach will add to all that. Ha, hopefully I can add AI to further optimize my health to make it hard for the next generation to beat my approach (lol!).\n\n# What framework / philosophy do you use in evaluating and optimizing your body? How do you navigate the scientific literature to optimize your health?\n\nI try to be as comprehensive as possible in my literature reviews for a given biomarker. For example, if I‚Äôm writing an albumin article and there are 500 abstracts related to albumin and aging, or albumin and mortality risk, etc., I‚Äôll look at every single one of them, so by the time I‚Äôm done with that biomarker, I have a comprehensive understanding of what‚Äôs known. Then, I‚Äôll write an article as succinctly as possible to summarize those findings. I‚Äôm not trying to bombard people into boredom with data, but I try to get to the point ASAP. Also, every few months I‚Äôll do another literature search to potentially update any data that I‚Äôve reported.\n\nI try to keep it simple: How does the biomarker change with age, and with risk of death for all causes?. Most of the time, the range that is best for these 2 variables is smaller/different than the reference range. Once you know what‚Äôs optimal for these biomarkers, then the goal is to use nutrition, supplementation (if necessary), and fitness to obtain a biomarker profile that is as close to biologic youth as possible. So maybe you‚Äôre chronologically old, but your biomarkers look like a 20yr old.\n\n&gt;***\"For example, although I‚Äôm chronologically 46y,¬† my data for those 2 tests show than I‚Äôm 15-20 years biologically younger.\"***\n\nThere are 2 key tools that I use to evaluate biologic youth: Levine‚Äôs Phenotypic age calculator, and aging.ai. They‚Äôre free, and are based on blood test data (which is not free). I have many articles on my blog about them and my data. For example, although I‚Äôm chronologically 46y,¬† my data for those 2 tests show than I‚Äôm 15-20 years biologically younger.\n\nSome think that epigenetic testing is the gold standard for biological age testing, but consider this: its correlation with biological age has been reported to be 0.97 (a correlation = 1 is as good as it gets). For Levine‚Äôs phenotypic age calculator, it‚Äôs 0.94, almost as good, and 4x more affordable in terms of price, so I can test more often for relatively similar output data.\n\n# How do you approach tracking and optimizing your gut microbiome? What service do you use for gut microbiome testing now that uBiome is defunct? What are your thoughts on prebiotics, probiotics, and fermented foods?\n\nSo far, I‚Äôve measured my gut microbiome composition 4x, and exclusively with uBiome. uBiome recently closed, so I‚Äôll need to use a different company going forward, and likely I‚Äôll use American Gut.\n\nEarly on with microbiome testing, I had almost no *Bifidobacteria*, and they‚Äôre important for producing short-chain fatty acids (SCFA), which strengthen gut barrier function. I took a lot of antibiotics as a kid, so that may have played a role in wiping them out. I tried various supplementation strategies to get them into my gut, but it took 3 separate trials to finally boost their levels. I have a blog post on my site about that. Nonetheless, the best way to optimize the gut microbiome is by eating lots of fiber, and from foods, not via supplements. Fiber is fermented by gut bacteria to directly produce SCFAs, which acidify the gut, thereby helping to minimize pathogenic bacterial growth (i.e. *Enterobacteriaceae*).\n\nIn terms of probiotics, I believe in quantifying your microbiome 1st to see what‚Äôs missing, then supplementing with probiotics if you think that will help your health. Then, repeated microbiome testing to make sure that you‚Äôve actually increased their abundance in the gut. Note that probiotics are seeds, so if you don‚Äôt eat what a certain bacterium likes (i.e. prebiotics), then they‚Äôll die off/be passed out of the gut. So getting the right prebiotic for a given probiotic is also important. In terms of fermented foods, moderation is key. Evolutionarily, we ate foods that were fermented if we didn‚Äôt have anything else to eat (for ex., rotten apples). More recently, pickling was used to maintain the freshness of various foods without refrigeration. However, they weren‚Äôt the cornerstone of a varied diet, but a small component of it. Interestingly, I hadn‚Äôt included yogurt, which is fermented milk, in my diet for a long time, and my *Lactobacillus* were almost zero in my gut microbiome. In conjunction with that, my circulating levels of red blood cells hadn‚Äôt been higher than \\~4.8, over the past 4 years but once I added the yogurt back into my diet, they suddenly they reached 5.1 on 2 different measurements. RBCs decline with age, so fighting off the age-related decrease is very important! Whether it was the bacteria, or something else in the yogurt, I don‚Äôt know, but it‚Äôs an interesting correlation nonetheless.\n\n&gt;\"***Nonetheless, the best way to optimize the gut microbiome is by eating lots of fiber, and from foods, not via supplements.\"***\n\nAs a final note, it‚Äôs important to not solely focus on the microbiome. Is it of any use if the microbiome is improved but circulating biomarkers get worse? The key is to improve both, simultaneously. So for any gut microbiome testing, there should also be blood testing.\n\n# How can we optimize our skin and oral microbiomes?\n\nI have sections on both in my book-for skin, it‚Äôs important to maintain its pH \\~5. However, most soaps have a pH that is much higher than that, and even worse, pH isn‚Äôt generally listed on soap. Optimizing the mouth microbiome is more complicated, as there are far less studies on that when compared with the amount that study the gut microbiome. Nonetheless, I make a homemade mouthwash with sodium bicarbonate + xylitol. In contrast with an optimal skin ph around 5, a pH \\~7 is optimal for the mouth. Some mouthwashes have a pH around 5, which is terrible when considering that caries accelerate at a pH &lt; 5.\n\n# Which biometrics / biomarkers / vitals are you tracking and optimizing currently? (If comfortable sharing, what are your physical stats?) What are your target levels?\n\n4-6x/yr I measure the analytes on the standard chemistry panel (i.e. albumin, glucose, lipids, liver enzymes, WBC and their differentials, etc.). In terms of what‚Äôs optimal for that, I have lots of blog posts for almost all of them on my website. It‚Äôs important to note that there is indeed a difference between the reference range and what may be optimal for health and longevity. Within that data, I‚Äôm able to calculate biological age using Levine‚Äôs Phenotypic Age calculator or with aging.ai. I‚Äôm interested in slowing aging, where my biological age doesn‚Äôt change as fast as my chronological age. For example, based on my blood test data over the past 4 years, my biological age metrics indicated that I had aged less than 2 years.\n\nI also track my diet every day, including weighing all my food with a food scale, and entering that data into cronometer.com. Then, for each blood test, I calculate the average dietary intake that corresponds with it, and because I have data for more than 20 blood tests over the past 4 years, I‚Äôm able to make hypotheses aimed at the role of my diet on optimizing my biomarkers.\n\nI track resting heart rate (RHR), heart rate variability (HRV), and sleep stages with a wearable on my wrist, and my goal is to get my RHR to \\~40 beats per minute, and to have HRV and the amount of deep sleep as high as possible. Since I‚Äôve been wearing the fitness tracker, I‚Äôve reduced my RHR, and within the past 2 months, significantly increased my HRV. Deep sleep seems to be more difficult to improve, but I‚Äôm actively working on different things to try to optimize that, too. I‚Äôm not shy about sharing any of my data, and there are lots of posts about that on my blog.\n\n# What are your thoughts on biological age testing? Which tests (epigenetic, blood biomarkers, telomere, etc) and specific services do you believe to be most useful?\n\nI‚Äôm a huge proponent of biological age testing. I also have many articles about this on my site, including aging.ai, phenotypic age, and epigenetic clocks. The phenotypic age calculator is pretty good when compared with the gold standard of epigenetic testing, but costs 4x less and is much easier to decipher. Plus it‚Äôs based on 50-100 years+ of research for each component (i.e. CRP, albumin, etc.), so knowing how its variables change with age and what‚Äôs optimal for health are more clear. There‚Äôs far less data on the epigenetic clock (&lt; 10 years), in contrast.\n\n&gt;\"***First, aging and disease are biochemical processes. Tracking internal measures of health is an important strategy for slowing both, and accordingly, the ability to blood test repeatedly, many times per year is essential to my approach.\"***\n\n# What else is in your biohacking stack? (Nutrition / diet, fasting, wearables or other products, fitness routines, supplements, drugs, services, lifestyle practices, sleep, mental health, etc. The more specific the better.)\n\nI have a wrist wearable that tracks heart rate variability, resting heart rate (and average daily HR), and sleep stages. I do structured exercise (weights/core/stretching) 3-4d/week, and for \\~1hr each session, and I walk 15-20 miles/week. For supplements, 1000 IU of Vitamin D in the winter, as that keeps me above 30 ng/mL, and a B6-methyl folate-methyl B12 stack that has a small, but positive impact on my homocysteine levels. In terms of nutrition, I shoot for \\~5-10% caloric restriction, and more specifically, I have posts on my site about my macros- and micros, and the average composition of my diet. I‚Äôm constantly making adjustments to my diet to attempt to positively affect my circulating biomarkers, which I measure 4-6x/year. Sleep is super important, and I‚Äôm obsessed with getting enough deep sleep every night, and which components can help me optimize that, especially considering that less deep sleep is linked with Alzheimer‚Äôs disease risk.\n\n# What is the one biohack that had the biggest impact on your life?\n\nIt‚Äôs a combination of blood testing and my wearable fitness tracker. First, aging and disease are biochemical processes. Tracking internal measures of health is an important strategy for slowing both, and accordingly, the ability to blood test repeatedly, many times per year is essential to my approach. Using that approach, it‚Äôs less likely that I‚Äôll end up with CVD, cancer, or any other disease, as I should be able to see deviations in my blood biomarkers first before a significant problem arises. Second, I‚Äôve always been relatively lean and fit for most of my life, but I had never tracked my RHR, HRV, or sleep stages. Since I‚Äôve been tracking those, I‚Äôve make significant gains for each (for more info, see the many posts on my website), and I feel better because of it, too. So less overtrained, more fitness gains. Consider this: exercise is well known to increase average, but not maximal lifespan, so there‚Äôs obviously something about exercise that is simultaneously good and bad for longevity. By tracking my fitness metrics and my circulating biomarkers, I hope to increase both average and maximal lifespan. Not being overtrained is likely a big part of that.\n\n# What developments in longevity / human microbiome / health optimization are you most excited about? Do you have a personal longevity goal?\n\nThe ability of AI to integrate as much clinical data as possible with lead to great advancements in health optimization, disease risk, and longevity. Also, I expect that vaccination for microbes that commonly affect older adults, like CMV, and the other herpes viruses (HSV-1, HSV-2, etc.) will further achieve health+longevity gains. However, note that despite 40+ years of research for a CMV vaccine, it still doesn‚Äôt exist. AI will also dramatically improve vaccine development. My personal longevity goal is to live longer than everyone that has ever lived. The current record is 122 years, so beating that is my #1 goal. Inherent in that is being as fit and lean on the outside and inside (through biomarker testing) as I was at 20 years old. I hate the idea of being less functional at any age!\n\n# Where can people find more about you and your work?\n\nMany places! My website, [michaellustgarten.com](https://michaellustgarten.com/), on Facebook ([@mike.lustgarten](https://www.facebook.com/mike.lustgarten)), Twitter ([@mike\\_lustgarten](https://twitter.com/mike_lustgarten)), and for those interested in donating to the cause, my university page ([https://hnrca.tufts.edu/research/labs/nutrition-exercise-physiology-sarcopenia-neps/michael-lustgarten-ph-d/](https://hnrca.tufts.edu/research/labs/nutrition-exercise-physiology-sarcopenia-neps/michael-lustgarten-ph-d/)).\n\n&amp;#x200B;\n\n\\--------------\n\n*Want to be featured on* [*BiohackStack.com*](https://BiohackStack.com)*? Contact me nathan (at) biohackstack . com*"
          ],
          [
           "Outlier (-1)",
           "Snapping to start a fire? Could it be real rather than a magic trick?. Is it possible to get a undetectable material to be on the area of your finger where your finger print is that ignites when rubbed together. A preferred reaction would be sparks. This \"implant\" or whatever it is could be used forever and in normal life. I can get ideas but I have no real way to start them.."
          ],
          [
           "Outlier (-1)",
           "FSA Eligible Attia Approved Items. I just got a notification that I have $300 in my FSA account that I need to spend before the 31st or I lost it. I don‚Äôt have or need anything to buy.\n\nIs there anything Peter approves of that is FSA eligible that could help me in my longevity journey that is around $300?"
          ],
          [
           "Outlier (-1)",
           "Achieve Longevity using Pulsed Electromagnetic Field therapy‚Äôs Anti-Ageing Effects."
          ],
          [
           "Outlier (-1)",
           "The 3 Pillars of Peak performance (this post is a long read). The topic of peak performance has so much information attached to it, and I think it is important to refine peak performance down to the basics and the fundamentals. These are the bare bones basics that everyone needs in order to unlock their peak performance. I have spent 4+ years experimenting on myself, studying books, courses and investing in coaching, and from all of that, these are the things that I have found work consistently. ENJOY!!\n\n\\-----------------------------------------------------------------------------------------------------------------------------------------------------\n\nInstead of talking about \"the single hack you can do to finally shit rainbows,\" or \"the magic pill you can take to read 10 books in .69 seconds,\" I'm going to dig deeper and talk about the **FOUNDATIONS**.\n\nSee, most of the time, when learning about peak performance/productivity, people often forget that without the foundations, being productive is like trying to shove a round peg into a triangular hole.\n\nSo now that the intro is out of the way, here are the foundations needed to build sustainable productivity.\n\nInstead of focusing on productivity focus on unlocking your PEAK PERFORMANCE (aka \"The Everest Factor\").\n\n**THE FIRST PILLAR IS** ***ENERGY***\\*\\*-\\*\\*\n\nDo you really think you are gonna be productive if you are barley able to keep your eyes open? Cultivating all day energy is the KEY to building the foundations of peak performance. Here are some easy ways to do this\n\n1. maintain a consistent sleep schedule. Wake up and go to bed at the same time every day. This means that when you are out at the club getting absolutely piss drunk on the dance floor at 2 am, you will most certainly not be able to crank out the 10 pages of creative writing you need to do the next day (but at least you had fun, right?.......RIGHT? GOOD!)\n2. I'm gonna sound like your mother here but EAT YOUR VEGGIES. For real though, diet it important. There is a reason you hear this over and over and over and over and over and over and over again. Most importantly, cut out sugar. All of it. This will drain your energy faster than a frat star drains Bud Lattes. Try to incorporate more fat into your diet. You won't become more fat, that's a BIG FAT lie that has been told to you since childhood (see what I did there? hehe). Olive oil and avocados don't make you fat, but they DO make you energized!\n3. Your breath. Stop breathing in through your mouth, there is plenty of science done by people WAAAY smarter than me that shows that breathing in through your nose is some voodoo magic shit when it comes to making you feel more calm, energized and present. Start getting in the habit of becoming a nose breather.\n\nIts all stuff that you have heard before, so why haven't you (YES YOU) started doing it??? GODSPEED!\n\n**THE SECOND PILLAR IS** ***STRESS MANAGEMENT SYSTEMS -***\n\nNow that you have become as energized as a 5 year old on halloween, it's time to shift gears a lil' and focus on your stress.\n\nIn order to be your highest performing self for longer than a few weeks, you are gonna need to relax a bit. Chill out. If you are all about the hustle and trying to become the first ever *trillionaire* (more power too you), you are gonna need to manage your stress so that you can keep the hustle going without experiencing burnout. It's all about sustaining that performance and sustaining the hustle.\n\nHere is a simple daily stress management system:\n\nEvery day set a timer on your phone to go off 3 times a day that reminds you to take 5 DEEP and SLOW breaths (I'm talking so deep it hurts). Do this every day for a week. By the end of the week you will start to automatically become aware of your breath and you will breathe deeper. Deep breaths are like kryptonite to stress.\n\nIn addition to your monk like breathing, you will also start to keep a stress journal. Every night write down these two things:\n\n*1) What was my biggest stressor today?*\n\n*2) What made today sexy/awesome/badass?*\n\nDo this for a week as well. At the end of the week, look back at that lil' rascal and notice what you wrote down, notice the pattern of what causes you stress, and start to shift your day and your actions to recognize and AVOID the stressors. Also notice how the stress tends to feel smaller after writing something positive :).\n\n**THE THIRD PILLAR IS** ***MINDSET***\n\nThis is one of the most overlooked parts of productivity, so get this right and you are on your way to the friggin productivity olympics baby!\n\nHere are the mindsets to adopt to be more productive:\n\n1. **persistence -** its gonna get HARD. Hustling is going to get hard. What are you going to do when it does? Are you going to start whining and quit? NO! you are going to keep going because you are a peak performance ninja and you are persistent.\n2. **positive attitude -** Really important to smile at all the haters. This is more of a rule of overall LIFE than just productivity. Keeping positive will allow you to achieve your goals when everyone and everything is dragging you down. Chin up!\n3. **vision -** no not THAT kind of vision! I mean having clarity on what your goals are and why you are going after them. When you get clear on your vision you will always know what to do and when, because you have a guiding compass that is leading you to where you need to go!\n\nTHATS IT, thats the end of the post. Thank you so much for getting this far! If you read the whole thing I know that you are super duper serious about unlocking your peak performance, and thats awesome!!\n\n\\-Ben"
          ],
          [
           "Outlier (-1)",
           "DNA/Gene testing in Europe.. I live in Europe and I am thinking about taking a DNA test. I don't care that much about ancestry and such since I am more interested in data about my body that I can use in my biohacking journey. I have heard that the amount of data you get from different companies can vary a lot. Does anybody have any recommendations about where I should get my tests?"
          ],
          [
           "Outlier (-1)",
           "ESS60?. https://www.myvitalc.com/ \n\nSaw this on Dr. Gundry‚Äôs podcast and seems too good to be true. Anyone heard of this stuff and can chime in? \n\nThanks."
          ],
          [
           "Outlier (-1)",
           "Longevity Biohacker Kenneth Scott is 82: Rejuvenation Approach."
          ],
          [
           "Outlier (-1)",
           "Has anyone here analyzed their own raw dna result?. I don‚Äôt like the terms of most of the sites that will do it for you and I think it‚Äôs kind of fun to do it yourself. There‚Äôs a lot of info on snpedia, but for topics like sleep and diet snpedia seems to be outdated and lacking in info. You can find research papers for these things, but it‚Äôs not as simple as ‚ÄúX;X is associated with increased X.‚Äù\n\nAny tips or resources?"
          ],
          [
           "Outlier (-1)",
           "Experience: Lumen.me. I wanted to share my experiences with the Lumen metabolism tracking device.  \n\nI was very interested in the concept of trying to understand my metabolism better and was looking for data to do this.  I've tried a variety of different devices that are out there.  I've seen as I've gotten older my metabolism definitely isn't what it used to be and was looking for every bit of data I could find to help with understanding how certain foods and drinks affect my body and so forth without having to prick my finger each time with a glucose meter.\n\nI ordered the Lumen device.  Came boxed up very nice.  The device itself is physically built really well.  That's about where the positives stop for me.  The mobile app is not very intuitive and there were several connection issues over different periods of time in getting the device to work.  When you get the device to work, if you hold the breath for just too long or take too much of a deep breath, the app forces you to restart everything again with a time delay built into it.  It's one of the most annoying things I've ever seen built into an app.  Sometimes to just get a breath reading, I would spend between 5 and 10 minutes from start to finish.  You have to take 3 breath readings to get a result back.  \n\nThere is an unreasonable amount of time and frustration that goes into using this device.  The results you receive back aren't very helpful as well.  It's just a color coded number 1-5 and they make some recommendations on what food to eat that day.  The food recommendations have no context to them.  I'm personally doing IM fasting and keto and the app is just like you should be eating these macronutrient levels.\n\nWould I recommend [lumen.me](https://lumen.me)?  Absolutely not.  It's concept as stated is a great idea but their execution in creating a product that is easy to use and providing valuable information for customers is terrible.  \n\nAnything I would recommend that's similar?  I like simple and straight to the point with reliable data and that's easy to use.  The device I've found that is easiest to use and gets the job done is Keyto.  Basically in 30 seconds you have results that I have found reliable from my experiences and use.  \n\nI wanted to share this because I was looking around for a place that had info on lumen and other products and didn't really find much.  I hope to learn from all of you and share other experiences as well."
          ],
          [
           "Outlier (-1)",
           "rfid crown microchip. I was wondering if anyone had heard of dental crowns with built in rfid/nfc chips"
          ],
          [
           "Outlier (-1)",
           "Bulletproof Vibe Dupe. Hey gang,  \n\nLooking for an affordable version of the Bulletproof Vibration Plate. Does anyone know of any alternatives that are cheaper?"
          ],
          [
           "Outlier (-1)",
           "Young and very active. Title: Concerned About High Blood Pressure Despite Healthy Lifestyle \n\nPost:\nHi all,\nI‚Äôm 29, 5‚Äô6‚Äù, 150 lbs, and a very active trainer. I do jiu-jitsu 3x/week, lift 3x/week, and include one day of steady-state cardio. I eat well and recently did a 24-hour ambulatory blood pressure monitor: 146/81 daytime, 126/60 at night.\n\nMy diastolic is usually fine, and my echocardiogram came back normal. Blood tests are also fine, except for occasionally high iron levels, with my most recent transferrin saturation at 80%. My dad passed away from a heart attack at 42, but he was sedentary, smoked, and drank heavily‚Äîvery different from my lifestyle.\n\nI‚Äôve been working with a holistic pharmacist who has me on supplements like L-citrulline, magnesium, theanine, and GABA, but they don‚Äôt seem to help much. I also did an OAT Mosaic test, which showed high HVA levels‚Äîcould that be related?\n\nI‚Äôm open to any insights, similar experiences, or advice. Thanks in advance!\n\nLet me know if you‚Äôd like any further adjustments!"
          ],
          [
           "Outlier (-1)",
           "Weight Training - Looking for resources.. Hey folks, \n\nI've recently picked myself up a copy of Superhuman (Dave Asprey) and thumbed through to the section on exercise. Here it recommends the following: Seated Row, Chest Press, Pull Down, Overhead Press, and Leg Press. \n\nUnable to go to the gym I'd like to start these at home with out expensive, expert equipment. Can anybody point me in the direction of some tutorials or articles so I can learn?\n\nMany thanks!"
          ],
          [
           "Outlier (-1)",
           "Genetic Data Questions. Hey all. I just got my Ancestry data and uploaded it to Promethease to get the full genetic analysis. I have to say that there is a LOT of data and I'm not really sure what I should be looking at first. Anyone have tips on how to go through this, specifically looking for actionable things.  Thanks!"
          ],
          [
           "Outlier (-1)",
           "Max HR - too high for active 36/M. I picked up a Morpheus HR monitor at the suggestion of Attia. 36 years old &amp; the more accurate HR during cardio now has my max HR at 202. I run/bike/exercise frequently and have a Vo2 Max in the superior range, however does 202 sound high/abnormal for a max HR for my age?"
          ],
          [
           "Outlier (-1)",
           "My RHR and HRV reveal what exactly ?. I started working out in January and got my RHR to 63 and my HRV to 45 in June according to my Fitbit tracker. \n\nBut since June I have been unable to work out and my HRV dropped to 17 and my RHR is up to 77.\n\nIs this what happens when you don‚Äôt work out?"
          ],
          [
           "Outlier (-1)",
           "Honest opinion on rfid chip implants... (As the title says, it's just an opinion, don't take it too seriously)\n\nI understand the idea and i like it, but honestly I think they're kind of dumb, surgeries always have a risk of something going wrong, and you could get the same \"abilities\" if you put an rfid chip in a ring, a bracelet, a necklace or even a tie, if you've got piercings then those would be the perfect place for it.\n\nThat being said, if you already have one, this post shouldn't effect to you at all.\n\nBut if you don't have an implant, and you're thinking about getting any type of implants, please consider wearable technology first, if the benefits of an implant are better than if it was only worn, and the risks aren't bad, go for it! And if there's really no other reason than \"I felt like it\" then sure, go for it too, I can't tell you what to do and i don't really care either\n\nAgain, this is just an opinion, don't take it too seriously"
          ],
          [
           "Outlier (-1)",
           "Gene databases?. New biohacker here. Anybody know about good gene databases I can use?"
          ],
          [
           "Outlier (-1)",
           "How NOT to install an RFID implant in your hand."
          ],
          [
           "Outlier (-1)",
           "Are tragus magnet implants affected by electric guitars?. I‚Äôm considering getting a magnet implant in my ear but I‚Äôm worrying that the electromagnetic field around the pickups will somehow be picked up by my ears and I get a very distorted noise. Will this be the case?"
          ],
          [
           "Outlier (-1)",
           "Does anyone know where to buy the North Sense?. I‚Äôm looking into buying the North sense implant, does anyone know where to buy one or if anyone is selling one?"
          ],
          [
           "Outlier (-1)",
           "Anti-aging treat: Dog drug could extend human lifespan, US scientists explore | The US-based company believes their research on canine longevity will also benefit humans.."
          ],
          [
           "Outlier (-1)",
           "Hanging upside down (inversion therapy). My back got better with hanging upside down; It‚Äôs hard to say was it really because of it, but science is there for it. Its been used since ancient civilizations, and it is still a popular tool among high performers like Tony Robbins and Joe Rogan.\n\nIt can be a free and time-efficient tool to corporate into a daily regimen like the best biohacks should be.\n\nI like to hang upside-down mornings or after the workout. One of the best feelings is when your back cracks during hanging!\n\nI wrote a blog post about it [https://ilmostromberg.com/incredible-benefits-of-inversion-therapy/](https://ilmostromberg.com/incredible-benefits-of-inversion-therapy/)\n\n**The following topics will be covered:**\n\nWhat scientific literature says about hanging upside down\n\nDifferent ways to do it\n\nNotable people using it"
          ],
          [
           "Outlier (-1)",
           "Creatine level high. So I just got blood work back and my urine creatine levels r 170, says range high is 125. I do dose creatine 5mg/1 scoop daily. According to huberman and galpin this is a good idea to dose creatine. I do work out, run 15mi a week and lift 2-3hrs a week. Is this something I should stop, slow, or is it ok for levels be that high? I'm going ask Dr too but curious what others think."
          ],
          [
           "Outlier (-1)",
           "How to properly replenish adrenal glands after overuse of pre workout?. Cheers!"
          ],
          [
           "Outlier (-1)",
           "Endurance athlete with questions/concerns. Saw another post from someone with a somewhat similar story to me so thought I‚Äôd ask for people‚Äôs thoughts. I‚Äôm a 49 year old male who has been an endurance athlete for 30+ years (less so now, but still active 4-5x/week). I have some health anxiety around my heart mostly because of family history (paternal\nGrandfather died in his 40‚Äôs to a heart attack, my father had 3 before he was 60). Most other vitals are good (BMI, Blood Pressure, diet) and have brought many out of range markers down through diet over the last year, but there are still a number of outliers specifically related to heart health (pretty much all other biomarkers are good):\n\nOut of range:\n\nApoB: 98 mg/dl\nHDL Large: 5984 nmol/L\nLDL Medium: 444 nmol/L\nLDL Particle number: 1952 nmol/L\nLDL Pattern: B \nLDL Peak Size 213.3 Angstrom\nLDL Small 494 nmol/L nmol/L\nLDL-Cholesterol: 115 mg/dl\nLipoprotein (a): 102 nmol/L\n\nWould appreciate any thoughts"
          ],
          [
           "Outlier (-1)",
           "Supplementing Ketones Without Keto Diet. I am seeking some input from the group about supplementing with ketones (eg. Ketone IQ shots) for performance improvement which mostly seems focused around cognitive and endurance benefits.\n\nAs a triathlete these ads keep popping up on my social medias claiming all sorts of athletes use them and wanted to see if it‚Äôs worth the hype. I don‚Äôt currently not have short term plans to do a keto diet but it still seems like there would be benefits.\n\nThanks!"
          ],
          [
           "Outlier (-1)",
           "Type 2 Diabetic. Hi everyone. I had some depression in my 20s and early 30s which led to a lot of binge eating and gaining weight. I had a BMI of 41. It is currently at 35. I was diagnosed with type 2 diabetes five years ago and have been taking it more serious lately. I was so addicted to processed foods. I am trying to reverse my diabetes. A1C is at 6 currently. Trying to get it below 5.5. Is there anything I can do to reverse this or am I metabolically damaged for life. So upset and wish I could go back and change things. Just having a bad day."
          ],
          [
           "Outlier (-1)",
           "35M Blood Test Results - Opinions on Anomalies Please. I recently had my bloods taken and it would be good to hear opinions on some of the more anomalous (to me) ones. I am quite strong (540kg total at my last powerlifting comp c. 5 years ago) and aerobically fit (vo2max of 50 according to garmin; I started running a few months ago after many, many years away from team sports). I work in a stressful finance job, over-consume caffeine, sleep under 6 hours a night (this is my average according to fitbit and it has been going down a few minutes a year for the last 5 years that I've been trackimg), I drink regularly or very frequently but I do binge when I do. \n\nI had fasted for 16/18 hours by the time I was able to do my test. I generally eat around 160g of protein and 80g of fibre a day.\n\nI know that these tests don't always have the greatest reference ranges, so I would value some insight. I am going to highlight the results that were out of the norm/too high/too low:\nPulse - my pulse was 'low' at 45bpm but I will put that down to fitness.\nHaemoglobin, Haematocrit &amp; Red Blood Cell Count - all low but all very borderline.\nHDL - low but other results are good, and I know that things like particle size matters\nApoB - it's show at 'too low' (at 27) but my understanding ks that the closer to 0, the better\nInsulin &amp; C-peptide - I would put this down to fasting time\nDiastolic blood pressure - no idea here\nCreatinine - I consume exogenous creatine daily\nH. pylori - this tests for antibodies so I guess I had it once in the past but do not necessarily have it now\nFolic Acid - I took a relatively high dose of vitamin B complex for a week to see if it would help with sleep (it didn't) so I am confident that is the cause.\n\nInput or commentary would be greatly, greatly appreciated!\n\nThanks"
          ],
          [
           "Outlier (-1)",
           "Resting heart rates - benchmarks. What heart rate at rest levels considered as good?\n\nMy Garmin tracker seem to measure this at night and it was ~54-56 bpm for a couple months, and in recent weeks it decreased a bit to ~51-53 bpm"
          ],
          [
           "Outlier (-1)",
           "Why is Nutrition So Damned Confusing for Life Extension?."
          ],
          [
           "Outlier (-1)",
           "Autophagy/senolytic fasting + supplement + peptide plan... Thoughts?. Hello all. I am not getting too much feedback so far from [r/Peptides](https://www.reddit.com/r/Peptides/) and [r/longevity](https://www.reddit.com/r/longevity/) curiously auto-removed my post. Then I remembered that r/Biohackers might be a good place to post. I would like your thoughts on a fast + supplements + peptides regimen I am currently embarking on. The primary aim is to trigger autophagy, apoptosis of senescent cells, BDNF/nerve growth, etc. So the plan is to fast for 5 days (from what I have read it is believed 5-7 days is when apoptosis happens, perhaps sooner) and to use autophagy/senolytic supplements and peptides during the fast.\n\nThe fast:\n\nWill be doing 5 days, with water and green tea (here and there). Will be supplementing with potassium, sodium, and some magnesium (have got the amounts from the [r/fasting](https://www.reddit.com/r/fasting/) page). I have been on a low carbohydrate diet for a week or two to hopefully lower my glycogen stores so that I can reach ketosis, autophagy, and apoptosis faster. I will be doing about an hour of cardio per day, at least for the first few days, and some light weight training to minimize muscle loss. I will also be taking 10 minute cold showers each day.\n\nSupplements:\n\nI will be keeping my electrolytes up by taking potassium and sodium after a couple days of the fast, about 1g each, perhaps more potassium than sodium, will read up more on that. Also will take some magnesium. As far as autophagy/senolytics, I will be taking two megadoses of **fisetin**, I believe on back to back days, on either day 3 and 4 or 4 and 5. The Mayo Clinic did 20mg/kg, so I will roughly follow that and do about 1.5g each of the two days. Fisetin is meant to promote apoptosis, be anti-cancer, etc. I will also be taking a supplement called \"Senolytic Activator\" by Life Extensions. It includes **fisetin**, **theaflavins, quercetin, apigenin, galactomannans,** and some other things. Need to do a bit more research on the ingredients here, but was thinking of doing three days (likely days 3, 4, and 5) taking maybe double the serving size. It gets a bit complicated trying to state how much of each ingredient that would be because Life Extensions has their Quercetin in a phytosome and their Fisetin is also supposed to be some way more bio-available form (so it is much lower on a mg basis than is commonly suggested), but it looks like I would be taking about 150mg of fisetin, 200 mg of glactomannans, 550mg of theaflavins, 50 mg of quercetin, and 100 mg of apigenin each of the three days. That is on top of the two days of mega dose fisetin I am planning and the EGCG and other stuff form the green tea I will be drinking. May also take my trace multi-metals supplement.\n\nPeptides:\n\nI have been dosing **Thymosin Alpha 1** at 1.5mg every three days for about two weeks now. I will be dosing the same amount on day 2 and day 5 of my fast. I have also been dosing 1.5mg of **GHK-cu** every day for two weeks; I will continue to do so during my fast. Potentially the X Factor, I also have 30mg of **FOX04-DRI**, which I believe I will be taking all at once, per my research, on day 5 (want to be as deep in the fast as possible for senolytic activity). In animal studies, they dose this for three days in a row, but I just did not have the money.\n\nRecovery:\n\nObviously, slow refeeding while avoiding sugars/starches. But then I also plan to begin taking 100mg/100mg of **Ipamorelin/Mod-GRF** starting the night of the day I break my fast, and then dosing at night and upon waking 5 days on 2 days on for maybe 2 months or so.\n\nSo:\n\nAny thoughts are welcome, honestly very encouraged. I am on day one right now. Again, I am trying to promote autophagy and senolytic activity. And let me stress: I am NOT shy about being aggressive. Should I dose TA1 back to back days towards the end of the fast? Should I be dosing Ipa/Mod-GRF as soon as the night I break my fast? Is my fisetin dose too high? Are there dangers with high fisetin doses (did not appear so from the literature). Am I missing anything obvious?\n\nEdit: I will now be taking my fisetin dose **after** my fast, on the first meal back and then again the next day during a meal (since it is fat soluble). I don't want to take any fat/oil during my fast. Also looking into the other compounds that have been mentioned in the comments of the various subs I have posted this in.\n\nThank you all."
          ],
          [
           "Outlier (-1)",
           "Wondering, what are your favorite biohacks for anxiety and/or stress?. I already know/have experience with:  Meditation, Cold Showers, ashwagandha, CBB, Resonance-Frequency and Box-breathing\n\nAny others you like/have experience with/know?"
          ],
          [
           "Outlier (-1)",
           "Trying to find a particular past study. I recall reading about a study a few years back.  It was by a university and my impression was that it was a legitimate study by a university.\n\nThe crux of the findings were in support of the idea that making multiple larger changes toward greater wellness were more effective than the incremental approach.  If I recall correctly the participants took up improved diet, an exercise program, and a meditation/relaxation practice all at once.\n\nI'm just trying to relocate the study so I can read over the results again and assess whether I find it truly credible.  Does anyone recall this or similar studies around whole-hog vs incremental approaches?"
          ],
          [
           "Outlier (-1)",
           "Biohacking for Misophonia?. So, I just started the docu \"Unnatural Selection\" on Netflix, and it has introduced me to biohacking... kind of blowing my mind.\n\nI have a loved one that has very severe Misophonia, an auditory disorder that is not yet in the DSM, meaning he cannot be protected legally from any discrimination.\n\nIs there anyone out there that has ever considered the idea of gene therapy for misophonia?\n\nI'm new to Reddit and I know there are some brilliant minds on here. Spread this post and maybe some magic will happen."
          ],
          [
           "Outlier (-1)",
           "Quick Read: Muscle Gene Linked to Type 2 Diabetes."
          ],
          [
           "Outlier (-1)",
           "What is the best software for genetic engineering?. Is there an AutoCAD or some kind of simulation program for genetic modification?"
          ],
          [
           "Outlier (-1)",
           "advice on how to reduce ALT (80's) - lean and physically active. Hello, \n\nAfter some advice on how to reduce ALT, its been between 60/85 over the last 9 months. Im not over weight  5'11 (150 lbs) if anything im underweight... I already excercise 3/times minimum a week. \n\nmy fibro was clear and my mri was clear, i havent had a liver biopsy however... \n\nDiet is pretty good, next to no fast food... rarely drink... probably once every 3/4 weeks...... Comsume  just under 1g per lb in protein for my bodyweight, nearlya ll lean white meat. \n\n3 types of fruit per day, oats for breakfast... at least 3/4 types of veg per day... \n\nSleep isnt great and i try to get 8 hours but it just doesnt happen... usually end up with 5/6\n\ncholesterol is fine... hba1c is 5.5% \n\ni dont know what im doing wrong... and the doctor cant advise me either,... \n\ntook 2 weeks of the gym, still walked everyday however... didnt really make a difference...   \nhoping someone has been in a similar situation..."
          ],
          [
           "Outlier (-1)",
           "Blood flow restriction. I‚Äôve recently bought some BFR cuffs and I‚Äôve been playing around with them a bit but apart from the usual 30x15x15x15 protocol for hypertrophy I can‚Äôt find any valuable guidelines on how to use BFR training.\n\nI‚Äôm interested in promoting recovery, strength training, VO2 max etc‚Ä¶\nHas anybody here found a comprehensive guide on how to best use the cuffs and stay away from injury?"
          ],
          [
           "Outlier (-1)",
           "How lower fasting insulin?. My bloodwork indicates a very high fasting insulin of 17.  \n\nQuestion is whether this measure takes time to go down - like months?  Or does that react to changes much more quickly. \n\nI‚Äôve lost over 40lbs of weight in the last 4 months so I‚Äôm surprised how high it remains. My fasting glucose is 93. HBa1c is 5.0%. \n\nMy diet is very good now, I work out quite regularly and I continue to lose weight. I worry about insulin resistance.  \n\nWhat else can I do? (And I am in wegovy due to liver enzyme issues which are now resolved)."
          ],
          [
           "Outlier (-1)",
           "Biohackers S2 : Release Date : Cast : Plot!!! - US Trend News."
          ],
          [
           "Outlier (-1)",
           "How to use HRV for fitness. Is the gist of it basically you should do:\n\n\n\nWhen HRV is lower than usual: low intensity cardio \n\nWhen HRV is high: heavy lifting , HIIT\n\n  \n?"
          ],
          [
           "Outlier (-1)",
           "Dreem has excellent customer service. Kind of academic now, since you can no longer buy a Dreem2 but mine was a bit broken, so I mailed customer support, ostensibly for another reason, and they asked me to send it in for repair, (keep the box!) they sent me a new one, just arrived, took about two weeks."
          ],
          [
           "Outlier (-1)",
           "Hey everybody first post here in this subreddit, do you know anything about fixing flat feet?."
          ],
          [
           "Outlier (-1)",
           "1 year update on opening a medicine 3.0 practice. Hello everyone,\n\nOver a year ago, I sought the perspectives and advice of this community as we were on the brink of launching our medical 3.0 practice. At that time, we were uncertain about the future and whether or not to pursue this path. The response we received was overwhelmingly supportive, with valuable insights and encouragement from both medical professionals and potential patients.\n\nI'm excited to share that a little over a year later, after taking the leap, we have officially started our pre-enrollment process. I wanted to express my gratitude to this community and everyone who reached out with their support. Your input has been instrumental in shaping our journey.\n\nThank you!\n\nInitial post: [https://www.reddit.com/r/PeterAttia/comments/13t6vn5/opening\\_a\\_primary\\_care\\_medical\\_practice\\_with/?utm\\_source=share&amp;utm\\_medium=web3x&amp;utm\\_name=web3xcss&amp;utm\\_term=1&amp;utm\\_content=share\\_button](https://www.reddit.com/r/PeterAttia/comments/13t6vn5/opening_a_primary_care_medical_practice_with/?utm_source=share&amp;utm_medium=web3x&amp;utm_name=web3xcss&amp;utm_term=1&amp;utm_content=share_button)"
          ],
          [
           "Outlier (-1)",
           "Rickson Gracie on The Importance of Learning to Breathe (from JRE MMA Show #114 with Rickson Gracie)."
          ],
          [
           "Outlier (-1)",
           "PARTICIPANTS WANTED: DIY tDCS Research Study."
          ],
          [
           "Outlier (-1)",
           "Hey I'm new to all of this, and would like to have some third party options!. So I was about 14 or 15 when I heard of biohacking, and   4 to 3 years later (I'm 18, M) I've done my first tattoo and I've remembered that you can put implants into your hands like nfc chips or magnet.. ect... \n\nI want to know how painful it is, and how it effected your daily life ?"
          ],
          [
           "Outlier (-1)",
           "Joe Rogan Experience #1701 - Dr. Rhonda Patrick."
          ],
          [
           "Outlier (-1)",
           "Covid-19 Vaccine Hesitancy Poll Please Vote. Please vote let‚Äôs get a poll going\n\n[View Poll](https://www.reddit.com/poll/o54bxm)"
          ],
          [
           "Outlier (-1)",
           "What are your thoughts on binaural beats? Is there actually an effect or isn‚Äôt completely placebo/pseudoscience?. Please upvote if you are also interested."
          ],
          [
           "Outlier (-1)",
           "Electromagnetic signal into water to infuse water with different effects?. Has anyone looked into electromagnetic signal into water as a possible way to infuse water with different effects? (please read a little bit from the links below before you dismiss this completely) Ben Greenfield Is experimenting with¬†device, which ‚Äúimprints‚Äù water, or your body, with frequencies of supplements and other things. Apparently everything from St. John's wort to coffee to Viagra to anything else you want from their ‚Äúinfoceutical‚Äù options. This seemed like complete bs to me, but I have been talking to people who have tried it and they seem to think it might be something there. The device is called ic hummer from infopathy.\n\n[https://www.infopathy.com/en/publications](https://www.infopathy.com/en/publications)\n\n‚ÄúExperimental evidence has accumulated to suggest that biologically efficacious informational effects can be derived mimicking active compounds solely through electromagnetic distribution upon aqueous systems affecting biological systems.‚Äù - [https://www.researchgate.net/publication/305343138\\_Quantum\\_Information\\_Medicine\\_Bit\\_as\\_It-The\\_Future\\_Direction\\_of\\_Medical\\_Science\\_Antimicrobial\\_and\\_Other\\_Potential\\_Nontoxic\\_Treatments](https://www.researchgate.net/publication/305343138_Quantum_Information_Medicine_Bit_as_It-The_Future_Direction_of_Medical_Science_Antimicrobial_and_Other_Potential_Nontoxic_Treatments)\n\nThis paper demonstrates that by transferring metronidazole information to water samples by an electronic amplifier (BRT device), the growth of axenically cultured trophozoites of¬†[*Entamoeba histolytica*](https://www.sciencedirect.com/topics/immunology-and-microbiology/entamoeba-histolytica)¬†and¬†*Trichomonas* *vaginalis*¬†is significantly inhibited, compared with those cultures treated with non and sham electro-transferred water samples. - [https://www.sciencedirect.com/science/article/abs/pii/S0014489410002328](https://www.sciencedirect.com/science/article/abs/pii/S0014489410002328)"
          ],
          [
           "Outlier (-1)",
           "Exercise programs for longevity. Where can I find the best exercise programs for longevity?\n\nDr. Andy Galpin mentions in his [podcast](https://performpodcast.com/build-muscle-size-strength-and-power-with-science-backed-programs/) that [Mash Elite Performance](https://www.mashelite.com) (Travis Mash) makes great exercise programs. They make [RiseFit: Evolution Of Adult Physical Fitness](https://www.bridgeathletic.com/product/risefitevolutionofadultphysicalfitness-1542149). It is a 14-week program designed to maximized all of the physical fitness markers that are important to health and longevity\n\nDo you know other great exercise programs for longevity?"
          ],
          [
           "Outlier (-1)",
           "Get consistent results with Bodyfat scale/BIA (Bio-electrical impedance)?. I‚Äôve just bought the Renpho bodyfat scale, and am looking to get consistent results.\n\nI know they aren‚Äôt accurate, but I just need them to be **consistent**, so I can **see if I‚Äôm progressing in the gym** by **measuring myself daily** and finding the **weekly averages in weight, body fat, muscle mass**, etc.\n\n**This is my plan for measuring consistently**\n\n* Morning\n* Same weight, same place\n   * On a leveled, hard, flat surface\n* After pooping/peeing\n* Without clothing or with the same clothing\n   * My plan is to only wear underwear\n* Calibrate\n* Stand straight &amp; still\n\n**Am I missing anything?**"
          ],
          [
           "Outlier (-1)",
           "Anti-Aging Enthusiasts Are Taking a Pill to Extend Their Lives. Will It Work?."
          ],
          [
           "Outlier (-1)",
           "Silicone Implants. Hey All,\n\nJust stumbled into this lovely world.\n\nIs there a resource for silicone implanted devices?\n\nThanks"
          ],
          [
           "Outlier (-1)",
           "How would I edit/mutate my DNA as an average person?. As in what websites could I use and such like"
          ],
          [
           "Outlier (-1)",
           "Blood markers to regularly monitor üíâü©∏. I wrote up this intro to blood markers I check with almost every blood test. Mainly as reference to friends and family who are new to the topic. This reflects my personal experience over the years, but is also heavily influenced by what Peter Attia recommends in his book and podcast.\n\nI'm posting it here in the hope it's useful for others as reference and to get potential feedback of anything I've missed or that could be added. I only want to list the most common and actionable markers here.\n\n* **Blood glucose**: Glucose is one of the body‚Äôs main fuel sources. But too much of it can cause damage and lead to diabetes, which accelerates other diseases including cancer and heart disease. So the goal is to keep glucose within a low and stable range at all times. One marker, hemoglobin A1c (HbA1c) measures average glucose levels over the past 3 months, but doesn‚Äôt tell us when and why it was high. To reveal this, a continuous glucose monitor (CGM) can be used to measure glucose responses to different foods. CGMs have become very affordable (about $/‚Ç¨ 50 for a device lasting 10-14 days) and simple to use. I like the ones from¬†[Sibionics](https://www.sibionicscgm.com/)¬†for their price and simplicity. Healthy individuals will stay within 70-140 mg/dl most of the time. Eating carbs early in the day or going for a walk after a meal are simple strategies to keep blood glucose in range.\n* **Lipids and cholesterol**: Fats are the body‚Äôs main fuel source at rest. They can be stored efficiently, but can‚Äôt travel through blood. Lipoproteins are used to transport fats to cells. Over long timeframes, these lipoproteins can cause cardiovascular disease. After following the topic for a long time, I believe it‚Äôs best to only focus on lipoproteins and not the cholesterol they carry. So my preferred measurements are Apolipoprotein B (ApoB) and Lipoprotein (a). ApoB is partly influenced by lifestyle. Lp(a) is purely genetic and can‚Äôt be changed with pharmacology or lifestyle. If Lp(a) is elevated, ApoB needs to be managed more aggressively. For ApoB, I aim for 60-80 mg/dl.\n* **Triglycerides**¬†are usually included in a standard lipid panel. They are increased when the liver converts excess sugar to fat. Or with extra body fat and lack of exercise. So lower is definitely better. Around 60 mg/dl is a good goal, but definitely below 90 mg/dl.\n* **Immune system and inflammation markers**: Inflammation is the body‚Äôs natural reaction to an injury, but an issue if it goes on for too long or if the source is unknown. High-sensitivity C-reactive protein (hs-CRP) and white blood cell count (WBC) help us track potential inflammation and immune system health. Without injury or a passing infection, hs-CRP should be close to 0 and WBC within 4‚Äì6.6 x10\\^9/L. Unexplained increases can indicate some type of infection, injury, overtraining, stress or even cancer.\n* **Liver markers**: As the body‚Äôs chemical factory and filter, the liver needs special attention. I track the three liver markers ALT, AST, and GGT. Increases in these markers can point to excess alcohol consumption or fatty liver. ALT and AST can slightly increase after exercise. They should still be at the low end of the lab‚Äôs range. A full liver panel will include additional markers, like bilirubin, alkaline phosphatase and serum albumin.\n* **Vitamin D**: I track this regularly since my levels are genetically lower and can vary by season. If levels are too low, I supplement. My goal is to stay above 30 ng/ml.\n* **Magnesium**: Like vitamin D, Magnesium is involved in many functions in the body. The most visible for me was muscle soreness. Several different types of magnesium serve different functions and are absorbed differently. I‚Äôve been using Magnesium glycinate mainly for superior absorption and aim for 2 mg/dl or more in the blood.\n* **Testosterone**: More relevant for men. Levels decrease with age, but if they get too low the result can be loss of muscle, bone strength, motivation, memory, and even hair. üë®‚Äçü¶≤üôà\n* **Prostate-Specific Antigen (PSA)**: Also for men from age 40. Testing for PSA can show prostate issues, including cancer early. But it doesn‚Äôt replace more specific tests or an ultrasound."
          ],
          [
           "Outlier (-1)",
           "Eight Sleep Discount?. Question for paid subscribers: what is the current Eight Sleep discount? I‚Äôm going to bite the bullet and buy one and I heard there was a $600 discount available to subscribers but a quick search on Attia‚Äôs website shows a $200 discount (which is what‚Äôs available from the eightsleep site). TIA"
          ],
          [
           "Outlier (-1)",
           "30x vs 100x whole genome sequencing. I‚Äôm deciding whether to drop another $700 for 100x sequencing ($700 more over the 30x cost). Has anyone weighed the pros and cons?\n\nMostly I‚Äôm doing this for curiosity and to get familiar with analysis tools, but it seems interesting to get rare variants and maybe worth it to go for 95% sequencing to close to 100%. Secondarily I‚Äôd like the health analysis to be more accurate. \n\nThis is through Nebula. Not sure if this link will work.  \n\nhttps://portal.nebula.org/cart/nebula-100x"
          ],
          [
           "Outlier (-1)",
           "way to legally obtain prednisone in US without prescription?. or is there an easy way to get a prescription online?"
          ],
          [
           "Outlier (-1)",
           "If you could train with only one equipment for the rest of your life, what would that be?. It doesn't matter if you have different weight sizes of the same equipment."
          ],
          [
           "Outlier (-1)",
           "I am trying to test grounding but always appears 0.0 on the screen with AC. The red cable I'm holding it and I'm barefoot. What I am doing wrong?."
          ],
          [
           "Outlier (-1)",
           "A question about the experience of endurance athletes using CGMs (lingo).. Although this really should go to r/velo or maybe advancedrunning, I‚Äôm going to try this here because it‚Äôs not a question about performance but of metabolism and low BG readings, and I don‚Äôt need the comment ‚ÄúI have this thing called a pancreas which does that for free‚Äù or ‚Äútry 100gm of CHO per hour.\"\n\nAbbott finally shipped the Lingo. ¬†It‚Äôs nothing like the initial design with lactate, but simply a CGM with an incredibly detuned IOS app, probably for the sake of FDA clearance (and it runs on a SE FWIW). ¬†Biotainment.  You can see the readings but you‚Äôre left to correspond readings to activities by eye. ¬†(They also tell you that large excursions in BG are bad, which I don‚Äôt think any science backs up, but that‚Äôs another discussion).\n\nI‚Äôm a few days in. ¬†This thing reads a bit low vis-√†-vis an Abbott freestyle. ¬†I‚Äôm near 60yo, VO2max thereabouts, ¬†CP \\~ 4w/kg, RHR 45 for context. ¬†Thank my parents.  Franky not looking forward what I'm going to live to see.\n\nI went for two three hour rides this weekend, intensity factor .8 to .85. ¬†I see a 10 beat decoupling from say middle of first hour to last hour. ¬†I bring only water.\n\nI flat line this thing to bottom of it‚Äôs range, which seems to be 55. ¬†Given the terrain and the traffic, some time is steady \\~250w , some is 200w minutes followed by 500w minutes, a few efforts at 1000w. ¬†Very stochastic and a range of demands. ¬†I‚Äôm occasionally tapping W‚Äô. So while this is technically hypoglycemic, I feel great, although I always feel best at lower BG, below 80. ¬†A1c 4.9 last reading. ¬†Not keto.\n\nI can also add that the o/a trajectory over three hours is very slightly upward from below 55 toward 58 at the end, so supply seems to meet demand just fine.\n\nI‚Äôm perusing research gate and google scholar, etc, and I this does not seem typical. ¬†I see spikes and collapse, and I see steady state at much higher levels then slow decline.\n\nI know there‚Äôs great data from high level athletes on this, but I‚Äôm not finding these published. What are your experiences, or can anyone point me to recent published studies?\n\nI can report back later this week after I do some higher intensity stuff and hit W' and drop DFAalpha down to .10 if anyone cares.  I expect the same."
          ],
          [
           "Outlier (-1)",
           "Prolonged fastings cause muscle loss or not?. At the time Peter was still doing them, he said they didn't. Does he still believe in that?\n\nI ask because I actually enjoy doing long fastings even if it doesn't have any benefits, but I struggled to build the muscle I currently have."
          ],
          [
           "Outlier (-1)",
           "3 Oura ring discount codes. Hi, I know several people have posted questions about Oura ring discount codes. \n\nI just received an email with a $50 off promo code to share with friends and family. They are not into this sort of thing, so thought I'd share here. It says the code can be used 3 times and is good through 1/31/21.\n\n[https://ouraring.com/discount/0285611556](https://ablink.m.ouraring.com/ls/click?upn=N8tmOVmhlLmN-2BvzIQBg5G6Wj9Ie-2BBWUaegfFuN-2FE6QHGEJ470jwHiT5FdE3cxWO2ERCDzUhsCHvpW-2F-2FLS67SvUK9IMekZCeJfj1RoCZDL9RzsooI6RRGkSseQCKPYd7vaJ1mHEFgvHrtziG0EvsNEBaHg3M9uKIa4hVGQMvucrc-3DWv0m_aYDSnN5bGlmIQhgIoA611akcsUE7MmEkU74GYMpmVjaCJQrTRfhOandoaZBC4NaQ2eqMB7Y9EE5LYyNgca0yBZJyqxlcUOWlZCfPYBuFWqRbQvMJ4d4U-2B6m5hqxu-2B-2BODqrtPI0CP5-2BCYpBh8QFoKWutVKbHAnghPw-2FxYBgB-2FuNPmqWrDGa09FtbTyyLWwOZzbYWvC4xyzG2aR-2Fb0Jw58REpjT8P9NEkZifDZo-2B-2BhehARTowvyU8-2BsIf2wSs5umcrTVEtL44cXkGYlp3Y-2FPmSRw959YEtuw1SvGMTOTOSntHJoHOw3VnYppcXuUt32Dp5Yo-2ByfvE1HStcQDgpPhpkq35kC-2FsAwwAFVeYMBNcP7tBrRHjmYRZEn3te98tNWGBr32gRTh6-2Fs5xOlpCXwgjQpQsZvFnGDJHSFC6jiLmPSCXP2KLtzwr51Cosp4vO7ks4vVxEF7QlRbc8pGVpUtOrwJxvWljqcDkmIMwkKNT4x2FbkMdn5CbS5uDpKsEHW0VlzmPjacrEM9vNnuoVzk8XNmoUBOtKA7ISCYbZVoC56fZ5DiP8gV8hec0qIzkJnv-2Bnp8bRA-2FCik9IWHTIJ-2FNa0ZA29kqEOIffGTm5iZBfW1uXnA-2BIuHGt0T3ksuaohrZRgYL7mdNDudACY-2BHQnjxvEWfdDmrcE2YudPBzhhxzf5CI-3D)\n\nEnjoy"
          ],
          [
           "Outlier (-1)",
           "Interesting correlation between pandemic lifestyle changes and resting heart rate in Oura users."
          ],
          [
           "Outlier (-1)",
           "Why does everyone in here feel so delusional and out of touch with reality? Are you guys aware of the fact?. Serious question"
          ],
          [
           "Outlier (-1)",
           "Please share your experience with ketogenic diet for mental performance. I want to increase my cognitive abilities, like memory, executive functions and creativity. I eat healthy diet, exercise and meditate, but I feel like I could get a bit more. I've tried keto for two months, but results were mixed, so I decided to stop. I felt much mor physical energy, but felt like my mental performance was worse. I don't care about how long i can run, or how much I can lift. All I strive for is cognition. \nI have no weight, metabolic or brain issues, and could be considered as generally healthy. \nSo, what is your experience with keto?"
          ],
          [
           "Outlier (-1)",
           "How to decrease Theta brainwaves and/ or increase Beta and Gamma waves?. Hi all. I have ADHD and I've been searching for ways I can improve my focus. One of the things that stood out to me is that there is a bunch of research that indicates people with ADHD have an abnormally high level of Theta waves (usually prevalent only in sleep and deep relaxation in neurotypical people). I purchased a brainwave monitoring device called Flowtime which gives real time feedback and tracks trends as you wear it. And sure enough, I have what seem like a high level of Theta waves, sometimes even superseding my Beta waves (which are your normal waking brainwaves throughout the day). No wonder I have issues...my stupid brain is literally in a sleep mode all the time.\n\nI've looked all over the internet trying to find any research into how to DECREASE Theta waves, but I can't find any. There's a ton of research into how to increase them, because increasing Theta waves is apparently the goal of most relaxation and meditation routines. But no love for us ADHDers. üòï\n\nAny thoughts?"
          ],
          [
           "Outlier (-1)",
           "The 6 Best Biological Age Tests for 2021."
          ],
          [
           "Outlier (-1)",
           "Is the reason the rich and wealthy live so long due to the fact that they get annual MRI/CT scans done?. If you are rich, you can mostly afford to get annual health checks like MRI and CT scans done. You can even do this without insurance covering the cost too.\n\nI think billionaires like Bill Gates, Jeff Bezos, and Warren Buffet said publicly that they get an MRI done every year to increase the chance of detecting heart disease and cancer early. In return, this would improve survival rate if the doctors catch any disease.\n\nIt seems that a lot of rich celebrities are doing the Prenuvo scan every year ever since Kim Kardaashian made it well-known. I think this is the reason the rich and wealthy live until their 90s. Even with a bad diet and minimal exercise, early detection seems to be the key. \n\nLet's also not forget that wealthy people have better treatment options than the general public. I do believe there is already a cure for cancer but that cure is only for the elite and wealthy, not for average people. Big medicine is corrupt in that they want people to get sick from cancer so that it keeps them in business. I do believe if they revealed the cure, a lot of corporations would start to go bankrupt. This might be me believing in a conspiracy theory but I don't think it's unrealistic to believe that.\n\nI know most people can't afford to get an MRI done every year but maybe getting one every 2-3 years would be beneficial. Most countries in Europe actually include an MRI as part of an annual check-up for adults that are 18 and over. Why doesn't the US do this too? It seems like a lot of lives would be saved if medical providers and hospitals didn't reject asymptomatic people. Why do we need to have symptoms first in order to get an MRI/CT scan approved? It makes no sense..."
          ],
          [
           "Outlier (-1)",
           "COVID-19 ORF8 70-bp potential target sequences for LEAPER. Below listed are some of COVID-19 ORF8 potential target sequences based on [this research paper](https://www.biorxiv.org/content/10.1101/605972v1.full.pdf). TAG/UAG is the preferable target site.\n\n* GAAATTTCTTGTTTTCTTAGGAATCATCACAACTGTAGCTGCATTTCACCAAGAATGTAGTTTACAGTCA (starts from 27,896)\n\n* TTTACAGTCATGTACTCAACATCAACCATATGTAGTTGATGACCCGTGTCCTATTCACTTCTATTCTAAA (starts from 27,956)\n\n* TGGTATATTAGAGTAGGAGCTAGAAAATCAGCACCTTTAATTGAATTGTGCGTGGATGAGGCTGGTTCTA (starts from 28,026)\n\n* TACCTTTTACAATTAATTGCCAGGAACCTAAATTGGGTAGTCTTGTAGTGCGTTGTTCGTTCTATGAAGA (starts from 28,144)\n\n* TCTTGTAGTGCGTTGTTCGTTCTATGAAGACTTTTTAGAGTATCATGACGTTCGTGTTGTTTTAGATTTC (starts from 28,184)\n\n* TTCCCTCGAGGACAAGGCGTTCCAATTAACACCAATAGCAGTCCAGATGACCAAATTGGCTACTACCGAA (starts from 28,469)\n\n* GGCGGCAGTCAAGCCTCTTCTCGTTCCTCATCACGTAGTCGCAACAGTTCAAGAAATTCAACTCCAGGCA (starts from 28,805)\n\n* CGCAACAGTTCAAGAAATTCAACTCCAGGCAGCAGTAGGGGAACTTCTCCTGCTAGAATGGCTGGCAATG (starts from 28,844)\n\nEdit: I have accidentally included ORF9 target sequences into this list."
          ],
          [
           "Outlier (-1)",
           "Plans to microchip UK workers spark privacy concerns."
          ],
          [
           "Outlier (-1)",
           "Cancel Pendulum Subscription. Hello,\nI am subscribed to pendulum glucose control and one more product and I would like to cancel my subscription but can‚Äôt.\n\nWhen I log in into my account it says I have no orders. However I do receive orders and I have order numbers and I get charged. I‚Äôm sure email address is correct because if I use others I have I don‚Äôt receive a log in code and I do receive one with the email address I know I used.\n\nBecause it doesn‚Äôt show the order history I can‚Äôt cancel online. I can‚Äôt find a customer service number and the chat bot says it can‚Äôt find orders under my email address. \n\nAnyone has a customer service number or knows how to help me cancel this subscription? Thanks a lot !"
          ],
          [
           "Outlier (-1)",
           "Ben Greenfield - What's your response?. [https://regenexx.com/blog/harry-adelson-review-nd-review-the-biohacker-and-the-chinese-hamburger-2/#gref](https://regenexx.com/blog/harry-adelson-review-nd-review-the-biohacker-and-the-chinese-hamburger-2/#gref)  \n\n\nWhat's your response to this article?"
          ],
          [
           "Outlier (-1)",
           "Variant Vo2 max marker for longevity. Vo2 max is the most powerful marker for longevity per Attia.\n\nThough Attia doesn't singularly prescribe improving this fitness metric. Other things that can be trained in the gym like strength, grip strength, muscle mass, balance, toe strength, etc are considered.\n\nIt would be interesting if there was a large vo2 max and longevity study that also measured some of these aspects- to do a linear regression and see if Vo2 max AND some other metric mixed together provide an even stronger predictive factor.\n\nOf course some statistical care needs exercised to account for overfitting/ p hacking etc. (With enough degrees of freedom any dataset can be fitted in a way that doesn't actually generalize or provide insight- economy of factors - how much insight each factor provides per the cost of adding another factor which is the risk that it is due to chance.)\n\nI think it would be interesting if a single equation could incorporate vo2 max and strength to predict health span- because it could guide a unified approach to training- IE- make this number go up- and you are on track."
          ],
          [
           "Outlier (-1)",
           "Brian Johnsson - My Top 3 BREATHING Books of All Time (+ a Life-Changing Idea From Each!)."
          ],
          [
           "Outlier (-1)",
           "Strength training apps with good workouts?. There are a bunch of apps in existence, like Strong, Stronger, Stronger by the day, Fitbod, Caliber, some official ones from Nike (training club) and also Peloton own app. Apple Fitness, etc.\n\nDo you guys recommend any and has Attia recommended some for proper training technique? My goal is to do bodyweight training and weightlifting properly at home, with rings, resistance bands, dumbbells, barbells, bench and so on, but not sure what app program would be proper."
          ],
          [
           "Outlier (-1)",
           "Best way to focus while you are on Computer working?. Block add ons doesnt work for me. What works for me is: \n\n1 Nose breathing. Mouth breathing  deconcentrate and my theory is related with  **ADHD**  \n\n2 Avoid to open more of 2  tabs in browser \n\n3 Try to create discipline through repeat the same hardwork at the moment you want to be productive"
          ],
          [
           "Outlier (-1)",
           "Anyone try the Prenuvo scan?. Any thoughts? Worth the money?"
          ],
          [
           "Outlier (-1)",
           "Eat Less, Live Longer? Insights into the Geroprotective Effects of Calorie Restriction and Prolonged Fasting on Metabolic Health &amp; Longevity."
          ],
          [
           "Outlier (-1)",
           "Heart Rate Variability Question. Recently got an Apple Watch 8.  Male 51, VO2Max 46;  Resting HR about 50.  HRV all over the place. Average around 50 but measurements as low as 15 while others 120.  Any ideas why there is a such wide distribution?  I cant see any patterns with respect to sleep vs. exercise differences."
          ],
          [
           "Outlier (-1)",
           "Will OMAD with Cardio improve my insulin resistance even if my meal contains high carbohydrates?. like pasta, rice, potatoes, not all together of course, but there are days when my only meal is spaghetti. I always try to eat with some protein or a salad with lettuce beforehand, to try to reduce the peak"
          ],
          [
           "Outlier (-1)",
           "Sprints. I hate it, I hate thinking about it leading up to it, but once I have put in a decent session (~8 x 80m/ 90% over 20-30 mins) I honestly feel like I have taken a motivation/ happy pill that last for hours. And that‚Äôs just the immediate effects. Days after my libido is ridiculous, I sleep better and noticeable changes in body composition after a week or two. I‚Äôm shocked more people don‚Äôt bang on about this."
          ],
          [
           "Outlier (-1)",
           "Gary Brecka - Genetic Methylation Test?. Hey all\n\nJust listened to the new Joe rogan podcast with Gary Brecka.\n\nI don't know enough to try and fact check him but his discussions definitely piqued my interest.\n\nHe mentioned taking a genetic methylation test to see what our bodies could potentially be missing as far as methylated supplements goes. \n\nIs this all smoke and mirrors? Is there validity to what he's saying. I respect the fact that he's taking a much different approach to looking at this. Most of the time people will just tell you to take certain supplements, exercise, eat healthy etc. Which is all beneficial but we already knew that.\n\nJust want to start a discussion on this I'm very interested to hear others inputs."
          ],
          [
           "Outlier (-1)",
           "Introducing the YOUTH Early Adopters Program üéâ We are giving 10 people the chance to test our new preventive program | What‚Äôs included in the program: - Check-ups with the Youth app beta ü§≥ - Results for 6+ organs and 20+ biomarkers üß¨ - A doctor visit + tailored health plan | Interested?."
          ],
          [
           "Outlier (-1)",
           "99-103 morning glucose - What's happening? - 6.1' 29M - How to optimize it?. Hey there,\n\nI've been on and off with weight - Currently I most likely have around 20% Body Fat and still have some to lose.\n\n**Yet, I go to gym 4-5 times a week where I lift weights, run 15 minutes, then go to sauna.**\n\n**I've been eating around 1,200-1,500kcal** \\- I am taking a shitload of supplements so I am not sure what's going on.\n\nDo taller people have higher blood glucose?\n\n**I even take metformin 500-750a day.** I take **Magnesium**. 4-5G of EPA &amp; DHA. Honestly just a lot of supplements so I am not sure why am I seemingly mildly insulin resistent. \n\nAny help please?"
          ],
          [
           "Outlier (-1)",
           "Returning Dodo will involve building its native habitats."
          ],
          [
           "Outlier (-1)",
           "DNA data analysis. Hey - I was listening to Gary Brecka on a podcast and was thinking about what his DNA test reveals. I did a 23andMe test years ago and wondered if there is a way to get the raw DNA data from them and look through it to see if I have those genes he was talking about.  Or upload it to another company to have them professionally analyze it?  A quick Google search found a few companies that do it, but I don't know if they'll reveal what I'm looking for - I'm looking for actionable data.\n\nHere are some sites that came up on the google search:\n\n[https://sequencing.com/marketplace](https://sequencing.com/marketplace)\n\n[https://nebula.org/free-dna-upload-analysis/](https://nebula.org/free-dna-upload-analysis/)"
          ],
          [
           "Outlier (-1)",
           "Wouldn't a slow metabolism be better for longevity?. From what i saw many animals who live very long have a very slow metabolism, move very slow.\n\nWouldn't that be true in humans also? \nMy thinking is that a fast metabolism make everything grow faster but also die faster.(you may have more energy , feel good but you die faster)\n\nWould exercising in that case be a bad thing if you are skinny? (Exercise raise metabolism)\n\nAlso many athletes don t live long, chinese people who do a little work and never run or lift weights seem to do better."
          ],
          [
           "Outlier (-1)",
           "Leveraging high motivation into more momentum. What are some ways in which you hack peak motivation periods into longer term high productivity/motivation periods?\n\nI have adhd, tried a lot of things"
          ],
          [
           "Outlier (-1)",
           "280 ‚Äí Cultivating happiness, emotional self-management, and more | Arthur Brooks Ph.D.."
          ],
          [
           "Outlier (-1)",
           "Future fit app coach that follows Attia?. I was using the Future fit app last year and really liked the accountability and structure of working with an actual personal trainer. But, my trainer was not at all familiar with Attia type of routines. \nShort of quizzing every possible trainer offered in the app (hundreds?), I thought I‚Äôd see if anyone here has found either a Future coach that can incorporate Attia workouts, or, another online trainer or app that does the same. \nI know I can build my own withouts, and I do that, but I miss the accountability of interacting with a human, even if only online."
          ],
          [
           "Outlier (-1)",
           "Surprising way to increase one's cognitive performance. Will it work?."
          ],
          [
           "Outlier (-1)",
           "Pulsetto or Apollo neuro for elderly ?. Hi everyone. I‚Äôm trying to decide between a pulsetto or an Apollo neuro (vagus nerve stimulators ) for my 82 year old father with Parkinson‚Äôs disease. Any advice ? Are these contraindicated for heart issues? I imagine they help . Thank you"
          ],
          [
           "Outlier (-1)",
           "Am I doing myself any harm my taking these ? Without genetic test #garyBrecka. See attached photo , recent #garyBrecka cult member. Trying to 10x myself but not pay for the $600 genetic test."
          ],
          [
           "Outlier (-1)",
           "Peak glucose during HIgh intensity exercise. Does anyone know a reference that measured peak glucose during high intensity exercise in non diabetics? I have seen writing on the Internet that gives a range was high as 150-250 being normal, but there was no reference attached. Curious if anyone has seen any studies?\nThanks!"
          ],
          [
           "Outlier (-1)",
           "Where are these doctors. Where are people getting doctors that are willing to implement Attia's recommendations? I went into a cardiologist with high LDL. I'm in my 40s and I started asking about things like ApoB and Lp(a) and the guy just stared at me. It's uncomfortable to bring in a treatment plan from a book when the doctor is supposed to be the expert. I did get the cardiologist to order a CAC.\n\nAnyone have any tips about getting a doctor to entertain some of these ideas? I think most would believe it's overuse of medical resources. Are people using concierge doctors that are more willing to placate their patients? There's 0% chance my doc would ever prescribe something off label like Attia does (e.g.  Rapamycin  etc.) ."
          ],
          [
           "Outlier (-1)",
           "We want to give out something nice for Christmas | 1 in 10 wins $100 worth AG1 Kit | Everyone gets to try our app beta | What do you think?."
          ],
          [
           "Outlier (-1)",
           "10x HealthSystem uses Cell Science Services methylation testing (branding it as their own) @ almost 100% markup. The methylation test that 10X Health uses is done through Cell Science Services‚Ä¶ \n\nhttps://cellsciencesystems.com/ \n\nIf you go directly through Cell Science Services, the cost is $375‚Ä¶ Almost half of what 10X charges. I really think I got ripped off‚Ä¶.\n\nAny opinions?"
          ],
          [
           "Outlier (-1)",
           "How come I can order prescriptions on Canadian drug store but everywhere else I would of needed a prescription ?."
          ],
          [
           "Outlier (-1)",
           "Selling Chroma Skylight Portal Mini - UK Only. Available on getchroma.co for $400 or ¬£326. Selling for ¬£180. Used just a couple of times."
          ],
          [
           "Outlier (-1)",
           "Those of us with desk jobs: how do you incorporate healthy habits?. I work in front of a computer for 8 hours a day and I'm sure I'm not the only one here! Most of my coworkers literally sit all day, which blows my mind that they don't care. Like many of you, I take very very conscious steps to add movement throughout my day: stairs, bathroom and coffee breaks, changing positions, stretching, lunch walks, switching from sitting to standing to sitting, ebiking to work. Still, I always wonder what other health-motivated desk workers incorporate into their work life to ease the stress of sitting all day.\n\nWhat habits do you desk worker health jockeys incorporate into your sedentary work life?"
          ],
          [
           "Outlier (-1)",
           "Climbing over 50 steps of stairs a day may help reduce heart disease risk by 20%."
          ],
          [
           "Outlier (-1)",
           "Anybody has recommendations for ordering ApoB tests in the Bay Area?. I had tried to browse around but somehow I found it very difficult to make a straight forward appointment for the ApoB blood test. Has anyone tried this in the Bay Area, aside from reaching out to your primary physician?"
          ],
          [
           "Outlier (-1)",
           "Increase brain power. What are some tips that has helped you to achieve increase in sharpness of your mind that has helped you excel in your personal as well professional life?"
          ],
          [
           "Outlier (-1)",
           "\"My journey with LucyMod.shop has been exceptional. From the moment I placed my Modafinil order, their user-friendly website made the process a breeze. In just 3 days, my package arrived, and the product quality was unparalleled. Their responsive customer service team addressed my queries promptly.."
          ],
          [
           "Outlier (-1)",
           "The fact that I have been dieting all my life has screwed me over.. I feel like a thermodynamic anomaly when I look at my physical activity and what I eat. I do between 5 and 6 hours of cardio per week on a treadmill in zone 2, and I also do between 9 and 10 hours of weight training at low intensity.  I have a caloric maintenance around 1400 kcal, I am 1m80 tall for 96 kg,  I have a decent muscle mass since I have been training for several  years.  For November, I had an average of 14,500 steps per day, and I decided to go on a 2000 kcal diet for this month, but the problem is that I gained almost 2 kilos.  I think I am doomed to stay above 20% body fat for life."
          ],
          [
           "Outlier (-1)",
           "Bryan Johnson reveals his entire morning routine."
          ],
          [
           "Outlier (-1)",
           "The Fatal Conveniences You Are Using EVERY DAY | Darin Olien."
          ],
          [
           "Outlier (-1)",
           "I just CAN'T FOCUS. Hey everyone,\n\nLately, I've been finding it increasingly difficult to stay focused on tasks, be it work-related or even personal projects. It's almost like there's an irresistible urge to grab my phone every few minutes, browse social media, or check messages.\n\nDespite understanding the consequences of my distractions, breaking the habit seems like an uphill task. I've tried various techniques like setting my phone on Do Not Disturb or even placing it in another room. While these methods have had some success, the distractions from my wandering thoughts remain an issue.\n\nHow did you overcome it? Would love to hear any strategies or tips that have worked for you. Thanks in advance!"
          ],
          [
           "Outlier (-1)",
           "Would anyone be willing to help interpret this report. Good morning, \n\nI've been trying to work on my health now for a while since mold has affected me and was hoping to share these methylation/detox reports from genetic genie. So I seem to understand what each thing is, but was hoping to get insight on what supplementation may help my body in it's recovery per the reports\n\nThanks"
          ],
          [
           "Outlier (-1)",
           "Short term memory. how can I improve my short term memory,  damaged my brain from stress and I want to improve my short term memory. The situation is very out of hand"
          ],
          [
           "Outlier (-1)",
           "Is Vibroacoustic Therapy Bunk?. I mean, I know it probably feels good - just like how it feels good to \\* feel \\* the music at a concert - but does it actually effect long-term changes? Apparently it is FDA-approved for increasing circulation, pain relief, and increasing mobility. \n\nThe [Opus SoundBed](https://feelopus.com) is the closest product I've seen to making it mainstream/a consumer device rather than something you do at a clinic. It sounds really cool but I'd be disappointed if it only made me feel relaxed. \n\nTL;DR - Does lying down on a bunch of (glorified) subwoofers actually do anything for your health?"
          ],
          [
           "Outlier (-1)",
           "Evidence for Intermittent Fasting without losing muscle. Peter talks a lot about choosing to not do IF and miss out on the benefits of it because of the muscle mass loss. This fairly recent study seems to say that the assumptions around this are incorrect if muscle stimulus is done throughout the fasting. Has Peter mentioned anything about this and potentially changing his mind?  \n\n\n[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718030/](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718030/)\n\n&amp;#x200B;\n\nSummary, a 10-day fasting program with physical activity is safe, preserves muscle protein like in animals, and does not hinder muscle performance improvements from training.\n\n&amp;#x200B;\n\n&amp;#x200B;"
          ],
          [
           "Outlier (-1)",
           "Genetic/DNA Testing Kits. Hi I don‚Äôt know if this is really related to the forum or not but I am interested in getting a dna testing kit to determine which medications work best for my genetic makeup. I have depression, anxiety, and adhd and I‚Äôm on medications but would like to know if there is something out there for me that would work best.\n\nHas anyone tried any of these kits where they deliver the sample and results to you after you prick yourself?\n\nI am interested in the Clarity kit."
          ],
          [
           "Outlier (-1)",
           "Does Peter Attia advocate for any focused mobility training? What does the literature say about limited mobility strength?. I'm keeping active with aerobic conditioning and strength training (3 days of zone 2; 3 days of full body weight lifting; 1 day of HIIT). I'm also maintaining a diet that includes 150g of protein (I weigh 170) and includes mostly whole foods. \n\nBut my mobility is really poor. I can't squat parallel. My ankle and hip mobility is very limited. Some people work to get their fingers to link behind their back, and I struggle to get my fingers to touch the back of my neck (when reaching overhead to touch my back). \n\nI definitely recognize that I need to improve my mobility in general, but what's the thinking behind just how much mobility one should work on? For example: Should I just work to squat parallel? Or should I work get ATG?"
          ],
          [
           "Outlier (-1)",
           "Apoe4, Statins and (No) Medicine 3.0. I was dismayed to hear in the recent Rhonda Patrick Podcast that Peter seems to now caution against statins for those with apoe4 because of the (theoretical?) issue with a reduction of desmosterol leading to worse Alzheimer's outcomes.\n\nI (early 40s) petitioned my Doctor to put me on a low dose statin because of a very strong family history of heart disease ‚Äì my Dad had it before he was 50. \n\nI‚Äôm wondering now whether this was the right decision. The challenge is that I'm in the UK and I‚Äôm not sure I can access the necessary test for desmosterol levels; medicine 3.0 sounds great but I think it‚Äôs only for the privileged few at the moment. \n\nIs anyone else in the statins-apoe4-what-the-hell-do-I-do boat?\n\n&amp;#x200B;"
          ],
          [
           "Outlier (-1)",
           "Anyone else high risk with APOE e4/e4?. Curious if anyone is APOE e4/e4 and how you're dealing with it?  I tested in March of this year - was not surprised, but also when I first found out, I was like WTF did I even do this test? lol  I sort of knew what I was up against with my relatives health issues, although the only heart issues in the family so far has been my paternal grandmother who died of heart disease/stroke at 77 and paternal grandfather got Alzheimers in late 80s, lived until 92.   My Cholesterol has run high since my 40s - anywhere from 212 - 245.  Additionally, I am recovered from fighting Lyme and CoInfections for 4 yrs with a lot of antibiotics and herbals.  Once I finally started feeling better in 2022, I became determined to rebuild my immune system and become healthier.  I'm 56F, lost 40lbs over the past yr by reducing carbs/increasing protein, 16/8 fasting and walking daily, plus yoga and hiking.  Still rebuilding stamina and plan to implement strength training.  I first bought Dr Hyman's book, purchased the Function Health testing, including the Galleria cancer testing - Yeah lots of $$$ that insurance doesn't even recognize.   All of #'s are perfect.....except cholesterol, my A1C is 5.3 - which is acceptable, but want to get it lower and should be able to. Cardio IQ test through Quest came up with the following:  APO B - 114;   LP(a) - 190; Cholesterols, Total - 235;  HDL - 54, Triglycerides - 101; LDL-C - 160; CHOL/HDLC Ratio 4.4;  Non-HDL Chol-181; LDL Particle # - 1580; LDL Small - 213; LDL Medium - 372; HDL Large - 5195; LDL Pattern - A;  LDL Peak Size - 222.3\n\nMy regular physician took me off Lipitor in March 2023 because my total cholesterol was under 180 (this was before I read Outlive). I've recently started Cholest-Plex supplement by Patient One.  Reduced my saturated fats.  My Lyme (Functional) Dr wants me to continue with only the Cholest-Plex for now, but I'm really thinking I need to start back on the Lipitor based on Peter's suggestion.  I'm paying attn to my Omega 3 intake, Vit D, magnesium, sleep, exercise, started HRT at 53 due to extreme hot flashes.  Life Line screening shows mild plaque build up on one carotid artery.  Also going to try to get my dr to order a CT Angiogram to measure current damage.  And really hoping the drug in clinical trials to reduce LP(a) works!"
          ],
          [
           "Outlier (-1)",
           "I used the Supersapiens continuous glucose monitor, really interesting insights."
          ],
          [
           "Outlier (-1)",
           "Oura Ring Discount ‚Äì 40 ‚Ç¨/$/¬£ Off + One Month Free - 5 Codes. Hi, All\n\nOura just recently have lunched a new stress measuring feature and a new batch of discount codes has dropped, so I thought I'd share.\n\nUse this link to get 40 EUR/USD/GBP off and one month free for an Oura Ring: \nhttps://ouraring.com/raf/6fbc80c3a1?utm_medium=iac \n\n5/5 left!"
          ],
          [
           "Outlier (-1)",
           "Any hacks to suppress appetite / weight loss ?. I eat too many calories in a day and I want to lose about 20lbs to be at a healthy bmi. I don‚Äôt expect this to happen quickly, but I would like to see slow steady progress. I have a problem eating too much, and too often. I‚Äôd like to get my physical activity up but I‚Äôve been making reasonable progress in that refused. Any advice would be helpful."
          ],
          [
           "Outlier (-1)",
           "I recently discovered ambient music for myself and this playlist. It helps me to focus and stay strong. Maybe something for you too :)."
          ],
          [
           "Outlier (-1)",
           "Body composition workout. 15 year old male 6 feet\n96 kg"
          ],
          [
           "Outlier (-1)",
           "Biohackers thoughts about subliminal thing. What do you guys think about it and similar stuff like binaural beats etc? You believe in it? Tried it before?"
          ],
          [
           "Outlier (-1)",
           "How to get your ApoB tested in US without doctors script?. My PCP has no problems ordering blood work twice a year. Last time, I got my wish for ApoB to get measured as well, this time they forgot to put it so I got only your standard LDL, HDL, VLDL, Trigs.\n\nAs I implement changes in diet and exercice I‚Äôd like to track my ApoB levels more frequently. Where can I order these blood lab works without going back to my PCP? I don‚Äôt mind paying out of pocket. NJ/NY reaction in US.\n\nThanks!"
          ],
          [
           "Outlier (-1)",
           "Resting HR up and HRV down when restricting calories?. I started tracking/weighing intake and macros this week. 200g of protein. 2400 calories a day. 48m 6‚Äô4‚Äù 288bs. \n\nI‚Äôve been consistently exercising every day for a little over a month. Resistance, zone 5, 2 etc‚Ä¶. I am already feeling incredibly better. Throughout that time my resting heart rate during sleep was coming down and was at about 51 last week. HRV was on the move up as well showing a nice increase and recovery (data from Oura ring)\n\nI have only been monitoring intake like this for 4 days and on nights 3 and 4 I am already noticing my sleep is not as great and my RHR has been at 58 while HRV is down to the 30s from 60s last week. \n\nI‚Äôm wondering if this could be due to just the initial shock to my system and things recalibrating or if I‚Äôm not getting enough calories and causing some issues with recovery/rest?"
          ],
          [
           "Outlier (-1)",
           "What would you do going into the new year?. I‚Äôm curious of everyone‚Äôs new year routine, new or old. What are the main things you will continue to do or implement in the new year?"
          ],
          [
           "Outlier (-1)",
           "Fasting - Urolithin A (Mitopure) dose timing?. I do a weekly 24 hour fast and try to do a 2-3 day fast once a month. I am looking to maximize the autophagy of fasting. I am planning on taking urolithin A during fasts but can not find any recommendations for timing the dosing. \n\nBest to take once fasted 14+ hour? Best to take when initiating a fast? \n\nAnyone have experience with this or recommendations ?"
          ],
          [
           "Outlier (-1)",
           "The Early Program. Has anyone participated in the Early program with Dr. Attia? If so, what are your thoughts on value for the price? Thx."
          ],
          [
           "Outlier (-1)",
           "Need help with dealing with food cravings.. So I‚Äôll try and keep this quick. I‚Äôm needing to cut back on food, I know this. I started out at 350lbs, the lowest I got was 215 but I‚Äôm currently 255. I know the process of what to do, (CICO) but I‚Äôm having a much harder time of controlling my appetite than I ever have. I use to smoke/vape to help with my cravings but I quit that in November and I‚Äôm still dealing with the side effects of that, and then I got put on Prozac which has also increased my appetite. Iv been trying to eat large breakfast‚Äôs to control my hunger thru the day which has always helped me in the past. Right now I‚Äôm eating 2 packets of oatmeal with 12g of protein each and a protein shake with 25g of protein, but I‚Äôm never full from that, or I‚Äôll do two turkey sausage and cheese biscuits that have about 40g of protein combined with the shake and I still usually get a snack during break (all this after quitting and the Prozac). There are days where I litterly can never get full. My gym has suffered because of it all and Iv gained weight (10-15lbs once all this started) is there anything I can take to help control my Ghrelin output or something? I know I could stop taking the Prozac but this medication has helped me mentally and I‚Äôd prefer to stay on it but I‚Äôm at a breaking point now. If I don‚Äôt change now, I‚Äôm afraid I‚Äôll end up at 350 again"
          ],
          [
           "Outlier (-1)",
           "Which tests to measure. I wanted to measure a few a la carte tests that were missed on my last comprehensive blood draw. Namely, testosterone and C-Reactive protein. For C-Reactive protein I either see C-Reactive protein cardiac, or C-Reactive protein quant. Which one do I want for inflammation levels? Also, for testosterone, can I just get the testosterone serum for $26? Or do I have to get the expensive $100 free + total testosterone panel? These prices are from own your labs."
          ],
          [
           "Outlier (-1)",
           "How many of you have a regular stretching routine? And if you do, what is it?. Hey everyone!\n\nI just wrote a blog about the benefits of stretching and maintaining flexibility for longevity: [https://www.zest.science/blog/september-longevity-challenge-improve-your-flexibility](https://www.zest.science/blog/september-longevity-challenge-improve-your-flexibility)\n\nI was pretty amazed at how crucial maintaining range of motion is for healthy aging and how little stretching is talked about/focused on compared to cardio or strength training. (I know PA talks about it a bit but I couldn't find that much advice on it from him?)\n\n**Was wondering how many of you here include regular, focused stretching in your protocol, and if you do, what your routine is?**\n\nWould also love to hear any thoughts or feedback on the blog! I tried to summarise the science behind why flexibility is important for longevity and why stretching is so beneficial, and also included some suggestions for weekly stretching protocols taken directly from scientific studies.\n\nCheers!"
          ],
          [
           "Outlier (-1)",
           "Survive newborn baby. What's the best way to mitigate aging and damage to my body as a result of having a new baby? This will be my third baby and my first two really took a lot out of me and seems like I aged a lot, especially with the second one.\n\nBTW I'm the dad so I'm not talking about physical damage from childbirth. More like sleepless nights, lack of exercise (compared to normal where I workout quite a bit), and high stress."
          ],
          [
           "Outlier (-1)",
           "My Husband, The Cyborg. A relationship in the era of technology.I started following my husband‚Äôs journey into cybrogism in 2016 and made a documentary of it. As I enter it to festivals I wanted to share the trailer in the community hoping it can be of interest and spark an interesting conversation."
          ],
          [
           "Outlier (-1)",
           "How bad is my insulin resistance?. A1c is 5.5, insulin is 14.8. Also, how is an Lp(a) of 22? My memory from the book is that we can't change Lp(a) so it's just what we're given and it seems that 22 is pretty good both according to Attia and the \"recommended range\"."
          ],
          [
           "Outlier (-1)",
           "What are your thoughts on a plant based diet when it comes to longevity?. Hey guys.\n\nSo there‚Äôs two camps. One group is saying to stick to a strict plant based diet. While another is saying to mix a plant based diet with other food choices like milk, eggs, and fish.\n\nI wanted to know based on the longevity books you guys have read what would be the best solution."
          ],
          [
           "Outlier (-1)",
           "What blood tests to get?. Apologies for the noob question but what do you typically ask doctor for when trying to understand baseline metrics.\nDoes a blood work cover everything like hormone levels, metals, vitamins etc? Or do I have to ask for specific tests?\n\nI am just trying to understand things like testosterone, cortisol but also capture any broad markers that may not be optimal."
          ],
          [
           "Outlier (-1)",
           "My dad‚Äôs memory is in decline. Please help.. At age 77 he‚Äôs actually in excellent shape physically. He‚Äôs still pretty active; I think he swims once a week, he volunteers at a recycling center (though he exhausts himself) and cleans up litter from the side of the road. He still lives on his own (meaning not in a nursing home) with his lady friend. And he can still carry on a conversation very well. But I‚Äôm really starting to worry about his memory. I won‚Äôt go into detail but the warning signs are there. I don‚Äôt want to put him on Alzheimer‚Äôs drugs (yet). Are there any suggestions for foods/supplements I can incorporate into (or remove from) his diet? I‚Äôve read about omega-3 (which he already takes), vitamin D, Ceylon cinnamon, THC edibles (which he takes occasionally), green tea and resveratrol. What else? Fasting? Or is he too old for that? I‚Äôm open to anything."
          ],
          [
           "Outlier (-1)",
           "Growth hormone. So, did some of ^. Roughly 2-4iu every other day/3x a week for 4-6 months (helped the fuck out of my injuries but wasn‚Äôt magical either)\n\nThing is, now my fasting blood sugar is regularly 100-120 (was in the 80s) A1c is a 5.3 (over the years it‚Äôs only ever been 5.2 between maybe 6 tests) and my c-peptide was a 1.7ng/mL (reference range 1.1-4.4)\n\nI‚Äôve noticed that my ‚Äúfasting‚Äù blood sugar goes down to the high 90s/low 100s later in the morning/even at the end of the day after meals\n\nSo what‚Äôs going on? Will the higher FBG go down over time?"
          ],
          [
           "Outlier (-1)",
           "This looks very promising. https://elicit.org/\n\nWhat is Elicit?\nElicit is a research assistant using language models like GPT-3 to automate parts of researchers‚Äô workflows. Currently, the main workflow in Elicit is Literature Review. If you ask a question, Elicit will show relevant papers and summaries of key information about those papers in an easy-to-use table."
          ],
          [
           "Outlier (-1)",
           "No fap. Anyone tried it? Did you see any benefits?"
          ],
          [
           "Outlier (-1)",
           "The different ways to monitor glucose and insuline. I find myself undable to summarise they what/how/why for these measure than I do for lipids for some reason.Can any of you compare the following measures and what insights they give or lack :- fasting glucose\n\n\\- fasting insulin\n\n\\- HbA1C\n\n\\- 2 weeks with a CGM\n\n\\- OGTT\n\n\\- OGGT + insulin\n\n&amp;#x200B;\n\nMore precisely, I wonder, if your goal is to do one test (or series of tests) per year, to track your evolution from insuline sensitive to insulin resistant to pre-diabetes to diabetes.Which one would the best (earliest detection of change) and why ?(of course I'm aware some of these tests include some others + more, but I wanted list them all regardless)  \n\n\nFunny note: I've asked a doctor and a lab about OGTT testing, it's called HGPO in France and is only  prescribed for (some) pregnant women. OGTT+insulin doesn't exist (the lab is happy to do it if I pay)."
          ],
          [
           "Outlier (-1)",
           "Pulsetto?. So basically I'm thinking of buying a pulsetto for vagus nerve stimulation. But I have heard certain things such as: \n\nReturn service being rubbish\n\nThey charge you for premium even if you have cancelled it\n\nTheir website states scientific research but the only research I can find is on vagus nerve stimulation in general and NOT specifically for their device? \n\nDoes anyone have any experience with the pulsetto good or bad? \n\nThanks!"
          ],
          [
           "Outlier (-1)",
           "Major editing problems with Outlive. Background: \n\nI‚Äôm a CRNP. I‚Äôve been a fan of Attia for a long time, I‚Äôve read many sections of his book though not in its entirety and listened to numerous podcasts on the Drive as well as Attia on Rogan, Huberman. I believe in his work and agree with his principles. I‚Äôve incorporated many into my own practice.\n\nThe issue:\n\nI purchased two copies of Outlive. One for my wife and one for my Dad. My wife is nurse anesthetist. She opened the book today and within the first few pages is a gross medical inaccuracy. I have to wonder, as meticulous as Peter is, a self-admitted perfectionist, how can something so basic and elementary get into the final copy? \n\n‚ÄúMeanwhile, one of the residents began doing chest compressions on her prone body.‚Äù \n\nProne. Face down. I‚Äôve been to so many codes and cannot count. I‚Äôve never done chest compressions on a prone patient because that‚Äôs impossible, you‚Äôd be doing back compressions. And‚Ä¶ I am (just about) 100% certain that even a lay person would be giving chest compressions on a patient in supine position, on their chest. \n\nThis is weird for me because I just started reading Dr. William Seeds book on peptides and it‚Äôs the same thing in the first few pages he blurts out a gross inaccuracy. It makes me wonder who is editing? How is this missed? One would think that he had a colleague read this prior to print, right? \n\nIf you want to build trust and faith in the information within the text, with anyone, especially the medical/scientific community, you just can‚Äôt miss basics like this because we just roll our eyes. It‚Äôs like a scene in a movie or a TV show where someone sticks a harpoon-like needle perpendicular to the insertion site to place an IV, or the patient is getting major abdominal surgery and there‚Äôs no breathing tube, the list goes on. These things are basic, second nature to any healthcare provider. It‚Äôs disappointing that I have to say, ‚Äúoh keep reading, he will get more accurate later‚Äù‚Ä¶\n\nThis doesn‚Äôt change my opinion at all in Attia‚Äôs work, his principles, his knowledge. I‚Äôve heard and read enough to know he is the real deal and knows his stuff. In all truth, he can run circles around me in terms of his knowledge base. But it is just weird that someone so knowledgeable and perfectionistic can miss a basic term-  how did this pass the edit.\n\nMaybe with enough attention in this thread someone in Attia‚Äôs circle will get this and fix it.."
          ],
          [
           "Outlier (-1)",
           "subcutaneous fat decreases, visceral fat increases? Why?. Hey everyone, I'm severely confused.   \nMy digital scale seems to think that my subcutaneous fat is at the all time low(which I can visually see too) , and my visceral far is at all time high (I wouldn't say it's crazy visible but I can definitely tell that I do have something around my abdomen when I don't engage my core muscles).\n\n  \nF25, For the past month I've been doing x3/week strength workout aka crossfit (I mainly do it fasted in the morning &amp; then have a shake + breakfast right after), + some gentle yoga and runs here and there. This is all to say that I'm active. Diet is lots of protein (\\~1g/pound) and fiber. \n\nWhile I know the scale might not be super accurate, I find this very concerning. What could be some potential causes and what could I do/check for?"
          ],
          [
           "Outlier (-1)",
           "walking desk - long time health implications. I installed a walking desk 2 months ago in my office and have worked myself up to 10 miles a day average, with some days exceeding 14 miles. Usually I walk at 3 MPH.  While I am aware of the positive effects of physical activity I am wondering if I kept this routine for the next 30 years of my working life if there could be any negative effects to my joints (hip and knees especially) from walking so much?"
          ],
          [
           "Outlier (-1)",
           "5.8 a1c, slightly anemic and high blood pressure. In general, lipid panel is all within range, thyroid levels are good. Would love to hear perspectives from everyone as the three issues seem related in my mind. Any thoughts on what I should focus on to improve? I‚Äôm in my mid 40s(F), generally active with strength training twice a week, long walks and cardio a couple of times a week. I hardly eat sweets and  don‚Äôt drink alcohol or anything sugary."
          ],
          [
           "Outlier (-1)",
           "Negative for APOE4. Any actionable reason to look at APOE further?. Report is back from 23andMe, was particularly concerned about APOE4 as I have Alzheimer's in my family history. Thankfully, negative for APOE4.\n\nIs there value into looking at APOE further, that is if I'm APOE22, APOE23, APOE33?"
          ],
          [
           "Outlier (-1)",
           "Detecting magnetic north. Hi I really want an implant (or external device) which detects magnetic north. Is there anything available at the moment? North sense seems to have completely disappeared"
          ],
          [
           "Outlier (-1)",
           "brainmarket. Hello friends, does anyone know a promotional code for brainmarket.it? It's urgent.\r  \n\r  \n\\#supplement #gym #healthylifestyle #health\n\n&amp;#x200B;"
          ],
          [
           "Outlier (-1)",
           "How could I have lost this much strength in 6 weeks?! And will I get it back faster this time?. I've been working pretty hard for over a year on strength training. I think gains have been curtailed somewhat by sleep apnea that I'm having a really hard treating, as well as being 61. But there were definitely non-trivial gains. I took a 6 week hiatus while moving and working on new house. I can't give you anything precise, but I think it set me back about six months. This may be partly mental, as I always find it takes a week or two to get back into the swing of making that intense effort. Still, it's a bummer. Is this normal? Or might the apnea be not only limiting gains but also sort of dragging things back down more quickly than would otherwise happen? And lastly, do we tend to get back into shape faster with a break than it took the first time, from scratch?"
          ],
          [
           "Outlier (-1)",
           "Ok hackers. Let's build men beautiful butts.. Sorry for the NSFW ..  \n\nBut ( he he ) has anyone built up a butt. My butt is ok, but I would like stretches and exercises to build it up.\n\nAnyone?\n\nBeuler?"
          ],
          [
           "Outlier (-1)",
           "Compression socks?. I want to get some to improve circulation in my legs. However I read somewhere that you should consult a doctor for what kind to get, there's a term I can't remember. I assume it denotes how much compression a certain sock would give.\n\nAnyway my question is, do I really need to consult a doctor or can I just buy any compression sock? Or is there a good starting points for how much compression to look for?"
          ],
          [
           "Outlier (-1)",
           "I recently stopped sweating during my workouts. How can this be?. I weight train 2X/ wk, and I lift to muscle failure. I usually sweat through my undies and bra. \n\nThis past week, I did the same but didn‚Äôt sweat. Could my supplements combo be doing this? I just at recently added B1, BTW.\n\nMy supplements:\nVitamins B1, C, D, E, K2\nOmega 3‚Äôs\nMultivitamin\nCurcumin\nChlorophyll"
          ],
          [
           "Outlier (-1)",
           "What's your daily routine/schedule look like?. Curious what everyone's daily routine consists of. For myself:\n\n* Wake up at 6am\n* Breakfast \n* Hike with my dog \n* Work (WFH)\n* Lunch \n* Hit the Gym for weight training \n* Come home, do some more work\n* Cook Dinner\n* Chores, clean up etc \n* Respond to emails, pay bills\n* Video games with friends (always feel guilty about this, feels like wasted time that could be spent on more productive endeavours) \n* Bed at 10pm, read until 10:30ish, sleep"
          ],
          [
           "Outlier (-1)",
           "Marginal decade goals: how to work towards still being able to drive at 85-95 years old?. Firstly is this an unrealistic goal? I‚Äôm a 36 year old female. I‚Äôm less clear on how to work on cognitive goals such as this than physical ones. Would it just involve focusing on anything that slows cognitive decline? Thanks. üôè"
          ],
          [
           "Outlier (-1)",
           "Sudden hearing loss / please help!. My mother has it. She heard really bad even before this. What could be tried ?"
          ],
          [
           "Outlier (-1)",
           "lowering sugar. i need advice lowering my sugar :( \nfor some background:\n‚Ä¢i‚Äôm a 21 female who is slightly overweight, but not obese. \n‚Ä¢last time i went to the doctor my sugar levels were high but not diabetic level\n‚Ä¢with the holidays i‚Äôve been loading up on the sugar &amp; im worried about my sugar levels\nany tips on how to lower these levels ?????"
          ],
          [
           "Outlier (-1)",
           "Has anyone tried (re)magnetizing an old magnetic implant?. I don't have any magnetic implants, but I've been reading up on them to evaluate the pros and cons. One thing that comes up is that it seems as though the magnets weaken over time just like any other magnet, but most people seem to remove or replace them at that point. Has anyone tried to strengthen the magnetic field of the magnet after it weakens, either using another strong magnet or an electromagnet? I could see how some implantable magnets could have a configuration that would make this more difficult, but I feel like something like the axially oriented xG3 v1 https://dangerousthings.com/product/xg3/ could be (re)magnetized using an external electromagnet. Is there a reason this isn't possible or normal to do? Has anyone tried this? Thanks!"
          ],
          [
           "Outlier (-1)",
           "Fasting with POTS. Hey guys! I‚Äôm wondering if anyone has any insight to fasting with POTS. \n\nI‚Äôm looking to start off with a 24 hour fast and work up to a 3 day fast. I‚Äôve been reading about so many health benefits doing a 3 day fast, and I would love to get some feedback back"
          ],
          [
           "Outlier (-1)",
           "27F &amp; 2x APOE4 bad bois. Heya, Chris Hemsworth and I have something in common ;)\n\nOk so, we‚Äôve got:\n\n- no smoking\n- no alcohol\n- cardio (z2 + vo2 intervals)\n- some resistance training\n- sleep well\n- socialise \n- try to lower sugar intake\n- keep brain active\n- fasting (not super sustainable for me)\n\nAm I missing anything from his book / podcast? Thanks!"
          ],
          [
           "Outlier (-1)",
           "Genetic testing for health. What's the best way to determine one's propensities to suffer from diseases, etc?\n\nGreat-uncle lived to 90, so there's that. Four died of cancer, likely due to starting to smoke as teenagers. Two people suffered from dementia (calcification of cerebral vessels due to hypertension for 50yrs in my grandmother). I inherited Gilbert's Syndrome\n\n&amp;#x200B;"
          ],
          [
           "Outlier (-1)",
           "Blood work and genetic tests. Hi all, with the popularity of biohacking on the rise, I am looking to get a genetic test done to know what supplements I need to take based off of my genetic makeup. This was inspired by a bunch of Gary Brecka‚Äôs work. \n\nI am wondering if anyone has done this, how much it costs, how much it costs for recurring supplement orders, and then is it worth it? I have heard great things but from what I‚Äôve seen it can be $600 for the test then recurring payments of ~$100/month to get your individualized supps. Let me know thoughts!"
          ],
          [
           "Outlier (-1)",
           "Ketosis Benefits / Considerations. It seems like the state of ketosis can be hugely beneficial for a variety of ailments both mental and physical. I‚Äôm going to give it another go this year but I‚Äôm wondering what precautions should be considered when doing so. My general focus will be:\n\nLow carb/high protein, nutrient dense whole foods\nZero PUFAs or as close to it as possible\nLow glycemic carbs usually post work out \nClean fats, minimal dairy \nNo caloric debt to start - still in strength build phase\n\nGoals: higher energy, strength, agility and alertness\n\nSupplements: NAC, omega 3 (only) vitamin d, zinc, milk thistle, calcium/magnesium oxide 2:1, ashwaganda, b12, lions mane, reshi mushroom extract, mind mushroom complex, kre alkaline creatine, EEA+BCAA, ATP lab supreme beef protein, thrust testosterone complex, l glutamine \n\nI think I will add MCT oil to this \n\nThis year I think I will get a gut-biome test done to provide further insight \n\nAny links or videos or personal anecdotes are appreciated."
          ],
          [
           "Outlier (-1)",
           "Caloric Restriction in relation to‚Ä¶ what?. I‚Äôll preface this by saying that I have only recently become acquainted with, and started reading, Outlive, but this question around Caloric Restriction has been bouncing around my head for a bit and my cursory internet searching hasn‚Äôt yielded a simple answer. \n\nSay that my TDEE (and therefore maintenance calories) is around 3,000kcal. For CR, that would mean, with a 30% reduction, decreasing my daily intake to around 2,100kcal. \n\nSticking to this plan, I would continue to lose weight to the point where 2,100kcal is my maintenance calories - at which point I‚Äôm no longer restricting my calories in relation to where I started. \n\nAlso, along the way I‚Äôm no longer restricting by 30% of the original 3,000kcal reference as maintenance reduces as I lose weight. \n\nSo at what point does CR stop and I eat at the new maintenance? How is that decided?\n\nI wouldn‚Äôt be able to indefinitely CR relative to current weight as that set point would just get lower and lower the more weight I lose.  \n\nI hope that makes some sense. Looking forward to engaging in a discussion!"
          ],
          [
           "Outlier (-1)",
           "Very fat and unhealty - My baseline Dexa scan query. Hi,\n\nI'm 36M, 310pounds and 5ft7 (140kg, 170cm). I have included my dexa scans for reference. Based on Peter's book and witnessing chronic illnessess creep into my age group friends, I've realised I'm not long for this world unless I do something about it. Thus far I've been lucky with my health, I take no pills for any chronic illnesses, my sugar and BP levels are within range, but on the higher end of normal. I have weight related (probably) obstructive sleep apnea for which I use a CPAP. \n\nIn my high school days I used to be reasonably athletic. I had a sub12 second 100m time and played rugby in winter and cricket in the summer. I've always been considered by friends to be reasonably strong. All circumstantial and non substantive, I know, but still. BMI measurements have always been a joke. Even as a much slimmer high school kid, according to the BMI I've always been obese. I just thought I was big boned (lol), but my scan shows that I cant be any more average when it comes to bone density. Even just recently I completed a 20mile hike in Norway (Trolltunga) with no problems. Ok thats an exaggeration. I had a lot of problems (mainly fatigue and muscle ache) but did manage it.\n\nMy scan was done in Central London. My visceral fat is off the chart bad, but my muscle mass is off the chart good. The tech said hes never seen anything like it. I put my details into the FFMI calculator below and I was past excellent, superior and even suspicous. I was on the high side of unlikely\n\n[https://ffmicalculator.org/](https://ffmicalculator.org/)\n\nSo my question is, based on the info provided and in your opinion, is the dexa machine's calibration off, or do I actually have an abnormal physiology. Anyone else out there who can relate?\n\nhttps://preview.redd.it/omggspbeuzpb1.jpg?width=915&amp;format=pjpg&amp;auto=webp&amp;s=7dcbdee7de1e0782dcff87e066bffd8c2e73a847\n\n&amp;#x200B;\n\nhttps://preview.redd.it/en383cf1vzpb1.jpg?width=881&amp;format=pjpg&amp;auto=webp&amp;s=31605fc53092b76c444d84e2e41ed33cedda099c\n\n&amp;#x200B;\n\nhttps://preview.redd.it/5qb83ni3vzpb1.jpg?width=900&amp;format=pjpg&amp;auto=webp&amp;s=2fea230dfd60f9c9d62d38136ceb0ed768eb0c69"
          ],
          [
           "Outlier (-1)",
           "Best online functional medicine DR?. For men.  There is many in my area for women but no men, any good online ones?"
          ],
          [
           "Outlier (-1)",
           "Elevated resting heart rate after cold. My resting heart rate stays high for months after a cold.\n\nSometimes my RHR stays stable during a cold, then goes high after.\n\nNLR (neutrophil-to-lymphocyte ratio) is high which suggests \"inflammation and/or low grade infection\"\n\nAny ideas where to start digging? My doctor will order any labs I ask for."
          ],
          [
           "Outlier (-1)",
           "What are ALL the major categories of health?. Like physical health, mental health, financial health, etc. (i may be wrong with this) \n\nand for example: sleep fits into physical health (again i might be wrong) \n\nI want to be the healthiest person in the world and to further my research I think I need to organize it. So I'm gonna need to know ALL the MAJOR categories cause frankly im clueless thx alot."
          ],
          [
           "Outlier (-1)",
           "Low MMA‚Ä¶?. I recently had several blood tests done, for wellness not any specific issue.  It came back saying my MMA was low.  All I can find says that low mma doesn‚Äôt have any known impact.  I struggle to understand what this means.  \n\nDoes anyone have some knowledge nuggets?\n\n(I know high mma indicates a b-12 deficiency, my score is the opposite)\n\nThank you!"
          ],
          [
           "Outlier (-1)",
           "IF (Intermittent Fasting) Protocols. What IF protocols do you run and why?"
          ],
          [
           "Outlier (-1)",
           "Complementary Resources to Outlive?. About to order *Outlive* and have come across a few \"summary guides\" and was wondering what y'all think are the best guides, summaries, and other works that would be beneficial to have alongside his book?\n\nBackground: 27M, don't know shit about medicine (what the hell is apob?), I like running and lift occasionally, and I got hooked on Dr. Attia through his Armchair Expert interview. I love the idea of increasing my \"health-span\" (without getting too carried away) while also learning about things in the world of health/medicine."
          ],
          [
           "Outlier (-1)",
           "Any studies supporting grounding by walking barefoot outside?. I heard this helps and is important but I‚Äôm curious if it‚Äôs backed up by any science. Not being negative and doesn‚Äôt mean I won‚Äôt try it regardless, just curious."
          ],
          [
           "Outlier (-1)",
           "Got all my blood tests back....anything I have to work on?."
          ],
          [
           "Outlier (-1)",
           "Lower resting heart rate. How long does it take to lower resting heartrate?"
          ],
          [
           "Outlier (-1)",
           "Lol us transgirls are actually the real biohackers.. So I've been on here for a while and was surprised by how much u all just talk about supliments. Like I'm out here DIYing my own hormones and wanna get a payment chip implant lol. Haha I want a third nipple! And to get my balls turned into ovaries with Crispr cas9.\n\nOk maybe we have more scope for biohacking than u guys, but idk, do better:D\n\nAlso is a light hearted post not meant to trigger anyone, so if your feeling triggered and are about to write something angry... Take a second. Think it though."
          ],
          [
           "Outlier (-1)",
           "How to Improve Your HRV | Dr. Andy Galpin &amp; Dr. Andrew Huberman."
          ],
          [
           "Outlier (-1)",
           "Lyme Disease. Hey guys,\n\n&amp;#x200B;\n\nI hope this post finds you all well. I'm a 29-year-old who's heavily into bjj and weight training, eats healthy, and recently got a blood test done. I've been dealing with some health concerns and could use your insights, particularly regarding Lyme disease and a low white blood cell count. I'm really worried at this point because I've been sick every month for the past year, probably due to Lyme disease. I took doxycycline for 20 days, but 6 weeks later, I'm sick again with the same symptoms. This mess really fucks with my head, and I would really appreciate any suggestions you guys have regarding Lyme disease and or the low white blood cell count.\n\n&amp;#x200B;\n\n**Medications I take:**\n\n\\- Elvanse 30/50mg (every day)\n\n\\- Attentin 2,5 (3/week)\n\n&amp;#x200B;\n\n**Supplement I use:**\n\n\\- Omega 3 (fish oil/third party tested)\n\n\\- B12\n\n\\- Magnesium\n\n\\- Vitamin D3 (5000IU Week)\n\n\\- K2\n\n&amp;#x200B;\n\n**Diagnostics**\n\n\\- Lyme Disease\n\n\\- ADD (seasonly mixed with low-medium anxiety &amp; depression)\n\n&amp;#x200B;\n\n**Bloodtest** \n\n&amp;#x200B;\n\nhttps://preview.redd.it/0mnjop817fgc1.jpg?width=3024&amp;format=pjpg&amp;auto=webp&amp;s=900771eba98bfdfbc361a1b4a8e57a98e61182c1"
          ],
          [
           "Outlier (-1)",
           "how to make memory level genius?. I am 18 years old and I have a terrible memory, I have to reread everything several times and I still don't remember anything, I don't have any memories from my childhood. I really want to improve my memory and learn English"
          ],
          [
           "Outlier (-1)",
           "ELON MUSK explains the latest developments with NEURALINK his BRAIN INTERFACE DEVICE."
          ],
          [
           "Outlier (-1)",
           "I don‚Äôt know if Peter has made me feel more illogical. I come here quite often and message about things mainly in regards to weight and my heart health because I‚Äôm heavily anxious person and maybe this new age of influencers has made it worse.\n\nSo me a 22 man who‚Äôs obese with hypothyroidism, anxiety, many vitamin deficiencies.\n\nI‚Äôve had so many heart tests due to my symptoms. Stress test, 2 heart echos, over 50 ECGs, bloods, 7 day monitor and a CT scan. 3 cardiologists \n\nIn all this I know.\n\nApoB: around 72-80\n\nLDL: 80-90\n\nHDL: 35-40\n\nTrigs: 100\n\nHbA1c: 5\n\nFasting Glucose: 78\n\nInsulin levels: despite my obesity are 6/7 both times tested.\n\nLp(a) 150nmol, the only high value which isn‚Äôt stupid high. \n\n0 calcification in coronary arteries\n\nAvg bp 110/70\n\nSo I‚Äôve watched so many of peters videos, so many health things. I‚Äôm losing weight. Just like I have this consistent nagging feeling in my head I have severe heart disease like a 70% blockage causing angina, like surely this can‚Äôt be possible with all my stuff. Like I get smaller blockages are possible for anyone but 70% is where angina pain begins near end stage atherosclerosis like I can‚Äôt be there at 22 it can‚Äôt be possible no?\n\nSomeone help me understand what‚Äôs going on? Is this logical thinking?"
          ],
          [
           "Outlier (-1)",
           "Are xylitol or stevia safe/healthy to use to sweeten things for taste? What about their effects on blood sugar?."
          ],
          [
           "Outlier (-1)",
           "Am I tripping or is HBOT underrated for longevity?. HBOT = Hyperbaric Oxygen Therapy\n\nBasically my assumptions are these:\n\n1. One big-if-true study about HBOT being able to *significantly* extend telomere length (as well as cut senescent cells)\n2. Seemingly the entire community shitting on it because \"telomere length is a terrible marker of aging\" and just doing HBOT won't make you immortal (shocker)\n3. But like.... cells are still becoming senescent because they hit the Hayflick limit... right? So extending telomere length should allow them to reproduce longer without hitting the limit, right? Or am I missing something?\n4. I also haven't heard of **any** other mechanism, tested in humans, that has lead to an increase in telomere length (let alone by 20%), except via modified RNA, which isn't accessible to the general public and likely won't be for quite some time (I assume, could be wrong)\n\nEverything else I read about is ways to \"potentially\" \"slow down\" the shortening of telomeres, not actively increasing it by 20%.\n\nSo like if I were an older person, why the wouldn't I want to be on HBOT assuming the study is legit?\n\nIf there is literally **no other** publicly available way to increase them, and again they are *crucial* to getting past the Hayflick limit (because otherwise that presumably all of our vital cells will become senescent eventually).\n\nRight?\n\nI must be missing something, what am I missing? Is my high-level understanding of telomeres all wrong or something?\n\nHow is this not a monumentally big deal? (even though there are other *obviously* parts of aging to work out)"
          ],
          [
           "Outlier (-1)",
           "What are the best biohacks for studying?. Which biohacks gives you enchanced focus, higher mental capacity, more brain energy,..."
          ],
          [
           "Outlier (-1)",
           "Illumina Launches Genomic Sequencing AI (HUGE news)."
          ],
          [
           "Outlier (-1)",
           "Need for a DIY personal genome explorer?. Hi, I develop genome analysis programs. I wonder if there is need for a personal genome explorer in biohackers. Basically, an app with which you can analyze your own genome, but more in a DIY way. What 23andMe reports do, but more data, more control of analysis, you can make custom analysis modules, etc. Local analysis. \n\nAnything you wanted to do with your DNA data but couldn‚Äôt? What kind of things do you want to know with your DNA?"
          ],
          [
           "Outlier (-1)",
           "What‚Äôs essential to you that most people don‚Äôt even know about?. Over the last two years, I had two game-changers as far as my health was concerned:\n\nA turf toe injury that wouldn‚Äôt heal led me to discover so much regarding the health of our feet. Now it seems obvious to have shoes with a wide toe box. I discovered the topics of zero drop, minimalist shoes, etc.\n\nA doctor also pointed out that I was getting tired of breathing at the end of each day because I couldn‚Äôt breathe through my nose at all. A sinus cleaning and septum deviation surgery later, and I‚Äôve never been able to breathe as easily as now. Total game changer. At the same time, I learned about mouth taping, belly breathing, etc., and those were also great improvements.\n\nThat‚Äôs all good, but I now wonder if there aren‚Äôt any other topics just like that. Things that I don‚Äôt even know I should look into turn out to have big long-term impacts.\n\n&amp;#x200B;\n\nDo you guys have some similar experiences? Something essential to your health that most people don‚Äôt even know they should look into?"
          ],
          [
           "Outlier (-1)",
           "Biggest challenge following advice in Outlive is finding the right doctor. Biggest challenge following advice in Outlive and Peter in general has been finding a doctor that will break from ‚Äò medicine 2.0‚Äô. (Eg. prescribe statins since I‚Äôm in great shape, youngish, but have LDL-C of 126.) Longevity doctors often don‚Äôt take insurance and do a lot of"
          ],
          [
           "Outlier (-1)",
           "Is this channel real? That'd make me so happy.... I started numerous n=1 health experiments between 2011 and 2014 as an amateur competitive eater and engineer to produce tightly controlled, reliable, and repeatable results. I started with 4 week diets using single food sources doing full blood work and DEXA scans. I used the first 6 months of my experiments to guide my experiments on cholesterol, fasting glucose, body composition and BMR. My cholesterol experiments were so tight my control diet (only bananas) had a 142 mg/dL +- 4 mg/dL over the three years in 6 different measurements blowing away expected biological and laboratory tolerances. I continue to use this information for my diet and health although less organized and not within an experiment design.\n\nI have been searching for the place to discuss, on Reddit in particular, for ten years and I am so hoping this is it... So I have to ask... Is this indeed the right place? If so, any particular tips and guidance for a noob to this subreddit?"
          ],
          [
           "Outlier (-1)",
           "Canadians under 50: Have you been able to get a colonoscopy (either covered or out of pocket)?. My GP recently retired, I've managed to find a new doctor to take me on in Edmonton, Alberta, will be seeing them next month.\n\nI'm nearing 40. I know PA suggests colonoscopy at 40, and given my medical history both personal and family I think it would be wise for me to get one.\n\nHas anyone successfully gotten approval for a colonoscopy in Alberta at this age? If yes, how did you go about it? I'm willing to pay out of pocket if need be."
          ],
          [
           "Outlier (-1)",
           "Master Thread on Longevity Benefits of Steam Rooms. Hi,\n\nHope everyone here is taking steps to increase their longevity. I am increasingly persuaded that to focus on increasing personal longevity, there needs to be a balance between consumption of information, and the applied practice of such information. Spend too much time consuming, critiquing studies, and commenting on reddit, and it is possible (not necessary), that too little time is devoted to actually pursing longevity practices such as exercise, sauna, sleep and so on reduce.\n\nTherefore, what I intend start a practice in this subreddit of having master threads on certain topics, which are comprehensive and definitive posts that can be used as a comprehensive reference point for those who interested both in research and practice. I will constantly update the post to reflect the consensus discussion in the comments. I am looking for members of the thread to share their knowledge/expertise/experience on the topic which is the subject of the master thread.\n\nThe topic I propose today, which is of personal interest to me are steam rooms. Not Finnish Saunas (which are essentially dry), not infrared saunas. Only Steam Rooms.\n\nThe standard questions:\n\n(a) **Are there any medical studies, in which the individuals who were the subject matter of the study were exposed to Steam Rooms, and not Saunas?**\n\n\\[Context: Many researchers, read studies on finnish/infrared sauna's and reason through analogy that Steam Rooms will be similarly beneficial, given that steam rooms create a similar affect on the body. But, I have realized that logical reasoning cannot be applied to biology. Corollaries may or may not be true in medicine. Hence looking for studies that in which the subjects of the study were made to sit in a steam room\\]\n\n(b) **Assuming that medical literature on steam rooms is insufficient, would the benefits found in Medical studies w.r.t Finnish Saunas be similarly found in Steam Rooms?**\n\n\\[This question is of personal interest to me, since I am debating internally whether to continue the practice of sitting in steam rooms?\\]\n\n(c) **According to current medical literature, for a sizeable longevity benefit, what is the minimum duration, for sitting in the steam room?**\n\n(d) **According to current medical literature is the minimum temperature IN STEAM ROOMs, to produce actual longevity benefits?**\n\n\\[This question is of actual interest to me, since according to the answers in the comments, I can request my local club to change the temperature, according to the consensus of the ideal temperature in the comments section\\]\n\n(e) A**ctivities allied with steam rooms - Some longevity researchers/influencers advocate contrast therapy - for instance cold showers interspaced with sauna use. Are there any studies which support this?**\n\n(f) **Although this question is not as relevant for me since I am 27 years old, but for the sake of comprehensiveness for the sub, would past cardiac events, be a contra-indication for using steam rooms, given the propensity of steam rooms to increase blood pressure?**\n\n**(g) Any precautions to take while using steam rooms?**\n\n\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\n\nIn case you feel there is any additional question that would be useful for members of this subreddit, please comment, and I will update the post accordingly. Thanks."
          ],
          [
           "Outlier (-1)",
           "What to ask my new Dr. for. Hey all. New here. I just finished outlive. It has changed my life. I have made a variety of positive changes already. I have a meeting with my new Kaiser Dr. on Monday. I would like to communicate effectively the type of care I am looking for. That said, the scientific speak in the book is overwhelming and I do not remember all of the specifics. \nI thought you fine folks might be able to give me a summary of what to ask for.\n\nMy Health and Family History:\n I am a 38 year old Male, somewhat overnourished however moving in the right direction (I ran 4 miles at an 11 min pace the other day to give you an idea of my current fitness level-my heart got as high as 165 and was fluctuating between 155-165). I do cardio almost every day and my diet is now very good/sustainable and I am hitting my protein goals daily. Working on core strength and stability and plan to get back to lifting weights soon. I have obstructive sleep apnea but use a CPAP religiously. \n\nOne of my uncles had melanoma. No other direct lineage cancer I am aware of. Both of my grandparents suffered from dementia in their later years 70‚Äôs for grandma 90‚Äôs for grandpa. I do not know about my dad‚Äôs parents. \n\nNo diabetes in my family (and I‚Äôm honestly shocked some of my Aunts and Uncles have not developed type 2 given their lifestyle choices).\n\nIn the recent past I have smoked/vaped cannabis heavily (smoked it a lot when I was younger, vaped it a lot in the past few years) but am no longer doing so outside of occasional use. When I was 20 I smoked a lot of cigarettes for about a year.  \n\nNo heart issues that I know of in my family history, although no one was a smoker. \n\nSorry for the novel, and thank you for reading if you got this far. Appreciate any help or guidance."
          ],
          [
           "Outlier (-1)",
           "PCAge - new clinical aging clock identifies signatures of healthy aging and provides normative targets for clinical intervention."
          ],
          [
           "Outlier (-1)",
           "2 weeks on CGM - what should I try?. So I have set up CGM partially because 90% of my family are diabetics (and I once was too close to the pre-diabetic score), partially because i wanted a more healthy lifestyle.\n\nAlready tried workouts, going to sleep late / early, eating out (suprisingly Subway gave me a spike to 220, not confirmed by pricking, but external device showed 180 anyways... not going there anymore), and also my wife found out her glucose goes down to 50 if she doesn't eat late at all.\n\nAnything else I should try? Maybe there's some kind of a list i could go through?"
          ],
          [
           "Outlier (-1)",
           "Walking barefoot at home - Pros and Cons? What do you do?. I vaguely recall Peter mentioning the importance of walking barefoot. It might have been in conversation with Beth Lewis regarding stability. Basically wearing shoes over time leads to loss of stability and mind-body connection with one's feet, which is important for balance, force transfer during movement/lifting, and preventing falls in old age. \n\nObviously people don't wear shoes often at home, but many still wear socks. For the past year I have even stopped wearing socks, going completely barefoot. I have also noticed in many of Peter's exercise posts on instagram that he is often barefoot in those videos.\n\nHowever, I have grown some calluses at the bottom of my feet as a result. They aren't too bad but sometimes they can pinch. If they continue to thicken then maybe it might become more uncomfortable. So far I still think walking barefoot at home is worth it for the aforementioned reasons (not to mention that socks also increase chance of slipping, especially on stairs).\n\nI am just curious if others here have thought about it and have opted for either socks or barefoot at home in light of certain considerations. For instance, one thing I haven't considered is hygiene, I don't know if there's increased risk of bacterial/fungal infections on feet over time from constantly walking barefoot at home. Then again I feel like socks compress one's toes leading to loss of mobility/proprioception through the toes. It also feels nice psychologically when my toes are free. Barefoot also seems the most natural in an evolutionary context and therefore perhaps more beneficial/less risky than socks. \n\nNow I'm sure some people will roll their eyes because in the grand scheme of health and longevity this question seems trivial. However, as Peter has suggested before, when it's a matter of implementing a given alternative on a chronic time-scale, a seemingly trivial matter can magnify over time to have non-trivial significance."
          ],
          [
           "Outlier (-1)",
           "Does anyone have a truly optimized workout regimen for stability, strength, and longevity?. I've been extremely sedentary for years now and want to start working out again but now I'm worried about creating imbalances and generally don't know what to be wary of. I just was hoping to find a regimen that sets me up best for old age. I'm concerned of exercises that'll ultimately be more likely to cause injury down the line like deadlifts. I know having a strong core is important but I'm not sure what to do for that. Also what's the safest back exercise that doesn't risk injury. Then there's the whole issue of how to warm up exactly for best effects. There's also the concern of how to prevent joint damage from all the exercising."
          ],
          [
           "Outlier (-1)",
           "Any hacks/tips to offset being sedentary for people who drive for a living? Specifically regarding posture?. Edit: Referring to anything that can be done WHILE driving, not before/after."
          ],
          [
           "Outlier (-1)",
           "Conditioning loss from 2 vs. 4 weeks of inactivity?. I'm planning to do a silent meditation retreat this spring and considering either 2 or 4 weeks. I've been working pretty consistently on aerobic conditioning and especially weight training for the past 18 months, and I'm 62, so at a point where it's going to take somewhat longer to bounce back from inactivity than in the past. My take is that you don't start to lose in a serious way until 10 - 14 days, but I'm wondering how things might be after a whole month without any vigorous exercise--that being one of the commitments you make for such a retreat. I know there won't be any sort of precise answer but wonder if folks can offer general comment, or advice."
          ],
          [
           "Outlier (-1)",
           "In soles?. I‚Äôm very much into my health and fitness but I wouldn‚Äôt say I‚Äôm a runner. \n\nI strength train at the gym 5 times a week, walk a heck of a lot, do yoga, cold water sea swims, mountain hike, and soon plan on cycling more. \n\nI care about my foot health eg ensuring the shoe is suited to my feet, wide around the toes and good for my gait, posture and longevity of my body to ensure fewer injuries in future. \n\nAs I say I rarely run but I do a lot of walking so I thought this shop that does tailored in soles could be good. It‚Äôll be expensive and typically aimed at runners so do you think I‚Äôm wasting my money https://momentumsic.com/rs-footscan-and-phits-insoles/\n\nPlease take a look before commenting, thanks!"
          ],
          [
           "Outlier (-1)",
           "Seeking Advice: HRV is still at 34 after 90 Days of HRV Training - 40 y/o M. Hey All -\n\nLooking for some advice here - 40 y/o M, I've been practicing HRV breathing (Following a YouTube Video - 5 breaths per min for 10 minutes) every morning for the last 90 days, followed by 10 minutes of vipassana meditation, and my HRV score is still at 34.  I have seen some spikes throughout the 90 days (some days in the 50 range), but the average per month is still at 34, with some days in the low 20s.\n\nMy HRV started at 34 and has been consistently at that for the last 2 years. \n\nFor tracking, I use an Apple Watch.\n\nPhysically, I eat fairly well, get 7-8 hours of decent sleep, supplement, and exercise regularly (5-6 times per week), and all of my exercises do get the heart date up  (mostly HIIT, Zone 2 Cardio, or traditional strength training.)\n\nMentally, I journal daily and see a therapist once a month to help with anxiety but would consider myself an avoidant/anxious person (not sure how much that would impact HRV, but thought it would be worth mentioning).\n\nI don't drink alcohol heavily (4 drinks per month) which may have impacted my score. I just got back from vacation where I did drink more.\n\nAnyways, feeling pretty discouraged and would love some feedback on my protocol or any advice as I would love to get my HRV higher."
          ],
          [
           "Outlier (-1)",
           "Precision Biohacking - My recommendation having tried a bunch of DNA Health sites. Hi all, I just wanted to share some of my feedback on SelfDecode which I've increasingly used as my 'guide' to precision biohacking. As a bit of a genetics buff I've used 23AndMe, Nutrition Genome and Nutrahacker but always return to  [SelfDecode](https://selfdecode.com/?a_aid=6452b2dd10d04)  as the best of the bunch. Reasons for recommendation below:\n\n* The change that has pushed them to the top of the pile for me are the polygenic health reports for those of us that want to understand our risks of certain health conditions. They parse up to 83 million genetic variants to get a summary of your risks and areas to target.\n* It produces really detailed recommendations on supplement/lifestyle options to overcome the issues or prevent them from occurring there are loads more than on the other sites but also it explains why they recommend the interventions.\n* A year ago I wouldn't have chosen SelfDecode as a recommodation for others due to its complexity but wow have they made some amazing changes to their portal over the last year and so now they beat out Nutrition Genome as they have something aimed at every level of biohacker.\n* If you want top line info it is industry leading on the polygenic reports but for anyone who like me really likes to drill down into certain SNPs etc I've found it provides that ability where the other reports just didn't allow that in the same way.\n* Diet info now added and you can even build meal plans etc. I haven't used this yet and just saw it today and thought this platform has just become such amazing value compared to the others.\n\nHere's a link for anyone interested. For me it's a really interesting approach to biohacking and endlessly fascinating!\n\n [SelfDecode](https://selfdecode.com/?a_aid=6452b2dd10d04) \n\n&amp;#x200B;\n\nHere's a sample report if it's of interest. It's worth noting that they have dashboards etc and reports for what seems like endless numbers of ailments! The way that I see it is that I'm determined to be the best me that I can be and this is going to help me do the job as best I can!\n\n[https://sh-newsite-bonuses.s3.amazonaws.com/Anxiety+-+John+Doe+-+20+Mar+2022.pdf](https://sh-newsite-bonuses.s3.amazonaws.com/Anxiety+-+John+Doe+-+20+Mar+2022.pdf)\n\n&amp;#x200B;\n\n&amp;#x200B;"
          ],
          [
           "Outlier (-1)",
           "Is a saliva swab reliable for a DNA / genetic test?. Wondering how realiable swabs are? I thought blood would be most accurate."
          ],
          [
           "Outlier (-1)",
           "Doctors in NY Bay Area who practice similarly to Peter Attia?. Good morning, \n\nAny doctors out there that practices with focus on longevity and medicine 3.0? \n\n**got the idea from the OP who posted about SF area."
          ],
          [
           "Outlier (-1)",
           "Signing up for Early?. Is anyone planning on signing up for Early? I know it‚Äôs pricey - but there is so much information in his book and podcasts, I would love to have tools to tell me exactly what to do! \n\nHas anyone done the Early before?"
          ]
         ],
         "hovertemplate": "Topic Group=%{customdata[0]}<br>document=%{customdata[1]}<extra></extra>",
         "legendgroup": "Outlier (-1)",
         "marker": {
          "color": "rgba(200, 200, 200, 0.15)",
          "symbol": "circle",
          "opacity": 0.2,
          "size": 4,
          "line": {
           "color": "rgba(150, 150, 150, 0.05)",
           "width": 0.2
          }
         },
         "mode": "markers",
         "name": "Outlier (-1)",
         "showlegend": true,
         "x": {
          "dtype": "f4",
          "bdata": "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"
         },
         "xaxis": "x",
         "y": {
          "dtype": "f4",
          "bdata": "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"
         },
         "yaxis": "y",
         "type": "scattergl"
        },
        {
         "customdata": [
          [
           "Other Topics",
           "Do You Fast?. I am utterly confused about if and how to get started. Sould I consult a nutritionist to guide me in the process?\n\n[View Poll](https://www.reddit.com/poll/17ho84w)"
          ],
          [
           "Other Topics",
           "Children's potential. Looking on guidance and best practices when it comes to child nutrition and how to maximize growth potential."
          ],
          [
           "Other Topics",
           "Do you ever feel like something is missing in your life?. I get 8-9 hours of sleep, workout daily, 12,000 + steps, eat all Whole Foods, sunlight, all that stuff, but constantly feel like something is missing in my life"
          ],
          [
           "Other Topics",
           "How do you manage to eat enough calories while eating clean?. I started eating clean (unprocessed) a few months ago and I find I cannot eat enough calories (maintenance) without recurring to processed foods or saturated fats.\n\nWith my current activity levels, my maintenance calories are around 2500.\nThat‚Äôs 2500 calories to be distributed between carbs, fat and protein:\n\n- Protein: I eat 160 to 200g a day. Not a problem with this, but that‚Äôs only 800 calories top.\n\n- Fat: I try to avoid, as I am extremely sensitive to fats (spikes my LDL and Apob, and I have high genetic LPA).\n\n- Carbs: if I keep my fat intake to 500 calories or less, I have 1200 kcal left which is roughly 300 grams of carbs (which seems a lot from a T2D prevention perspective)\n\nEven if I follow this approach, the volume of food is so big that I cannot finish eating without later on feeling sick.\n\n\n So, how do you all manage to eat ‚Äúclean‚Äù? Just statins and eat as much saturated fat as you want?\n\nI‚Äôm currently limiting my activity levels because of this. I could train way more, but I‚Äôd be on a big deficit. Sometimes I have no other option than slurping down 3-5 tbsp of olive oil, which is gross."
          ],
          [
           "Other Topics",
           "Reducing food intake. Hi,\n\nI think I've found a good diet for me (something between paleo low carb and keto, with nothing processed, no alcohol etc). \nIt drastically make my cravings disappear and I feel great. I have more energy, my skin is better than ever.\nI've lost 4 kgs when starting (my weight is and was normal).\nI've noticed that I was still having the tendency to eat a bit too much even with healthier food, especially when tired/stressed etc.\nIdeally, I would like to lose 4 kgs more. \nHas anyone found a way to naturally eat a bit less, with smaller quantities etc?\nI'm probably thinking more about a mindset thing that a supplement or a change of diet as I think the root cause is more on behavior side.\nIt sound stupid but it's not easy for me. \n\nThx!\n\nEdit : thanks for the comments \nTo precise, I've been doing it for 6 months. \nBut it's not cravings at all. It's more than maybe instead of eating 3/4 of a plate (for instance) I'm going to eat a bigger portion (even of healthy food)"
          ],
          [
           "Other Topics",
           "19m 128lb: realistic goals. as the title says i‚Äôm 19 years old and weigh in at 128lb at this moment (58kg) and i wanna know what are some realistic goals for working out and building muscle. \n\nI just started going to the gym basically everyday (about 5 days a week) and I want to dedicate myself to becoming better. I have a goal of 180lb (81kg) but I don‚Äôt know how long it would realistically take to achieve that. I plan to use creatine and protein powder to help me. and i work at a pizza place so I have plenty of extra calories at my disposal. also i want the 180lb to be at least mostly lean and after that i for the most part just want to maintain the physique at around that weight. \n\nis there anyone who can give me a realistic time period to shoot for? I obviously want to more ambitious goal so i can push myself. I was thinking somewhere around 2-3 years to get there or at least close, but i really have no idea. \n\nalso any tips would help a lot. thanks."
          ],
          [
           "Other Topics",
           "Water retention, higher blood pressure after doing strength training in the morning. Hi all, I‚Äôve noticed when I lift weights in the morning, I feel more puffy, feel heavier and like i have a bit elevated blood pressure the rest of the day. Is this normal, how can I fix this? \n\nNote, this doesn‚Äôt happen when I train in the evening."
          ],
          [
           "Other Topics",
           "How do you fast without becoming skinny. I love fasting and it's easy but I shed weight way too fast, I'm 6'0 160lbs and if I fast I go even lower. I loved how my body was at 180lbs.\n\nHow do you fit enough calories in an 8 hour eating window? I eat healthy whole foods so they're not calorie dense and I fill up fast."
          ],
          [
           "Other Topics",
           "Sudden HR drop. I've noticed what seems to me to be a strange pattern in my overnight HR. I usually wake up to pee once during the night, and it seems like my lowest HR tends to come right after that, but it often suddenly drops several BPM at that point. See the two screenshots - you can see the wakeup corresponding with a big movement line indicating getting up to pee, and down below you can see the sudden drop in BPM that roughly corresponds with that. Anybody ever see something like this / have any ideas?\nM/45"
          ],
          [
           "Other Topics",
           "How Many Calories Are Optimal For Health?."
          ],
          [
           "Other Topics",
           "Thoughts on high oleic peanut butter. I‚Äôve read various takes on peanuts and peanut butter. How does it sound to get 500 cal every few days (or every day) from several tablespoons of high oleic (and therefore low linoleic) peanut butter?"
          ],
          [
           "Other Topics",
           "Is Protein Timing and Calorie Cycling really a thing?. Hey, \n\nthis subreddit is very helpful in answering fitness and health questions! \n\nCurrently I exercise   \nMo,We,Friday,Sa = Boxing   \nTu,Thu = Walking/Running/Zone2 in the morning + Rest  \nSu = Full Day Rest\n\n(31M,112kg,180cm)  \nI eat about 2500 kcal/day ( I know its way to low, just scared to bump up my calories, working on that) and try to Recomp / stay at maintenance. \n\n**My Questions:**\n\n1. If Weekly Calories stay the same, can I eat on my workout days 3300kcal and on my Running Days about 500kcal? What are the limits of this approach?                                    *It's called Alternate Day Fasting and* ***I don't do it for fat loss reasons****.*  *It just fits into my schedule, work, gym and student life.*  *Also, it's very annoying to have to eat and prepare food all the time.*  *I also love the cognitive benefits of running on an empty stomach.* *So if nothing else, it would help me a lot with my time management.* \n2. I aim for 220g of protein per day. Of course, on the low calorie days I can only eat about 80g of protein. Is the timing of protein important? Or should I just aim for a weekly protein intake? \n\nI would really appreciate any answers!"
          ],
          [
           "Other Topics",
           "What is the best and safe way to lose weight quickly?."
          ],
          [
           "Other Topics",
           "Finding the right Balance. I've been deep in this space for close to a year now, before that I've already always tried to live as healthy as possible.\n\nOne thing I started to notice lately time and time again is how obsessive I've become with healthy eating. I'm constantly looking to improve my diet, remove this, eat more of that... I'm really not sure whether it's that much more advantageous to constantly be aware of what certain food is doing to your body. One thing I'm trying to do now is eating as healthy as possible most of the time and getting a solid basis like this with lots of veggies, greens and good fats, and supplements. And if my grandma for example made a nice cake I'll gladly accept it.\n\nWhat do you think about this? How do you find the right balance for yourself?"
          ],
          [
           "Other Topics",
           "Olive oil for gaining weight?. I'm a 22 year old male with a high metabolism trying to gain weight. Part of the problem is that I feel full from eating  little so I think I may not be eating as many calories as I should be. I've done some research and found a shot of olive oil should be 360 calories. If I take two shots a day that should be an extra 720 calories a day that should be easy to get down regardless of how full I feel. Does anyone have experience with doing this?"
          ]
         ],
         "hovertemplate": "Topic Group=%{customdata[0]}<br>document=%{customdata[1]}<extra></extra>",
         "legendgroup": "Other Topics",
         "marker": {
          "color": "rgba(200, 200, 200, 0.15)",
          "symbol": "circle",
          "opacity": 0.2,
          "size": 4,
          "line": {
           "color": "rgba(150, 150, 150, 0.05)",
           "width": 0.2
          }
         },
         "mode": "markers",
         "name": "Other Topics",
         "showlegend": true,
         "x": {
          "dtype": "f4",
          "bdata": "4F0FQCBpDEAnSN8/0y71P2TK+D/TKAJAYXqfP19J8D+pgpg/7l72P7zz8D8lD/Q/pxXxP4Dz9T/q9fc/"
         },
         "xaxis": "x",
         "y": {
          "dtype": "f4",
          "bdata": "lhRlQL/HYEBMImNAcJNpQFh5Z0DayWJAHt5iQOMabUBHAmRAg4tpQPuIZUAxb2tAyWBtQPXiZEAh+GNA"
         },
         "yaxis": "y",
         "type": "scattergl"
        },
        {
         "customdata": [
          [
           "longevity_aging_link",
           "Have you found a longevity focused doctor?. Please share your experience. I feel this is like looking for a needle in a haystack. Peter discusses the idea of creating a network, but truly there is nothing out there I've found. If you did find someone, what tool did you use to search?\n\n[View Poll](https://www.reddit.com/poll/ll2fzr)"
          ],
          [
           "longevity_aging_link",
           "The tech entrepreneur paying millions to reverse his age - BBC Reel."
          ],
          [
           "longevity_aging_link",
           "How was your 2023 and what specific changes do you need to make in your life in 2024?."
          ],
          [
           "longevity_aging_link",
           "Robot bodies should be very lifelike within the next 10 years...  so how far are we away from being able to upload your entire brain onto a robot body to live forever?. I'm guessing there will be quite a battle over what's legal or not since this will only be viable for rich at first...\n\nAm I wrong?  What am I missing?  Thoughts?"
          ],
          [
           "longevity_aging_link",
           "Converting mortality rate to years added to life expectancy. The baseline mortality rate for humans doubles every 7-8 years. So if something halves mortality rate, it should add 7-8 years to your life expectancy (and the opposite if it doubles MR). If something results in a .25 HR/RR for mortality, it should add 14-16 years.\n\nAm I doing this right?"
          ],
          [
           "longevity_aging_link",
           "World's largest captive croc turns 120, giving scientists 'serious knowledge on longevity'."
          ],
          [
           "longevity_aging_link",
           "Longer Time is Taken to the Issue of Transfer Policy."
          ],
          [
           "longevity_aging_link",
           "Longevity.Technology‚Äôs most-read stories of 2021. We reflect on our most popular stories of the year.. **https://www.longevity.technology/longevity-technologys-most-read-stories-of-2021/?utm\\_source=reddit&amp;utm\\_medium=social&amp;utm\\_campaign=mostread**"
          ],
          [
           "longevity_aging_link",
           "Aging in place: technologies to live long and independently ‚Äì our comprehensive market intelligence report provides a deep dive into the opportunities and challenges facing the #aginginplace industry ‚Äì and explains why it‚Äôs time to put aging in place centre-stage.."
          ],
          [
           "longevity_aging_link",
           "Longevity Leaders Assemble! Can the LBA Cure Aging? Longevity Biotechnology Association Launch."
          ],
          [
           "longevity_aging_link",
           "Reason | Repair Bio &amp; Personal Longevity @ Longevity Frontiers Workshop 2023."
          ],
          [
           "longevity_aging_link",
           "Interviewing Jan Vijg Professor and Chairman of the Department of Genetics at the Albert Einstein College of Medicine. Please comment any questions, concerns, or thoughts about him or his work.. Jan Vijg joining the show soon. This is for an ongoing series in biotechnology, longevity, and science. Please see below for a sampled list of other episodes.\n\nEven if your question/comment doesn't get addressed, I will add it to a google doc for future guests to potentially answer instead.\n\n# Jan Vijg work\n\n  \nThe focus of Dr. Jan Vijg‚Äôs research interests, in general, is the process of human aging, its causal mechanisms and how these mechanisms limit the life span of our species. More specifically Dr. Vijg‚Äôs interests are in somatic DNA mutations and their possible causal role in age-related cellular degeneration and disease. His research has led to the development and application of mouse and Drosophila models for investigating different types of somatic DNA mutations in relation to the biological process of aging. More recently, work in the lab has been focused on single-cell whole genome sequencing as a tool to quantitatively analyze genome-wide mutations in primary human cells. \n\n# Link:\n\nhttps://www.vijglab.org/  \n\n\n# Potentially canceling the series \n\nI'm considering stopping the series on longevity based on audience feedback. The videos are not getting the same level of engagement (comments, subscribers, etc), and it seems like the content is played out. \n\n# Other episodes in the series\n\n1. [Aubrey De Grey](https://www.youtube.com/watch?v=DHvoPlcWwg4&amp;list=PLhO9b5_ciPgHJJgKFvpTGvL5-Hvs9ZJDD&amp;index=3&amp;ab_channel=LearningwithLowell) \\- LEV  \n2. [Varun Dwaraka](https://www.youtube.com/watch?v=kGbQsFA71vw&amp;list=PLhO9b5_ciPgHJJgKFvpTGvL5-Hvs9ZJDD&amp;index=1&amp;ab_channel=LearningwithLowell)\\- Bio aging clocks  \n3. [Mark Hamalainen](https://www.youtube.com/watch?v=TUtby_r0sNs&amp;list=PLhO9b5_ciPgHJJgKFvpTGvL5-Hvs9ZJDD&amp;index=2&amp;ab_channel=LearningwithLowell)\\- longevity biotech fellowship  \n4.[Oki O'Connor](https://www.youtube.com/watch?v=ZvAEMWvpTJY&amp;list=PLhO9b5_ciPgHJJgKFvpTGvL5-Hvs9ZJDD&amp;index=4&amp;ab_channel=LearningwithLowell)\\- Cyclodextrin and Cyclodextrin  \n5.[Kevin Perrott](https://www.youtube.com/watch?v=7jlIhZss74g&amp;list=PLhO9b5_ciPgHJJgKFvpTGvL5-Hvs9ZJDD&amp;index=5&amp;ab_channel=LearningwithLowell) \\- OpenCures  \n6. [Christin Glorioso](https://www.youtube.com/watch?v=-Q5Ubb6E3pI&amp;list=PLhO9b5_ciPgHJJgKFvpTGvL5-Hvs9ZJDD&amp;index=6&amp;ab_channel=LearningwithLowell)\\- Brain Longevity &amp; Metformin issues  \n7. [Jay Sarkar](https://www.youtube.com/watch?v=0_3DlxhO03A&amp;list=PLhO9b5_ciPgHJJgKFvpTGvL5-Hvs9ZJDD&amp;index=7&amp;ab_channel=LearningwithLowell) \\- Turn Biotechnologies and innovation  \n8. [Robin Mansukhani](https://www.youtube.com/watch?v=kZhlnmBE-lU&amp;list=PLhO9b5_ciPgHJJgKFvpTGvL5-Hvs9ZJDD&amp;index=8&amp;ab_channel=LearningwithLowell)\\- Immune Senolytic Drugs  \n9. [George Church](https://www.youtube.com/watch?v=yNplpykf0B4&amp;list=PLhO9b5_ciPgHJJgKFvpTGvL5-Hvs9ZJDD&amp;index=9&amp;ab_channel=LearningwithLowell) \\- Synthetic biology  \n10. [Lisa Fabiny-Kiser](https://www.youtube.com/watch?v=bE5jEGE5-OM&amp;list=PLhO9b5_ciPgHJJgKFvpTGvL5-Hvs9ZJDD&amp;index=10&amp;ab_channel=LearningwithLowell) \\- SENS  \n11. [Jennifer Garrison](https://www.youtube.com/watch?v=qVQaCJf43yc&amp;list=PLhO9b5_ciPgHJJgKFvpTGvL5-Hvs9ZJDD&amp;index=12&amp;ab_channel=LearningwithLowell) \\- Reproductive longevity  \n12. [Stephanie Dainow](https://www.youtube.com/watch?v=6V6HxoCvJZo&amp;list=PLhO9b5_ciPgHJJgKFvpTGvL5-Hvs9ZJDD&amp;index=13&amp;ab_channel=LearningwithLowell)\\- Lifespan.io  \n13. [Sebastian Brunemeier](https://www.youtube.com/watch?v=FUeWL898wDA&amp;list=PLhO9b5_ciPgHJJgKFvpTGvL5-Hvs9ZJDD&amp;index=14&amp;ab_channel=LearningwithLowell) \\- Immune System Rejuvenation  \n14. [Michael Forrest](https://www.youtube.com/watch?v=Nu6RMzVKv60&amp;list=PLhO9b5_ciPgHJJgKFvpTGvL5-Hvs9ZJDD&amp;index=16&amp;ab_channel=LearningwithLowell) \\- Metabolism &amp; Longevity  \n15. [Bjorn Schumacher](https://www.youtube.com/watch?v=ES2vid-ogmQ&amp;list=PLhO9b5_ciPgHJJgKFvpTGvL5-Hvs9ZJDD&amp;index=17&amp;ab_channel=LearningwithLowell) \\- DNA repair mechanisms  \n16. [Nikolina Lauc](https://www.youtube.com/watch?v=w8dMeevPYDY&amp;list=PLhO9b5_ciPgHJJgKFvpTGvL5-Hvs9ZJDD&amp;index=18&amp;ab_channel=LearningwithLowell)\\- Glycome and aging  \n17. [Eric Leire](https://www.youtube.com/watch?v=2p1YO3mseOo&amp;list=PLhO9b5_ciPgHJJgKFvpTGvL5-Hvs9ZJDD&amp;index=19&amp;ab_channel=LearningwithLowell) \\- Gene therapy and aging  \n18. [Collin Ewald](https://www.youtube.com/watch?v=v3x3s-Ge47g&amp;list=PLhO9b5_ciPgHJJgKFvpTGvL5-Hvs9ZJDD&amp;index=20&amp;ab_channel=LearningwithLowell) \\- Extracellular Matrix  \n19. [Matt Kaeberlein](https://www.youtube.com/watch?v=9QJ_ak3a05Q&amp;list=PLhO9b5_ciPgHJJgKFvpTGvL5-Hvs9ZJDD&amp;index=21&amp;ab_channel=LearningwithLowell)\\-  Rapamycin &amp; Longevity\n\n20. [Nir Barzilai](https://youtu.be/LuOAShcjOt0)\\- Metformin, B. Johnson, Longevity research"
          ],
          [
           "longevity_aging_link",
           "Investing in the Age of Longevity - a one-day masterclass. The lifespan revolution is coming ‚Äì find out how to connect, collaborate and invest.."
          ],
          [
           "longevity_aging_link",
           "Obituary: James F. Fries, discoverer of 'compression of morbidity'."
          ],
          [
           "longevity_aging_link",
           "Longevity Science is Alive and Well - Master Investor. Last week was ‚ÄúLongevity Week‚Äù with numerous events organised in the UK on what we now call geroscience.."
          ],
          [
           "longevity_aging_link",
           "Elon Musk's Fears of Longevity (&amp; What It Means for the Future)."
          ],
          [
           "longevity_aging_link",
           "Something for gamers to consider would be to use your username to spread awareness. ‚ÄúLongevity master‚Äù, ‚Äúlet‚Äôs cure aging‚Äù, etc.."
          ],
          [
           "longevity_aging_link",
           "Who is Who in Aging in China. A very interesting conference transpired this week at Peking University with the many big names presenting.   \n[https://qbio.pku.edu.cn/QB2021/organizationcommittee/index.htm](https://qbio.pku.edu.cn/QB2021/organizationcommittee/index.htm)  \n\n\nWho are the top leaders in aging research in China?"
          ],
          [
           "longevity_aging_link",
           "6 Pros and Cons of Immortality: The Ethics of Life Extension (Long Read)."
          ],
          [
           "longevity_aging_link",
           "The secret to a long life? Fraud and shoddy record keeping, says one researcher."
          ],
          [
           "longevity_aging_link",
           "Are there any longevity related startups that started (or could be ideally start) with up to USD 300K?. I am meeting with people that work in a startups incubator, and they invest ‚Äúlow amounts‚Äù in biotech (not their focus). I was wondered if I‚Äôd bring them some examples of successful startups that launched with those amounts, so to incline them to look more into the field and bring more money to the area."
          ],
          [
           "longevity_aging_link",
           "You May Live a Lot Longer | New York Times."
          ],
          [
           "longevity_aging_link",
           "Why does Larry Ellison, the Oracle boss, look so young at 80? Do billionaires have some secret to staying youthful?. https://i.redd.it/y1kvkfd23w9e1.gif"
          ],
          [
           "longevity_aging_link",
           "In a world flooded with health information, finding what truly works for you can be extremely overwhelming.. In a world flooded with health information, finding what truly works for you can be extremely overwhelming. The journey to cracking the code of aging shouldn't be clouded by unnecessary complexity. At Nyla, we believe in cutting through the noise.\n\nLet our experts work with you to identify what actually works for you. Our mission is to provide clear, science-backed information, and personalized solutions to simplify your path to longevity.\n\nSo, how do we help you reach your own, personal longevity goals?\n\n\\- We connect you with vetted and certified coaches that can help you understand your needs and build goals for you to work towards, together.\n\n\\- We help you build a personalized longevity regimen, including proven supplements and better habits.\n\n\\- We make it easy for you to track your progress, adjust your regimen, and establish a long-lasting routine.\n\n\\- We encourage you to ask questions and receive personal support when and where you need it.\n\nJoin us in this mission by signing up, and share your thoughts below on how we can help you navigate through the clutter: [https://mynyla.app.link/](https://mynyla.app.link/1)2"
          ],
          [
           "longevity_aging_link",
           "Longevity Panel: The scientists working on reversing aging. Aubrey de Grey (Founder of SENS Research Foundation, author of \"Ending Aging\")\n\nDavid Sinclair (Harvard Medical School, Life Biosciences, author of \"Lifespan: Why We Age -- and Why We Don't Have to\")\n\nJoao Pedro de Magalhaes (University of Liverpool, CSO at Centaura)\n\nLiz Parrish (Founder of Bioviva Science)\n\nJean Hebert (Albert Einstein College of Medicine, author of \"Replacing Aging\")\n\nAlexandra Stolzing (SENS Research Foundation, Loughborough University)\n\nGreg Fahy (Intervene Immune)\n\nDavid Gobel (Methuselah Foundation, Methuselah Fund)\n\n[https://open.spotify.com/episode/4zK3LerfgYjeo4xn18JAcT](https://open.spotify.com/episode/4zK3LerfgYjeo4xn18JAcT)"
          ],
          [
           "longevity_aging_link",
           "How to start a career in longevity/biotech?. Hi all,\n\nI hope it‚Äôs alright I post here. I‚Äôm a 25 yr old girl and I‚Äôm curious as to how someone without a scientific bg can get a foot in the door in the longevity space? If possible.\n\nI have a bachelor‚Äôs degree not at all related to the natural sciences. I have a good chunk of work experience but it‚Äôs all over the place (admin for oil &amp; gas company, business analyst for 1 year, travel photojournalism, some translation work....) I‚Äôve spent most of my free time over the past 3 years digging into metabolism, endocrinology, and lifestyle interventions for chronic conditions, mind-body (not really recognized but still my hobby) and I think I still have time to change my career into something I will love, rather than remaining on the sidelines all my life. I‚Äôm posting here because I don‚Äôt know where to really start. I‚Äôve looked into entry level jobs at biotech startups but I don‚Äôt feel qualified. I had long term goals of going to Physician Assistant school but I‚Äôm starting to think that I‚Äôm more interested in working in a less traditional environment than a hospital system or even private practice. My first step for that plan is to go into vocational nursing, but no matter what my position is I can‚Äôt quite accept that I‚Äôll be working off an outdated curriculum and giving care I don‚Äôt necessarily agree with. Overall clinical skills are much more positive than negative, I just want to craft a long term goal that I won‚Äôt outgrow a couple years or months into practice because I know myself and want to work in something a little more forward thinking or research focused. While my focus has been on patient care, I can‚Äôt help but think there are other options. I‚Äôm not sure what those are however. I don‚Äôt think it‚Äôs too late to go into STEM provided I have a previous record of doing well in engineering courses in college.\n\nA friend suggested working at a biotech company in customer support or operations and then working my way up. For those that may have any insight or experience in this, I would love your insight :)"
          ],
          [
           "longevity_aging_link",
           "Fall Is Here, but It‚Äôs Full Steam Ahead for Lifespan.io - The fall editorial looking at some recent activities the Lifespan.io team has been up to in the longevity space.."
          ],
          [
           "longevity_aging_link",
           "How long can a person live? The 21st century may see a record-breaker."
          ],
          [
           "longevity_aging_link",
           "CE/CME conferences or workshops?. Any idea where to find longevity/anti aging workshops or continuing education? I‚Äôm a Np Interested in longevity and biogerontology. Would love to continue expanding my education on this topic as I am newer to it."
          ],
          [
           "longevity_aging_link",
           "Longevity Research Advances: November 2024 Highlights."
          ],
          [
           "longevity_aging_link",
           "Human longevity may have reached its upper limit."
          ],
          [
           "longevity_aging_link",
           "Are our kids killing us?. This is the question that The Juice newsletter tackles this week, exploring the complex relationship between parenthood and longevity. While research suggests that having children can actually lead to a longer lifespan, the stresses and challenges of parenting can also take a toll on our health.\n\n**Here are 6 key takeaways from the newsletter on how to navigate parenthood and longevity:**\n\n1. **Balance is key:** Embrace the joys of parenthood while prioritizing self-care and stress management. Chronic stress can have negative health consequences, so find healthy ways to cope and unwind.  \n\n2. **Get tested:** Understanding your potential health risks is crucial for taking preventive measures. Discuss key health markers with your doctor to identify any areas of concern and develop a personalized plan.  \n\n3. **Prioritize a healthy diet:** Focus on whole, unprocessed foods, plenty of fruits and vegetables, and limit sugary drinks and unhealthy fats. This will nourish your body and provide essential nutrients for optimal health.  \n\n4. **Move your body:** Regular exercise is vital for maintaining physical and mental well-being. Aim for at least 150 minutes of moderate-intensity cardio per week and incorporate strength training and mobility exercises.  \n\n5. **Join a community:** Surround yourself with like-minded individuals who share your passion for longevity. Online communities can offer support, advice, and motivation on your journey.  \n\n6. **Embrace technology:** Utilize health-tracking tools and wearables to monitor your sleep, exercise, and other health metrics. This data can provide valuable insights and help you make informed decisions about your health.  \n\n\n**Bonus tips:**\n\n* Sleep is essential for overall health and longevity. Aim for 7-9 hours of quality sleep each night.\n* Consider supplements like magnesium and vitamin D, which can support sleep, muscle function, and overall well-being.\n* Experiment with different wellness practices like meditation, yoga, and mindfulness to manage stress and improve mental clarity.\n\nRemember, longevity is a journey, not a destination. Embrace the challenges and celebrate the joys of parenthood while prioritizing your own health and well-being. By taking small steps and making informed choices, you can create a healthy and fulfilling life for yourself and your family.\n\n**Let me know in the comments below what your thoughts are on the relationship between parenthood and longevity.**"
          ],
          [
           "longevity_aging_link",
           "Scaling Laws in Longevity - Dr. Geoffrey West."
          ],
          [
           "longevity_aging_link",
           "Upgrade Labs: the Longevity clinic of the future? - Longevity.Technology."
          ],
          [
           "longevity_aging_link",
           "Quantified Self for Longevity: The Ultimate Guide."
          ],
          [
           "longevity_aging_link",
           "Do you think there's any truth behind the extremely wealthy having access to things we do not?. Mainly eating or drinking things that are not of common knowledge or considered taboo?"
          ],
          [
           "longevity_aging_link",
           "Monday, July 12th @ 10:30AM (PST). Building and Investing in Longevity Biotech Startups - On Deck Longevity Biotech Fellowship Q&amp;A Panel."
          ],
          [
           "longevity_aging_link",
           "Longevity start-up NOVOS closes on $3.15m financing round."
          ],
          [
           "longevity_aging_link",
           "Are there any stats on global longevity-related R&amp;D funding over the last 10 years?. I always seem to see news on some new investment/funding here and there but I am wondering what has been the trend over at least the last 10 years? \n\nAssuming there has been an increase, I am wondering if it was \"just\" linear or if the funding has exploded compared to previous years."
          ],
          [
           "longevity_aging_link",
           "VitaDAO: Decentralised Funding for Longevity Research | Tyler Golato and Brian Kennedy."
          ],
          [
           "longevity_aging_link",
           "Limits of Human Longevity: New Study Insights."
          ],
          [
           "longevity_aging_link",
           "Repair-based approaches...how much are they accepted nowadays?. You may already know about the large amount of resistance there was to the repair-based approach in the past (i.e. ~2005), namely with SENS. Nowadays, there appears to be more acceptance of SENS, as well as the Hallmarks of Aging (introduced in 2013).\n\nNumerous companies have been made to tackle mechanisms of aging per SENS and/or HoA. Senolytics is one of, if not the, most commonly targeted.\n\nSome of those who were skeptical back in 2005 now appear to be more on board. Among them Brian Kennedy and S. Jay Olshansky, [going by what they have said in 2015 and 2021](https://en.wikipedia.org/wiki/Talk:Aubrey_de_Grey#2005_Criticism_and_More_Recent_Positive_Comments), respectively. While there are surely (and understandably) still those who are doubtful today, the tide appears to be ebbing somewhat.\n\nI'm not quite sure about press coverage, but it seems that that has improved at least a little. MIT Technology Review, for example, appears to have become more open; in late 2017, it published an article by Aubrey de Grey: [Undoing Aging with Molecular and Cellular Damage Repair](https://www.technologyreview.com/2017/11/28/147426/undoing-aging-with-molecular-and-cellular-damage-repair/). It should be noted that former editor in chief/publisher Jason Pontin, a notable critic who held a certain 2005 contest, stepped down earlier that year.\n\nAll that said, this is by no means an argument for \"mission accomplished\". Only a question of whether things are looking up."
          ],
          [
           "longevity_aging_link",
           "Title: üéâ Unlock the Future of Longevity: A Breakthrough Challenge Entry That Could Revolutionize Our Understanding of Aging üß¨. Hey, longevity enthusiasts of r/longevity! üëã  \nAs someone deeply passionate about understanding the science behind aging, I've entered the esteemed Breakthrough Junior Challenge. My entry delves into the enigmatic world of age reversal, focusing specifically on the potential of Yamanaka factors and Partial Reprogramming.  \nüë©‚Äçüî¨ Why This Should Excite the Longevity Community: üå±  \nIn-Depth Exploration: My video takes you on a 2-minute journey through the cutting-edge science of Yamanaka factors, breaking down complex ideas into digestible insights.  \nRevolutionary Avenues: The research touches upon techniques that could unlock new pathways for age reversal‚Äîsomething this community dreams of!  \nNext-Gen Investment: Winning the $250K scholarship would fuel further research and potentially catalyze advancements in longevity science.  \nüåü How Can You Be a Part of This? üåü  \nGet Informed: Click on the link to educate yourself on this fascinating topic.\n\nLink:[https://youtu.be/huWNLjMj5Qw?si=XDX73a720u\\_hXrqw](https://youtu.be/huWNLjMj5Qw?si=XDX73a720u_hXrqw)  \nfacebook: https://fb.watch/mTlEEcR-EV/?mibextid=qC1gEa\n\n  \n\n\n  \nShow Your Support: If you like what you see, please ‚ÄúLike‚Äù the video on YouTube to help it gain visibility.  \nShare and Discuss: Upvote this post and let‚Äôs ignite a discussion right here. Your thoughts could add invaluable perspectives to this field.  \nYour active participation could make a significant impact in pushing the frontiers of longevity science. Let's make age reversal a talking point that can't be ignored any longer!"
          ],
          [
           "longevity_aging_link",
           "Longevity Science Foundation's $1 billion, 10 year distribution shows shift in attitudes since SRF inception - SENS Research Foundation."
          ],
          [
           "longevity_aging_link",
           "Dr. Saul Newman: debunking the 'Blue Zone' longevity myth."
          ],
          [
           "longevity_aging_link",
           "Does a Data Science job help you in your Quantified Self journey?. In 6 months I'm done with my bachelor's degree in Software Engineering.\n\nI'm not sure about the exact direction I wish to push my career, but I know I'm very interested in health, building software &amp; analyzing data.\n\nIt seems like everybody in this forum is Data scientists, so I thought this would be a great place to ask:\n\n**Does a Data Science job help you in your Quantified Self journey? Is it as interesting as analyzing your own data? Do you get inspired on the job on ways to explore your own data?**\n\nWhat are your thoughts on this?"
          ],
          [
           "longevity_aging_link",
           "Pro-longevity quotes?. What quotes from big name people are, or at least can be seen as, pro-longevity?  I'll start with a few:\n\nGroucho Marx ‚Äî \"I intend to live forever, or die trying.\" (part of this phrase was used for this subreddit a while ago, wasn't it?)\n\nDavid Bowie ‚Äî \"I should like to replace all parts of my body with plastic equivalents. Then I couldn't grow old. I could just sit inside and watch it all function perfectly.\""
          ],
          [
           "longevity_aging_link",
           "Check out this campaign I just joined. Super awesome longevity franchise coming!"
          ],
          [
           "longevity_aging_link",
           "Lifespan extension: separating fact from fiction."
          ],
          [
           "longevity_aging_link",
           "My name's Sergey Young and I run the Longevity Vision Fund. I launched a free newsletter that focuses entirely on the longevity space and I would love to hear from you about what we should cover. My goal is to live to 200‚Äîand to find an affordable way for everyone else to do the same. We are on the brink of a Longevity Revolution, with new scientific discoveries and exciting technological advances now making it possible to reverse aging and treat previously incurable diseases. To get as many people as possible aware of the cutting edge science and research happening in the longevity space I created this newsletter that curates everything that's going on in the space: [https://sergeyyoung.com/newsletter](https://sergeyyoung.com/newsletter)\n\nI'd love to hear your thoughts on what we should talk about or cover so feel free to shoot reply in the thread.\n\n&amp;#x200B;\n\nüññLive long and prosper\n\n\\-Sergey"
          ],
          [
           "longevity_aging_link",
           "Longevity poll: just what does your future look like? We want to know! Your future is getting inexorably nearer ‚Äì but will that be in high-tech comfort in your own home, down the road in a state-of-the-art facility or one giant leap away, perhaps to another planet?."
          ],
          [
           "longevity_aging_link",
           "‚ÄòIt‚Äôs always too early to say something‚Äôs impossible‚Äô."
          ],
          [
           "longevity_aging_link",
           "Longevity Market Recap ‚Äì October 2024 | A monthly digest of what has been happening in the longevity investment/Desci world.."
          ],
          [
           "longevity_aging_link",
           "Average age here?. From my experience on the lifespan.io discord it seems many of you are 22 or younger. Is this true? If so, you're all very lucky! But it also explains a lot of the optimism."
          ],
          [
           "longevity_aging_link",
           "Which experts can‚Äôt be trusted?. It‚Äôs often hard to know what‚Äôs true or BS in the longevity world.\nPersonally I generally give credit and trust most (not all) of what I hear from Huberman, Sinclair and Attia but I am curious who you think is full of it and can‚Äôt be trusted or just in it for the money/likes/ego"
          ],
          [
           "longevity_aging_link",
           "We might be able to Reach Longevity Escape Velocity By 2030, According to Experts."
          ],
          [
           "longevity_aging_link",
           "Guardian Masterclasses' October Book of the Month: \"Ageless\" by Andrew Steele."
          ],
          [
           "longevity_aging_link",
           "Longevity Sector Growth in September 2024."
          ],
          [
           "longevity_aging_link",
           "Should we believe in or even want immortality?."
          ],
          [
           "longevity_aging_link",
           "Creating a Research group to study and try to solve the ageing problem.. I am an Senior Undergad CS Student. I want to create a Research group where we can all share Inputs and different outlooks towards trying solving this Goal one experiment at a time.\n\nLearning together about unique and different domains and trying experiments ourselves and as a group, implementing research papers etc. and formulating legitimate progress towards the goal.\n\nI am looking for people with diverse backgrounds who are serious about this. If you can contribute **academically/practically** consider joining.\n\nForm: (will communicate via email a discord link): [https://forms.gle/roSvkRPNEfrhjwWR6](https://forms.gle/roSvkRPNEfrhjwWR6)\n\nconsider dropping a dm also if you have any questions."
          ],
          [
           "longevity_aging_link",
           "The Lowest Hanging Fruit of Longevity?. One could spend a great deal of time, money, and effort in the pursuit of longevity, but some things are easy, cheap, and do not require much time, but are very beneficial for longevity.  An easy one is maintaining good dental hygiene. The difference between health outcome of poor dental hygiene vs excellent dental hygiene are drastic, but the difference in time, effort, and money is not so much.  What are some other things you all can think of that are low in at least two of the three (time, effort, financial cost)?  \n\nI understand that this may be very subjective, as ‚Äúlow‚Äù cost and effort can mean different things for different people, but I‚Äôm still interested in your answers!"
          ],
          [
           "longevity_aging_link",
           "Introductory Videos and Charitable Donations for Longevity Research - Dec 2024. **Introduction:**\n\n- [What is Aging?](https://www.fightaging.org/faq/#what-is-aging)\n\n- [SENS Damage-repair Strategy](https://youtu.be/AvWtSUdOWVI)\n\n- [Why Age? Should We End Aging Forever?](https://www.youtube.com/watch?v=GoJsr4IwCm4)\n\n- [Why Die?](https://www.youtube.com/watch?v=C25qzDhGLx8)\n\n- [How to Cure Aging ‚Äì During Your Lifetime?](https://www.youtube.com/watch?v=MjdpR-TY6QU)\n\n- [The Jackson Laboratory: Healthspan vs Lifespan](https://www.youtube.com/watch?v=syn9ZJExEzw)\n\n- [C-SPAN \"Ageless\" Presentation and Interview with Author Andrew Steele](https://www.c-span.org/video/?511443-1/ageless)\n\n\n.\n\n**Charitable Donations for Longevity Research:**\n\nLet us continue our funding efforts for our future health. Our regular donations will help to speed up Scientific Research to prevent and reverse age-related diseases. You can consider following research groups suggested by members or any other research group working on longevity.\n[ ](https://www.drivehq.com/file/df.aspx/shareID11575863/fileID5243585497/5243585497.jpg)\n\n\n- [Longevity Escape Velocity (LEV) Foundation](https://www.levf.org/): \"Longevity Escape Velocity (LEV) Foundation exists to proactively identify and address the most challenging obstacles on the path to the widespread availability of genuinely effective treatments to prevent and reverse human age-related disease\" ([levf.org](https://www.levf.org/))\n\n- [SENS Research Foundation](http://www.sens.org/donate): They fund research that uses regenerative medicine to repair the damage underlying the diseases of aging ([about SENS](https://www.sens.org/about))\n                        \n- [LEAF/lifespan.io](https://www.lifespan.io/) Various Campaigns such as \n[Become a Lifespan Hero](https://www.lifespan.io/campaigns/join-us-become-a-lifespan-hero/), [SENS Mitochondrial Repair Project 2](https://www.lifespan.io/campaigns/mitosens-transgenic-mouse-project/), [NAD+ Mouse Project](https://www.lifespan.io/campaigns/can-nmn-increase-longevity/), [MouseAge Project](https://www.lifespan.io/campaigns/mouseage-photographic-aging-clock-in-mice/). Other options: [LEAF on Amazon Smile](https://smile.amazon.com/ch/46-5328762), [eBay](https://charity.ebay.com/charity-auctions/charity/life-extension-advocacy-foundation/2095512/),  [Humble Bundle](https://www.humblebundle.com/store?partner=2095512&charity=2095512)  \n\n- [Dog Aging Project](http://dogagingproject.com): \"The University of Washington‚Äôs Dog Aging Project is dedicated to promoting healthy aging in people and their companion animals.\"\n\n- [National Institute on Aging (NIA) ](https://www.nia.nih.gov/about/donations): \"NIA, one of the 27 Institutes and Centers of [NIH](https://www.nih.gov/), leads the federal government in conducting and supporting research on aging and the health and well-being of older people\". ([mission](https://www.nia.nih.gov/about/mission))\n\n- [Methuselah Foundation](https://www.mfoundation.org/) \n\n- [The Robert and Arlene Kogod Center on Aging at Mayo Clinic](https://www.mayo.edu/research/centers-programs/robert-arlene-kogod-center-aging/). Read more on this [Reddit Comment] (https://www.reddit.com/r/longevity/comments/abdqtn/donations_january_2019/ed74080/)\n\n- [Vaika Foundation](https://www.vaika.org/): Group of scientists working to prolong the lifespan and healthspan of domestic mammals. Read More on this [Reddit Post] (https://old.reddit.com/r/longevity/comments/dt3449/researchers_investigate_drug_that_inhibits_enzyme/)\n\n- [Buck Institute](https://www.buckinstitute.org/research): Advancing the frontiers of research on aging Using cutting-edge science to tackle aging, the #1 risk factor for chronic disease.\n\n.\n\n\nThanks to following members of this subreddit who have shared their donation efforts. These are based on their public comments on this subreddit. Please share your donation efforts here. It will motivate others to participate.\n\n.\n\n|\tLast Updated\t|\t\n|\t:------------:\t|\t\n|\tDec 29, 2024\t|\t\n.\n\n**Summary**\n\n\n\n|\tMonth/Year\t|\t2024\t|\t2023\t|\t2022\t|\t2021\t|\t2020\t|\n|\t:------------------\t|\t------------:\t|\t------------:\t|\t------------:\t|\t------------:\t|\t------------:\t|\n|\tJanuary\t|\t[$2,786.81](https://old.reddit.com/r/longevity/comments/18vkhhr/introductory_videos_and_charitable_donations_for/)\t|\t[$2,191.81](https://old.reddit.com/r/longevity/comments/100mmux/introductory_videos_and_charitable_donations_for/?)\t|\t[$2,842.81](https://old.reddit.com/r/longevity/comments/rto9m9/introductory_videos_and_charitable_donations_for/)\t|\t[$1,847.09](https://old.reddit.com/r/longevity/comments/ko1hxv/introductory_videos_and_charitable_donations_for/)\t|\t[$2,625.69](https://www.reddit.com/r/longevity/comments/eib2lc/introductory_videos_and_charitable_donations_for/)\t|\n|\tFebruary\t|\t[$2,426.81](https://old.reddit.com/r/longevity/comments/1afzsyj/introductory_videos_and_charitable_donations_for/)\t|\t[$2,221.81](https://old.reddit.com/r/longevity/comments/10qgbnt/introductory_videos_and_charitable_donations_for/?)\t|\t[$3,403.81](https://old.reddit.com/r/longevity/comments/shjk7e/introductory_videos_and_charitable_donations_for/)\t|\t[$2,395.64](https://old.reddit.com/r/longevity/comments/l9rs0j/introductory_videos_and_charitable_donations_for/)\t|\t[$1,458.18](https://www.reddit.com/r/longevity/comments/ex0igb/introductory_videos_and_charitable_donations_for/)\t|\n|\tMarch\t|\t[$2,426.81](https://old.reddit.com/r/longevity/comments/1b3imsb/introductory_videos_and_charitable_donations_for/)\t|\t[$2,221.81](https://old.reddit.com/r/longevity/comments/11ett66/introductory_videos_and_charitable_donations_for/?)\t|\t[$2,858.81](https://old.reddit.com/r/longevity/comments/t3z2tr/introductory_videos_and_charitable_donations_for/)\t|\t[$2,301.76](https://old.reddit.com/r/longevity/comments/luxqxd/introductory_videos_and_charitable_donations_for/)\t|\t[$1,979.63](https://www.reddit.com/r/longevity/comments/fbn4mb/introductory_videos_and_charitable_donations_for/)\t|\n|\tApril\t|\t[$2,436.81](https://old.reddit.com/r/longevity/comments/1bspfsa/introductory_videos_and_charitable_donations_for/)\t|\t[$2,231.81](https://old.reddit.com/r/longevity/comments/1285i8i/introductory_videos_and_charitable_donations_for/?)\t|\t[$2,664.04](https://old.reddit.com/r/longevity/comments/ttg2ig/introductory_videos_and_charitable_donations_for/)\t|\t[$2,854.86](https://old.reddit.com/r/longevity/comments/mhlsqg/introductory_videos_and_charitable_donations_for/)\t|\t[$1,825.31](https://www.reddit.com/r/longevity/comments/fspzty/introductory_videos_and_charitable_donations_for/)\t|\n|\tMay\t|\t[$2,426.81](https://old.reddit.com/r/longevity/comments/1ch8pt2/introductory_videos_and_charitable_donations_for/)\t|\t[$2,221.81](https://old.reddit.com/r/longevity/comments/134bgt5/introductory_videos_and_charitable_donations_for/?)\t|\t[$2,574.06](https://old.reddit.com/r/longevity/comments/ufsdil/introductory_videos_and_charitable_donations_for/)\t|\t[$5,337.47](https://old.reddit.com/r/longevity/comments/n26vlu/introductory_videos_and_charitable_donations_for/)\t|\t[$2,581.21](https://www.reddit.com/r/longevity/comments/gb82bn/introductory_videos_and_charitable_donations_for/)\t|\n|\tJune\t|\t[$2,426.81](https://old.reddit.com/r/longevity/comments/1d59dte/introductory_videos_and_charitable_donations_for/?)\t|\t[$2,221.81](https://old.reddit.com/r/longevity/comments/13x1ji9/introductory_videos_and_charitable_donations_for)\t|\t[$2,554.83](https://old.reddit.com/r/longevity/comments/v24i0q/introductory_videos_and_charitable_donations_for/?)\t|\t[$2,723.17](https://old.reddit.com/r/longevity/comments/npjue4/introductory_videos_and_charitable_donations_for)\t|\t[$2,565.60](https://old.reddit.com/r/longevity/comments/gusyf0/introductory_videos_and_charitable_donations_for/)\t|\n|\tJuly\t|\t[$2,426.81](https://old.reddit.com/r/longevity/comments/1dsk6ah/introductory_videos_and_charitable_donations_for/)\t|\t[$2,321.81](https://old.reddit.com/r/longevity/comments/14nh45o/introductory_videos_and_charitable_donations_for/)\t|\t[$2,584.02](https://old.reddit.com/r/longevity/comments/vopqoo/introductory_videos_and_charitable_donations_for/?)\t|\t[$14,450.69](https://old.reddit.com/r/longevity/comments/obcyys/introductory_videos_and_charitable_donations_for)\t|\t[$1,937.56](https://old.reddit.com/r/longevity/comments/hizdk5/introductory_videos_and_charitable_donations_for/)\t|\n|\tAugust\t|\t[$2,436.81](https://old.reddit.com/r/longevity/comments/1eh49fo/introductory_videos_and_charitable_donations_for/)\t|\t[$2,341.81](https://old.reddit.com/r/longevity/comments/15ey6xv/introductory_videos_and_charitable_donations_for/)\t|\t[$2,569.58](https://old.reddit.com/r/longevity/comments/wd70kx/introductory_videos_and_charitable_donations_for/?)\t|\t[$6,062.38](https://old.reddit.com/r/longevity/comments/ovi85z/introductory_videos_and_charitable_donations_for/)\t|\t[$1,728.64](https://old.reddit.com/r/longevity/comments/i1jqnv/introductory_videos_and_charitable_donations_for/)\t|\n|\tSeptember\t|\t[$2,426.81](https://old.reddit.com/r/longevity/comments/1f6ilxe/introductory_videos_and_charitable_donations_for/)\t|\t[$2,421.81](https://old.reddit.com/r/longevity/comments/166u24k/introductory_videos_and_charitable_donations_for/?)\t|\t[$2,553.66](https://old.reddit.com/r/longevity/comments/x2szye/introductory_videos_and_charitable_donations_for/?)\t|\t[$2,368.68](https://old.reddit.com/r/longevity/comments/pfkfqv/introductory_videos_and_charitable_donations_for/)\t|\t[$2,100.94](https://old.reddit.com/r/longevity/comments/ik9fi3/introductory_videos_and_charitable_donations_for/)\t|\n|\tOctober\t|\t[$2,626.81](https://old.reddit.com/r/longevity/comments/1fteity/introductory_videos_and_charitable_donations_for/?)\t|\t[$2,421.81](https://old.reddit.com/r/longevity/comments/16wo8ng/introductory_videos_and_charitable_donations_for/?)\t|\t[$2,341.96](https://old.reddit.com/r/longevity/comments/xsmsa1/introductory_videos_and_charitable_donations_for/?)\t|\t[$2,735.97](https://old.reddit.com/r/longevity/comments/pyyrvb/introductory_videos_and_charitable_donations_for/)\t|\t[$2,259.73](https://old.reddit.com/r/longevity/comments/j2z6l7/introductory_videos_and_charitable_donations_for/)\t|\n|\tNovember\t|\t[$2,436.81](https://old.reddit.com/r/longevity/comments/1ggtbti/introductory_videos_and_charitable_donations_for/?)\t|\t[$2,456.81](https://old.reddit.com/r/longevity/comments/17kz5hp/introductory_videos_and_charitable_donations_for/?)\t|\t[$2,713.78](https://old.reddit.com/r/longevity/comments/yiwf4n/introductory_videos_and_charitable_donations_for/?)\t|\t[$3,044.12](https://old.reddit.com/r/longevity/comments/qklt96/introductory_videos_and_charitable_donations_for/)\t|\t[$2,186.84](https://old.reddit.com/r/longevity/comments/jlsxos/introductory_videos_and_charitable_donations_for/?)\t|\n|\tDecember\t|\t[$2,436.81](https://old.reddit.com/r/longevity/comments/1h3wxct/introductory_videos_and_charitable_donations_for/)\t|\t[$2,431.81](https://old.reddit.com/r/longevity/comments/1882odx/introductory_videos_and_charitable_donations_for/?)\t|\t[$2,331.81](https://old.reddit.com/r/longevity/comments/z9d8d0/introductory_videos_and_charitable_donations_for/?)\t|\t[$2,816.86](https://old.reddit.com/r/longevity/comments/r63yc2/introductory_videos_and_charitable_donations_for/)\t|\t[$4,186.36](https://old.reddit.com/r/longevity/comments/k4b985/introductory_videos_and_charitable_donations_for/)\t|\n|\t\t|\t\t|\t\t|\t\t|\t\t|\t\t|\n|\tYearly Total:\t|\t$29,721.72\t|\t$27,706.72 \t|\t$31,993.17\t|\t$48,938.69 \t|\t$27,435.68\t|\n|\t\t|\t\t|\t\t\t\t|\t\t|\t\t|\n|\tPrior Years\t|\t[$41,179.68](https://old.reddit.com/r/longevity/comments/1882odx/introductory_videos_and_charitable_donations_for/)\t|\tSince 2017\t\t\t|\t\t|\t\t|\n|\t**Grand Total:**\t|\t**$206,975.66**\t|\t\t\t\t|\t\t|\t\t|\n\n.\n\n**This month donations**\n\n|Member ID|USD|Donated To|Remark|Post Link|\n|:-------------------------------------|---------------:|--------------|:------------------------------------|:----------------------------:|\n|**NEW!** lleonard188|$50.00|[levf.org](https://www.levf.org/)|One off|[Link](https://old.reddit.com/r/longevity/comments/1h3wxct/introductory_videos_and_charitable_donations_for/lzv1cva/)|\n|Noltan101|$5.00|SENS|Monthly Donation|[Link](https://old.reddit.com/r/longevity/comments/18vkhhr/introductory_videos_and_charitable_donations_for/khfhwkp/)|\n|Historical_Fox5434|$75.00|SENS|Monthly Donation|[Link](https://old.reddit.com/r/longevity/comments/166u24k/introductory_videos_and_charitable_donations_for/k098bpm/)|\n|Historical_Fox5434|$75.00|Buck Institute|Monthly Donation|[Link](https://old.reddit.com/r/longevity/comments/166u24k/introductory_videos_and_charitable_donations_for/k098bpm/)|\n|Historical_Fox5434|$50.00|[levf.org](https://www.levf.org/)|Monthly Donation|[Link](https://old.reddit.com/r/longevity/comments/166u24k/introductory_videos_and_charitable_donations_for/k098bpm/)|\n|DINKcatgamer|$100.00|[Sinclair lab](https://sinclair.hms.harvard.edu/join-sinclair-lab-family)|Monthly Donation|[Link](https://old.reddit.com/r/longevity/comments/yiwf4n/introductory_videos_and_charitable_donations_for/iuwuml7/)|\n|K1ngN0thing|$13.00|[levf.org](https://www.levf.org/)|Monthly Donation|[Link](https://old.reddit.com/r/longevity/comments/xsmsa1/introductory_videos_and_charitable_donations_for/iu0njee/)|\n|Ricardh01|$10.00|lifespan.io|Monthly Donation|[Link](https://old.reddit.com/r/longevity/comments/x2szye/introductory_videos_and_charitable_donations_for/in3b4pv/)|\n|Nirug|$50.00|lifespan.io|Monthly Donation|[Link](https://old.reddit.com/r/longevity/comments/wd70kx/introductory_videos_and_charitable_donations_for/ilqle63/)|\n|Nirug|$50.00|SENS|Monthly Donation|[Link](https://old.reddit.com/r/longevity/comments/wd70kx/introductory_videos_and_charitable_donations_for/ilqle63/)|\n|splooter26|$40.00|SENS|Monthly Donation|[Link](https://old.reddit.com/r/longevity/comments/v24i0q/introductory_videos_and_charitable_donations_for/icmidhm/)|\n|Humes-Bread|$100.00|lifespan.io|Monthly Donation|[Link](https://www.reddit.com/r/longevity/comments/cki41u/donations_august_2019/ewffb03/)|\n|imlisteningtotron|$10.00|[Methuselah](https://www.mfoundation.org/)|Monthly Donation|[Link](https://old.reddit.com/r/longevity/comments/t3z2tr/introductory_videos_and_charitable_donations_for/i21g1ux/)|\n|Ari_Rahikkala|$113.00|SENS|Monthly - 100‚Ç¨|[Link](https://old.reddit.com/r/longevity/comments/shjk7e/introductory_videos_and_charitable_donations_for/hxhmpm6/)|\n|tusing|$200.00|lifespan.io|Monthly Donation|[Link](https://old.reddit.com/r/longevity/comments/rto9m9/introductory_videos_and_charitable_donations_for/htvaroa/)|\n|tusing|$100.00|SENS|Monthly Donation|[Link](https://old.reddit.com/r/longevity/comments/rto9m9/introductory_videos_and_charitable_donations_for/htvaroa/)|\n|ChristmasRex|$10.00|SENS|Monthly Donation|[Link](https://old.reddit.com/r/longevity/comments/qklt96/introductory_videos_and_charitable_donations_for/hj0mmli/)|\n|not_lurking_this_tim|$25.00|SENS|Monthly Donation|[Link](https://old.reddit.com/r/longevity/comments/qklt96/introductory_videos_and_charitable_donations_for/hiyfkm6/)|\n|imlisteningtotron|$10.00|lifespan.io|Monthly Donation|[Link](https://old.reddit.com/r/longevity/comments/obcyys/introductory_videos_and_charitable_donations_for/h5uqdps/)|\n|viscont_404|$100.00|[lifespan.io](https://www.lifespan.io/)|Monthly Donation|[Link](https://old.reddit.com/r/longevity/comments/npjue4/introductory_videos_and_charitable_donations_for/h2azc1i/)|\n|viscont_404|$100.00|SENS|Monthly Donation|[Link](https://old.reddit.com/r/longevity/comments/npjue4/introductory_videos_and_charitable_donations_for/h2azc1i/)|\n|Valmond|$30.00|SENS|Monthly - 25‚Ç¨|[Link](https://old.reddit.com/r/longevity/comments/n26vlu/introductory_videos_and_charitable_donations_for/gwjbed5/)|\n|Slow-Volume3372|$10.00|SENS|Monthly Donation|[Link](https://old.reddit.com/r/longevity/comments/mhlsqg/introductory_videos_and_charitable_donations_for/gutfpza/)|\n|liviaathene|$25.00|lifespan.io|Monthly Donation|[Link](https://old.reddit.com/r/longevity/comments/luxqxd/introductory_videos_and_charitable_donations_for/gq5oiy9/)|\n|liviaathene|$25.00|[Methuselah](https://www.mfoundation.org/)|Monthly Donation|[Link](https://old.reddit.com/r/longevity/comments/luxqxd/introductory_videos_and_charitable_donations_for/gq5oiy9/)|\n|mareleurs_64|$25.00|lifespan.io|Monthly Donation|[Link](https://old.reddit.com/r/longevity/comments/k4b985/introductory_videos_and_charitable_donations_for/gezj3zm/)|\n|not_a-bot|$10.00|lifespan.io|Monthly Donation|[Link](https://old.reddit.com/r/longevity/comments/l9rs0j/introductory_videos_and_charitable_donations_for/gmooubn/)|\n|Mr-R00T|$60.50|SENS|Monthly - 50 EUR|[Link](https://old.reddit.com/r/longevity/comments/ko1hxv/introductory_videos_and_charitable_donations_for/gjbq2go/)|\n|solsticesmoke|$20.00|SENS|Monthly Donation|[Link](https://old.reddit.com/r/longevity/comments/jlsxos/introductory_videos_and_charitable_donations_for/gdx7hxi/)|\n|AncientElevator9|$25.00|lifespan.io|Monthly Donation|[Link](https://old.reddit.com/r/longevity/comments/gb82bn/introductory_videos_and_charitable_donations_for/fqydhik/)|\n|AlchemyAled|$1.96|SENS|Monthly Donation|[Link](https://www.reddit.com/r/longevity/comments/fbn4mb/introductory_videos_and_charitable_donations_for/fktvp7n/)|\n|OhWellWhaTheHell|$50.00|SENS|Monthly Donation|[Link](https://www.reddit.com/r/longevity/comments/eib2lc/introductory_videos_and_charitable_donations_for/fcyix35/)|\n|OhWellWhaTheHell|$50.00|lifespan.io|Monthly Donation|[Link](https://www.reddit.com/r/longevity/comments/b7v8k1/donations_april_2019/ekzk7tt/)|\n|carbourator|$45.00|SENS|Monthly Donation|[Link](https://www.reddit.com/r/longevity/comments/cyalp1/donations_september_2019/f0cxy5p/)|\n|Nufferflutter|$25.00|SENS|Monthly Donation|[Link](https://www.reddit.com/r/longevity/comments/cyalp1/donations_september_2019/eyy498v/)|\n|RiouG|$10.00|lifespan.io|Monthly Donation|[Link](https://www.reddit.com/r/longevity/comments/c7odll/donations_july_2019/eue26rx/)|\n|Username928351|$16.95|SENS|Monthly 15 EUR|[Link](https://www.reddit.com/r/longevity/comments/b7v8k1/donations_april_2019/ekybj9l/)|\n|Username928351|$10.00|lifespan.io|Monthly Donation|[Link](https://www.reddit.com/r/longevity/comments/b7v8k1/donations_april_2019/ekybj9l/)|\n|SpookyPony|$35.00|SENS|Monthly Donation|[Link](https://www.reddit.com/r/longevity/comments/b7v8k1/donations_april_2019/ejy3520/)|\n|timmyc1989|$25.00|SENS|Monthly Donation|[Link](https://www.reddit.com/r/longevity/comments/b7v8k1/donations_april_2019/ejupq5y/)|\n|timmyc1989|$25.00|lifespan.io|Monthly Donation|[Link](https://www.reddit.com/r/longevity/comments/avzzao/donations_march_2019/eigb5hi/)|\n|JoeyvKoningsbruggen|$100.00|LEAF|Monthly - [Heroes](https://www.lifespan.io/campaigns/join-us-become-a-lifespan-hero/)|[Link](https://www.reddit.com/r/longevity/comments/avzzao/donations_march_2019/ehsdinc/)|\n|Kebakeboev11|$20.00|SENS|Monthly Donation|[Link](https://www.reddit.com/r/longevity/comments/avzzao/donations_march_2019/ehk3k5o/)|\n|Libertology|$25.00|LEAF|Monthly Donation|[Link](https://www.reddit.com/r/longevity/comments/alyudr/donations_february_2019/efkc6hm/)|\n|Libertology|$25.00|[LRI](https://thelri.org/)|Monthly Donation|[Link](https://www.reddit.com/r/longevity/comments/alyudr/donations_february_2019/efkc6hm/)|\n|Libertology|$50.00|SENS|Monthly Donation|[Link](https://www.reddit.com/r/longevity/comments/alyudr/donations_february_2019/efkc6hm/)|\n|Libertology|$25.00|[Methuselah](https://www.mfoundation.org/)|Monthly Donation|[Link](https://www.reddit.com/r/longevity/comments/alyudr/donations_february_2019/efkc6hm/)|\n|DieMidgetLover|$10.00|lifespan.io|Monthly - [Heroes](https://www.lifespan.io/campaigns/join-us-become-a-lifespan-hero/)|[Link](https://www.reddit.com/r/longevity/comments/abdqtn/donations_january_2019/ed7azst/)|\n|Ittybittygs|$10.00|SENS|Monthly Donation|[Link](https://www.reddit.com/r/longevity/comments/a23p5x/donations_december_2018/ebtkn1n/)|\n|Rodion-Raskalnikov|$10.00|SENS|Monthly Donation|[Link](https://www.reddit.com/r/longevity/comments/9t6ggg/donations_november_2018/e9u36tw/)|\n|soarinpenguin|$5.00|SENS|Monthly Donation|[Link](https://www.reddit.com/r/longevity/comments/9t6ggg/donations_november_2018/e9crleg/)|\n|Cristiano_Ronaldinho|$1.00|SENS|Monthly Donation|[Link](https://www.reddit.com/r/longevity/comments/9t6ggg/donations_november_2018/eamsurv/)|\n|Sabsonic|$10.00|SENS|Monthly Donation|[Link](https://www.reddit.com/r/longevity/comments/9kd71u/donations_october_2018/e8u8mud/)|\n|Sabsonic|$10.00|lifespan.io|Monthly - [Heroes](https://www.lifespan.io/campaigns/join-us-become-a-lifespan-hero/)|[Link](https://www.reddit.com/r/longevity/comments/9kd71u/donations_october_2018/e8u8mud/)|\n|CainSeldon|$20.40|SENS|Monthly + [Amazon](https://smile.amazon.com/)|[Link](https://www.reddit.com/r/longevity/comments/9kd71u/donations_october_2018/e7y7v3r/)|\n|magicwaves2018|$25.00|lifespan.io|Monthly Donation|[Link](https://www.reddit.com/r/longevity/comments/9kd71u/donations_october_2018/e83686s/)|\n|Bretwalda1|$10.00|[Dog Aging](http://dogagingproject.com)|Monthly Donation|[Link](https://www.reddit.com/r/longevity/comments/93lwpr/donations_august_2018/e47xcw5/)|\n|Demosthenes237|$40.00|SENS|Monthly Donation|[Link](https://www.reddit.com/r/longevity/comments/8v7o5g/donations_july_2018/e31moq7/)|\n|Demosthenes237|$10.00|lifespan.io|Monthly Donation|[Link](https://www.reddit.com/r/longevity/comments/8v7o5g/donations_july_2018/e31moq7/)|\n|Senf71|$50.00|SENS|Monthly Donation|[Link](https://www.reddit.com/r/longevity/comments/8v7o5g/donations_july_2018/e1vkzo9/)|\n|AlexanderSyros|$50.00|SENS|Monthly Donation|[Link](https://www.reddit.com/r/longevity/comments/8g5ut6/donations_may_2018/dylfjsl/)|\n|Kernel128|$20.00|SENS|Monthly Donation|[Link](https://www.reddit.com/r/longevity/comments/812u4h/donations_march_2018/dwbnfne/)|\n|Kernel128|$10.00|lifespan.io|Monthly Donation|[Link](https://www.reddit.com/r/longevity/comments/812u4h/donations_march_2018/dwbnfne/)|\n|Produktivitaet|$25.00|SENS|Monthly in Crypto|[Link](https://www.reddit.com/r/longevity/comments/6zvonz/sens_research_could_be_moving_3_times_faster/dmz9fj3/)|\n|NoMoreCensorship1|$10.00|SENS|Monthly Donation|[Link](https://www.reddit.com/r/longevity/comments/6vussk/i_donated_please_post_your_donations_here/dm460rk/)|\n|uniquan|$10.00|SENS|Monthly Donation|[Link](https://www.reddit.com/r/longevity/comments/6vussk/i_donated_please_post_your_donations_here/dm5f77h/)|\n|TheImmortalPeacock|$10.00|lifespan.io|Monthly - [Heroes](https://www.lifespan.io/campaigns/join-us-become-a-lifespan-hero/)|[Link](https://www.reddit.com/r/longevity/comments/7a1jkb/donations_november_2017/dp7suxg/)|\n|TheImmortalPeacock|$10.00|SENS|Monthly Donation|[Link](https://www.reddit.com/r/longevity/comments/7a1jkb/donations_november_2017/dp7svio/)|\n|Anle-|$10.00|lifespan.io|Monthly - [Heroes](https://www.lifespan.io/campaigns/join-us-become-a-lifespan-hero/)|[Link](https://www.reddit.com/r/longevity/comments/7a1jkb/donations_november_2017/dpilcb7/)|\n|nekomajin|$15.00|SENS|Monthly Donation|[Link](https://www.reddit.com/r/longevity/comments/7ng9yd/donations_january_2018/dt8xcxj/)|\n|aminshreya|n/a|lifespan.io|Monthly Donation|[Link](https://www.reddit.com/r/longevity/comments/b7v8k1/donations_april_2019/el4bszc/)|\n|SmeagleEagle|n/a|SENS|[Amazon Smile](https://smile.amazon.com/)|[Link](https://www.reddit.com/r/longevity/comments/avzzao/donations_march_2019/eicfey5/)|\n|Northus |n/a|SENS|Monthly Donation|[Link](https://www.reddit.com/r/longevity/comments/6i4r4n/56_seconds_to_change_the_world/dj5dfpy/)|\n|Ofpes|n/a|SENS|[Amazon Smile](https://smile.amazon.com/)|[Link](https://www.reddit.com/r/longevity/comments/6i4r4n/56_seconds_to_change_the_world/dj3og7r/)|\n|jwagoner|n/a|SENS|[Amazon Smile](https://smile.amazon.com/)|[Link](https://www.reddit.com/r/longevity/comments/7ugkqo/donations_february_2018/duf9e37/)|\n|Joanjo|n/a|SENS|Every 3 months|[Link](https://www.reddit.com/r/longevity/comments/6yzvs4/donations_september_2017/dmrjofx/)|\n|ToonUK|n/a|SENS|[HumbleBundle.com](https://www.humblebundle.com/)|[Link](https://www.reddit.com/r/longevity/comments/6vussk/i_donated_please_post_your_donations_here/dm4ldz2/)|\n|**Total**|**$2,436.81**||||"
          ],
          [
           "longevity_aging_link",
           "\"I'm meeting with people very high up on all 3 branches of Government in the US...who can actually drive things, and they're beginning to pay attention to [geroscience]...we might be close to that watershed [moment for longevity research]\" - Jim Kirkland, MD/PhD, Mayo Clinic."
          ],
          [
           "longevity_aging_link",
           "Donate to longevity via bing search engine. Here is another way to donate to longevity. Bing has new charity feature. You can sign up for bing charity for free and turn it on. You get to pick from a list of charities including SENS and methuselah. Basically it donates money for every search you do. \n\nHonestly, doing something like this and/or donating using Brave browser (see the pinned charity donations post) to fund longevity research is the least we can ask of longevity fans. Please do this as it will add up and increase longevity research funding."
          ],
          [
           "longevity_aging_link",
           "New crypto investor-backed fund aims to back technologies with the potential to extend healthy human lifespan by more than 10 years.."
          ],
          [
           "longevity_aging_link",
           "Announcing Talent Bridge: Helping Exceptional People in Low-Resource Countries Build Careers in the Biology of Aging."
          ],
          [
           "longevity_aging_link",
           "U.S. Transhumanist Party Report from Longevity Summit Dublin."
          ],
          [
           "longevity_aging_link",
           "Revolutionizing Longevity Research with SENS CEO Lisa Fabiny-Kiser (chapters and timestamps in first comment)."
          ],
          [
           "longevity_aging_link",
           "L1 Digital (Swiss Investment Firm) Proposes $500,000 Contribution and Participation in VitaDAO Longevity Science."
          ],
          [
           "longevity_aging_link",
           "So glad to see Tufts Dr. Michael Levin invited on Lex Fridman - If there is one name that will become synonymous with longevity in the years to come, it is him."
          ],
          [
           "longevity_aging_link",
           "In a documentary on aging Swapna Krishna, a science journalist, says that humans should learn to live a fulfilled life and then \"die meaningfully\" due to Star Trek quote \"Mortality gives meaning to human life, captain.\" and because medical treatments for aging might be accessed by the wealthy first.."
          ],
          [
           "longevity_aging_link",
           "Mr. Beast Hopeful That Science Will Let Him Live Several Hundred Years."
          ],
          [
           "longevity_aging_link",
           "There is Such a Thing as Too Much of a Focus on Low-Hanging Fruit in the Longevity Industry."
          ],
          [
           "longevity_aging_link",
           "What Science Tells Us About Living Longer | National Geographic Interview with Dr. Matt Kaeberlein."
          ],
          [
           "longevity_aging_link",
           "Unlocking the Best Version of You: Optimizing Men‚Äôs Health in 2024."
          ],
          [
           "longevity_aging_link",
           "Structuring, Financing &amp; Growing Novel Longevity Ventures - Dr. Tobias Reichmuth Ph.D., Founding Partner, Maximon - The Longevity Company Builder."
          ],
          [
           "longevity_aging_link",
           "Longevity for Millennials - We have to avoid burnout."
          ],
          [
           "longevity_aging_link",
           "Making longevity tangible for everybody as soon as possible with Marc P Bernegger."
          ],
          [
           "longevity_aging_link",
           "Anyone trying blueprint ?. hey there.\n\nAs most of you already know what it is but in recap blueprint is the reverse-aging process lead by Bryan Johnson.  He does share everything for free on his website.\n\n&amp;#x200B;\n\nI wanted to know if some of you guys implemented a part of his research in your daily routine, and if so, what is working best for you ?"
          ],
          [
           "longevity_aging_link",
           "Want To Live Longer? How Life Extension Industry Will Reboot Health, Wellness and The Economy."
          ],
          [
           "longevity_aging_link",
           "The Hevolution Foundation Advancing Geroscience Efforts (HF-AGE) will provide up to $5 million per project for geroscience related projects deemed meritorious by the National Institutes of Health (NIH) NIA but were not funded in fiscal year."
          ],
          [
           "longevity_aging_link",
           "Dr Charles Brenner: longevity is not a simple engineering problem."
          ],
          [
           "longevity_aging_link",
           "JFK‚Äôs nephew links with Harvard and MIT scientists for longevity skin-care brand Aramore."
          ],
          [
           "longevity_aging_link",
           "The Longevity Biotech Fellowship (LBF) is back and accepting their third cohort."
          ],
          [
           "longevity_aging_link",
           "USC scientists may have found a path toward increasing human lifespan."
          ],
          [
           "longevity_aging_link",
           "Decreased lifespan in female ‚ÄúMunchkin‚Äù actors from the cast of the 1939 film version of The Wizard of Oz does not support the hypothesis linking hypopituitary dwarfism to longevity [2022]."
          ],
          [
           "longevity_aging_link",
           "[DISCUSSION on r/IAmA]: I‚Äôm Dr. Lewina Lee, Assistant Professor of Psychiatry &amp; Clinical Research Psychologist. Ask me anything about the role of psychosocial stressors on health, the lifelong legacy of childhood adversity, how optimism boosts longevity, &amp; healthy aging.."
          ],
          [
           "longevity_aging_link",
           "Journey From Rock Star To Rethinking Aging, Longevity &amp; Mental Health - Brett Anderson, MSG, MSW."
          ],
          [
           "longevity_aging_link",
           "Google‚Äôs $1.5 billion research center to ‚Äúsolve death‚Äù."
          ],
          [
           "longevity_aging_link",
           "Live Forever? Humans Could Reach Immortality in 8 Years Through Nanobots, Says Former Google Engineer."
          ],
          [
           "longevity_aging_link",
           "If a Clam Can Live to 500, Why Can‚Äôt We? | Prof Steven Austad."
          ],
          [
           "longevity_aging_link",
           "Hevolution Foundation Announced, Saudi Royalty puts $ Billions in Longevity Research - News."
          ],
          [
           "longevity_aging_link",
           "Do you think the longevity space needs more scrappy start-ups?. I stumbled across a post from 2019 on here, stating that interest and funding in the longevity space is outpacing scrappy start-ups/entrepreneurs. Basically, a lot of interest and cash, but not a lot of talent to act on it.\n\nDo you think this is a significant factor weighing down growth in the space? Has growth in the field been slower than you expected, given that science is pretty advanced and (undoubtedly) interest is rising?"
          ],
          [
           "longevity_aging_link",
           "Book requests. What are a couple good books to read about the science of longevity? I'm looking to develop good foundations in the field over several years. No pop sci shallow stuff please. I have a science background so am not scared by technical stuff but I am starting with almost zero chemistry and biology. Any good warps to the boss you can recommend? Thanks."
          ],
          [
           "longevity_aging_link",
           "First VitaDAO Crypto meets Longevity Symposium hosted by Max Unfried and Eleanor Sheekey."
          ],
          [
           "longevity_aging_link",
           "Really great interview and discussion with Dr. Valter Longo (longevity expert)."
          ],
          [
           "longevity_aging_link",
           "Upcoming VitaDAO \"Crypto meets Longevity Symposium\". The VitaDAO \"Crypto meets Longevity Symposium\" is happening soon.\n\nThe organizers aim to \"to educate the Crypto field on Longevity, and the Longevity Biotech sector on Blockchain technology\". The symposium will cover aging conference staples such as senolytics, small molecules, fasting-mimicking diets, and the eternally hot, controversial topic of parabiosis, recently joined by another controversial upstart reprogramming.  You get to hear many amazing speakers for free including Brian Kennedy, Marco Demaria, Valter Longo,  Irina Conboy,  Morten Scheibye-Knudsen and more.\n\nYou can sign up for the conference here, it will be streamed and recorded on youtube.  \nDate: Wednesday 13th of April starting 4pm CET [https://www.meetup.com/vitadao/events/285057395/](https://www.meetup.com/vitadao/events/285057395/)\n\nIf you want to read a bit more about the scientific background of the conference you can do this here:  \n[http://biogerontolgy.blogspot.com/2022/04/vitadao-crypto-meets-longevity-symposium.html](http://biogerontolgy.blogspot.com/2022/04/vitadao-crypto-meets-longevity-symposium.html)"
          ],
          [
           "longevity_aging_link",
           "Aging By Autodigestion: Geert Schmid-Sch√∂nbein, PhD."
          ],
          [
           "longevity_aging_link",
           "\"Enough Is Enough\" - Robert F. Kennedy Jr. - \"Make America Healthy Again\"."
          ],
          [
           "longevity_aging_link",
           "Harvard says it's unlikely that human life expectancy will significantly increase?. What are your thoughts on the recent Harvard study? Looks pretty bleak to me:  [https://hsph.harvard.edu/news/life-expectancy-may-be-reaching-upper-limits-for-now/](https://hsph.harvard.edu/news/life-expectancy-may-be-reaching-upper-limits-for-now/)"
          ],
          [
           "longevity_aging_link",
           "MIT Longevity Research Inspired by Peter. Hey! From 10/25 to 10/27, our student groups¬†are hosting a longevity research event at MIT to explore how emerging scientific paradigms can solve the age-old inscrutability of aging and biological complexity, inspired by Peter's approach to practical longevity, amongst some other theoretical thinkers. \n\nWe're joined by¬†[Nick Norwitz PhD](https://www.youtube.com/@nicknorwitzPhD)¬†from Harvard Med/Oxford,¬†[Gil¬†Blander PhD](https://www.linkedin.com/in/gilblander/)¬†founder of InsideTracker,¬†[Michael Lustgarten PhD](https://www.youtube.com/@conqueragingordietrying123)¬†from Tufts,¬†[David Barzilai MD PhD](https://x.com/agingdoc1),¬†[Kennedy Schaal](https://x.com/KennedyMSchaal)¬†from¬†[SingularityNet](https://singularitynet.io/), and Curt Jaimungal from¬†[Theories of Everything](https://www.youtube.com/@TheoriesofEverything).¬†[Lifespan.io](http://Lifespan.io)¬†is a media partner too.\n\nLet me know what you think of this concept, want to keep improving. Hope to see some of you there! RSVP for free and more info here:¬†[https://lu.ma/mindbody](https://lu.ma/mindbody)"
          ],
          [
           "longevity_aging_link",
           "$54k innovation longevity research prize launched by Maximon."
          ],
          [
           "longevity_aging_link",
           "Apollo Health partners with VitaDAO and Molecule on decentralized financing for longevity biotech."
          ],
          [
           "longevity_aging_link",
           "Interviewing Nir Barzilai - director oInstitute for Aging Research at the Albert Einstein College of Medicine, Paul F. Glenn Center for the Biology of Human Aging Research and of the NIH - next week for Learning with Lowell. Please comment any questions, concerns, or thoughts about him or his work.. Nir Barzilai is joining the show next week to do a deep dive on his work and the longevity space. Looks like nothing is off the table, so we can have fun with where we go. This is for an ongoing series in biotechnology, longevity, and science. Please see below for a sampled list of other episodes.   \n\n\nEven if your question/comment doesn't get addressed, I will add it to a google doc for future guests to potentially answer instead.  \n\n\n# Nir Barzilai\n\n  \n\"Dr. Nir Barzilai is the director of the Institute for Aging Research at the Albert Einstein College of Medicine and the Director of the Paul F. Glenn Center for the Biology of Human Aging Research and of the National Institutes of Health‚Äôs (NIH) Nathan Shock Centers of Excellence in the Basic Biology of Aging. He is the Ingeborg and Ira Leon Rennert Chair of Aging Research, professor in the Departments of Medicine and Genetics, and member of the Diabetes Research Center and of the Divisions of Endocrinology &amp; Diabetes and Geriatrics.  \nDr. Barzilai‚Äôs research interests are in the biology and genetics of aging. One focuses on the genetic of exceptional longevity, where we hypothesize and demonstrated that centenarians have protective genes, which allows the delay of aging or for the protection against age-related diseases. In a Program he is leading we take full advantage of phenotypes, DNA, and cells from the Ashkenazi Jewish families with exceptional longevity and the appropriate controls and his group have established at Einstein (over 2600 samples of which \\~670 are centenarians) and discovered underling genomic differences associated with longevity. Longevity Genes Project (LGP) is a cross-sectional, on-going collection of blood and phenotype from families with centenarian proband. LonGenity is a longitudinal study of 1400 subjects, half offspring of parents with exceptional longevity, validating and following their aging in relationship to their genome. The second direction, for which Dr. Barzilai is holding an NIH Merit award that focuses on the metabolic decline of aging, and his team hypothesize that the brain leads this decline. His lab has identified several central pathways that specifically alter body fat distribution and insulin action and secretion by intraventricular or hypothalamic administration of several peptides that are modulated by aging including: Leptin, IGF-1, IGFBP3 and resveratrol.  \nHe has received numerous grants, among them ones from the National Institute on Aging (NIA), American Federation for Aging Research, the Ellison Medical Foundation and The Glenn Medical foundation. He has published over 280 peer-reviewed papers, reviews, and textbook chapters. He is an advisor to the NIH on several projects and serves on several editorial boards and is a reviewer for numerous other journals. Dr. Barzilai is in the Scientific Director and on the board of the American Federation for Aging Research, is its co-scientific director, and has served on several NIA study section. He is also a founder of CohBar Inc., a biotech that develops mitochondrial derived peptides as therapy for aging and its diseases and of Lifebioscince biotech. Dr. Barzilai has been the recipient of numerous prestigious awards, including the Beeson Fellow for Aging Research, the Ellison Medical Foundation Senior Scholar in Aging Award, the Paul F. Glenn Foundation Award, the NIA Nathan Shock Award, the 2010 Irving S. Wright Award of Distinction in Aging Research and the IPSEN Longevity Prize (2016).  \nHe is currently leading an international effort to approve drugs that can target aging. Targeting Aging with METformin (TAME) is a specific study designed to prove the concept that multi-morbidities of aging can be delayed by metformin, working with the FDA to approve this approach which will serve as a template for future efforts to delay aging and its diseases in humans.  \nBorn in Israel, Dr. Barzilai served as chief medic and physician in the Israel Defense Forces. He graduated from The Ruth and Bruce Rappaport Faculty of Medicine at the Technion-Israel Institute of Technology in Haifa and completed his residency in internal medicine at Hadassah Medical Center in Jerusalem. He served in a refugee camp during the war in Cambodia (1979-1980) and built a nutritional village in the homeland of the Zulu (1983 ‚Äì Kwazulu). He has completed 2 fellowships at Yale (metabolism) and Corenell (Endocrinoology and molecular Medicine). He was an invited speaker to the 4th Israeli President Conference (2012) and a Vatican conference on efforts to enhance cures (2013, 2016). He has also taken part in Global initiatives and spoke at The Milken Global Institute, Asian Megatrends and is an advisor for the Prime Minister of Singapore on Aging. Dr. Barzilai has been on the ‚ÄòForward 50, top 50 influence Jews in the US (2011). His work has been profiled by major outlets, including the New York Times, the BBC and PBS' NOVA science now, TEDMED and several TEDx talk is the leading feature on the Ron Howard/Jonathan Silberberg/National Geographic film about the Age of Aging. He authored Age Later (2019)\"  \n\n\n# Finally, Please check out the other episodes in the series thus far:\n\n&amp;#x200B;\n\n1. [Aubrey De Grey](https://www.youtube.com/watch?v=DHvoPlcWwg4&amp;list=PLhO9b5_ciPgHJJgKFvpTGvL5-Hvs9ZJDD&amp;index=3&amp;ab_channel=LearningwithLowell) \\- LEV\n2. [Varun Dwaraka](https://www.youtube.com/watch?v=kGbQsFA71vw&amp;list=PLhO9b5_ciPgHJJgKFvpTGvL5-Hvs9ZJDD&amp;index=1&amp;ab_channel=LearningwithLowell) \\- Bio aging clocks\n3. [Mark Hamalainen](https://www.youtube.com/watch?v=TUtby_r0sNs&amp;list=PLhO9b5_ciPgHJJgKFvpTGvL5-Hvs9ZJDD&amp;index=2&amp;ab_channel=LearningwithLowell) \\- longevity biotech fellowship\n4. [Oki O'Connor](https://www.youtube.com/watch?v=ZvAEMWvpTJY&amp;list=PLhO9b5_ciPgHJJgKFvpTGvL5-Hvs9ZJDD&amp;index=4&amp;ab_channel=LearningwithLowell) \\- Cyclodextrin and Cyclodextrin\n5. [Kevin Perrott](https://www.youtube.com/watch?v=7jlIhZss74g&amp;list=PLhO9b5_ciPgHJJgKFvpTGvL5-Hvs9ZJDD&amp;index=5&amp;ab_channel=LearningwithLowell) \\- OpenCures\n6. [Christin Glorioso](https://www.youtube.com/watch?v=-Q5Ubb6E3pI&amp;list=PLhO9b5_ciPgHJJgKFvpTGvL5-Hvs9ZJDD&amp;index=6&amp;ab_channel=LearningwithLowell) \\- Brain Longevity &amp; Metformin issues\n7. [Jay Sarkar](https://www.youtube.com/watch?v=0_3DlxhO03A&amp;list=PLhO9b5_ciPgHJJgKFvpTGvL5-Hvs9ZJDD&amp;index=7&amp;ab_channel=LearningwithLowell) \\- Turn Biotechnologies and innovation\n8. [Robin Mansukhani](https://www.youtube.com/watch?v=kZhlnmBE-lU&amp;list=PLhO9b5_ciPgHJJgKFvpTGvL5-Hvs9ZJDD&amp;index=8&amp;ab_channel=LearningwithLowell) \\- Immune Senolytic Drugs\n9. [George Church -](https://www.youtube.com/watch?v=yNplpykf0B4&amp;list=PLhO9b5_ciPgHJJgKFvpTGvL5-Hvs9ZJDD&amp;index=9&amp;ab_channel=LearningwithLowell) Synthetic biology \n10. [Lisa Fabiny-Kiser](https://www.youtube.com/watch?v=bE5jEGE5-OM&amp;list=PLhO9b5_ciPgHJJgKFvpTGvL5-Hvs9ZJDD&amp;index=10&amp;ab_channel=LearningwithLowell) \\- SENS\n11. [Jennifer Garrison](https://www.youtube.com/watch?v=qVQaCJf43yc&amp;list=PLhO9b5_ciPgHJJgKFvpTGvL5-Hvs9ZJDD&amp;index=12&amp;ab_channel=LearningwithLowell) \\- Reproductive longevity\n12. [Stephanie Dainow](https://www.youtube.com/watch?v=6V6HxoCvJZo&amp;list=PLhO9b5_ciPgHJJgKFvpTGvL5-Hvs9ZJDD&amp;index=13&amp;ab_channel=LearningwithLowell)\\- [Lifespan.io](https://Lifespan.io)\n13. [Sebastian Brunemeier](https://www.youtube.com/watch?v=FUeWL898wDA&amp;list=PLhO9b5_ciPgHJJgKFvpTGvL5-Hvs9ZJDD&amp;index=14&amp;ab_channel=LearningwithLowell) \\- Immune System Rejuvenation\n14. [Michael Forrest](https://www.youtube.com/watch?v=Nu6RMzVKv60&amp;list=PLhO9b5_ciPgHJJgKFvpTGvL5-Hvs9ZJDD&amp;index=16&amp;ab_channel=LearningwithLowell) \\- Metabolism &amp; Longevity\n15. [Bjorn Schumacher](https://www.youtube.com/watch?v=ES2vid-ogmQ&amp;list=PLhO9b5_ciPgHJJgKFvpTGvL5-Hvs9ZJDD&amp;index=17&amp;ab_channel=LearningwithLowell) \\- DNA repair mechanisms \n16. [Nikolina Lauc](https://www.youtube.com/watch?v=w8dMeevPYDY&amp;list=PLhO9b5_ciPgHJJgKFvpTGvL5-Hvs9ZJDD&amp;index=18&amp;ab_channel=LearningwithLowell) \\- Glycome and aging\n17. [Eric Leire](https://www.youtube.com/watch?v=2p1YO3mseOo&amp;list=PLhO9b5_ciPgHJJgKFvpTGvL5-Hvs9ZJDD&amp;index=19&amp;ab_channel=LearningwithLowell) \\- Gene therapy and aging\n18. [Collin Ewald](https://www.youtube.com/watch?v=v3x3s-Ge47g&amp;list=PLhO9b5_ciPgHJJgKFvpTGvL5-Hvs9ZJDD&amp;index=20&amp;ab_channel=LearningwithLowell) \\- Extracellular Matrix\n19. [Matt Kaeberlein](https://www.youtube.com/watch?v=9QJ_ak3a05Q&amp;list=PLhO9b5_ciPgHJJgKFvpTGvL5-Hvs9ZJDD&amp;index=21&amp;ab_channel=LearningwithLowell)\\-  Rapamycin &amp; Longevity\n\n**Also, consider subscribing** we have some interesting things planned for when the youtube channel gets to its first 1,000 subscribers. Livestreams, twitter spaces, clubhouse, etc."
          ],
          [
           "longevity_aging_link",
           "Are you prepared to live longer?. I see lots written about people wanting to live longer and many people are living longer. My issue is that as a society we are not really set up/structured well for living long lives. The working world really needs to change and accommodate older people. Companies seem to just want to hire younger people. The last place I worked, it was rare to see anyone over 40. How can people possible support themselves until they're in their 90's if the workforce doesn't want older people? Not everyone is capable of saving millions by the time they're 40. \n\nI also don't think people should assume they will live into their 90's. Not to be a debbie downer but there are still many illnesses (cancer in particular) that can take someone early. I see lots of people doing things like having kids older thinking they will be around for as long as they feel like."
          ],
          [
           "longevity_aging_link",
           "\"Do your own research \". There are no less than 1,978,763,032 times in Reddit where contributors say \"Do your own research \".  For every topic, I can research it and find 100 different thoughts pointing me in 100 different directions,  and that is with a yes or no question.   Which sites can you actually believe the data and who can you trust?  I pretty much never believe anyone selling a product.  Can you even believe pay for sites like Consumer Labs?"
          ],
          [
           "longevity_aging_link",
           "The Longevity Prize just launched publicly - starting with a $20,000 prize for an interesting aging hypothesis."
          ],
          [
           "longevity_aging_link",
           "LEV not being reached in your expected lifetime doesn't mean you have no chance to make it. Hello,\n\nI see a lot of people obssessed with whether LEV will be reached in their \"remaining expected lifespan\" which is often their remaining life expectancy based on their country, their health status or whatever. \n\n&gt;A warning I must at this stage issue here is that, myself, I don't expect us to make it, by that I mean people in their 20s-50s which is probably the audience of this sub. However, I think there's a good chance for life-extension and a decent, small chance at LEV. Reminder that indefinite lifespan isn't immortality either, everyone would die of an accident at some point or something else. So prepare to die and the usual warnings.\n\nThat warning issued, my point is that, suppose you're currently a 40 years old male in a western country (not my age for anyone asking, I'm younger), your remaining life expectancy is about 40 years old. So a lot of people *want* LEV to be reached within the 40 next years so that that they make it but **LEV being reached in their current life expectancy is not required for them to make it**. In those 40 years remaining that young/middle-aged male will probably see gains to his life expectancy (medically speaking one is seen as \"young\" until ~50 oftentimes).\n\n**I'm going to detail two examples for an average Joe who is 40 years old today, and show how, with fairly pessimistic predictions (not much progress compared to today in life extension) he can make it to 111 and how he can make it to the LEV even if it is only achieved in 2127 with hypothesis that are not so crazy (slow life extension progress in the next 30 years).**\n\n**The following example shows how realistically with actually fairly pessimistic predictions, a male 40 today makes it to 111**\n\n If LEV isn't reached in their lifetime but out of their remaining 40 years, during the first 30 years the life expectancy progresses as it's going now (0.16 years gained every year in my country for example), their expected lifespan by the time they're 70 will be 80+30*0.16=85y, leaving them an expected 15 years left, not 10.\n\nNow, suppose those 30 years have averaged 0.16YLGY (for short, that's years of life gained per year, the yearly increase in life expectancy), honestly, that's a disappointment (LEV is defined as \"anything more than 1YLGY\").\n\n0.16YLGY, it means medical science has only improved at the current pace and not faster for the 30 next years. We KNOW that 85-90 average life expectancy can be reached without life extension technology because wealthy people in some rich countries already have a life expectancy of about 86-87 years old and progress can still be made on cancers, heart diseases, dementias, organ failures... which means that without any life extension altering our biology, 90 years old as a life expectancy population wide, even for males is posslbe.\n\nThose 30 years have averaged 0.16YLGY but during the remaining 10 years, life extension treatment start rolling out, giving population-wide a gain of 0.6YLGY over the next 10 years... But out average Joe does not have 10 years left, they're actually 15 since the 30 first years already saw some progress. 15*0.6=9, meaning our individual is now expected to live to be 94 years old! During those 9 years, more progresses are also made, suppose again 0.6YLGY, that's 5.4 more years. 99.4 years old expected, during those 5.4 more years, progress is even faster giving 0.7YLGY (LEV is more than 1YLGY fyi), those 5.4 years see an increase of 3.78 years, those 3.78 years gained themselves see an increase of 2.64 years, 2.64 years giving an increase of 1.85y, 1.29y, 0.9y, 0.6y, 0.44y, 0.3y, 0.2... and we suppose our male dies at that point. They lived to be 111 years old never having reached LEV, still 31 years more than their current expected lifespan! But LEV wasn't reached. I'm going to give another more optimistic case that reaches LEV and that isn't that crazily optimistic.\n\n**In the next example, I'm going to show how someone who is 40 years old today can make it while LEV is only reached in 2127!**\n\nLet's do another one on another perspective, this time with a \"sudden jump approach\". We still suppose that during the first 30 years, no progress is made on life extension biotechs but then suddenly a treatment giving 20% life extension comes out. 20% on 85y (85y because we gained 5 years in the 30 first years, which is expected at the current pace) gives 102 years old. The life expectancy becomes 102y when our male is 70y. During those 32 more years, we see more progress each year, not as radical as this \"jump\" but making 0.3YLGY, it's not huge but it's not unrealistic either, it's twice as fast as today. Those 32 more years yield therefore a gain of 9.6 years. 111.6 years old expected. However, 20 years later (it's 2072, our male is now 90y) another \"sudden improvement\" is made with a treatment that gives another increase of human life expectancy by 10% only this time, with the 0.3YGLY he's now expected to live to be 118.8y, which are 121.3 actually because of my 10 more years at 0.3YGLY based on his 30 more years which brought him to 102. So our 102 years old still has 19.3 years left to go on average. During those 19.3 years, progress is again incremental but much more sustained as we are much more efficient on the damage of aging, 0.7YLGY now, it's not LEV but it's 70% of LEV. He gains 13.51 years from the 0.7YLGY pace. 134.81 expected. We now reach 0.8YLGY. He's expected to reach 145.61 years old. We now assume that at this point, which is a whopping 105 years from now, 2127, LEV has been reached. **Our male is, today, 40 in 2022, LEV was reached only in 2127 but, still, as unbelievable as it may seem: he made it.**\n\nLife expectancy gains during one's lifetime could yield happy results, they cannot be estimated as of now, but reaching LEV during our lifetimes isn't the matter, at all. Because before we reach LEV, progresses are going to be made incrementally, at some point we'll be \"close to LEV but not at LEV\". LEV is more than 1YLGY, life expectancy rising faster than time going by. But reaching 0.6-0.9LEV while one has still quite some years to go makes them live long, really long. Because near-LEV speeds are still incredibly fast gains. Today we're only at 0.1-0.2LEV depending on countries which makes the progress slow but if we reach in a decade 0.3LEV, three decades from now 0.5 LEV, four decades from now 0.6 LEV, five decades from now 0.7 LEV, seven decades from now 0.9 LEV, and nine decades from now LEV, that still means that anyone aged 40 today is expected (assuming they always survive as long as their expected lifespan isn't reached) to reach the LEV even if it's NINE decades from now, with the odds being far better from anyone below 40, yet LEV isn't reached anywhere close their expected lifespan.\n\n**That also means people who will reach LEV in the nick of time will live a huge time being \"old, very old. Their life will be a continuous struggle against death on the verge of it either ending in death or achieving the miracle of rejuvenation. Still, what a battle it would be.**\n\nI don't expect LEV to be reached soon but if you're 40, you still have 40 years of clinical trials before you on average (or even a bit more as some progresses are already expected without life extension). If you're 20, you still have 60 (or a bit more also). I think it's fairly likely such timespan yield some results at least. Even 20years should yield some results. I don't mean anything radical, but in the range of 10%-20% lifespan gained, maybe even 40% on the longer timespans. This was achieved in mice already, it seems in the realm of possibilities if we're lucky on humans with the technologies that could be in trials within 20 years.\n\n10% gained lifespan on a 85years one is 93.5y.\n \n20% gained lifespan on a 85years one is 102y.\n\n40% gained lifespan on a 85years one is 119y, everyone becomes Jeanne Calment (with better healthspan)!\n\n**Now the grimer sides**, Life expectancy means what the average joe will live to be at time of death. It doesn't mean everyone reaches it. That's a gross math mistake (coflating median lifespan and life expectancy which is terrible maths) but I'm going to make it for simplicity, it means you have 50% chances to reach it. 50% chances to die earlier. A mishap with a disease that is not yet treatable means death even if the prospects are good otherwise. The life expectancy increasing by 1 every year(aka LEV) doesn't mean you're out of the woods, it means at the current pace, most people are out of the woods. LEV can be reached but only temporarily. A decade can see a 1YGLY but then science doesn't keep the pace and we go back to lower than LEV and it's fucked. Your lifespan biologically isn't your only concern. Many things can kill you, catastrophes, wars... a nuclear war and LEV or not, it doesn't matter, you're toast. I believe AGI will be completed within the next 100 years. Which means singularity within 100 years, and that's a tossed coin. We don't know what will happen next. It's possible AI will kill us all and whether LEV was reached or not didn't matter at all. It's also possible LEV wasn't reached or even close to it, but singularity happened and the miracle cure to aging is immediately found while actual immortality is reached, even better than LEV. We don't know what is possible after the singularity. Singularity could even be a greatest concern for you than LEV if you live 40-100 more years.\n\nThanks for reading and sorry for being confuse and overly long. Live strong!"
          ],
          [
           "longevity_aging_link",
           "Doctors against longevity research. Pretty simple question. If the main goal of doctor work is safe human life then why mostly they are so much against longevity as idea and moslty deny it even though we have more and more research in this area?"
          ],
          [
           "longevity_aging_link",
           "Longevity &amp; Aging Series (EP 2): Dr. Steve Horvath's Special Collection in Aging | Aging-US."
          ],
          [
           "longevity_aging_link",
           "Shrinking pool of data as studies disappear from the internet.. The thing that stood out to me was 170 open access journals have shut down in the last 20 years. \n\nhttps://www.nature.com/articles/d41586-024-00616-5"
          ],
          [
           "longevity_aging_link",
           "film review - Year 2235, All Humans Become Immortal &amp; Death Becomes A Privilege."
          ],
          [
           "longevity_aging_link",
           "longevity is burning bright in Ireland - Longevity Events CEO on why the Celtic Tiger is outsizing longevity in Ireland."
          ],
          [
           "longevity_aging_link",
           "Brian Kennedy - Health, Ageing and Longevity Conference Interview."
          ],
          [
           "longevity_aging_link",
           "How the anti-aging industry turns you into a customer for life."
          ],
          [
           "longevity_aging_link",
           "Find your Longevity Blueprint with a Personalized Anti-aging Approach."
          ],
          [
           "longevity_aging_link",
           "In which research lab would you do a PhD ?. I am entering the final stage of my Master (Integrative Biology and physiology) and I am having a bit of a hard time choosing in which lab to pursue my last internship before the PhD, as it is a 6 months commitment, often followed by a few intense years for the doctorate.  \n\n\nI gathered a lot of names by their publications, but it is a lot of guesswork as to which teams foster growth in their graduates and interesting research dynamics.  \n\n\nAs a bit of background, i have been  graduating top of my class the past two years, my master is a blend of physiology, biotech and bioinformatics with oncology as its main topic, i have a solid foundation in molecular biology wetlab, and i am currently doing a data analyst certification on the side.  \nI am receiving a few offers from cancer research labs here (europe) but i would like to dedicate myself 100% to aging research and am ready to move for it.  \n\n\nSo, with the longevity field as it is now, where would you pursued you PhD if you had to do / redo yours ?"
          ],
          [
           "longevity_aging_link",
           "Humans to achieve immortality in 8 YEARS, says former Google engineer."
          ],
          [
           "longevity_aging_link",
           "Audacious Folks are Curing Aging - Sharing my experience attending GRC's Inaugural Systems Aging Conference."
          ],
          [
           "longevity_aging_link",
           "‚úÖThe more complete the partners' supply, the more lives will be saved in Ukraine."
          ],
          [
           "longevity_aging_link",
           "Replacing Aging with Jean Hebert | Moonshots Podcast #6."
          ],
          [
           "longevity_aging_link",
           "Have you heard a new longevity song? It's epic. Here it is: [https://soundcloud.com/biogerontology/legends-of-longevity-biotechnology-9th-ardd-conference?utm\\_source=twitter&amp;utm\\_medium=post&amp;utm\\_campaign=social\\_sharing](https://soundcloud.com/biogerontology/legends-of-longevity-biotechnology-9th-ardd-conference?utm_source=twitter&amp;utm_medium=post&amp;utm_campaign=social_sharing)\n\nOriginal post from Twitter where I found it: [https://twitter.com/biogerontology/status/1542414954346582016](https://twitter.com/biogerontology/status/1542414954346582016)  \n\n\nWe definitely need more things like that, culture is the best marketing IMO. Songs, movies, books, comics, manga, etc.  \n\n\nWhat do you think? Share your thoughts below, maybe something new gonna born in the comments"
          ],
          [
           "longevity_aging_link",
           "Are you an up-and-coming leader in aging research? Become a Beeson Scholar: Apply for NIA‚Äôs premier career development award.."
          ],
          [
           "longevity_aging_link",
           "Dr. Sinclair Reveals His TOP 7 SECRETS To Live Over 140 Years (Genius) Longevity Research."
          ],
          [
           "longevity_aging_link",
           "Longevity Technology calls on longevity companies seeking pre-seed funding for Series A equity financing to complete a brief survey to be introduced to their investor network.."
          ],
          [
           "longevity_aging_link",
           "The Centers for Medicare and Medicaid Services (CMS) released annual payment rules, including the FY 2022 proposed payment rule for inpatient rehabilitation facilities (IRFs).."
          ],
          [
           "longevity_aging_link",
           "Andrew Steele Sees Aging as the Root of Disease | The scientist and longevity journalist wants to attack disease by slowing the deterioration that the years wreak‚Äîand thinks all methods are worth a look.."
          ],
          [
           "longevity_aging_link",
           "20,000 charity gift cards (value: 50 USD) just went live from Ray Dalio. Meaning you can choose a US-registered charity where 50 USD will be given, at no cost to you. The process only takes a minute or 2. [$50 can go to SENS Research Foundation!]."
          ],
          [
           "longevity_aging_link",
           "best biomedicin company to invest when it comes to longevity.. Hello frends and future 1000 year old comrades. soon our life will change drastically and for the better.. im all in on the id√© of living for a long time and was thinking on making some buck on it. \n\nso im asking you, what company has the most potential to deliver on there promise and at the same time make some money for us??\n\nAburey De Gray say that the biggest problem for the R&amp;D in longevity field is funding. so why not start some form of grass rout movement to help out the best we can."
          ],
          [
           "longevity_aging_link",
           "The goal of geroscience is life extension."
          ],
          [
           "longevity_aging_link",
           "Thank you to all Longevity Amateur Youtubers! (such as Sheekey Science Show). Thank you to all Longevity Amateur Youtubers! (such as Sheekey Science Show)\n\nNo matter how big or small, or whether you are a content producer or social supporter, it all helps in growing the movement for the Longevity Cause. I believe that the Aging cause is not as progressed as some would like... but, at least we are not viewed as social outcasts or bizarre, as in the momentum is gaining traction.\n\nPlease keep it up everyone if you are making content or thinking about it. If its good stuff, we will support it!"
          ],
          [
           "longevity_aging_link",
           "Hunter gatherer longevity?. I've heard that hunter gatherers can continue to hunt effectively well into their 50s and 60s which is insane considering the state of average folk living in developed countries at that age. Admittedly, I don't have any academic research specifically exploring the longevity of hunter gatherers who live into old age but check out this example:\n\n[50 year old shaman hunting and climbing tree](https://www.youtube.com/watch?v=wstis7Uk_a4)\n\nHe's 50 and he's basically keeping up with a 30 year old world class tree/free climber.\n\nIs the hunter gatherer lifestyle, or something closely approximating it the key to human longevity?"
          ],
          [
           "longevity_aging_link",
           "Did anyone's interest in this area result from a health incident or death of a loved one?. As title asks, I'm wondering if anyone else came to be interested in longevity as a result of having a loved one die or a health scare, rather than simply discovering you weren't particularly enthusiastic at the prospect of dying üòÖ"
          ],
          [
           "longevity_aging_link",
           "Hello. I'm in the middle of production of a documentary film on aging and longevity. Maybe we can find some idea on cooperation.."
          ],
          [
           "longevity_aging_link",
           "Open platform set to democratise longevity therapeutics R&amp;D."
          ],
          [
           "longevity_aging_link",
           "What is happening with longevity? | 2024 Update."
          ],
          [
           "longevity_aging_link",
           "People on the fence about aging/longevity should watch The Father. What a gut punch.\n\n[The Father 2020 on IMDb](https://www.imdb.com/title/tt10272386/)"
          ],
          [
           "longevity_aging_link",
           "We cannot cheat ageing and death Philosophers, artists and scientists - and probably all the rest of us ‚Äì have long obsessed over the key to human immortality. Now, a new study gives us evidence for our inevitable death."
          ],
          [
           "longevity_aging_link",
           "Juvenesence (1): from strength to strength in R&amp;D and investment firepower - Longevity.Technology."
          ],
          [
           "longevity_aging_link",
           "Geroscience Education Reception, April 29, 2024 | Alliance for Longevity Initiatives."
          ],
          [
           "longevity_aging_link",
           "Is there a resource to find longevity-related jobs (both in academia and pharma)?. I've got a MSc and a PhD in a relatively related fields, and while there is kind of a central repository for jobs in both of those disciplines, I couldn't find one for Geroscience. \n\nThe closest I've found on this subreddit is the aging laboratories google sheet, but that document lists only 325 labs in the whole world.\n\nI'm looking for both academic and non-academic positions at a post-PhD level in this field, so if anyone could point me to a resource that isn't \"nature careers\", I'd be super thankful."
          ],
          [
           "longevity_aging_link",
           "Holocaust survivors live an average of seven years longer than Jewish people who avoided death camps | Daily Mail Online."
          ],
          [
           "longevity_aging_link",
           "Unique MIT suit helps people better understand the aging experience | Students, researchers, and actors don AGNES for a taste of the friction, frustration, and fatigue that older adults often experience.."
          ],
          [
           "longevity_aging_link",
           "US$400 Million For Healthy Aging and Elder Care - Ms. Shelley Lyford, President and CEO of West Health, the Gary and Mary West Foundation, and the West Health Institute."
          ],
          [
           "longevity_aging_link",
           "A Tour of Longevity Industry Therapies Presently in Clinical Trials."
          ],
          [
           "longevity_aging_link",
           "Interview with longevity investor Christian Angermayer."
          ],
          [
           "longevity_aging_link",
           "One approach to solving the problem of people outliving their financial resources. Though not related directly to longevity research, there was [an article in today's Wall Street Journal](https://www.wsj.com/articles/japans-aging-population-breathes-new-life-into-a-centuries-old-investment-idea-11582628400?mod=lead_feature_below_a_pos1) about how the Japanese are handling the problem of people outliving their financial resources. I'm posting it here since, in discussions of longevity, this issue regularly arises as a drawback of people living longer.\n\nThere's a WSJ paywall, so here's a quote with the gist:\n\n*In a classic tontine, investors pool their assets to create an investment portfolio and receive periodic payouts while they are alive. When participants die, their shares are either distributed among the remaining participants or kept in the pool until the last survivor takes all the funds. Payouts are influenced by both the investment performance of the portfolio and the lifespan of the participants.*\n\n*The modern Japanese version is an annuity product in which policyholders pay into the system starting in their 50s and receive a lifetime stream of income beginning in their 60s or later. The tontine products are similar to life annuities available in the U.S. The difference is the amount of money returned when the contracts are canceled or when the customers die prematurely is kept low to increase the income for others.*"
          ],
          [
           "longevity_aging_link",
           "If you haven't read Laura Demming's (Longevity VC) Write-up on \"Everything Longevity\", you should!."
          ],
          [
           "longevity_aging_link",
           "Nothing has extended human lifespan and increased longevity more than fossil fuels.. Need an IV? Want to live through a harsh winter (or summer)? Would you rather have machines harvest crops without waste or use donkeys and do it all by hand? Do you like Amazon deliveries or keeping your local grocery and pharmacy stocked? Then thank fossil fuels for changing the harsh and deadly climate on earth, at least in your home,  and keeping you alive and well.\n\nIf we banned petroleum and coal products this year then by next year this time billions would be dead. For our longevity and survival lets all acknowledge the roll that fossil fuels have played. Let me know in the comments how your life is better due to fossil fuels and how much longer you expect to live due to their use. Or how using them in the future could further extend your longevity and quality of life.\n\nIf we transitioned to clean and reliable GenIII or IV nuclear grid which eats radioactive waste as fuel and cant' melt down maybe we can help the poorer african and Asian nations with reduced lifespan. Many are forced to use open fires for cooking and warmth and have been dissuaded from using fossil fuels by certain Intl organizations that promote unreliable and and wasteful solar panels that don't serve their needs. Maybe if we can fully transition to a nuclear power grid we can then lift up the billions of humans with reduced longevity by exporting fossil fuels to them so their people don't have to use open fires for cooking and warmth. Should double their lifespans as it did ours in the west."
          ],
          [
           "longevity_aging_link",
           "Longevity challenges. I am a long time follower/fan of Dr Peter Attia and his work with functional medicine and fitness. I was particularly motivated by the concept of longevity challenges he discusses in Limitless. I'm looking to put together a series of longevity challenges to undertake for 2023 (thinking one per month) all based around science-backed life extending protocols. If anyone has any ideas please comment suggestions for challenges, and if you're keen to join in I have just started a FB group for us to use for challenge-related discussion.   \n\n\nThe link to the fb group is [https://www.facebook.com/groups/zestlongevitychallenges/](https://www.facebook.com/groups/zestlongevitychallenges/)"
          ],
          [
           "longevity_aging_link",
           "Stolen-looking bike with an r/longevity sticker in Seattle. Anyone here lose a bike? There's a hybrid bike abandoned in the bus stop by my house in Seattle. Has a big ol /r/longevity sticker on the frame. \n\nPM me if it's yours."
          ],
          [
           "longevity_aging_link",
           "102-Year-Old Who Still Works At Resort She Co-Founded in 1940 Shares How She Stays Fit And Healthy."
          ],
          [
           "longevity_aging_link",
           "The greatest generation - 4 veterans who look amazing."
          ],
          [
           "longevity_aging_link",
           "Discussion thread | Anti-aging conversation with Dr. Richard Miller, aging researcher outspoken against SENS marketing."
          ],
          [
           "longevity_aging_link",
           "Elon Musk looking for ways to donate his money more effectively. [Elon Musk offers $100M prize for best carbon-capture technology - Business Insider](https://www.businessinsider.com/elon-musk-100-million-prize-carbon-capture-technology-contest-2021-1?utm_source=reddit.com) \n\n \"Critical feedback is always super appreciated, as well as ways to donate money that really make a difference (way harder than it seems),\" Musk [tweeted](https://twitter.com/elonmusk/status/1347356316763705344) earlier this month. \n\nNot that I think that anyone here is in Musk's list of contacts but he's been known to respond to random twitter users I think.  If anyone here has a twitter and wants to reach out to him suggesting to donate to aging then that would be a big help.  Thanks!"
          ],
          [
           "longevity_aging_link",
           "It‚Äôs not just about child mortality, life expectancy improved at all ages."
          ],
          [
           "longevity_aging_link",
           "Psychological impact of a longevity pursuit. I'm in my late twenties and I have aggressively - and perhaps too strictly - pursued health-span extension for the best part of a decade. Assuming many on this sub-reddit broadly fit that description, I was wondering if anyone has found this pursuit to come with its own unique mental challenges? By this I mean not the difficulty of adherence, but the the challenge in so many of your life choices being dominated by delaying your inevitable decline. I guess in this framework: one of your - if not *the* \\- core mental value structures becomes doing whatever necessary to win at a game you will always lose. I assume reconciling these two things is difficult. Perhaps I just need a good therapist, or perhaps this is a topic (in a niche community) few people discuss. Either way - let me know if I'm crazy!"
          ],
          [
           "longevity_aging_link",
           "Short interview on aging with Dr. Gordon Lithgow."
          ],
          [
           "longevity_aging_link",
           "CEO of FTX, Sam Bankman-Fried, Founder of Ethereum, Vitalik Buterin, and Managing Partner at Dragonfly Capital, Haseeb Qureshi share their views on charitable giving in crypto and Effective Altruism. Vitalik talks about the importance of funding aging research.."
          ],
          [
           "longevity_aging_link",
           "Thursday April 29th, 2021 @ 1PM PST / 4PM ET: A.I. longevity drug discovery - Kristen Fortney (BioAge Labs) - The Longevity Biotech Show."
          ],
          [
           "longevity_aging_link",
           "AI COMPANY. Hello, I am a 20-year-old student of Political Science and  International Relations and I am actively engaged in trade. I do about 4  different jobs, I am a partner of a company. I have previously dealt  with Python and cyber security and I have made some personal gains, but  my question is:     \n \n\n  As a team of 2 people, we want to establish an artificial  intelligence-based biotechnology company. We want to contribute to the  field of neuroscience neurotechnology (consciousness problems or brain  interface), biotechnology and artificial intelligence-based drug  development, clinical stages and similar medical processes.   \n\nOr I want to make a serious contribution to the concept of  \"LONGEVITY ESCAPE VELOCITY\" or like \"rejuvenation\" by establishing a really big artificial  intelligence company based on the principles of biotech fundamentals and  principles.   \n\nIf you had to draw us a road map, how and what would it be?  (I am thinking of studying for a master's degree in one of these  subjects.)   \n\n\nI thought like this Python -&gt; Advanced Python -&gt; Python  Project with AI -&gt; Machine Learning + Statistics -&gt; Deep Learning  (The programming languange.)     \nI know that we need to get a lot of funding and investment for a  biotechnology company based on biology and artificial intelligence. We  need to develop a product for our corporatisation. So, how can we find  this and how can you draw a road map about this issue?     \nIs there anyone with experience to mentor us on these issues?"
          ],
          [
           "longevity_aging_link",
           "Scientists publish a blueprint to apply artificial intelligence to extend human longevity."
          ],
          [
           "longevity_aging_link",
           "The Case For Life Extension Advocacy Foundation (EA Forum)."
          ],
          [
           "longevity_aging_link",
           "Does looking younger correlate to a longer lifespan?. I've read through a lot of the articles here and can't find this specific topic.  Maybe I just missed it.  I'm 46(M) and often get told that I look late 20's, maybe early 30's and have even had people ask to see my ID because they didn't believe me.  Most of my family is realively long lived most lasting into their 90's.  I've always joked that I have to plan my retirement to last into my 100's because I live pretty healthy and workout on top of the fact that my family is long lived, then add in advances in medicine.  The question is: is there scientific data to back this up?"
          ],
          [
           "longevity_aging_link",
           "Is anyone actually planning to progress longevity, if so what field or graduate degree are you pursuing.."
          ],
          [
           "longevity_aging_link",
           "On self-preservation. Self-preservation is the first law of nature.\n\n-S. Butler, Remains (c.1675)"
          ],
          [
           "longevity_aging_link",
           "Longevity Series Lecture: Brain Aging | Christin Glorioso, MD, PhD."
          ],
          [
           "longevity_aging_link",
           "NIA blog: current efforts to expand and support diverse small businesses interested in aging-related research and other topics within NIA‚Äôs mission.."
          ],
          [
           "longevity_aging_link",
           "What are the highest ROI actions one can take to increase their longevity? (according to you and science). Please list between 1 to 100 starting from the most important ones  : )"
          ],
          [
           "longevity_aging_link",
           "In his podcast ep177 of the interview with Dr Steven Rosenberg, Peter Attia mentioned a paper that I can't find.. He mentioned a paper that calculated the increased average life expectancy if cancer and cardiovascular disease didn't exist. \n\nDo any of you have a link to this paper, or title?"
          ],
          [
           "longevity_aging_link",
           "Good undergraduate sized studies to conduct?. Hi, I'm working on a grant application (few thousand dollars) for a small undergraduate experiment on longevity. I have a few ideas I'm working with but I'm wondering if anyone has any suggestions. \n\nSpecifically it's for this bioengineering competition thing, so I'm looking for some sort of cheap aging related technology that's ready to be worked on. But any ideas will help."
          ],
          [
           "longevity_aging_link",
           "Who Is the oldest Living Woman in North Carolina and what are her lifestyles and legacy?."
          ],
          [
           "longevity_aging_link",
           "Any new biohacks your going to add to you‚Äôre routine in 2025?. My main issue atm is inflammation so going to start LDN &amp; cold baths with Sauna into routine. \n\nAnything your going to do to start of 2025 ?"
          ],
          [
           "longevity_aging_link",
           "Longevity.Techology is running surveys for Longevity investors and execs from Longevity start-ups and scale-ups. When they asked investors about their investment focus the discovered that: gene therapy; age tech; senolytic drug therapy; AI; and biohacking are the top 5.."
          ],
          [
           "longevity_aging_link",
           "Why is so little money going into longevity research?. I guess I'm selfish, but if I was a billionaire I would be pouring 95% of that money into longevity research. After all: if you have everything already what is there left to buy but more time? Forgive me for generalizing, but aren't most billionaires pretty selfish generally? Surely governments should be investing in this too. So what gives? What good does sitting on all that money do for them?\n\nI can only think of a couple of reasons:\n\n* Reluctance to believe it's even possible\n* Religion acting as a safety blanket\n\nIs there anything else I'm missing?"
          ],
          [
           "longevity_aging_link",
           "Bar chart race: Life expectancy 1900-2020."
          ],
          [
           "longevity_aging_link",
           "Financial solutions for longevity???. üôã‚Äç‚ôÄÔ∏èüôã‚Äç‚ôÄÔ∏èüôã‚Äç‚ôÄÔ∏è Hello the incredible longevity community!\n\nAs a total novice, some 4 weeks ago I asked a simple question about how many ppl around the world are aware of anti-ageing/ longevity issues. I had such an enthusiastic response and valuable insights! Thank you all. üôèüôèüôè\n\nI have a different question and food for thought.\n\nIf we're going to live longer... this for sure puts pressure on us as individuals and the public system  (part. healthcare and the pensions system) on how to support a population which is 65+... some may be working, others chose not to work, others are too sick to work, etc. \n\nWhat are the economic / financial solutions for this issue? Do you know of start-ups, VCs, hedge / investment funds, etc. that are specifically focussed on solving this problem from a financial standpoint?   \n\n\nThank you!"
          ],
          [
           "longevity_aging_link",
           "Fable of the Dragon Tyrant, Vitalik Buterin, Twitter, and SENS Research Foundation. Greetings. Vitalik links to  Fable of the Dragon Tyrant directly in his Twitter profile it seems. Awesome! that fable has a moral that can relate to aging/healthspan potentially. \n\n[https://www.nickbostrom.com/fable/dragon.html](https://www.nickbostrom.com/fable/dragon.html)\n\n[https://twitter.com/VitalikButerin](https://twitter.com/VitalikButerin)\n\nIs his top pinned Tweet, he also tries (unsuccessfully) to link to (@)SENSTweet (SENS Research Foundation). \n\n[https://twitter.com/VitalikButerin/status/1273742863688499203](https://twitter.com/VitalikButerin/status/1273742863688499203)\n\n(@)senstweet is the correct link. What you link to for SENS is wrong Twitter handle. I hope Vitalik might notice and fix that to help educate humans about radical life extension. \n\nVitalik has a lot of social influence due to Ethereum and he is really doing all humans a favor by helping to educate humanity about the potential of longevity escape velocity and rejuvenation research. He was recently on a cast with Aubrey de Grey as some of you might know. \n\nSo, please maybe Vitalik might notice if some of us (more than just me), Tweet to him on Twitter and note how much we appreciate all he does for longevity/healthspan research, and also suggest he perhaps fix the link to (@)SENStweet so more humans can be educated about and onboarded to the idea of healthspan/longevity research more effectively. \n\nCheers and serenity."
          ],
          [
           "longevity_aging_link",
           "The implications of having to perpetually contend with error and limitation as the natural template of physical existence. Trouble-shooting.exe is the entire social matrix. An aerial view of cities resemble a computer chip that endlessly shuttles units back and forth due to their innate imperfections for managing cyclical dearths of energy, the entropy of their material compositions, and insatiable desires of their conscious minds. Without incompleteness as its *sine qua non*, what core essence remains in human identity? \n\nConstantly modifying problems is an exhausting and pointless program. Even if Sisyphus finds happiness, we've already modeled the ceiling effect, homeostasis, and hedonic treadmill of that endeavor."
          ],
          [
           "longevity_aging_link",
           "20: Optimizing Biological Age with Dr. Michael Lustgarten, PhD. | The Art of Fitness and Life."
          ],
          [
           "longevity_aging_link",
           "Is anyone here 70+ years old? I want to interview you.. Hi, I'm a market researcher currently working on a project about people who are extremely health engaged, i.e. biohackers, and looking to interview someone who is 70+ years old. I'll pay you well for your time. Feel free to message me. Sorry if this isn't allowed, I figured this would be the best place to find someone to discuss the topic!"
          ],
          [
           "longevity_aging_link",
           "For those of us fortunate enough to still have living parents (or other older relatives), are you hoping for things like SENS, nanobots, gene-therapy, etc.. to come faster more for your sake, or for their sake?. My reason for asking this question is: I'm currently 23 (turning 24 next month), and my parents are entering their 60s. Going by the life expectancy here in Brasil, and my family history (making it to 80s with few to no problems), I can expect, for my peace of mind, that both will live well into their 80s, possibly 90s. What I want to know is if concern for a relative plays a significant part in convincing people to search for longevity solutions (not a lot of people my age worrying about mortality).\n\nCurrently typing this next to my 85 and 86 year old grandparents, who, thankfully have few serious issues, and lived to meet their great-grandchildren.\n\nI apologize in advance if this question brings any uncomfortable memories/feelings to the forefront."
          ],
          [
           "longevity_aging_link",
           "British Society for Research on Ageing (BSRA) Begins Fundraising for Research to Slow Ageing."
          ],
          [
           "longevity_aging_link",
           "Longevity venture capital ‚Äì a case in point Talking venture capital and the Longevity investment landscape with Elysium Health CEO Eric Marcotulli.."
          ],
          [
           "longevity_aging_link",
           "Nora Super - Senior Director of the Milken Institute Center for the Future of Aging and Executive Director of the Milken Institute Alliance to Improve Dementia Care."
          ],
          [
           "longevity_aging_link",
           "ARPA-H Seeks Applicants for Program Managers (U.S. Citizens)."
          ],
          [
           "longevity_aging_link",
           "Foresight Institute - Longevity Investment: Aubrey de Grey, Karl Pfleger, Sonia Arrison, Nils Regge, Joe Betts-Lacroix."
          ],
          [
           "longevity_aging_link",
           "Dr Ronald Kohanski (National Institute on Aging) Interview - NIA's Systemic Approach to Healthy Life Extension with LEAF CEO Keith Comito."
          ],
          [
           "longevity_aging_link",
           "Any important longevity terms you'd add to this glossary for beginners?."
          ],
          [
           "longevity_aging_link",
           "9 common traits of people who live past 100: scientist."
          ],
          [
           "longevity_aging_link",
           "Lack of Time Is an Illusion. *‚ÄúHe who gains time gains everything.‚Äù* **-BENJAMIN DISRAELI**¬†\n\nI have a full understanding that time itself is finite. The main idea here is the ‚Äúlack‚Äù we feel when it comes to utilizing time to work on habits to better serve our authentic self is a complete illusion. We are constantly exchanging things of real value for things of little to no value. Whenever time is spent mindlessly on a low value activity, we have just spent the most precious resource we have. We must pay attention to how we spend our greatest resource and should guard it at all costs. Many experts will say that an hour a day focused on a project can change your life. James Clear only asks for [2 minutes](https://na01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.youtube.com%2Fwatch%3Fv%3DXT5O_7u3-VU&amp;data=05%7C02%7C%7C22eba09035b5488d45ff08dc581bfe12%7C84df9e7fe9f640afb435aaaaaaaaaaaa%7C1%7C0%7C638482124493040877%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C0%7C%7C%7C&amp;sdata=9OrjaAvIroD2wm2Yv65JXqPRCZi68aYDMYfSyvJGLvA%3D&amp;reserved=0)! At least to start the habit. The issue is that we have set up **excuses** that we use as roadblocks to keep ourselves in our comfortable [average](https://na01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.universal-progress.com%2Fdont-be-average&amp;data=05%7C02%7C%7C22eba09035b5488d45ff08dc581bfe12%7C84df9e7fe9f640afb435aaaaaaaaaaaa%7C1%7C0%7C638482124493052677%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C0%7C%7C%7C&amp;sdata=5YUhvvAztfHcOiwIaqwds2%2BOIQmH6%2BHlABMgpukZzlQ%3D&amp;reserved=0) life. These roadblocks are either placed in front of us by mindlessly following America‚Äôs frequency of mediocrity or they are built with fear. Either way, you need to identify your excuse and make the decision to overcome the obstacle or leave it and stay where you are.¬†\n\nI am starting with **time** because using the excuse of not having the time is the easiest way to kick the can of progress down the road. You can find countless examples of people who are busier than you, and making more progress in all the areas you keep making excuses about. ‚ÄúI cannot get in shape because I do not have enough time‚Äù cannot be used when Jeff Bezos is in better shape than me and is running Amazon and [Blue Origin](https://na01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.blueorigin.com%2F&amp;data=05%7C02%7C%7C22eba09035b5488d45ff08dc581bfe12%7C84df9e7fe9f640afb435aaaaaaaaaaaa%7C1%7C0%7C638482124493059973%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C0%7C%7C%7C&amp;sdata=JCmbsyppUqlgxJcCK6GupYeBWn%2BQifhra4BvmxSyrG0%3D&amp;reserved=0) at the same time. When a 60-year-old human who¬†is responsible for a trillion-dollar business and flying rockets into space can squeeze in an hour of time for cardio, it becomes impossible to build a case that whatever schedule you happen to have is too busy to spend time working on yourself. When you really break down your day like a budget it becomes obvious that the **illusion** we create around **lack** of time is figment of our imagination. Arnold Schwarzenegger wrote about this in his new book...¬†¬†\n\n\n\n**Arnold‚Äôs 24-Hour Breakdown**¬†\n\n8¬†¬†¬†¬†¬†¬† Hours for sleep¬†\n\n30¬†¬†¬† minute morning routine¬†¬†\n\n45¬†¬†¬† minute commute to work¬†\n\n8.5¬†¬† Hours Work¬†\n\n45¬†¬†¬† minutes commute home¬†\n\n3.5¬†¬† hours of quality time with friends and family¬†\n\n1¬†¬†¬†¬†¬†¬† hour exercise¬†\n\n~1¬†¬†¬†¬†¬†¬† hour life changing project/habit~¬†\n\n24¬†¬†¬†¬† hours¬†\n\n\n\nSomewhere out there in Ohio my snarky brother Dan is asking his wife how much time Arnold allocates for the nanny- I get it no one is perfect Dan! The next thing Arnold tells people to do is to open their phone and open settings and go to see their screen time. Then proceed to erase all those hours from your daily budget and realize where this time debt is coming from in your schedule. We all doom scroll on our pocket mind control device. I cannot imagine someone having less than two hours of screen time if they are not making a constant conscious effort to mitigate the time they are scrolling. The fact of the matter is if you are using the excuse ‚ÄúI do not have time‚Äù it is **time** to learn how to use a time budgeting technique such as [timeboxing](https://na01.safelinks.protection.outlook.com/?url=https%3A%2F%2Ffinishersecrets.com%2Fblogs%2Fnews%2Ftimeboxing-learn-this-time-management-technique-to-destroy-procrastination-in-5-minutes%23%3A~%3Atext%3DTimeboxing%2520is%2520used%2520by%2520Elon%2520Musk%252C%2520Jeff%2520Bezos%252C%2Cdistraction%2520in%2520less%2520than%25205%2520minutes%2520a%2520day.&amp;data=05%7C02%7C%7C22eba09035b5488d45ff08dc581bfe12%7C84df9e7fe9f640afb435aaaaaaaaaaaa%7C1%7C0%7C638482124493065776%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C0%7C%7C%7C&amp;sdata=PeYftTscMGmTrIXLBnxaXu44fae85r8ubCAx%2F1gYj48%3D&amp;reserved=0) to create time in your schedule and eliminate this excuse.¬†\n\nNow that you have freed some time let us talk about the tremendous benefit that just 3 hours/week or 30 minutes/day will do to your chances of living a longer life. Going from zero minutes a week to 3 hr/wk will reduce your all-cause mortality by 50% [\\[](https://na01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.youtube.com%2Fwatch%3Fv%3D5-vZMmoZ2SI&amp;data=05%7C02%7C%7C22eba09035b5488d45ff08dc581bfe12%7C84df9e7fe9f640afb435aaaaaaaaaaaa%7C1%7C0%7C638482124493071633%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C0%7C%7C%7C&amp;sdata=DCII4w%2BJ%2BvQz0vlOdhBSAT5Z3DsQqpdRP3utUlPeMV4%3D&amp;reserved=0)[12:40](https://na01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.youtube.com%2Fwatch%3Fv%3D5-vZMmoZ2SI&amp;data=05%7C02%7C%7C22eba09035b5488d45ff08dc581bfe12%7C84df9e7fe9f640afb435aaaaaaaaaaaa%7C1%7C0%7C638482124493077643%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C0%7C%7C%7C&amp;sdata=bea3vEZTux4306Bxj6HBt4Y0kZGlx1gPlU2IXnWnj48%3D&amp;reserved=0)\\]. This means that freeing up 3 hr/wk and dedicating that to exercise would reduce your chances of dying more than if a smoker gave up smoking- DON'T SMOKE!!! Unless you want to, but just know the trade off!¬†The great news is if you happen to open more time for exercising, the benefits will only go up from there!¬†\n\nI feel like most of my conversations end with the ole... ‚ÄúAt the end of the day,‚Äù but ***at the end of the day*** any time you can give yourself today dedicated to exercise/training/health will help you increase your chances to accumulate the most precious resource we have later in life. It is important to consistently prioritize your time daily **now** to give this amazing gift to your **future** self. Try to envision your future 80-year-old self, thanking your past self for putting in the consistent work today to help make their existence possible. If you desire to give yourself more time, carve into your daily routine time dedicated to your health and start/continue the path to a stronger, healthier, and hopefully **longer** life on this wonderful planet.¬†\n\n*‚ÄúRemember how long you‚Äôve been putting this off . . . that there is a limit to the time assigned you, and if you don‚Äôt use it to free yourself it will be gone and will never return.‚Äù* ***-*****Marcus Aurelius**¬†\n\n**If you want to read more or join my newsletter sign up at my website thanks!**\n\n  \n[Lack of Time Is an Illusion | Universal Progress (universal-progress.com)](https://www.universal-progress.com/lack-of-time-is-an-illusion)\n\n  \nBrian"
          ],
          [
           "longevity_aging_link",
           "Yale Pathology department are hiring an Aging Center Director as well as junior faculty. See links for job descriptions.."
          ],
          [
           "longevity_aging_link",
           "Stellar Speakers to Make Targeting Metabesity 2020 One of the Most Important Healthy Longevity Conferences of the Year."
          ],
          [
           "longevity_aging_link",
           "Aubrey de Grey Feb editorial - Extreme Human Longevity: The Fraught Intersection of Historical and Scientific Research."
          ],
          [
           "longevity_aging_link",
           "Aging discussion with Prof. George Church, Oct 26 12 PM PST. Yes, this George Church: https://en.wikipedia.org/wiki/George_Church_(geneticist)\n\nPost questions below if you cannot make it.\n\nEdit: The meeting will be held on Zoom.  \n\nhttps://us02web.zoom.us/j/85261115634\n\nFor some reason I think this one is going to be packed."
          ],
          [
           "longevity_aging_link",
           "Register for the British Society for Research on Ageing Annual Scientific Meeting, 4th ‚Äì 6th September 2024, University of Birmingham."
          ],
          [
           "longevity_aging_link",
           "Longevity Platform looking for Customer Experience Superstar. friends, we are looking for a customer experience person  \n\nknowledgeable about longevity? help educate other people and help them live longer healthies.\n\nWe'd prefer someone in Michigan but will make exceptions for the right person!\n\n[description here](https://docs.google.com/document/d/1wAt9w1ZKSM5qlJCepDPq29KBdgN9ADQNL9w70xwvhRo/edit?usp=sharing)"
          ],
          [
           "longevity_aging_link",
           "Life extension and longevity accounts to follow on Twitter. Here is the list of I've compiled, I thought you might like it:\n\n[https://twitter.com/i/lists/1276560146664026117](https://twitter.com/i/lists/1276560146664026117)\n\nWhom am I missing? Any suggestions?  \n\n\nAlso, check out more lists here (tech, startups, science and research, VC, product development, etc): [https://max2c.com/vc-twitter-and-more-tech-lists-you-might-like/](https://max2c.com/vc-twitter-and-more-tech-lists-you-might-like/)\n\n&amp;#x200B;"
          ],
          [
           "longevity_aging_link",
           "Mortality rate by education level? Education has a big effect on mortality rate."
          ],
          [
           "longevity_aging_link",
           "list of 2024 aging/longevity conferences just fully updated. The 2024 aging/longevity conferences schedule is coming into focus. [AgingBiotech.info/conferences](https://AgingBiotech.info/conferences) now fully updated w/ latest announced info.  \n15 events in 2024 w/ announced dates &amp; locations   \nw/ up to 7 more typically-annual confs that may yet announce 2024 dates.  \n\n\n  \nAs usual &amp; noted in \"scope\" tab, the list focuses only on confs that are   \n1: specific to aging (not broader bio/heath/medicine) &amp;   \n2: broadly aging, not sub-slices of the field like single hallmarks (eg cell senescence, stem cells, mitochondria, etc) or individual chronic diseases  \nA full list &amp; description (esp of diffs vs my list) of other lists of aging confs in the other lists... tab. Eg https://www.nature.com/nataging/conferences includes confs about aging sub-areas &amp; specific diseases, but also includes confs that my site wouldn't consider to be aging/longevity.  \nEurope is once again dominating the aging conf circuit over the US (opposite to the way the US dominates corporate biotech &amp; pharma): as of now   \n9 European events vs only 5 in the US   \n(plus 1 in the middle east, in Israel)  \nDespite only 15 events, there are conflicts, tho most w/ diff likely attendees:   \nMost direct conflict w/ prob some overlapping potential attendees:   \nJune's Madison AGE vs Barcelona Gordon Systems Aging confs  \nProb easy choices for most, in Sep:   \nBSRA-ASM vs RAADFest &amp;   \nLIC vs CSHL"
          ],
          [
           "longevity_aging_link",
           "Dr. Todd Haim, Chief, Office of Small Business Research, National Institute on Aging (NIA), U.S. NIH, discussing small business funding for longevity R&amp;D and commercialization."
          ],
          [
           "longevity_aging_link",
           "2019 Longevity Year in Review - a summary of the year's major advances."
          ],
          [
           "longevity_aging_link",
           "Future of Retirement when AI Extends Lifespan. https://www.retirementsingularity.com/the-future-of-retirement-ai-and-the-quest-for-longer-healthier-lives/"
          ],
          [
           "longevity_aging_link",
           "Dr David Luu: 'All doctors should be longevity doctors.'."
          ],
          [
           "longevity_aging_link",
           "Intersection of longevity and falling fertility rates in the public funding space. Do you think the longevity industry stands to benefit from the growing global concern about falling fertility rates?  Would it be a direct or indirect benefit?  Would reducing demographic shifts be a more palatable and desirable mission than increasing healthspan, for policymakers and public research institutions?\n\nI ask this because there appears to be a large amount of public funding chasing the fertility rate problem with minimal success.\n\nhttps://www.economist.com/leaders/2024/05/23/why-paying-women-to-have-more-babies-wont-work\n\nFrance spends about 4% of its GDP on family policies with intentions to become more aggressive about boosting fertility.  South Korea is contemplating handouts of $70,000 per baby.  Poland and France have schemes in effect that result in costs of $1m-$2m per extra birth, since handouts mostly go to babies that were going to be born anyway.  Even Sweden with its generous child care programs only achieves a fertility rate of 1.7. \n\nI see the opportunity for longevity medicine to market itself and find success with the fertility rate problem.  With longer healthspan and more youthful reproductive systems, it seems obvious that more children would be born.  Particularly for those who push off parenthood to later years.  Though the biggest challenge I see is the fact that the industry has not yet definitively proven it can extend healthspan or lifespan in humans."
          ],
          [
           "longevity_aging_link",
           "Undergrad needs advice. I apologize if this is the wrong place to ask for advice, if so, a mod can delete this.\n\nMy end goal is finding a comprehensive cure for human aging, or rather, doing research that contributes to that goal.  I need advice on the best path for my bachelors degree (and beyond.)\n\nI am an older returning student.  I have a family and a career, so online school is my best bet.  I plan to continue to save and invest while finishing my undergrad degree, then resign to attend grad school full time.  I work for the post office, so I am pretty much stuck in this location until I resign.\n\nI am in SW Florida.  I had planned to go to University of Florida for their online Microbiology program.  I am second guessing that decision because it focuses a lot on prokaryotic life that wouldn't be as useful.\n\nI will have 69 credits after this semester.  I have a 4.0 GPA and can get letters of recommendation from any professor.  I have completed Organic Chemistry.\n\nI don't know where to go from here.  Does anyone have advice on the best path through my undergrad degree and beyond?  I can take time off here and there for in-person labs, but I would prefer most of my undergrad work to be online.  I am not averse to leaving the state or even the country for grad school though, if need be."
          ],
          [
           "longevity_aging_link",
           "Life Extension Advocacy Foundation Rejuvenation Roundup January 2020."
          ],
          [
           "longevity_aging_link",
           "Universities for Longevity. Does anyone know what are good universities for Longevity and aging? And just in general what courses and etc."
          ],
          [
           "longevity_aging_link",
           "8 great longevity books to learn the current science and theory behind life extension research."
          ],
          [
           "longevity_aging_link",
           "Register for Longevity San Francisco 2024 Kickoff Event on Jan. 30th."
          ],
          [
           "longevity_aging_link",
           "Should we live longer or not? [Arguments for and against.]."
          ],
          [
           "longevity_aging_link",
           "Interview with Karl Pfleger, Longevity Investor and Advocate | A4LI H-SPAN Podcast."
          ]
         ],
         "hovertemplate": "Topic Group=%{customdata[0]}<br>document=%{customdata[1]}<extra></extra>",
         "legendgroup": "longevity_aging_link",
         "marker": {
          "color": "rgb(127, 60, 141)",
          "symbol": "circle",
          "opacity": 0.7,
          "size": 7,
          "line": {
           "color": "rgba(0,0,0,0.5)",
           "width": 0.8
          }
         },
         "mode": "markers",
         "name": "longevity_aging_link",
         "showlegend": true,
         "x": {
          "dtype": "f4",
          "bdata": "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"
         },
         "xaxis": "x",
         "y": {
          "dtype": "f4",
          "bdata": "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"
         },
         "yaxis": "y",
         "type": "scattergl"
        },
        {
         "customdata": [
          [
           "ldl_cholesterol_apob",
           "Trodusquemine? Anyone familiar with this?. Some articles stating it completely reversed arterial  plaque?"
          ],
          [
           "ldl_cholesterol_apob",
           "Should You Take A Statin To Lower Your Cholesterol?."
          ],
          [
           "ldl_cholesterol_apob",
           "Any experience with elevated AST/ALT on Ezetimibe/Zetia?. I went on a small dose (5mg daily) of Ezetimibe 8 weeks ago after lots of research AND the advice of my cardiologist‚Ä¶I have an awful family history of CVD and had a CAC score of 15 last year at 44 years old, while otherwise healthy by every other metric. Diet mods brought LDL-c down to 85 and ApoB to 70 but wanted to try for more‚Ä¶got tests at 6 week mark and quite happy, LDL-c to 58 and ApoB to 59! But‚Ä¶.AST/ALT came back at 43/66. Obviously concerned, I retested 1 week later (this week) and they are at 56/89! I‚Äôve stopped the Ezetimibe until I can discuss with my cardiologist, but I‚Äôm also curious to know about any experiences that some of you may have had. Admittedly, don‚Äôt know much about liver health so I don‚Äôt know whether this elevation is extraordinarily bad or no big deal‚Ä¶I know Peter recommends ALT under 25 so that‚Äôs really all I have to go on."
          ],
          [
           "ldl_cholesterol_apob",
           "Should I go on a PCSK9 inhibitor?. Male, 37, BMI of low 18s, blood pressure usually 100/60-110/70, active runner and weightlifter, family history of high cholesterol/blood pressure in my dad when he hit his 60s (despite a similarly low BMI like me) and his dad/my grandad (who died of a heart attack).\n\nHave been doing basic lipid panels for about 7 years, LDL always been borderline between 80-110. I live in the Philippines where diets are poor and cardiologists here are generally useless. Read Outlive last year and decided to take it more seriously. Got my ApoB/ApoA and Lp(a) done recently for the first time. Results attached as a photo (pls ignore the CBC results - couldn‚Äôt crop those out).\n\nThe spike in my results a couple months ago was due to a semi keto diet I was on for a couple months to try and resolve some stomach issues - but I stopped that immediately when I saw the spike and cut my saturated fat and increased my fiber to bring the levels back down pretty quickly. \n\nGood to see my Lp(a) low but obviously would like my LDL and ApoB lower still. Not sure why my ALT/AST are going up but possibly stress/insomnia related due to other stomach issues that have been plaguing me over the last few months or maybe because I did vigorous runs the days before the recent blood draws. You can see my CBCs are pretty messed up as a result too, though my doctors aren‚Äôt worried about them.\n\nI don‚Äôt like the idea of statins driving up my H1Ac though, especially if I would be on them for 30+ years. I‚Äôm willing to pay the money for a PCSK9 inhibitor if needed. Was also reading about ezetimibe. I would appreciate thoughts from this forum on whether the benefits of a PCSK9 inhibitor would outweigh the costs/side effects for my current situation or if I should just focus even more on diet and lifestyle first, although I don‚Äôt want to completely give up eating meat and travel a lot, which can make it hard to control lifestyle much more beyond what I‚Äôve managed to date. At home, I do eat very healthy - nuts, loads of veggies, fruit, EVOO, salmon, just a bit of meat with dinner, etc. I do need to take in at least 2600+ calories a day to keep up with my physical activity, which can make it hard to keep saturated fat below 20g a day. \n\nAppreciate any views! Thanks!"
          ],
          [
           "ldl_cholesterol_apob",
           "CAC scan update. I posted here (https://www.reddit.com/r/PeterAttia/comments/1f0fzcg/first\\_cac\\_scan\\_what\\_to\\_expect/) a couple months ago about what to expect from a CAC scan, and you all gave great comments. A quick summary is that I'm 40, have a serious form of FH (familial hypercholesterolemia), had LDL well over 200 mg/dL before going on statins at age 18. LDL averaged about 130  mg/dL over the years since then, but is now at 30mg/dL on Repatha. I've done endurance sports basically my whole life. \n\nResults: Total CAC = 3. I am disappointed that it is positive, and I hope I can forget about it and keep the LDL at rock bottom from here on. \n\nHowever, given my family history, it could have been a lot worse, and I'd also like to argue that the CAC score of 3 in my case could be a better sign (or less bad) than it would be for an average person with the same score. Here is my logic, which might give others in a similar situation some comfort. \n\n\\-Consider two people age 40 with the same CAC score, say between 1 and 10.\n\n\\-Person A has a genetic predisposition for high LDL (maybe diagnosed FH, maybe not). They are a lifelong athlete and their LDL was high even when young, and maybe they are on statins now.\n\n\\-Person B doesn't have any genetic predisposition for high LDL, but doesn't exercise and has gotten progressively out of shape with age. Presumably, their LDL has steadily increased over time. They are not (yet) on a statin.\n\nI argue that Person A is less likely to have undetected soft plaque than Person B, and therefore Person A is better off. While it's true that for a fixed high LDL level, a long history means a higher cumulative LDL load, and a higher likelihood of plaque buildup (calcified or otherwise), this comparison is already assuming the same amount of calcified plaque. In estimating the amount of undetected noncalcified plaque, Person A has several advantages. \n\n\\-First, Person A's LDL has been high for a longer time, so their \"median\" LDL particle hit them longer ago than did Person B's, and any resulting plaque has had a longer time to calcify.\n\n\\-Second, Person A's has been a lifelong exerciser, which also promotes stablization/calcification of plaques.\n\n\\-Third (depending on the scenario), Person A is now on statins, which further promotes calcification and possibly has other benefits preventing plaque buildup, even for a fixed LDL level.\n\nIn contrast, Person B's plaque development has been a more recent phenomenon and has been less inclined to calcify.\n\nIn short, the CAC score seems more likely to be the full extent of the damage for person A, but not for person B. If both maintain a healthy lifestyle and proper treatment going forward, A is more likely to keep the CAC score from rising, while B's might rise as some of the existing soft plaque calcifies. \n\nMy recollection is that Peter Attia's situation in his mid-30s more closely resembled person A, and in fact, his CAC score did not increase when evaluated again over a decade later. \n\nHappy to hear feedback."
          ],
          [
           "ldl_cholesterol_apob",
           "Very high cholestrol and HDL despite being healthy and exercising everyday/ High bp as well. Cholestrol total: 226\n\nHDL : 96!!!!\n\nLDL : 116\n\ntrig: 60\n\nwhat do i do? BP is also high normal which is 132/80 despite taking telmisartan 40 \n\nall other tests are fine \n\ni exercise for 2 hours a day, heart rate is 50, other tests like echo, TMT (METS 13.4), 70 EKGs, are fine. \n\nAll other blood tests are fine but the very high HDL is troubling me"
          ],
          [
           "ldl_cholesterol_apob",
           "#129 - Tom Dayspring, M.D.: The latest insights into cardiovascular disease and lipidology."
          ],
          [
           "ldl_cholesterol_apob",
           "Direct to total bilirubin ratio. Hey, 38M, white, 68 kg, from Europe, 172 cm, non smoker, not had alcohol for 8 months. I do not take any medication or use recreational drugs. No existing medical issues.\n\nI had bilirubin tested around 8 months ago. Total was 0.8 (direct 0.1), percentage of direct was therefore 12.5%. \n\nLast week I got tested again and this time total was 1.3 (lab values went up to 1.2) with direct being 0.2 (direct range went up to 0.3) so the percentage of direct was 15.38%.\n\nBecause of this midly elevated number I decided to test at another lab this week and the results are now total bilirubin 1.1 (range went up to 1.2) and direct 0.4 (range goes up to 0.5). Both are with this lab's ranges, but this time the direct/total percentage is 36.36%.\n\nDoes this direct/total % matter when both are in normal range. The reason I was getting tested was to see if I had Gilberts disease. \n\nI have read that direct bilirubin should be lower than 20% in gilberts disease but would that only apply if I was consistently getting abnormal levels?\n\nAll my other liver markers are fine, GGT: 12, ALT 18, ALT 18, etc. \n\nSo, even if I don't have Gilbert's, does this % matter much as long as the values are within the normal lab range?\n\nThanks"
          ],
          [
           "ldl_cholesterol_apob",
           "Most accurate test to determine arterial blockage?. Posted recently about my rapid increase in score on my calcium scan. \n\nBrief summary been on statins since my 20s due to family history. Had a calcium scan at 37 and scored a 4. Have kept ldl at 100 since then. Did another calcium scan this week and got a 107. This is 5-6 years later. I am 43 now, several people in my family have had their first heart attacks at my age. Family history is as bad as it can get but I‚Äôm the only one who‚Äôs ever attempted taking meds, lifestyle changes etc. \n\nNow, two people in my family have had stress tests as well as echocardiograms which came back normal only to suffer heart attacks within 6-12 months that revealed 95%+ blockages. \n\nFrom my understanding, an angiogram would be the most accurate way of establishing any blockages, but will any doc even consider that without me having had a heart attack?\n\nI would love to believe my family history combined with the increased calcium score would be sufficient to warrant an angiogram  but I‚Äôm constantly baffled by how doctors work so idk. \n\nSecond, does the increase in calcium score become a factor in insurances willingness to cover something like repatha?  My ldl hangs around a 100 and until now I‚Äôve been laughed out of the room by docs when asking if I should be lowering it to 70 or less. \n\nI don‚Äôt tolerate Ezetimibe, so if Im not able to get a PCSK9, my only other option really is to increase my crestor from 10 to 20mg and add bempedoic acid."
          ],
          [
           "ldl_cholesterol_apob",
           "Help with bloodwork - contradictory results?. Hi All,\n\nI would appreciate some feedback on my bloodwork, as I have some seemingly contradictory results.\n\nSome background: \n\n* Recently turned 40, and have 3 young children. \n* Historically lead a relatively unhealthy lifestyle, bad diet and too much Alcohol.\n* Have 2 copies of  *APOE4* , was a big part of what motivated me to change my lifestyle when I learnt  this (and reading Outlive).\n* In last 14 months have focused on my health and exercise 4-6 per week, healthy diet and good sleep. Feel great and regret not doing earlier.\n* Have lost 56lbs, BMI still high at 29, but working on it.\n* All other bloodwork in a good place apart from Ferritin, which has been high on my last 2 tests, (521 ug/L, and 495.0 ug/L). I have 1 variant in the HFE Gene, I think this could possibly be related.\n\nMy Cholesterol is generally not good - see below data (please note the test was done in the UK, that use different units to what is commonly used in the US, so I have searched online to find conversions and targets)\n\n&amp;#x200B;\n\nhttps://preview.redd.it/1iy2wjokp86c1.png?width=655&amp;format=png&amp;auto=webp&amp;s=db1e38b222e2c87247b77c69aec7b7621788d2d8\n\nMy observations of this:\n\n* Apob seems high and is double that suggested by Peter, but within range on my test!\n* LP(a) Is very low, and Triglycerides low, but Cholesterol is high.\n* Lp PLA2 is worryingly high, but CRP HS is very low\n\nIf anyone can give me some insight into these results, and suggested next steps it would be greatly appreciated,\n\nThanks, \n\nMatt"
          ],
          [
           "ldl_cholesterol_apob",
           "Mendelian randomization studies on cholesterol. Can someone explain to me in layman's terms how these studies work? \n\nIs it looking at people's genetics for predisposition to high or low LDL(apob) and then looking at the outcomes and making conclusions based just on that?\n\nIs it just purely based on genetics? \nDoes it account for lifestyle and diet choices in any way?"
          ],
          [
           "ldl_cholesterol_apob",
           "Peter Says 80% of His Patients Over 45 Take a Cholesterol-Lowering Drug: \"What's the most prevalent cause of death globally? Cardiovascular disease ... If you go to 2019, 18.6 million people died of heart disease. Number two, cancer, 10 million. Nothing is in the zip code of atherosclerosis.\"."
          ],
          [
           "ldl_cholesterol_apob",
           "Lipid etc fine but bp is 132/80. docs say no need to add more meds. at the docs my first reading is always high - 145-150/80 then it falls to 130-4/80 and docs say no need to add anything more than telmisartan 40 which i am already taking."
          ],
          [
           "ldl_cholesterol_apob",
           "Seeking Insights: Pre/Post-Statin Tests Recommended by Peter and Tom Dayspring?. Does anyone know what tests Peter (or Tom\nDayspring) like to run before/after putting their patients on statins to test for negative effects?  I seem to remember in one of the (very many) podcasts they did together Peter mentioned the Boston Heart Cholesterol Balance test but can‚Äôt find that now. \n\nReally appreciate any pointers üôÇ"
          ],
          [
           "ldl_cholesterol_apob",
           "Positive Antibody. I got back my autoimmune diabetes test and one of the four antibodies came back positive :/. I got the results an hour ago so I‚Äôm feeling very down. My ZNT8 was 28 U/ml which was high and I was referred to an Endo. I called to make an appointment with them to understand my next steps. \n\nTo the community: \nIs it certain I now will have type 1 because I tested positive for one of the antibodies? \nI‚Äôm reading about a drug called TZield which is new, have any of you guys tried it? \n\nI‚Äôve been wearing the Dexcom 7 CGM now for a week and my 14-day avg glucose is 95 mg/dl. You can see the rest of my results in my previous post here: https://www.reddit.com/r/Biohackers/s/JXgut5Xfr4"
          ],
          [
           "ldl_cholesterol_apob",
           "High CRP and Normal ESR. I have high CRP (4) but normal ESR. My doctor wants to recheck in 2 months. I am freaking out. Should I change my doctor and ask for second opinion?"
          ],
          [
           "ldl_cholesterol_apob",
           "Help understanding cholesterol bloodwork. My question is, I understand that ApoB gives a measure of the total cholesterol particles in my blood excluding HDL, but including LDL, VLDL, triglycerides, lp(a), etc., -- so *if all of these are measured in the same exact way (in mg/dL)*, how can ApoB be lower than some of those numbers by themselves? Here were my recent results, the first time I've tested these:\n\nTotal Cholesterol = 204\n\nLDL-C = 143\n\nHDL-C = 52\n\nTriglycerides = 62\n\nVLDLC = 9\n\nLP(a) = 110\n\nApoB = 111\n\nWith the above, I'd expect to have to add everything (excluding HDL) to get the ApoB number, but the ApoB came in at 111 which, while elevated, is far below the sum of the total. Could anyone help me understand, please?\n\n&amp;#x200B;\n\nAnd yes, I know I need to lower these :(\n\n&amp;#x200B;\n\nAlso as a second question, if my LP(a) is 110, which I understand is somewhat genetically predetermined, does that mean, if this is a type of LDL particle, that I can't lower my LDL below 110?  My bloodwork claims these are all measured using the same exact mg/dL, but I don't really have a sense of how they're interacting.\n\nThank you so much!\n\n&amp;#x200B;\n\n&amp;#x200B;"
          ],
          [
           "ldl_cholesterol_apob",
           "Prepping for first cardiologist visit. **tl;dr**\n\nM/51/5'9\"/155lbs/no current medical issues or medications\n\nCurrent bloodwork:\n\nTC = 246 mg/dL  \nHDL-C = 109 mg/dL  \nTrig = 30 mg/dL  \nLDL-C (calc) = 131 mg/dL  \nnon-HDL-C (calc) = 137 mg/dL  \nch/HDL ratio = 2.26\n\nSeeing cardiologist for first time as GP is worried about high TC/LDL-C; what should I ask the cardiologist?\n\n&amp;#x200B;\n\n**Background**:\n\nI'm 51/M, 5'9\", 155lbs with no current health issues. I am not on any medications. I began following a paleo-style whole foods diet in 2011 along with daily TRE (18:6), and in 2018 started playing around with a higher fat keto-style diet. I have been a regular exerciser for 30+ years, through a number of different modalities. I currently strength train 3x a week for 1 hr, and do LISS/Z2 on a stationary bike or treadmill 3x a week for 1 hr. I throw in 1x week of Z5 HIIT for about 20 min. I also practice yoga daily in the morning (15-30 min, gentle), and meditate for 20 minutes every day.\n\nAt my annual physical in January of 2022, my TC was high, with **calculated LDL-C at 178** (I apologize - I don't have the rest of those numbers at this time).\n\nBecause I had had spikes in TC before and found that I could mediate those with dietary changes, my GP and decided I would take this approach again and see what happened. I moved back from a HF-Keto style diet to a paleo/whole food diet (i.e., increased carb and fiber intake, decreased fat intake, particularly SF). After 6 weeks, my numbers changed fairly dramatically:\n\nFeb 10, 2022\n\nTC = 256 mg/dL  \nHDL-C = 99 mg/dL  \nTrig = 50 mg/dL  \nLDL-C (calc) = 147 mg/dL  \nnon-HDL-C (calc) = 157 mg/dL  \nch/HDL ratio = 2.59\n\nBecause my GP was happy with that change, she agreed to give me another few months to see what further changes I could make via lifestyle. After about 10 more weeks, I had another blood draw. These are my most recent numbers:\n\nApr 4, 2022\n\nTC = 246 mg/dL  \nHDL-C = 109 mg/dL  \nTrig = 30 mg/dL  \nLDL-C (calc) = 131 mg/dL  \nnon-HDL-C (calc) = 137 mg/dL  \nch/HDL ratio = 2.26\n\nadditionally, on this most recent test:\n\nhbA1C = 5.1  \nBP = 102/70  \nRHR = 50 bpm\n\nNow I am scheduled to see a cardiologist in a week.\n\n**Questions:**\n\n1. Should I expect a cardiologist to want to put me on a statin at this point? While I don't doubt their usefulness or efficacy in appropriate cases, I also don't love the idea of being on a drug for the next 30 years if I don't really need it.\n2. After listening to Peter's podcasts on this topic (Dayspring, etc.), I will clearly be asking for an Apo(B) test (and/or LDL-P) before agreeing to any treatment. Is there anything else I should be asking for, test-wise?\n3. Am I correct in guessing that with low TG and high LDL-C, I might expect Apo(B) to not be elevated? Or is it really just impossible to guess? (I will ask for the test regardless)\n4. I do believe my dietary changes have helped me a lot, and I am VERY happy eating this way. Is it appropriate to expect further improvements in test numbers over the coming months, or is there a point where I've gotten all of the lifestyle benefits I can reasonably expect?"
          ],
          [
           "ldl_cholesterol_apob",
           "Abo B and LDL Questions re WHAT TO DO NEXT?. 68 year old male.  Had a calcium scan in my 40's and it was moderate.  Have been on Pravachol for about 30 some years.  LDL has been around 100 and ApoB around 80.  Wanted to get more aggressive so I switched to 10 mg Rosuvastatin.  I was hoping it would get my LDL down to the magical 70 number **but it's stuck at 85**.   Doc suggested I go to 20 mg Rosuvastatin but I feel so good right now I'm leery about doubling the dose (concerned with muscle cramping and especially pushing me into prediabetes  as my glucose numbers sometime get close to 100.  I think I've seen or heard Attia say that the benefits from increasing dosages are hard won in that 80% of the benefit comes from the lower doses.  They also suggested Ezetimibe but I'm concerned with gastro issues.    Took me a long time to figure out how to calm my stomach and digestive tract and she said there are potential gastro side effects from it.  Ok I know I sound like a real whiner : ) but just looking for advice from anyone who has successfully reduced their LDL in maybe a similar (or even not similar?) situation.  Thanks!!"
          ],
          [
           "ldl_cholesterol_apob",
           "Blessed with good cholesterol genetics... should I still take a statin?. Age 29, M. BMI 28. No hx of CVD in my family. Diet isn't terrible but I don't pay close attention to it either. Maybe 1-2 hours of active zone 5 exercise a week. \n\nCholesterol 137, TG 70, HDL 63, LDL 60\n\nLp(a) &lt;7, Apo(B) 57\n\nHgb A1c 4.8%, ALT 24\n\nThinking about crestor 10. Or I could opt for a lower intensity statin like pravastatin 10 or simvastatin 10. I know peter advocates for LDL ~30 in his book (LDL close to \"infant level\" but I feel like my profile and family hx if pretty favorable. Thoughts?"
          ],
          [
           "ldl_cholesterol_apob",
           "Peter Attia Dives Deep on STATINS (side effects &amp; the best alternatives)."
          ],
          [
           "ldl_cholesterol_apob",
           "ApoB questions. 42m. Last year my Apob was 105. This year it came in at 91. In 2023 I lowered my saturated fat consumption, increased fiber consumption, and increased my exercise. A marginal improvement, and it's unlikely I'll be able to lower it much further without medication. I'm starting rosuvastatin 5mg tomorrow.  Idk my LPa or CAC. My dad died at 70 of a heart attack. My mother is in her 80's and has had a couple strokes, and she's had hypertension for decades.\n\n&amp;#x200B;\n\nShould I ask my doc for ezetimibe now, or wait until my next Apob test in 2 months and go from there? \n\nAlso, what should be my ApoB target... Peter aims for 20-30, but what should a mere mortal such as myself aim for?"
          ],
          [
           "ldl_cholesterol_apob",
           "No calcified atheroma?. I was reading my CT report from 2 years back regarding other issue I noticed it says No calcified atheroma which I though it mean not calcification in the arteries while report also states below in red no coronary artery calcification I am bit confused here I am 45 do i have calcified arteries my Cardiologis or surgeon I seen did not recommend anything now my anxiety is crazy can‚Äôt sleep"
          ],
          [
           "ldl_cholesterol_apob",
           "Interested in hearing how to increase my HDL and general thoughts on my numbers. (41M) Had my lipid panel done in February and again yesterday.  Doctor put me on 10mg rosuvastatin which I take on Sunday and Thursday every week.\n\nSupplements I take daily are 500mg berberine, CoQ10, D3/K2, ZMA, and 5g Creatine.\n\nLP(a) came in at 15.\n\nCAC - 1\n\nLifting weights 3 days per week, and brisk walking/cycling 4 days per week.  High protein diet, but not keto.  A lot of protein shakes, bars, chicken, hard boiled eggs, and fish a few days per week.\n\nhttps://preview.redd.it/0h6zjx83i3lb1.png?width=662&amp;format=png&amp;auto=webp&amp;s=e137dc9b414de8318abc7e642ff2473a29005a30"
          ],
          [
           "ldl_cholesterol_apob",
           "Lp(a) in mg/L. Just looked at a blood test I did 2 years ago, where my Lp(a) was measured to be 206 mg/L.\n\nHow would you interpret that? Most results online shows the value in either nmol/L or mg/dL, and from my understanding conversion can be tricky."
          ],
          [
           "ldl_cholesterol_apob",
           "How much does dietary fiber actually decrease cholesterol (available studies)?. I'm wondering if it a linear relationship? As in if you have 15g vs 30g vs 60g will you see a proportional decrease in cholesterol? Are there any studies that go really in depth on this? Just looking to optimize my cholesterol levels as much as possible."
          ],
          [
           "ldl_cholesterol_apob",
           "Cholesterol/ apo b. Any idea what I can do to lower apob? I already exercise 6 days a week. Three days full body strength. Two days run- one intervals and two zone two 45-60 minutes. I eat plenty of protein 150g or more a day . Usually fiber is 40g a day. Saturated fats average about 15-20g a day. I‚Äôm 40 yo female. Do I need even less saturated fats? I rarely eat dairy and rarely eat red meat- if I do it‚Äôs leaner cuts. \n\nMy labs show I‚Äôm very good metabolic wise. Thank you"
          ],
          [
           "ldl_cholesterol_apob",
           "The Straight Dope on Cholesterol - discussion. PA wrote a 9-part series of articles on cholesterol on his website in 2012 entitled, \"The Straight Dope on Cholesterol\" that were the most informative I've ever seen but also puzzling. Perhaps we can have some discussion. \n\nThe puzzling parts to me are as follows:\n\nPart 1, he states that 75% of cholesterol in the body is synthesized endogenously. Of that, 20% is synthesized by the liver and 80% by other cells. It isn't clear to me from this how much of the 80% enters circulation. He doesn't elaborate on the 80%, which is .75\\*.8=60% of the cholesterol in our body. Does the 60% enter circulation? Where is it made?\n\nHe then discusses cholesterol absorption mechanisms in the small intestine. The headline here was that there is esterified cholesterol (CE) and unesterified cholesterol (UC). Of these, the intestine can only absorb UC. He then says \"Much (&gt;50%) of the cholesterol we ingest from food is esterified (CE), hence we don‚Äôt actually absorb much, if any, exogenous cholesterol (i.e., cholesterol in food)\". I immediately thought that 49% could be a meaningful amount. But based on that percentage he states that eating cholesterol has very little impact on the body. This is a position he reiterates throughout the series. \n\nInterestingly, 85% of the UC (which is absorbable) in our gut is made by our own body. It is dumped into the intestine via biliary secretion. So the liver dumps cholesterol into the intestine, then the intestine re-absorbs it. \n\n\n\nHere's where it gets interesting to me: his dietary recommendation to address heart disease at this point in time was a low carb diet. Now he seems to have moved away from that because many of his patients experienced sky-rocketing cholesterol (about 1/3 by his own report). \n\nFiber is not a dietary lever he mentions, yet I've seen studies indicating that it is effective at binding to cholesterol in the gut and thereby preventing re-absorption. So when the liver dumps cholesterol into the intestine it leaves the body instead of being re-absorbed. The production of short-chain fatty acids by fiber-fermenting bacteria also seem to help. Anecdotally there was a guy in r/cholesterol that reported cutting his cholesterol in half in part by consuming plenty of fiber. \n\n  \nSome links:\n\n  \n[https://www.health.harvard.edu/blog/fiber-full-eating-for-better-health-and-lower-cholesterol-2019062416819](https://www.health.harvard.edu/blog/fiber-full-eating-for-better-health-and-lower-cholesterol-2019062416819)\n\n  \n[https://pubmed.ncbi.nlm.nih.gov/9925120/](https://pubmed.ncbi.nlm.nih.gov/9925120/)\n\n  \n[https://www.medicalnewstoday.com/articles/how-fiber-helps-lower-cholestrol-and-what-to-eat#does-fiber-lower-cholesterol](https://www.medicalnewstoday.com/articles/how-fiber-helps-lower-cholestrol-and-what-to-eat#does-fiber-lower-cholesterol)\n\n  \nHas PA missed this?"
          ],
          [
           "ldl_cholesterol_apob",
           "Latest Blood Work. Hi all,\n\nLong time listener, first time caller. 33-year-old male. Workout 4-6 times per week and eat relatively well. Found my latest blood work (first time with this level of detail) interesting and was wondering if there was much to be concerned about. Specifically, my Lp(a) and ApoB aren't off the charts, but my LDL is quite high. Any thoughts would be appreciated!  \n\n\n|Marker|Result|\n|:-|:-|\n|Lp(a)|18.3 mg/dl|\n|ApoB|81 mg/dl|\n|LDL|137|\n|Total Chol|199|\n|HDL|54|\n|Triglycerides|43|\n|Non-HDL Chol|140|"
          ],
          [
           "ldl_cholesterol_apob",
           "Father is 73 with a calcium score of 475 but otherwise healthy. I‚Äôm 40 and decided to get a calcium score for baseline knowledge (medicine 3.0); Dr was annoyingly reluctant. I had to battle him a little bit just to order it. It came back 0, which is great, but he was very flippant about it.  Like ‚Äúya see, it‚Äôs 0.‚Äù What is it with doctors? What are they afraid of? He‚Äôs a pretty young, smart doctor, always just so surprised at the reluctance."
          ],
          [
           "ldl_cholesterol_apob",
           "Cystatin C. I asked my pcp to order a Cystatin c egfr test for me. My egfr came back at 121 and my Cystatin c was .71. Very happy. Just thought I‚Äôd share"
          ],
          [
           "ldl_cholesterol_apob",
           "Did I become a paranoid zealot?. I know my PCP certainly thought I was off my rocker when I asked for a CGM hahaha.\n\nAnyhow, I'm curious what the group here thinks about these numbers.  I have what seems to be off the charts LPa, and higher than optimal apoB.  My cardiologist tells me that my other numbers are great and are offsetting high LDL and my LPa risk factors.  Prescribed course of action: get a calcium scan. If it comes back as zero, take no further intervention.  I got the calcium scan and it came back as zero (awesome!).  That said, I'm willing to take action to help it stay there as long as possible.  My concern is the learning that aboB and LPa are causal for cardiovascular disease.  While HDL and Triglycerides may be at favorable levels, I'm not convinced this offsets my risk.\n\nThoughts?\n\nMale 38\n\nCholesterol: 210\n\nTriglycerides: 38\n\nHDL: 83\n\nLCL: 119\n\napoB: 88\n\nLPa: 248\n\nCalcium scan score: 0\n\nFor reference, I strength train 3x a week, BJJ 2x a week, and Zone 2 jog/walk at 45 minutes sat/sun.\n\nDiet is not super dialed in, but I would say isn't terrible. I typically grab a protein shake for breakfast, 8-10 oz of meat for lunch, and dinner is typically a hello fresh concoction. \n\nThoughts?"
          ],
          [
           "ldl_cholesterol_apob",
           "Lowering CVD risk. What medications , besides statins, can lower LDL and overall CVD risk? I know statins come with risks and some people can have side effects.  So I‚Äôm wondering if there are medications that have fewer, if any side effects , but can help lower LDL/ApoB"
          ],
          [
           "ldl_cholesterol_apob",
           "Tests Back. I got my results back from by cholesterol tests. ([Prior Post](https://www.reddit.com/r/PeterAttia/comments/vnkfa7/comprehensive_test_list/?utm_source=share&amp;utm_medium=web2x&amp;context=3) of what I ordered)\n\n I think the numbers look pretty good from what Quest says but not sure where the more aggressive thinking standards would put them. I remember an episode that went into great detail about particle size and number but now I don't know which and there are so many.\n\nIn parentheses I have the numbers from last year. While they go in the wrong direction (more LDL and less HDL) the change wasn't dramatic and I did change to eating significantly less whole grains this past six months and more eggs.\n\nNot sure next steps, might be done for a while but just recheck some of the values again in 5 years? Not really sure which tend to change vs. static.\n\nSome family history of heart disease but both incidents were lifetime smokers in the 80s who died at \\~65; so not really sure it's relevant.\n\n|Age|37||\n|:-|:-|:-|\n|Height|72|in|\n|Weight|165|lbs|\n|Total|146 (145)|mg/dL|\n|Triglycerides|50 (46)|mg/dL|\n|APO A1|146|mg/dL|\n|HDL|48 (59)|mg/dL|\n|HDL Large|5404|nmol/L|\n|Apo(b)|65|mg/dL|\n|LDL Medium|285|nmol/L|\n|LDL Pattern|A||\n|LDL Peak|220|A|\n|LDL Small|196|nmol/L|\n|LDL|86 (73)|mg/dL|\n|LP(a)|13|nmol/L|"
          ],
          [
           "ldl_cholesterol_apob",
           "Phase 2 trials [Lp(a) reduction] Muvalaplin and Zerlasiran. I just saw two reports worth reading\n\n[https://jamanetwork.com/journals/jama/fullarticle/2826683](https://jamanetwork.com/journals/jama/fullarticle/2826683)\n\nOriginal Investigation\n\nNovember¬†18, 2024\n\nOral Muvalaplin for Lowering of Lipoprotein(a)\n\nA Randomized Clinical Trial\n\n\n\n[https://jamanetwork.com/journals/jama/fullarticle/2826608](https://jamanetwork.com/journals/jama/fullarticle/2826608)\n\nOriginal Investigation\n\nNovember¬†18, 2024\n\nZerlasiran‚ÄîA Small-Interfering RNA Targeting Lipoprotein(a)\n\nA Phase 2 Randomized Clinical Trial"
          ],
          [
           "ldl_cholesterol_apob",
           "Ezetimibe+Rosuvastatin and lifestyle changes with already Low LDL, triglycerides ‚Äì Before/After. Hey, I wanted to share my progress here. I wanted to reduce my LDL as much as possible. First through lifestyle changes and then additionally with medication. I am aware that I already belonged to the group of people who were happy with their LDL. ApoB was not tested.\n\nMy starting point was as shown in the table (7 months ago)\n\nBased on this, I made some changes to my everyday life:\n\n* Increased fiber (15g psyllium husk)\n* Increased olive oil (20g per day)\n* Increased fish oil (10g per day)\n* Citrus Bergamot (500¬†mg)\n* NAC (1g)\n* Nattokinase 10000 IU\n* 3x per week 3x15 min sauna sessions\n\nThis has brought my values down to the second column (3 months ago). I am already doing bodybuilding since a couple of years and was therefore active in the gym.\n\nA month ago, I added 10 mg of Ezetimibe and 5 mg of Rosuvastatin.  The values then improved again. I don't have side effects, and my other blood values have not deteriorated. Interestingly, my LDL levels did not improve significantly, probably because I already had good levels. \n\nFeedback, questions, or any suggestions? \n\n&amp;#x200B;\n\n||Now|Before (pre ez/ros)|Before (pre lifestyle)|\n|:-|:-|:-|:-|\n|Cholesterol|120 mg/dL|106 mg/dL|159 mg/dL|\n|Triglyceride|34 mg/dL|58 mg/dL|58 mg/dL|\n|HDL|64 mg/dL|49 mg/dL|60 mg/dL|\n|LDL|39 mg/dL|47 mg/dL|82 mg/dL|\n\n&amp;#x200B;"
          ],
          [
           "ldl_cholesterol_apob",
           "Is this slight tick up in LDL cholesterol notable, or just noise?. &amp;#x200B;\n\nhttps://preview.redd.it/kufsljy05lsc1.png?width=684&amp;format=png&amp;auto=webp&amp;s=5422eeae45f05beb4bdb3238352e6d387f885d83\n\nUnits are mg/dL\n\nFirst test was fasted, second test was random. I read that can influence things?\n\nSoon after the first test, I changed my diet to include less carbs and more fat. Fats mainly in the form of olive oil, chia seeds, dark chocolate. I did this because my cholesterol results looked good to me, and when I wore a CGM, my blood glucose levels and oscillation didn't seem to be as good. Now I just want to make sure that these changes haven't made my cholesterol worse. To me it looks like it could be noise, or because the second test wasn't fasted, but curious if you all think I should pay attention to any of the changes?"
          ],
          [
           "ldl_cholesterol_apob",
           "Lathosterol/Desmosterol results. Got my test results and Lathosterol shows high at 128 while Desmosterol is 50. \n\nThe absorption markers of Beta-sitosterol and Campesterol are low at 78 and 67 respectively. \n\nThe cholesterol balance score is 1.6 indicating an over producer. \n\nDoes this mean my body is producing more cholesterol than it can absorb and I need to incorporate some pharmaceutical options? \n\nIn terms of saturated fat I eat 6 eggs a week, avocado and 8oz salmon daily. \n\nHaven‚Äôt done a recent blood test but my 8 month old advanced lipid panel results are\n\nA1C is 5.3 \nApoB 98\nLp(a) 26\nCholesterol total 191\nHDL 52\nTriglycerides 95\nLDL 119 (High)\nNon-HDL Cholesterol 139 (high)\nLDL particle number 1748 (high)\nLDL small 298 (high)\nLDL medium 453 (high)\nHDL, large 6302 (low)\nLDL pattern A\nLDL peak size 218.7\n\nAny ideas ?"
          ],
          [
           "ldl_cholesterol_apob",
           "Eating a bit more SFA while on meds before a blood test?. Is it kinda crazy, or just a tad obsessive, to consume more saturated fatty acids (SFA) before a blood test? Specifically, I‚Äôm wondering if anyone has intentionally indulged in foods rich in SFA, such as cheese, chocolate, eggs, and cream, before getting their LDL and APOB levels measured while on medication. My goal is to maintain very low LDL and APOB levels, and I‚Äôd prefer not to strictly follow the guidelines set by the American Medical Association (AMA). I‚Äôm considering increasing my SFA intake about 3 weeks before the blood test, but afterward, I‚Äôll return to a low SFA diet with only around 140 calories from SFA.\n\nAs a 58-year-old, lean, and fit individual with blood pressure slightly below 120/80, my previous diet included little red meat but did include eggs, cheese, chocolate, full cream milk, and occasional baked goods. I‚Äôm one of those hyper-lipid individuals.¬†\n\nBefore starting medications, my stats were as follows:\n\n* Total cholesterol (TC): 200\n* LDL cholesterol: 130\n* APOB: 102\n* Calcium score: 200 (a surprising result!)\n\nAfter taking rosuvastatin for a month, my levels decreased by about 50%.\n\nNow that I‚Äôm also on ezetimibe, I‚Äôm planning to continue enjoying my ‚Äòold‚Äô diet while taking rosuvastatin (20mg) and ezetimibe (10mg). However, I‚Äôm curious about the long-term effects if I don‚Äôt change my diet and rely solely on medications for the next 15 to 25 years.\n\nAnd, what's wrong with being a bit obsessive about trying not to have a heart attack or stroke down the track!"
          ],
          [
           "ldl_cholesterol_apob",
           "TRT with a Positive CAC. Thoughts on TRT for a 40yr old with a 50 CAC score. Currently on ASA, Crestor, Zetimide and Amlodipine. Obesity but no Diabetes. \n\nTrying to get the diet and exercise together and was reading on TRT. Current T levels are below normal range. \n\nCertainly don‚Äôt wanna screw around with my heart as it‚Äôs caused a lot of anxiety in the past year, but finding conflicting information. \n\nThanks\nMcNulty"
          ],
          [
           "ldl_cholesterol_apob",
           "High Apolipoprotein B but Zero Calcified Plaque in Coronary Arteries. Middle-aged, non-smoker, non-drinker, decades long weightlifter....I just eat a lot. \n\n&amp;#x200B;\n\nI recently had a blood test and have moderately high cholesterol (224 mg/dL), high LDL (148 mg/dL), normal HDL (40 mg/dL) but a \"very high\" Apolipoprotein B of 132 mg/dL. I requested a CT Calcium score which found \"No calcified plaque in the coronary arteries.\" \n\n&amp;#x200B;\n\nI was just recently put on a statin, after this most recent blood work, so the levels I've listed above are my baseline. \n\n&amp;#x200B;\n\nAm I to interpret this as having \"gotten away with\" decades of being overweight and overeating? But  what's up with my Apolipoprotein B? Should I be taking a statin?\n\n&amp;#x200B;\n\nI realize you're not Attia, just curious if anyone here has heard his thoughts on someone with both high Apolipoprotein B but with no calcified plaque. \n\n&amp;#x200B;\n\nTIA"
          ],
          [
           "ldl_cholesterol_apob",
           "Am I too young for a full blood panel?. 22F finishing up my last year of undergrad. I‚Äôve fallen down this path of become fascinated with my longevity journey and have become a fan of Peter‚Äôs and his work in the process. I‚Äôve found places in my area (Seattle) to do a DEXA scan when i‚Äôm home for summer break but am also looking at doing a full panel to see where i stand in other areas of my health. I had a type of heart disease (Kawasaki) when i was 8 years old and so i‚Äôm definitely wanting to get a cardiac calcium score done as well. Do you think that I‚Äôm too young to get this work done? Will doctors even give me the time of day because i‚Äôm not even 25? Any help or advice will be appreciated!!! So many knowledgeable people on the sub and i love reading all the posts and comments :)"
          ],
          [
           "ldl_cholesterol_apob",
           "Low LDL. Is low ApoB low enough?. I am on a statin with a goal to keep my LDL at 50 or lower.  I am having a routine follow up with my cardiologist and so I got a lipid panel since I changed from rosuvastatin (40 mg) to atorvastatin (80 mg) 5 weeks ago.  I also decided to get an ApoB test.  I had one in 2018 but not since then.  (In 2018, LDL was 182 and ApoB was 125).\n\nThe current lipid panel has LDL at 48 and ApoB at 62.  Trigs were 83.  I have seen it recommended here that ApoB should be below 60 to be at lowest risk.  I read a study about this which said the low treatment goal for ApoB is unclear.  Statins reduce LDL far more than they do ApoB so it is very difficult to get ApoB to be at the same percentile as a statin.\n\nI am not sure if I need to work about the ApoB being 62 or not.  I had a CAC score about a year and a half ago of 638 (I was 68f at the time).  I had an angiogram 14 months ago that found 4 blockages.  The most serious was 60% to 70% of the LAD and another of 60% in another artery.  The cardiologist did an FFR though and I was fine so no stents were needed.\n\nLast December my PCP had me do some lab work from Cleveland Clinic (through Quest).  At that time LDL was 49.  ApoB was not tested but my LDL-P was 740 which was considered optimal as it was under 935.  My small LDL-P was 461.  \n\nI am not really sure what more the cardiologist might do given my LDL is 48 and I am at 80 mg.  I could ask for ezetimibe but not sure he would do it.  I discussed it with my PCP and he didn't want to do it.  He was worried about it possibly being hard on the liver and if my LDL was under 50 on atorvastatin then he didn't want to add another medication.  I can ask the cardiologist what he thinks (and will).  I have read a lot about ApoB but it mostly about people with LDL goals and LDL higher than mine.\n\n&amp;#x200B;\n\n&amp;#x200B;"
          ],
          [
           "ldl_cholesterol_apob",
           "Concerning lipid panel / high lp(a). Male, 34 here.. 6'0'', 178 lbs\n\nhave been a regular on the Peloton 3 - 4x/week for the last 1.5 years. Recently (around 2 months ago) discovered Attia and started being more deliberate in my training - 3-4 zone 2 workouts per week (steady state on the Peloton) with weight training in between.\n\nSignificant history of heart issues on my dad's side. Father with heart disease in his 50s, uncles i believe also had high cholesterol / procedures in their 50s and 60s\n\nDon't smoke, drink usually 1-2x per week, pretty active lifestyle. Sleep approx. 7 hours/night\n\nI have minimized red meat pretty significantly (maybe 1x per month, if that) the last few years, but paid little attention to saturated fats. Just started tracking my food in Cronometer a few weeks ago, trying to limit my saturated fats, increase fiber, etc. Very early on in my \"dieting\" process. Debating going full veggie - i havent had meat the last several weeks.\n\n  \nBelow are my last three lipid panels, and the most recent, which include elevated ApoB and high Lp(a).\n\n  \nConcerned with my numbers, obviously. Find it odd my LDL improved but my triglycerides spiked vs. last year. Lp(a) is a huge bummer and really upset about it. It comes down to hammering my ApoB and LDLs to a level to mitigate the risk of Lp(a). My primary care is suggesting statins given the elevated lp(a) and LDLs.  I am very open to this, but also want to see how my diet (given i'm only a few weeks in) could impact this. Should i wait a few weeks to re-test, see how well cutting saturated fats has worked on my LDLs and ApoB before starting statins? I'd like to see how much I can move without help from the meds.  Or should i start statins ASAP?\n\n  \nShould i also see a cardiologist? Scared to know how helpless my case is here?\n\nhttps://preview.redd.it/al5qk5xu122d1.png?width=586&amp;format=png&amp;auto=webp&amp;s=43553bf02b34d4805715d8bef9dc96c46774b890"
          ],
          [
           "ldl_cholesterol_apob",
           "LDN's Impact on Chronic Inflammatory Diseases."
          ],
          [
           "ldl_cholesterol_apob",
           "Heart Health/ EKG Results. Recently got an EKG and the notes mentioned it was normal. There was a note, however, mentioning ‚Äúearly repolarization‚Äù. How concerned should I be?\n\n29, Male, no family history of cardiac issues. Personal history of drinking.\n\nThanks!"
          ],
          [
           "ldl_cholesterol_apob",
           "UK Blood Testing - Medichecks (results &amp; questions re: chol &amp; test). 41yr / Male \n\nLooking for advice on blood testing in the UK. Medichecks is pretty comprehensive and presents the results in a nice way, using standard rules for reference ranges. \n\nMy cholesterol was high when I checked it 4 years ago by these measures, and has crept up a bit since then. My issue is that it‚Äôs not a fill panel with Apo-B and LDL particle size so I‚Äôm looking at where to get that from now and how *bad* my current situation is.\n\nAlso, while I‚Äôm here Testosterone is too high? For my age I‚Äôd expect that to be going down but not looked in to it being too high. I take no exogenous TRT or anything. B12 is high but that‚Äôll be supps and red meat.\n\nQuestion does anyone know a good place for a more complete lipid profile in the UK and what would I be looking for?\n\nThe health care system works rather differently here, so wondering whether to take this private test result to my NHS Doctor (GP) or, likely, pay for further tests myself. I have private healthcare which is I guess rarer in the UK but then I don‚Äôt want them to keep putting my premiums up.\n\nThank in advance for any tips!"
          ],
          [
           "ldl_cholesterol_apob",
           "Apob 50% reduction?. I stumbled across this study where dawn to dusk dry fasting seems to have cut Apob in half (and the benefits remain a week after each fast).\n\nI'm using AI to help me interpret the study results. If anyone is able to verify that AI is correct regarding the 50% reduction please share. \n\nOriginal study;\n https://www.sciencedirect.com/science/article/pii/S2589936822000524\n\n\nPer AI;\n\nThe study you provided discusses the effects of 4-week dawn-to-dusk dry fasting on the proteome of peripheral blood mononuclear cells (PBMCs). The results show significant changes in the levels of various gene protein products (GPs) after fasting.\n\nRegarding apoB levels, the study found a significant decrease in apoB GP levels at the end of 4-week dawn-to-dusk dry fasting, with a log2 fold change of -1.01 and a P-value of 0.008.\n\nTo estimate the potential decrease in apoB levels for someone with an initial apoB level of 115, we can use the log2 fold change value.\n\nAssuming a similar decrease in apoB levels, we can calculate the estimated decrease as follows:\n\nlog2 fold change = -1.01\nfold change = 2^(-1.01) ‚âà 0.495\n\nThis means that apoB levels decreased by approximately 50.5% after 4-week dawn-to-dusk dry fasting.\n\nInitial apoB level = 115\nEstimated decrease = 115 x 0.505 ‚âà 58.075\nEstimated new apoB level ‚âà 115 - 58.075 ‚âà 56.925\n\nSo, if someone with an initial apoB level of 115 followed the same protocol and experienced a similar decrease in apoB levels, their estimated new apoB level would be approximately 56.9."
          ],
          [
           "ldl_cholesterol_apob",
           "How to read a detailed cholesterol panel?. For most of us, a detailed cholesterol panel will give some good and some bad numbers. Is there a good resource (ideally straight from PA's site or podcast) on how to weigh the various data?"
          ],
          [
           "ldl_cholesterol_apob",
           "Advice Needed - high cholesterol, triglycerides, ldl at 34. 34 f, recent bloodwork shows high cholesterol, triglycerides, and ldl \n\nMy doctor recommended changing my diet and retesting in a year even. High cholesterol and heart disease are common on both sides of my family. \n\nAny recommendations on best lifestyle changes? Should I retest sooner? Consult a specialist? I want to be informed so I can best advocate for myself and make changes asap."
          ],
          [
           "ldl_cholesterol_apob",
           "Does Peter give any absolute numbers for LDL-C that he likes to see?. For example, my LDL-C has come down to 91 mg/dL after starting on a statin. I understand that multiple times in his book and podcast he often aims for ‚Äúphysiological levels‚Äù of that (level) when you were a child.  \n\nI‚Äôve searched, but can‚Äôt seem to find much in his blogs. Does anyone have any references to more concrete numbers?"
          ],
          [
           "ldl_cholesterol_apob",
           "Recent Blood Work - Lowering Homocysteine and Other Things. I recently got some blood work done and:\n\n1. I am going to try a few things to see if I can lower my ApoB a bit more and retest in about three months.\n2. My homocysteine seems a little high at 9.42 umol/L. From what I've gathered, Peter seems to think that under 6 would be optimal.\n3. My A1C seems a little high. I could have big blood cells (as Peter has mentioned he does on a podcast) that naturally make it high, because everything else looks good. I am going to cut out all the white rice I eat (I do a lot of that) and get a Dexcom CGM to double check.\n4. My testosterone seems a bit lower to prior tests I've done and it may be due to lifting weights a bit less than usual during a busy time at work, but I may test free testosterone in the future because that is the one Peter suggests.\n\nDoes anyone have any interventions that successfully lowered homocysteine? I am MTHFR (TT variant) and take 400mg folate and 36mg riboflavin. I unfortunately do not have my homocysteine reading before taking these supplements.\n\n&amp;#x200B;\n\nBloodwork Results:\n\nMale 33 Years Old - No current or historical medical problems - 6 foot 3  about 175lbs \n\nHigh-Sensitivity CRP - 0.23 mg/L\n\nHomocysteine (HCY) - 9.42 umol/L\n\nFerritin - 64.1 ng/mL\n\n25-(OH) Vitamin D - 89.45 ng/mL\n\n% Hemoglobin A1C - 5.5 %\n\nInsulin - 4.64 uIU/mL\n\nTriglycerides:HDL Ratio 0.56\n\n25-(OH) Vitamin D - 89.45 ng/mL\n\nDaytime Cortisol - 7.4 ug/dL\n\nDehydroepiandrosterone Sulfate (DHEA-S) - 161 ug/dL\n\nTestosterone, Total (Males) - 4.43 ng/mL\n\nFolate - 10.4 ng/mL\n\nApolipoprotein A1 (APOA1) - 197 mg/dL\n\nApolipoprotein B (APOB) - 48 mg/dL\n\nHDL Cholesterol - 80 mg/dL\n\nLDL Cholesterol - 42 mg/dL\n\nTriglycerides - 45 mg/dL\n\nTotal Cholesterol - 131 mg/dL\n\n&amp;#x200B;\n\nEdit: forgot to include apoB - now added."
          ],
          [
           "ldl_cholesterol_apob",
           "Question: Lipid Approach for Teens.. Hi, I'm a teenager and these are my lipid numbers: \n\nHDL-C: 62mg/dL; LDL-C: 87 mg/dL; TOTAL CHOL: 160 mg/dL; TG: 53mg/dL\n\nMy parents/doctors will not allow me to take statins this early to lower LDL-C as much as possible (as is advised in the book),  so what should my approach be? I'm involved in sports/lots of exercise and already diligent about what I eat, so I don't know what other factors I could change, or frankly, if I even need to change anything at this age."
          ],
          [
           "ldl_cholesterol_apob",
           "Cholesterol Esters: Underrated Metabolites That Are Associated With Youth And Survival."
          ],
          [
           "ldl_cholesterol_apob",
           "Repatha and High Bilirubin. I started Repatha six weeks ago and had my first blood work done. LDL is down to 87, HDL is the highest I‚Äôve ever seen it at 48, and triglycerides are at 86. This is all great news and from what I‚Äôve seen the LDL should continue to go down. I‚Äôve had zero side effects and the sureclick injector is really convenient. \n\nThe problem is my Bilirubin is high. Now, I don‚Äôt have a baseline for this number but my overall Bilirubin is at 1.2 mg/dl and direct is at .4 mg/dl. I‚Äôd never even heard of Bilirubin until last night and haven‚Äôt talked with my cardiologist yet. I can‚Äôt seem to find much on the topic. Everything sort of says it‚Äôs unlikely to cause it but I‚Äôm assuming my cardiologist knew what she was doing when she ordered that lab. \n\nAny experiences in here with this at all? Anyone have any knowledge as to what is flat out too high to sustain for 40-50 years? I‚Äôm only 37 so running these elevated numbers for such a long time is scary."
          ],
          [
           "ldl_cholesterol_apob",
           "Can't Get Doctor to Prescribe a Statin. 48 years old, male.  Went to the doctor in November and, despite a family history of heart disease (father, grandparents), couldn't convince my GP to prescribe me a low-dose statin.  My total C was 205, triglycerides at 76, HDL at 66, and LDL (calculated) at 121 (non-HDL at 138).  I got my ApoB tested by myself and it was 105.  My doctor said that he would send me to get a CT calcium score, which came back at 6.  Based on that, he said nothing was necessary and that the the risks outweighed the rewards.\n\nI'd like to get a low-dose statin.  Do you think that is unnecessary?  Based on what PA says, and correct me if I'm wrong, he'd put me on a statin.  If a statin is warranted, how do I go about finding a doc to prescribe one.   Seems like I'd have an easier time getting anabolics than a statin!"
          ],
          [
           "ldl_cholesterol_apob",
           "slightly elevated ALT for months. Hello, \n\nwas after some advice please, i have had elevated liver enzyme (ALT) for months. Im 40, quite fit and healthy. 156 pounds 5ft 11inch so not overweight... diet pretty good...  non smoker, rarely drink... \n\nSleep isnt great but other than that i feel ok... the ALT was flagged on an annual work blood test and since then ive had numerous tests to figure it out but nobody has any ideas at the moment. \n\nI exercise 4 times a week, combination of weights and cardio... \n\nHan an MRI which was clear (i do have Liver haemangiomas) but they havent grown since discovery and are only small so ive been told they are not the problem.  \n\nFibro scan results were: \n\nLIVER STIFFNESS : 4.8  kPa\r  \n IQR : 0.5\r  \n\rIQR BY MEDIAN RATIO : 10 %\r  \n\rCAP SCORE : 175\r  \n\rEQUIVALENT FIBROSIS SCORE (METAVIR) : F0-F1\r  \n\n\nBloods... \n\n  \nDate\t      ALT\tALP\tglobulin\talbumin\ttotal protein\tBilirubin\t         GGT\r  \n07/08/2023\t32\t60\t28\t               44\t       72\t          16\t\r  \n11/01/2024\t65\t65\t24\t               49\t       73\t          12\t                  16\r  \n14/02/2024\t64\t64\t29\t               45\t       74\t          15\t\r  \n11/03/2024\t40\t61\t29\t                44\t       73\t          10\t\r  \n09/04/2024\t54\t73\t28\t                44\t       72\t          11\t\r  \n\n\nive taken a week off the gym and re-tested and they still come back slightly elevated... \n\n anyone experience this?  occasionally take vitamin d3 with k2 and magnesium but since my elevated tests ive scaled back on those..."
          ],
          [
           "ldl_cholesterol_apob",
           "What level of ApoB reverses plaque in your arteries?."
          ],
          [
           "ldl_cholesterol_apob",
           "Improvement analysis. Hi all, I read Outlive about 8 months ago and immediately added cardio to my exercise routine. I do about 3-4 times cardio per week, (3 45-min zone 2 and then 1 4x4. We had a baby 7 months ago, so this is the most I can manage for now, I know a little more would be better to move the needle).\n\nMy LDL went from 115 (before cardio) to 110 (1 year later after starting consistent cardio for 8 months). Is this a significant improvement? I was hoping to see it lower. I also started taking psyllium husk supplement every day. My total cholesterol (172)  and HDL (43) remained about the same. \n\nMy APOB is 84 and Lp(a) is 20.3. \n\nI‚Äôll try to increase the cardio per week when I can."
          ],
          [
           "ldl_cholesterol_apob",
           "Any GAD65 Antibody Gurus in here?. Hoping to connect with someone familiar with the GAD65 Antibody marker. Type 1 diabetic which the test is often used for in diagnosing. So having a positive result isn‚Äôt the weird part. \n\nIt‚Äôs the highly elevated nature of my result. And the connection to stuff person syndrome. Which I have many of the symptoms of."
          ],
          [
           "ldl_cholesterol_apob",
           "57 yr old male. Where to begin?. I read the book and I listen to hours of podcasts but I‚Äôm overwhelmed. Scared too.\n57 yr old male. 6‚Äô1‚Äù 220 pounds. \nCalcium score in the 800s. \nOn rosuvastatin and zetia and a blood pressure med. \nSurprisingly I ‚Äòlook‚Äô quite healthy but I know I‚Äôm a ticking time bomb. \nWhere is the fitness plan for someone like me? Is there a website : trainer you‚Äôd recommend. \nI‚Äôm getting much better with nutrition (mainly Mediterranean diet with lots of egg whites.) \nOr is it too late? \nPS: my older brother ‚Äî one year older ‚Äî dropped dead from a heart attack when I was 52."
          ],
          [
           "ldl_cholesterol_apob",
           "Health Journey, results and tests. I was struggling for a while with anxiety about my health but decided to take charge. I‚Äôm 23 male, got hypothyroidism and I‚Äôm 290lbs (6ft 1) I‚Äôve lost 20lbs recently I know I‚Äôm obese but getting there. Had a lot of testing including a CTCA which was perfect with CADRADS: 0\n\nBlood work.\n\nCholesterol \nLDL: 2.1\nHDL: 1\nTrigs: 1.1\nLp(a): was 170nmol, now 100nmol.\nTotal: 3.4\n\nBlood sugar\nFasting: 82\nA1c: 5.1\n\nVitamins and inflammation\nVit D: 28 (on supplements)\nFolate: 2 (on supplement)\nB12: 180 (on supplement)\nFerritin: 45 (need supplement)\nHsCrp: 3 (I don‚Äôt know what to do to lower this, feel it‚Äôs related to thyroid and psoriasis)\n\nI‚Äôm on a Mediterranean diet now to lose weight as I want for do it naturally and trying to figure out the best way to lose fat and build the muscle still. I want to be in perfect shape next year. \n\nBF%: 32\nMuscle%: 64\n\nAny advise to lose this weight or supplements to take to help me?"
          ],
          [
           "ldl_cholesterol_apob",
           "Managing high Lp(a) with Repatha, blood results with Repatha and combination therapies. TL;DR 42 year old male / high Lp(a) / CAC 73.  I have been able to significantly lower my ApoB and my Lp(a). See table for results. \n\nhttps://preview.redd.it/hjy9we7wklad1.png?width=2490&amp;format=png&amp;auto=webp&amp;s=139c884863ac2c0d7cf45376aefe472cf7e61615\n\n  \n  \nLast year I found out that I had a high Lp(a) and the \"arteries of a 60-year old\" via a Carotid ultrasound. Based on that I got a calcium scan which showed that I have a calcium score of 73. That puts me in the 99th percentile for me age, not good. :( Peter Attia says any score above 0 when you are below 50 is a ‚Äúfour alarm‚Äù on hands on deck situation. This news was quite alarming to me and came as a shock given how [other aspects](https://www.reddit.com/r/PeterAttia/comments/1bxk4jv/improved_my_almi_over_two_years_zscore_051_056_by/) of my health were going well and I was sad to learn that I drew the short genetic stick here.   \n  \nAfter going through a grief cycle of sorts I went into action and got on Ezetimibe + Rosuvastatin. They addressed my ApoB well (91 -&gt; 50, 45% reduction!) but, as expected, didn't really nudge the Lp(a). Since no direct Lp(a) therapeutics are available I decided to try a PCSK9 inhibitor, Repatha, since it was reported that it lowered Lp(a). It worked like a charm and lowered it by \\~50%! (101 -&gt; 52). I was curious what each therapy was doing to achieve this effect so I ran a few tests which are seen in the table. Unfortunately I did not get my sterols tested before any meds. You can clearly see the impact Rosuvastatin has on them though given the last two readouts. Based on these results I'll either keep with Repatha + Rosuvastatin or all three (I have not yet discussed with my doctor).\n\nhttps://preview.redd.it/6zye4zp5llad1.png?width=2564&amp;format=png&amp;auto=webp&amp;s=6cb6334119a717dc9919ca261f9dbcfd436bc28d\n\n  \n  \nWRT Repatha and cost... Unfortunately my insurance refused to pay for Repatha because my LDL-C numbers are not high enough to be classified as Familial hypercholesterolemia. My doctor argued in vain that I clearly had the phenotype of importance here (CAC score) but the insurance company didn't budge. I'm going to try again and highlight the lowering of Lp(a) with Repatha (which I paid for out-of-pocket using my HSA card) but I am not hopeful since the insurance companies are simply not incentivized to address longer term risks like this."
          ],
          [
           "ldl_cholesterol_apob",
           "Conflicting lipid panel results...help appreciated!. Hi! Long time listener, first time caller. Hoping for some input from this community of smart folks.\n\n40 yo, male. I've historically had not-spectacular lipids...low HDL and higher-than-I'd-like LDL. Over the past few years, I've adopted a lot more physical fitness and healthier eating, driving LDL down from 120s to 80s/90s (mg/dL).\n\nI recently did two more detailed lipid panels (including LP(a) + ApoB) out of curiosity: one through ownyourlabs/LabCorp and one through Thorne/Quest, within a couple weeks of each other. I'm struggling to interpret the results, as some parts seem positive, some less-so, and some seemingly conflicting with each other.\n\n**Here's the basic lipid results:**\n\n||LabCorp|Quest|\n|:-|:-|:-|\n|Chol (mg/dL)|145|159|\n|Trigs (md/dL)|109|76|\n|HDL (mg/dL)|47|51|\n|LDL-C (mg/dl)|78|91|\n|Chol/HDL Ratio|3.1|3.1|\n\nSeems reasonable...any thoughts? Fasted for both, but had some elevated trigs on the first one there.\n\n**Lp(a) + ApoB results:**\n\n||LabCorp|Quest|\n|:-|:-|:-|\n|Lp(a) (nmol/L)|85.9|106|\n|ApoB (mg/dL)|Did not test|77|\n\nMy understanding, according to Attia, is that Lp(a) is primarily genetic and we don't yet have any drugs to control it, so to focus more on the things we do control (ApoB, LDL). However, it does appear to be on the higher side? Also, a surprisingly amount of Lp(a) variation between the two tests...I'm not sure if that is expected or not.\n\nOn ApoB, this seems surprisingly low/positive? I thought that LDL was a subset of ApoB, so I'm not sure how my ApoB is lower than my LDL?\n\n**More detailed lipid panels:**\n\nLabCorp has the NMR LipoProfile test and Quest has a Lipoprotein Fractionation Ion Mobility test. \n\nOn LabCorp NMR, the numbers roughly match up with the basic lipid panel, but not exactly. It gives me a LDL-P of 1055 nmol/L, which is in the Moderate (20-50th percentile) range, while an LDL-C of 80 mg/dL which is in the Optimal range. There are a bunch of additional results, which are on the moderately positive side of the percentile spectrum (see attached screenshot below)\n\n[LabCorp NMR LipoProfile](https://preview.redd.it/knrozoqmq33c1.png?width=1289&amp;format=png&amp;auto=webp&amp;s=4ef03a9a4c876306aaa285b89b220fa61bf9c505)\n\nOn the other hand, the Quest Lipoprotein Fractionation Ion Mobility has surprisingly high/negative results, which seems to conflict with the other lab results:\n\n[Quest results](https://preview.redd.it/7zkg3p38r33c1.png?width=1264&amp;format=png&amp;auto=webp&amp;s=a1f17ada2a53a802b6aac3d96c561765d1af2054)\n\nThis is a vastly increased LDL-P compared to the LabCorp result (1820 vs 1055). Also, I'm not sure how to benchmark the LDL small and medium results against the LabCorp results, but those also seem very high.\n\nAny thoughts here? I thought I was in decent shape lipid-wise, but these Quest results are surprising/concerning to me. Thanks for your help!"
          ],
          [
           "ldl_cholesterol_apob",
           "Attia article or pod succinctly making the case for statins/reducing cholesterol?. I‚Äôve read Outlive and I‚Äôve listened to numerous podcasts with Attia and others, both in the ‚Äúpro-statin/minimize LDL camp‚Äù and the ‚Äúanti-statin/LDL isn‚Äôt a significant risk factor camp.‚Äù While I‚Äôm generally skeptical of medicine and inclined against pharmaceutical interventions,  I‚Äôm firmly convinced lowering LDL is importance and would like to start a low-dose statin. My doctor, though, is very anti-statin. He sends me all these studies showing statins provide minimal benefits and aren‚Äôt worth the risks for anyone except super high risk cohorts. I know the general talking points against those studies, but I‚Äôm wondering if there‚Äôs an article or pod where Attia explains his position really succinctly as to why he‚Äôs in the pro-statin camp."
          ],
          [
           "ldl_cholesterol_apob",
           "Got my Lipid Profile done, what now?. 40M, not overweight, moderately active. Got my lipid profile done with below numbers. My GP hasn‚Äôt followed up with me yet. Is this high Lp(a) not a concern? What other tests should I ask him to recommend to get more in depth analysis on where do I stand with my cardiovascular health. \n\nAll measurements in mmol/L\n\nCholesterol: 3.77 \nLDL Cholesterol: 2.25\nHDL Cholesterol: 1.23\nChol/HDL Risk Ratio: 3.07\nNon HDL Cholesterol: 2.54\nTriglycerides: 0.63\nLipoprotein(a): 137"
          ],
          [
           "ldl_cholesterol_apob",
           "PA's Blood Pressure Targets / Optimal Ranges. Does anyone PA's recommended blood pressure targets? I thought I remember hearing him throw some numbers around either on JRE or one of his podcasts but I failed to write it down. thanks!"
          ],
          [
           "ldl_cholesterol_apob",
           "Experience with mildly elevated ALT?. As you all may know, Peter has recommended over and over again that ALT does not exceed 25. I‚Äôm a 45-year-old male and for the past year, my numbers have floated between 35 and 46. If I hadn‚Äôt been a long time listener of Peter, I wouldn‚Äôt have thought anything of this, and my GP doesn‚Äôt seem to be worried at all either, as it is (just) within current recommended values. However, some other figures in the longevity space have made the same comments (above 25 indicates an issue‚Ä¶) and it‚Äôs bugging the hell out of me! \n\nI‚Äôve had 7-8 separate tests done in the last year and they are always on that range, but otherwise my numbers are stellar across the board‚Ä¶cholesterol, inflammation, bmi, etc. I am what I would consider very fit, active and healthy for my age with quite a good diet. Other markers that correlate with Metabolic disorders are great (trigs 45, fasting insulin 2, hba1c 5.1) and I don‚Äôt take any unusual supplements. I‚Äôm at a loss to sort it out, and I  am just wondering if maybe it‚Äôs not a big deal after all? I know Peter is VERY aggressive with many of his markers."
          ],
          [
           "ldl_cholesterol_apob",
           "Is it worthwhile to supplement Vitamin K2 with statins? What about ubiquinol?. Statins inhibit the effects of Vitamin K2, which include reducing vascular calcification to an extent. This could be part of how statins cause calcification of plaques. Would it be logical to supplement Vitamin K2 then? \n\nHowever I read this article saying Vitamin K2 MK4 had no effect. \nhttps://www.nature.com/articles/s41598-021-82724-0?utm_source=other&amp;utm_medium=other&amp;utm_content=null&amp;utm_campaign=JRCN_1_LW01_CN_SCIREP_article_paid_XMOL\n\nI wanted to avoid this calcification issue but I read a paper that said PCSK9 inhibitors also cause calcification even without statins. So I figured calcification is just part of the LDL lowering process to an extent. Hoping for any advice. \n\nAlso what are the benefits of supplementing CoQ10/ubiquinol in general?"
          ],
          [
           "ldl_cholesterol_apob",
           "Should I consider Statin. I'm in my early 50s. My LDL is 117. My overall cholesterol is 186. HDL is 57. Triglycerideides are 62. Lipoprotein (a) is 14. Apolipoprotein B is 88. \n\nMy mother had a heart attack in her 50s. However, her Lipoprotein (a) is very high. \n\nMy doctor doesn't think I'm a candidate and doesn't recommend a CAC scan. Thanks! \n\n&amp;#x200B;\n\n&amp;#x200B;"
          ],
          [
           "ldl_cholesterol_apob",
           "Goofy eGFR numbers‚Ä¶is it 49 or 58??. A few months back I had lab tests done via my PCP , and my estimated Glomular Filtration Rate (eGFR) was 49, based on Creatinine at 1.5¬† They used the Creatinine equation, which can be found here.\n\n[https://www.kidney.org/professionals/gfr\\_calculator](https://www.kidney.org/professionals/gfr_calculator)\n\nPlugging in the Creatinine number, the National Kidney Foundation calculation aligns.\n\nhttps://preview.redd.it/t7kpy1davzpd1.png?width=604&amp;format=png&amp;auto=webp&amp;s=c3e3fc4419dcc6e3e594f4130bbf250112876f69\n\n  \nJust a few weeks ago, did as set of labs from Function Health (Function was great, by the way, pretty prompt and good clinician notes) and eGFR was 58, with Creatinine at 1.3.¬† Plugging in that number we get 58.\n\nhttps://preview.redd.it/rpgrk8zcvzpd1.png?width=545&amp;format=png&amp;auto=webp&amp;s=cb5e5e03964c7cf416c8633253a5ad51cfb3d5dc\n\n\n\nNot great but better, and after all I am 72yo.¬† But has my kidney function improved by approximately 20% over the past month?¬† That‚Äôs absurd, obviously.\n\nAnyway, I have always been suspicious about the Creatinine equation, and this confirms my suspicion. Peter has said that Cystatin C as an individual marker is better to assess kidney function, so I will get a test for that in the near future."
          ],
          [
           "ldl_cholesterol_apob",
           "HELP!! Not sure what to think of my blood work, need recommendations!. 28y/o, male, 5'6\" 157lbs, bf 15%.\n\nSo I recently got my blood work done, my doctor is insisting my cholesterol, HDL, LDL and ratios are too high. I disagree, as I'm on an animal based diet (Paul Saladino) eating no processed food and no trans fats. I workout 3-4 times a week and have a resting heart rate of 45-55bpm. Fasted glucose is ideal. All other bio-markers are healthy.\nWhat I would like help with is identifying if I am right in my belief that I am in good cholesterol range and healthy. I want help understanding my cholesterol panel. Please see picture of blood work panel.\n\nTL/DR: help me dissect my blood work! Especially cholesterol!"
          ],
          [
           "ldl_cholesterol_apob",
           "What Blood Tests for Heart health?. What other blood tests would you add/remove for your own heart health check up? \n\nMale: 35 years old\n\nCholesterol/Trig/HDL/LDL\n\nCRP (C-Reactive protein)\n\nLipoprotein a (LPa)\n\nApolipoprotein A1 / B"
          ],
          [
           "ldl_cholesterol_apob",
           "If I have a 0 CAC score, will statins increase it?. I've seen conflicting evidence on this.  Some doctors like Attia, have stopped plaque progression in it's tracks; he had a positive scores at age 36 and halted it with statins(but now mainly others, psk9i, bempedoic acid) other doctors I've seen too also halted their own progression of calcification.\n\nSo, if I'm a healthy 33 year old with a 0 CAC score but FH, High ApoB and start statins, what is the evidence out there that suggests that statins might increase it?"
          ],
          [
           "ldl_cholesterol_apob",
           "Comments on lipid panel?. I‚Äôm female, mid 60s and last years blood test (Cleveland heart lab) was: \nHDL 86\nTRI 62\nLDL 101\nApob (apoliprotein) 82\nFasting glucose 91\nHbA1c 5.6\nEst avg glucose 114\nCalcium score (ultrasound) 0\nMPO 184\nNo meds, BMI 21, weight training x3/wk, 10 hrs hiking/wk, 1 hr swimming/wk\nDo I need a statin ? Do I work on getting apoB lower per Attia‚Äôs recommendation? Do I work on getting HbA1c lower?  Should I care what LPa is?"
          ],
          [
           "ldl_cholesterol_apob",
           "Dilated aortic root and kettlebell training. I'm 42 y/o male, 29% body fat and 69% lean mass as of three months ago, and that likely shifted in healthier direction as I've been losing fat and gaining muscle, at modest rate, the past few months.\n\nHad a CAC test recently, which scored 31, and yes I'm terrified, that's a separate issue. ApoB and LP(a) tests coming, in a few weeks. My overall cholesterol is high, as of my last lipid panel a year ago.\n\nCAC also revealed aortic root dilated to 47mm, my cardiologist is concerned, has ordered a CT angiogram for more info but I'll have to wait at least a month, possibly two to get in for that.\n\nWhat I'm asking here I'm also asking of my cardio, and I will treat whatever is shared here as perspective, not as formal medical advice.\n\nBecause of this alarming data about my heart at my age, and my broader buy-in on most of what Peter advises for principles of healthspan, I'm currently very motivated to reduce body fat and increase lean mass. For the latter, I do mostly kettlebell routines, push-ups and pull ups. (Yes I do a lot of Z2 cardio too). With KBs I do snatches, clean and press, swings, squats, mostly with a 53lb bell. I will do two exercises for two minutes total, every hour or two throughout each work day. That's the extent of my resistance training.\n\nI'm now very concerned about exertion with KBs, or anything really, given this aortic root dilatation.\n\nDoes anyone have formal knowledge of exercise guidelines in my case? I think we all know how important muscle mass is so I'm trying to find right balance here."
          ],
          [
           "ldl_cholesterol_apob",
           "Apo B test - what‚Äôs a normal range? Lab says 53-180 normal. I have super high LDL 240 ;/ but normal HDL and Triglycerides. Went to do an apo B test and result was 163!  But lab results said 53-180 is their reference normal range coz it depends on their instrument. Anyone who knows about this pls do clarify?!  Appreciate it."
          ],
          [
           "ldl_cholesterol_apob",
           "Exercise's impact on lipids. I am under the impression exercise, although extremely worthwhile, does not do a hell of a lot for your lipid panel. \n\nAm I right in the assumption or not?"
          ],
          [
           "ldl_cholesterol_apob",
           "Need help interpreting cholesterol results. Took a fasting lipid test\n\nTotal cholesterol 162\nLDL 103\nHDL 35\nTRIG 147\n\nWhich numbers here look like they need work? \nFYI I‚Äôm a male in my late 20‚Äôs."
          ],
          [
           "ldl_cholesterol_apob",
           "Radiation from CT Angiogram. 33 years old (M).  Have been feeling slight discomfort in left side of chest on and off over past few weeks.  72 y/o father recently underwent quadruple bypass surgery (successful!), so felt like I should be proactive about it.  Saw a cardiologist who ordered me a CT Angiogram.  Upon further research, it appears CT Angiograms have among the highest radiation levels among radiology scans.  I am a regular exerciser (4-5x/week), eat very well and have no prior medical history.  I am wondering if the radiation exposure is not worth it given the low likelihood the scan finds anything wrong from a cardiac perspective (the cardiologist himself said he is 90% sure this is not cardiac related and more likely muscular or GI given age/health profile).  Thoughts on if the radiation exposure is worth it?"
          ],
          [
           "ldl_cholesterol_apob",
           "Anyone know Peter Attia personal cholesterol numbers?. Given that he takes a PCSK9 inhibitor and a statin, does anyone know what his numbers are? \n\nApoB, Lp(a), LDL etc"
          ],
          [
           "ldl_cholesterol_apob",
           "High CAC Score and Lpa, How do I get a cardiologist to help?. In the last 4 years, I've received concerning test results: a CAC score of 350 and Lp(a) of 330 nmol/L (self-initiated test). I'm 50 years old.\n\n\nMy cardiologist didn't seem worried about the CAC score but prescribed a statin for high cholesterol. With the statin, I've managed to lower my LDL to 85 mg/dL. However, the doctor only wants to see me annually and wait for any incidents.\n\n\nTaking matters into my own hands, I've incorporated supplements like MK-7, Vitamin D, Magnesium, and plant stanols (Benecol, which reduced my LDL by 20 points). These efforts have further lowered my LDL to 65 mg/dL.\n\n\nDespite this progress, I'm frustrated that my doctors seem reluctant to take additional action. I'd like to lower my LDL even more to potentially achieve some regression in my calcium score. Additionally, I've found that ezetimibe would be more cost-effective than Benecol chews.\n\n\nQuestions:\nHow can I obtain an ezetimibe prescription?\nAm I wasting my time pursuing further LDL reduction?\nAny advice on convincing my doctors to be more proactive?\nI apologize for venting, but I'm eager to take more aggressive steps in managing my cardiovascular health and save money with the ezetimibe. Any insights or experiences would be greatly appreciated."
          ],
          [
           "ldl_cholesterol_apob",
           "Decreased LDL by 42 % and ApoB by 25% in 5 weeks w/o statins. Me: 33F, active, first time testing lipids and such on Sep 5. \n\nStarting numbers on Sept 5:\n\n* LDL: 123 mg/dl\n* ApoB: 82 mg/dL \n* HDL: 61 mg/dL \n\nNew numbers on Oct 11:\n\n* LDL: 72 mg/dl\n* ApoB: 61 mg/dL \n* HDL: 70 mg/dL \n\nHBA1C also went from 5.4% to 5.3% - hope to get that down after 2 more months of my new diet. \n\nMy starting diet didn't seem bad (all whole foods, little processed junk) that seemed to support my fitness goals, but I think for me, it all came down to a high amount of saturated fats - I was eating a lot of high-fat meats like pork neck, chicken thighs, eggs, and high fat dairy products like milk and cottage cheese. \n\nMy new diet is pretty strict mediterranean diet on weekdays and keeps to less than 10g saturated fat and looks like this:\n\nLunch: 1/4 cup oats, 1 tbsp flax, chia, hemp, 1/2 ounce walnuts, 1 scoop whey protein, 1/2 cup blueberries \n\nDinner: \n\n* Monday &amp; Tuesday: Salmon, sweet potato, veggies\n* Wednesday &amp; Thursday: lentil pasta with tofu, veggies\n* Friday: chicken breast, buckwheat, veggies, avocado\n* Saturday: Cheat meals\n* Sunday: chicken breast, buckwheat, veggies, avocado\n\nSnacks:\n\n* Rice cakes\n* hummus &amp; carrots\n* protein bar \n\nDessert: \n\n* 1 cup fat free greek yogurt + casein protein powder + banana + almond slivers \n\nIt's pretty plain but I'm motivated to see my baseline in 2 months with much lower saturated fats and then re-introduce a bit more of specific foods that I miss one-by-one starting with chicken thighs. \n\nI was considering getting the APOE testing done to know more about foods that increase my cholesterol, but honestly, given my personality, I don't know if it's worth it for me with the possibility of finding out i'm high risk alzheimers."
          ],
          [
           "ldl_cholesterol_apob",
           "Methods for eliminating soft coronary plaque before starting statins?. [According to Attia](https://peterattiamd.com/coronary-artery-calcium-scan/) in a 2019 newsletter, \"statins are known to increase the calcification of atherosclerotic plaque. Researchers have hypothesized that statins can promote or increase calcification through various actions.\"\n\nI'm wondering if there are some therapies one can leverage to eliminate or minimize existing soft plaque before beginning statins? Assuming that part of this increase in calcification results from the calcification of preexisting soft plaque.\n\nIdeas I've read for decreasing soft-plaque is prolonged fasting, as well as possibly berberine supplementation. Anyone have evidence supporting these, or have ideas for any other intervention?\n\n(my interest is in the context of a 64f family member with a coronary calcium score of 147 that is to begin statins, though I assume this idea could be applied to anyone getting on statins)"
          ],
          [
           "ldl_cholesterol_apob",
           "Cholesterol is 198 MG/DL, is this dangerous? HDL is decreasing. I‚Äôm a 35 year old female and I‚Äôve always had borderline high cholesterol (always meaning I first was tested in 2018 and I believe it was 200 MG/DL).\n\nIn 2024 my HDL is 78 and LDL is 99.6.\nIn 2023 my HDL was 83 and LDL was 83\nIn 2018 my HDL was 94 and LDL was 91\n\nIt appears my HDL is decreasing but I‚Äôm maintaining a pretty high overall cholesterol. My LDL is getting into a territory I‚Äôm not too comfortable with. But I‚Äôm wondering if having a consistently high HDL is also something to watch. \n\nI don‚Äôt really understand cholesterol and my doctors seem to be unphased, but I can‚Äôt help but wonder if I should be doing something to address this."
          ],
          [
           "ldl_cholesterol_apob",
           "Nervous - Advice Needed (lp(a)). Hi all,\n\nI just got a blood test and a bit concerned. Please find my results below. For background, in my late 20s and considered myself a fairly healthy person diet/exercise wise. Any advice would be greatly appreciated, especially considering my lp(a) levels. \n\nTotal Cholesterol: 185\nHDL: 61\nLDL: 100\nCholesterol/HDL Ratio: 3.0\nNon-HDL Cholesterol: 124\nLp(a): 145\nApoB: 81\nCalcium Score: 0"
          ],
          [
           "ldl_cholesterol_apob",
           "The LDL cumulative exposure hypothesis: evidence and practical applications. Paper from Nature.\n\nStudies incidence of atherosclerotic events based on cumulative years of LDL normalized to 3 mmol/l. If you have 70 mg/dl LDL and no comorbidities (hypertension, T2D, smoking) then lifetime risk of cardiac event is 10% @ 80. Higher LDL exposure increases risk. the comorbidities each essentially double risk. \n\nMy inferences: Ending states of hypertension, T2D &amp; smoking equivalent to cutting LDL in half. Cutting LDL in half equivalent to quitting smoking. Reducing LDL to v low levels like 25 mg/dl provide seemingly high relative risk reduction but not high absolute risk reduction vs keeping LDL @ 70 mg/dl. Paper doesn't look for any unintended consequences of low LDL, only atherosclerotic events.\n\n[Nature Paper](https://www.nature.com/articles/s41569-024-01039-5#:~:text=Cumulative%20exposure%20to%20LDL%20reflects,of%20having%20a%20major%20adverse)\n\nKey images:\n\nhttps://preview.redd.it/zh8nwimjfvdd1.png?width=685&amp;format=png&amp;auto=webp&amp;s=ec59995e130ab61ac11b1174cb8c379d6988fa64\n\nhttps://preview.redd.it/kpc85xnyfvdd1.png?width=1200&amp;format=png&amp;auto=webp&amp;s=fb51b0c553e0b17a2adcd45846816f392c3dce39"
          ],
          [
           "ldl_cholesterol_apob",
           "Preventing and Treating Cardiovascular Disease | Dr Thomas Dayspring | Lipid Series Part 3."
          ],
          [
           "ldl_cholesterol_apob",
           "Decreasing LDL-C?. 36m. My doctor was reticent to even order a lipid panel and wouldn't get me one with APO-B so I guess I will have to pay for one out of pocket later on but he got me a standard lipid panel:\n\nTotal Cholesterol 148 mg/dL\nTriglycerides 131 mg/dL\nHDL-C 52 mg/dL\nVLDL-C 23 mg/dL\nLDL-C 73 mg/dL\n\nThe LDL-C seems very high compared to Attia's recommendation of 10-20 mg/dL. Are statins really the only good option for lowering this?\n\nI exercise 6 days/week, however I eat around 30 grams of saturated fat/day according to my nutrition tracking."
          ],
          [
           "ldl_cholesterol_apob",
           "Should I take PCSK9 inhibitors (Repatha) or try different statin?."
          ],
          [
           "ldl_cholesterol_apob",
           "Higher cholesterol problems. Hi,\n\nI am just looking for some advice regarding my health after the last check-up from my GP. \n\nMy results in 2022:\n* Cholesterol 4.5 mmol/l (ref. range 2.9 - 5) == 81 mg/dl  \n* Trigs 0.54 mmol/l (ref. range 0.45 - 1.7) == 10 mg/dl \n* LDL 2.88 mmol/l (ref. range 1.2 - 3) == 52 mg/dl \n* HDL 1.51 mmol/l (ref. range 1 - 2.1) == 27 mg/dl \n\nIn 2024:\n* Cholesterol 5.67 mmol/l == 102 mg/dl \n* Trigs 0.98 mmol/l == 17 mg/dl\n* LDL 3.9 mmol/l == 70 mg/dl\n* HDL 1.39 mmol/l == 25 mg/dl\n\nSo I went over the reference values in the last two years for cholesterol/LDL. There is also some slight vitamin D deficiency and my blood pressure was slightly over ~140/90 both medical visits, but I have 120-135/70-80 at home measurements, so still a bit elevated and something I should be careful about. \n\nI am 28m 183cm/80kg with slim build my entire life (too slim until I started weight lifting). My father and grandma also have high cholesterol since young age, but both had/have way worse lifestyle and diet then me, with my father being a lifelong smoker and overeater (was also always slim though).\n\nThese results surprise me I guess and I am wondering if it is just genetics playing a role, because 2 years ago I was coming out of covid where I had not exercised much and was finishing University, so fairly stressful part of my life. In the last two years I've been weightlifting 1-3x/week and in the last year also running 30-60km/week + football and floorball training once a week. Diet-wise I would say I eat slightly better then people around me, trying to add vegs/fruits for dinner and having an oatmeal in the morning, eating some kind of meat every day for lunch though. Since high school I also struggle with ED/low libido and inconsistent morning boners and I am wondering if everything is connected to my cardiovascular system? The higher BP and now cholesterol problems on top of that.\n\nDoes this warrant a visit to cardiologist/urologist? I've been kind of putting it off as life was busy and the values are just slightly higher and I am kind of used to the ED/low libido over the years. My GP told me to come in 3 months to measure cholesterol again, he will also put me on 24h BP monitor next week so we have a better picture what is it like during the day/night.\n\nI apologize if posts like this are not allowed here."
          ],
          [
           "ldl_cholesterol_apob",
           "Is a statin a good investment for future health?."
          ],
          [
           "ldl_cholesterol_apob",
           "How Can I Improve My Lipid Panel?. Check out these scores.... they're pretty good I think, right?\n\nIs there any where I can improve to meet Attia's standards? I feel proud of these lol, but still want to see if I could better. I know Attia can have some high standards but I don't know what they are.\n\nAlso, I'm a 33M\n\nhttps://preview.redd.it/hfsuezcr2zpd1.png?width=2428&amp;format=png&amp;auto=webp&amp;s=b69984d14298b04a7aebc76e1f00874aa1cda5be\n\nhttps://preview.redd.it/fyhhy6ds2zpd1.png?width=2434&amp;format=png&amp;auto=webp&amp;s=760bee63d257b38c11e3eba0c35e8ce25a6f0caf\n\nhttps://preview.redd.it/dpscbvzs2zpd1.png?width=2434&amp;format=png&amp;auto=webp&amp;s=a15836b2cdbc2c543e64aa27d27adf296eb50eb7"
          ],
          [
           "ldl_cholesterol_apob",
           "Question - ApoB vs LDL Particles. In episode #229, Peter discusses ApoB being the most important metric because it amounts for all atherogenic particles.\n\nHe also mentions there is no question that measuring LDL particles is a better assessment than measuring LDL-C. \n\nMy cardiologist is measuring my LDL particles. Should I still be measuring ApoB? Or is measuring LDL particles enough?\n\nMy intention is purely preventative measures - I have no heart issues."
          ],
          [
           "ldl_cholesterol_apob",
           "Why does Attia not take a statin but other cholesterol lowering drugs?. If memory serves I recall a recent podcast where Dr. Attia indicates that he takes a PCSK9 Inhibitor and Ezetimibe but not a statin.   why is that??"
          ],
          [
           "ldl_cholesterol_apob",
           "A class of cyclodextrin (CD) dimers has emerged as a potential new treatment for atherosclerosis."
          ],
          [
           "ldl_cholesterol_apob",
           "Cholesterol. First time poster: female, early 40s, 5‚Äô7 and 116 lbs. No health issues. My cholesterol - both LDL and HDL are steadily increasing (most recent: HDL of 95; LDL of 95; LPa of 9.7; APOB of 69). My GP said I am ‚Äúfine‚Äù. I then saw a cardiologist this morning whose first question was ‚Ä¶ ‚Äúdo you eat a lot of cheese?‚Äù (Oh how I wish Peter was there!) I do not have the gene for familial hypercholestemia. Question: should I push to start a statin? I know P.A. argues there is no good/bad cholesterol and without an explanation for the continued rise‚Ä¶?"
          ],
          [
           "ldl_cholesterol_apob",
           "High Lp (a) but lower ApoB. I recently got my lipids tested and came out with the following \n\nApoB 72 mg/dl\nLp (a) 70 mg/dl !!! \nTotal cholesterol 190\nHDL 97\nLDL 87 \nVLDL 6\nTriglycerides 31 \n\nI‚Äôm having a hard time getting in touch with my doctor about these results. Hence why I‚Äôm asking here. I know this is high for Lp (a) but not sure what I can do about it. Should I try to lower ApoB further with meds / diet exercise? I‚Äôm 45."
          ],
          [
           "ldl_cholesterol_apob",
           "Help Interpreting Recent Blood Work. Hi.  I just recently had a blood panel done as part of a medical exam for work.  The only thing out of range is cholesterol, however my risk ratio is low.  My PCP is not concerned about anything in my blood work.  I just wanted to get some other options and see if these results indicate anything that I should press for follow up on.\n\nI definitely want to get my apoB tested.  Anything else?\n\nhttps://preview.redd.it/ttrb6ksnp6td1.png?width=2446&amp;format=png&amp;auto=webp&amp;s=5d8e2502bc72711141c49af00b0acee0b974e3ca\n\nhttps://preview.redd.it/sklwbksnp6td1.png?width=2449&amp;format=png&amp;auto=webp&amp;s=670747ddf0fda435e734c805fe5f5dab573b6bfb"
          ],
          [
           "ldl_cholesterol_apob",
           "Has anyone seen this result from an Lp(a) test?. This test was bought from Ulta Labs and taken at Quest. Clearly it says the result is &lt; 10. I want to make sure this isn‚Äôt a default response. Has anyone else had this result?"
          ],
          [
           "ldl_cholesterol_apob",
           "Do I have fatty liver? 24M. Hi all, posted here recently about elevated ALT levels and statins. My ALT and AST numbers have deteriorated further. Plus, some additional blood test metrics.\n\nBackground:\n\n24M, lean, active, historically normal blood panels, with elevated apoB and borderline hba1c. Average ~3 drinks/week. Recently started and statin (9 months ago) and ezetimibe (2 weeks ago) and my latest LDL reading was 51.6 (don‚Äôt have a more recent apoB reading). 2 days ago, I stopped statin/ezetimibe therapy, given the &lt;1% chance of elevated transaminases. Hba1c was 5.9% as of 2 weeks ago (5.6% and 5.4% the last 2 years). \n\nSummary of my out of range numbers which lead me to believe I may have fatty liver:\n\n- hba1c: 5.9%\n- ALT: 163 \n- AST: 98\n- Triglycerides: 196 (up from 71)\n-HDL: 40 (down from 60)\n\nAll other hepatic function test numbers were in normal range. Also tested negative for various forms of hepatitis. \n\nThese tests are following a 2 week fever (now 2 weeks fever free) and a CRP blood test of 96 (seemingly related to elevated liver enzymes; but perhaps coincidental). \n\nSo what are the odds this is fatty liver? Seems like the next step is an ultrasound. I‚Äôve been cycling 10 hours/week the last 6 months, and have justified my consequent carbohydrate increases (90gram carb drinks on a 2 hour ride) - very possible I‚Äôve overdone it. Just frustrating given my overall risk profile seems rather low.\n\nSure hope I can reverse this if it is NAFLD - maybe a 1 week fast and a low carb diet is in the cards here shortly (if that is truly effective).\n\nAny insight or advice in navigating this is very much appreciated."
          ],
          [
           "ldl_cholesterol_apob",
           "LDH blood test/my experience. Hi! ¬†I would like to share this: In Feb during a routine check, my LDH level was a little elevated:\n\nLDH-223 (124-222u/l).     Feb\n\nLDH-236 (124-222/ul). ¬† ¬† July\n\nLDH-213 (124-222/ul). ¬† ¬† Sept ¬†\n\nLDH-208 (124-222/ul). ¬† ¬† ¬†Oct\n\nDuring the whole period before Oct. ¬†I was concerned because everywhere on the internet saying LDH high was indicating cell/muscle damage and even cancer. ¬†Meantime, my VO2 was stuck even going down to 33‚Äôs during May-Sept. I started getting worried, especially at the Sept check, Doc said that my heart got a little bigger than before from the X-ray. ¬†I was a little shocked, but the Doc said not to worry too much, just wait and see. ¬†Then starting from the beginning of Oct., my VO2 suddenly started to go up fast, and I am running faster with a slower BPM than before, plus, my RHR kept getting lower. ¬†Japanese heart doctor failed to explain to me what happened to me physiologically......."
          ],
          [
           "ldl_cholesterol_apob",
           "How long to retest?. Just started on rosovastatin 10mg and ezetamide 10mg last week.   My doc wants to retest in 3 months but I want sooner as my Lp(a) is nearly 400 and apo B like 110.  No Repatha yet but kind of want to start it soon if current cocktail doesn‚Äôt get my levels great.   I suspect I will need Repatha anyway \n\nI want to find out sooner rather than later if I need Repatha so how soon after starting my current meds can I retest my lipid levels? \n\nThanks."
          ],
          [
           "ldl_cholesterol_apob",
           "Help Interpreting Lipid Panel Through Medicine 3.0 View. Just wondering if I could receive some help interpreting these results through Dr. Attia‚Äôs medicine 3.0 lens.  From what I remember, he‚Äôs mentioned lowering triglycerides to less than 2x HDL which would be lower than 134 in my case.  Any other recommendations?"
          ],
          [
           "ldl_cholesterol_apob",
           "Help getting started. I'm just reading Peter's book and primarily trying to manage my heart health. There's a lot of info to absorb and I was wondering if anyone here has references to help me get started quickly. I'm 45 and my dad had a heart attack around 50. \n\n1. I went to a cardiologist and got a calcium score of zero but my LDL was top of the normal range. How do I get a doc who will help prescribe meds if needed to lower my apob further?\n\n2. Are there any simple, concrete diet plans? Right now I'm just following general advice but it'd be nice to see more concrete meal and supplement suggestions\n\n3. Haven't gotten to the exercise bit and want a starter exercise plan. I used do to tons of strength training and currently do some kind of sporadic interval training on a rower. As I understand it Peter recommends a more well rounded training program than I used to do so I just want a quick starting point."
          ],
          [
           "ldl_cholesterol_apob",
           "Amer College Cardiology 2022 article questioning statin benefits. Hello folks. \n\nI want to ask Attia this question but I have heard he is prone to blocking people who in any way question statins. \n\nMaybe some of you have seen him answer this point -- even the American College of Cardiology is questioning the benefits of statins. How does he respond? \n\nI found this prepring by the American College of Cardiology  from March 2022 [https://www.acc.org/latest-in-cardiology/journal-scans/2022/03/15/18/47/evaluating-the-association-between-ldl](https://www.acc.org/latest-in-cardiology/journal-scans/2022/03/15/18/47/evaluating-the-association-between-ldl)\n\n and published articl, [https://jamanetwork.com/journals/jamainternalmedicine/article-abstract/2790055](https://jamanetwork.com/journals/jamainternalmedicine/article-abstract/2790055) \n\n  \nEvaluating the Association Between Low-Density Lipoprotein Cholesterol Reduction and Relative and Absolute Effects of Statin Treatment: A Systematic Review and Meta-Analysis. *JAMA Intern Med* 2022;Mar 14:\\[Epub ahead of print\\]. \n\n \n\n## \"Conclusions:\n\nAbsolute risk reductions of treatment with statins in terms of all-cause mortality, MI, and stroke are modest compared with the relative risk reductions. A conclusive association between absolute reductions in LDL-C levels and individual clinical outcomes was not established, and these findings underscore the importance of discussing absolute risk reductions when making informed clinical decisions with individual patients.\n\n...\n\n  What percent of patients who are statin eligible by the guidelines would take a medication with a 5-10% risk of muscle aches, about 5-10 per 1,000 risk for diabetes, and 5-10 per 10,000 risk for hemorrhagic stroke with &lt;1 in 100 chance of having the wanted effect ?\"\n\nHere, one of the authors writes a more readable article from her substack, \n\nfile:///C:/Users/Anne/Downloads/maryannedemasi.substack.com-New%20analysis%20shows%20statins%20have%20minimal%20benefits.pdf \n\n\" Our analysis showed that trial participants taking a statin for an average of 4.4 years, showed a 29% RRR in heart attacks, but the ARR was only 1.3%. If this is not effectively communicated to a patient, can they make a fully informed decision\".   \n\n\nThank you."
          ],
          [
           "ldl_cholesterol_apob",
           "What are Peter‚Äôs thoughts on LpPLA2 Activity?. 32M. Recent bloodwork. Was able to get a statin script given my family history and some not so good numbers you‚Äôll notice above. \n\nJust curious on the general consensus with LpPLA2 activity. My number is nearing the borderline threshold (already high according to some other labs). Does this mean I likely already have plaques, or maybe just some minor inflammation? Would this number be 0 in a healthy person?\n\nI wasn‚Äôt able to find much out about this online.. Making some more lifestyle changes alongside the statin will hopefully bring this down either way. Appreciate any insight!!"
          ],
          [
           "ldl_cholesterol_apob",
           "Red Rice üçö Yeast üåæ Lowered my Cholesterol. LDL went from 173 to 113 in a month .\n\nTook a pill every morning along with :\n\nBasically eliminating dairy \nEating oatmeal"
          ],
          [
           "ldl_cholesterol_apob",
           "What preventative prescription medications do you take?. Things like metformin or others that you take for prevention but need a prescription for.\n\nPeter seems to recommend metaformin and a statin at least?"
          ],
          [
           "ldl_cholesterol_apob",
           "Does Attia address using niacin vs statins?. I am a subscriber to Attia (love the written transcripts). \n\nIt seems he is very big on statins.  Does he ever address using niacin derivatives as a starting point, before going to statins?   I have searched his website and not found anything. \n\nI haven't heard him caution to use CoQ10/ ubiquinol when using a statin.  \n\nHas anyone heard him recommend these with statins.  He seems very casual about using statins--which do have side effects. Maybe I haven't read/listened enough. \n\nTHank you."
          ],
          [
           "ldl_cholesterol_apob",
           "Dietary Cholesterol, how much should I care?. Good afternoon everyone!\n\nI had a quick question on dietary cholesterol. Over the past few months I have been trying to make my diet even better than it was. Part of that was cutting down to 2 eggs a week because I have seen that dietary cholesterol can have some impacts on our cholesterol levels.\n\nI currently eat 2 scoops of whey protein a day, which has 65 mg of cholesterol per scoop, as I make desserts out of them (protein pancakes, and avocado pudding). I don't eat red meat, I upped my fiber by including psyllium, flax, and just a bit more veggies/fruits in general. But I wanted to make sure this whey protein was not also a reason my cholesterol and then LDL was slightly higher than what most doctors say it should be (212 total).\n\nI know whey is a more complete protein for muscle than pea, so I would prefer that, but will cut it if need be.\n\nThank you!"
          ],
          [
           "ldl_cholesterol_apob",
           "Thoughts on optimizing ApoB as a 25 year old?. Hi all,\n\nI'm 25M, healthy, active, and wanted to get grounded on my thoughts here.\n\nI'm thinking of taking ezetimibe for an ApoB of 79.  I'm currently about the 50% percentile for my age, and while certainly not a huge risk currently, I'm thinking that reducing my ApoB even by a few points would reduce CVD risk significantly in the long term as I'm starting so early.  Yes, this is likely overoptimization that would get clowned on in most places.  While I think the risk/reward isn't yet worth it for a statin, ezetimibe seems so well tolerated that I'm thinking it's worth it as monotherapy.\n\nAny reason this is a bad idea I should rethink?"
          ],
          [
           "ldl_cholesterol_apob",
           "Lab interpretation. My calcium score is zero; \nI am 50.\nI dont eat red meat; \nThe only oil i have at home is olive oil;\nI take omega 3 supplements"
          ],
          [
           "ldl_cholesterol_apob",
           "A Phase 1 Study of ABBV-CLS-7262, Rosuvastatin, and Digoxin in Healthy Subjects."
          ],
          [
           "ldl_cholesterol_apob",
           "Calcium score. Has anyone lowered or kept calcium score from increasing over the years? If so, what did you do?"
          ],
          [
           "ldl_cholesterol_apob",
           "62M probably on way to Repatha?. 62M with celiac disease. chronic high LDL of 170, low HDL, ApoB 160, hsCRP 6.2, very high particle count etc. . On and off statins over the years. Intolerant to every statin. Even Zetia causes shoulder tendonitis.  Cardiologist ordered a CAC score to determine how to treat going forward. I assume if calcium score is high, I will wind up on PCSK9? I'm hoping my low saturated fat diet and fiber intake plus the Zetia will mitigate some of my bad lipid profile. I am apoe3/4, so statins could have a deleterious affect on cognition. Would a PCSK9 help me and not compromise me as far as late onset Alzheimers ? I have lost height from over 6'2 to 6'1.5. At 198, I could really go down to 190 to lower BMI and bring down triglycerides from 140 to below 100. my fasting glucose is 88 and my a1c was 5.0. I did a CGM and there were never any spikes and some readings my glucose dropped low at times. anyone intolerant to statins have problems with PCSK9?"
          ],
          [
           "ldl_cholesterol_apob",
           "Should I get markers beyond apoB?. I have an apoB of 47, which I am working on getting down to 40. I have heard Peter mention VLDL, OXLDL, and LP(a). Should I get these done at my next blood test, or should I only look at apoB?"
          ],
          [
           "ldl_cholesterol_apob",
           "Low carb for 10+ years, LDL and APOB concerns. https://preview.redd.it/xv9bk63r7cwd1.jpg?width=511&amp;format=pjpg&amp;auto=webp&amp;s=029bcaa25faa6bdb0ca135244b555b3d38febb3e\n\n47 years old  \n175 Pounds  \nRegular exercise.  \nResting HR 50\n\n\n\nI recently gave up dairy/cheese and added some fruits (dates, apples, citrus) and popcorn on the weekends, and occasional sweet potatoes.  I thought adding these carbs would lower my cholesterol but I was wrong.  I eat mostly lean turkey, eggs, leafy greens, cruciferous veg, olive oil, moderate red meat.  I am honestly scared of medications and take nothing.  Are there any diet changes I should try?"
          ],
          [
           "ldl_cholesterol_apob",
           "I‚Äôm beginning to have a number of data points from this year, since some worrying numbers. Any suggestions on how to tabulate the data so I can see potential correlations?. I have wickedly high cholesterol panel and am in the process of working out what to do about it. As such I‚Äôm trying to get to grips with the data. \n\nAny tips on how to organise the info?"
          ],
          [
           "ldl_cholesterol_apob",
           "Lowered Apob to 61 but elevated ALT and AST after ezetimibe monotherapy. This is an update since my [previous post](https://www.reddit.com/r/PeterAttia/comments/17bm154/decreased_ldl_by_56_and_apob_by_23_in_4_months_on/) when I was only taking rosuvastatin (5mg per day). Tried ezetimibe monotherapy for a couple of months (10mg per day). \n\nNew results:\n\n* Total Cholesterol: 151 mg/dl\n* LDL: 81 mg/dl\n* HDL: 62 mg/dl\n* TG: 80 mg/dl\n* ApoB: 61 mg/dl \n* ALT: 35 u/L (previously 24)\n* AST: 34 u/L (previously 31)\n\nGoing in, I knew I would respond well cause I knew I was an \"over-absorber,\" according to the sterol test. But to my surprise didn't know it would lower Apob so much without the statin.\n\nShould I be worried about the elevated ALT and AST?"
          ],
          [
           "ldl_cholesterol_apob",
           "Interpreting LP(a) and ApoB numbers. Me: 37 yo overweight, family history of heart disease (dad had first heart attack at 48 and quad bypass later in life)\n\nLp(a): &lt;8.4 nmol/L\nApoB: 96 mg/dL\n\nAnyone with more confidence than me want to tell me how I might be able to interpret these in the short term? I have an appt with my primary doc soon and will discuss further there, but in the meantime, how should I interpret these? Thank you."
          ],
          [
           "ldl_cholesterol_apob",
           "LDL-C dropped 44% in 3 months. June 2023:\nHDL 56\nLDL-C\t 188\nTotal Cholesterol\t259\nVLDL\t15\nTriglycerides\t54\nApoB\t??? (PCP didn't order)\nLp(a) (nmol/L)\t??? (PCP didn't order)\nA1c \t5.7\n\nSeptember 2023\nHDL\t38\nLDL-C\t 104\nTotal Cholesterol\t155\nVLDL\t13\nTriglycerides\t66\nApoB\t86\nLp(a) (nmol/L)\t36.2\nA1c \t5.4\n\nI've always had high-ish cholesterol since I started getting routine physicals in my late 20s, but my LDL-c ballooned to 188 in June and that's when I made a drastic lifestyle change after getting hooked on Attia podcasts. I'm 36M, 161 lbs, 5'10\". I've always been reasonably healthy in terms of working out a few times per week and eating healthy but never bothered tracking fat intake and I had a huge sweet tooth. Since June I've virtually cut most sugar from my diet. Added lots of veggies, beans, oatmeal/all bran cereal daily, and supplement with psyllium husk a few times per week.When I bake I use monk fruit sugar, olive oil instead of butter and oat flour instead of flour. Also cut as much as I can in terms of saturated fat from my diet as well. Ramped up Z2 cardio to 180 mins/week + 4 weight training sessions + 1 HIIT session. I'm very surprised by the drop in LDL-c (I know I still have a ways to go but I want to give it another 3-6 months before hopping on a statin) but also find it a bit unusual my trigs actually increased, and my A1c didnt move as much as i thought (perhaps it's my fruit intake?)."
          ],
          [
           "ldl_cholesterol_apob",
           "28 yo male debating starting low dose statin?. I'll preface this by saying I'm coincidentally a medical doctor  in residency. Only reason why that matters is that of the standard teachings for lipid lowering pharmacology are different that Dr. Attia's - however I believe his approach to early and aggressive cholesterol lowering make total sense and I buy it. \n\nIm 28 yo and recently got some new labs done: ApoB 74, LDL 101, Total Cholesterol 166. I am interested in starting a low dose statin - such as Crestor 5mg qdaily. My mom had a heart attack at 65 without any knows risk factors other that mildly elevated LDL. \n\nAm I being too aggressive on lowering cholesterol for my age?"
          ],
          [
           "ldl_cholesterol_apob",
           "High CAC learned after improvements - now what?. **Summary:**  \n\nAge 51, recent reductions in cholesterol and weight after 30 years of sedentary lifestyle.  CAC score of 1100.  \n\n**Question:**  \n\nWhat should I expect to happen next?\n\n**Background:**\n\nI'm 51 years of age.  I retired 3 years ago after company I worked for IPOed and have recently started to care about health.  OSA and Diabetes and Hypertension for 15 years.  Weight recently reduced from 320 to 245lbs with Mounjaro and diet changes.  Exercising 3-4 times per week cardio and strength.  Cholesterol has improved dramatically:\n\n&amp;#x200B;\n\n**Table of certain medical test results/measurements over 3 years:**\n\n&amp;#x200B;\n\n|Marker|\\~3/2021|\\~3/2024|\n|:-|:-|:-|\n|Weight|320|245|\n|LDL-P|2698|741|\n|LDL-C|135|53|\n|HDL-C|28|44|\n|Cholesterol Total|208|113|\n|Lipoprotein (a)|n/a|23.9|\n|Apo B|n/a|52|\n|A1C|9.5%|5.3%|\n|Glucose|226|106|\n|Blood Pressure|160/80|160/80|\n|Body Fat|32%|27%|\n\n**Medications:**\n\nCurrently on Mounjaro and Metforming for Diabetes, Lisinopril, Carvedilol, Amlodipine and Hydrochlorothiazide for Blood Pressure, and 5mg Rosuvastatin for Cholesterol.  I take about 15 supplements ranging from Vit. D/K2 to NMN to L-Arginine etc.  \n\n**Food:**\n\nI'm a strict vegetarian since 2009 with high intake of eggs and cheese and milk.  Recently diet has reduced carbohydrates and trans fats but prior had much.\n\n**Other Measurements:**\n\nI had a stress-EKG where I hit 105% of reference max heart rate, and the tech said I was the in the lower 5%-ile for heart risk based on my stress EKG.\n\nI did a VO2 max earlier this week and results were poor but okay, specifically Anaerobic threshold at 135bpm, with a VO2 at 32.2 mlO2/kg.\n\nMy impression is that while I've stopped circulating bad cholesterol, the damage is done and the arteries have collected the plaque.   So now what?\n\n**Calcium Score:**\n\nCalcium scores reported as:\n\nTotal Calcium score - 1443 - \n\n* Left Main Coronary Artery - 0\n* Left Anterior Descending Coronary Artery (LAD) - 689 - \\[PCP says 1 of 2 primary concerns)\n* Right Coronary Artery - 587 - (Other primary concern)\n* Left circumflex coronary Artery - 167\n\nThe cardiologist my PCP recommended is no longer accepting new patients and we are discussing who else he might recommend.  My wife's cardiologist isn't available for 60 days and they referred me to the earliest availability with an Invasive Cardiologist (foreign MD, USA residency/fellowships) who finished his fellowship in 2021.  Should I see him?  Is my problem routine and banal, or should I look for someone with more breadth of experience?\n\nAs I understand it, next steps after consultation w/ cardiologist are either a non-invasive angiograph or a sedated Angiogram which could allow a stent to be put in if necessary as part of the investigative die catheterization.  Worst case is a bypass, but I guess this is all premature speculation until they look and see how blocked the arteries are?\n\nPrinceton Radiology [article](https://www.princetonradiology.com/service/screenings/cardiac-calcium-scoring/) suggests statins and other interventions can lower plaque:\n\n&amp;#x200B;\n\n&gt;What to Do After the Results  \n&gt;  \n&gt;As  mentioned earlier, the test is a wake-up call to take better care of  your heart. If your score was zero, keep working hard to maintain it  that way. When it is between 100 and 300, immediate action is necessary,  which mostly involves lifestyle changes. Those at a very high risk of  getting heart problems may get prescriptions that help lower the risks.  The drugs help unclog the arteries, reduce cholesterol levels, and  strengthen the heart muscles.\n\nI was under the impression that once the plaque is there, the body doesn't get rid of it.\n\nI had previously had an LDL score of 19 when I was on 10mg or 20mg of rosuvastatin.  My Metabolic Dr. felt that was too low, so we reduced the Rosuvastatin.  Would it make sense to go whole hog on lowering LDL and raising HDL and add Zettia or other cholesterol reducing meds in consulation with my doctor?\n\nI'll see the Cardiologist and consult with my PCP, but I'd love to hear thoughts from folks more informed than me on what you'd do if you were in my shoes.  Hopefully most of you are smart enough not to end up in my shoes.\n\nThank you for reading and thoughts!"
          ],
          [
           "ldl_cholesterol_apob",
           "Sterol question. I‚Äôm trying to find it, but does lowering sterols, particularly demosterol, through statins risking brain health???"
          ],
          [
           "ldl_cholesterol_apob",
           "Thoughts on carotid ultrasound?. What are Peter's thoughts on carotid intimate media thickness test (CIMT) as a form of gauging cardiovascular health."
          ],
          [
           "ldl_cholesterol_apob",
           "First time checking Lipoproteins. Looking for guidance.. Assuming these results mean I should reduce saturated fat? LDL is higher than I would like. I don‚Äôt really trust the ‚Äúnormal‚Äù ranges from the doctor. Getting a CT calcium scan soon also. 39 female, active powerlifter, normal blood pressure."
          ],
          [
           "ldl_cholesterol_apob",
           "Lost 20 Lbs and improved my numbers but still high LDL. I just started listening to Outlive and trying to wrap my head around these numbers. Based on my most recent results, I've my doc started me on 5mg of Crestor. M 47Y. Any suggestions or insights? thanks.\n\nhttps://preview.redd.it/qelabwqc2wqc1.png?width=415&amp;format=png&amp;auto=webp&amp;s=533c5f737dcae360fbac36826e4add393721ddb2\n\n&amp;#x200B;\n\nhttps://preview.redd.it/4jbbvqde2wqc1.png?width=429&amp;format=png&amp;auto=webp&amp;s=7cf3d60e27343054c3a088f715bf7ad3fdb08910\n\nhttps://preview.redd.it/vydanz8f2wqc1.png?width=854&amp;format=png&amp;auto=webp&amp;s=507715df3a9f417b62451cdab08370f5691a51f2\n\nhttps://preview.redd.it/c6v2gusg2wqc1.png?width=858&amp;format=png&amp;auto=webp&amp;s=8b9b67cd1b685c8cd3ab5f426323c6300d3c0181\n\nhttps://preview.redd.it/3u2pwd4g2wqc1.png?width=840&amp;format=png&amp;auto=webp&amp;s=c6df3d9a2a910706fde1855a0592f72e2ded7508\n\nhttps://preview.redd.it/01t1p5vh2wqc1.png?width=852&amp;format=png&amp;auto=webp&amp;s=f2a578e9544385b7f28d54c0c81483b148c60489"
          ],
          [
           "ldl_cholesterol_apob",
           "Statin (crestor) for 170 LDL. So I‚Äôve had LDL of around 170 for a year (likely longer) despite reducing saturated fats and exercising about 200 mins per week. 38 yo male, 26 bmi, healthy.\nDr Attia would clearly suggest Crestor 5mg asap but my PCP does not recommend.\nSince this is the Attia community I assume most would say listen to him but thought I‚Äôd ask in case any other perspectives or folks who encountered similar decision to make before"
          ],
          [
           "ldl_cholesterol_apob",
           "Uh oh, cholesterol is high - what can and should I do next?. 39/m and after thorough lipid panel found I have fairly high lp(a) among other things:\n\nTotal cholesterol: 222\nLDL(c): 148\nHDL(c): 65\nTriglycerides: 52\nLp(a): 53\nApoB: 113\n\n\nI exercise regularly and follow a fairly good Mediterranean diet. \n\nWhat next?"
          ],
          [
           "ldl_cholesterol_apob",
           "Question about Zero Calcium Scan and elevated LDL. Hi all,\n\nI'm a 52 yo female, diagnosed with prediabetes in July 2022 and I also have high blood pressure. I lost 40lb, lowered my A1C from 5.8 to 5.3, lowered my blood pressure medication because of that and it is excellent/very well controlled now. I've been eating low carb, albeit not keto. I don't eat much red meat either, only at special occassions. I eat chicken breast and fish only. But I do eat full fat dairy and I'm actually not willing to give that up, since I don't think it'll be sustainable for me on the long [term.](https://term.No) No smoking, almost no alcholol (special occasions only). I'm active for at least 30 minutes daily, usually more.\n\nMy LDL increased from 110 to 130. I didn't do ApoB and Lpa just yet, I'll have those done on my own in a few months.\n\nFamily history includes both mom and grandma dying of hemorragic strokes in their early to mid 70s. Both had diabetes, although both weren't diagnosed. The reason I think they had diabetes is becuase diabetes was noted on my mom's death certificate, my mom's brother has diabetes, and they both mom and grandma were obese, although not morbidly obese. I discussed my increased LDL cholesterol with my PCP two days ago and asked if I should go on statins since I'm not going to go to low fat diet and she said to do a calcium scan first. Since it's zero, I think she'll say no statin.\n\nQuestion: should I insist, should I take supplements instead, should I try something different, or should I just do nothing?"
          ],
          [
           "ldl_cholesterol_apob",
           "Rosuvastatin or pravastatin? combination with zetia. what to tell doctor? appointment next week.. I will ask my do next week for rosuvastatin 5 or 10mg or maybe pravastatin. I read pravastatin is the least lipophilic and will cross blood brain barrier the least.\n\nAlso wanted to ask for zetia 10mg.\n\nWhat should I go for 5 or 10mg rosuva, or what would be an equivalent dose pravastatin?\n\nis 10mg rosuva still a low dose? I think he might talk me into a baby dose as I am 35 years old and I am  quite healthy now. Although my blood lipids are because of genetic reasons a bit higher in my family. There were several times when I was a bit overweight when my cholesterol was way too high and i got warned by some docs.\n\nI read  there is a 20% drop in CVD risk seen for every 39 mg/dL decrease in LDL and even very low levels are safe.\n\nSo I should go for it I guess?"
          ],
          [
           "ldl_cholesterol_apob",
           "Cleaned up my act but lipids went up‚Ä¶dafuq?!. Hey team.  Over the last month I made changes re longevity. Inc exercise. TR diet 18/6 stopped alcohol have always had great sleep and emotional health   My ldl climbed from 99 to 148 and apo B from 80 to 120. Shit!!!   HDL dropped but still ok 85 to 63 and tglycerides still below 100.  Fasting insulin is 8.  Am I in trouble.  Almost feel like the alcohol (low to moderate) was helpful.  Seriously.  WTF?!!!"
          ],
          [
           "ldl_cholesterol_apob",
           "When is it worth getting a calcium scan?. I'm a 57M and have been on statins for about 6 years.  My cholesterol was moderately high (261) in the past, but the statins keep it in check.  I've never had a calcium scan and am wondering if I have any deposits, but at this point my target is keeping my ApoB under 60 and whether or not I have calcium deposits probably isn't going to change how I manage my cholesterol.  Is there any point to getting a calcium scan?"
          ],
          [
           "ldl_cholesterol_apob",
           "APoB 120! Eating 2 full eggs every day for the last 5 years. Should I reduce?. Do eggs increase ApoB? Can you point me to PA guidance / latest research? Cannot find anything reliable. \n\n&amp;#x200B;\n\nThanks in advance."
          ],
          [
           "ldl_cholesterol_apob",
           "Those that are optimizing for longevity, how low are you driving your ApoB or LDL-C. And how are you doing it?. I don‚Äôt have ASCVD in my family but I‚Äôm theorizing that super low ApoB will help mitigate my double ApoE4 carrier status. You know, what‚Äôs good for the heart is good for the brain as PA likes to say.\n\nMy ApoB goal is 50 mg/dL. Recent test had it at 52, achieved with a low saturated fat, high fiber plant-based diet + 10 mg ezetemibe mono-therapy. It‚Äôs been as high as 108."
          ],
          [
           "ldl_cholesterol_apob",
           "Anyone had any luck getting ApoB tests done in Canada (Vancouver, specifically)?. I'm sure this sounds familiar - my family doctor said it's not something that's typically done, only cardio specialists can refer if there's a problem.\n\nMy latest results came back and puzzled the hell out of me:\n\n- LDL = 3.54 (obviously, high)\n- HDL = 1.78 (also high, but it's good in this case)\n- Trig = 0.45\n\nIt's the last one that's puzzling. Everything I've read suggests high LDL and high trig go together most of the time and in rare cases when LDL is high but trig is low then it suggests something different (what exactly I'm not sure - I can't get through medical jargon enough to understand). Found some links that said it's a good thing and in this case LDL is not really bad, but who knows how trustworthy this is.\n\nIn one of AMA Dr Attia even mentions \"strange cases you see once in a while with high LDL but suddenly trig are very low\" (in reference to berberine apparently working on lowering LDL in this particular case, so guess what's amazon delivering today).\n\nLong story short, I'm now very interested in doing ApoB because lipid panel turned out to be less than clear. But I don't know how to go about it."
          ],
          [
           "ldl_cholesterol_apob",
           "Heart Health, 55M, Advice on Cleerly Health. I‚Äôve been an Attia fan for years but just discovered this SubReddit. Looks like some great discussions and expertise here, so I thought I would ask the community for advice.\n\nI‚Äôm 55M with a family history of heart disease (father died of MI at 52), although I don‚Äôt have FH. At age 49 had LDL-C of 170, and started Atorvastatin 80 mg. (I wish I started earlier but my doctors didn‚Äôt think I needed it, ugh). Attia taught me otherwise. LDL-C post treatment was in the 60-75 range, much better. An aside: I asked for one apoB test, it was 61 and my LCL-C measured on the same test was 74 (why are many doctors resistant to testing apoB?). 3 years later (age 52), I insisted on getting a CT coronary calcium scan (doctor didn‚Äôt think I needed it). Score was 87, 82nd percentile for age and gender, with most calcification in my LCX (82). I asked for a referral to a preventative cardiologist, suggested adding Ezetimibe 10 mg, and he agreed. LDL-C knocked down to 55 ‚Äì great. \n\nAt the beginning of this year I had to switch to Kaiser and lost my PCP and cardiologist. LDL-C has slowly crept up, and is up to 66 now. This is in spite of a better diet and exercise program that I‚Äôve really focused on. I do 2-3 hrs of Zone 2 cardio, 1 4x4 HIIT session, 4 sessions of strength training, and regular stretching each week. Per a recent Dexa scan I‚Äôm 15% body fat, only 0.76lb of VAT (&lt;10th percentile). No side effects from the heavy statin dose, although my fasting blood sugar has crept up from &lt;90 to 100, hba1c is 5.3.\n\nI am doing a lot for health and longevity, but remain concerned that in spite of my interventions, heart disease remains my largest risk factor. I would like to get my LDL-C (or it‚Äôs apoB equivalent) below 50 to ensure I dramatically slow the progression of heart disease. I think the only way to get there is a pcsk9 inhibitor like Repatha. I‚Äôve mentioned this to my new PCP, but she thinks it‚Äôs unnecessary, even though I‚Äôm willing to pay for it 100% out of my own pocket. Unfortunately Kaiser won‚Äôt go beyond the standard of care, and I clearly don‚Äôt meet it.  But no one has been able to give me a good reason why a pcsk9 inhibitor is likely to harm me ‚Äì side effects seem limited, and I‚Äôve heard enough Attia and Dayspring to understand that lower for longer is better when it comes to LDL/apoB. \n\nSo I‚Äôm considering [Cleerly Health](https://cleerlyhealth.com/individuals), a startup that gives you a consult with a cardiologist, then you schedule a CCTA scan, then Cleerly uses their AI software to analyze the scan. I am thinking I could use the scan results in consultation with the cardiologist to determine if a more aggressive treatment plan makes sense. I would be willing to pay out of pocket to see the right preventative cardiologist who will really work with me on a customized plan. I live in San Jose, tried to see [Ethan Weiss](https://profiles.ucsf.edu/ethan.weiss) at UCSF but was told he is no longer accepting new patients.\n\nThoughts on my plan and Cleerly Health specifically? Other suggestions?  Any cardiologist recommendations? Is an LDL-C target &lt;50 appropriate for me given this history or should I be fine with my current program and LDL-C the high 60‚Äôs?"
          ],
          [
           "ldl_cholesterol_apob",
           "Starting Statins.  What else?. 45yo caucasian male.  6' tall, 162#.  Looking for some Attia-esque feedback on how to attenuate some negative trends.  My PCP is not terribly proactive.  They're more like \"you're getting older.  These things happen.\"  At my request, I've done a full blood panel, cardiac calcium score, etc.  All of the basic biomarkers (CMP, CBC, etc.) are normal.  Things that worry me:\n\n1. Cardiac Calcium Score: Agatston score of 2--While low, it's not zero--which it should be for someone my age and activity level.  I eat clean and I exercise every day (sometimes twice a day) with a good mix of cardio and strength training.  Cardio is biking - I ride 6-12 hours per week.  Strength training is free weights at the gym, 4-6 times/week.  \n\n2. ApoB: 95--Depending on what reference range you look at, it's either moderate or acceptable, but it's definitely higher than I'd like.\n\n3.  LDL:  113--High, and consistently high (I fluctuate between 100-120, with a one-time spike to 160).  I take a ton of fish oil, fiber, eat clean, etc.\n\n4. My family HX:  Terrible family hx on both sides.  CVD of all forms (MI, TIA, stroke, carotid plaque issues, dementia).  \n\n5.  Blood pressure: I'm borderline hypertensive, with periodic hypertensive episodes.\n\nOther than exercise, I take psyllium husk, a multivitamin, fish oil, Vitamin D (I'm deficient without a supplement), AG1 Daily Greens and creatine.  I'm set a f/u appointment with my doc to ask for a low dose statin (rouvastatin or pravastatin, with a preference for rouvastatin based on efficacy).  I've read and watched all I can find.  Interested in and genuinely value feedback.  I'm in a relationship with the love of my life, and want to have a long and healthy lifespan ahead of me.  Separately, if relevant, I have celiac's, and thus some difficulties with nutrient absorption.\n\nA. What else should I be pursuing other than a statin?  \n\nB. Once I'm on a statin, should I supplement with Coq10?\n\nC. What else should I be adding to the mix?\n\nD. How much should I be worrying about muscle fatigue with statin use, vs my exercise schedule?"
          ],
          [
           "ldl_cholesterol_apob",
           "CCTA Indicated in my case?. 52M. On 5mg rosuvastatin since a couple months\n\nApoB = 155 baseline. 80 on rosuva.\n\n3 years ago: CAC=0, clean carotid ultrasound. \n\nI was having some mild chest pain/discomfort a few months ago which triggered cardiologist to order a CTA. The chest pain has gone away and I have an active mind/anxiety that has historically caused phantom symptoms. \n\nI'm wondering: is this CTA necessary? How would it change management?\n\n**Also**: How the hell does Peter claim to get CTAs done at 1-2 msV? I'm in a major metro and have called around to the major places with the best machines including the big teaching hospital and the best I can do is an estimated dose of approx 7 msV.\n\n&amp;#x200B;"
          ],
          [
           "ldl_cholesterol_apob",
           "Should I take a statin at 19 years old?. I am mostly worried about the side-effect of increased calcification of plaque - I don't think that's good at my age. The soft plaque in my arteries at my age isn't acutely dangerous to me. Iirc soft plaque is easier to reverse than calcified plaque, so I prefer my plaque be soft for now. On the other hand, I doubt I have much plaque to calcify. I'm already on ezetimibe and don't have access to bempedoic acid or pcsk9 inhibitors. My ldl is 100. I was thinking of taking just a low dose of some statin. Thank you for the advice!"
          ],
          [
           "ldl_cholesterol_apob",
           "How can i monitor my heart on my test + NPP cycle?. I plan on using nebivolol, telmisartan, taurine, ezetimbe for cholesterol and propranolol for anxiety. Any more suggestions how I can stay safe etc?"
          ],
          [
           "ldl_cholesterol_apob",
           "Trying to understand why K2 is good for arterial health when calcification stabilizes plaque and if you have no plaque there is nowhere in the arteries for calcium to adhere to anyway. I have always wondered this and gave it a whirl with ChatGPT and did not end up with any greater understanding. You can see my chat here and see if I am missing anything:\n\n[https://chatgpt.com/share/c04cd9a7-6f8f-435f-bed5-3659ad6110f8](https://chatgpt.com/share/c04cd9a7-6f8f-435f-bed5-3659ad6110f8)"
          ],
          [
           "ldl_cholesterol_apob",
           "Has anyone had this before (minor basal atelectasis/fatty liver). Minor basal atelectasis. Visualised pleural spaces are clear. On limited views of the upper abdomen, liver is of low attenuation\nraising the possibility of fatty liver\n\nNoted possible fatty liver.\n\n____\n\nHas anyone had this before and treated this? I'm worried"
          ],
          [
           "ldl_cholesterol_apob",
           "Why an 88 YEAR OLD Had Normal Blood Cholesterol Despite Eating.. 25 Eggs/Day."
          ],
          [
           "ldl_cholesterol_apob",
           "Should I be concerned about any of the results from a recent full blood test?. My details - 33 year old British white male. 5 foot 11. About 173 pounds. No current regular medication, but I take daily multivitamins.\n\nI had a blood test done last week after telling my doctor about certain symptoms I've been having for months now, namely lightheadness (e.g. head rushes when I move abruptly), fatigue/tiredness, occasional dizziness. Recently I also noticed that my nails are kind of discoloured, with like a band across the top of them, from what I can tell. I was worried these could be \"Terry's Nails\".\n\nOn the blood test form, the doctor put \"leukonychia\" as the reason for it to be done.\n\nThe results are now available on my NHS app, but the doctor didn't tell about them directly.\n\nI was wondering if any of the following results are potential causes for concern, or what should be monitored, or what next steps I should maybe ask my doctor to take, as they don't seem to be overly concerned about my symptoms.\n\nI've tried to include what I think is relevant information - please let me know if there's something I might have missed that could be important.\n\nAlso, some of the results have comparisons with another blood test which I had done roughly 6 months ago in December, but I don't have data for all of them.\n\nThe test I did six months ago was one I did NOT fast for, whereas I did fast for the one last week. How much of a difference could this make to the results?\n\nThank you!\n\n**Full Blood Count**\n\n**My doctor's comment: \"abnormal - no action required\" - how can they be abnormal but not require further investigation?**\n\nHaemoglobin estimation: 138 g/L (down from 139 g/L six months ago)\n\nTotal white cell count: 3.7 10\\*9/L (the same as it was six months ago)\n\nRed blood cell count: 4.46 10\\*12/L (down from 4.68 10\\*9/L six months ago)\n\nHaematocrit: 0.40 (down from 0.42 six months ago)\n\nMean corpuscular volume: 89.2 fL (down from 90.4 fL six months ago)\n\nMean corpuscular haemoglobin: 30.9 pg (up from 29.7 pg six months ago)\n\nMean corpuscular hb conc (MCHC): 347 g/L (up from 329 g/L six months ago)\n\nRed blood cell distribution width: 13.5% (up from 13% six months ago)\n\n**(The following markers are the ones I'm particular curious about as - from what I can tell - they seem low and could be something to be worried about?)**\n\nPlatelet count: 215 10\\*9/L (down from 242 10\\*9/L six months ago) -¬†**should I be worried about this decrease?**\n\nNeutrophil count: 1.5 10\\*9/L (down from 1.9 10\\*9/L six months ago) -¬†**should I be worried about this decrease?**\n\nLymphocyte count: 1.7 10\\*9/L (up from 1.4 10\\*9/L six months ago)\n\nMonocyte count: 0.4 10\\*9/L (up from 0.3 10\\*9/L six months ago)\n\nEosinophil count: 0.1 10\\*9/L (up from 0.0 10\\*9/L six months ago)\n\n**Serum Lipids**\n\n(No previous recorded information for the following to provide comparison)\n\nSerum total cholesterol level: 4.2 mmol/L\n\nSerum HDL cholesterol level: 2.77 mmol/L\n\nSerum triglycerides: 0.44 mmol/L -¬†**the lab comment says \"patient unfasted\" even though I fasted for about 14 hours before the test was done**\n\nSerum LDL cholesterol level: 1.23 mmol/L\n\nNon HDL cholesterol: 1.4 mmol/L\n\nSerum cholesterol/HDL ratio: 1.5\n\nSerum C Reactive Protein Level\n\nSerum C reactive protein level: &lt;1 mg/L\n\n**B12 + FOL + FER**\n\n(No previous recorded information for the following to provide comparison)\n\n**My doctor's comment: \"abnormal - no action required\" - again, why is this?**\n\nSerum ferritin: 276.0 ug/L\n\nSerum vitamin B12: 701 ng/L -¬†**above normal range/cause for concern?**\n\nSerum folate: 6.3 ug/L 0 -¬†**in 'normal range' but near the lower threshold, is this anything to worry about?**\n\n**Total Vitamin D**¬†- 48 nmol/L\n\n**Haemoglobin A1c**¬†- HbA1c level - IFCC standardised: 35 mmol/mol\n\n**Serum Gamma GT Level**\n\nSerum gamma GT level: 12¬†[](https://www.reddit.com/user/L/)¬†-¬†**in 'normal range' but near the lower threshold, is this anything to worry about?**\n\n**NT-PROBNP**\n\nN-terminal pro-B type natriuretic p: 69 ng/L\n\n**Rheumatoid Factor**¬†- &lt;10 ku/L"
          ],
          [
           "ldl_cholesterol_apob",
           "CohBar announces positive human data from obesity and NASH study - positive topline results from the Phase 1a/1b study of CB4211 under development for non-alcoholic steatohepatitis and obesity announced.."
          ],
          [
           "ldl_cholesterol_apob",
           "Macrophage Dysfunction is the Important Target if Seeking to Treat Atherosclerosis."
          ],
          [
           "ldl_cholesterol_apob",
           "Very high cholesterol at 30. Hi everyone!\n\nI am very concerned because I just received the result of my blood test and my cholesterol is incredibly high : 246 mg/dl and LDL : 163 mg/dl.\n\nI really don‚Äôt understand because I‚Äôm pretty healthy. Im not stressed, sleep is not bad (but definitely not perfect. I do sport 3x/week, and my diet is quiet balanced :\n\nBreakfast: smoothie with avocado, whey protein and blueberries \n\nLunch: 4 eggs, bit of salad \n\nDiner: it varies but in general I will have some meat with carbs and fiber \n\nThats crazy because it‚Äôs even higher than when I went carnivore for a month.\n\nI supplement with D3 and magnesium only \n\nDoes someone have an explanation? And maybe some tips to help me dropping this. \n\nMany thanks !"
          ],
          [
           "ldl_cholesterol_apob",
           "I don‚Äôt know how to approach my lipid panel.. Sept 14 2023 was the second to last time I got my panel done. I had it checked because I had drastic weight loss due to anxiety. Everything since my last test has been lowered, and my ratio is now 2.3 instead of 2.2.\n\nI read that low HDL and high LDL is bad. I‚Äôve had a pretty strictWFPB diet (occasional sardines/tuna) for close a year now, with daily 30-45 minute moderate intensity exercise. The bulk of my calories come from nuts, seeds and EVOO. The rest are veggies and whole grains.\n\n4‚Äô11 87-89 lb female with PCOS. I don‚Äôt get it, why are my labs crappy?"
          ],
          [
           "ldl_cholesterol_apob",
           "If I was deficient in Omega 3 6 or 9, would that deficiency appear in my lipid panel or my triglyceride lab work?."
          ],
          [
           "ldl_cholesterol_apob",
           "Female,25 non drinker no disease. Help me interpret my blood work \nAm I anemic or is there anything concerning?"
          ],
          [
           "ldl_cholesterol_apob",
           "Kidney is functioning at 85%. Has anybody else experienced this? If so, what did you do? Doc doesn‚Äôt seem worried. I‚Äôm 34F with 4 kids though, so I want to remain as healthy as I can. \n\nDoes anybody have similar experience? If so what did you do? Or if you did, what would you suggest?\n\n\nThanks!"
          ],
          [
           "ldl_cholesterol_apob",
           "Using gene modified minipigs, researchers demonstrate that high blood pressure alters the structure of arteries leading to more accumulation of LDL cholesterol and faster development of atherosclerosis.."
          ],
          [
           "ldl_cholesterol_apob",
           "Doctor wants me on Statins (31M). Doctor recently reccomended I start taking statins to lower my cholesterol, with an overall reading of 200. \n\nI respectfully declined as I believe that I have been making significant improvements to my health year after year. My recent triglyceride level for this year is 88, which is exceptional as I have been making strides to remove seed oils and processed foods from my diet the past year or so. I have also been supplementing with Omega 3 fish oil daily and cooking predominantly with Avacado oil as well as exercising.  \n\n2024:\nTotal: 200 | Triglycerides: 88 | HDL: 43 | LDL: 41\n\n2023:\nTotal: 218 | Triglycerides: 117 | HDL: 44 | LDL: 153\n\n2022: \nTotal: 220 | Triglycerides: 158 | HDL: 39 | LDL: 152\n\nI do not have any other underlying health issues &amp; feel like the doctor recommending Statins based off the readings of the past three years is a little odd. \n\nI feel like doctors are fast to prescribe medication unnecessarily these days. that Am I crazy?"
          ],
          [
           "ldl_cholesterol_apob",
           "The changing landscape of atherosclerosis."
          ],
          [
           "ldl_cholesterol_apob",
           "David Sinclair: ‚Äúa new study that definitively says dietary cholesterol has almost zero impact on blood cholesterol‚Äù. He mentions this in the recent podcast with Andrew Huberman at the 1:25:05 mark. Does anyone know what study he‚Äôs referring to?"
          ],
          [
           "ldl_cholesterol_apob",
           "Another piece of the puzzle. Hi all, first of all, thank you to the 120+ of you who responded to my previous [post](https://reddit.com/r/Biohackers/s/TpYIMRXM3X), where I talk about my super high insulin resistance, and other somewhat mysterious ailments.\n\nI now have another puzzling element: just today, I was diagnosed as JAK-2 positive, meaning my body makes too many platelets. My platelets have been high for a few years‚Ä¶ and I finally looked into it. \n\nThe puzzling bit: I am at only 1%. So, the doctor doesn‚Äôt know whether to diagnose me with essential thrombocythameia or not. She doesn‚Äôt know whether this is the beginning of disease or whether it will stay at 1%. And, familiar answer: we don‚Äôt know what caused it. We don‚Äôt know how to put it into remission.\n\nIs this related to all my other ailments? Is it not?\n\nIt‚Äôs super scary."
          ],
          [
           "ldl_cholesterol_apob",
           "Beyond Cholesterol: What You Need to Know About Apolipoprotein B's Crucial Role in Cardiovascular Risk."
          ],
          [
           "ldl_cholesterol_apob",
           "Low UIBC, high iron, high LDL, high non-HDL, and high cholesterol. What would you do?. I'm curious how others would address these lab results if you received word from your doctors office that these were the results. Thoughts?"
          ],
          [
           "ldl_cholesterol_apob",
           "I thought it was good to be high in HDL cholesterol?. Why was my immunologist saying I was \\*too\\* high in the HDL or good cholesterol? He added that it was positive I was not high in the LDL cholesterol. I eat very clean and exercise."
          ],
          [
           "ldl_cholesterol_apob",
           "LDL Cholesterol. Hi all,\n\nAfter a few years of eating rubbish, working from home and having a lazy, sedentary lifestyle, i have decided to look at improving my health. \n\nI have lost a bit of weight (c10kg) and am now generally feeling good, aged 35, with BMI of 22.\n\nI recently had a blood test and there were no issues (fasting glucose/insulin, liver profile, hormones etc) except for cholesterol...\n\n- Total: 268 mg/dl\n- Hdl: 52.7 mg/dl\n- Ldl: 228.5 mg/dl\n- Triglycerides: 113 mg/dl\n\nIt appears all is in line with norms  except my Ldl is v high. I continually find conflicting information on the implications of this.\n\n Does anyone have any insights into the risk factor of the above profile and whether i should be concerned?\n\nThanks."
          ],
          [
           "ldl_cholesterol_apob",
           "Worse biomarkers after IF, vegetarian diet. Hi guys! \n\nThe title pretty much sums it up. I began intermittent fasting and a (for the most part) whole-food, plant-based diet some 1.5 years ago.\n\nSurprisingly, I recently had some blood work done and:\n\n- Fasting glucose is 95, up from 80 in 2019\n- Hemoglobin A1c is 5.4% (no data from 2019)\n- Total cholesterol is 153 (HDL: 58; LDL: 85), up from 130 in 2019\n- Triglycerides are 49, up from 36 in 2019\n- No ketone bodies in urine \n\nI've also got high albumin (50.6 g/L), a bad creatinine/urea ratio (0.78 mg/dL and 37 mg/dL), low alpha 1 globulin (2.8%) and high lipoprotein (a) (44.9%).\n\nAny idea as to what might be driving this? I'm particularly surprised by the higher glucose, bad A1c and worse lipid profile after dropping meat and starting fasting.\n\nAny input/ideas will be highly appreciated. Thanks a lot!"
          ],
          [
           "ldl_cholesterol_apob",
           "JUST WANT TO ADD THIS UPDATE ABOUT SLU-PP-332!. So Saturday afternoon I raised my dosage to 750 micrograms of SLU-PP-332. The next day, sunday, I took 750 mg twice a day. Then on Monday morning I took 750 mg before cardio. About 3:00 a.m.. following that I ate breakfast. Then I went to the gym. The pump was incredible! I could not finish my sets for fear that I was going to hurt myself. I've read that this compound flips the same switches in the mitochondria that exercising flips, fat burning, ATP absorption. My heart rate stayed low, in the '70s through 90s. I just thought that you guys needed to know."
          ],
          [
           "ldl_cholesterol_apob",
           "Curious liver reading. My ALT is slightly raised but my ALP is slightly low.\n\nWhat is going on? All blood otherwise normal apart from cholesterol. \n\nCan someone shed some light?!"
          ],
          [
           "ldl_cholesterol_apob",
           "Calcium Carbonate. Is calcium carbonate really that bad? I recently heard calcium carbonate can lead to kidney stones, gastrointestinal issues and cardiovascular issues. Is it the calcium carbonate itself or overdosage of calcium carbonate responsible for the side effects? I've been taking around 800mg of calcium per day from eggshells (1g twice a day) for a while now because milk makes me gassy and cheese is pretty high calorie/high sodium for the calcium content."
          ],
          [
           "ldl_cholesterol_apob",
           "How can I fix my blood work?. Concerned about markers highlighted red, also BUN and Urea on higher side. \n\nAlso;\n\nMagnesium - 0.77 mmol/L\nFasting Triglycerides - 1.6 mmol/L\nHDL Cholesterol - 1.7 mmol/L \nLDL Cholesterol - 2.3 mmol/L\nHbA1c - 37 mmol/mol\nCRP - 0.4 mg/l\n\nI‚Äôm 23M. BMI 29 but around 13/14% body fat (high muscle mass) \n\nI take 5000iu D3, 7.5g creatine monohydrate, 250mg magnesium glycinate, and have a diet high in EPA/DHA (atleast 3g daily) and B12. I also drink a Huel shake daily which is essentially my multivitamin."
          ],
          [
           "ldl_cholesterol_apob",
           "Nanoparticles Containing Cyclodextrins to Sequester Cholesterol Do Well in an Atherosclerosis Animal Model."
          ],
          [
           "ldl_cholesterol_apob",
           "Testing positive for MTHFR c677T and a1298c. What the heck does this mean? Iv been dealing with anxiety lately and a dietitian ordered blood work with this test.. all vitamin lvls checked out fine. Only one was low vitamin d lvl. \n\nShould I be worried I tested positive for this? It‚Äôs kinda giving me more anxiety now. wtf"
          ],
          [
           "ldl_cholesterol_apob",
           "Low Total Cholesterol: Biological Youth Or Increased Mortality Risk?."
          ],
          [
           "ldl_cholesterol_apob",
           "Cordyceps as potential therapeutic agents for atherosclerosis."
          ],
          [
           "ldl_cholesterol_apob",
           "Had a really hard time on carnivore diet with breathing and skin problems. 30 days. Lots of eggs and red meat. Found out it‚Äôs high sulphur. Last night had beer. Didn‚Äôt know about sulphates in drinks.. Drank Carlsberg Pilsner. Unsure of any sulphur products in it. But after a couple hours Heart rate went crazy and chest got tight for hours. Luckily I have a albuterol in hand for occasional asthma symptoms. Couldn‚Äôt sleep at all until like 4 am. I‚Äôve been learning a lot about MTHFR and other gene problems this week. Both my parents did 23and me and they both have 1 MTHFR mutation each. Pretty sure I have it. I understand it‚Äôs not the ‚Äúmost important‚Äù. I‚Äôve had a bad keto rash (it‚Äôs dying down now after breaking keto). But prior to that I had been having hives on my hips, and general skin itchiness for a couple years TbH\n\nI read that the molybdenum will clear out sulpur so I want to take it. Just went to a specialty store in my town and bought. \n\n400mcg Methylfolate\n\n200mg SAMe \n\nGlycine \n\nNAC with molybdenum and a little selenium. \n\nAny suggestions as to which I should take first? I‚Äôm not interested in doing them all since I wouldn‚Äôt be able to gauge what affected what. \n\nMaybe none of these are correct IDK. But reading about sulphur last night, all these were mentioned."
          ],
          [
           "ldl_cholesterol_apob",
           "ADD and Heart condition.. Hello, Recently found this sub and thought it might be a good place to ask about an issue I‚Äôve had for a long time.\nI‚Äôm sorry if I‚Äôm breaking any rules.\nI‚Äôm a 39 year old male. I have had pretty severe ADD my whole life. in my mid 20‚Äôs I was diagnosed with a heart condition (sick sinus syndrome) and required a pacemaker. In my early 30‚Äôs I started having episodes of A-Fib. I had an ablation and the A-fib was resolved.\nAfter my heart diagnosis in my 20‚Äôs I was taken off adderall. And since then my life has been a mess. I have gotten by and live a pretty good life but I feel my ADD has caused depression and anxiety because of how I live my life in disarray. Sometimes I can start a new hobby or something that interests me and get a dopamine rush, but it inevitably results in a crash of depression. And causes anxiety from my life being in disarray. \nI abuse caffeine and and nicotine pouches. Which I feel isn‚Äôt any better than the adderall.\nI am prescribed 450mg of Wellbutrin daily.\nI would be very appreciative if anybody had any insight or suggestions. Thank you."
          ],
          [
           "ldl_cholesterol_apob",
           "Triglycerides. Bloodwork came back with my triglycerides at 599!!! \n\nNo clue why or how. 5‚Äô10 200lbs. Weight train and cardio 5 days/week.\n\nDiet isn‚Äôt perfect but definitely not horrible\n\nMeds I take are 200mg 1/week of test\n\nWhat the hell could be going on?"
          ],
          [
           "ldl_cholesterol_apob",
           "Peter Attia: \"My target for ApoB is 30-40 mg/dL. Therefore, that would require pharmacology. And so I take 3 drugs to do that. I take a PCSK9 inhibitor called Repatha, and I take a combo drug called Nexlizet, which is bempedoic acid and ezetimibe combined into a single pill.\"."
          ],
          [
           "ldl_cholesterol_apob",
           "How to lower triglycerides?. I heard 273 was high."
          ],
          [
           "ldl_cholesterol_apob",
           "Still convinced clenbuterol is the best fat burner.. I quit PEDs but there's one drug I like that's not a steroid, clen. \n\nI haven't tried semaglutide, but there's nothing like clen when it comes to fat loss imo.\n\nIt instantly leans me out while maintaining muscle (even without test or any steroid), it curbs my appetite like I could legit eat one meal the whole day on this if I wanted to. I'm not, but I could and not feel hungry.\n\nI know some people get racing heart sife effects but keeping it up to 60mcg, I have zero side effects.\n\nJust amazing."
          ],
          [
           "ldl_cholesterol_apob",
           "Thoughts on inulin?. Looking at some studies, it does seem to have its shadow sides, one even reports increased blood cholesterol."
          ],
          [
           "ldl_cholesterol_apob",
           "Real-world evidence for preventive effects of statins on cancer incidence: A trans-Atlantic analysis."
          ],
          [
           "ldl_cholesterol_apob",
           "Association between hypercholesterolemia and mortality risk among patients referred for cardiac imaging test: Evidence of a ‚Äúcholesterol paradox?\"."
          ],
          [
           "ldl_cholesterol_apob",
           "Evaluating the Impact of CoQ10 on Dyslipidemia and Statin-induced Myopathy."
          ],
          [
           "ldl_cholesterol_apob",
           "Abnormal levels of ALT and ALP. I recently had blood work done as have been suffering with brain fog for almost 2 years now. Granted, it is getting better. I suspect SIBO or SIFO post-Covid to be the cause.\n\nHowever my ALT (92 U/L) and ALP (151 U/L) levels came back abnormally high, suggesting to my GP that I require a liver ultrasound.\n\nSo I have two questions: could this be caused by SIBO, or could this be caused by my supplement usage? For long covid I have been taking Nattokinase and Apalolactoferrin, although I have now stopped as of a few days ago. I also take high strength fish oil for the EPA which I believe has made a noticeable impact on my brain function. I‚Äôve also recently started taking Candex SIBO formula.\n\nAnyone with any experience here? Thanks in advance Reddit!"
          ],
          [
           "ldl_cholesterol_apob",
           "DHEA-S Is A Weakness In My Data: Blood Test #5 in 2022."
          ],
          [
           "ldl_cholesterol_apob",
           "Help interpreting this information. https://preview.redd.it/5toqpcyazpid1.jpg?width=2054&amp;format=pjpg&amp;auto=webp&amp;s=5cccc851ee95f5a10d815286fac697fedd7a050e\n\nhttps://preview.redd.it/5nai5cyazpid1.jpg?width=1954&amp;format=pjpg&amp;auto=webp&amp;s=023b28e372626b91c694b90f75a3d6ea00c4ee56\n\nhttps://preview.redd.it/idi2pcyazpid1.jpg?width=2124&amp;format=pjpg&amp;auto=webp&amp;s=efe739bdbdfb316f9b14510bad0af1173e01d6b8\n\nhttps://preview.redd.it/suytzbyazpid1.jpg?width=1978&amp;format=pjpg&amp;auto=webp&amp;s=c1d48d32b687937fa547fdf422f2faa870d511e6\n\nI'm trying to figure out how to interpret these results. I'm very active, don't drink or smoke and have an OK diet. The bad cholesterol reading really leaves me puzzled, as does the high T. Am I going to die?"
          ],
          [
           "ldl_cholesterol_apob",
           "Two months of diet changed my total Cholesterol and LDL toward the positive side. So two months of diet change lowered my total cholesterol. Im now at 202, was 224 two months ago. LDL still high at 131 but was 159 two months ago. I think i'm on the right track. \n\nChanges made:  Oatmeal, fiber, apples most of the week. More exercise. Less take out. Watch the Sat Fat intake. No trans fat."
          ],
          [
           "ldl_cholesterol_apob",
           "Blood results. I am 22 years old and my weight is 80kg. What would be the best way to fix my liver and cholesterole?"
          ],
          [
           "ldl_cholesterol_apob",
           "Calcium Affects The Association For Oxalate Intake With Cardiovascular Disease-Related Events."
          ],
          [
           "ldl_cholesterol_apob",
           "Doctors Gene-Edit Patient's Liver to Make Less Cholesterol."
          ],
          [
           "ldl_cholesterol_apob",
           "Turmeric + Resveratrol + Red Yeast w/ CoQ10 for Cholesterol?. Is this stack (turmeric, resveratrol, and redyeast rise with CoQ10) good, too much, or ineffective to lower and control cholesterol?"
          ]
         ],
         "hovertemplate": "Topic Group=%{customdata[0]}<br>document=%{customdata[1]}<extra></extra>",
         "legendgroup": "ldl_cholesterol_apob",
         "marker": {
          "color": "rgb(17, 165, 121)",
          "symbol": "circle",
          "opacity": 0.7,
          "size": 7,
          "line": {
           "color": "rgba(0,0,0,0.5)",
           "width": 0.8
          }
         },
         "mode": "markers",
         "name": "ldl_cholesterol_apob",
         "showlegend": true,
         "x": {
          "dtype": "f4",
          "bdata": "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"
         },
         "xaxis": "x",
         "y": {
          "dtype": "f4",
          "bdata": "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"
         },
         "yaxis": "y",
         "type": "scattergl"
        },
        {
         "customdata": [
          [
           "zone_training_max",
           "Great discussion from today's Huberman Lab episode with Andy Galpin about the 'breathing gear system' for assessing whether you're in zone 1, 2, 3, or 4."
          ],
          [
           "zone_training_max",
           "New podcast Peloton riders!. Anyone who has listened to the newest pod, Peter goes in depth (again) about various metrics that he likes to see optimized. He mentions the ranges he likes to see for power, which is your weight in kg to the watts you can hold. I realized that I could easily calculate this bc I have an FTP on my Peloton. Not sure why this just occurred to me, but I took the numbers and plugged them in to an online calculator. Just thought I'd throw the rec out there for anyone wondering what their power is and how it stacks up to his recs."
          ],
          [
           "zone_training_max",
           "Zone 2 / Cardio Question. Hi everyone,\n\nI hike/walk about 4 miles every day, in the mountains with my dog. Now, I know the majority of this probably isn't Zone 2 and its definitely not sustained zone 2 for 60 minutes. Its probably a mix of 1 &amp; 2 I would guess.\n\nSo if I am lifting 2x per week and I want to make 1 day cardio, should I focus on ACTUAL zone 2 training or should I do VO2 max (since I hike so much)?\n\nThoughts? \n\n&amp;#x200B;"
          ],
          [
           "zone_training_max",
           "Recent VO2 Max Test and RER. Have any of you gotten a VO2 Max test recently? \n\nI've started following some of Attia's recommendations and noticed he talks a lot about zone training. I wanted to see where I was at with all of this and make a plan for my training going forward - avid runner and your average \"every day athlete\". A friend referred me to this gym in San Francisco that does VO2 Max testing (linked their site) and I was surprised at how precise the zone readings were. One of the things I found most interesting was the RER which basically reflects the fuel source being burned by using a CO2:O2 ratio. The guy doing my test was super helpful and gave me a clear breakdown of all these markers which was helpful for building a plan. \n\nI guess I'm writing to see what you guys have seen from your own Vo2 tests (if you've done one) and if these numbers are very different person to person. Could the same general strategies Attia mentions be applied to everyone in this sub or would certain athletes have different results per their conditioned training style? \n\nCheers!"
          ],
          [
           "zone_training_max",
           "Can I Weight Train, then Zone 2?? Does \"The Interference Effect\" Inhibit Gains?. An evergreen subject given PA said cardio after strength training limits gains by \"15%\", however this meta-analysis disagrees: [https://www.strongerbyscience.com/research-spotlight-interference-effect/](https://www.strongerbyscience.com/research-spotlight-interference-effect/)\n\n&amp;#x200B;\n\n&gt;*They found that concurrent training* ***did not lead to significantly smaller strength gains than resistance training alone****, nor did it lead to significantly less hypertrophy. However, concurrent training did lead to significantly smaller improvements in explosive strength than resistance training alone.*\n\nSo, can you do strength training, then your Zone 2 without limiting your gains? \n\nIt seems YES, UNLESS you're an athlete training for explosive strength, e.g., sprinting, baseball, et al\n\n&amp;#x200B;\n\n&gt;*... they found that the modality of endurance training (running versus cycling), the weekly frequency of endurance training, the training status of the subjects (‚Äúactive‚Äù versus untrained; they didn‚Äôt run a subgroup analysis on specifically resistance-trained subjects), the age of the subjects (18-40 years old versus &gt;40 years old), and the timing of resistance and endurance training sessions (performing both in the same training session versus different sessions) all failed to significantly modify the effect.*\n\n&amp;#x200B;"
          ],
          [
           "zone_training_max",
           "Zone 2 Percent of Max Heart Rate. I heard Attia talk about subjectively what Zone 2 feels like, and yet I feel very uncertain as to what being able to hold a conversation means. \n\nI'm curious what percent of max heart rate is for those who train in Zone 2. \n\nSeparately, I can **easily** go an hour at 75% of max -- is that likely too low?"
          ],
          [
           "zone_training_max",
           "I√±igo San Mill√°n - Why Riding Slower Makes You Faster: The Secrets Of Zone 2 Training."
          ],
          [
           "zone_training_max",
           "Figuring out my zone 2. Trying to figure out how to best go about completing my zone 2 workouts.  I recently purchased a lactate meter to help me gain some insight. I previously was already doing 10000 steps religiously so I thought I could kill 2 birds by using my zone 2 45 mins on the treadmill.  Started out with 6% incline, 3mph (for reference HR was 120s) for 45 min, lactate was 1.0. So I figured I needed to work a little harder. Next time I attempted it I did 10% incline still at 3mph. This time my HR was 130s and I definitely felt subjectively like it was a true zone 2.  Checked my lactate again and it was 1.1. Am I just clearing the lactate well?  For reference, I'm 43 yo female, I used to be an avid runner (6 marathons, 30+ halfs), haven't done a race in a couple years. I strength train 5 days a week for about 2 hours, been doing this for the past 15 years, serious training for the past 5 years or so. \n\nI really don't want to have to run to get myself into this zone, the older I've gotten the more I \"feel\" the toll running takes on my body. Realistically I don't plan to train like this forever, I know I will need to scale as I get older. Should I just keep upping the incline, lower the mph if need be? Or just keep these 10% incline walks since they \"feel\" like zone 2?"
          ],
          [
           "zone_training_max",
           "Elevated resting lactate. 38 male.\n\n5'11\" 172 lbs.\n\nVery fit, intense exercise (often competitive), and high daily activity.\n\nBefore recently, my endurance training was all very intense. Hard intervals, little to no rest, usually 30-45 minutes. I haven't done zone 2 specific training in over a decade. I learned some things, changed up my program, and am now working primarily on zone 2 for all my foreseeable future.\n\nI had a lactate test done this morning for training strategy purposes, and discovered a very high resting serum lactate level of 3.6, then re-tested at 4.0. The device was calibrated and safe to assume as accurate.\n\nThe level dropped through zones 1 and 2 as expected down to 1.5,  then slowly moved up through the zones, and the max was tested at 9.2.\n\nI believe it to be significant in that I was fasted for 12 hours prior to the test, and approximately 1 hour before the test, had a very stressful panic type situation unrelated to the training. It lasted about 30 minutes, and is a type of anxiety attack I experience somewhat often due to personal life circumstances.\n\n12 weeks ago I also had a very broad blood test that revealed low lactate dehydrogenase of 87, high homocystine of 26--assuming this is related.\n\nWhat is going on here? It's very unhealthy to have a resting serum lactate this high, and from whati read is borderline acidosis. Why is this happening?"
          ],
          [
           "zone_training_max",
           "Clarification on Zone 5 training.... So you can do it two ways?:\n\nOn Zone 2 days, in the last 20-28 minutes, repeat 4-minute intervals of: 3 minutes in Zone 2 followed by 1 minute in Zone 5.\n\nOr / and... \n\nOn dedicated Zone 5 days, do 4x4s: 4 minutes as fast as you can go without slowing down. Then 4 minutes at a very easy pace. Repeat this 4-6 times.\n\nIs this accurate? The reason I'm asking is because the latter (4x4s) seems significantly harder. The former would be 5-7 minutes in zone 5, whereas the latter would be 16-24 minutes in zone 5."
          ],
          [
           "zone_training_max",
           "Zone 5 questions from HIIT noob. Hey all,\n\nI've dialed in my Z2 training: knowing my true max HR, training \\~75% of that, making sure it lines up with the correct RPE, etc.\n\nThat being said, I've been avoiding zone 5 because I never really understood what the intensity feel like or what my HR should climb to, I have no clue what my VO2 max is, and there seems to be mixed messages about how long each Z5 interval should be.\n\nCan someone please guide me on this? Is knowing (or at least estimating) my VO2 max a necessity? I do Z2 on a stairclimber and plan do also do Z5 on one immediately following a Z2 workout."
          ],
          [
           "zone_training_max",
           "What‚Äôs your favorite indoor cardio ?. Was running, but got hurt, plus it‚Äôs like 15¬∞ where I live lol. Looking to switch to either cycling, swimming, rowing, incline tread etc on non lifting days. What is your go to indoor cardio?"
          ],
          [
           "zone_training_max",
           "Does anyone know PA‚Äôs take on an electrolyte supplement post-Z2 workout?."
          ],
          [
           "zone_training_max",
           "Zones during strength sessions. Though I've been a fan of PA for nearly a decade, I've only recently started following his fitness guidance related to zone training. I don't have a lactate meter so I'm only able to crudely approximate my zones based on my HR monitor, but I have a lifetime of fitness behind me and a pretty good sense of how I'm doing as far as sustainability goes. \n\n\nI don't have much trouble with the aerobic sessions, those are pretty straightforward. However I'm wondering if there is are any guidelines for the lifting sessions related to the zones. Is optimal strength training defined by zones at all, or should one aim for any particular composition of zones during a lifting session? \n\n\nI wear my HR monitor during my lifts and on some of the sets I'm pushing the upper limit of zone 4, and feeling it. My age is 35 with a lot of military, CrossFit, trail running and no known health issues. I lift 4 times per week and do aerobic work about 4 hours per week. \n\n\nThanks for any help!"
          ],
          [
           "zone_training_max",
           "Is it zone 2 if you alternate between walking and running to maintain heart rate?."
          ],
          [
           "zone_training_max",
           "Running mountains. This isn‚Äôt your typical biohacking post, but I‚Äôd like to tell my story.\n\nShortly before covid broke out I started running up mountains in the high peaks in the Adirondacks, Algonquin specifically. I‚Äôm at 85 ascents now (4 hour drive ü•≤).  Running up/down mountains has fundamentally changed my life, from day to day perceptions of difficulty to my reaction times, balance, and mental acuity, metabolism etc. Only in the last year though, I‚Äôve noticed my reaction time has more than doubled (nothing that falls around me ever hits the ground anymore lol). It‚Äôs like that part of my brain that handles that stuff just grew bigger? \nFurthermore, over a dozen times now, whenever a wound I have becomes infected (I usually don‚Äôt do anything for cuts from work anymore) the infection is gone the next day after the run. I‚Äôd love to have a study be done on that. Same with when I‚Äôm sick! Every time I‚Äôve gotten sick in the last 5 years, I‚Äôll force myself to get up there. And again, boom, it‚Äôs gone in the morning. Covid, the flu, colds etc (if you‚Äôve seen some lunatic running up Algonquin with a mask on hello).\n\nIf you do it right, it‚Äôs literally just like an hour long meditation. It‚Äôs the same yearning as wanting to just sit on the couch after a long hard week. And you don‚Äôt even feel it the next day.\nYou need to separate the pain of what your body is doing physically and turn all the no‚Äôs into yes‚Äôs, the way I understand it, you need to make a deal with your body that you can allocate the resources necessary to do this but only if I can eat a shit ton of of food after. Also it‚Äôs important to find balance in the holy trio of your breaths, pace, and heartbeat. If you can find that sweet spot where you can hyperventilate for a whole hour (what are you gonna do, stop breathing?) and match it to your pace, your heart beat will follow and you can do a full sprint to the top without a break or even feeling tired. Here‚Äôs a catch though..  I smoke a full joint beforehand to disassociate so I can ‚Äúmake that deal‚Äù with my psyche. I‚Äôve tried it sober and it‚Äôs genuinely scary and I couldn‚Äôt focus to keep my breaths at a constant rate. I blame the adhd for that. \nIt‚Äôs unbelievable, I know. But you won‚Äôt know it unless you try it!"
          ],
          [
           "zone_training_max",
           "vo2 Max Testing (Los Angeles). Where can one get a vo2 max test in LA area? University, Kaiser, Insurance?"
          ],
          [
           "zone_training_max",
           "Zone 2 and breathing. I wonder, if there is a way to determine if you are in zone 2 based on your breathing rate or effort? When Peter says you can hold a conversation but people on a phone would notice you are exercising, is this not a reflection of your breathing? Also, can you do a zone 2 session just breathing through your nose or would that imply too low intensity?"
          ],
          [
           "zone_training_max",
           "To those of you allergic to cardio, how did you successfully make it a habit?. I'm a healthy 22 year old male at 5'9\" (175 cm) and 178 lbs (80.7 kg) \\~14-16% body fat. I lift 5/6 times per week and 90% of what I consume is very healthy. I look deceptively in shape but am not. I can't get myself to do cardio for the life of me. I will gladly lift heavy on a leg day and get my heart rate up, but the slow burn of zone 2 is the bane of my existence. My resting heart rate is probably in the 70-80 bpm range (very sad I know). \n\nFor those of you previously in my shoes that now have good-to-exceptional cardiovascular fitness, what made it stick? Are there any psychological tricks you use to make it more tolerable? I currently use the sauna to sweat and get my heart rate up to offset the lack of cardio (even though it doesn't fully replace it)."
          ],
          [
           "zone_training_max",
           "Does exiting zone 2 for 30-60 seconds ruin zone 2 adaptation ?. We know Entering zone 3 or above will alter the energy system being used and it takes something like 10-20 mins of time in zone 2 to shift to zone 2‚Äôs energy system.\n\nWhat if your HR periodically breaks into zone 3 for like few seconds, maybe just shy of a minute ? Does the body shift to zone 3‚Äôs energy system fast enough for that to impede the benefits of dedicated zone 2 cardio?"
          ],
          [
           "zone_training_max",
           "Rent lactate meter. Anyone want to rent me a lactate meter for a few weeks? Doesn‚Äôt seem like something I need to do for more than a few weeks but I do want to check where I‚Äôm at since I‚Äôm putting so much time into z2 base training right now. \n\nThe formula 180-age (34) leaves me at 146 which seems pretty high in terms of RPE. I can nose breathe but if I talk it‚Äôs like 3-5 words before I have to breathe. 132 seems closer so I‚Äôd like to check my lactate"
          ],
          [
           "zone_training_max",
           "Zone 2 or HIIT for fat loss?. What will lose more fat 1 hour of zone 2 running or 20-30 minutes of high intensity work?"
          ],
          [
           "zone_training_max",
           "12 weeks of respiratory muscle training (8% increase in VO2 Max?). You can read my blog post here with all the results, pictures, and scientific sources: [https://ilmostromberg.com/wello2-mybreath-experiment/](https://ilmostromberg.com/wello2-mybreath-experiment/)\n\nHere is also a summary of the experiment:\n\n**Goal:**\n\nTrain my respiratory muscles for 12 weeks and see what happens in different metrics.\n\n&amp;#x200B;\n\n**Devices used:**\n\nWellO2 (for respiratory muscle training, RMT)\n\nMybreath (smart mouthpiece that measures metrics like maximum inspiratory pressure (MIP) &amp;  maximum expiratory pressure (MEP)\n\nGarmin watch (For estimated VO2 Max)\n\n&amp;#x200B;\n\n**Experiment length:**\n\nDecember to February\n\n&amp;#x200B;\n\n**Training routine:**\n\nOne session is 4 minutes (17 exhales, and 16 inhales)\n\n4-6 times a week, usually one session per day, sometimes double. Gradually increasing the resistance. \n\nOne deload week in the experiment.\n\n&amp;#x200B;\n\n**Results after 12 weeks:**\n\n60% increase in MIP (my baseline was below my age group)\n\n16% increase in MEP (my baseline was already above my age group)\n\n8% increase in estimated VO2 Max (screenshots in the blogpost)\n\n&amp;#x200B;\n\n**Comments about VO2 Max increase** \n\nThe estimated VO2 Max started to increase in week 6, and the most rapid increase happened from week 10 to 12.\n\nGarmin watch is not the same as laboratory level VO2 Max test. The main question in my case isn‚Äôt the actual VO2 Max value; rather, did my VO2 Max increase during the experiment?\n\nLuckily I have estimated VO2max data in my Garmin watch since 2019. This is the first time there has been such a sharp increase. Usually, data fluctuates +-1, sometimes 2\n\nBased on this, I conclude that there‚Äôs high certainty that my real VO2 Max did increase during the experiment.\n\nThis was also the reason why I did such a deep dive into RMT &amp; VO2 Max literature. My own meta-analyses showed that, most likely, RMT has a positive effect on VO2 Max (especially when the experiment length is long enough and there‚Äôs sufficient rest before the end test). You can find all the details in the actual blog post.\n\n&amp;#x200B;\n\n**Feel free to comment,  critique, or ask a question!**"
          ],
          [
           "zone_training_max",
           "Zone 2 ‚Äúmeasurement‚Äù, heart rate vs power output. I‚Äôm doing zone 2 on a peloton. I have a chest strap heart rate monitor. If I purely want to max out the time I get in zone 2 for the stats, I would start out going harder until my heart rate gets high enough. However I understand that zone 2 is actually a lactate thing and I‚Äôm probably going out of the lactate range by doing this.  There‚Äôs also a power meter on the bike which I calibrated by doing an all out ride (forget what it‚Äôs call, power zone something) and so I also have a roughly accurate zones it terms of my power output. \n\nShould I just stay in zone 2 power range until my heart rate catches up?  I tried going a little harder at the beginning recently and I think it made the overall first half of the ride considerably more uncomfortable."
          ],
          [
           "zone_training_max",
           "Exercise with bad knees. What exercises that are conducive to longevity and healthspan can I do? Alternatives to sprinting for the HIIT benefits and something to mimick zone 2 cardio perhaps?"
          ],
          [
           "zone_training_max",
           "What's the best way to improve your VO2 max?."
          ],
          [
           "zone_training_max",
           "Having trouble prioritizing.... I do F3 multiple times per week. It's a fitness group that is free and open to all men. It's peer-led, which means you show up and whoever's leading that morning leads whatever kind of workout they want to. Sometimes we jog, sometimes we lift concrete blocks (strength training), sometimes we spring. Often, it's a mix of all of these things. It's awesome, and I love it.\n\nAt home, I try to do the Attia big 3: Zone 2, V02max, and traditional strength training. But it's a lot, so I feel like I've got to make F3 work for one of them.\n\nI can just go super slow and easy during the workouts, and they will be suboptimal zone 2 sessions.\n\nI can go crazy hard for intervals during the workouts, and it will be suboptimal Vo2 max sessions.\n\nOr I can focus on the strength components and make sure to squeeze the orange there, and let my F3 workouts replace 1-2 strength sessions per week.\n\nWhat would you do?"
          ],
          [
           "zone_training_max",
           "Can't seem to break into Zone 5. My second week of VO2 max training today - swimming laps and can't seem to break into Zone 5!  This is assuming the zone estimates by Polar H10 as a 33F. I pushed myself as hard as I could sustain for 4-5 minutes for each hard interval and wondering if I should just shorten the intervals to 1-2 minutes in an attempt to get my heart rate up higher for a shorter burst of pure sprint? The hard intervals in the image above correlate to 1. freestyle 2. backstroke 3. freestyle 4. backstroke 5. medley (minus breast).\n\nI'm not sure if this is an endurance issue on my end? I swim once or twice a week, so it may not be my strongest cardio compared to biking or rowing. Any thoughts appreciated.\n\nhttps://preview.redd.it/uyukra8zmvib1.png?width=2356&amp;format=png&amp;auto=webp&amp;s=aa1d31d7734ee7ab6d8e95fff6e5a137fef2ab90"
          ],
          [
           "zone_training_max",
           "Is My Zone 2 Heart Rate Too Low?. After reading up on how to do zone 2, it has come to my attention that it should be performed in a low steady-state intensity. However, according to my Whoop fitness tracker, zone 2 is in 60-70%, so I've been staying around an average of 128 BPM in my z2 sessions, however in Peter Attia's book Outlive it states 70-80% of max HR. Mine was 194 BPM after a hard, running session (almost threw up). Is my zone 2 avg 128 BPM too low? If so what should it be? 130? 140?"
          ],
          [
           "zone_training_max",
           "Only one home exercise for longevity?. Just had another kid and can‚Äôt do my usual gym or surfing as there is very little time atm.\nWhat‚Äôs one exercise I can do daily at home that would give some general benefit for M50.\nNot trying to stay fit or have an intense workout but just keep things moving a little and feel like I am doing something. \nThings like push ups or burpees or I don‚Äôt know??"
          ],
          [
           "zone_training_max",
           "How ‚ÄòTrainable‚Äô Is VO2 Max Really? ‚Äì A Case Study Blog| ByAlan Couzens. This blog post says the best way to improve VO2 max is through large amounts of Zone 2 training. He doesn‚Äôt quantify how much constitutes a large amount. But he makes the claim that ‚ÄúLSD‚Äù training is far more effective than Zone 5 intervals."
          ],
          [
           "zone_training_max",
           "Sometimes the most simple things are so powerful. [https://www.youtube.com/watch?v=1HcwDBiX7oo](https://www.youtube.com/watch?v=1HcwDBiX7oo) \n\nJust stumbled upon this Box Breathing method. I heard in a podcast that they teach this to paramedics and Navy Seals. I added this breathing method to my morning routine and I have grinding thanks to this. I find myself coming back to it multiple times a day. Guess I should share, hope anyone else finds it useful :)"
          ],
          [
           "zone_training_max",
           "VO2 max and HIIT training suggestions?. I'm a longevity doctor experimenting with the concept of longevity challenges (as seen in Limitless ft Peter Attia and Chris Hemsworth) and for this month's challenge we're focussing on Vo2 Max and HIIT. Any suggestions on good protocols? We are quite keen on the Ronnestad or Hickson protocols, but would love to hear what most people do for their HIIT training.   \n\n\nIf you're keen to join in our monthly challenges, we have a facebook group where we post info, answer questions and share experiences [https://www.facebook.com/groups/zestlongevitychallenges](https://www.facebook.com/groups/zestlongevitychallenges)"
          ],
          [
           "zone_training_max",
           "Attia-approved exercise schedule I landed on. Hey all,\n\nI have spent a lot of time tinkering with an exercise schedule that fits the Attia's core recommendations and feels physically and psychologically sustainable for me.\n\n**The criteria I personally wanted in a schedule was**:\n\n1. I am OK with going to the gym every day, but not multiple times per day\n2. Never doing both cardio and lifting in the gym session\n3. Equivalent of 3 hours / week Z2\n4. Z2 to Z5 ratio of 4:1\n5. Lifting: Equivalent of 10-20 working sets per major muscle group per week\n6. Never doing Z2 or Z5 the day after lifting legs, as my performance always seemed to be worse doing it that way\n\nI landed on a 4 day cycle, which means it does not sync to a weekly calendar. This does not bother me, but I imagine it would be a non-starter for many. This is not meant to be ideal for others, it's just what works for me and wanted to share it in the hopes of sparking ideas.\n\n\\-----\n\n**The schedule** (\\~60 MET hours/week):\n\nDay 1: Lifting, lower body, 20-25 working sets over 60-90 minutes\n\nDay 2: Lifting, upper body, 20-25 working sets over 60-90 minutes\n\nDay 3: Zone 2, 60 minutes\n\nDay 4: Zone 2, 45 minutes (*FOLLOWED BY*) Zone 5, 4x4 (32 minutes)\n\n*-Z5 occuring every other cycle, aka once every 8 days*\n\n\\----\n\nFeel free to provide thoughts, feedback, or share your own schedule!"
          ],
          [
           "zone_training_max",
           "Is a 5 minute interval at the end as effective as 4x4s for vO2 max?. I read the article by Inigo about his talk with Peter, but I wanted to see if there was any conflicting information on whether or not it is true. To me, it seems more manageable to do a 5 minute high intensity session at the end of zone 2 training 2-3 times a week, rather than a 4x4 which ends up taking 32 minutes at least in itself. Are they equally effective?\n\nThank you."
          ],
          [
           "zone_training_max",
           "My VO2 is max is not going up despite months of consistent training. Hello, I'm trying to get my VO2 max to 70 due to what I've heard from Huberman and Attia about the longevity benefits of it. However, despite months of training, my VO2 max stays around 55ish.\n\nThis is what I've been doing: \n\n* Mon: 35 min easy run\n* Tue: intervals 3 min/3min rest x 4\n* Wed: 35 easy\n* Thur: Intervals 1 mile / 5-6min rest x 4\n* Fri: 45 min Row \n\nAlso, occasionaly I'll doing rowing on Saturday and Sunday as well. Why Isn't my VO2 max going up? How can I adjust my training to maximize it?"
          ],
          [
           "zone_training_max",
           "Is my zone 2 threshold really this terrible?. I‚Äôm a 49yo overweight F (BMI 28 today after gaining almost 20 lbs in the last year), and exercise daily with a rare skipped day. Mostly Peloton, some elliptical, some strength. Dry sauna almost daily.\n I was originally aiming for a HR of ~130 for my zone 2 workouts based on Peter‚Äôs general recs in podcasts based on HR. Then I saw KellyAnn Niotis in person (who now works for Peter) and she said that was probably way too high and I should aim for HR 115 for my zone 2. Then I got a lactate meter and discovered that at a HR of 121 on the peloton my lactate was 4.1. (but I was postprandial). Several more lactates were 2.0-10.1 (!) at a HR of 115, with the high being when I was underslept and had a URI. When I lower my HR to 104-110 on the Peloton my lactate has still been 2.1-2.4.  Seriously? WTF? So I did one at a HR of 97 and my lactate was 1.4, and next one at a HR 103 my lactate was 1.2. I‚Äôve definitely noticed a clear increase in lactate when I‚Äôve eaten sugar or carbs before exercising or when I‚Äôm sick, but it seems so ridiculous that my goal  on a good day should only be about 105? Got my VO2 max tested last week on a bike and it was 31.2 (though my heart rate was max 159, it didn‚Äôt quite get up to what I think my max is based on running sprints I‚Äôve done when I‚Äôve been maybe 166ish, so may have been slightly lower than my best because I gave up early?). In any case, I am just shocked that my mitochondria are so puny that my lactate threshold for zone 2 seems to be a HR of like 105 when cycling. It almost feels like a waste on an hour when I sit on the bike with a goal HR of 105, like did I even exercise at all? ü§£ My resting HR during sleep is in the high 40s. I just thought I was more fit than I am, I guess. Of note, I have never done it entirely fasted- I always have a decaf coffee with fat and prebiotic fiber in the morning first. \nComments, advice or input welcome!"
          ],
          [
           "zone_training_max",
           "Rhonda Patrick on why high-intensity training is necessary for increasing VO2 max: \"There are individuals who engage in more moderate intensity steady-state zone 2 training that do not experience significant improvements in VO2 max.\"."
          ],
          [
           "zone_training_max",
           "Video of someone in zone 2?. Is there a video somewhere of somebody in zone 2 that is talking? I feel like this would really help me understand the right effort level. Can‚Äôt find one."
          ],
          [
           "zone_training_max",
           "Peter on Zone 2 vs Zone 5 cardio workouts. Referring to this clip: [https://youtu.be/Eb92hyaoGrU](https://youtu.be/Eb92hyaoGrU)  \n\n\n[https://peterattiamd.com/exercising-for-longevity-peter-on-zone-2-and-zone-5-training/](https://peterattiamd.com/exercising-for-longevity-peter-on-zone-2-and-zone-5-training/)  \n\n\n\"...obviously much more in zone 2 than zone 5...\"-PA at 43s  \n\n\nNot sure if I'm doing something wrong here based on PA's suggested approach in regards to zone 2 vs zone 5 cardio workouts. I'm 5'8\", 144lbs, and I mainly do 20:4 IF. Overall goals are: long-term fitness and retain/gain muscle.  \n\n\n3 days a week (M,W,F) all I do for my workouts are HIIT sprints on my treadmill - 20s all out sprinting at 9mph, 45s break, 10x, 15% incline (max). T and Th I do strength and muscle building so something I should be mindful of is cardio workouts that don't make too much of a negative impact on this.  \n\n\nAm I making a mistake by not incorporating 1x or even 2x steady state zone 2 cardio workouts?"
          ],
          [
           "zone_training_max",
           "Wait. Do you really need Z2 4x/week to improve, or just 3?. I checked this in the book again at the library and there he says you need to do 4x45min/week. But I was sure he's said in the podcast 3x/week to improve, twice to maintain. I realize it's probably just an incremental difference, but it sure sounds like a firm requirement to improve metabolic health in the book. \n\np.s. Yes, aNOTHer zone 2 question, sorry. ;) It's kind of endless but this is bugging me."
          ],
          [
           "zone_training_max",
           "Glucose Disposal Agents and Zone 2. Hello - I've found this: \n\n[https://pubmed.ncbi.nlm.nih.gov/10333946/](https://pubmed.ncbi.nlm.nih.gov/10333946/)\n\nI was wondering if anyone else uses GDAs before doing zone 2 workouts? I have stopped berberine because the fine doctor has said metformin raises lactate and I think berberine has the same mode of action. \n\nBut ALA is another option and this article seems to suggest its use is promising. But I figured there were smarter people out there who know much more on this subject."
          ],
          [
           "zone_training_max",
           "Zone 2 confusion. Just when I thought I had it figured out, a pair of videos on the Zero app have totally confused me on exactly what Peter means by ‚ÄúZone 2‚Äù.\n\nPreviously, Peter had given some non-lactate-meter guidance on using heart rate to find a person‚Äôs Zone 2. This is important because lactate measurement isn‚Äôt something most of us have ready access to, but a heart rate monitor is. Other metrics, like perceived exertion are difficult to determine in practice, at least for me.\n\nAccording to his Zone 2 AMA, Peter very casually mentioned that he recommends 78% true max heart rate (not calculated) to his patients. This corresponds, according to Peter, to Peloton‚Äôs lower end of Zone 3. \n\nI‚Äôve been doing 78% max heart rate four times per week for 45-60 minutes on a Peloton bike, which corresponds to my lower end Zone 4 output (!) and lower end Zone 3 heart rate. I just figured Peter meant Zone 3 heart rate and misspoke. At this effort, my legs feel tired very early on, but I do adapt and am able to finish the ride without issue. In other words, it‚Äôs not as low intensity as Peter makes it seem ‚Äî but I figured that was just because I‚Äôm some plebe and not an athlete. \n\nHowever, today, I saw two videos on the Zero app (for which Peter is an scientific advisor) that make me think I‚Äôve been going about things all wrong. Both are about exercising while fasted. I don‚Äôt know if I‚Äôm able to link to the specific videos since some content is behind a subscription paywall. \n\nThe first video by Thomas DeLauer references Peter specifically and says that Zone 2 is situated between 60 and 70% max heart rate. The accompanying text links to a video by Peter on the same theme in which he says that Zone 2 is situated between 70 and 80% of the maximum *output* you are able to sustain for an hour. \n\nOn a bicycle, that ‚Äúmax output for an hour‚Äù metric is known as your FTP. According to Peloton, Zone 3 (output) is 76-90% of your FTP. In other words, a lower end Zone 3 ride on Peloton correspond to roughly 78% of your maximum output that can be sustained for an hour. This makes me think I either misunderstood the guidance or Peter misspoke, leading to confusion. Zone 2 is probably best determined by triangulating the following: 1) Roughly 78% FTP, 2) a heart rate in the neighborhood of 60-70% max, and 3) an effort that allows you to carry on a conversation without heavy breathing. In other words, I was probably doing too much work and my quickly tired legs were likely a big clue. \n\nI know there‚Äôs a lot of confusion about this because I‚Äôve engaged with others here about doing Zone 2 cardio, and people are all over the place with their understanding. I think Peter very specifically avoids giving much guidance based on something other than lactate, and when he does it‚Äôs not very detailed information, so it‚Äôs hard to make it actionable. I think I‚Äôve finally figured it out, though. Please let me know what you all think if you managed to read everything. \n\nTl; dr: Zone 2 is probably best determined by triangulating the following: 1) Roughly 78% FTP, 2) a heart rate in the neighborhood of 60-70% max, and 3) an effort that allows you to carry on a conversation without heavy breathing.\n\nEdit: \n\nVideo 1: https://go.zerofasting.com/s/3qwM3WFqunfi6kS28\n\nVideo 2: https://go.zerofasting.com/s/85fG6AGUXunET2Zo9\n\nVideo 3: https://youtu.be/l00ovBIPxz8"
          ],
          [
           "zone_training_max",
           "What‚Äôs your favorite way to move your body. Looking for a new fitness pursuit or challenge. Ran a sub 90 min half marathon and now looking at bjj as something to try, as well as weight lifting, what do you all do?"
          ],
          [
           "zone_training_max",
           "Weight lifting for 15 mins ?. Kinda dumb question but is it viable to lift weights for different muscle groups six days a week ? I already do yoga 6 days a week and spin classes 4 times a week because they make me happy but weight lifting is boring so trying to keep it as short and effective as possible"
          ],
          [
           "zone_training_max",
           "Peter tells Huberman why he stopped taking metformin (he stopped back when he got serious about zone 2; it was raising his resting lactate to 1.6 mmol ‚Äî healthy resting lactate levels are &lt;1 mmol)."
          ],
          [
           "zone_training_max",
           "Exercise Criteria to tell if you are in shape?. I've heard Peter list some basic exercise goals to set a baseline for if you are in shape including:\n\n&amp;#x200B;\n\n\\-dead hang for 2 minutes (male)\n\n\\-farmer carry your body weight\n\n\\-wall sit for 2 minutes\n\n&amp;#x200B;\n\nAre there any others that he uses that I missed?"
          ],
          [
           "zone_training_max",
           "Zone 2 - rowing or cycling?. Sorry in advance for a most likely stupid question, but is it me, or would it actually make sense to use a rowing machine opposed to a stationary bike for zone 2 given that one would potentially spend 5 hours a week conditioning way more mucles? Or should it not be counted as a muscle conditioning but rather a cardio/mitochondria training instead? Would be interested to hear what your thoughts are :-)"
          ],
          [
           "zone_training_max",
           "How often can you use a PEMF mat in a day?. I have one that I use for relaxation, concentration, headaches, aches and pains. \nHow many sessions with different frequencies can I do in a day?"
          ],
          [
           "zone_training_max",
           "Opinions on zone 2 timing with strength training.. Most days, I am to knock out my zone 2 first thing in the morning, and then a strength workout at lunch.  That way there is some good separation between them.  I have a couple days a week though where I‚Äôm only free for a couple hours at lunch and want to combine them.  I know they usually say cardio after lifting - but does that go for z2 also since it‚Äôs so light?  Could  I treat a low end, 45 min z2 as a warm up and not compromise effort for the lift?"
          ],
          [
           "zone_training_max",
           "zone 2 my problems and observation. I'm starting to experiment with running and trying to find \"zone 2\"\n\nI run 70-80km per week\n\nI have a hr sensor on my chest. which works well for sure.  And the highest heart rate it has shown me so far up to 185 but I rarely run above 180 on intervals.\n\nMy threshold heart rate is 174.\n\nI have tried different zones. I was running from 140-150 I could run like that, but I felt fatigue at the end especially on long runs. \n\nNow I'm trying to run at a lower heart rate i.e. 125-135 and it's easy, but I feel like I couldn't run like that with my mouth closed. And talk to someone all the time.\n\nDo you guys think I'm just trying too hard or is there something to it?"
          ],
          [
           "zone_training_max",
           "Peter's StairMaster Zone 5 Training Protocol: 3 Min. of Zone 2, 1 Min. at VO2 Max, Repeat for 20-30 Min. (3-minute podcast clip)."
          ],
          [
           "zone_training_max",
           "Stephen Seiler: You don't need to be polarized if you are training endurance three times a week. Just listening to [Inside Exercise #46](https://podcasts.apple.com/us/podcast/46-what-are-we-polarizing-in-polarized-endurance-training/id1631457776?i=1000612992025) \"What are we polarizing in polarized training\" with Stephen Seiler. Seiler is of the most vocal researchers on the benefits of prolonged low-intensity exercise. Obviously, he is the guy behind the well known Ted-talk \"How normal people can train like the world's best endurance athletes\" and known for pushing the 80/20 principle. \n\n@ 1:37:30 (The whole episode is worth a listen. )\n\n\"**Now what about three days ? Do I need to be polarized at three days a week? Probably not, cause you got so much recovery time\"**\n\nHe goes on to say  \"However, even for the three day a weeker I would say, look, try to make one of those days longer, dont just think intensity... Have a long run, an interval day and a middle run day...I still want to use intensity and duration as stimulus.\" \n\nHe also says earlier in the talk that the 80/20 rule is a guardrail, not a straight-jacket. \n\nSeiler **does** say that if you are exercising 7-10 hours a week, you should be using polarized training.\n\n*Thus I think we can put this issue to rest, if you are a recreational runner three times a week, you should not think in terms of polarized training, think in terms of a longer run, an interval day and a medium day. Polarization is a principle that comes into play when exercising back-to-back days.*\n\n&amp;#x200B;"
          ],
          [
           "zone_training_max",
           "From ‚Äúlow‚Äù to above average VO2 max in 14 months. Next stop high üí™üèª."
          ],
          [
           "zone_training_max",
           "Skating is a very underrated sport.. I was watching a podcast where a heart doctor said strong leg muscles are critical to metabolism. Running will certainly develop them BUT at a high price. Every time you run, you are running a jackhammer on your joints. Speedskating can give you a lot of benefits with less chance of injury. Protective gear (helmet, wrist, elbow, knee) is always suggested. In thousands of miles, the one time I needed it saved me! I think if it like a seatbelt or airbag. Eventually you build a tolerance to skate 10, 20, even 30 miles. You can skate uphill. You can try to break speed PRs. It develops your balance and makes you immune to falling. Your brain has to work in different ways to coordinate you more than almost any other sport.\n\nThe skaters on YT look like they are doing very well #skatefreshAsha is in her 50s (a 30+ year veteran). She is in better shape than some 20year olds. There are some others too. You also get lots of fresh air and its great for mental state."
          ],
          [
           "zone_training_max",
           "Personal Trainer Suggestions?. Hey all - I‚Äôve been a fan of Peter‚Äôs for some time now, and have been more and more interested in longevity, which has only been intensified by a recent injury that limited my range of motion for some time. I‚Äôm on the hunt for a personal trainer to help focus on muscle groups and exercises that more closely to conform to stability and injury prevention, along the lines of what Peter typically suggests. Has anyone successfully found a trainer that specializes in this type of training? Is it as simple as finding someone willing to listen and adapt to your needs? Are there people that specialize in this field? My initial searches have not returned very strong results. \n\nAny feedback/stories would be appreciated!"
          ],
          [
           "zone_training_max",
           "Recorded max HR of 192 in 39 male - cause for caution?. https://imgur.com/a/0Ifytga\n\nAge 39, male, 71kg avg, 6ft, v02 is around 49.  RHR 49 - 54.  My main sport is climbing which i do to a fairly high level for a non professional, train strength 3x a week for it for 14 years and outside of that I run for all the health benefits. I don't consider myself a runner at all,  - climbing is my sport - but I'll do 3x a week most weeks varying between HIIT and longer zone 2 runs.  \n\nAnyway, I've always used the 220-age formula for max HR.  After hearing Peter say this isn't a great metric I went out and tried to really push it hard to see where I could land, and hit 192. \n\nThats obv quite a bit higher than 220-age.  \n\nWhat could I read into this? \n\nIs it a sign that I am fit (because I can get into that number range at my age) or did i nearly kill myself by accident and make my heart go pop? For what its worth I'd say it was at maybe 90% I felt like I could have gone harder but when i saw 192 i thought ok... that'll do.  but this could just be my inner gimp speaking"
          ],
          [
           "zone_training_max",
           "Zone 2: Muscle Burn vs. Breath - What to Focus On?. I am coming from weightlifting/bodybuilding background and just started focusing on Zone 2 cardio. Attia recommends to keep lactate below 2mmol, so I assume any muscle burn is generating extra lactate. However, his another heuristic is that you should be able to breath easily through your nose only and it should be all-day pace.\n\nI am doing my zone 2 cardio on airbike and my breath and cardio is totally fine and I barely feel like I am exercising, but my legs are burning and I think I am at that point generating lots of lactate despite easily maintaining conversation and breathing through nose.\n\nMy question then is, besides getting lactate meter, what should I focus on in order to stay in zone 2 and under 2mmol lactate: breath/cardio or muscle?\n\nI might have just much better cardio than muscle endurance? And if that is the case what would you recommend to me to stay under  2mmol of lactate?"
          ],
          [
           "zone_training_max",
           "Boost Your Stamina and Drive Naturally It‚Äôs not about being enough it‚Äôs about being more."
          ],
          [
           "zone_training_max",
           "How do you fit 4 x strenght training, 4x45min zone 2 cardio and 1 VO2 max training into a week?. That‚Äôs what I understood he recommends. When do you mix cardio and strength on the same day?\nI am doing Mon-Wed-Fri strength, Tue &amp; Thu Zone 2 Cardio and Sunday VO2 max. Friday rest."
          ],
          [
           "zone_training_max",
           "Anybody have thoughts on ice bath after zone 2?. That is all"
          ],
          [
           "zone_training_max",
           "COVID and VO2 Max association?. I got COVID just about a year ago and my VO2 max as measured by my Apple Watch tanked ‚Äî I was in the mid to high 40‚Äôs and then went to 36 (ouch). \n\nI‚Äôve been doing 30-45 mins of Z2 or a VO2 max training protocol almost everyday for about a year and I‚Äôm barely catching to where I used to be (I average around ~44). \n\nAnyone else go through something similar? It‚Äôs incredibly frustrating."
          ],
          [
           "zone_training_max",
           "Lancet tips? Not generating enough blood.... Just got an edge lactate meter. When I use the lancet (on the 5 setting) I puncture my skin and barely generate any blood. I've tried 4 times and haven't once generated enough blood to get a result from the lactate device. Any tips on how to generate more blood??"
          ],
          [
           "zone_training_max",
           "Prepping for a marathon in under 2 months. Do I do what Tim Ferris said and just train the crap out of VO2 Max, with minimal endurance training? Would love to hear what yall would recommend."
          ],
          [
           "zone_training_max",
           "Zone 2 and beta blockers. Hello,\n\nI have a father that is very unhealthy. He's obese and in the far past he had an heart attack due to severe smoking. For that reason he takes beta blockers. He's in his late 50s.\n\nHis physical training of choice is taking walks outside. When he does he does so with an Apple Watch, which can measure heart rate pretty accurately.\n\nFrom his Apple Watch I can see that he's not pushing himself nearly enough to have a serious workout: it's all zone 1. He however makes the point that he can't even get high heartrate due to the meds he takes (tenormin).\n\nAnd so, here I am trying to understand: how do beta blockers influence zone 2 training?\n\nIs he making excuses and can I make him push himself harder?"
          ],
          [
           "zone_training_max",
           "Did Zone 2 cure my hypertension?. For the first time ever my blood pressure has been well below 120/80, even though I'm already a very clean eater and have exercised in the past. Zone 2 treadmill work 2-3x a week per Peter's recommendations has my blood pressure normalized to better than normal levels. And that's only after about 5 weeks of diligent work. The only other variable is that I started supplementing Boron around the same time and I doubt it would have such a significant effect. I'm pretty stoked!"
          ],
          [
           "zone_training_max",
           "How much Z5 do you aim for?. Lately, I‚Äôve been able to get ~6 minutes of zone 5 in my 4x4 VO2 max training sessions. Is there some ‚Äòminimum‚Äô I should be pushing for? I know more is better, but just am wondering if there‚Äôs some amount I should really be aiming for (e.g., 8 minutes, 10 minutes, or more of Z5)"
          ],
          [
           "zone_training_max",
           "Why does that slight burning sensation when you push an exercise/lifting set hard lead to muscle growth?. I know when we workout a little harder and push to the point where the  last few reps are close to failure we get more muscle growth.\n\nThat slight burning sensation you get when you get close to those last few reps is always a good sign your pushing it hard enough.  \n\nWhy is that.  What is happening during that particular feeling of muscle burning or fatigue that causes muscle growth?"
          ],
          [
           "zone_training_max",
           "Slight burn when training zone 2. Too much lactate?. Hi folks!\n\nNew to doing targeted zone 2 training, and Peter seems to suggest that heart rate isn't the greatest indicator for what zone you're in‚Äîseems more about lactate. I'm not willing to get a lactate meter, and I don't want to talk to myself out loud in a busy gym and look like a crazy person. I recall him saying that if you feel a \"burn,\" then you're likely pushing it too hard. In the past several sessions on the bike, I've noticed that I feel the slightest burn in my legs throughout my ride. I remain at a consistent 130-140 HR (about 60-70% my max HR). I never feel fatigued but again, experience a minor burn. Just curious if this is normal/appropriate for zone 2. Thanks and happy training!"
          ],
          [
           "zone_training_max",
           "Fueling for exercise studies / papers wanted. I realize I could post this in the nutrition or fitness subs but I'm worried I'll get mixed responses so here goes.\n\nI've been training to improve my fitness Z2, VO2Max, strength, etc as a full time job. Been making all my own meals and weighing ingredients and logging it all in an app so I have a really high resolution picture of my macro nutrients. I'm trying to get better at forecasting nutrition, especially fueling exercises. I've been caught off guard in longer z2 bike rides or long weekend social rides and bonking. I can see this in my CGM. \n\nI have somewhat recent data on my VO2 performance (fat-ox vs glucose-ox from an actual test) and would like to use that data to refine my fueling needs. I realize this gets into the realm of athletic performance and sports nutrition.\n\nI'm wondering if anyone has any recent papers or studies (hopefully with a good cohort, like they progressed in some fitness metric, hopefully VO2max or running times) on how to plan and structure meals and how to properly calculate and time macro nutrients? \n\nI read this paper from 2017 [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5753973/](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5753973/) which had good content but left me with more questions than answers. I'm particularly concerned about developing insulin resistance when always fueling for glucose needs. Because the reality is that we do need carbs to make glucose to fuel 20-30% of our energy needs even in zone 2. And probably 80% of our needs during HIIT. So I'm trying to optimize fueling so I fuel with the right amounts and types. \n\n&amp;#x200B;\n\nThanks!"
          ],
          [
           "zone_training_max",
           "Help interpreting this data. As the title suggests. 40M set my max HR to 180. \n2nd pic shows entire run was aerobic.\n\nAm I to assume this is what zone 2 looks like despite my garmin watch showing higher zones given it's a 100% aerobic workout?"
          ],
          [
           "zone_training_max",
           "What is the best way to maintain aerobic fitness while in a muscle building block?. My main goal right now is to gain weight and put on muscle , so I know I need to lift heavy and eat A lot, but what is the best way to maintain fitness? Rowing, sprinting vs distance running , cycling , swimming? Any advice would be great!"
          ],
          [
           "zone_training_max",
           "Can we use breath markers or the \"talk test\" to determine our fat-burning zone? Short answer: We cannot.."
          ],
          [
           "zone_training_max",
           "Breathing exercises. I hear a lot of people talking about breathing exercises, but I‚Äôm not sure what each one does, or what they are. Below are the ones I know of and what I *think* they are. Can anyone confirm and / or suggest your favorite breathing exercises with description of what it is? Also descriptions of what they are doing in the body? \n\nThe ones I‚Äôve heard of are:\nBox breathing (4 seconds deep breath in 4 seconds hold, 4 seconds out, 4 seconds hold, repeat) not sure what it does \n\nButeyko (2 second shallow breathe in, 4 second breath out, hold breath until air hunger, repeat) (I‚Äôve done this before to help with congestion and it works. Not sure why / how \n\nWim hof (deep breath in, deep breath out. Repeat several times, then hold bread on the out as long as you can and repeat.) not sure what it does \n\nPranayama - no idea \n\nI‚Äôm sure there are others. Would love to know everyone‚Äôs favorite and why!"
          ],
          [
           "zone_training_max",
           "How much difference between 90 and 95% MHR for VO2 max?. I ask because it's winter and I'm in New England. There are times when, between cold temps and short days, I can't do my usual carry-heavy-weight-up-the-mountain routine. And I find it far more difficult mentally to do really high intensity indoors on an exercise bike. I think I might be able to hack it if I just stay at 90%. And maybe also do say 2 - 3 min instead of 4. Any thoughts (educated thoughts, of course) on how much benefit I may be missing?\n\nAlso, doing this at maintenance level would be fine--I can concentrate on going all out when I'm able to be outside in winter and of course also during the summer."
          ],
          [
           "zone_training_max",
           "Zone 5 Life Hack. Stupid satire/lowkey troll post.\n\nAlways had issues getting into Z5. Donated blood on Thursday and I did my intervals this morning, hit my Zone 5 BPM beautifully. IYKYK."
          ],
          [
           "zone_training_max",
           "Zone 1 is having a profound impact on me !. Stats :\n\nM/165 CM/84 KGs\n\nI have been sedentary for most of the time from past 8-10 years. From past 5 months, I have been doing workouts here and there and recently I started doing zone 2 walking on my threadmill for 50 mins 3 to 4 times a week. The results with bit \" meh \" and I never felt that kick or feel good thing which I brushed off as thinking my body is adapting that it will eventually come. I have been on this routine from past 2 months. I also added a bit if HIIT here and there which absolutely makes me feel terrible. Anyways this week I wanted to see what will happen if I just stick to Z1 ( 50 to 60 % of my MHR). So from past 1 week, I have been exclusively doing Zone 1 for 1 hour daily and this has been truly life changing to me. After the workout, I feel refreshed, my mind clear and calm, I have this sustained energy for whole day, I feel sharp and most importantly my sleep quality has increased dramatically and most pronounced affect I see is that my HRV literally doubled ( from 50s to 110s). \n\n&amp;#x200B;\n\nDoes anyone has any idea on why Z1 is having such a dramatic impact on my biology please ?"
          ],
          [
           "zone_training_max",
           "Tips for Knee Pain on Ellipitcal while doing Zone 2?. I use this compact elliptical (Stamina InMotion) for general cardio, which also includes  Zone 2.  The motion is circular, but more compact than what you would experience on a traditional elliptical at a gym. This device was perfect for me since I can just do it in my office when I have a busy schedule. I always do it standing up, and not sitting down.  I usually do it 45-60 minutes.\n\nLately, however, I have been getting knee pain from doing it. This is disappointing since this is supposed to be low impact. Even when I alternate pedaling forwards and backwards in increments, I get the knee pain.  I used to not get knee pain from this.\n\nDoes anyone have any tips on how to avoid knee pain while using a machine like this?\n\nIs it simply a matter of resting enough days in between sessions? Can I try to concentrate on a certain form that would alleviate knee pain, such as trying to keep my knees over my toes, or keeping my hips pulled back? Currently, I just do it in a normal standing/walking position.  Is there something possibly inherent about the machine that causes knee pain? \n\nHere is a link of what it looks like, although I usually remain standing while doing it. (The person is not me.)  \n\n[https://www.youtube.com/shorts/bu8lD4TpoeI](https://www.youtube.com/shorts/bu8lD4TpoeI)"
          ],
          [
           "zone_training_max",
           "Zone 2: better to undershoot or overshoot?. I'm doing my Zone 2 training based on the breath test. I know it should be pretty easy to figure out whether you're in Zone 2 based on this, but I still find it's sometimes a bit hard for me to figure out whether I'm working hard enough or too hard. I think there is a bit of confusing information about the breath test out there and how hard you should be working when in Zone 2.\n\nFrom what I've read from Attia, it's really not ideal to go over Zone 2. So, should I be a bit conservative with this and maybe risk undershooting the \"ideal\" Zone 2 level of work? As long as I'm sweating pretty well, that should mean I'm out of Zone 1?"
          ],
          [
           "zone_training_max",
           "Improving Balance + Body Coordination?. This is a pretty specific thing I'm looking to improve.\n\nBasically I live in the mountains and really like big mountain skiing. I have no problem hucking cliffs etc, but I find it very hard to land flips &amp; spins and its really hindering my progression skill-wise.\n\nI am not really sure how to improve my balance for spins, flips, and general athletic/acrobatic shit. I know this sounds very niche strange, but it's pretty much the only athleticism related thing I struggle with. I'm in good shape, have great physical performance, but seem to lack that 6th sense that a lot of my friends have in these types of sports.\n\nThe only thing I've been able to find about this is Alpha GPC + Choline supplementation. if anyone can point me in a direction here, I'd love it. Additionally, if anyone knows good home exercises to fix balance and better get in touch with body, I'd love it."
          ],
          [
           "zone_training_max",
           "Zone 5 interval training. Should I count recovery intervals in the total time?."
          ],
          [
           "zone_training_max",
           "Had a good 4x4 session today. Don‚Äôt think I‚Äôve seen a 178Hr before ü•µ."
          ],
          [
           "zone_training_max",
           "Help with blood lactate test results. Hi. I‚Äôm 47M 166lbs and started running last November. I am currently running approx 45km per week, mostly easy runs. Last week I managed to perform a blood lactate test using the treadmill at home. The protocol was:  \n1)Test at rest  \n2)20min easy warm up followed by testing  \n3)4min duration steps with subsequent increments of 1km/h starting at 8km/h each step followed by testing at minute 5\n\nI managed to go up to 14km/h (please be nice!) and the results are in the links below. I was wondering if anyone here could help me interpret the results (id‚Äôing training zones). I also got a bit confused with results between 10 and 11km/h where Lactate levels dropped a bit (sampling problem?). In case you are wondering why I got the device since I‚Äôm such a newbie‚Ä¶ I had the opportunity to get it for free via an award program at my employer and being 47y I am trying to optimize my training as much as possible to avoid injuries and energy expenditure at the wrong place (or paces). Does that make any sense? TYA!\n\n[https://imgur.com/a/IVjXcHe](https://imgur.com/a/IVjXcHe)\n\n[https://imgur.com/a/DdECg79](https://imgur.com/a/DdECg79)"
          ],
          [
           "zone_training_max",
           "Treating my hypertension dropped my vo2 max?. I‚Äôd had a blood pressure of about 135/85 for a few years and inspired by the podcast, I went to the dr and got put on Losartan, which very nicely brought my level down to 110/70. This is great and I‚Äôm very happy. \n\nBut I also noticed on my Apple Watch that directly corresponding to the time I started taking Losartan, my VO2 max which had been stable for whole year since I began tracking it, dropped from 47 to 41 and has stayed there. \n\nIs there some sort of blood pressure math where lower BP results in lower VO2 max? I believe I‚Äôm overall healthier all things considered but I was curious at the change."
          ],
          [
           "zone_training_max",
           "Cycling vs Rowing. Does the additional whole body muscle workout of Rowing make it a better exercise for longevity than cycling?"
          ],
          [
           "zone_training_max",
           "How much value in adding a little Max heart rate to my warmup before weight training?. tl/dr: I think the core question here is: does anyone know how sustained high-intensity aerobic needs to be to make a real contribution to BDNF and other brain-health stuff. I realize there may not be a clear answer but wonder even if people have thoughts or advice on how to think about this.\n\nI've stepped away from doing full-on VO2 max as Peter outlines it. It just feels like too much right now. I've been experimenting with different types of high-intensity aerobic work, including tabatas, HIIT, and one min over 90% MHR/one min going easy...and repeat four times. I've been doing one of those things 3 or 4 times a week. What I'm especially focused on, at 62 and starting a new, demanding career, is long-term brain health and possibly even improving things like short-term/working memory and overall cognitive function, all of which have taken a hit from a decade of high stress, insomnia (mostly gone in the past month or two), and of course aging. I have in my head the importance of high-intensity aerobics for BDNF...and other stuff... which both Rhonda Patrick and Wendy...neuroscientist at NYU who was on Huberman once, and the idea that with a lot of this stuff you may even be able to increase the size of hippocampus. A little. So I'm wondering if it's even worth adding a little after my warmup for weight training 3x/week. Today I did a three min warmup and then ramped up to over 95% MHR, probably had 90 sec over 85%. Then on to the weights. Is this sort of thing likely to help, or do you really need it to be sustained to make a difference."
          ],
          [
           "zone_training_max",
           "Excercise snacks-how to do them?. Rhonda Patrick recommends doing exercise snack 3x a day for 1-3 minutes. Like hillsprints or burpees, but if I was to just get up from my desk and do a 100% effort hill sprint I would tear my quad off the bone. If i start warming up for these 1 minute exercise snacks I would be taking an hour a day to do these things. Is there some sort of high intensity workout we could do that doesn't require a warmup?"
          ],
          [
           "zone_training_max",
           "Help me fit it all in (Weekly programming for Strength, Vo2max, zone 2 (and climbing!). I currently do strength training 6 days a week (I'm currently following a high frequency, low daily sets, program, a la K Boges), and Rock Climb twice a week (mostly indoor bouldering).\n\nI've recently purchased a BikeErg and have begun incorporating zone 2 into my week.  \n\nI aim to follow Attia's advice to complete 4 x 45 minute zone 2, and 1 x vo2max (4 min on, 4 off, x 4 - 6 reps).  I've heard his personal programming but wonder if there are any ways of doing this in a alternative way?  \n\nI have plenty of time to work out, so could in theory split to am and pm.  \n\nThere seems to be a lot of conflicting info out there on whether i can do zone 2 and THEN strength, or the other way round.....\n\nAny input would be awesome.\n\n&amp;#x200B;"
          ],
          [
           "zone_training_max",
           "Looking for Advice - VO2 Max Session. Yesterday was a zone 5 session for me. I am wondering if this heart rate chart is what it should look like. I am open to any tips or suggestions. Total session was 1 hour, started with 20 mins Zone 2, last 40 were 4 minutes on, 4 off. I am still figuring out what my max sustainable rate for 4 minutes is and felt that my first 4 minutes on was a little less than what it should have been."
          ],
          [
           "zone_training_max",
           "Variations of V02 Max Exercises. Hey guys, I'm curious to hear if you have any variations of your V02Max exercises? As in, do you use multiple exercises as opposed to doing the same each week. I would like to know what you do so I can add some variety beyond running 4x4 every week."
          ],
          [
           "zone_training_max",
           "Progressing without using HIIT. I really struggle recovering from high intensity intervals above 85%. It just causes too much mechanical stress and injuries. I have been doing about 80% of my training around Zone 2/MAF intensity averaging 75% around 130-135HR. I only do some intervals slightly above anaerobic threshold up to 85% at 150HR for 2-3 minutes at a time trying to progress. \n\nI am not a serious athlete but just trying to improve my heart and vascular health so I am not looking for peak performance. Moderate intensity clearly helps but I always wonder how much intensity I need to do.\n\nHow effective would it be to do mostly Zone 2/MAF training and only do moderate intervals &lt;85% rather than higher intensity sprints? Would this still enable continual progress but just not as quickly?\n\nWhat do you recommend for making the most progress when you just can't do higher intensity?"
          ],
          [
           "zone_training_max",
           "Comment on zone 2 session. Would like to have your comments on whether this is considered a good zone 2 session. I don‚Äôt know my HR max \n\nM 75kg \n1hour assault bike \nDistance 21 miles \nAverage watts 221 \nAverage speed 20.8 m/hr\nAverage RPM 54\nHR reading on my Garmin smartwatch was 162-166 for most of the session which my smartwatch apparently considers zone 4.\n\nSince idk my HR max, I tried to keep the watts close to 225 based on the 3watts/kg rule of thumb."
          ],
          [
           "zone_training_max",
           "Finally getting better at keeping my jogging in zone 2.."
          ],
          [
           "zone_training_max",
           "Any swimmers? I have questions.. Hi,\nI‚Äôm a fairly new masters swimmer (m45), working towards being competitive. Swimming every other day (typical swim workouts, intervals etc 2500-3000m/session), dryland (strength, power, core focus) 2x a week, 1hr brisk walk ~5x a week. \n\nI‚Äôm trying to see how to introduce some z2 biking into this - any suggestions? I was considering using my rest day (every 4th day), but not sure if this is the best approach. Is the Attia z2 approach compatible with competitive swimming (my z5 would essentially be in the pool)? \n\nTIA"
          ],
          [
           "zone_training_max",
           "Those that follow PA's fitness protocol, what progress are you seeing?. For those that follow Attia's fitness recommendations (particularly, Zone 2 and VO2max), I'm curious what progress you're seeing?\n\n* What is your protocol?\n* How are you measuring progress?\n* What has your progress been and over what time period?\n\nI've been running the past few years, with some considerably injury breaks. Most recently, over the past few months, I've been mostly attempting to stay in zone 2 (using PA's recommendation of \\~78% of max HR, which while high, is about as low as I can manage while running). \n\nI'm measuring progress by velocity at that heartrate over a \\~45 min session. Unfortunately, I'm not seeing much progress yet, so really trying to trust the process. Some of that may well be related to heat and humidity, but I also know Z2 benefits are supposed to accrue slowly. I'm just curious *how* slowly based on others' experiences."
          ],
          [
           "zone_training_max",
           "Tracking progress from 5 months of Zone 2 workouts on a Peloton. I started doing Zone 2 workouts a couple times per week in December 2022. I do a lot of these workouts on a Peloton and keep track some of the basic metrics such as average resistance, average wattage, and average heart rate. I also cycle and run outdoors and some of those outdoor workouts are Zone 2 workouts too. I did a lot of those outdoor workouts in February and April, which is why there are gaps in the chart.\n\nOn the Peloton, I usually set the resistance to a fixed number for the entire ride and keep my RPM around 90. When I first started doing these workouts, I was trying to keep my heart rate in the 120s. After doing a lactate test in February, I learned that I could probably let that run into the 130s and maybe even creep into the low 140s while remaining in Zone 2 on the bike, so that's the range I've been trying to stay in lately.\n\nWhen I plot my workouts, I think I can start to see an improvement in my average wattage relative to my average heart rate. I'm going to continue to track this over time to see if the trend continues. Let me know if you have ideas on how to analyze this data in a better way.\n\nhttps://preview.redd.it/zsdp7gh7znxa1.png?width=1570&amp;format=png&amp;auto=webp&amp;s=fe06cc3e5d9cfbf951038c6ccd73e9ec5090aee6"
          ],
          [
           "zone_training_max",
           "Would 1 hour of Zone 2 training every day be too much? Indoor cycle and/or jogging.. I do one 1 hr session of either the stationary bike or jog. My wattage to maintain zone 2 on the bike has increased quite a bit lately and it's starting to feel more like a leg workout. Thankfully I can now jog slowly and stay in zone 2 so I can give my legs a rest from the bike. Am I over training by doing an hour of zone 2 every day?"
          ],
          [
           "zone_training_max",
           "is my zone 2 too high?. Hi! F/50kg-late 60‚Äôs. an American in Tokyo. I did not know VO2 till April of last year. I had been walking (power walking) 5 miles 5-6/week, nothing else. My 1st VO2 was 31.7 last April and rose to 35.8 this April. 8 months ago I changed from walking to running 4 miles, 5-6/week. Then I started to hear zone 2. My zone 2 range (120-130)) it was calculated by the Norwegian 4x4 HIIT site (I bumped into its website randomly). I have not been trained on any 4x4, too old for that?! Now I‚Äôm getting concerned if my zone 2 is too high. because I started to notice people are using zone 2 with much lower ranges"
          ],
          [
           "zone_training_max",
           "Zone 2 on an Elliptical. Does any use an elliptical for zone 2? What is your rough watts/kg?\n\n\nI've noticed that my watts/kg is approx 3-3.5. Now I'm reasonably fit, VO2max approx 50, but this seems high compared to what I've seen on a bike. I suspect it's easier to increase output and still be in zone 2 on an elliptical because you can also use your arms."
          ],
          [
           "zone_training_max",
           "Benefits to other zones?. I know that Peter and this sub tend to focus on zone 2 and 5, but I was wondering if there are any benefits to zone 3 and 4? Wouldn‚Äôt most endurance athletes perform in zone 3&amp;4? Are there no health benefits to this? Just curious if Peter ever talks about this, cause so far I haven‚Äôt seen anything about it. Thanks!"
          ],
          [
           "zone_training_max",
           "Norwegian 4x4 seven weeks in: time to increase speed?. I've noticed that I've been gradually reducing the amount of time spent in zone 5 when going all out during the four minute intervals. Most of the sessions have been at a pace of 15km/h and the odd time I've moved it up to 15.2km/h or 15.5km/h.   \n \n \nBased on the below graphs, should I look to increase the speed to keep it at 15.5km/h or even a little faster? I guess it's a sign of progress that I'm spending less time in zone 5 whilst keeping the same speed, but then again maybe this is a sign that I should increase the tempo a bit.  \n \n\n  \n \n[4x4 Progress](https://ibb.co/2tYBxFR)  \n \n\n \n[Week 1](https://ibb.co/nfQTRqG) \n\n[Week 2](https://ibb.co/mGRSk3h) \n\n[Week 3](https://ibb.co/y8NhB4t) \n\n[Week 4](https://ibb.co/4pHVHqx) \n\n[Week 5](https://ibb.co/nQRm4DZ) \n\n[Week 6](https://ibb.co/YftNj0g) \n\n[Week 7](https://ibb.co/JdkGYQS)"
          ],
          [
           "zone_training_max",
           "32 VO2 MAX at 39.. I‚Äôll new to much of this but been healthy most of my life. Recently gave up drinking. After some burpees I measured my Vo2 max and came home with 32. At 39 I think that‚Äôs pretty good!"
          ],
          [
           "zone_training_max",
           "Alternative to 4min on, 4min recovey?. Currently, my weekly regimen includes one workout session where I  do the Attia classic - 4min on, 4 min recovery for 4 sets.. I won't sugarcoat it ‚Äì it's undoubtedly fucking awful. I'm fully conscious that it's not designed to be a leisurely stroll in the park. Nonetheless, I'm genuinely curious about exploring alternative workout approaches that hold comparable effectiveness to the one I've described above.\n\nTo illustrate, I'm contemplating whether it might be an idea to opt for an all-out sprint lasting around 60 seconds as an alternative option. perhaps with 2 min recovery?  For 8 - 10 sets.... It's worth noting that the 4-minute effort I currently engage in equates to roughly 80% of my maximum effort level."
          ],
          [
           "zone_training_max",
           "Any significant benefit to doing exclusively nose breathing during zone 2 cardio?. I was noticing the other day that Zone 2 can be light enough that I could probably just breathe through my nose. I was wondering if this might enhance the metabolic benefit, sort of analogous to high altitude training or blood flow restriction training. Or if it would end up being net negative because my power output and hence volume of work produced during the workout would be decreased. Or if it's a coin toss (or at best only slight benefit) then I'm not at a point where I'm trying to optimize down to the 1% level. Just curious if anyone had any actual knowledge around this, or strong anecdotal data?"
          ],
          [
           "zone_training_max",
           "Heart Rate Zone Calculator?. Trying to reset my heart rate zones for cycling. At some point in the past I apparently edited my heart rate zones using some training protocol I do not recall. I think I want to reset them to standard practice in both Strava (top) and Garmin (lower, with two variants apparently). I am 57 and believe my max heart rate is about 175 and my lactate threshold is between 157 and 160 (measured at 164 but that was 10 years ago). \n\nThere are plenty of heart rate zone calculators online but figured I would see if there are any better than the rest? Strava? Garmin? Or third party?"
          ],
          [
           "zone_training_max",
           "VO2max is Overrated. Myths and Realities for Longevity and Performance."
          ],
          [
           "zone_training_max",
           "Zone 2 after upper body strength training, conflict?. I do 4 lifting sessions a week (upper/lower x2) where I do HIIT/4x4 intervals after legs and x2 45 minute zone 2 sessions on two of my off days, with the last off day being a completely off day.\n\nMy question is: is there interference with upper body lifting and zone 2 training immediately after on my upper body days? Considering the same muscles are not actually used at all, and if there is in fact interference, how negative is it? Am I better off doing a different type of cardio on those days?\n\nI want my schedule to look like this: \nLower / 4x4 intervals after legs\nUpper / 45 minute zone 2\n45 minutes zone e\nLower / 4x4 intervals after legs \nUpper / 45 minutes zone 2\n45 minutes zone 2 \nOFF \n\nI can‚Äôt do two a days, and I‚Äôm not willing to compromise on lifting, but I want to gain as much benefit from cardio as possible.  Mainly doing it for a lower resting heart rate/blood glucose benefit/heart health (I‚Äôm an ‚Äúenhanced lifter‚Äù). I couldn‚Äôt care less about calories burned. Highly appreciate input!"
          ],
          [
           "zone_training_max",
           "Lower bound for effective zone 2 training?. My zone two has gotten sporadic since the summer and is getting more so now that snow and ice are making outdoor biking difficult. So far I just have not been able to bear long aerobic training inside the gym. Somewhere here, a year or two ago, there was what seemed like credible information on how MHR below 70% and/or the \"talk test\" is still helpful for mitochondria. I think the suggestion was that if you did enough volume, lower intensity was still helpful. What I'm thinking is maybe I can do some brisk walks, maybe an hour or more, and still get enough benefit? This is all of particular interest since I'm going off ketogenic diet and am hoping that zone 2 can help make up for the decreased energy that often comes with leaving keto. I'm 63 and need to be working at a high level for some years to come so staying fit is really key. \n\nAlternatively, I'm considering just not worrying about zone 2 for now and being sure to do plenty of a mixture of brisk walking and shorter duration HIIT at the gym."
          ],
          [
           "zone_training_max",
           "Help me overcome my skepticism about Zone 2 training (vs. Zone 3-4 etc). Hi All! New here: 40 y.o. male (the typical Attia-listener, I gather), I‚Äôve been reasonably active all my life but really trying to take my fitness to the next level. I‚Äôm reading Outlive and have listened to numerous episodes of The Drive. Help me understand why Zone 2 is so important vs. Z3 and Z4.\n\n  \nTo be clear: I understand and have no argument with Peter‚Äôs emphasis on VO2 max training and strength training. The benefits of these forms of exercise seem quite logical to me. Where Peter loses me is Zone 2. Specifically - if I can do an hour (or more) of either Zone 2 OR Zone 3+, why on earth is Zone 2 the better option? Logically it just does not seem to follow that my mitochondria and heart/lungs are getting a much greater benefit by going at the painfully annoying run/walk pace that Zone 2 seems to require. Can someone point me to the research (or explain) why deliberately going at a pace that is below what I know I can sustain for an hour or more is somehow better than doing Zone 3 or Zone 4 for an hour or so?\n\n  \nNot exactly a criticism of Attia, but he seems to preach ‚ÄúZone 2 as measured by lactate‚Äù all the time, but I haven‚Äôt seen him give a strong explanation of how he and others came to the conclusion that this is superior to training in the other zones.\n\n  \nThank you all in advance!"
          ],
          [
           "zone_training_max",
           "Out of shape or faulty equipment?. So I've recently been ill and trying to get back into shape with my cardio, and today was my first zone 5 workout. Or at least that was the plan.\nAfter 10 minutes of warming up on the assault bike I started my working sets, but I could not go past high part of zone 3. It was impossible. Most intervals ended on high zone 2. Lactic acid through the roof and severely out of breath at 159 bpm (max hr 192). However hard I sprinted I could not get HR up.\n\nIs this normal after being down with a cold? Or could my HRM be giving faulty reads? I did 8x1-2 minutes."
          ],
          [
           "zone_training_max",
           "Should zone 2 sessions be more continuous than the session here? More of a steady state HR?. With this session, switched machines a couple times to add variety."
          ],
          [
           "zone_training_max",
           "Rate the routine of a newbie. I haven't consistently worked out in a few years and plan to do the following starting tomorrow, please give me suggestions if you think it's not ideal:\n\n  \nMonday: 45 full body workout followed by 10-15 minutes of stretching\n\nTuesday: 30 minute zone 2 cardio, followed by 4x4 to hit vo2\n\nWednesday: same as monday\n\nThursday: 30 minute zone 2 cardio, followed by some form of hiit \n\nFriday: same as monday \n\nOn weekend I will probably do 1 day of hiking, tennis, or some sort of random sport\n\nThoughts?"
          ],
          [
           "zone_training_max",
           "New to Peter Attia please advise. Hey, just hoping to get some guidance. \nSo I came acrossa video of Peter attia with an interview with a professor. The things I took away from it were to do about an hour of zone 2 and then intervals of zome 5 (4x4). \n\nI've been doing it for a few weeks (zone 2 on the bike and zone 5 on the running machine). \n\nI know Peter attia said don't worry about HRMs but I just find when I'm going for an hour having a number to look it is a way to check I don't go to high or low. I've found for me around 120bpm is equivalent to what Peter says one should feel like in terms of breathing and talking. That seems to be mid to upper end of zone 2 according to my polar hrm, so that's the number I aim to stay around.\n\nI do that for around an hour depending on time I have. It's a little boring but I try to put a podcast on or send some emails. \n\nAnyway at the end of that I jump off (my legs were often pretty sore hence I changed exercise, although it's getting better now), and I jump on the treadmill. \n\nThe zone 5 stuff is what I really enjoy tbh. But I can't do it for very long. \n\nI go for 15-16kmph (sorry I'm in the UK). And I keep it there until it feels too hard to continue. Then I lower it to about 12kmph and keep going at a heart rate of about 170 or so. I'm able to keep going for about 3mins on a good day and then slow down to 5kmph which is a brisk walk and allow my heart rate to drop. Usually it takes about 2-3mins to do so. I then repeat. I'm not able to do more than 2x3mins of the above zone 5 training yet. \n\n I've attached a screen shot of my heart rate.\n\nTo give some background I'm a male in my late 30s. \nI used to play alot of sports but in the last 5 years it's been weekly hiit or circuit training and strength training. \nI'm a regular 9-5worker. I'm not interested in becoming an athlete just want good health abd longevity.\n\n\nMy question is, does the above sound right? Particularly zone 5. I am doing it right? Am I doing enough, should I aim to add another round in due course? \n\nThe other thing I struggle with is doing the above 4 tomes a week! Even 3 along with 2x strength training is difficult for me. How do others manage? \n\nAny tips or advice would be greatly appreciated"
          ],
          [
           "zone_training_max",
           "How many hours per week do you train?. Hi,\n\nsimple as that: How many hours per week do you train?\n\n[View Poll](https://www.reddit.com/poll/1hmjdom)"
          ],
          [
           "zone_training_max",
           "Overweight runner transitioning to cycling:. Is Zone 2 limited by muscle fatigue?\n\nI often feel like I‚Äôm in Zone 2, and my lungs could carry on for hours, but my legs start burning badly due to a lack of conditioning for cycling. Is Zone 2 more about cardiovascular effort than muscle fatigue? How should I adjust my approach?"
          ],
          [
           "zone_training_max",
           "Exercise routine. I am obese and prediabetic. I am focusing on what I am eating and minimizing carbohydrates, etc.\n\nBut - my question is, can someone give me a quick introductory exercise routine? \n\nLet's say I can exercise for 30 to 45 mins 4 or 5 days a week. What should I do? \n\nI don't quite understand the zones, so examples would be helpful -- I have access to 45 min HIIT classes at my gym. I can lift weights. I have a Peloton, treadmil, and live in a hilly area."
          ],
          [
           "zone_training_max",
           "Recommendations for optimising my Z2 training. Hi all, I have recently made the switch from doing my Z2 training from running to indoor cycling due to some knee issues and to generally reduce the impact. Really loving it! My concern at the moment is that although I thought I had decent leg endurance, cycling is brand new to me and as a result I find my legs burning out faster than my cardio system, so I have to reduce my pedalling which puts me into the upper end of Z1 for a while until my legs recover. The result of a 1 hour Z2 workout ends up looking something like the below - almost an even split between Z1 and Z2 (noting I have clear 5 minute warm-up and cool-down periods on both sides of my 50 minute work period, which will be Z1 always). This puts me at about 60% of Z2 over the work period.\n\nMy question at the moment: does this look ok to you for someone new to the bike and still building leg endurance? Or would I be better off doing shorter workouts where I push harder to stay in Z2 but have to hop off the bike earlier? I suppose my objective here is to maximise the Z2 minutes over time?"
          ],
          [
           "zone_training_max",
           "Zone 2 benchmark equivalent to vo2 max. Is there any test or benchmark to measure our mitochondrial efficiency (what we‚Äôre trying to improve with zone 2 training) similar to how for vo2 max the gold standard benchmark is a lab test wearing an oxygen mask, or at home on a low budget you can run a Cooper test for a good enough proxy. Anything similar to measure zone 2? Or how do you track zone 2 progress?"
          ],
          [
           "zone_training_max",
           "High Knees versus Cycling. Its well known that a low resting HR &lt;60 is the result of a large stroke volume. I'm trying to figure out if jogging in place or spinning is more effective for increasing resting stroke volume and lowering resting heart rate. \n\nI have noticed that running in place at 120-130HR I'm breathing just as heavy as when spinning at 140-150HR but can't figure out the physiology behind this, or which is more effective for increasing stroke volume and lowering resting heart rate.\n\nI have asked GPT many times and keep getting mixed answers. The theory I get most often is that because running in place engages many more muscles there is more blood returning from the contracting muscles which places less strain on the heart, but still stretches the chambers from increased preload. \n\nDo you think running in place or spinning has a stronger effect on increasing stroke volume and lowering resting heart rate?\n\nWhy do you think running in place I am breathing much heavier than spinning at the same 120-130HR?\n\nDo you think there is more blood stretching the heart chambers with more muscles engaged?"
          ],
          [
           "zone_training_max",
           "Jumping on a trampoline. There's information going around on Tiktok saying that jumping on a trampoline even for 10 minutes is better cardio than running for 30+ minutes. \nIs that true? How does that work?\nSorry if this question is dumb, I'm no scientist."
          ],
          [
           "zone_training_max",
           "Anyone use a lactate meter to test for zone 2?. Based on this article, I am interested, but no idea how to get started. \n\n  \n[https://peterattiamd.com/exercising-for-longevity-peter-on-zone-2-and-zone-5-training/](https://peterattiamd.com/exercising-for-longevity-peter-on-zone-2-and-zone-5-training/)"
          ],
          [
           "zone_training_max",
           "Join crossfit or train alone?. So, I'm not sure what to do. I have a free gym option (very basic, at my workplace) where I could do strength training alone or sometimes with a colleague, and I try to do it but I just miss the community aspect of strength training, it's very boring and I don't really enjoy it. I used to go to a kettlebell class and it was a lot of fun. Now my problem is time (it also costs quite a bit but we can afford it if it's worth it for my health). My boyfriend found a nice crossfit gym where I'm thinking of going as well, like 3 times a week. But it takes a lot more time to go there and back than just hopping in to the workplace gym for half an hour and we have two small kids (4 and 2.5 years old, I do bedtime every night and it's minimum 1 hour) so I would severly limit my free time, since it will take around 5-6 extra hours with getting there and all that, which also takes away from running, although I could probably cram that in too, but that mean I would have to work in the evenings as well (my job is very flexible with a laptop).\n\n  \nI feel like I would love the motivation and the social aspect of training together with others and I do prefer calisthenics over weights, but I'm worried about mental burn-out with the limited relax time I will have. What would you do in my place?"
          ],
          [
           "zone_training_max",
           "Should I do running on a treadmill to get myself into zone 2?. I wanted to focus on my zone2 training. Yesterday I walked on a treadmill at 4mph and 13.5 as inclined for about 35 mins. I am 31 years old. Even after such a effort I could never get my heart rate to zone 2.\n\nThe only way it goes into zone 2 is when I run on a treadmill at around 5.6mph to 6mph pace. Is running on treadmill a good long term exercise for zone 2?\n\nI have attached screenshot for both inclined walking which kept me on zone 1 and treadmill running which took me into zone2"
          ],
          [
           "zone_training_max",
           "Update on my cardio health progress.. 51 yo female, 5‚Äô5‚Äù, 150lbs \n\nVO2 max\n 02/21/23 - 18.3\n04/02/23 - 18.5\n04/03/23 - 17.9\n04/04/23 - 18.8\n04/05/23 - 18.8\n04/06/23 - 20.3\nVO2 max captured a lot because I was hiking Zion.\nNot captured again till last night as I have been doing my bike instead of walking or hiking.\n05/26/23 - 20.3\n\nI‚Äôm so disappointed!! \nI‚Äôve been doing what I think is zone 2 on my bike 3-4x/week since about mid March and I haven‚Äôt gained anything on my VO2 max!!\n\nI‚Äôm not sure what happened to me.  I looked back and my VO2 max in Oct 2019 was 39.  I had a number of medical procedures in 2020/2021 and did a lot of laying around.  But I also developed inappropriate sinus tachycardia after one of the procedures.  So was it the laying around, the procedure or the IST?  Something drastically changed.\n\nI do take metoprolol.  Is that effecting my VO2 max?  Would I have a better chance of training my HR to overcome the IST if I was off that?  Tried to do some research on I but couldn‚Äôt really find anything.\n\nAlso what is the proper way to capture my VO2 max.  Last night I was leisurely walking and talking at the same time.  Should I be walking as briskly as I can and not talking?\n\nHelp!  So frustrated!"
          ],
          [
           "zone_training_max",
           "VO2 Max vs Heart Rate. Just did a VO2 test a week ago. Am male and 32. Score of 50. \n\nIt looks like I reached my VO2 max right around 157-158 BPM. Given that I‚Äôm 32, this is right in the middle of Zone 3. How should I interpret this (understanding that hr is influenced by other variable)? for Reference, I run 3-4 days a week, cycle, lfit, and am generally active bc I have a kid."
          ],
          [
           "zone_training_max",
           "Oxygen O2 Enhanced Exercise - Learn about EWOT machines based on clinical research."
          ],
          [
           "zone_training_max",
           "Somewhat new to Zone 2 training and want to make sure I‚Äôm doing things right. Advice?. If I do Z2 on a bike, is it better to hold heart rate or wattage constant? A friend of mine has a lactate test kit that he is letting me borrow‚ÄîI bought some test strips but I‚Äôm unsure about the best protocol to test on the bike.\n\nI was thinking of starting at 50 watts and increasing by 50 watts every 10 minutes, testing lactate levels until around 250 watts or so. Then graphing lactate levels on the Y-axis and bike wattage on the x-axis. Does that seem like the right approach? This would completely ignore heart rate, but do I even need to focus on HR if I have wattage and a lactate meter?\n\nAny advice on this process or corrections to my thinking would be much appreciated!"
          ],
          [
           "zone_training_max",
           "\"zone 2\" during power zone ride?. I see a lot of discussion here on \"zone 2\", but wanted to get people's opinions on my numbers. I'm 44, max HR 180, I do all my cardio on Peloton power zone rides. I thought that the endurance rides (PZ2 and 3, out of 7) would match \"zone 2\", but my HR goes up to 165 in PZ3 and sometimes I have to drop to PZ2 to avoid getting to HRZ5. However, my breathing is still fine at PZ3/160bpm (but I haven't yet done a proper talk test :-)).\n\nam I overthinking it? :-) thanks!"
          ],
          [
           "zone_training_max",
           "Attia: \"Walking is Zone 1...most of Rucking is below Zone 2 except when you're going up hills...there's very little of a Ruck that's actually in Zone 2\". From his latest AMA: [https://youtu.be/NivjpZ0VBro?t=1296](https://youtu.be/NivjpZ0VBro?t=1296)\n\nThis is just to follow up from last week's post in this sub about Huberman's claim that walking is Zone 2: [https://www.reddit.com/r/PeterAttia/comments/14ppjoy/huberman\\_the\\_best\\_way\\_to\\_get\\_zone\\_2\\_cardio\\_isokay/](https://www.reddit.com/r/PeterAttia/comments/14ppjoy/huberman_the_best_way_to_get_zone_2_cardio_isokay/)\n\n&amp;#x200B;"
          ],
          [
           "zone_training_max",
           "Andrew Huberman says your Zone 2 training can be short?. In a recent Huberman podcast science supported tools to accelerate your fitness goals he mentions that you can achieve youe zone 2 training goals even by doing fragments of short everyday activities.\n\nThings like walking a bit faster to the groceries store etc. In essence he doesn't think of zone 2 workouts as workouts cause they are just fragments of daily activities.\n\nAndrew Huberman provides some examples of such activities and these aren't 30-60 min activities,  just short daily ones like 15 minutes here, 10 minutes there. \n\nThat's in contrast to what I remember hearing from Peter in that a zone 2 activity/workout should be longer, let alone not be like 10-15 minutes long.\n\nLike really? Does what Huberman implies that brief daily activities done with a little bit more intensity can count towards your Zone 2 weekly duration goal? \n\nIs a 15 minutes session zone 2 training pointless\n I don't mean pointless per set, as doing 15 minutes are better than 0 minutes, but for the purpose of improving mitochondrial function and specifically reaping the benefits of zone 2 training, would 15 min be on the verge of useless for that purpose?\n  \n [https://podclips.com/c/Rqt3Rb](https://podclips.com/c/Rqt3Rb)"
          ],
          [
           "zone_training_max",
           "NMN Improves Aerobic Capacity in Runners."
          ],
          [
           "zone_training_max",
           "Fit guy: Z2 trouble on spin bike. Tldr:  why can‚Äôt a fit guy spin in Z2? I have to work pretty damn hard to get above 100bpm. \n\n44yo male, 165lbs, daily exercise for 30 years alternating between strength training, running, sprinting, and mountain biking. I‚Äôm pretty fit. Sub 21:00 5k, run 4:00 intervals at 6:10 pace, can do 10 strict pull-ups with 35 lbs, and bench 185# 12 times slowly. \n\nI love mountain biking, and routinely do 10-15 mile rides, usually on a singlespeed, with 1000-2000ft of elevation, and i ride hard. With a HR monitor, I‚Äôll average 130bpm over a ride and hit around 165 max HR on climbs. max HR, when running, is 180. \n\nResting HR is 42-45 bpm.\n\nI‚Äôm on the spin bike right now for an hour of Z2. I‚Äôm working pretty hard just to get my HR over 105.  Legs are getting tired but I‚Äôm hardly breathing heavier. If i ride at a sustainable 60-90min pace, my HR will be below 100. I don‚Äôt have this issue when running."
          ],
          [
           "zone_training_max",
           "How do you measure progress in cardio (zone 2 and HIIT / 4x4)?. Even for the typical participant on this subreddit, paying for a formal vo2 max test is excessive. Smart watch vo2 max is pretty inaccurate. So how do you measure your progress for cardio (including zone 2, HIIT, vo2 max training, 4x4, etc.) to make sure that you're making progress and doing things right? Beep test? Mile test? Something else?"
          ],
          [
           "zone_training_max",
           "45 or 60 minutes for Zone 2?. I have heard Peter recommend ‚Äú45-60‚Äù minutes per Zone 2 workout. I interpret that as instructions a little unclear. Does that mean 45 minutes is sufficient and 60 is optimal? I recall on Inigo San Milan‚Äôs latest podcast with Peter, he‚Äôs a fan of longer bouts closer to 60 minutes, 3-4 times a week. Apparently you get more mitochondrial benefits by increasing duration. \n\nI‚Äôm typing this as I‚Äôm laying in bed after embarrassingly quitting a Zone 2 early, at around the 35 minute mark. I wear a 30-pound ruck vest and walk on my treadmill at around 3 mph. My treadmill doesn‚Äôt have incline so rucking allows me to reduce the pace to something more manageable to reach Zone 2 while possibly getting some of the rucking benefits Peter is quick to advocate for. The problem is I‚Äôm either too unconditioned or lack sufficient motivation to keep going for a full 60 minutes like that. My compliance is low and I think it‚Äôs just a mental block issue, but keeping cardio days to 45 minutes vs 60 would probably help. \n\nIs there a consensus in this sub on what an ‚Äúoptimal‚Äù Zone 2 workout looks like outside of a bike trainer, ergometer and lactate strips? I‚Äôm really trying to adhere to Peter‚Äôs recommendations but right now it‚Äôs pretty miserable, at least until I can sufficiently train myself. \n\nThank you."
          ],
          [
           "zone_training_max",
           "30 minutes of hard steady state running - what zone?. I like to run a hard effort for 30 minutes on the treadmill. It's not a pace I could do for an hour without a break.  \n\nIf you can keep a pace up for 30 minutes only,  what zone is this likely in? Would this be considered a threshold run?"
          ],
          [
           "zone_training_max",
           "Zone 2 vs Zone 5 for Mitochondria biogenesis.. In one of the recent videos with Peter and Rhonda, they had a discussion about the importance of mitochondria health. Peter was promoting Zone 2 while Rhonda was promoting HIIT. Rhonda basically says HIIT is the best way to increase the number of mitochondria through biogenesis. Peter on the other hand was focused on mitochondria efficiency, in the form of metabolic flexibility, ability to burn fat.\n\nIt seems the reasoning behind the Zone 2 routine is to promote fat burning and metabolic flexibility. But is Rhonda right? How much mitochondria biogenesis can we get from Zone 5 at the cost of training fatigue build up? \n\n# Zone 2 Training\n\n**Mitochondrial Benefits**:\n\n* **Biogenesis**: Zone 2 training, which is typically performed at 60-70% of maximum heart rate, is excellent for promoting mitochondrial biogenesis‚Äîthe creation of new mitochondria. This is largely because prolonged, moderate exercise increases the demand for aerobic energy production, which stimulates the production of new mitochondria to meet this demand.\n* **Efficiency**: Continuous Zone 2 training also enhances the efficiency of mitochondria. It improves the ability of mitochondria to burn fat and carbohydrates to produce energy, which is crucial for endurance.\n\n**Scientific Support**:\n\n* Studies such as those by Holloszy and Coyle (1984) have long supported the notion that aerobic endurance training increases mitochondrial content in muscle fibers, which enhances the capacity for aerobic metabolism and endurance performance.\n\n**Citation**:\n\n* Holloszy, J. O., &amp; Coyle, E. F. (1984). Adaptations of skeletal muscle to endurance exercise and their metabolic consequences. *Journal of Applied Physiology*, 56(4), 831-838. [Link to study]().\n\n# Zone 5 Training\n\n**Mitochondrial Benefits**:\n\n* **Biogenesis**: High-intensity training (HIT) or training that reaches Zone 5 (90-100% of maximum heart rate) also promotes mitochondrial biogenesis but does so by creating a different adaptive signal compared to Zone 2. The high intensity induces more stress and a greater immediate need for energy, which can signal the body to increase mitochondrial mass.\n* **Efficiency**: Zone 5 training can rapidly improve mitochondrial efficiency, particularly in converting glucose into energy, which is especially beneficial for sports that require bursts of high energy.\n\n**Scientific Support**:\n\n* A study by Granata et al. (2016) indicates that high-intensity interval training significantly increases mitochondrial capacity for substrate oxidation, which can be an efficient way to boost mitochondrial efficiency in a shorter period.\n\n**Citation**:\n\n* Granata, C., Jamnick, N. A., &amp; Bishop, D. J. (2018). Principles of exercise prescription, and how they influence exercise-induced changes of transcription factors and other regulators of mitochondrial biogenesis. *Sports Medicine*, 48(7), 1541-1559. [Link to study](https://link.springer.com/article/10.1007/s40279-018-0894-4).\n\n# Views of Peter Attia vs. Rhonda Patrick\n\n**Peter Attia**:\n\n* Peter Attia emphasizes the importance of Zone 2 training for enhancing lipid oxidation and improving metabolic health. He advocates for the use of Zone 2 training to increase mitochondrial volume, which he associates with improved metabolic flexibility and healthspan.\n\n**Rhonda Patrick**:\n\n* Rhonda Patrick has often discussed the benefits of high-intensity interval training for rapidly boosting mitochondrial biogenesis and efficiency. She highlights the role of intense, brief stimuli in inducing powerful biochemical responses that lead to enhanced mitochondrial function and resilience.\n\nBoth Zone 2 and Zone 5 training are effective for improving mitochondrial function, but they do so in slightly different ways. Zone 2 is better for long-term mitochondrial biogenesis and enhancing fat oxidation efficiency, making it ideal for endurance athletes and those interested in improving metabolic health. Zone 5, on the other hand, is more effective for quick improvements in mitochondrial efficiency and capacity, beneficial for sports requiring high power output and quick recovery.\n\n# Zone 2 Training: Cost-Benefit Analysis\n\n**Benefits**:\n\n1. **Mitochondrial Biogenesis**: As previously mentioned, Zone 2 training stimulates the growth of new mitochondria. This training enhances the body's ability to utilize oxygen and improve endurance over time.\n2. **Increased Fat Oxidation**: Regular Zone 2 exercises improve the muscles' ability to oxidize fat, leading to better energy management and potentially aiding in weight management.\n3. **Lower Injury Risk**: Since Zone 2 training is moderate in intensity, it generally carries a lower risk of injury and is easier on the joints and muscles.\n\n**Costs**:\n\n1. **Time Consumption**: Zone 2 training typically requires longer sessions to achieve significant mitochondrial adaptations. This can be time-consuming, which might be a drawback for individuals with limited time.\n2. **Slower Adaptation Rate**: The adaptations from Zone 2 training might develop more slowly compared to high-intensity workouts, requiring consistent training over a longer period to see substantial improvements.\n3. **Potential for Plateau**: Over time, the body may adapt to the demands of Zone 2 training, leading to a plateau in performance improvements unless the duration or frequency is increased.\n\n**Fatigue to Benefit Ratio**: Relatively low fatigue compared to the benefits in mitochondrial health and endurance capabilities, making it sustainable and suitable for long-term training plans.\n\n# Zone 5 Training: Cost-Benefit Analysis\n\n**Benefits**:\n\n1. **Rapid Mitochondrial Adaptations**: High-intensity training like Zone 5 can quickly increase both the efficiency and number of mitochondria, leading to significant improvements in aerobic capacity and power output.\n2. **Time Efficiency**: Zone 5 workouts are usually shorter but intense, which can be more time-efficient for inducing physiological changes.\n3. **Metabolic Boost**: This zone can also stimulate higher increases in metabolic rate post-exercise than Zone 2 training, aiding in weight loss and improving metabolic health.\n\n**Costs**:\n\n1. **Higher Injury Risk**: The intense nature of Zone 5 training increases the risk of overuse injuries, muscle strains, and joint stress.\n2. **Greater Recovery Needs**: Due to the high intensity, Zone 5 training demands more recovery time, which can reduce the frequency of training sessions and might interfere with other training routines.\n3. **Increased Fatigue**: High-intensity workouts can lead to significant fatigue, which may temporarily decrease overall activity levels or affect subsequent training sessions.\n\n**Fatigue to Benefit Ratio**: Higher fatigue levels relative to the benefits, but the adaptations are achieved more rapidly. This makes Zone 5 training ideal for short-term boosts and specific training goals but potentially challenging to sustain over the long term without adequate recovery strategies.\n\n  \nIt's important to note that the amount of Zone 2 or Zone 5 you do, has a lot to do with your goals. If you're going to exercise you want to do a routine which can be sustainable. Zone 5 because of the high fatigue is not as sustainable but it's something people do to reach a fitness peak. The mitochondria have a high turn over rate and do not last long. The adaptations from HIIT or Zone 5 may last for a few days to a week. The benefits from Zone 2 last around the same time. But if you have a large build up from doing months of Zone 2 it's something you can maintain, while you can build up really fast with HIIT or Zone 5, but then it has a tendency to fissile out either due to you burning out, or just reaching the maximum level your VO2Max can support at the time.\n\nBoth Zone 2 and Zone 5 will achieve mitochondria biogenesis. The difference seems to be in the amount of time each one takes. I view this like I view investing. When you invest long term the power of compounding works in your favor. Zone 2 allows you to compound for months, which should build more and healthier mitochondria over all because you have more time to win the adaptations and benefit from the recovery state. Zone 5 saves a lot of time, and it seems for younger people doing HIIT or Zone 5 is actually a good idea because younger people can recover faster. If you're over 40, or over 50, doing Zone 5 could put you past your ability to recover, which could result in injuries, or set out back through over training.\n\nSo it appears to be a balance. 80/20 was arrived at because that is what endurance athletes do. Some of us are better off with 90/10. Some might favor more Zone 5 because they don't want to spend hours a week, and I understand that too. If someone can do an hour of Zone 5 a week this could keep this extremely fit in less time than someone doing 5 hours of Zone 2. But how many people can do an hour of Zone 5 a week?"
          ],
          [
           "zone_training_max",
           "Rate my HISS (high intensity steady state) cardio workout üèÉü´Ä. Some folks didn‚Äôt believe it yesterday when I said I do zone 4&amp;5 steady state cardio. I‚Äôm not kidding guys, I absolutely do train this way 4-5 days a week. \n\n\nIs it the best way to improve my heart health ? I honestly have no idea. But I fuckin love it. I plan to increase my workouts from 30-50mins to 90 mins. And no, this does not effect my workouts the following day. My question is can I keep getting the benefits of both HIIT and zone 2 cardio if I increase my workouts to 90 mins ?"
          ],
          [
           "zone_training_max",
           "Lactate &amp; Zone 2. The double Ph.D. and sports med authority Ted Hughes explains why the lactate measures for zone 2 are mostly a useless fad. \nHere is the thread: https://x.com/drtehughes/status/1792256541032161753?s=46&amp;t=HVIuMSUGBqGYGbbvQ6Jx-w\nThoughts? Would love to hear PA address this. (In fairness to PA, he often notes the carry-a-conversation test as sufficient measure)."
          ],
          [
           "zone_training_max",
           "Can you increase Vo2 max and if so what's the recommended way?. Hello, I'm confused about Vo2 max...I find articles on line that say you can increase your Vo2 max and some you can't.\n\nCan anyone help clear this up for me?\n\nI'm 70 and have been strength training but until 6 months ago did not do much cardio for the last 8 years. I recently learned the importance of Vo2 max as a health and longevity marker.\n\nCurrently when I try to test my Vo2 (not in a lab) I come out poor to fair. So I'd like to increase it if I can. ¬†Just for reference all my strength numbers come out in the advanced category."
          ],
          [
           "zone_training_max",
           "Questions for people who know alot about biochemistry, respiratory quotient, and what Ray Cronise means by the 'glycogen treadmill' , see vid. What is meant by the \"glycogen treadmill\"?. [https://www.youtube.com/watch?v=vnW-jA863Ro](https://www.youtube.com/watch?v=vnW-jA863Ro)\n\n&amp;#x200B;\n\nhttps://preview.redd.it/mjzj1ldcv4e91.png?width=1210&amp;format=png&amp;auto=webp&amp;s=d6a6f07b64fe8e25baded5d5ce0b57d6de399820\n\nhttps://preview.redd.it/s0u4oyxfv4e91.png?width=1214&amp;format=png&amp;auto=webp&amp;s=8a3acfc4c9541dbad8ed704f41fe103b878f2eb6\n\n \n\n**And so, the ratio of carbon dioxide to oxygen is called the respiratory quotient or RQ.**\n\nIt tells us like a thumbprint what fuel we're burning.\n\nSo, if you look at this general stoichiometry, like the combustion of ethanol.\n\nEthanol plus oxygen equals CO2 plus water.\n\nAnd you do the balance equation like you did, you'll see that you get a three on one side,\n\ntwo on the other or two on the one side, three on the other...no, two and then three, and\n\nyou get the respiratory quotient of 0.67.\n\nSo that's a number.\n\nSo, if I'm mainly metabolizing alcohol, my respiratory quotient will push down.\n\nCarbohydrates of all kinds, it doesn't matter what kind they are, all of the glucose, anything\n\nthat's dropping in there, those have a respiratory quotient about 1.\n\nAnd then fats or lipids, are around between 0.69 and 0.7.\n\nSo, what's really interesting is that...and amino acids, they average 0.84, if I average\n\nall of them.\n\nSo, proteins are kind of mixture.\n\nOne protein might be slightly lower, slightly high, but they average 0.84, which is great\n\nbecause the only way we measure protein is not through the carbohydrate because by that\n\ntime, the deaminations happen.\n\nYou've lost all that energy through urea and it looks like sugar coming out otherwise,\n\nright?\n\nBut what we can do with protein is we collect the urine, which is why I'm carrying an orange\n\njug around all day.\n\nToo much information but it's science, right?\n\nSo, we get the nitrogen from the urine and then we can back out.\n\nBut by knowing the carbon dioxide produced and the oxygen, we can see the ratio of glycogen\n\nto fat burn, real time.\n\n\\[Rhonda\\]: And you're saying that you have not seen someone's metabolism that's been\n\nbroken?\n\n\\[Ray\\]: Meaning they're at their...\n\nTheir metabolic rate, which will be like speed of the car, is what all of the industry is\n\nfocused on.\n\nEverybody wants to increase their metabolic rate.\n\nWhat I'm saying is how fast you're going only matters if you're headed in the right direction.\n\nYou need a compass too.\n\nAnd RQ is kind of a compass.\n\nIt is the indicator.\n\nAm I burning mainly carbohydrate or am I burning mainly fat?\n\nYou can run your ass off for hours, and if you're only burning carbohydrate, you just\n\nget on the glycogen treadmill.\n\nAnd so then, what people do to counter that is they say, \"Oh, I'm going to remove all\n\nthe carbohydrate and shift my body into ketosis so I'm burning fat all the time.\n\nSo that when they're running, they are burning fat.\n\nBut, again, it's not necessary because it turns out, when we become more restrictive,\n\n**your body is smart.**\n\nAnd when we become more restricted, you naturally start shifting to more and more and more fat\n\nbecause your body knows to reserve glucose...conserve it.\n\nIt wants to.\n\nSo, where I'm going with metabolism is that all the discussions we have about metabolism,\n\nabout boosting metabolism, about all these things, even cold stress, a lot of them fall\n\ninto that simple thing I said earlier, which is we use to eat to support our activity because\n\nfood was rare.\n\nAnd today, we're active to support our eating.\n\nAnd the more simple thing is you can't out exercise your mouth.\n\nIt's impossible.\n\nIt's thermodynamically impossible.\n\nYou can swallow way more than you can move.\n\nIt's just not...\n\nSo, while I was talking about metabolism, what I'm saying about not being broken is,\n\nyou don't have a slow metabolism.\n\nThat's not your problem.\""
          ],
          [
           "zone_training_max",
           "Is Zone 2 considered 60-70% of max HR or 70-80%? Seeing conflicting information. 36/F, somewhat fit but not an athlete. I haven't determined my max HR yet with 100% accuracy, but the highest I have seen my Fitbit get is 188 when going as hard as I can, might be as high as the low 190s.\n\nSo if according to Peter, Zone 2 training is \"being able to carry a conversation but it's strained / people know you're exercising\", that describes how I feel at a heart rate of 150-155. That seems to be more aligned with the 70-80% of max.\n\nbased on all this do you think Zone 2 for me would be around 145-155? Or is that too high?"
          ],
          [
           "zone_training_max",
           "Question: Zone 2 (jogging) vs Zone 5 (sprinting) for longevity?. There's lots of hype on zone 2 training at the moment. \n\nIs low-intensity running for a few hours a week better than shorter workouts that sustain a heart rate that is close to your max heart rate?\n\nFor example - sitting on the exercise bike and sustaining an effort at whatever your zone 2 intensity is for an hour \n\nvs doing 30m of interval training that brings your heartrate up to 170 (15m up 15m down)."
          ],
          [
           "zone_training_max",
           "VO2 max zone. Should vo2 max workouts be done at zone 5 or zone 6 LTHR zones?"
          ],
          [
           "zone_training_max",
           "How do I start zone 5 training?. I do 6 sessions of 40 minutes zone 2 a week. Also 40 minutes of strength and 20 minutes of shoulder rehab on alternating days. 1 day rest. \n\n4x4 minute sets of cardio at an HR of +166 sounds daunting. How do I ease into this? Do I start with shorter sets and longer breaks? \n\nThe gym has bikes, ellipticals, jump ropes, treadmills and a ski erg. We have a lap pool as well. I prefer low impact to pretext the knees."
          ],
          [
           "zone_training_max",
           "Z2 steady state stationary bike ride. Just a pretty textbook sesh this am and wanted to share. 239 avg watts. Did a separate 25 min z1 warm ride up prior to this.."
          ],
          [
           "zone_training_max",
           "What‚Äôs your zone 2/3/4 split look like across the week. Hey all,\n\nHow are you guys programming zone 2/3/4 sessions throughout the week. Extra interested in those balancing this with lifting and mobility training.\n\nEver lift in the morning and cardio later in the day? (2x a day training?)\n\n\nThanks!"
          ],
          [
           "zone_training_max",
           "Rate my fitness level + question. Hey guys,\n\nI got into zone training seriously last winter. Before then I did tons of cardio for 2+ years, some of it very intense (like, getting up to 80% of my max heart rate and maintaining it for an hour, that sort of thing), but no targeted zone training.\n\nI'm 44 years old, 182 pounds, 20% body fat. Since January 1st I've been doing two hours of Zone 2 every other day on incline treadmill. My tested max heart rate is 182, and for Zone 2 I get up to a heart rate of about 137 to get the kind of perceived rate of exertion that Attia talks about.\n\nTo do this, I set the treadmill at a 12% incline and 2.5 MPH. That gets me up to around HR 137. Is that indicative of a decent level of fitness? I thought it wasn't bad, but read that Peter does 15% incline at 3.0 MPH to get to Zone 2, so I'm not so sure. \n\nAlso -- and I'm sure this has been covered before but I can't find it in search -- to be in Zone 5 your heart rate doesn't actually have to be that high, right? Just the level of exertion to get you there? I ask because to actually get my heart rate up that high I have to do say 15% incline at 3.7 MPH but there's a very long lag before my HR gets that high and I usually stop before then. But all the time spent at that level counts as being in Zone 5, right? I don't actually have to have my heart literally going 175 BPM to get the benefits of Zone 5 right? Or do I?\n\nThis is all excruciatingly basic I'm sure but I'm just getting started, so sorry about the n00b-ness."
          ],
          [
           "zone_training_max",
           "Feel awful after Zone 2, feel great after Zone 4 and 5 workouts. Lately I've been trying to up my Zone 2 (and higher-end Zone 1) workouts. I've done everything I can to make these longer training sessions tolerable‚Äîwatching podcasts, movies, listening to audiobooks, etc. They are somewhat boring workouts but I've made them tolerable. They just became part of my week.\n\nBut after a few weeks I found that the longer (60-90 minute) Zone 2 sessions have physically drained me in a way that I find somewhat confusing. Usually I find it extremely hard to do anything meaningful in my day after a long Zone 2 session. Usually I want to hop in the shower and then veg out on the couch. Often I'm too tired to eat. Also, I find that my feelings don't change if I eat a balanced meal afterward; I'm just zonked.\n\nEager to change things up and see how I might adapt, I started cutting out Zone 2 sessions and re-introducing some 1 minute on, 1 minute off Zone 4 and Zone 5 sessions. It's only been a couple of days, but I think I feel better‚Äîclear-headed, refreshed. I know this might sound weird to say, but I feel \"cleaner\" on the inside, like my muscles have flushed out some waste.\n\nMy Apple Watch says that I'm really burning the candle at both ends, with my HRV dipping from its normal 90-120ms range down to 40-50ms. My resting heart rate has gone from my typical 44-48bpm up to around 60bpm. So it's clear that I have some recovery to do‚Äîor maybe there's just an adaptation period and these metrics will go back to normal.\n\nAny speculation as to why I might feel this way? If Zone 5 is putting this much more strain on my system, when why do I feel so much better?"
          ],
          [
           "zone_training_max",
           "Does peter mention what forms of cardio are best for zone 2 and zone 5? Exercise bike, elipitical, running outside, rower, treadmill etc?. Just as the title says does he have any recommendations for what to use? If so if you could list them or point me where to find more. Thanks."
          ],
          [
           "zone_training_max",
           "Zone 2 and temperature. I‚Äôve noticed my heart rate on a hot day is about 20 bpm faster than on a cold day.\n\nIs zone 2 important because of the lactic build up or because of the actual bpm?\n\nWhen running on a super hot or cold day, should I be more focused on effort or bpm?"
          ],
          [
           "zone_training_max",
           "Training at home for 10-15 mins: what's the most scientifically proven way to be efficient?. Hi, let's say i have only 10-15 mins a day in the morning to do any sort of physical exercise.\ni can adhere to one thing only. i kept reading about \"push-up challenges\" or \"plank challenges\"\nbut wondered, if there's a scientifically proven way to like what's the most efficient exercise I can do in this amount of time\nAlso what do you think about EMS\nForgot to mention: I'm obese, I have flat feet, and I recovered from Achilles rupture, so I cant do some stuff that's too harsh on ligaments. and My fitness level at the moment is probably ZERO\nPS: I'm totally aware of what I'm asking, I'm not expecting huge results from doing 15 mins of training only, but certainly doing that is better than not doing anything at all."
          ],
          [
           "zone_training_max",
           "VO2 max and genetics. Seen Peter and others talking about how high VO2 max is correlated with lower all cause mortality. Wanted to ask a hypothetical about the genetic influence:\n\nSuppose I have a poor VO2 max genetically and my friend has a good VO2 max genetically. We then do an identical workout regimen for a long period of time (same time running / biking, etc.) and by the end of it I have a VO2 max of 50 and my friend has one at 55. All else equal, would we expect both of our all cause mortality to be the same, as we have done the same workout and VO2 max is primarily good because it correlates to working out? Or would we expect my friend to have lower all cause mortality as his VO2 max is lower even with the same workouts?"
          ],
          [
           "zone_training_max",
           "HIIT vs Moderate Intensity. This is an interesting study on the effect of HIIT vs moderate intensity exercise on longevity in a population of old geezers in Norway. \n\nHIIT   =  90% of peak heart rate 2 sessions/week\n\nMICT = moderate intensity continuous training at about 70% of peak heart rate \n\nIt is not \"statistically significant\" and I do have other qualms about the study. The control group was asked to follow the Norwegian government's recommendations for exercise which includes 5 days a week of 30 minutes /day moderate intensity exercise. The HIIT group was asked to exchange 2 of those days for HIIT. The MICT group exchanged 2 of the gubmint recommendation days for 50 minutes of continuous work at about 70% of peak heart rate. Hard to imagine that increased mortality which is one of my major qualms but still. \n\n[https://www.bmj.com/content/371/bmj.m3485.long](https://www.bmj.com/content/371/bmj.m3485.long)\n\nAGE 70-77\n\nDesign Randomised controlled trial.\n\nSetting General population of older adults in Trondheim, Norway.\n\nParticipants 1567 of 6966 individuals born between 1936 and 1942.\n\n&amp;#x200B;\n\n&amp;#x200B;\n\nGROUP SIZES\n\nCONTROL: n = 780\n\nMICT          n = 387\n\nHIIT            n = 400\n\n&amp;#x200B;\n\nMORTALITY\n\n\\#         %\n\nCONTROL    37        4.7\n\nMICT+HIIT  35        4.5\n\nMICT            23        5.9\n\nHIIT             12        3%\n\n&amp;#x200B;"
          ],
          [
           "zone_training_max",
           "Is doing mostly Zone 2 cardio ‚Äòenough‚Äô? Feels weird to not be exerting more. Maybe kind of dumb question here. I‚Äôm used to mentally associating cardio with a sense of high exertion, heart rate. Peter thinks that doing a lot of Zone 2 cardio should be the main priority (with one Zone 5 session a week). Zone 2 cardio doesn‚Äôt feel that tough though. Am I missing out on anything by prioritizing Zone 2 rather than Zones 3/4, which is where I feel like I‚Äôm working harder?"
          ],
          [
           "zone_training_max",
           "Quick Zone 2 question.. 1. Zone 2 needs to be at the intensity for 45-1hr  and the mitogenesis starts \n\nOr\n2. A Total of 45-1hr"
          ],
          [
           "zone_training_max",
           "Morpheus device and shifting Zone 2 and Zone 5 calculations question. Background: 68 YO male. Purchased a Morpheus device (chest strap and app) for Zone tracking (recall Attia saying he tested it and thought it was pretty accurate re exercise zones).   Went to a Performance Lab to have my aerobic and anaerobic thresholds and VO2 max calculated.  My aerobic threshold **was calculated at 118 bpm heart rate and my zone 2 was effectively between 108 and 118 BPM.**  Here is my issue:\n\nOn my Morpheus the ZONES change daily based on my morning Recovery Score (a combo of factors including RHR and HRV score plus).  I assumed that my thresholds remain constant (for example always be between 108 and 118 to be IN zone 2).  If I go by my Morpheus device my zone 2 shifts depending on the Recovery Score.  At first the zone 2 threshold was often 118 but it would move from between 118 to around 122 for example depending. Lately it's been shifting between 118 and 124 a lot.  \n\nSO MY QUESTION IS: should I be following my performance lab threshold of between 108 and 118 OR should I be following the shifting zones my Morpheus calculates?  I guess the more fundamental question is: do your aerobic and anaerobic thresholds for zones CHANGE DYNAMICALLY depending on your physiological state?   IAnd also, is it safe to assume that as I get more fit, my zones would move \"up\"?  Maybe these are dumb questions : ) Any opinions on this?  Hope thats clear and thanks."
          ],
          [
           "zone_training_max",
           "Anybody use OXYGEN?. Anybody ever use an oxygen machine or any of those oxygen dispenser cans? Do they work?"
          ],
          [
           "zone_training_max",
           "Does healthy bulking help cardiovascular fitness improvements when training VO2 max?. Am very curious if he has addressed this or if any fans are knowledgeable about it. \n\nI know that the denominator of vo2 max is kg, so higher weight at the same fitness results in a lower VO2 max. But does attempting to gain muscle in a lean bulk context also help the heart improve as a response to strenuous training? Does extra protein and calorie surplus help the muscular adaptions the heart goes through to become more efficient after vo2 max training? \n\nI am currently committed to the bulk because I have very low muscle mass for my age, so I‚Äôve really cut down on cardio until I have trained myself to eat much more than usual. But now I am wondering if I should be placing a high priority on vO2 max training during this time. When I was in a caloric deficit my VO2 max has plateaued for over a year."
          ],
          [
           "zone_training_max",
           "Vo2max training (hiit?). Usually i thought hiit kettlebell training for 20min per week is good.\n\nHow can i exercise to improve vo2max?\n\nKettlebell hiit? How?\nI own also rowing machine and weight vest of 20kg."
          ],
          [
           "zone_training_max",
           "What zone would you consider this?. 35. Male. In pretty good shape; rock climber. This was 25 minutes on an echo bike. Zone 3? I was definitely beyond conversation territory."
          ],
          [
           "zone_training_max",
           "Vo2 max workout better before partying or after?."
          ],
          [
           "zone_training_max",
           "The Science Behind PPAR Agonist Cardarine &amp; Exercise Endurance."
          ],
          [
           "zone_training_max",
           "Is walking Zone 2 as effective as running Zone 2?. When I run at night and the temps are in the 70s, I can run at about a 12:30 minute/mile pace and my heart rate will be in Zone 2.\n\nWhen I run during the day and the temps are in the 90s, my heart rate will quickly shoot up, as expected with the high heat. However, if I walk, my heart rate goes down to Zone 2. \n\nMy question is, with all else equal, if I run 5 miles in Zone 2 in cool weather is it training my aerobic capacity the same as if I were to walk 5 miles in Zone 2 in hot weather? Obviously there will be some muscular differences but is it the same if I'm focused on improving my cardiovascular system?"
          ],
          [
           "zone_training_max",
           "My line-up - too much?. 59F. No health issues. Run 3x week, strength train 3x. Not sure how to ascertain if they are making a difference"
          ],
          [
           "zone_training_max",
           "Is this too much zone4/5 at end of my zone2?. I walk with a 30lb vest.  It gets me in my zone 2 for 40-50minutes.  I end my walk with a steep hill where I suspect I‚Äôm in zone 4/5.  This hill takes me about 6minutes to get to the top.  I do this 5 times a week.  Is that zone 4/5 hill too much across 5 days or should I only do that 2 of the 5 days?  My objectives are some fat loss but also want to build some stamina for challenging hikes without my weighted vest."
          ],
          [
           "zone_training_max",
           "academy sports sells bottled oxygen. I was at academy sports just now and saw that they sell cans of 95% pure oxygen for $16.99, I was wondering how much of a benefit would I get from breathing it. Would it help with recovery after a hard workout? And is $16.99 worth about \"200 seconds\" (their words) of oxygen"
          ],
          [
           "zone_training_max",
           "VO2 Max Training Question. Do you ever vary from the 4x4 pattern, and if so, how do you structure that?\n\nI‚Äôm used to periodizing my lifting, usually with a deload every 6th week.  It feels like VO2 max training ought to benefit from something similar.  How would you set up a 5wk progression with a 1wk deload, assuming just one VO2 max workout per week and 3 Z2 sessions per week?  Or is there some reason I‚Äôm missing that makes this inappropriate?\n\nThanks, newer to cardio than lifting!  My last VO2 workout made me realize I was WAY underestimating my Z2 pace‚Ä¶ figuring this out as I go and appreciate the help!"
          ],
          [
           "zone_training_max",
           "Why did 4x4 become most popular VO2 max workout?. Norwegian Method is described as 4x4 and Seiler is often reported as the vector of its popularity. However, in his 2011 paper it clearly shows that 4x8 was better. Higher VO2max improvement, power improvement, TTE improvement, etc. All with a lower RPE even though the subjects did 2x the duration of work.\n\nIs it simply a matter of saving 16 minutes?\n\n[https://www.researchgate.net/publication/51543724\\_Adaptations\\_to\\_aerobic\\_interval\\_training\\_Interactive\\_effects\\_of\\_exercise\\_intensity\\_and\\_total\\_work\\_duration](https://www.researchgate.net/publication/51543724_Adaptations_to_aerobic_interval_training_Interactive_effects_of_exercise_intensity_and_total_work_duration)"
          ],
          [
           "zone_training_max",
           "I was asked to coach football. I am a high school teacher. I was asked by my school if I would join the coaching staff at the high school football team. I  used to be a coach 17 years ago.\n\nI made a post the other day about how high my heart rate was when I was helping, my brother in the heat of the day, about 100¬∞, moving some fencing material at my mom‚Äòs house. Cortinas school football is going to require me being out in the heat in July, August, September, and it starts getting cooler in October.\n\nI started to eat better, having vegetables and greens, at least half of my plate to get my gut down. I‚Äôm 225 right now and honestly I‚Äôd like to go to 165, which was my military weight.\n\nI do zone two training four times a week, 60 minutes a pop. I do one session of high intensity cardio one time a week. I do get in the sauna about 20 minutes four times a week for my zone to cardio sessions.\n\nBut that hundred degree heat into our practices I know it‚Äôs going to wear on me. Any tips to get my body acclimated and ready for that heat? I‚Äôm thinking of going to the school starting today during what would be the practice time in jogging 1000 yards, just back-and-forth on the football field, taking it easy and drinking plenty of water. Maybe doing some push-ups in between as well. Just getting my body used to it.\n\nDo you guys think that would be helpful? I‚Äôm not going to start my zone two sessions I‚Äôm gonna keep those."
          ],
          [
           "zone_training_max",
           "Can I please get your advice/opinion on my cardio training?. 70 yrs old, been lifting for years, at the start of the year decided I needed more cardio. I mostly cycle in and outdoors and indoor row. The chart taken from the Polar Flow app shows low percentage in zone 2 which I understand should be higher. Probably not important is that I walk the dogs about 2 miles a day, but with dogs you stop a lot. Thank you for your comments.\n\n[combination of cycling and rowing for the year](https://preview.redd.it/q3tcudzkxj8d1.png?width=459&amp;format=png&amp;auto=webp&amp;s=181998fc6f0948668739e699c967b528b501724b)"
          ],
          [
           "zone_training_max",
           "Andy Galpin: \"Ideally, again, at the end of every quarter, you take a week off‚Äîwhether that is a true full week off, which I'm fully in support of. I mean, friends, we're only talking about 4 weeks off a year; that's absolutely fine. Or, it could even be a slight deload week if you wanted to be.\"."
          ],
          [
           "zone_training_max",
           "My FatMax is well below my AT, here is my VO2 max results, what HR should I target for Zone 2 building?."
          ],
          [
           "zone_training_max",
           "Anyone else love the feeling of DOMS?. honestly without it I dont feel like I got as good of a workout? Anyone else feel this way?"
          ],
          [
           "zone_training_max",
           "Best type of exercise for heart health. Anyone know of research showing what sort of exercise is best for heart health? I do it all (zone 2, resistance, a bit of zone 5, etc.), but I have a high CAC score and high LPa (on statins and ezetimibe, couldn't get insurance approval for pks9), and I was wondering if this was a case where more zone 2 was finally better, or if it doesn't matter so much as long I am training intensively and regularly. PA talks about preventing calcium build up and etc ‚Äî but I have never heard him discuss how he counsels patients who already have heart disease."
          ],
          [
           "zone_training_max",
           "Vo2/ zone 2 ranges. Like a lot of others here I'm trying to improve my Vo2 max. I'm 33 year old male, muscular, 5'10, 200lbs.prior to my garmin, my research told me my zone 2 should be in that 130-147 range. Garmin is showing it below that at 113-131.i have been training in the 130-147 range the past month or so with no change in Vo2. Garmin is showing my Vo2 max at 35. Have I been training in the wrong zone? Any help would be appreciated!"
          ],
          [
           "zone_training_max",
           "Dr. Peter Attia describes his 2022 weekly exercise routine: 4 zone 2 Sessions, 4 Lifts, no off days. * He works out every day of the week\n* 4 40-minute zone 2 sessions\n* 1 zone 5 session\n* 4 strength training sessions\n* No off days\n\nActually surprised to hear he doesn't take a day off. Guess the zone 2 workouts are less intense than I was imagining.\n\n[Here's the clip](https://podclips.com/c/peter-attias-2022-weekly-exercise-routine-4-zone-2-sessions-4-lifts-no-off-days?ss=r&amp;ss2=biohackers&amp;d=2022-02-23&amp;m=true) from his podcast where he discusses in depth"
          ],
          [
           "zone_training_max",
           "Why is it so hard to get into zone 5?. I am carbing up, drinking caffeine but I still find it extremely hard to get into zone 5 and I never get to my supposed max hr (220-18).\nWhat am I doing wrong, cause I really feel like I am giving my all yet it‚Äôs only on the last interval I even touch zone 5."
          ],
          [
           "zone_training_max",
           "Plateauing on Zone 2?. I was and am a pretty active person (53 y/o male, 5'11\" 175 lbs/80kg), but never really had much of an aerobic base (my sports were all fast-twitch oriented). I was inspired by Peter's convo with Inigo San Milan about Zone 2 training and put myself on a program using scenic rides on my Peloton. I worked my way up to 60 mins 3x/week, using the Maffetone formula for my target heart rate (180-age, which equals 127 in my case). I slow down if my HR exceeds 130. I know people think the Maffetone rate is too low, but my RPE seems to line up with the Maff limit.\n\nI made some pretty decent progress for the first couple of months but seem to be hitting a plateau. My average watts PR for 60 mins is 100w, and I have hit small PRs once every 2 weeks if everything goes well. I have been doing this about 5 months. I have felt some benefits (lost 10 lbs, overnight resting HR 49-51 bpm) but I seem to be hitting diminishing returns. \n\nI did one of Rhonda Patrick's genetics tests, and found that I have a gene that supposedly makes me unresponsive to aerobic training, which makes sense anecdotally but I don't know how accurate this is.\n\nSo, a few questions for you Zone 2 warriors:\n\n1. Is it normal to plateau around the 6 month mark and I just need to accept that new PRs will be very slow? (i.e. I might hit 150 watts, but that might take 3 more years)\n2. Do you think that more high intensity training will help? I know Z5 trains a different energy system, but just looking for possible solutions.\n3. Is there anything to the genetic argument? I have always been \"in shape,\" with no medical conditions (bloodwork and blood pressure all normal) but anything involving running or endurance was torture for me. Maybe I just haven't built a \"super base\" from doing years/decades of Z2?\n\nI have attached a graph of my \"progress.\" The latest dip is right before I got COVID, so that might be a short-term factor. However, I was plateauing long before that."
          ]
         ],
         "hovertemplate": "Topic Group=%{customdata[0]}<br>document=%{customdata[1]}<extra></extra>",
         "legendgroup": "zone_training_max",
         "marker": {
          "color": "rgb(57, 105, 172)",
          "symbol": "circle",
          "opacity": 0.7,
          "size": 7,
          "line": {
           "color": "rgba(0,0,0,0.5)",
           "width": 0.8
          }
         },
         "mode": "markers",
         "name": "zone_training_max",
         "showlegend": true,
         "x": {
          "dtype": "f4",
          "bdata": "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"
         },
         "xaxis": "x",
         "y": {
          "dtype": "f4",
          "bdata": "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"
         },
         "yaxis": "y",
         "type": "scattergl"
        },
        {
         "customdata": [
          [
           "biohacking",
           "Biohacking community, what is your experience with Diatomaceous Earth?. The title says it all, appreciate anyone‚Äôs input!"
          ],
          [
           "biohacking",
           "Female Biohack Start. Hi Guys,\n\nI‚Äôm interested in knowing the basics without having to read a book first. Is there any resources any one can point me to?\n\nIf there was one basic beginner book, what would it be?\n\nSupplements would be useful also- top 5\n\nAlso, I see a lot about testosterone, what is the equivalent for a female to help? Sorry if these are dumb questions really want to start my journey.\n\nI currently have a PMEF mat, Red lights, sauna etc. just curious to learn."
          ],
          [
           "biohacking",
           "Seeking podcast recommendations around the topic of biohacking ?."
          ],
          [
           "biohacking",
           "Achieve Daily Peak Health &amp; Biohacking. Take charge of your health and mitigate the risk of diseases with [Project Serotonin](https://www.sr.tn/about). Our 8+ years of R&amp;D on micronutrition, genetics, exercise, sleep, fasting, and lifestyle protocols ensure your hyper-personalized programs are driven by precision, and designed to help you achieve peak health and longevity. Join us today and experience the benefits firsthand."
          ],
          [
           "biohacking",
           "biomat + endo. Hi! Has anyone had experience using the BioMat for endometriosis? thanks in advance :) Im also curious how often the BioMat can be used and if it can cause discoloration of tissues like a heating pad can over time."
          ],
          [
           "biohacking",
           "testing out biohack coaching for a week. Does anyone want a free physical and mental wellness coach for a week?\n\n**Qualifications:**  \n‚Ä¢ graduated from the top program at a top 10 university (mental)  \n‚Ä¢¬†bio-hacker familiar with the scientific literature around supplements and optimal health metrics (wellness)  \n‚Ä¢ can perform 19¬†pull-ups, a 6 minute plank, and 73 pushups (physical)"
          ],
          [
           "biohacking",
           "What problems do you usually encounter when trying to biohack?. title says it all really. any major/minor problems you experience when try to biohack?"
          ],
          [
           "biohacking",
           "Most Effective Biohack Habits. I think biohackers can get into niche, unique, habits but what‚Äôs been the most helpful even if it‚Äôs obvious? What are you most effective biohacking habits that has the most positive impact on your health? Obviously this is anecdotal but I‚Äôm curious people‚Äôs experiences with what made a difference and what didn‚Äôt.\n\nFor example, from most effect to my over all health are:\n1. Filtered water instead of tap water\n2. Electrolytes in the morning\n3. Eating something fermented every day for gut health (usually raw Kefir)\n4. Lifting 3x per week and eating 80/20 Whole Foods\n\nThese four alone have kept my immune system so strong I haven‚Äôt been sick in over 2 years. I feel fantastic. \n\nWhat‚Äôs made the biggest impact for y‚Äôall?"
          ],
          [
           "biohacking",
           "What biohack can you now not live without?. Curious to know what biohacks have been game-changers for you. I just recently found this sub and am really interested!"
          ],
          [
           "biohacking",
           "Anxiety and biohacking. Hi, was wondering if someone got any informations about any biomedal/biohacking studies /inventions in terms of anxiety? I have no scientific background but id love to read about that"
          ],
          [
           "biohacking",
           "Please share ideas!. Who are the best biohackers you learn from online?\n\nPlease share ideas!"
          ],
          [
           "biohacking",
           "What would be the perfect day in the life of a biohacker?. Imagine you could program a human being who is a student of medicine just like you can program a robot to do exactly what you have planned for him. The idea is that this goes on for weeks, months or even years.\n\nThe ultimate biohacker would probably wake up after 9 hours of a good nights sleep. Let‚Äôs say his days starts at 4:30, from 8-16 he has classes in the hospital.\n\nWhat schedule would be perfect if one had the discipline of a machine (or David Goggins ;) ) ?"
          ],
          [
           "biohacking",
           "South Africa Biohackers? (Genetic Engineering Types). Hey, just checking in to see if anyone is out and about in South Africa or knew of any biohacker groups out here?"
          ],
          [
           "biohacking",
           "Biohackers Spain new subreddit :). https://www.reddit.com/r/BiohackingSPAIN?utm_medium=android_app&amp;utm_source=share r/biohackingSpain"
          ],
          [
           "biohacking",
           "Virtual Biohacking Conference: Recharge Your Cells and Upgrade Your Life. &amp;#x200B;\n\n# Looks like a good line up. Dave Asprey, Joe Dispenza, Liz Parrish...\n\n&amp;#x200B;\n\n# [Virtual Biohacking Conference Recharge Your Cells and Upgrade Your Life - Biohacking Conference](https://upgrade.biohackingconference.com/) \n\nhttps://preview.redd.it/nioheu4y8yt61.jpg?width=1080&amp;format=pjpg&amp;auto=webp&amp;s=8df23382b4d4ce86f8f56caffc0f88465c9b9b97"
          ],
          [
           "biohacking",
           "Reddits related with biohacking??. Can you put more reddits related with biohacking?\n\n \n\n* sunshine - [r/HumanRewilding](https://www.reddit.com/r/HumanRewilding/) [r/SapienMovement](https://www.reddit.com/r/SapienMovement/)\n* meditation - [r/Meditation](https://www.reddit.com/r/Meditation/)\n* breath work - listen to James Nestor on JRE\n* exercise\n* sleep hygiene - [r/sleephackers](https://www.reddit.com/r/sleephackers/)\n* elimination diet - [r/AutoImmuneProtocol](https://www.reddit.com/r/AutoImmuneProtocol/) [r/zerocarb](https://www.reddit.com/r/zerocarb/)\n* intermittent fasting - [r/intermittentfasting](https://www.reddit.com/r/intermittentfasting/)\n* inclined bed - [r/InclinedBedTherapy](https://www.reddit.com/r/InclinedBedTherapy/)\n* basic supplementation - vitamin-d &amp; magnesium\n\nu/greyuniwave was who puts all these\n\nMore like these I mean"
          ],
          [
           "biohacking",
           "Unnatural Selection. Netflix debuted a new docuseries titled, \"Unnatural Selection,\" that dipped into more of the genetic hacking prevelant in the biohacking world.\n\nBeing new to the biohacking world a few months ago, this is more or less what I expected to see a lot of when I started researching this world -- however, it seems like most of the community tends to teeter more towards the \"get more sleep, eat a healthier diet, &amp; exercise\" camp than the actual hacking side of things.  \n\nWhile I do view those steps as important, they strike me more as optimizing what we already have -- not hacking for improvement.\n\nSo my question to you, fellow biohackers, is WHAT ELSE is going on in the community in 2021?\n\nHave there been any other promising moves on the genetics front?  Are there new tools or technologies to more aggressively exploit cognitive function?  New experiments to potentially solve currently unsolvable issues?"
          ],
          [
           "biohacking",
           "What to study to learn most about biohacking itself and general cognitive enhancement?. Which university field to choose to learn as much about it, answers welcome:)\n\n&amp;#x200B;\n\nWish u all nice day!"
          ],
          [
           "biohacking",
           "Jean Fallacara Acquires Biohacker‚Äôs Update Magazine. **NEW YORK, NY, USA, January 13, 2021 /**[**EINPresswire.com**](http://www.einpresswire.com/)**/ --** [**CYBORGGAINZ**](https://cyborggainz.com/about) **is delighted to announce the acquisition of** [**BIOHACKERS UPDATE magazine**](http://biohackersupdate.com/)\n\n*Biohackers Update Magazine Acquired by Jean Fallacara under his Organization Cyborggainz Neuroscience Calisthenics Lab.* \n\n The first magazine about Biohacking and Self Optimization, Biohackers' Update is entirely committed to sharing all the essential hacks, updates and trends from the Biohacking World with the community at large. #HackOn"
          ],
          [
           "biohacking",
           "Do you think biohacking is wrong in anythin??. what aspect do you think that biohacking is wrong?"
          ],
          [
           "biohacking",
           "Where to Find You?. Does anyone else here write up/record their biohacking journey? Interested in your blog, YouTube channel, FB group, podcast, etc. \n\nPromote yourself below!"
          ],
          [
           "biohacking",
           "Is Garden of Life or Life Extension reputable companies for biohacking ?."
          ],
          [
           "biohacking",
           "Who Are Your Favorite Longevity, Health &amp; Biohacking Youtubers?. I have a few Youtubers who I follow who are into longevity, biohacking and health. But, I want to find some more good content. I am particularly interested in those who like to self-experiment and share their short or long-term results. If you have any favorite Youtubers you watch who are into any of these things, can you please share it below? Thanks!"
          ],
          [
           "biohacking",
           "I'm biohacker because.... Hey guys! \n\nI do some research in health and preventive medicine. I need your help with that...\n\nCould you honestly complete the sentence: \"I'm biohacker because I ...\"\n\n[View Poll](https://www.reddit.com/poll/hv4e7l)"
          ],
          [
           "biohacking",
           "We launched our crowdfunding campaign!. Hi folks,\n\nAfter working under stealth mode for a while, we finally launched a crowdfunding campaign on WeFunder along with 12 other companies. We are developing new medicines from gut microbes. Check it out, and we would love to hear from you!\n\n[https://wefunder.com/petri.bio](https://wefunder.com/petri.bio) \n\nBest,\n\nYour nerdy friend"
          ],
          [
           "biohacking",
           "What are the main types of biohacking?. I'm gonna list 6 things and whatever one you see the most of or like the most just tap. If you have something outside these options please comment. Thank you\n\n[View Poll](https://www.reddit.com/poll/hv4bs4)"
          ],
          [
           "biohacking",
           "Starting Out. Hi so I've decided to start my DIY Biology \"hobby\" out but creating some e.coli bacteria which fluoresces. I've been watching all the videos I can get my hands on about the process and what is needed to do it. My major issue is finding where I can buy some non-pathogenic e.coli samples, I was looking at NEB Turbo but then I saw the price (a little out of my price range I have to say lol).\n\nAm I looking at the wrong thing? Am I starting off with something way too complicated? And are all samples around the ¬£200+ range?\n\nSorry if this is a really obvious question to some of you :/"
          ],
          [
           "biohacking",
           "Want to do some learning.. I want to start learning a bit about biology and chemistry, bio chemistry. However I am awful at science in general but especially chemistry. How would I go about learning some comprehensive chemistry."
          ],
          [
           "biohacking",
           "How I Use Biohacking to Experience Cyborg Gains in My Calisthenics Training. Check Out the Interview"
          ],
          [
           "biohacking",
           "Any Good Biohacking Book Recommendations?."
          ],
          [
           "biohacking",
           "Any citizen scientists/DIYBio groups in Switzerland?. Any groups around Basel or Zurich? Have been looking for a community lab space and it would be awesome to meet any of you who are local :)"
          ],
          [
           "biohacking",
           "Getting started. I have heard about this for years, but i forgot the existence of all of this, i usually make robots, but i really want to be a part of this, i think it has so much potential.\n\nHow can i get started? \n\nEdit: i saw the comments, and i was referring to the electronic area, grinding"
          ],
          [
           "biohacking",
           "Any Biohackers in Bristol, UK. I‚Äôm very interested in this community and would love to meet some like minded individuals, I‚Äôve also been Microdosing for 6 months so if this is an interest of yours too DM me."
          ],
          [
           "biohacking",
           "Books on biohacking examples of solving patients disease. Has anyone come across a good book that talks about actual real patient cases where some form of biohacking stopped their disease? I am reading a book called \"Deep Medicine\" and it starts out by describing a young newborn with intense seizures. Doctors didn't know what to do, but a genomics test and AI scan revealed that simply supplementing with B-6 and arginine while avoiding another amino acid stopped the seizures rapidly. \n\nI would be interested to read about more of these kinds of situations where a disease seems impossible and then suddenly a simple natural solution is found to be the solution."
          ],
          [
           "biohacking",
           "Biohacking palces in the US?. Hey Everyone!  \nDoes anyone know places similar to Upgrade Labs or Bulletproof Labs in the US?  \nI need them for a University Assignment, but I only found Hackd Fitness and Biohackers Fitness Centre ."
          ],
          [
           "biohacking",
           "Magazine about Biohacking?. Hi, \n\nWould any of you be interested if there was a magazine about biohacking and self-optimization?\n\nA sort of collection of knowledge from all cultures and professions. Brought together into one?"
          ],
          [
           "biohacking",
           "Any biohackers in relationships?. I'm young at the age of 18 and I would find it great if I could date a fellow biohacker. Does anyone have any expierence similar to this or any expierence with trying to explain biohacking to there partner."
          ],
          [
           "biohacking",
           "Poll: should we create a rule to remove off-topic posts?. There was a recent [post](https://www.reddit.com/r/Biohackers/comments/197bfw5/this_sub_has_nothing_to_do_with_biohacking/?utm_source=share&amp;utm_medium=web2x&amp;context=3) by u/unswunghero that criticized this subreddit for having a lot of over-glorified supplements and WebMD/Quora-type posts. Frankly, I agree - there are a ton of subs for supplements and that kind of content, but biohacking should be many steps beyond that. We are attempting to hack our own biology by self-experimentation using biological science. \n\nAfter talking with my fellow mod, u/zhandragon, we've decided to set up a poll to ask users whether we should create a rule against off-topic posts, so as to shape this subreddit to focus on more hardcore biohacking. \n\nWhat do you all think? \n\n[View Poll](https://www.reddit.com/poll/19aalqx)"
          ],
          [
           "biohacking",
           "I need to become the ultimate office worker drone. What stack would you recommend for someone who wanted to become amazing at dull office work. 12 hour days sat in front of a computer, cranking out dull office documents/answering emails/teams calls."
          ],
          [
           "biohacking",
           "HELP:I wanted to publish my research, but I didn't have any experience.Is there anyone here experienced in publishing papers?. First of all, I'm not a scientist, just a biology enthusiast. Last year, I discovered an amazing cell in my home lab and studied it in depth.I wanted to publish my research, but I didn't have any experience.Who can help me?"
          ],
          [
           "biohacking",
           "Getting started. Hey I‚Äôm male 18 interested in biohacking but I literally cannot find where to start"
          ],
          [
           "biohacking",
           "Can someone give me a quick crash course in biohacking?. What started as a general interest in weight loss has transformed into interest in health.\n\nCan someone explain basic concepts/tips to me? I understand the basics of the body but I would like to know more."
          ],
          [
           "biohacking",
           "An Article on the Scientific Benefits of Sensory Deprivation Tanks. Hey everyone, I'm going to be writing articles about the wellness/biohacking space every day. \n\n[https://extravertedintuition.com/blogs/journal/floatation-rest-a-comprehensive-look-at-the-scientific-benefits-of-sensory-deprivation-tanks](https://extravertedintuition.com/blogs/journal/floatation-rest-a-comprehensive-look-at-the-scientific-benefits-of-sensory-deprivation-tanks)\n\nOpen to comments and criticism, hoping to provide an informative resource to ya'll.\n\nThanks!"
          ],
          [
           "biohacking",
           "best underground voices in biohacking. Who are the best underground biohacking voices? ie. NOT Huberman, aspery, attia, rhoda patrick, ferris, etc. Just looking for cool ppl trying new things to improve their body. \n\nCan be people on twitter, youtube, insta, anything. Thanks."
          ],
          [
           "biohacking",
           "Urgent: microbiology questionnaire. Hi,\n\nFor a student project, we would like you to answer a questionnaire on biohacking and microbiology. It only takes 5 minutes. Here is the link:\n\n[https://forms.gle/Y2jQdiaisexK8C9JA](https://forms.gle/Y2jQdiaisexK8C9JA?fbclid=IwAR1b6eiTJo5PsOW6n8Y7whlV-4W3RHFWC7BwlCCcb5k-c6GSYURv4p3_u0E)\n\nThank you for your time!\n\nWe need prompt answers ;)"
          ],
          [
           "biohacking",
           "New to Biohacking if you can pick one device which one would you start with?. Hi new to biohacking and learning a bunch of info and I have the budget to start on one thing and want to get the most bang for my buck. Any recommendations?\n\nIm looking at a PEMF, Cold Plundge, rapid reboot, Infrared sauna and red light therapy devices."
          ],
          [
           "biohacking",
           "Seeking spreadsheet for Microbes for biome and receptor sites. Someone shared a comment or link with me before and I lost it, just curious does anyone have a link or spreadsheet that shows which microbes correlate to receptor targets ?"
          ],
          [
           "biohacking",
           "Who is your fav most legit biohacker you follow and trust and why?. It is very hard to trust ppl who sell you stuff all the time. \n\nWho do you trust?"
          ],
          [
           "biohacking",
           "New to biohacking - General help. TLDR: after years of neglect and poor hygiene I am looking for beginner resources to optimize my health.\n\nMaybe the wrong place for this, but even if someone can just direct me to some resources or where to ask around that would be amazing. \n\nI (25M) have neglected my body for years‚Äî my father taught me to start smoking at a young age (roughly 9 years now at ~a pack per day, I have recently stopped this). I was raised with poor dental hygiene and it‚Äôs something I‚Äôve only now begun to address. I am and always have been very underweight, and struggle to put on weight still. I am about 6 feet tall and weigh 118lbs. \n\nI am most interested in improving my lungs, teeth and heart after years of neglect and hoping to find some accessible herbs or supplements that may help enhance my overall health as I continue to take better care of myself. Any resources, books, or ideas would be appreciated to help me learn to take better care of myself and optimize my body. \n\nI‚Äôm not in a panic, I know I am young and capable of being healthy, and although I worry that I have done years of damage I am hopeful I can live a healthful life if I continue to educate myself on what that looks like."
          ],
          [
           "biohacking",
           "Your Current Activity. What are you trying to biohack right now? \n\nAnd what have you most recently tried to biohack?"
          ],
          [
           "biohacking",
           "Biohacks that have been proven in peer-reviewed, randomized trials?. What are some?"
          ],
          [
           "biohacking",
           "Any advice for a new bio-hacker?. I‚Äôm completely new to bio-hacking and was wondering what routine / supplements would you recommend for productivity, clarity and energy. I‚Äôm an entrepreneur and sometimes I struggle to stay accountable and find myself slacking. I think a large part of that is due to neglecting my health for years and now I want to get things on track. Any advice is appreciated"
          ],
          [
           "biohacking",
           "Tired of feeling like garbage, want to know where to start in biohacking. Hi, I hope this is alright. I keep seeing people post in this sub about how they are learning the science they need to keep themselves in good shape, and I‚Äôm inspired and wish to do the same. I was wondering if anyone has any good books or websites on where to start?\n\nFor some general background, I‚Äôm a 27-year-old female with a seemingly unending list of vague energy and comfort level-related symptoms that every specialist just kind of shrugs at. I never feel fit, or healthy, or with it.\n\nI do have ADHD, anxiety, and some prior surgeries, but no conditions that should cause me to exist in a state of perpetual grogginess and exhaustion.\n\nI‚Äôve done keto in the past, and I lost weight, but I never felt any better.\n\nI‚Äôm happy to provide any additional information, just let me know what I need to cover.\n\nAny advice is welcome, thank you for your guidance, and I apologize if this is improperly formatted or not the right kind of post for this subreddit."
          ],
          [
           "biohacking",
           "What kind of bio-hacking are they selling?. HELP! My mum has been overweight most of her entire adult life and I wish to help educate her and find solutions for her to shed some pounds.\n\nTypically we are familiar with workouts and diet (such as low-carb diets) to help lose the fat but I have recently seen companies selling programmes that claim to not use any drugs, no workouts and no diets.\n\nBiohackk is one of such company. Feel free to google them. They are based in Singapore.\n\nWhat do you think they are trying to sell here? Epigenetics? Real Biohacking? They talk about toxins and impurities and it sounds really vague to me. Appreciate any help!"
          ],
          [
           "biohacking",
           "Need intro do bio hacking. I want to start bio hacking but I‚Äôm not sure where. My goals are to get gains in strength, speed, and endurance. I‚Äôd rather it be sustainable whatever I do but I‚Äôm not open to short term gains. Anything is on the table as long as it won‚Äôt kill me or ruin my life. :)"
          ],
          [
           "biohacking",
           "Hacking the Human Body: The Role of Biohacking in Achieving Immortality."
          ],
          [
           "biohacking",
           "Best books about the menstrual cycle?. Title. I'm very interested in learning more about the menstrual cycle, like on a day by day level. Thanks in advance for your recommendations."
          ],
          [
           "biohacking",
           "Biohacking Wellness Tech at Home - Technology #1."
          ],
          [
           "biohacking",
           "Is there anything we can do as bio hackers to help reach a \"flow state\"?."
          ],
          [
           "biohacking",
           "Join The International Biohacking Community Forum!. # What Is The International Biohacking Community Forum?\n\nThe International Biohacking Community Forum is where biohackers, grinders, and DIY-biologists can share information regarding anything biohacking. This can range from the use of subdermal implants to human longevity.\n\nSignup: [https://biohackingintl.com/invites/o4qxGC3DLA](https://biohackingintl.com/invites/o4qxGC3DLA)\n\n# Why Should I Join?\n\nWhile platforms like Reddit and Discord are great mediums for communicating ideas, they are generally unsuitable for organized, long-term communication, which provides various benefits. Having a conversation on a specific topic that can last for years is a great way to build off of the ideas of others and communicate your experience and findings.\n\nTopics on the International Biohacking Community Forum currently cover the following:\n\n* [RFID/NFC Implants üíâ](https://biohackingintl.com/c/rfid-nfc-implants/6)\n* [Nootropics &amp; Supplements  üíä](https://biohackingintl.com/c/supplements-nootropics/11)\n* [DIY-Biology üß¨](https://biohackingintl.com/c/diy-biology/10)\n* [Magnets üß≤](https://biohackingintl.com/c/magnets/7)\n* [Cybernetics ü¶æ](https://biohackingintl.com/c/prosthetics-wearables-and-haptics/9)\n* [Procedures  ü©∫](https://biohackingintl.com/c/procedures/12)\n* [Coatings &amp; More ‚ö°](https://biohackingintl.com/c/coatings-transdermals-other-implants/8)\n\nAdditionally, the forum is hosted on Discourse, an open-source and free alternative to proprietary forum hosting options. This allows for stable, long-term support enabling discussions to continue for years. I am also very passionate about grinding and biohacking, meaning I will always be here to keep the forums updated and supported through proper backups, security measures, and more.\n\n&amp;#x200B;\n\nIf you have any questions, comments, or concerns, please let me know!"
          ],
          [
           "biohacking",
           "I am new to the biohacking space and have very little knowledge on the topic. Any resources to help me get started would be greatly appreciated.."
          ],
          [
           "biohacking",
           "Biohacking for women. Most people talking about this topic are men and they've done research on men's bodies. But what about women? does someone know a brand/person that does biohacking focused on women's bodies?\n\n&amp;#x200B;\n\nI know many of the principles will have benefits for both male and females,  but I am sure there are extra tips for women as our bodies are different.\n\nThank you community!"
          ],
          [
           "biohacking",
           "Introduction to Biohacking. So I am doing different things for my health, mood, and productivity, but I haven't consciously focused on improving. In the following, I will go through my general 'hacks' and would love to get some feedback or recommendations from others. Also, if you have any good sources for further investigating, I'd be happy if you'd share them.\n\nAbout me: I'm a 21 yo male student and I work in IT. I'm somewhat lean but not skinny. I don't have any health problems. I have an active life, travel a lot, and spend quite a bit of time in nature and with people. I almost always get my 10k steps in, the average is somewhere at 13-15k depending on the month.\n\n# Nutrition\n\nI try to eat protein-rich and fiber-rich and diverse.  In general, I try to reduce carbs over the day and only eat more for dinner, but sometimes I'm lacking low-carb alternatives that are cheap, healthy, and fast. I try to reduce processed foods, sugars, and non-organic (if affordable). I take drugs like MDMA or LSD with a 3-month gap and barely consume alcohol or caffeine.I take the following supplements:\n\n* CBD\n* Omega 3,6,9\n* \"All in one\" for vitamins, minerals\n* Vitamin B (for higher activity)\n* Vitamin D\n* Magnesium and iron every 3 days\n* Glutamine Acid in the exam period\n\n# Sleep &amp; morning routine, evenings\n\nI sleep fairly consistently from 11 pm to 6:30 am. I don't have alarms. However, I can only fall asleep with distractions, be it podcasts or TV shows. It takes me usually about 30 mins. I drink a glass of water after waking up and make about 20-30 min of Yoga. I almost walk and bike every morning for half an hour, but always at least one of those.I go for a walk, about half an hour by 8 pm. I usually spend a bit of time with the people at my dorm and talk to them before I prepare to go to sleep.\n\nI'm happy about any suggestions!"
          ],
          [
           "biohacking",
           "Hi everyone!. Goodevening from Belgium everyone! \n\nI‚Äôm a 28M and have been fascinated with biohacking for a few years now, never know that a whole community existed about it! In my life so far I‚Äôve done a lot of things (good &amp; bad) health wise (e.g. steroids (test, ana, winstrol), drugs, sarms) but the last 3 year I became more serious with being healthy and focusing on become the best version of myself. \n\n- started Muay Thai and Brazilian Jiu Jitsu \n- taking vitamins &amp; peptides for health &amp; injuries (pept. BPC157 yet a bit let down about the effects) \n- every morning 20 min stretching\n- 90/10 clean eating (fianc√© has to follow a FODMAP diet so I eat clean with her) \n- no pre-made foods as much as possible \n- limit alcohol intake \n- 4L of water whenever not in prep for a BJJ competition \n\nWhat‚Äôs your routine or vitamine/etc stack and what benefits do you experience? I know I‚Äôm not talking with doctors, but I would love to hear some personal experiences. \n\nP.S. fianc√© and I will start with trying to get pregnant from next month on, if anyone has some tips to make her pregnancy as smooth as possible: greatly appreciated and thanks in advance!"
          ],
          [
           "biohacking",
           "What are your daily biohacks?. Let‚Äôs hear them. Daily routines, diet, supplements, exercise, etc‚Ä¶"
          ],
          [
           "biohacking",
           "Using modern tech to Biohack: Best use cases/ things to avoid. Below I want to outline my current perceptions of \"weapons\" we have to biohack and my thoughts, good and bad, on them:  \n**1. metabolic health**\n\nPersonally not sure how these things are as successful as I perceive them to be for non-diabetic users. Happy to know of other use cases, but how is it not already obvious that when you eat an apple, fruit, or other sugary food in the morning, it's going to spike your glucose, and then you‚Äôre going feel crappy later on. Maybe I am just overestimating how in tune people are with their bodies, however, massive shoutout to Levels and Nutrisense for gamifying knowing your blood glucose levels for regular people. I see a pretty low overall ceiling for that, and not sure how helpful it is over a long duration (i.e. people will use the product for a couple of weeks, then move on)   \n**2. Blood tests**\n\n I think I see a new startup every couple of months using at-home blood tests. There's definitely a camp of people that are using these tests to make data decisions about biohacking. On one end of the spectrum, there are people who get blood tests once a year and frankly have no idea what their health is. This is definitely going to seem antiquated in the future. Then there are people like Dr. Lustgarten who are literally testing their blood maybe more than once a week. In his recent video, he‚Äôs working with a company called Quantify to do his tests. He‚Äôs literally optimizing his life around improving DHEA, which most haven‚Äôt even heard of. The middle ground I see is normal people doing a test like 4 times a year to see where they‚Äôre really at with at-home kits, then meeting their doctor once a year to review those results, and maybe doing more tests if something is off.  \n\n**3. Hormonal health**  \n Whether people realize it or not it seems that a growing majority of the men I know in their 40s/50s/60s are becoming more open to TRT. This appears in part due to rising awareness as well as easy access to at-home testosterone testing. Now, fewer people see it as a ‚Äúbodybuilding thing‚Äù. I think we‚Äôll look back and think, why weren't we using this tech to measure and optimize our hormones into our later decades?? Do we really know how beneficial it might be to have testosterone optimized well past your 30's?  \n**4. Supplements** \n\nThis is the one thing that simply hasn‚Äôt grown as quickly as I thought it would. People who take NMN, rapamycin, etc. for longevity are still (IMO) perceived as wild biohackers. Obviously, this is partly due to these supplements‚Äô longitudinal effects that are hard to measure compared to say TRT, but I still feel like I've never heard them mentioned in the mainstream yet, even though most supplement companies are looking to add these things to their stacks. I know it's not exactly in the same vein, but EVERY company now has some sort of a ‚Äúgreens powder‚Äù. How many years until every supplement company has a longevity stack/ offering? \n\n&amp;#x200B;\n\n **What other tech am I missing that I need to add or become aware of?**"
          ],
          [
           "biohacking",
           "Want to share your story of biohacking?. I'm writing an interesting batch of articles for a longevity blog. We know famous biohackers, but there are people who do not go public but have outstanding stories and biohacking techniques,  tips and more that would be interesting for many people.\n\nSo, are you willing to share your story with me? To make it easy for you, I have interview questions,  you will just need to answer them in a written form (or as you wish)."
          ],
          [
           "biohacking",
           "Biohack lab in the garage. I'm a surgeon and I have bought a house where garage is available for me to make a research lab. I was initially looking to do clinical medical research but a friend suggested I look into a bio hack lab. \n\nIf money wasn't the issue and you had the opportunity to create your own at home garage bio hack lab how would you design it and what equipment etc would you want?\n\nIt's my first post here and please let me know if this is the wrong group."
          ],
          [
           "biohacking",
           "What is something you wish you had to make your biohacking life simpler?. I've been involved with biohacking for a few months and have done all the simple steps to make sure I am keeping my biological health optimal. Now I am looking into certain tools/products for sleep, glucose monitoring, breathing monitors, brainwaves, and I'm more adamant on my nutrition, along with other daily life things.   \nI was curious before I go down this journey even further if anyone here has anything to say about what they wish they had in the beginning of their biohacking journey, or they wish they had at their current stage? Or you wish their was this one method, product, you had that would make tracking or monitoring your progress even better?"
          ],
          [
           "biohacking",
           "Anyone know of any Bio-related NGOs/NPOs/student-led/anything that host events, workshops, hackathons, ideathons, the whole package?. Basically looking for organizations I can follow and participate in the events they host. Plug if you know of any!"
          ],
          [
           "biohacking",
           "What are some of the common misconceptions you loathe about biohackers?. I've been reading about Josiah Zayner and Aaron Traywick and the portrayal of \"notable\" biohackers in the media. Obviously they do not reflect the entire community as a whole, but I would love to hear about what the community as a whole thinks."
          ],
          [
           "biohacking",
           "Exploring the Frontier of Biohacking: What's Your Edge?. As we continue pushing the boundaries of what's possible with our bodies and minds, I'm curious about the diverse biohacking strategies we all employ. From nootropics for enhanced cognitive function to CRISPR for genetic tweaks, and everything in between‚Äîwhat are the most innovative or effective biohacking methods you've tried or want to try? How have these techniques transformed your daily life and long-term health?\n\nLet's dive into the details and share our experiences. What‚Äôs the one biohack that has fundamentally changed the way you live or perceive your health?"
          ],
          [
           "biohacking",
           "Exiting Big Medicine?. Does anyone trust their biohacking routine/protocols enough to where they have completely exited from the world of big medicine. Meaning: No checkups, no regular doctor you see, no prescription meds, etc. if so when did you feel comfortable completely exiting Big Medicine/Big Health? And What protocols do you follow? Obviously for something like a broken bone etc you would still have to rely on a surgeon- not what im talking about."
          ],
          [
           "biohacking",
           "What's the current cutting edge of non-invasive biohacking concepts?. Curious student here, just eager to be \"in the know\" with the latest movements in biohacking. \n\nI'm particularly interested in adaptogens and combining them for various effect. Tending to personally and most commonly lean into Ayurveda, I feel we're just re-discovering or re-learning most of this body science.  \n\nI'm trying to explore new (to me at least) things in our DIY self optimizing world.\n\nGrateful for, and glad to receive any kind of insight here üß¨ü§ìüëÄ"
          ],
          [
           "biohacking",
           "Interest in Biostasis: Much More Than You Wanted to Know. Results from the ACX 2021 Biostasis/Cryonics Survey."
          ],
          [
           "biohacking",
           "If I were to open a longevity/biohacking center what are the must haves that should be inside?. Thinking of potentially opening a longevity/wellness/biohacking business. What are some of the must haves inside the facility?"
          ],
          [
           "biohacking",
           "How can I start bio hacking at a young age. I almost never fall sick but I would like to live a long Time and be healthy I am 14 so nothing like too long i already go to the gym 3 days a week for half an hour each I do 50 press-ups every day I play football one hour 5 days a week and I walk on the weekends I also try to eat healthy and eat at 7:30 bowl of weetabix with cinnamon and ginger and milk 3:30 I eat a snack most likely a banana cooked in a pan with a tiny bit of olive oil and cinnamon ginger and dark chocolate then i go to the gym or do homework and at 7:00 I'll eat lunch"
          ],
          [
           "biohacking",
           "Life changing hacks. What are some small tweaks that one should change in their life, to have better health. \n\nEg. \n1. Adding pinch of pink salt in water to increase cellular absorption \n2. Pacing at incline instead of running to lose calories faster. \n\nI would like to know other bio life hacks from everyone. \n\nThanks in advance."
          ],
          [
           "biohacking",
           "How to biohack recovering from surgery?. How would one go about bio hacking their surgery recovery from both a dietary and supplement standpoint?"
          ],
          [
           "biohacking",
           "Spooky2 Rife Machine. I am fixing to invest in the Genx Pro. Before I take the leap does anyone have any tips, tricks, reviews/testimonials &amp; a coupon code they‚Äôre willing to share. Any advice given would be greatly appreciated. I don‚Äôt make that much money but am willing to make this investment if others have had life changing results. Thank you guys so much for your time. I‚Äôll be making my decision when I get off work today @5 pm."
          ],
          [
           "biohacking",
           "My daily stack. Right now this is my favourite stack.\nI microdose, gym, and meditate."
          ],
          [
           "biohacking",
           "Biohacking Discord Server - International Biohacking Community. **Join The Biohacker Lounge:** [https://discord.com/servers/the-biohacker-lounge-985888960653963264](https://discord.com/servers/the-biohacker-lounge-985888960653963264)\n\nhttps://preview.redd.it/wpcmf8jdxcbd1.png?width=1500&amp;format=png&amp;auto=webp&amp;s=3895486c394896007b06d8abf36ff7e23bfaf570\n\nThe International Biohacking Community is the digital home of biohackers. The International Biohacking Community is a place where people across the globe can share information on their experiments, learning, and development on things from subdermal electronics systems to CRISPR protocols."
          ],
          [
           "biohacking",
           "Community Discussion: What biohacks will be commonplace in 10 years?. While defining \"biohacks\" can be subjective, these are some that seem to be commonplace now:\n\n* Blue-light blocking glasses/computer glasses\n* Smart home lighting to assist with setting circadian rhythm\n* Fasting methods\n* Mouth taping\n* Taking ice-baths and/or cold showers\n\nComment below, what are your expectations for \"biohacks\" that will be a common addition to a future person's routine?"
          ],
          [
           "biohacking",
           "What are the biggest struggles in your biohacking journey?."
          ],
          [
           "biohacking",
           "Nightly Biohackers Discussion: What is everyone's main goal with biohacking, and why is that goal important?."
          ],
          [
           "biohacking",
           "Biohackers of Reddit, We're Baaaaack!. And we've got some major updates on our DIY pharmaceutical R&amp;D technology stack.\n\nWe can't give you all the details until after [our presentation at DEF CON](https://defcon.org/html/defcon-32/dc-32-speakers.html#54498) (live streaming [on Twitch](https://www.twitch.tv/defcon_dctv_two), no account needed), but we can say that we'll be showing off a novel method to make sofosbuvir (the cure for Hepatitis C) at a tiny fraction of the price big pharma charges.\n\nWe'll also be demoing the newest edition of [the MicroLab](https://github.com/FourThievesVinegar/solderless-microlab/blob/master/docs/index.md), our DIY lab reactor that you can build at home for a few hundred dollars. Together with our Recipe Press (which generates instructions for the MicroLab) and ChemHacktica (our hijacked machine-learning-based chemical synthesis planner), the MicroLab Suite provides all the tools needed to plan and execute reactions that you need for DIY medicines.\n\nAre you ready for DIY drug development? What medications would you hijack? The era of computer-aided home chemistry is dawning and we can't wait to see where you all take it.\n\nAs always: Keep each other healthy. Keep each other safe."
          ],
          [
           "biohacking",
           "Biohacking on a budget: 10 free or low-cost hacks that beats expensive treatments. Hey fellow biohackers! üëã \n\nBeen messing around with some cheap (or free!) biohacks lately and thought I'd share what's been working for me. No need to break the bank to optimize your body and mind!\n\nSo, first things first - GET OUTSIDE! Seriously, just a quick 15-min walk outdoors does wonders for your brain. Something about that \"soft fascination\" stuff. Way better than sweating it out indoors.\n\nNext up, and this might sound weird, but... **check your poop**. Yeah, I said it. Look at your üí© every day. Color, shape, how often - it's like a report card for your gut. Gross but effective.\n\nNow, for the brave souls out there:\n1. Eat some liver (I know, sounds nasty, but it's like nature's multivitamin)\n2. Take cold showers (11 minutes if you can handle it - it SUCKS but works)\n3. Go barefoot for 30 mins (hippie stuff, but helps with sleep and inflammation)\n\nOh, and here's a game-changer: L-theanine + coffee. Magic combo. 200mg L-theanine with your morning joe. Thank me later.\n\nFor the night owls: Wear dorky orange glasses 2-3 hours before bed. You'll look like a dork, but sleep like a baby. Speaking of sleep, crank down that thermostat! Keep your bedroom between 60-67¬∞F (15-20¬∞C). Your sleep quality might jump by 20%! Worth the extra blanket, trust me.\n\nRandom stuff that's been working for me:\n- Chew your food slowly. Might save you 300 calories per meal.\n- Breathe through your nose. Sounds dumb, but it's legit. More oxygen, less mouth-breathing.\n- Brain training: Dual N-Back for 20 mins a day. It's like CrossFit for your brain. Might make you 40% smarter (don't quote me on that lol)\n\nPro tip: Try cold exposure + meditation. It's like unlocking a cheat code for stress.\n\nCost vs. Benefit (cuz we're all broke, right?):\nFasting is FREE and works like expensive stem cell treatments\nCold showers beat $10k cryo sessions\nDeep breathing = poor man's psychedelics\n\nStay safe out there! Remember, we're all different. What works for me might not work for you. Listen to your body and don't do anything crazy without checking with a doc first.\n\nAnyone else tried these? What cheap biohacks are you into?"
          ],
          [
           "biohacking",
           "[When2Meet] r/Biohackers Weekly Zoom Hangout."
          ],
          [
           "biohacking",
           "Ultimate bio hack (for me). I believe the ultimate bio hack for me was going through myofunctional therapy and getting my tongue tied snipped (frenectomy). It‚Äôs fixed so many issues for me: chronic neck and facial pain, I can breathe easier and take deeper breaths, I swallow better and digest better, i can look over my shoulders without tight restriction. I just feel amazing. It was a long process but worth it. \n\nI wasn‚Äôt identified as being tongue tied until later in life. I breastfed for a year no issues, and I never had a speech impediment. It wasn‚Äôt until I was an adult (28) that I figured out I was tongue tied. I‚Äôm also an SLP."
          ],
          [
           "biohacking",
           "Kent Kemmish(tree) Presents Demonpore inc.."
          ],
          [
           "biohacking",
           "The SENSible Blog: The Iron Fist senolytic strategy unleashed."
          ],
          [
           "biohacking",
           "any youtube channel For Everybody ( Non bio) to learn biology/industry in simple way ?."
          ],
          [
           "biohacking",
           "Who is Stephen Skinner?. The name Stephen Skinner has been mentioned in this subreddit. Is he a biohacker? All I know is that he's based in Britain."
          ],
          [
           "biohacking",
           "What did you blokes &amp; blokettes buy on Black Friday/cyber Monday ?. What did you buy for your biohacking needs and how much did you spend?"
          ],
          [
           "biohacking",
           "What Biohacking habit that will be normal in 10 years?. I think people will become more careful about their wearable data, demand ownership of it! Possibly, get something in return too. Saw someone share [Intra](https://www.intra.so) here, but not sure whether tools like this can be trusted yet. \n\nI also think, supplements would be replaced with specific compounds, with clear dosing and targeted problems! \n\nPossibly, some degree of genetic and bionic interventions will be widely accepted"
          ],
          [
           "biohacking",
           "We‚Äôre still looking for a few more people on the biohacker side‚Äîjoin us if you‚Äôre eligible. Thank you!."
          ],
          [
           "biohacking",
           "New Biohacking Skool. On the programm skool: https://www.skool.com/refer?ref=4eb6d27744e342beb9568c5dfc34a0c7 \nThere opend a Biohacking skool called Anime Shreds try it out if u want it's from Nate and Luke Belmar."
          ],
          [
           "biohacking",
           "Bio hacking UTI. Just looking for recommendations on bio hacking for UTIs. Thanks!"
          ],
          [
           "biohacking",
           "Dr. John Kim on Debunking Detoxification Myths | Biohack-it."
          ],
          [
           "biohacking",
           "Biomedical gerontology. Hi! I really want to go into biomedical gerontology but I have no clue how, where should I apply? What courses do I need?? Could anyone help please?"
          ],
          [
           "biohacking",
           "semi OT: male biohackers, do you shave or have beard?. i know it might sound completely off-topi, but please listen to me.\n\nI had the beard for 25y, so trimming it once a week and it was done. \n\nA month ago I had to shave, and have been shaving since. I also moved to double edge shaving after having tried the usual multiblades.\n\nAnd here it comes to you: that 20-30 minutes needed to shave could be better invested in sleeping, working out, reading, having sex, meditating, improving your mental health, etc. So I was wondering if you, so attentive to improving yourself, do you \"waste your time\" shaving each day or each other day, or rather you keep a beard to avoid all the need? so it is rather a practical choice, more than aesthetic one. \"Practical\" not it the sense \"it's faster in the morning\" but \"I can use my time better than looking at a man doing weird faces in the mirror\".\n\nthanks"
          ]
         ],
         "hovertemplate": "Topic Group=%{customdata[0]}<br>document=%{customdata[1]}<extra></extra>",
         "legendgroup": "biohacking",
         "marker": {
          "color": "rgb(242, 183, 1)",
          "symbol": "circle",
          "opacity": 0.7,
          "size": 7,
          "line": {
           "color": "rgba(0,0,0,0.5)",
           "width": 0.8
          }
         },
         "mode": "markers",
         "name": "biohacking",
         "showlegend": true,
         "x": {
          "dtype": "f4",
          "bdata": "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"
         },
         "xaxis": "x",
         "y": {
          "dtype": "f4",
          "bdata": "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"
         },
         "yaxis": "y",
         "type": "scattergl"
        },
        {
         "customdata": [
          [
           "app_watch",
           "Dreem 2 availability?. I discovered the Dreem 2 headband a week or two ago and was sold after having read and watched a handful of reviews about how accurate of a sleep tracker it is compared to everything else on the market. I‚Äôve been checking their website over the past few weeks and it looks like it‚Äôs been sold out this whole time. Any idea how long it‚Äôs been sold out and whether people have generally had issues obtaining one?"
          ],
          [
           "app_watch",
           "Oura Ring vs Muse S for sleep tracking accuracy. I am currently looking for the best way to monitor sleep for the day. I am debating on getting a Muse S or an Oura ring (or both). I am curious if the Muse is any more accurate for sleep tracking than an oura ring, or are they just the same? I don't need the meditation music, I just want the best data I can look at and compare."
          ],
          [
           "app_watch",
           "OMRON HeartGuide. Anyone here tried this thing out? It‚Äôs a continuous blood pressure monitoring watch that doesn‚Äôt require constricting arteries.\n\n[link](https://omronhealthcare.com/products/heartguide-wearable-blood-pressure-monitor-bp8000m/)\n\nEdit: the watch doesn‚Äôt monitor BP continuously, I was mistaken about that. It also inflates against your wrist."
          ],
          [
           "app_watch",
           "Can you use a chest strap heart rate monitor for sleep stage tracking?. I'm not 100% sure how the algorithms for Fitbit, Apple work exactly - but I believe a large portion of the sleep stage tracking inference is based on simple heart rate tracking.\n\nThey only really have an accelerometer and heart rate monitor to worth with, so I'd imagine they use movement and heart rate.\n\nI have a Garmin heart rate chest strap for exercise, I was wondering if there were any apps that were able to infer sleep stages using the HR data from a generic bluetooth HR strap.\n\nAlternatively, can the Fitbit app ingest data from other sensors - like the HR strap?"
          ],
          [
           "app_watch",
           "Free iPhone binaural beats app for Alpha(flow) state. As title suggests. Been going through some of Ben Greenfields stuff and then watched this today (https://www.youtube.com/watch?v=KhyqpvEfMxI) and thought ahhh I'd like to try it again. Used to have access to a drop box with a whole bunch of free ones but is no longer. I'd even torrent. Don't care. Anyone got a free app thats good? Thx"
          ],
          [
           "app_watch",
           "Beginner fitness and / or sleep tracker? (US). Looking for a general-purpose fitness and / or sleep tracker.  Seems like there are a lot of reasonable options -- I've heard good things about Garmin, Apple, Oura, and Whoop, for example.  Never owned a wearable so not really sure what I'm looking for and just looking for something that will give me some useful information, doesn't have to be perfect.  I'd go for something high-end but don't want to overcommit money since I'm not sure exactly what features etc. I want yet.\n\nAny suggestions?  Thanks!"
          ],
          [
           "app_watch",
           "Chpeast device to measure my VO2 max during exercise?. I know their a bunch of smart watches and trackers that measure your VO2 max, I just need the barebones.  The cheapest device that decently accurately measured my VO2 max so I can track my progress.\n\nThanks!"
          ],
          [
           "app_watch",
           "Can HRV4TRAINING read sleep data from Apple Watch?. The last thing I want to do is a manual entry everyday tbh"
          ],
          [
           "app_watch",
           "Gatorade made a smart patch that measures your sweat and hydration."
          ],
          [
           "app_watch",
           "How to increase HRV?. My wife has an average HRV of 24, I've bought her magnesium (from bioptimizers), TruKava, &amp; the Apollo. Is there any other hacks y'all may know of? Thank you!"
          ],
          [
           "app_watch",
           "Analyze event impact on your health ‚Äì looking for beta testers!. Hi folks!\n\nWe‚Äôre looking for beta testers for a new version of [Tunum](https://www.tunum.health), an iOS app that securely organizes your wearable and lifestyle data and helps you analyze and optimize your health.\n\nWe‚Äôve been working hard on expanding Tunum‚Äôs analysis capabilities, and are now thrilled to introduce our brand new Event Analysis.\n\nEver wondered how that late night coffee or an extra drink impacts your sleep? With Event Analysis, you can now **create custom, nuanced events and explore their impact on your health metrics.**\n\nWe'd like to invite you to be among the first to beta test this feature! Please DM or comment if you‚Äôre interested, and I‚Äôll give you an invite.\n\nThank you!\n\nTunum Team"
          ],
          [
           "app_watch",
           "Best sleep tracker?. Ok so I‚Äôve had my Garmin (Forerunner 645) for a few years, and whilst I love it, the watch isn‚Äôt particularly accurate sleep-wise. \n\nI‚Äôve been wearing a Fitbit simultaneously the last few weeks (as part of this dementia study that I‚Äôm taking part in) and the sleep stats there are much more negative (and I think) accurate compared to the Garmin.\n\nI wanted to give the Ultrahuman Air ring a try (as I don‚Äôt necessarily want to buy a new watch but something that focuses on sleep), but the annoying thing is that size 7 is far too loose and size 6 is too small lol. So that‚Äôs not an option either.\n\nSo my question to you is - what do you use as a sleep tracker?"
          ],
          [
           "app_watch",
           "Best HR Chest Strap for Elite HRV? I'm Having Issues with Wahoo Tickr. I've been using my Wahoo Tickr for my morning HRV readings on EliteHRV. The issue is that I often get erratic spikes. This is generally due to the leads not being wet. But even after wetting them, I still get the spikes. I wear the strap for 10-15 minutes (after wetting the leads) and only then do the readings tend to stabilize. \n\nI'm looking for a better HR Chest Strap that doesn't have this issue with the erratic spikes and works well with Elite HRV. I'm also a cyclist so something that works well with Wahoo Elemnt Bolt would also be a plus, but not necessary.\n\nDoes anyone have a chest hr strap they suggest or other measuring device they find accurate and reliable?\n\nEdit: thanks all ordered Polar H10"
          ],
          [
           "app_watch",
           "Any experiences with the Oxa breathing sensor?. Oxa provides a chest band that's supposed to give you real-time biofeedback (breath/heartbeat measurements) to train you to breathe in a way that promotes relaxation and increases your heart rate variability. Has anyone had any experiences with this device?"
          ],
          [
           "app_watch",
           "Aktiia continuous blood pressure monitor. Hey, I heard Peter mention the Aktiia continuous blood pressure monitor and as I‚Äôm in Europe I decided to try it.\n\nMy sleeping BP average is 114/63 and my daytime is 122/71.\n\nI see spikes to 126-129 at times.\n\nI‚Äôm just curious if I should be aiming to try and keep all spikes to below 120 to be optimal and will these 129 spikes hurt me long term?\n\nI‚Äôve attached images of a daily example and then also my previous week averages. \n\nhttps://imgur.com/a/9fY8u0I\n\nI‚Äôm curious if anyone else has used this and what the true accuracy is?\n\nWhen ever I took my own BP I‚Äôd see 130/70, I assume this is because I‚Äôm being conscious of taking it vs the monitor as I am unaware and don‚Äôt spike it."
          ],
          [
           "app_watch",
           "re looking for feedback. apple watch thinks this is 32.6 v02wamax which seems horrible\n\ni am talk test whole time, barely breaking a sweat\n\nam i crazy?"
          ],
          [
           "app_watch",
           "Morpheus m7 recovery bug. When i was checking my recovery for today, and the morpheus app or the strap itself started glitching. On the app the countdown went faster than normal, and when I tried to cancel it to start again, it continued to measure even tho I cancelled it. \n\nBut my main question is, is there a way to do the recovery test again or is it what it is?"
          ],
          [
           "app_watch",
           "overall health tracking watches. I see the vast majority of people seem to mention the apple watch along side the oura, bio strap, whoop, ect. and the other watches aren't mentioned as often. samsung, polar, garmin, all seem to be just as good if not better in areas.\n\nI think the polar watches (unite / ignite) especially seem to give a good amount of health stats as well as sleep tracking, recovery tracking ect. as well as the garmin looks good, can add in some apps.\n\nTL;DR: just curious why the apple watch seems to take the cake in the watch category and the others are seldom mentioned. any reason behind this? maybe most people are just in the apple space? I'm trying to decide on a watch / fitness tracker and I'm not a apple user so curious what everybody here has to say about the others."
          ],
          [
           "app_watch",
           "App to track your blood tests. What is the best?"
          ],
          [
           "app_watch",
           "Adequate sleep quantity and quality is essential for optimizing health and performance! Do you use sleep tracking tools? Do they influence sleep habits/lifestyle practices? Wether or not you utilize these tools, we would like to hear from you!. Wether or not you use sleep tracking tools, we would like to hear from you!    \n\nContribute to research on sleep quality and sleep trackers with this BRIEF 2-3 MINUTE SURVEY! (Anyone 18+)      \n\nHere is a [LINK TO THE SURVEY!](https://www.surveymonkey.com/r/L3XNQ5J)"
          ],
          [
           "app_watch",
           "Privacy and menstruation apps. The right to privately use menstruation and ovulation tracking apps is in EVERYONES interest. \nThey reduce more unwanted pregnancies than any policies ever will. And therefore also the need for abortions. \nSo it's important that no one messes with the ability to use apps freely."
          ],
          [
           "app_watch",
           "What would the perfect Self Tracking tool look like to you?."
          ],
          [
           "app_watch",
           "Continuous HRV Monitoring?. Have been considering buying a Polar H10 Strap to use with the Sweetbeat app to monitor HRV throughout the day and manage stress. \n\nBut I‚Äôm wondering if anyone has experience with devices or apps that could continuously monitor HRV and perhaps alert you when HRV dips and you need to use measures to de-stress? Any insight would be appreciated. Ultimately, trying to lower cortisol &amp; increase testosterone and figured managing stress by watching HRV might be an effective way to do so. Currently use Whoop to track sleep but it only provides a HRV measurement at one point during sleep."
          ],
          [
           "app_watch",
           "Recommend a better CGM app?. For Christmas, I received a Levels membership that included a Dexcom G6 continuous blood glucose monitor. The raw data from the FREE Dexcom app has been very informative but I've found little value in the Levels app @ $199 annually.\n\nIt would be great to have fitness tracker (Fitbit) and food logging (myfitnesspal or Loseit) integration. Are there any such CBG apps out there?"
          ],
          [
           "app_watch",
           "Self Sport - Fighting a decade of anxiety disorder and bad self esteem, I decided to build an app. We just launched last week.. Hey All, \n\nLast week, I launched an app I've been working on for over a year (around having a newborn and learning to code at night!) and I want to share with all of you. I asked Mods and seems this is okay.  \n\n\n**What is it, and (more importantly) why?**  \nIn short, Self Sport helps you to bring attention to your lifestyle and do more in your days. It does this by letting users quickly 'track' their actions across 12 life categories, like a rapid journal you use during your days. This allows you -- via metrics views -- to see how your time is balanced across areas of life. There are community features as well, to inspire and keep you moving.   \n\n\nYou can get it here: [https://apps.apple.com/us/app/self-sport-lifestyle-tracker/id6450458673](https://apps.apple.com/us/app/self-sport-lifestyle-tracker/id6450458673)  \n(iOS only, sorry I had to start somewhere)\n\nThe purpose is to build a sort of self-awareness and self-efficacy (i.e., \"I'm capable and super satisfied with life\") by engaging with how you spend your time. Think of this like a fitness or calorie tracker, but for time, with challenges, goals and community features built in.   \n\n\n**Why I built it**  \nAs it says in the title, I spent a decade (13 years actually, and I almost called my company \"Project 4745\" for the number of days during those years) with really bad anxiety due to some trauma. I was avoiding key things in life, had some substance abuse (just drank too often for my liking) and wasn't pursuing my life in a meaningful, earnest and honest way. I was somewhat stable around panic attacks, and eventually got engaged. Problem was, I dreaded my wedding day.   \n\n\nDue to this, I began to look inward and wondered if I was dealing with a life-long chemical imbalance or 'curse' as I called it, or if it was something else. Were these symptoms, not the root cause? Through this inward search, I began to recognize how my self esteem was really the culprit. In public settings, I was exposed as the person I wanted to hide from the world. A person unhappy with himself, unfulfilled, and lacking confidence. This led me to research into self-affirmation, self-concept, etc. and -- eventually - to designing the idea for Self Sport.   \n\n\n2 years later and a lot of work, the app is out. \n\n&amp;#x200B;\n\n**I hope you'll love it.**   \nThis app is a passion project. I've posted it to two other subreddits (this is the last) and am working every day to get the word out. Right now we have a few active users (which is awesome! Some people really 'get it' already) but I want to do so much more. I hope you'll check it out but, more than that, I hope you get something out of it.   \n\n\nThanks so much, happy to answer questions.   \n\n\nClay from Self Sport"
          ],
          [
           "app_watch",
           "Let‚Äôs talk about emotional health. I am an Attia fan girl. I love his message and the way he delivers it. I mostly do what he says because he has a great deal of credibility with me. Where I differ is protein sources but that is beside the point. \n\nHe posted a video in Instagram today about emotional health, relationships and human connections and how important that are. \n\nI don‚Äôt know what I‚Äôm missing because I do not seek human connections. I live alone and many days the only people I see are at the gym but I do not interact with them. Many days I do not speak to anyone. \n\nBut I love it!!! This is the way I want it. \n\nI have a very healthy lifestyle but I worry I should be more social, even though I do not want to be."
          ],
          [
           "app_watch",
           "Dreem 2 Question. Hello!\n\nIf I buy a used Dreem 2, are you still able to sign up for the app to export the data?\n\nOr has anyone created an app to export the data or have the Dreem Viewer available to download?\n\nIt would suck to buy a headband and not have something to output the data.\n\nThanks!"
          ],
          [
           "app_watch",
           "Apple Watch link t o weak wrist. Had it been shown the watch can make your wrist weaker ?"
          ],
          [
           "app_watch",
           "Top Fitness Trackers for Every Budget and Lifestyle."
          ],
          [
           "app_watch",
           "HRV Therapy. I mostly in fight or flight response. I've seen Bryan Johnsons uses a HRV Therapy device in [this video](https://youtu.be/I3r7q63bMqg?t=83).  \n\n\nDoes anyone know what's the name of this device? Thanks in advance!\n\n&amp;#x200B;\n\nhttps://preview.redd.it/1pcwz2uihrza1.jpg?width=1432&amp;format=pjpg&amp;auto=webp&amp;s=c45c13bb80a11f26bd6fe6d390757a0fd2c34c46"
          ],
          [
           "app_watch",
           "Has anyone tried this yet?. I just came across this product and wondered if anyone here had tried it: [https://www.happyring.com/](https://www.happyring.com/)\n\nIf you have tried it, how does it compare to an Oura Ring?"
          ],
          [
           "app_watch",
           "Looking for a tool to track my breathing rate 24/7. The only one I've come across is the Polar chest strap which is fine but it would be good to have another option. Ideas?"
          ],
          [
           "app_watch",
           "Android app to enable mobile use of Proxmark3 Easy?. Hey all! I've been searching online but have found very little documentation on ways to use the Proxmark3 Easy with an OTG cable and my Android smartphone. From what I found online, it looks like the app RFIDTools is supposed to support the PM3, but I'm unsure of how to get started with it. I went into the app, connected my PM3, gave the app access permissions, and then went to the Flash section to get the PM3 and client firmware on the same version number. After 10+ minutes of an \"Executing\" message, nothing has happened to indicate a successful flash.\n\nAm I doing something wrong, or is the application out-of-date? If it is out-of-date, is there another application that would work as of now?"
          ],
          [
           "app_watch",
           "Is there such thing as an integrated health app?. Not sure this is technically a bio hacking question but thought it‚Äôd be a good place to ask‚Ä¶\n\nI use several health gadgets and apps but would love if there was one app that could take all the data and make it useful. Is there such a thing?? \n\nFor example I wear a cgm, track my food in Cronometer, have an Oura ring, use Vivoo strips and use Welltory with some other stuff too. Is there an app that can take all this info into one place and make sense of it all and/ or give some sort of AI-generated recommendations? \n\nI guess I‚Äôm looking for something that will say ‚Äúx is/ isn‚Äôt happening because of y‚Äù or ‚Äúx will improve if you change y‚Äù\n\nI feel like I have all this data but it‚Äôs essentially useless because I can‚Äôt make sense of it all in a bigger picture. \n\nTIA"
          ],
          [
           "app_watch",
           "Morpheus M7. Is there a Morpheus support community where you can ask technical questions to more experienced users? I know Morpheus has a Facebook and Instagram account, but it says in the rules that technical questions have to go through their support and I‚Äôm an inexperienced new user of my Morpheus M7 and relatively new to fitness training using this sort of technology so some of my questions are quite basic (in potentially obvious and annoyingüòÄ). \n\n- John"
          ],
          [
           "app_watch",
           "[Feedback Needed] New web/mobile app merges your data from apps and smartwatches into one centralised hub to fully optimize your productivity, mental, and physical wellness.. Hi all! I am currently developing a web/mobile app for health and longevity enthusiasts who are unhappy with existing methods of tracking their data through apps and smartwatches. It is a web tool that helps you uncover what's holding you back personally, then uses it to guide your future behaviour and keep you aligned with your goals. Unlike existing solutions, this will utilise the power of AI to produce deep, below-surface insights and is completely tailored to your motivation, colour preferences etc. at every stage.\n\nI am developing this with you guys in mind and so would love to hear your feedback and requests.\n\nI plan to launch a private access early beta next week and would love to personally invite you to contribute to its performance and feedback. Here are some things which will be included in the long-term vision of the product:\n\n\\- Seamless integrations with hundreds of apps (Open source community integrations too)\n\n\\- Daily report logs (Log your entire day, mood, and custom variables in less than 60 seconds)\n\n\\- AI-based insights which dive deep below what the conscious mind can identify.\n\n\\- An entirely tailored experience. You choose the tone of your assistant, what sits on your dashboard, and even motivation techniques - everything is FULLY customisable.\n\n\\- Exciting new features: Experiment tracking, In-app scientific journals, friendship Leaderboards and much much more.\n\nP.S data will be stored locally and so no one will have access to your data - not even us.\n\nI would love to hear your thoughts and opinions on what you'd like to see, please let me know in the comments or I can personally invite you to our community."
          ],
          [
           "app_watch",
           "HR monitor shows odd spikes. Why?. This happens to me occasionally and I'm seriously starting to wonder what the heck it is. I use a Polar Unite to check my HR when exercising. Periodically, when doing cardio, I get odd spikes that are ridiculously high for no apparent reason. Sometimes I feel bad for a sec and that triggers me to check the watch and see the spike, other times, I don't feel it at all, and just notice it later in the chart. \n\nWhat could cause this?  Faulty watch? A health condition?"
          ],
          [
           "app_watch",
           "Converting my Apple Watch into a bio hacking device. Any recommendations?."
          ],
          [
           "app_watch",
           "How do you track your health when changing treatments?. I‚Äôve got all the wearables, but the data is spread.\n\nI‚Äôve tried to keep track of my symptoms (gut, mental health etc.) but are manually correlating my symptoms, treatments, exercise, stool and food intake in Google Sheets.\n\nIt‚Äôs almost like the data collection is too sporadic ‚Äì and it‚Äôs hard to keep up. The cost/benefit isn‚Äôt great.\n\nHow do you track your health and correlate it with your treatment on an on going basis?"
          ],
          [
           "app_watch",
           "Do you use HRV to improve your health and physical performance?. Hello everyone, I am seeing lately that there are quite a few applications to measure HRV (heart rate variability) with many applications and devices.\n\nI am finding HRV4Training to be the best app of all as it can be paired with a chest strap to ensure morning measurement.\n\nI wanted to know if someone here uses it, what they can see with it and how they improve it"
          ],
          [
           "app_watch",
           "Best sleep monitor?. Preferably not one that goes on the head but rather on the wrist.  Would be nice if option to track SPO2 and HRV.  Right now I have a Garmin Vivosmart 4 (sucks) and a Elite HRV Corsense (for spot checking HRV).  I really don't think the ring devices could be as accurate since they are smaller but I could be wrong.  Sleep tracker is the main thing, not worried about fitness."
          ],
          [
           "app_watch",
           "What wearables do you use to track your stats and why?. Please comment if you use other devices.\n\n[View Poll](https://www.reddit.com/poll/qlwl7j)"
          ],
          [
           "app_watch",
           "My WHOOP Review. If you're on the edge of buying a WHOOP or not, here is my review after 6-months of using it!\n\n# Pros:\n\n1. **Great for Sleep Metrics**\n   * I didn't realize how few hours of sleep I was getting during the work week until consistently wearing my WHOOP. Also, I learned how terrible my sleep can be (via the light/deep/REM sleep metrics) when sleeping on the couch.\n2. **Resting/Recovery State**\n   * Having heart rate variability and resting heart rate measured is a nice touch to help me explain why I feel a little extra sore or stressed on what should be an otherwise normal day.\n3. **Strain Measurements**\n   * I didn't realize how little strain my light-weight workouts were having on my body in comparison to full-court basketball - interesting to know I should probably be pushing myself harder in the gym!\n4. **Zero Display/Watch Face**\n   * As someone who is extremely dopamine addicted/adhd it feels, not having a lit up watch face blasting notifications at me all day is a nice touch.\n5. **Battery**\n   * Lasts way longer than you think! For me 2-3 days without charging.\n\n# Cons:\n\n1. **Expensive**\n   * A subscription model is a bit... extreme.\n2. **Accuracy of Calories Burned**\n   * I will sometimes lightly play basketball and it will say I burned thousands of calories... I don't know how realistic that is.\n3. **Band Quality**\n   * I got the all black basic band. I am somewhat of a salty sweater. My salty sweat marks are all over the band and I can't wash them off at all (not the best to look at when you are supposed to wear this 24/7).\n4. **Replacement Bands**\n   * Both times I tried to change into the sport bands they offer, it jammed while putting it in. On the bright side, they shipped me a new tracker both times!\n\n**In Summary:** A bit pricey, but a great sleep tracker that doesn't distract you while being on your wrist!\n\nHow does everyone else feel about their wearables? Anyone have any recommendations?"
          ],
          [
           "app_watch",
           "The Value of Tracking Biomarkers for Fitness and Life Performance."
          ],
          [
           "app_watch",
           "Morpheus Coaching. Is there a database anywhere for fitness coaches that are familiar with using the Morpheus system and could help a new user learn how to use Morpheus properly.\n\n- John"
          ],
          [
           "app_watch",
           "Best tools for biological snapshot of your energetic state?. What are the best diagnostic tools, even if expensive, that show metrics indicative of your energy level while using these tools? Such tests would be interesting for people who have ‚Äúon‚Äù and ‚Äúoff‚Äù days to compare what is physically different."
          ],
          [
           "app_watch",
           "Aura vs Fitbit vs Garmin vs WHOOP - I Tried Them All!!. Since I've tried almost all the wearables at this point, here is my breakdown of each!\n\n# Aura Ring\n\n* **Pros**:\n   1. Sleep tracking is phenomenal (REM, deep sleep, readiness, etc.)\n   2. Very minimal design. People who don't know about the Aura ring won't go asking you 1,000 questions about it - ie - it won't become your whole personality at dinner parties.\n   3. Battery life is insane (mine usually lasts 5 days!)\n* **Cons**:\n   1. If you already wear rings, this will feel like the chunkiest ring alive. It is very big in comparison to a regular ring.\n   2. Almost no workout/activity tracking beyond basic steps/calories.\n* **Score:** 6/10\n\n# Fitbit\n\n* **Pros:**\n   1. Very affordable\n   2. Very User-friendly (it takes me a while to get used to new tech but this was easy)\n   3. Smartwatch features (notifications/music controls)\n* **Cons**:\n   1. Not really any recovery or strain data in comparison to the Aura ring or WHOOP band\n   2. Somewhat basic in its features\n   3. Not aesthetic and usually looked down upon by others who wear wearables.\n* **Score:** 5/10\n\n# Garmin Watch\n\n* **Pros:**\n   1. Amazing for endurance athletes (all my marathon friends rave about the precise metrics - I don't use them - but they seem to love them!)\n   2. Great durability (my salty sweat doesn't seem to bother the watch at all) \n   3. Cool features (GPS, advanced tracking/mapping, metrics for swimming/biking) \n* **Cons**:\n   1. Heavy and bulky (you can definitely notice you are wearing it)\n   2. Prevents you from wearing a fancy watch since you would never wear two watches (I work in finance and am judged for wearing a garmin instead of something more client-appropriate)\n   3. I might not be the most tech-savvy, but this still felt difficult to understand some metrics.\n* **Score**: 8/10\n\n# WHOOP\n\n* **Pros:** \n   1. Amazing sleep and strain metrics\n   2. Minimal design and easier to put higher up forearm so you can wear a watch as well\n   3. Super light-weight so I barely notice I am wearing it 24/7\n   4. Constant updates (just this week a bunch of new features were added)\n* **Cons:** \n   1. Pricing - a subscription model is kinda crazy to me.\n   2. Customizability - the alternate bands jammed when trying to change them.\n   3. Easily stained - my band has salty sweat stains on it.\n* **Score**: 9/10\n\n# Anyone use other wearables I should try out?"
          ],
          [
           "app_watch",
           "A health assistant in WhatsApp based on all your wearables."
          ],
          [
           "app_watch",
           "fitness watches for sleep tracking, is Garmin okay?. I was really drawn to Garmin due to Mozilla reporting positively on their privacy of data: [https://foundation.mozilla.org/en/privacynotincluded/categories/wearables/](https://foundation.mozilla.org/en/privacynotincluded/categories/wearables/)\n\nBut I was reading some comments on the garmin subreddit where users suggest the sleep tracking on Garmin isn't very good? \n\ni've never had a fitness watch before so this is new territory for me. All I care about: \n\nhigh quality sleep monitoring and heart rate monitoring (HRV, ECG, etc) \n\nEverything else is extra on top. \n\nCould I buy a Garmin watch and trust the data I'm getting?"
          ],
          [
           "app_watch",
           "HRV: the ultimate marker for health and longevity."
          ],
          [
           "app_watch",
           "Moving from Internet of Things to Internet of Bodies - Sergey Young discusses how wearable, portable, embeddable and ingestible tech will deliver early diagnoses, radically reducing disease and death.."
          ],
          [
           "app_watch",
           "Is there a subreddit on resonance breathing/HRV training?. I have recently started resonance breathing 20 minutes twice a day to improve my HRV score and general wellbeing. Does anyone here do the same or is there a subreddit where people share their progress and experiences?"
          ],
          [
           "app_watch",
           "Muse S digital sleeping pill. Hi,\nDoes the digital sleeping pill of Muse S really work? Moreover, would anyone mind sharing their experience using the Muse S and whether or not they‚Äôve seen an increase in sleep quality?\n\nThanks"
          ],
          [
           "app_watch",
           "Morpheus and swimming. I am trying to figure out how to record my swimming sessions with Morpheus app. Morpheus M7 does not work well in the water, so I have to use another HRM for that. \n\nI have polar OH1+ which records swimming well, however it seems not to have constant connection to my phone with the app, either because I‚Äôm swimming too far from it or being submerged under water. \n\nOH1+ has built in memory for recordings but  Morpheus app only supports its own M7 for ‚Äúsync‚Äù.\n\nDoes anyone have a solution for this?"
          ],
          [
           "app_watch",
           "Smart co2 monitor with a phone app?. Does anyone know of a co2 monitor that can log and graph co2 levels on my phone?"
          ],
          [
           "app_watch",
           "Garmin Watch. Does anyone use a Garmin watch as a simple way to check Vo2 max? I know it‚Äôs not the most efficient way but I‚Äôm guessing it should be able to help tell you if you‚Äôre on the right track with your cardio and fitness levels.\n\nIf you use one, which watch do you use?"
          ],
          [
           "app_watch",
           "This app will make you smarter in 20 days‚Ä¶."
          ],
          [
           "app_watch",
           "Oura Ring feedback / reviews?. Does anyone have experience with the oura ring? Particularly for sleep tracking? Is it worth the cost? I have an Apple Watch currently and was thinking about getting it, but it‚Äôs $$$."
          ],
          [
           "app_watch",
           "How do you keep track of your progress?. I‚Äôm looking to chat to a few people about how they track their progress and manage the metrics around their health - ideally people with one or two forms of wearables (like apple watch, oura, garmin etc)\n\nIf you have 30 minutes to spare, use this link to book a call please üôèüèº  \n\n\n[https://calendly.com/tara-zinc/30-minute-meeting](https://calendly.com/tara-zinc/30-minute-meeting)"
          ],
          [
           "app_watch",
           "Best app that helps count calories by taking pictures of your food?. Initially I thought it's non-sense but tested one of them (calorie mama) and it uses the camera and AI to recognize the food, thus making recording calories much easier. So they work, but since that particular app has some issues running on android I'm wondering which one of this kind is the best from your experience?"
          ],
          [
           "app_watch",
           "Any EEG headbands that work with Bluetooth and have a mobile app. I got the Muse s head band and it has only tracked 2 out of 6 sessions so far and I'm considering returning the device \n\nI want one to use as a reference device see the accuracy of smart watches but the Muse s headband has not really worked most of the time like yesterday it only got 40 minutes and then it just stopped working out of nowhere"
          ],
          [
           "app_watch",
           "Apps for monitoring blood test results / biomarkers. Does anyone know any apps or websites which allow you to track your blood results and biomarkers, e.g. blood pressure, blood glucose level, etc.. \n\nIdeally, they should also give you some feedback for each test. For example, an app called longevity has a couple of biomarkers and tells you if they need work or are optimal. Inside tracker seems like it might do some of this but I can't really tell as it needs an expensive subscription.  [Selfdecode.com](https://Selfdecode.com) also looks like it might do something similar. Anyone using either of these sites or have any suggestions?"
          ],
          [
           "app_watch",
           "Oura or Ultrahuman Ring????. Looking to buy one of these. I like that the Ultra human does not \n\nrequire a subscription, but if the Oura is superior I do not mind paying.\n\nAnyone's input would be appreciated, Thanks!"
          ],
          [
           "app_watch",
           "How does everyone here organise and keep track of their health and fitness protocol?. Hey everyone.\n\nI'm currently formulating a 3-month longevity protocol (as a monthly challenge for this group: [https://www.facebook.com/groups/845815923352471/](https://www.facebook.com/groups/845815923352471/)). The idea is that you come up with a plan for how much and what kind of exercise you will do, what fasting protocol, what sleep targets, what hot/cold exposure etc. and although I've got a good idea for what I want to include, I haven't yet found a good website or tool to help me note it down or organise it (I'm just making a bulletpoint list on Google Docs atm).\n\nDoes anyone here have any suggestions?"
          ],
          [
           "app_watch",
           "Accurate heart data tracking. I'm a whoop user but have repeatedly seen/heard that the Garmin HRM / belt provides more accurate data\n\nIs it possible to use it without the watch? (I don't like wearing watches)\n\nIf not, does any of you recommend another device similar to the Garmin HRM for accurate data tracking?"
          ],
          [
           "app_watch",
           "What‚Äôs your gadget stack?. Vr, gsr (galvanic skin response), polar heart monitor, blood pressure gauge, headphones and dumbphone, and an Apple Watch for sleep tracking mostly."
          ],
          [
           "app_watch",
           "how to use EliteHRV (also about app-update). Recently I started using EliteHRV. I would very much like to gain insights in how heavy my workouts are to my body such that I can manage the workloads accordingly. My goal is not to become a top athlete, but just to optimize my energy management such that I will have more energy to spend in my life. However, I have plenty of questions on how I should use this app, but I don't seem to find a central place where I can ask/discuss all these questions. So I am pretty much figuring things out on my own by reading a lot of blogposts, scanning some articles and watching some youtube video's about it. So I thought I'd reach out to discuss my questions with some other people that measure HRV\n\nSo some questions that I have are:\n\n\\-should I be sitting, standing or lying down? \n\nnote that [Jason Moore is sitting](https://www.youtube.com/watch?v=IzDslOCiAs0) , but on the bottom of [this article](https://www.uphillathlete.com/why-we-stopped-relying-on-hrv-apps/) the people from ithlete suggest you should be standing. I sit in [meditation posture](https://www.youtube.com/watch?v=fZrJPUU9fTE&amp;feature=emb_title) now during my morning readiness measurements\n\n\\-should I be using paced/guided breathing? \n\nOnce again Elite HRV suggests something different than ithlete. EliteHRV suggests you should not be using paced breathing during morning readiness, but in the same article I linked to earlier the people from ithlete suggest you should have a paced breathing. I was using paced breathing until EliteHRV had an update. It is still able to guide your breathing, but I am unable to find the settings to set the inhale-time and exhale-time which makes the feature much worse than it used to be. So I am considering to measure without guided breathing now. \n\n\\-if you don't use guided breathing, what do you think about during the measurement?\n\nwhat do you guys do during the measurements? I took 4 minute measurements up until today with guided breathing, but due to this app update the guidance does not seem to be able to guide me in my old rhythm. So I turned this feature off and now I have a hard time NOT to focus on my breath in those 4 minutes which kind of defeats the purpose of not having guided breathing I guess.\n\n(-is this a logical place to ask these questions?)"
          ],
          [
           "app_watch",
           "What tools are there for quantifying sleep,. HRV, and other important markers other than the Oura ring? \n\nSorry for getting the title cut in half."
          ],
          [
           "app_watch",
           "An app that helps you visualize how much lifetime you have left/with loved ones. I seem to recall Peter talking about this somewhere but can't find it -- would love to find an app that helps visualize this."
          ],
          [
           "app_watch",
           "How do you use a morning HRV and Readiness reading (Elite HRV) ?. I got a Polar H10 a few weeks ago and have been taking a morning HRV reading with with Elite HRV and getting the Readiness score.\n\nI'm not sure how to interpret the score/rating.\n\nThis morning for example, I had 9 readiness which is good in the app. \n\nElite HRV said I was ready to train hard and handle more stress today.\n\n[https://i.ibb.co/TP7gyhD/ELite-HRV-Readyness.jpg](https://i.ibb.co/TP7gyhD/ELite-HRV-Readyness.jpg)\n\nThe thing is, I trained hard yesterday lunch time (martial arts) and was totally knackered for the rest of the day. \n\nI had a pretty bad sleep despite going to bed early (Fitbit said 6h26m with a sleep score of 71 (fair) I normally get about 73). I was in bed for about 9 hours. Fitbit says my HRV is in normal range (44).\n\nI felt pretty sore from training too and generally tired and crappy when I woke.\n\nA few hours on, I feel better but not like I could go and train hard again. But I do feel better than I did when I woke.\n\nSo is the HRV/readiness just off? Or does it know something I don't and I am more ready than I think/feel?\n\nIs taking just one HRV reading in the morning enough or should I be collecting more data, especially when I train? \n\nI just have a Fitbit which doesn't really capture much and I don't wear anything when doing the martial arts. \n\nI often feel really crappy when I wake but if I get out of bed quickly and stand walking around a bit, I tend to feel better. Is that normal?\n\nThoughts?"
          ],
          [
           "app_watch",
           "The App That Helps Prepare You for Death."
          ],
          [
           "app_watch",
           "A breathwork app that runs in the background?. I can read on my phone and do breathwork at the same time, in theory! Unfortunately my app - breathly - which is otherwise great, doesn't run in the background.\nAnyone have one? I'm on Android. Thanks"
          ],
          [
           "app_watch",
           "Chains that Measure VO2max and How to Choose Equipment. What are some places where one can do a VO2max? I know you can estimate it using free tools, an Apple watch and such. I am interested specifically in places like DexaFit, and want to know what are some others. Specifically interested in national chains and not an academic center (I know those can be cheaper, but for logistical reasons I would like to go with a chain). If this place also measures RMR that's a bonus.\n\nAlso, how much does the the equipment, treadmill vs bike and the capturing software and input computer make a difference in interpretation? I heard that treadmill is more accurate than bike‚Äîis this true? If so, why? Or does it depend on what you are used to, e.g. if I've never biked in my life, but am an avid hiker and runner, would the treadmill give more accurate results? Thanks."
          ],
          [
           "app_watch",
           "Health optimization app?. I'm on the lookout for an app that aligns with Attia's metrics,  focusing on tracking zone 2, z2 heart rate, strength etc. In my search, I've come across Biobay, which appears to incorporate some of these metrics. I've tested Zones and Strava, but  they haven't quite met my needs. I'd love to hear your thoughts and recommendations!"
          ],
          [
           "app_watch",
           "Biohacking social app. Hi all! Not seeing an to app to create your own health protocols, I decided to make my own. I am building an app that lets you build detailed health protocols that only display on your main feed based upon cues like time, weather, and location. The content appears in an Instagram story like format. The cool part is that you can download routines that your favorite content creators and integrate them into your own. So you can essentially create an ultimate routine by nesting routines from five of your favorite morning routines you‚Äôve seen.\n\nThis is in its early stages of development. What do you guys think so far? Interested? Dm me an email"
          ],
          [
           "app_watch",
           "Social Exoskeleton to Enhance Social Interactions. This isn't about physical enhancement, but rather about amplifying social skills.\n\nWhat Is It?\n\nUnlike traditional exoskeletons focused on strength, this one is designed to be an interface between the user and the social environment. It provides real-time information and insights to improve communication and connection.\n\nFunctions:\n\n * Facial Micro-expression Reading: Cameras and algorithms analyze subtle facial cues to reveal hidden emotions and intentions.\n\n * Body Language Analysis: Sensors detect posture, gestures, and movements to gauge comfort, interest, and engagement.\n\n * Tone of Voice Interpretation: Microphones capture vocal nuances like intonation and rhythm to help interpret emotional state and sincerity.\n\n * Response and Behavior Suggestions: Based on gathered data, the exoskeleton suggests appropriate responses, conversation topics, and behaviors that foster empathy and connection.\n\nPotential Benefits:\n\n * More Effective Communication: Better interpret others' emotions and intentions, leading to stronger relationships.\n\n * More Successful Negotiations: Understand the motivations and weaknesses of others for strategic advantage.\n\n * Improved Networking: Facilitate authentic connections, expanding networks and opportunities.\n\n * Self-Knowledge and Personal Development: Receive feedback on one's own behavior and impact on others.\n\nEthical Implications:\n\nThe development of a social exoskeleton raises concerns about privacy and potential for social manipulation. Transparent and ethical use is crucial to ensure it serves the greater good.\n\nWhat are your thoughts on this futuristic concept?"
          ],
          [
           "app_watch",
           "Can anyone explain HRV low frequency (LF) power and high frequency (HF) power parameters?."
          ],
          [
           "app_watch",
           "Best sleep tracker?. What is the best sleep tracker?\n\nAs of right now I am using Samsung smart watch which is I guess fine, but I think it would be cool to have realtime tracking\n\nIdeally I'd have smart watch or something similar which would stream data in realtime and this data could be used to set up some automations like waking me up after x amount of cycles during light sleep\n\nI haven't yet looked into how smart watches do it, but I would be willing to bet that it's not that complicated, I probably could DIY something similar but I feel like this should be a last resort"
          ],
          [
           "app_watch",
           "Backcasting Template in Spreadsheet. Need degradation rates. Hey all, hoping to get some help, i know Peter has mentioned degradation of v02 max and strength in a few podcasts but can't find them. I am building a spreadsheet to backcast and tell me where my fitness levels should be today so i have a target to strive for. Does anyone remember them or know where i can find them? Specfically looking for strength and Vo2Max values."
          ],
          [
           "app_watch",
           "Implantable Loop Recorder connected to phone?. Has anyone made a implantable heart rate monitor that can be connected to your phone for accessibility? And where can you surgically implant it that will still get accurate results? If not what alternatives can be used to track vitals passively via an implant?"
          ],
          [
           "app_watch",
           "Best continuous heart rate monitor. I use apple watch but for HIIT, it has such a delay in reporting current heart rate and I also think its less accurate. \n\nMy friend recommends this: [https://www.polar.com/us-en/products/accessories/polar-verity-sense](https://www.polar.com/us-en/products/accessories/polar-verity-sense)\n\nI know Attia has his recommendations, but I am worried he is not unbiased and may make money from some of his recommendations.  \n\nWhat do you guys like and why?  For what it's worth, I have an iPhone which I would like to use as the screen where I continuously monitor HR."
          ],
          [
           "app_watch",
           "Microsoft looking to explore Continous Blood Pressure Monitoring via wearable and machine learning."
          ],
          [
           "app_watch",
           "Android apps for passive tracking of Location, Sleep, Phone usage and activity? (Steps, running, cycling). I'm looking for one app or seperate apps for **passive tracking**, with ability to **export as .CSV**:\n\n&amp;#x200B;\n\n* Location (With addresses)\n* Sleep\n* Phone usage\n* Activity? (Steps, running, cycling)\n\nI tried the Instant app that seems really good, but the export to .CSV only gives Phone usage data."
          ],
          [
           "app_watch",
           "World's first wearable, fitness tracker for the mind.. Hello fellow Biohackers!  \n\n\nI‚Äôm Jake and I‚Äôm building the world‚Äôs first **fitness tracker for our mind.**\n\n* Every felt ‚Äústuck in the rut‚Äù? Brain fog? Stress? Burnout? Writers‚Äô block?\n* Have a huge, important project due but can‚Äôt pull yourself together?  \n\n\nUnlike Apple Watch / FitBit which focus on your physical fitness - **Eden focus on your mental fitness**\n\n* Understand how mindful / stressful / relaxed / focus / ‚Äúin the zone‚Äù are you in real time.\n* Gain access to highly personalised, real time advice to maximise your performance while avoiding burnout\n* Gain access to your mental energy in clear % in real time.\n* Gain access to ‚ÄúRemote control of your mind‚Äù - ability to shift your state of mind immediately, on command.\n* So that you are able to train, rest, recover and perform like a professional athletes\n* So that you are able to 5x your productivity and creativity while feeling incredibly awesome without burning yourself out\n* So that you wake up feeling **READY** every. single. day.\n\nWe already have a working prototype - check it out [here](https://edenband.io/).  \nI need your feedback as I am looking for smart and talented people to build and refine this product together.  \nI invite you to join me on this once in a lifetime journey of discovering, quantifying and elevating human consciousness level.  \nPlease send me a message if you resonate with my mission. Alternatively you can signup on our website on the link above"
          ],
          [
           "app_watch",
           "Desired smart wearable device functions. If we were to make a wearable device, what features would you expect to be added that aren't on the market right now."
          ],
          [
           "app_watch",
           "AWU users: Athlytic or Bevel?. For Apple Watch users who like to track biometrics, I've just discovered these apps and are now on the free trial periods for both.\n\nI use the AWU and the Oura ring now, and it seems like I'm going to have to start using the AWU for sleep tracking with these apps. Aside from that, any other things to look for?\n\nAny opinions on the pros/cons of these apps?"
          ],
          [
           "app_watch",
           "Budget HRV: Polar H10 or Other?. Hello, apologies if this has been asked many times, but I'm looking to get an accurate, *low cost* entry into HRV monitoring. I'm over 40 and I play competitive/recreational  basketball, so I would like to use HR + HRV for two reasons: 1]  To inform me on recovery, rest, overtraining, sleep, autonomic status etc via an HRV App (the main reason). 2] To track my HR during basketball sessions, ie. wearing a discrete device, with my phone on the sidelines, up to 20M away (a secondary, less important reason).\nI looked at the Polar armbands (Verity Sense and OH1) but it seems they don't give HRV-compatible data. The H10 chest strap is recommended on EliteHRV's site, but I don't know whether it would have the range needed for basketball. \nWhich HR monitor should I buy?!?"
          ],
          [
           "app_watch",
           "Dashboard to track personal progress towards Peter's optimal longevity metrics. Has anyone set something like this up? Was thinking of building this for myself but I figured someone already has.\n\nI'd ideally want to cover the foundations (fitness, sleep, metabolic health) and the two big disease categories (ASCVD, cancer). \n\nIn fitness you'd have goals like: VO2 Max &gt;58, Appendicular Muscle Mass &gt;10.5, VAT &lt;1kg, etc. \n\nIn ASCVD you'd have goals like apoB &lt;30mg/dL, Blood Pressure 70/110, etc."
          ],
          [
           "app_watch",
           "What‚Äôs the Best Mobile Game You've Played for Health Optimization? ü§ñüí™ Let's Share Our Top Picks!. Hey fellow biohackers! üéÆ\n\nI‚Äôve been diving into mobile games that double as health tools‚Äîthings like step counters, glucose trackers, or even cognitive enhancers‚Äîand I‚Äôm curious to hear what everyone else is using.\n\n1Ô∏è‚É£ **What‚Äôs your go-to mobile game for healthcare purposes?** Whether it‚Äôs helping you track steps, monitor diet, or even boost your brainpower, I want to know what‚Äôs working for you.\n\n2Ô∏è‚É£ **If you could design your dream health-focused mobile game, what features would it have?** Think outside the box‚Äîwhether it‚Äôs gamifying your daily workouts or integrating with wearables, the sky's the limit.\n\nLet‚Äôs brainstorm and share ideas! Your suggestions could inspire the next big thing in biohacking. üöÄ"
          ],
          [
           "app_watch",
           "Consumer or Medical Grade Endoscope. I'm interested in checking out my vocal folds and was wondering if any knew of an accessible endoscope that I could do the procedure myself. The medical grade ones are &gt;$1000, but there are ones that mechanics use for checking out pistons in a cylinder that are around $50...\n\nDoes any biohacker know of something that would work for me? Thanks!"
          ],
          [
           "app_watch",
           "Oura ring - is it worth it?. I have a huawei gt 2, and while the sleep tracking isn't perfect and it for instance doesn't measure HRV or temperature, I'm not sure how I would use those measures if I had them. For those of you that have both a decent smart watch for sleep tracking and an Oura, is the Oura worth the $300? How did the additional measures it provides help you improve your sleep?"
          ],
          [
           "app_watch",
           "Some questions on headband Dreem 2. I am thinking of buying the headband Dreem 2, but I still have some questions from those that have already bought it:\n\n1) Is the headband comfortable? I am concerned that it will bother me and that I would remove it during my sleep\n\n2) Does the headband need to be turned on from the phone? I usually have my phone turned off 30 min before I go to bed, and the phone is loading in my living room\n\n3) For those that have also the Oura ring, is the Dreem headband really better than the Oura ring?"
          ],
          [
           "app_watch",
           "Launch Y Combinator: SiPhox - Convenient at-home health tracking."
          ],
          [
           "app_watch",
           "Best tracker for activity, sleep, etc. I am only familiar with Apple Watch, fit bit, oura ring and whoop. I‚Äôm sure there are others on the market too. Which one is the best for tracking movement, sleep, and any other levels? \n\nI do have an Apple Watch I tried sleeping with it but it was off so badly. I feel like it‚Äôs only somewhat accurate for steps."
          ],
          [
           "app_watch",
           "Apple Watch versus Oura ring. I have an SE that I love and use constantly, including during sleep. I was recently recommended to check out the Oura ring and am intrigued but not convinced. \n\nFor those of you who have both an Apple Watch and an Oura ring, I have a couple of questions:\n\n1) why choose one over the other? What does the ring give you over the watch and vice versa (besides battery life)?\n\n2) now that Oura is moving to a paid subscription model, are you thinking of continuing?"
          ]
         ],
         "hovertemplate": "Topic Group=%{customdata[0]}<br>document=%{customdata[1]}<extra></extra>",
         "legendgroup": "app_watch",
         "marker": {
          "color": "rgb(231, 63, 116)",
          "symbol": "circle",
          "opacity": 0.7,
          "size": 7,
          "line": {
           "color": "rgba(0,0,0,0.5)",
           "width": 0.8
          }
         },
         "mode": "markers",
         "name": "app_watch",
         "showlegend": true,
         "x": {
          "dtype": "f4",
          "bdata": "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"
         },
         "xaxis": "x",
         "y": {
          "dtype": "f4",
          "bdata": "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"
         },
         "yaxis": "y",
         "type": "scattergl"
        },
        {
         "customdata": [
          [
           "blood_tests_test",
           "Lifeforce vs Function Health: My Thoughts and Decision. I wanted to start a discussion about **Lifeforce vs Function Health**, as I noticed there aren‚Äôt many reviews for Lifeforce. I got an ad about their Black Friday sale: $249/year compared to Function Health's $499/year.\n\nFrom what I can tell, Lifeforce offers fewer biomarkers than Function Health, but there‚Äôs one major feature that‚Äôs a game-changer for me: Lifeforce sends an phlebotomist **to your house** for blood draws every 3 months, while Function Health requires you to go to a Quest Diagnostics lab.\n\nThis is a huge deal for me because Quest labs in my area are always packed and poorly managed‚Äîlong lines, slow service. It‚Äôs probably just my local experience, but it‚Äôs been a big barrier to keeping up with regular health checkups.\n\nI‚Äôm leaning towards trying Lifeforce because of the convenience, and I plan to share my experience after a couple of weeks.\n\nHas anyone else used Lifeforce or Function Health? I‚Äôd love to hear about your experiences before I take the plunge"
          ],
          [
           "blood_tests_test",
           "Get the most from DEXA scan and VO2 Max. My brother and I are heading for DEXA scans and VO2 max tests on the 19th August in London. Total cost was ¬£234 each. \n\nHas anyone got any tips for how to get the most from these tests?\n\nDo you guys have any questions you‚Äôd like us to ask whilst we‚Äôre there? \n\nWe‚Äôll be filming the experience and happy to share that here if there‚Äôs interest."
          ],
          [
           "blood_tests_test",
           "ND is lying about their in house testing."
          ],
          [
           "blood_tests_test",
           "Neko Health is a Swedish health tech startup that offers full-body scans backed by AI software to detect various health conditions. Each scan takes 10 minutes and costs ‚Ç¨250.."
          ],
          [
           "blood_tests_test",
           "Does anyone else requests their blood test results as a pdf?. I store them locally, but it's a bit hard to keep track of what changed in between them. And what lifestyle changes I did to affect each biomarker. Solutions InsideTracker cost a whopping $150/year, idk if it even takes pdf's. Anyone else wish there was a free/cheap website that you could upload your lab results to, and get pretty graphs, and even an automated analysis from?"
          ],
          [
           "blood_tests_test",
           "How do you find a doctor?. I need to find a doctor who is evidence-based but will support when I want to do non-standard things like get an insulin sensitivity test, potentially prescribe metformin, etc.\n\n&amp;#x200B;"
          ],
          [
           "blood_tests_test",
           "DEXA scans in Pittsburgh, PA?. Hello,\n\nI'm coaching my best friend on all this stuff and they're located in Pittsburgh, PA. I'm in Texas and DEXA scans are easy to come by and cheap ($40). I did google maps searches in Pittsburgh and only come across medical DEXA machines at medical imaging offices. They all require a doctor script. I also found out that all of the ones that I called only report bone density and not fat/lean mass/VAT etc. \n\n&amp;#x200B;\n\nThe Univerity of Pittsburgh sports medicine department does not have a DEXA (not public anyway) and they use the \"bodpod\" which I guess measures your body volume and from that you can figure out density and estimate fat. Not a great measurement. \n\n&amp;#x200B;\n\nAnyone know what the deal is with getting a DEXA scan (with muscle, fat, VAT info) in the Pittsburgh region?"
          ],
          [
           "blood_tests_test",
           "Reconstituted AOD-9604 is cloudy.. A few days ago I reconstituted some AOD-9604 and it turned out cloudy, still cloudy today as well, peptide structure is similar to frag and I've heard some people claim that if frag is cloudy its legit, however I've also seen others claim its bunk if cloudy, if anyone here has experience with these, is it still safe/worth using or should I contact the supplier for a different vial?"
          ],
          [
           "blood_tests_test",
           "Anyone interested in routine blood work/urinalysis, I need your help!. This is a field I've become interested in learning more about - filling out the form would help me out for a project I'm about to undertake would help tremendously! Thanks for your time\n\nhttps://forms.gle/jVUfDzjvm6a9Newa6"
          ],
          [
           "blood_tests_test",
           "Site that explains/tracks lab results?. Hi all, just getting into all of this and am trying to figure out the best place to start getting labs done.\n\nIt seems like there are a myriad of providers that are comprehensive in doing both the test but also providing insights into the tests themselves and tracking them over time (e.g. InsideTracker, Function). \n\nHowever, it seems like a less expensive approach is to get labs done yourself through something like ultalabs, or internationally. If I go this route, are there services that will provide insights and potential actions for improvement of results? It seems pretty overwhelming to do this all manually and why things like InsideTracker or Function are so appealing.\n\nThanks!"
          ],
          [
           "blood_tests_test",
           "any positive experiences with home test kits?. With home testing kits like Inside Tracker, Viome, and Thorne, have you found them to be helpful in actually improving your health? I know there's a difference between signal and noise and worry these tests a more noise than meaningful signals. For instance, I'm not certain Viome test can actually test for intestinal permeability directly, but only detect possible clues that might be coming from intestinal permeability."
          ],
          [
           "blood_tests_test",
           "What is the best way to test mineral levels? (like zinc, copper, selenium, iodine?). I want to supplement some minerals but before I want to test them, I was wondering what‚Äôs the best way to test them. A regular blood test? Urine? Or I‚Äôve also heard of a hair test but don‚Äôt know is that is accurate"
          ],
          [
           "blood_tests_test",
           "Bloodwork prescriptions?. Is there any online service that can prescribe bloodwork that will be covered by insurance in NJ.\n\nI have gotten a lot of tests covered by my an MD presiding but it is very annoying to go into office and wait on line."
          ],
          [
           "blood_tests_test",
           "Andy Galpin lab testing?. Hey all, does anyone happen to know which diagnostic lab(s) Andy Galpin's companies run his biomarker tests through? Is this Quest/LabCorp?"
          ],
          [
           "blood_tests_test",
           "Cord blood banking - yes or no?. Hi everyone,\nWe are having a baby in July and deciding on whether to 1) not bother with cord blood banking 2) donate cord blood 3) private bank for our own use. Does anyone have any experience that can help make this decision? Asking here since the community is into 3rd wave / next-gen medicine. Is there any benefit now or in future to the baby or the parents by banking the cord blood (I understand that chances of baby needing for medical condition are low, but looking beyond that for improved health or any other reasons I am not aware of).\nThank you"
          ],
          [
           "blood_tests_test",
           "Regularly testing cortisol?. I would like to test my cortisol levels fairly regularly right now due to a current and significant health concern atm. So I may want to retest a couple of times overall, and I would like to see a full picture of my cortisol levels through the day. Does anyone do something similar and can you share your process?\n\n(My doctor won't order tests because they do not feel like the data matters and dismiss it, you all know the routine I am sure. So while I have great insurance and great secondary insurance, I just can't get an order and so it cannot be paid for.) \n\nI know of Everly's stress+sleep (sleep may be good to test anyway) and also ultalabs and geneva labs. I am looking to corroborate other data (Levels CGM, Fitbit, etc) and so the more data the better. I live in Maryland, USA, and I have no preference for blood or urine technically but practically of course urine is preferred. I am going to investigate InsideTracker and such but do they do anything with cortisol? I am still learning."
          ],
          [
           "blood_tests_test",
           "Is at-home blood testing reliable?. Looking at a service that offers at/home blood testing kits for ‚Äúinflammation, hormones, metabolism and cardiovascular health.‚Äù Not going to mention the service but I think there‚Äôs a few. \n\nAll or most of the tests recommended by Attia. They‚Äôre a lot cheaper than a lab. A lot. \n\nAre these reliable? Or should I go to a physical lab and have the pros do it? \n\n\nAnyone have direct experience?"
          ],
          [
           "blood_tests_test",
           "Bloodwork interpretation through optimal lens. What are your favorite resources/lists that you use to reference optimal/functional medicine ranges instead of the more readily available normal/trad med ranges?\n\nThanks"
          ],
          [
           "blood_tests_test",
           "23M, recently got access to solid health insurance after ignoring my health for nearly 10 years.. As the title states, I now have access to solid insurance and I want to try and actually optimize my health alongside that, my questions is what are some recommendations of things I should to from a biohacking standpoint?\n\n&amp;#x200B;\n\nI talked to a doctor and was able to get a request for a blood test to look for a good variety of different things, but what else would you go for on my position to optimize health after such a long time? I don't have any major issues other than troubles with energy and sleep, but there may be a huge number of things that I don't even realize are issues with how long I've been neglecting them.\n\n&amp;#x200B;\n\nI realize a lot of biohacking will be things I do on my own and not through insurance or the healthcare system, but I was always hesitant to even try due to that potential roadblock and now I have no excuses."
          ],
          [
           "blood_tests_test",
           "Ordering labs, for yourself.. Has anyone just ordered their own labs to see current health status? I‚Äôm asking because I ordered myself a metabolic and folate/b12 blood test. Just wondering if anyone found useful info from it."
          ],
          [
           "blood_tests_test",
           "Coronary Calcium Score in Los Angeles?. Anyone have any tips for good places that do this at a reasonable cost in LA? I have health insurance through Kaiser Permanante but my GP won't refer me for the test. (Eye roll.)"
          ],
          [
           "blood_tests_test",
           "Please explain?. Is it possible to buy a medical grade ventitlator? I have a autoimmune disease &amp; take care of two kids with one as well &amp; am worried, ofc. There is a case in the county near me. What do you reccomend?"
          ],
          [
           "blood_tests_test",
           "Has anyone heard a company called Molecular You? They are from Canada? Are they the same as Inside Trackers? I am interested in using a company like Inside Trackers but not sure which one to use..."
          ],
          [
           "blood_tests_test",
           "Is there any company that will collect and store my current blood to ‚Äúdonate‚Äù it to my older self?. I would love to bank my 29 year old blood and have it stored so I can donate it to my 70 year old self for regenerative benefits. Are there any companies that can do this?"
          ],
          [
           "blood_tests_test",
           "considering hscrp exists, is there a reason to get crp?."
          ],
          [
           "blood_tests_test",
           "Blood Test - Mold/Heavy Metals/Microplastics - What To Request?. Hey,\n\nSo I live in Israel, and we don't have to pay for the blood tests here.\n\nCan you guys tell me what I should request for each one of them?\n\n\\- Mold  \n\\- Heavy metals  \n\\- Microplastics\n\nI started living healthier in the beginning of the month (healthy+organic food, sleeping and waking up at the same time, exercising etc..) and I want to make a blood test now, and then again in around 3-6 months."
          ],
          [
           "blood_tests_test",
           "NY - options for self-directed blood tests?. In NY, companies like OwnYourLabs are not allowed to operate (protection racket for doctors I suppose). We can order tests directly from Lab Corp ([https://www.ondemand.labcorp.com/products](https://www.ondemand.labcorp.com/products)) but it is a limited set of tests (e.g., no NMR lipid panel).\n\nAny other options?"
          ],
          [
           "blood_tests_test",
           "Where can I travel to get an extensive suite of tests?. I just entered my early 30s. I absolutely detest taking prescription medication unless I have to.\n\nI use Ashwagandha, vitamin d, vitamin c (occasionally), and fish oil (occasionally). I‚Äôve recently started with magnesium for improving my sleep.\n\nI lift 4-5 times a week and try to get 10k steps on most days of the week.\n\nI‚Äôd like to get an extensive suite of tests done to understand my health and what I can do to maintain mental acuity, and physical strength over the long term.\n\nI work in tech and my the US preventive check is absolute garbage, I get my blood work done whenever I visit home."
          ],
          [
           "blood_tests_test",
           "Indonesia Airport Caught Reusing Thousands of Coronavirus Tests."
          ],
          [
           "blood_tests_test",
           "Viome, FunctionHealth or LifeForce?. I've been considering between Viome and Function Health tests for a bit.  I need something to narrow down what I'm doing or not doing more than the typical doctors test as I feel they haven't answered my brain fog issues."
          ],
          [
           "blood_tests_test",
           "How much would you be willing to pay for regular blood tests?."
          ],
          [
           "blood_tests_test",
           "Blood Test Analysis: 100 - 111y (Centenarians, Semi- and Super-Centenarians)."
          ],
          [
           "blood_tests_test",
           "Function Health vs InsideTracker vs Mito Health vs Superpower. Anyone here tried any of these companies for comprehensive blood work? I‚Äôm thinking of getting it done but can‚Äôt decide which one to go with.\n\nMito Health seems like the most affordable option at $399/year. Got an invite link from u/Independent-Bear3136, and I‚Äôm still on the fence. Would love to hear your thoughts or experiences!"
          ],
          [
           "blood_tests_test",
           "Can you order tests directly from Labcorp or do you have to go through a middleman?. Labcorp has an insane amount of tests: https://www.labcorp.com/test-menu/search\n\nBut their \"OnDemand\" tests only allow you to pick from a very small subset of those listed above.\n\nIs there a way to order particular tests without going through something like Marek or other similar websites?\n\nThanks"
          ],
          [
           "blood_tests_test",
           "ROAST MY LABS. Just got some labs back. Not a complete list but still a lot of data to chew on. Help me make heads or tails of all this please!"
          ],
          [
           "blood_tests_test",
           "Lab work recommendations for a basic and/or comprehensive panel if you don‚Äôt have health insurance?. I was cited over 1k for a basic blood panel by quest and I‚Äôm wondering if there are other options that are more an affordable and comprehensive. Each test seemed to cost more and more money at quest."
          ],
          [
           "blood_tests_test",
           "Meta-Analysis vs Systematic Review?. Could someone who has a background in research please explain the difference between these two?"
          ],
          [
           "blood_tests_test",
           "How to clear foreign body particles from blood.. I have come across a movie where the characters are taken as experiments with foreign body being released into their blood. In a real life situation, what are the measures from home remedy to advance level we can do to detox these foreign body."
          ],
          [
           "blood_tests_test",
           "Preparing for radiation exposure (CT scan). I'm going in for a CT scan in 1 month, and want to do what I can to prepare my body for the exposure. \n\nI've had minor urinary and renal symptoms, so went for an ultrasound to check for stones and they detected an object ~2cm in the right kidney. A CT scan is standard procedure to precisely determine what the issue is, and whether it's a stone, cyst, or something else. \n\nI was hesitant to do it because they typically don't want to expose someone as young as me to radiation if it can be avoided, but the benefits of detecting something more serious are worth the minor risk. \n\nThat said, the contrast dyes have some risk of side effects, specifically for kidney damage. So the fact that I'm experiencing issues with the organ that is most at risk in a CT is something I really want to try and mitigate.\n\nAny advice or sources of information on radiation defense, and kidney protection would be greatly appreciated!"
          ],
          [
           "blood_tests_test",
           "Testing for deficiencies in people with autism, schizophrenia. Where would you start to learn if you have biomarkers for these, to discover any mineral deficiencies.  Are there any affordable ways to get a brain scan? I'm thinking 23andme to test for genetic biomarkers, and a full blood panel. What other ways can you test for nervous system, brain, genetic issues?"
          ],
          [
           "blood_tests_test",
           "Best Place to Get Metabolic Levels Checked?. I want to get some annual bloodwork done (Comprehensive Metabolic markers, T, Fatty Acids, DHA/DPA, etc. - I probably had 50 various levels checked in my last lab test) and wondering where the best place to do this would be? Last time I did a doctor and quest health and it was $$$. Does anyone have any recommendations? I am also about to do another cycle of Ipamoralin, CJC and BCP, is there any other specific tests to get outside of a comprehensive metabolic panel and glucose for those? \n\n&amp;#x200B;\n\nGreatly appreciate any guidance or advice in advance"
          ],
          [
           "blood_tests_test",
           "ZRT labs blood testing. Anyone have experience with \n\nhttps://www.zrtlab.com\n\nIs it legit?"
          ],
          [
           "blood_tests_test",
           "Neko Health raises ‚Ç¨60m for full body scan technology."
          ],
          [
           "blood_tests_test",
           "Location for CAC Test in Austin?. Hello - I‚Äôm wondering if anyone can recommend a place in Austin, TX to get a coronary artery calcium (CAC) test? I will be visiting Austin at the end of November and would like to take the opportunity to get the test done. Searching around online, I found the HeartSaver CT Lab in Austin, but when I click on the link to make a CAC test appointment it seems like I need to already have a doctor there (which I don‚Äôt). Any recommendations for other locations? Thanks!"
          ],
          [
           "blood_tests_test",
           "Sam Altman backs blood testing technology startup seeking to \"revolutionize\" diagnostics.."
          ],
          [
           "blood_tests_test",
           "Looking for a data driven PCP. tl;dr Any suggestions on how to find a more numbers oriented PCP willing to prescribe more frequent blood tests, glucose monitor, open to ‚Äúalternative medicine‚Äù, etc‚Ä¶\n\nI‚Äôm currently reading Life Force by Tony Robbins and am inspired to finally find a PCP who might understand my approach and goals.\n\nAs preachy as this sounds, I‚Äôm a big follower of Matthew Walker, David Sinclair, Tim Ferris, Andrew Huberman, and if you know who those are I believe it‚Äôs fair to assume you know who I‚Äôm looking for.\n\nI know there are startups like fountainlife, but they‚Äôre not cheap and also not available everywhere.\n\nAny suggestions on how to go about finding a PCP, that is hopefully in network with most major insurance providers, who also follows the research of the doctors I mentioned above?"
          ],
          [
           "blood_tests_test",
           "What is the most comprehensive bloodwork I can ask/get?. Does anybody has a list (and what they are for)?\n\nHere in Brazil doctors aren't big on extra work (for them)"
          ],
          [
           "blood_tests_test",
           "(Part II) Supercentenarian (112 - 116y) Blood Test Analysis."
          ],
          [
           "blood_tests_test",
           "Bloodwork advice. I saw this video and then tracked down the cost to do it, close to $2k\nLocally I can get 70% of it for $300, but not from an expert like the one she used.  \n\n$2k is a lot‚Ä¶but if it can really help, maybe‚Ä¶.\n\nDoes anyone have any experience or advice?"
          ],
          [
           "blood_tests_test",
           "Obtaining a Calcium Scan. In the USA, is a doctors order required for this? If so are there any websites that sell this similar to certain lab testing sites like WalkInLabs? I‚Äôm expecting to pay out of pocket, but would appreciate info on getting the physician order."
          ],
          [
           "blood_tests_test",
           "Where to get full panel tests done. A friend doesn‚Äôt have access to health insurance. Is 23M, but been getting constantly sick: fever, breathing problems or infections. Nothing explicable except that it started after he had Covid, and has gotten Covid 2x again since then. And the docs at ER don‚Äôt have anything useful to say. \n\nWhere can I direct him to get AFFORDABLE full panel tests done to check immune systems, minerals, hormones, etc?"
          ],
          [
           "blood_tests_test",
           "Immunologic vs Nephelometry ApoB Testing ‚Äì What's the difference?. Trying to choose between two different labs to check ApoB. Each lists a different methodology for testing it: Labcorp lists an \"immunologic\" methodology, Quest Diagnostics says \"nephelometry.\" See here [https://www.walkinlab.com/products/view/apolipoprotein-b-blood-test](https://www.walkinlab.com/products/view/apolipoprotein-b-blood-test)\n\nCan someone explain in layman terms how Immunologic and Nephelometry methodologies differ? Is one of them more preferable, or does it make any difference at all to go with one over the other?"
          ],
          [
           "blood_tests_test",
           "Donating Blood. I've come to learn that the only way to remove forever chemicals is to donate (remove) blood. However, I'm 5'2\" and 94lbs and in the USA you must weigh 115lbs.\n\nI'm thinking about getting pregnant soon and I would love for all the ingredients for making this baby were (less) contaminated. So... \n\nHow could a small fry like me safely dispose of some blood at regular intervals? Is there private clinics out there who will adjust their draw according to my height? \n\n I have thought about putting fishing weights in my clothes, but I don't want a Darwin award- so that might rule out DIY bleeding myself at home too. Any ideas?\n\nThanks"
          ],
          [
           "blood_tests_test",
           "Are at-home blood tests accurate?. I tried one and got a reading that my hs-crp levels were high. Just wondering what effect sending a blood sample in the mail could have on the results."
          ],
          [
           "blood_tests_test",
           "WellnessFX is Shutting Down. Visualize Your Data With BiomarkerDash: An Open-Source, Interactive Dashboard for Bloodwork Lab Results. [WellnessFX has announced its shutdown](https://www.wellnessfx.com/faqs/thorne-transition) following an acquisition by Thorne. If you have data stored there, it's crucial to export it **before September 10th.**\n\n&gt; **Sunday, September 10th, 2023 - Final Day for Account Access &amp; Result Retrieval**\n&gt; This marks the last opportunity for you to access your account on WellnessFX.com. We strongly urge you to sign in and either print or export your test results for your health records. Post this date, the website becomes inaccessible, and your data will be irretrievable. Act now and ensure your results are saved.\n\nTo assist with the transition, we've launched [biomarkerdash](https://github.com/NoTranslationLayer/biomarkerdash) ‚Äî a user-friendly, interactive dashboard designed specifically for importing WellnessFX's CSV files. You can now zoom into plots and hover over data points to access details on dates, an upgrade from the existing WellnessFX interface.\n\nWe'd love your feedback!"
          ],
          [
           "blood_tests_test",
           "What should I ask to get done with blood work. Hi, I am in the process of just starting Peter Attia book and I was wondering, what exactly should I ask my doctor when getting bloodwork done. I am in Ontario so our requisition form looks something like this\n\nhttps://preview.redd.it/masuw764thlb1.png?width=532&amp;format=png&amp;auto=webp&amp;s=d0be345ee8e4da6598c4672ea96ed65280f17c5b"
          ],
          [
           "blood_tests_test",
           "Do you think an Aktiia cbpm has value for compound testing?. It seems to have the same deviation as standard cuffs or ambulatory has in studie.\n\nWould want something to monitor bp and would use a polar h10 to determin accuracy validity for compounds like armodafinil, theobromine abd other compounds stacked ON top of each other so bp messurement is important"
          ],
          [
           "blood_tests_test",
           "Blood Test. I noticed on doctor requested blood tests the forms have a lot of boxes but only a coulple actually checked off. Is there anything I should be asking they check for that they normally don't? \n\nAny other tests I should request frommy Doctor? \n\n44 year old male, in good shape, decent diet, stopped drinking 2 years ago"
          ],
          [
           "blood_tests_test",
           "Cheapest micronutrient bloodtest.. Looking for a comprehensive panel for vitamins, minerals, and amino acids. Doesn‚Äôt have to have everything but looking for the best bang for my buck. Anyone have experience finding a good deal for a micronutrient test? Thanks"
          ],
          [
           "blood_tests_test",
           "Cyrex Array Food Tests. Are the cyrex food immune screens worth it? If so, which one?"
          ],
          [
           "blood_tests_test",
           "Calcium score test around Toronto. Hey all, wondering if anyone in the Toronto area booked a calcium score test. What is the cost and who did you book with?"
          ],
          [
           "blood_tests_test",
           "Blood test results. What is the best thread I can post by blood test results to, and get second options about it?"
          ],
          [
           "blood_tests_test",
           "Alternatives to Inside Tracker?. I want to do the Insider Tracker Ultimate which gets all your blood biomarkers, hormone levels, etc. However, where I am I'm sort of annoyed that they only do \"mobile blood draw\" in my area (New York City) which adds on an additional $150. It seems like a scheme to just charge more because there is a Quest Diagnostics blood drawing place literally within walking distance of my apartment and IIRC when I was window shopping Insider Tracker several months ago they actually used that location. I'm also not sure how I feel about someone coming to my home to do the blood draw vs. an actual lab with professional equipment. \n\nI've also heard their DNA profiling is not the best. Does anyone have any other recommendations or is Inside Tracker the best?"
          ],
          [
           "blood_tests_test",
           "Any online doctor recommendations that can look at bloodwork and provide investigative insight?. I am dealing with a lot of weird, semi-unexplicable blood tests, glucose readings, etc. etc. for years. I am healthy (at least I feel healthy) eat well, manage stress as best I can, exercise very regularly good weight, bla bla bla. My liver labs are high and my A1c has been high for years. My primary care (concierge) shrugs it off. I don''t have a lot of money to throw at it, so the naturopath route kind of gets to me. I can get blood tests through insurance and then just want to talk to a human that has more"
          ],
          [
           "blood_tests_test",
           "Free blood tests with blood donation through Lifetime and New York Blood Center partnership. Thought I'd share for other NYC based biohackers. Came across this sign up form at my gym (Lifetime in NYC). Looks like they are offering free blood panels as an incentive for donors:\n\n[https://form.typeform.com/to/qwotDb6L](https://form.typeform.com/to/qwotDb6L)\n\n\n\nSide note: Beyond being a good person, I didn't know the (supposed) health benefits of donating blood. Anyone know if these are legit claims or not?? I see this page by Columbia here: [https://www.cuimc.columbia.edu/news/surprising-benefits-donating-blood](https://www.cuimc.columbia.edu/news/surprising-benefits-donating-blood)"
          ],
          [
           "blood_tests_test",
           "Do Quest Labs reports show up in Epic‚Äôs MyCharts?. I am considering have a slew of out-of-pocket medical tests done by quest labs but I cannot tell if the results will show up in MyCharts.  I like to use doctors/clinics/labs that all post their results in such a way that i can view the data in Epic‚Äôs MyCharts.  I know that Lab Corps results show up in MyCharts but not sure about Quest."
          ],
          [
           "blood_tests_test",
           "Any biohacking clinics/programs in the UK?. \\^ title. I feel like I've reached the max that I can do with my GP-ordered blood test and searching for biomarker optimisation videos on youtube so want to take it to the next level and hopefully continue to improve my borderline health markers. Anyone have any recommendations?"
          ]
         ],
         "hovertemplate": "Topic Group=%{customdata[0]}<br>document=%{customdata[1]}<extra></extra>",
         "legendgroup": "blood_tests_test",
         "marker": {
          "color": "rgb(128, 186, 90)",
          "symbol": "circle",
          "opacity": 0.7,
          "size": 7,
          "line": {
           "color": "rgba(0,0,0,0.5)",
           "width": 0.8
          }
         },
         "mode": "markers",
         "name": "blood_tests_test",
         "showlegend": true,
         "x": {
          "dtype": "f4",
          "bdata": "twiKQLO1f0AKP5NA1/yIQLBCiECOd4VAxreDQOkshECB04FA7DuJQHW1ikAxN4BAs22FQA5CiUCUf4tA+R2DQHmoiUAgC4FAOHGIQBX2h0C4ioRAF9qEQG8Dh0CKcIxAOWiIQIOdhEAe/4VAV5x/QJZ8hUDvA4pAC72GQB4EhEByg4lAu1SEQMATikDcBIhA0cmGQLOOhkCxSX1A3pmBQJX8ckAlDYpA0mmJQGCihECYIYlAYY6LQNmJgUBCe4JABi2MQLaqg0CpZoVAYrCHQLf6iEAydIlAxymIQI8dgUDXmIVAFcl9QClphED8Z4tAFUeEQK7YgkDPdIhAyZWBQG1fjECnZ4hAsYiEQA=="
         },
         "xaxis": "x",
         "y": {
          "dtype": "f4",
          "bdata": "fAKBQHVXhkAEcXtA632HQEjfhEBiYoNA52qFQG40dUCmvHxAquSEQJnwgEAgWm9Au46AQF7HgkBd1HhATFWCQNfSf0B3r3xAlziCQGYog0BHj4VAp8GBQMNjiUDe/3VAvyV/QDWtdUDyeIBAPZZ8QIbXfEBDnYFAUud5QKxjdkACgoFArGKCQNk+g0D5N31Agzd2QHXrbEDw+4JAe9puQNFifkCngH5Ax02HQPSWhUD/UIJAqf6JQEDMfECGAndAnMJ0QMcBhUCjf4BA5ph8QDnUcEAoLn1ATIeEQEJ8fEDzVmtA8Vx4QF36dkA5/3ZAc4WFQEW4fUDfaoRAZPt+QEyreED5F4RAQ6yJQA=="
         },
         "yaxis": "y",
         "type": "scattergl"
        },
        {
         "customdata": [
          [
           "aging_cells_senescence",
           "Japanese scientists discover medical agent that could slow aging-related diseases."
          ],
          [
           "aging_cells_senescence",
           "A single short reprogramming early in life improves fitness and increases lifespan in old age."
          ],
          [
           "aging_cells_senescence",
           "Accelerating the Rate at Which We Onboard Humans to Help Defeat Aging."
          ],
          [
           "aging_cells_senescence",
           "How ‚Äòbio hackers‚Äô are exploring options to reverse aging."
          ],
          [
           "aging_cells_senescence",
           "Extending healthspan: AKG, human clinical trials &amp; aging biomarkers (Prof Brian Kennedy) - The Sheekey Science Show."
          ],
          [
           "aging_cells_senescence",
           "What happened to the Maximally Modifiable Mouse project?. I came across [this past post from 2019](https://www.reddit.com/r/longevity/comments/acd02e/aubrey_de_grey_thinks_that_once_robust_mouse/) where the sub discussed the latest milestones of antiaging research; in specific, the Robust Mouse Rejuvenation project, which, in turn, would need the Maximally Modifiable Mouse. Some comments suggested that we would be reaching that turning point by now, what are the latest outcomes of such project? is it undergoing? is it already here?"
          ],
          [
           "aging_cells_senescence",
           "Gordan Lauc | Glycans to Prevent Age-Related Diseases (EARD2020)."
          ],
          [
           "aging_cells_senescence",
           "Close to the tipping point. Even though the science and public opinion regarding ageing has changed in recent years to be more approving of anti-ageing research and methods, we‚Äôre still not experiencing the ‚Äúcultural tipping point‚Äù, that Aubrey de Grey describes, where the majority of people begin to be well-informed on the issue and funding rises to levels that are comparable to other diseases like cancer. But like Aubrey I also think we‚Äôre ridiculously close to that tipping point..  \n\nI look at my own motivations for why I see this research as being so crucial, and it really boils down to two points:\n\n1. Everyone will experience the effects of ageing and most people will die because of it. \n\n2. Death is the end. \n\n\nEvery generation that has lived before us has had a majority of people live under the assumption that death is not the end. And as agnosticism continues to grow in many parts of the world, especially in younger generations, it is only a matter of time before others who share those same two ideas in their thinking will begin to realize their mortality. \n\nNo one really wants to think about death when they‚Äôre young. It‚Äôs strange. When you‚Äôre young you know that one day you will die but it‚Äôs so far away in your mind that it almost doesn‚Äôt feel real. 'I know everyone will die, but surely not me?' It‚Äôs a strange lie we tell ourselves because we have to, to keep on working on whatever thing occupies our life at the time, to not be consumed by that thought.\n\nSo overall, I don‚Äôt think we‚Äôre quite there yet. But as younger generations continue to age and begin to feel the effects themselves, it will be harder and harder to continue telling that lie."
          ],
          [
           "aging_cells_senescence",
           "The mitochondrial derived peptide humanin is a regulator of lifespan and healthspan [2020, open-access]."
          ],
          [
           "aging_cells_senescence",
           "New discoveries in Ageing and the Reversal of Ageing."
          ],
          [
           "aging_cells_senescence",
           "3 reasons why people don't care about curing aging."
          ],
          [
           "aging_cells_senescence",
           "Lack of consensus on an aging biology paradigm? A global survey reveals an agreement to disagree, and the need for an interdisciplinary framework [2020]."
          ],
          [
           "aging_cells_senescence",
           "Vitality in Aging Longitudinal Study of Aging."
          ],
          [
           "aging_cells_senescence",
           "Anyone interested in a lit review of evolutionary entanglements of sex and ageing?. \\[First of all, not sure if this is allowed here, sorry if out of scope\\]  \n\n\nI am an undergrad of Biotechnology, currently undertaking a lit review on how sexual dimorphism and ageing are intertwined. Aside from the amassing experimental evidence of sex-bias in ageing pathways, ageing and sex have the same key components: caloric utilization, proliferation, survival and maintenance. So I want to look through existing research to find how these two phenomena work together and how this can be used in future therapeutics! Welcoming anyone willing to contribute/collaborate please! :)"
          ],
          [
           "aging_cells_senescence",
           "Targeting metabolic pathways for extension of lifespan and healthspan across multiple species."
          ],
          [
           "aging_cells_senescence",
           "Do you think significantly increasing human longevity will require minimizing exposure to the sun, Or will DNA repair mechanisms always be enough to combat reasonable exposure? We don't know what else sunshine does for the body besides vitamin D synthesis.."
          ],
          [
           "aging_cells_senescence",
           "Death and aging. What do you fear more, the process of aging and having a weak, fragile body, or actually dying?\n\n[View Poll](https://www.reddit.com/poll/ifu0bd)"
          ],
          [
           "aging_cells_senescence",
           "The Discovery of Druggable Anti-aging Agents."
          ],
          [
           "aging_cells_senescence",
           "Computational biophys research that help longevity research. I want to know if there's a link between computational biophysics and longevity research.\nWhat kind of molecule simulation that help aging research specifically?\nThank you for your attention"
          ],
          [
           "aging_cells_senescence",
           "Scientists Have Reached a Key Milestone in Learning How to Reverse Aging."
          ],
          [
           "aging_cells_senescence",
           "If you haven't already, please sign this petition to have the FDA classify aging as a disease."
          ],
          [
           "aging_cells_senescence",
           "How to advance in aging?. Hi all,\n\nI'm someone who wants to get into biological aging research and be able to publish papers on biological aging. However, I don't really know where to go forward so I'm hoping you all can help!\n\nI've read \"Ending Aging\" by Aubrey de Grey, and I've read multiple papers on biological aging, such as the well known \"Hallmarks of Aging\", but that's where I'm at right now. Many aging papers have really advanced vocabulary that I can't really understand (I've learned a lot from reading such papers, but I still don't have a good grasp on NOTCH1, hsp70, and other specific terms). However, I don't think introductory biology college textbooks would really help me out too much. \n\nI'm thinking I should be reading the big-impact papers (so ones similar to \"Hallmarks of aging\" I guess?) or some more in-depth books that have more to do with molecular or cellular biology. However, I don't know what these papers or books are.\n\nIf you know the landmark or high impact papers in this field, could you recommend them? Books which you think explain the terminology used in these papers would also be helpful, since most biology textbooks (such as Campbell's biology) don't seem to really help in understanding these papers. Also, if you think I'm heading in the wrong direction for where I am, what would you recommend I be doing right now?\n\nThank you!"
          ],
          [
           "aging_cells_senescence",
           "Aging is not a disease: a global call for action urging revision of the ICD-11 classification of old age."
          ],
          [
           "aging_cells_senescence",
           "A Popular Science Article on Young Blood versus Old Blood in the Development of Treatments for Aging."
          ],
          [
           "aging_cells_senescence",
           "New Breakthrough Paves the Way for Extending Human Lifespan ‚Äì Scientists Successfully Transfer Longevity Gene."
          ],
          [
           "aging_cells_senescence",
           "\"Biological Progress: Charting the Course of Advancements in Life Sciences\"."
          ],
          [
           "aging_cells_senescence",
           "WHO will modify the MG2A code by replacing the term \"old age\" by \"aging associated with the decline in intrinsic capacity\" in the ICD 11."
          ],
          [
           "aging_cells_senescence",
           "Dr. Brian Kennedy presents 4 molecules which show promising effects in both healthspan &amp; lifespan."
          ],
          [
           "aging_cells_senescence",
           "Targeting Biological Aging: A New Paradigm for 21st Century Medicine."
          ],
          [
           "aging_cells_senescence",
           "Why are there 8 hallmarks of aging?. Right now a problem that's brought up a lot a lot is that we invest a lot into solving all these age-related diseases rather than the underlying diseases that causes those(aging)\n\nI see a similar problem where we list 8 hallmarks of aging - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3836174/ - Telomere Attrition, Epigenetic alterations, stem cell exhaustion, cellular senescene, etc \n\nI want to look for the underlying mechanism and target that rather attempting to solve each of these hallmarks individually.  Overall I think aging is a result of all the entropy in biologically processes to maintain life over time. We've categorized the entropy and have plans to address each aspect but I want to hit the entropy in general \n\nIf we look at this problem from first principles, it is our DNA(genome) that describes biologically who we and the epigenome that describes what genes get expressed to make proteins, which are in charge of all the essential functions in our body/brain. Over time(general entropy in biological processes), there are disruptions that cause instability to the two(true of any system)\n\nIf we look at different people/species's DNA/epigenome and are able to determine the fundamental differences(from diagnostic tools like machine learning/AI) between 'young' and 'old' DNA/epigenome and develop mechanisms (gene therapy, etc) to restore or repair the old DNA/epigenome to the young version, wouldn't that solve the rest of the hallmarks(telomeres, mitochondria dysfunction, etc)?\n\nI believe there's already DNA repair mechanisms in our body. I believe one such mechanism are our sirtuins. Let's look at what those are doing and amplify them with nanotechnology"
          ],
          [
           "aging_cells_senescence",
           "UCL gene discovery raises hope of longer human lifespan. New study discovers that a group of genes that play an essential role in building components of our cells can also impact human lifespan.. [**https://www.longevity.technology/ucl-gene-discovery-raises-hope-of-longer-human-lifespan/?utm\\_source=reddit&amp;utm\\_medium=social&amp;utm\\_campaign=blog\\_innovation**](https://www.longevity.technology/ucl-gene-discovery-raises-hope-of-longer-human-lifespan/?utm_source=reddit&amp;utm_medium=social&amp;utm_campaign=blog_innovation)"
          ],
          [
           "aging_cells_senescence",
           "Can The Pharmaceutical Companies Use Basic Aging Biology To Develop Drugs For Age-Related Diseases? (Forbes)."
          ],
          [
           "aging_cells_senescence",
           "Gerotherapeutic Interventions in Targeting Aging: A Multiomic and Translational Approach (2020)."
          ],
          [
           "aging_cells_senescence",
           "Longevity Biotech Gero Begins Research Collaboration With Pfizer to Discover Potential Targets for Fibrotic Diseases."
          ],
          [
           "aging_cells_senescence",
           "Elon Musk tweeting about longevity. Elon Musk replied to a tweet about [Scientists Claim They've Reversed Aging in Mice](https://science.slashdot.org/story/22/06/04/0520205/scientists-claim-theyve-reversed-aging-in-mice) \n\n\"Remarkable, although, as noted, there are big differences between humans and mice. We can cure a mouse of almost any cancer, but most of those cures don‚Äôt work with humans.\" \n\n[https://twitter.com/elonmusk/status/1533182094784057346](https://twitter.com/elonmusk/status/1533182094784057346)\n\nImagine having the worlds richest Elon join second richest Bezos in pushing longevity and regenerative R&amp;D."
          ],
          [
           "aging_cells_senescence",
           "What‚Äôs your number one hack for reverse aging?."
          ],
          [
           "aging_cells_senescence",
           "Accelerated aging with HIV begins at the time of initial HIV infection [2022, open-access]."
          ],
          [
           "aging_cells_senescence",
           "Five Alarm Bio, Focused on Minimising the Effects of Aging in Humans, Raises Seed Investment."
          ],
          [
           "aging_cells_senescence",
           "Scientists make big breakthroughs in reversing ageing in humans."
          ],
          [
           "aging_cells_senescence",
           "Chula Medical Breakthrough! RED-GEM Molecules to Reverse Aging."
          ],
          [
           "aging_cells_senescence",
           "Researchers Turn Back the Clock on Heart Cells via Yamanaka Factors in Mice."
          ],
          [
           "aging_cells_senescence",
           "Immortality in 10 years?. How many more years would it take to come up with something that actually reverses the human age on a cellular level? (Cell regeneration, advanced level gene modifications etc.). It might sound little naive but I'm really interested in the future of anti-aging and really  would like to get the opinions of my fellow biohackers!"
          ],
          [
           "aging_cells_senescence",
           "Does increasing human growth hormone affect aging?."
          ],
          [
           "aging_cells_senescence",
           "African killifish may hold key to stopping ageing in humans."
          ],
          [
           "aging_cells_senescence",
           "There are at least 4 different ways of aging, scientists say."
          ],
          [
           "aging_cells_senescence",
           "If you were David Sinclair, who managed to reverse aging in the *eyes* of a mouse, wouldn't you attempt to reverse aging in the entire mouse just to see what would happen?. As many of you know, David Sinclair the anti aging scientist has managed to [reverse the epigenetic age of cells](https://www.nature.com/articles/s41586-020-2975-4) in the eyes of mice to recover lost vision. He accomplished this by injecting reprogramming genes into the eyes of the mouse.\n\nNow if you were a curious scientist, wouldnt the logical next step be to yolo experiment on the entirety of the mouse? Do you think David Sinclair has already performed this experiment but is not revealing the results because it was not authorized?"
          ],
          [
           "aging_cells_senescence",
           "Implications of aging in Plastic Surgery.. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6382222/"
          ],
          [
           "aging_cells_senescence",
           "An in-depth profile of partial reprogramming by Peter Ottsj√∂, covering its origin story, its potential for longevity, current research and future prospects:."
          ],
          [
           "aging_cells_senescence",
           "The Evolutionary Theory of Cancer | Dr. Charley Lineweaver."
          ],
          [
           "aging_cells_senescence",
           "The Ventricles of the Heart Age Differently | Lifespan.io."
          ],
          [
           "aging_cells_senescence",
           "Hallmarks of aging ‚Äì time for a paradigm shift?."
          ],
          [
           "aging_cells_senescence",
           "Should you cryogenically preserve your cells to have a young DNA backup?. If aging is in part caused by \"epigenetic drift\", and future gene therapies could theoretically restore such damage, would it be useful to have a backup of your genetic material from when it was more functional?"
          ],
          [
           "aging_cells_senescence",
           "Study suggests scientists may need to rethink which genes control aging."
          ],
          [
           "aging_cells_senescence",
           "I think we gonna find the cure of aging before finding live outside the earth."
          ],
          [
           "aging_cells_senescence",
           "Extending healthspans by targeting the hallmarks of aging."
          ],
          [
           "aging_cells_senescence",
           "Harvard/MIT Scientists Claim New \"Chemical Cocktails\" Can Reverse Aging."
          ],
          [
           "aging_cells_senescence",
           "Kaeberlein: This one is easy @politico. Focus the new agency on #geroscience. The @NIH approach to individual disease is broken. Biological aging is the greatest risk factor for every major cause of death and disability in the U.S. @POTUS if you want a real moonshot, there's your answer.."
          ],
          [
           "aging_cells_senescence",
           "Dr. Michael West at EARD22: Novel Therapeutics Targeting Aging."
          ],
          [
           "aging_cells_senescence",
           "We‚Äôll soon know more about our bodies than ever before."
          ],
          [
           "aging_cells_senescence",
           "What You‚Äôll Find Inside Medicine Cabinets in 2030 | Kaeberlein: \"These 21st-century medicines will work to keep people healthier longer by slowing or reversing the functional declines of aging by targeting the molecular mechanisms of biological aging\"."
          ],
          [
           "aging_cells_senescence",
           "Microbes turn back the clock as research discovers their potential to reverse aging in the brain."
          ],
          [
           "aging_cells_senescence",
           "Preventatives targeting aging biology may come sooner than expected | James Peyer, PhD of Cambrian Bio."
          ]
         ],
         "hovertemplate": "Topic Group=%{customdata[0]}<br>document=%{customdata[1]}<extra></extra>",
         "legendgroup": "aging_cells_senescence",
         "marker": {
          "color": "rgb(230, 131, 16)",
          "symbol": "circle",
          "opacity": 0.7,
          "size": 7,
          "line": {
           "color": "rgba(0,0,0,0.5)",
           "width": 0.8
          }
         },
         "mode": "markers",
         "name": "aging_cells_senescence",
         "showlegend": true,
         "x": {
          "dtype": "f4",
          "bdata": "wpu4QI70v0DDnb1AKKzBQIF/ukCQ475Ahri6QALYt0B1jcBAsf+/QIqbvEAbYLxATIO+QB5cvEA5pb5A/RO9QHkWuUAkabtA8kC9QARNwUDejLZAiqe8QGzxukDm5rVANDbCQHLIvUBPWsFAk4e5QD8xvUDebb1A6ibDQLKfuUBbHb1ABBS+QMyivEAsScBAOUu8QH6Gv0Cw1MBA52i8QB1Hu0CZL8BADZa9QI5DwEBj6b9A65vBQJCxvkB6T8FATDfCQDfWvkBnpr9AllXEQA+FwkB3CL1AD2u9QAezv0BGJbZArGi7QA3ewUAnX7pAIT3DQJKAu0A="
         },
         "xaxis": "x",
         "y": {
          "dtype": "f4",
          "bdata": "dpNrQGkBd0AuyHpAusF2QF7qbUCpNnZA/AdhQCDpgUBYAWlA5utuQIChfECzb3tAL8h5QBlcekCD42dAcC14QNfTgEBBe2NAMviBQHu2dkDg2nBA58uAQMrmakCsJGVAzxJvQITBeEDlqGxA9ytwQHdwYUDbEG9AHYloQCexaEDWFWBAXO1hQIpieECPIXZAwIZgQLtZcEBNKnFANi5iQMo8bUD6sHFAtX1iQCiUaUDTKHJADiN0QIN1YEB4CnhAAIB9QGKAd0DT+3ZAhsNkQI15a0C8UoJAEs1lQAD4b0A14HlAWU1hQIZWdUBi4mlAyNtwQGjvekA="
         },
         "yaxis": "y",
         "type": "scattergl"
        },
        {
         "customdata": [
          [
           "1_to_and_it_my",
           "If you experience feeling something that is not supported by facts, it is usually more helpful to accept the feeling, but put it in perspective. Try responding with, ‚ÄúJust because it feels true doesn‚Äôt mean it is true.‚Äù You might slowly come to see your situation differently.."
          ],
          [
           "1_to_and_it_my",
           "Ways to effectively recover from burnout. I've been working kinda hard for last 5 month. Now I feel tired, and have no motivation, and my sleep quality decreased. I'm really struggling with procrastination, even though it never did before.\n\nI took a week off, and want to use it as effective as possible. \n\nWhat kind of rest is preferred? Joyful rest, like movies/games/etc, or ascetic (dopamine fasting like), like doing nothing, walking, getting really bored.\n\nWhat are the best ways to recover from it? Do you have any techniques or general advices? Maybe there are some biohacks for it? :D"
          ],
          [
           "1_to_and_it_my",
           "Trouble with un-busying myself. Dear wonderful Fellow Biohackers, \n\nAs I am getting ‚Äúolder‚Äù (30‚Äôs) I have been trying to downsize responsibilities and gigs as I am really starting to see the value of downtime, hobbies, quality tome with friends and kids, keeping on top of physical health (I have always done this latter but lately I have been so busy for the first time in in my life I have been slipping a bit) etc. \n\nI am on two boards as a board of director(was just asked to be on a third one) , have a full time job, kids, and several side projects/gigs. \n\nHowever, I am finding myself having an extremely difficult time letting go of some of the projects I am on. I know I have to, I want to, I don‚Äôt need the money (money is always nice but I would be ok). \n\nAt the same time, there is such an enormous FOMO in me that I am paralyzed to walk away from any of the projects. \n\n I am really starting to run on fumes, my exercise routine is slipping, feel exhausted and burn out-y. \n\nMy question is, how do you guys downsize when finding yourself overwhelmed and how do I battle this paralyzing fomo? \n\nI love the projects I am on for the most part but it‚Äôs just been too much yet I am paralyzed when it comes to where to downsize and to actually doing it.\n\nI feel like a little kid trying to grab and carry all these shiny toys in her arm but it‚Äôs too much and they just keep falling and I am not fully being able to enjoy either because if the overcrowding. \n\nThank you so much in advance for any insights and input! I am looking for practical advice but also psychological tips/tricks on managing the fomo and overcrowding my life."
          ],
          [
           "1_to_and_it_my",
           "Mute all your notifications! A free method to drastically lower stress!. So I haven‚Äôt heard anybody about this but 1 simple thing you can do to lower stress levels and even increase your HRV (it worked for me) is to mute all your notifications on your phone. \n\nAdd important contacts to your favorite list (so you won‚Äôt miss an important call) and learn to pickup your phone less. Within weeks I went from picking up my phone every chance I could to only a couple times a day!\n\nBe the boss of your phone and not the other way around!"
          ],
          [
           "1_to_and_it_my",
           "I lost my ex boyfriend in plan crush ‚úàÔ∏è‚úàÔ∏èüò≠üíîüíîüò≠ Over 6 years now and no one ever make me feel happy üòÅ and may almighty God üôè sent me someone honesty and respect love for long term relationship with üôèüòá."
          ],
          [
           "1_to_and_it_my",
           "Thoughts/Feedback Of My Bio-Hacking philosophy. Diet and sport are not as important as everybody says\n\nStress reduction are the most important part of the health. That implies having a vocational job with low stress, with no bosses, no schedule. I know that is hard, but it is the ideal. If we have a job where we cannot move almost nothing, that is harmful too.\n\nThe boredom are a silent stressor, avoid it, we always have to be any interesting activity to do, talk with your friends, have sex, above all TO HAVE A MOTIVATION, a life purpose\n\nAnother silent stressor is to cook. I hate it, I hate to realize \"its time to eat and I don¬¥t know what to do, I havent anything good, I dont want to cook...\". I order a catering at home of  plates of prepared food in tuppers for the mealtime for all the week. For the supper I prepare the sundays suppers for the next 4 days. It is a little expensive but it worth it for your quality of life, instead of taking hundreds of dollars of supplement.\n\nConnection with nature should be at least the 10% of health, go to the nature 3 times a week. Shirtless in the forest to let the body impregnate with phytoncides, breath it, take the sun in forest, have sex in nature if you can (im not joking, everbody is  synergistic in nature), coffee in the forest, sport, grounding.\n\nadrenaline boosters: Rollercoaster, extreme sports. This has the effect of a reboot of dopamine the next days.\n\nMost of people are doing more sport than they should  tiring the CNS to the limit. Movement is as important as sport, walking for example. Sport are 15% of health, and movement other 15 %, diet 15% unless you eat like a pig that would be harmful, fasting 5%\n\nIf you take to the extreme sport and diet restricting basic food, it will be even harmful for you.\n\nAvoid \"superhabits\" like daily ice bath, fasting more of 24 hours. We don¬¥t have to take to the limit nothing of this\n\nAvoid to eat \"superfood\" very often, avoid to take tens of supplements\n\nPD: Im not english speaker, sorry for my english"
          ],
          [
           "1_to_and_it_my",
           "[Advice?] I dislike my job more and more by the day, and now only care for the pay. What‚Äôs some strategies to get better and care less?. I am a programmer in a support role now for a different company as a career. The job pays well and I am good at it because I care about integrity and a bit of an over achiever.\nYet, I hate the never-ending work and stress induced; taking at least until Sunday to reset from a 4-5 day week \n\nThis job is not rewarding nor progressive to have things get better or run more smoothly, slow down, or be less needy. \nWith my prior job, it is this hope that that I do impacts job and processes within to run more smoothly such as from code we wrote, or implementations we do. Here currently, support for a large number of apps appears never ending with little control over trying to make things more stable. People will call the Helpdesk whom submit tickets to us for nearly 100 different apps (some by 3rd parties, some we have the code for) to be supported and we are expected to learn  and be the experts to resolve anything. Things can also always happen based on alarms setup from monitoring tools as well. \n\nBetween the work being uninteresting (even if I‚Äôm good at it), feeling like have to answer to 5 different bosses, little skill sharpening, and overall stress from high workloads, I‚Äôm considering job searching. But I also think this is a bit drastic.\n\nWhat would you do to help lower stress, and view the job in more silver lining fashion if trying to stick it out for a few more months? I want to compartmentalize it better and return to my happy self. I want to remember to care less, do less, and not have it affect me mentally.  For example, One strategy that has helped thus far is working on my own programming projects to get back some missing feelings of what I enjoy (however this alone is not enough and many weeks I feel unhappy and disconnected from the present moment.\n\nTips, supplements, strategies, and advice welcome."
          ],
          [
           "1_to_and_it_my",
           "I get anxiety when i do cardio‚Ä¶. So lately i have been getting some type of health anxiety while doing cardio. I never used to get it in my 20s as i used to run a good pace or do stairmaster at a good pace but since turning 30 (also started finasteride around this time), i started getting anxiety, heart rate jumps and that sunken chest feeling when i do cardio. When im not doing cardio, i keep thinking about my heart. Im not sure what happened to me but it makes me scared of pushing the cardio like i used to. Has anyone had similar experience? What‚Äôs the best way to resolve this?"
          ],
          [
           "1_to_and_it_my",
           "Behavioral tips for ruminating. I am generally psychologically healthy, but I've decided that I \"ruminate\" too much.  \n\nThis runs in the family.  My mom and aunt were very famously able to hold grudges indefinitely, even for very small perceived injustices.\n\nFor example, let's say I am in a business meeting and Glenn says something dismissive about me or talks down to me.  I am now pissed off.  I tend to replay the event in my head and get myself progressively more angry.  This is not an anxiety attack: there's no racing heartbeat or fight or flight response.  Just retelling the story to myself and getting upset, even when Glenn probably forgot about the interaction immediately afterward, I focus on it to any unhealthy degree.\n\nAnyone done anything behavioral to move past this?"
          ],
          [
           "1_to_and_it_my",
           "What is the chemistry for the pit-in-the-stomach feeling?. When I'm facing a challenge that I don't feel well equipped for (or sometimes, is just not something that I can do anything about), for example, when a loved on is sick or depressed, I get this strange feeling in my stomach. I've noticed that I hate this feeling so much that I will physically do something to avoid feeling it.\n\n* Do you know what I'm talking about?\n* What is the chemistry behind it? Is there a chemical antidote to shut down this stress/flight-or-flight response?\n\nI am so confident if I can find a way to suppress this, my life will be orders of magnitude improved as there's actually exactly zero times when I've found this physiological response useful."
          ],
          [
           "1_to_and_it_my",
           "Overcoming procrastination?. Title \nMotivation that I may have depleted in a few days how to keep it rigorous"
          ],
          [
           "1_to_and_it_my",
           "How do some manage to stay calm, positive and happy in any situation. I used to not give a f about any situation and just overcome anything with a smile and optimism, but nowadays i kinda have lost that ability to just smile at negative situations. It feels as something inside my brain doesnt let me feel joyful inside and smile or take less seriously stuff. When doing deep breathing it feels as if the breath almost destroys this feeling but not completely, it touches it but doesnt get rid of it. How do some people do it? To me it also feels as if i have lost my self esteem to overcome some situations and they give me rage and self doubt."
          ],
          [
           "1_to_and_it_my",
           "Ways to build self discipline and self improvement?. Maybe this isn't correct sub to post about getting advice on ways to build displined determination and consistency. But I guess when people say the things you eat, is the type of person you become or the things you do on a daily basis is the type of person you become. I guess maybe it has something to do with affecting our lives in a good or bad way. I just been struggling to become displined and determined, have this stupid habit of giving up and letting anxiety control me. I just still haven't managed to find a coping mechanism to overcome this situation. Maybe fear and anxiety is normal for many people but honestly don't know how to find a way to not let it control me. I'm trying to better myself and work on my life but I don't know what to do"
          ],
          [
           "1_to_and_it_my",
           "I have better mood during illness. I am quite succesfull and extroverted but often I get shy or paranoid for little reason (maily after lunch) and Im always working on it. But when I catch cold, like 3x a year, I always become more calm, confident, happy, I dont overthink and I dont take any shit. (Of course if I am very very ill, I can feel worse). But why I am happier during mild illness?"
          ],
          [
           "1_to_and_it_my",
           "How to level up when you have kids?. My partner and I have a 14 month old and another baby on the way. From the outside, we look like a healthy, young, put together family. \n\nWe try to be generally healthy because of my digestive disease BUT we are totally failing at self improvement. It‚Äôs crazy that we can‚Äôt get it together because we are both amazing at our careers and pretty good (not perfect) parents. \n\nWe had a conversation last night and we found ourselves saying ‚Äúwhy can we succeed at everything we do EXCEPT this???‚Äù \n\nWhere we are struggling are things like work/phone/computer boundaries, binge eating junk food (boulder canyon chips, ice cream etc) on super stressful parent or work days, sleep habits (we trying to go to bed early and wake up early but we‚Äôre so tired because of the lack of consistence with our baby), lack of consistence working out. \n\nBasically the only things we are consistent in are getting morning sunlight and not drinking. In the last few years we‚Äôve been delving into podcasts and books by people like Peter Attia and huberman so we KNOW what we should be doing for longevity/good physical and mental health. \n\nWhy can‚Äôt we get this?"
          ],
          [
           "1_to_and_it_my",
           "Visible pulse in carotid at base of neck, palpitations, and generalized anxiety. After high stress, sitting a long time, or rigorous exercise, my pulse can move my skin up to a ¬º inch. Normally it ranges from barely noticeable to ‚Öõ of an inch. The palpitations aren't necessarily bad, but they usually follow a meal. Only had super noticeable flutters twice since it all started half a year ago. I see a cardiologist in two weeks, however I got an Echo and Xray done already. Both came back normal. But it was from a rural hospital where the staff has never really impressed me.\n\n\nI no longer smoke and use alcohol once every two weeks maybe. My weight is normal and I am in my late 20s. I take beet powder and an iron supplement for it now. I can't say it's helped significantly, but I do feel better.\n\n\nPeople close to me think it's anxiety, but also encouraged me to see a doctor nonetheless given the palpitations and neck pulsation aren't normal. My BPM sits higher than average for my age. I have been diagnosed with GERD as well, and know it could be related.\n\n\nAnyone have anything similar? What are you guys doing/taking?"
          ],
          [
           "1_to_and_it_my",
           "Anything that can reduce my annoying post masturbation after effects?. Ive been having this annoying problem for a long time:  after I masturbate, (to porn or not),  Im just 4 days in this completely altered state: I'm so anxious, unmotivated, tired, annoyed. Socially so anxious  that I have to cancel meetings because I just embarrass myself. Focus and mental cognition is also reduced, even to a point i get lost driving in my own city. Also self esteem falls off by a lot: everytime I speak in this state i am so insecure, i let myself be dominated by everyone who even slightly disagrees and I seem to go in a fight or flight state in meeting sessions as well.\n\n  I am not feeling guilty about doing it, so thats not it. Im in a longtime relationship but I dont have a problem,morally speaking,  to endulge in a bit of personal fantasy from time to time, it doesnt take away at all from our sex life.\n\nAfter sex i can say those feelings are a lot less compared to masturbation.  I obviously know about nofap but it is very unrealistic to just never engage in masturbation. Im a 38 year old male, but I had this basically always. I can say that around that day 5 benchmark of not masturbating, it clears up a lot, I feel more confident, am able to focus better, am more patient and so on..  \n\nSo I can definitely say its the effect of masturbation that induces this.  I assumed always its the high dopamine after effect, but walking , fasting, excercicing, cold showers, healthy eating, meditating : sure they bring a bit more calmth for a small period but it doesnt fully go away after i hit that Day 5 mark.\n\nBecause of this issue i reduced doing it to 1x  per 10 days or so, but i still get brutally punished. I feel like its not really fair, Im sure I cant be the only 'young'  male masturbating, especially in our sexualized technologic world. (not saying its a good thing at all , this over sexualization ).\n\nMy brother for example can have a lazy day, do it 2x times and then still lead succesful meetings in the afternoon. But ofc I know not all ppl are the same.\n\nI tried all kinds of diet changes and I tried to supplement all kinds of stuff : zinc, magnesium, omega 3, b vitamines, vitamine d,..  but no real effect.\n\nSo my question is :  does anybody know of any possible solution/'hack' to at least reduce this time or what it could be? If not I guess Ill have to do my absolute best to keep trying go full monk mode on the personal pleasure area. Thanks."
          ],
          [
           "1_to_and_it_my",
           "The key to being happier: changing the way you think. I‚Äôve long suffered, often not in reality but mentally, to the point I lose sight of the good things I have in my life and the fact I have people who love me and people I love. Often there are external events that impact my thought process, one being losing 3 cars in the past year and losing my savings to repairs while being in college. I was constantly down and began to become sick and tired of being sick and tired. \n\nI tried going to the gym, walks, supplements, and swelling in the suffering to see if I can overcome it. I had mixed results but nothing stuck. \n\nI started analyzing my thought processes and realized how often I‚Äôd let negativity overtake and consume me which would dampen my motivation and love for life. I began changing the way I think in several different ways: I know longer accept negative thoughts, as soon as I recognize myself spiraling I deny the thoughts and tell myself I am happy, and begin thinking positive thoughts and often count my blessings. This stops the rumination that leads me to feeling down. Second I now pay more attention to my surroundings and keep my head up because looking down doesn‚Äôt stimulate your senses which opens the floodgates for deep thinking. Third I constantly remind myself of the things I have and tell myself I am happy, okay, and have a future ahead of me. I do this even when I‚Äôm not necessarily feeling that way. \n\nThese three things have quite literally changed my life. What‚Äôs more interesting is I haven‚Äôt necessarily changed my external habits. I still smoke, look at my phone, drink, and don‚Äôt socialize as much as I should. So it‚Äôs nothing necessarily external that‚Äôs changing my mindset but I can tell you all these things have become easier to quit and I have more motivation to do all these things.\n\nI wanted to point that out to highlight the power of the mind and the way we think. But now externally changes you can make that will also change your life is what you already know: limit drinking, limit phone time before bed, go outside, force yourself to socialize, go to the gym, take supplements, specifically magnesium, vitamin D, and a multivitamin. I also find rhodiola rosea to help me manage stress significantly. But last and most importantly is stick to a routine. Force yourself for 2 weeks to have a daily routine that includes variety of activity and scheduled eating times. \n\nBack to the example of my car, I lost my car a couple days ago, now the third car which has impacted my ability to get to the places I need to go, my income, and freedom but what‚Äôs different about this time? I don‚Äôt feel sad, at all. In fact in a very odd way, I am happy thinking of all the opportunities it opens up, including walking to places, the next car I‚Äôll be able to get, and overall change of pace. It‚Äôs very strange but I don‚Äôt feel anything negative about it, even though the future for myself is unclear. \n\nTruly, forcing positive thoughts, not allowing myself to ruminate and counting my blessings has changed my life. \n\nNow here‚Äôs what should you expect when starting this new way of thinking: you will often feel the feeling of what I call ‚Äúteetering,‚Äù being unsure if your actually happy or not. This eventually goes away but I can guarantee it feels much better than being depressed. You also may feel what I call ‚Äúbody depression,‚Äù basically the physical symptoms of depression but your mind will be much more at ease allowing you to cope with these sensations much better. But rest assured this will also go away. Finally you will fail, you will have intrusive negative thoughts and temptations to fall back into your old way of the thinking but this although scary will be easy to conquer because the fear of feeling the way you use to feel will compel you to keep up your new way of thinking and eventually it will go away to the point it‚Äôs no longer a major problem. \n\nNow for the scientifically minded, don‚Äôt worry this is not just my personal testament. The brain is plastic and malleable and studies confirm the power of positive thinking and stopping yourself from continuing to ruminate https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4760272/"
          ],
          [
           "1_to_and_it_my",
           "I am not expert of feeling so i have a question. Hello I have a serious question to ask I haven't cried for 5 years but I had a heat-up conversation with close members of the family they claimed in the conversation that they helped me when I was down so I refuted their claims and in the middle of the heating conversation I started crying and yelling with all emotional responses \n‚àÜ The question is it has been a couple of months and I cry every day I feel like I am not sure what I feel but more like I need to cry I am not feeling good when I cry but I feel good after it so how can I stop it and I am a science guy so I do want to know why is that happen after a long time of no crying"
          ],
          [
           "1_to_and_it_my",
           "Advice : lifelong fatigue, ADHD, procrastination,laziness, brain fog. Long story short : I‚Äôm 22 and my entire life I‚Äôve had severe diagnosed ADHD, severe issues with procrastination, laziness , fatigue, etc. Can‚Äôt bring myself to start task like homework, and feel like doing most things is a monumental task. I could spend my entire day in my room doing nothing.\n\nJust wondering if anyone has any lifestyle or supplement suggestions, or any other type of advice on things that could possibly improve it ? Whether it‚Äôs for fatigue , ADHD, etc. or any possibly genetic causes. I can‚Äôt keep living like this. \n\n\n***I exercise 5 days a week, eat a healthy diet (lean meat , veggies and fruits, healthy fats like fish) , healthy bmi, no obvious health issues,"
          ],
          [
           "1_to_and_it_my",
           "Is there any way to feel time passes more slowly?. When someone feels good, working or studying hard makes time fly by.   Is there any way to maintain a good mood while feeling time pass more slowly?"
          ],
          [
           "1_to_and_it_my",
           "Biohacking for ADHD burnout. I am looking for indirect advice regarding mitigating ADHD burnout, and inducing flow state for combating procrastination and brain fog. anything helps, and i apologize if this is the wrong place to start this discussion but i feel lost in my search."
          ],
          [
           "1_to_and_it_my",
           "Its crazy how much stuff you gotta do to at least be subpar healthy. After leaving vacation from hawaii, I come back to my stinky home and its crazy how the air quality is from hawaii to here. You have to clean your house to get better air, you have to change lights to get natural lighting, you have to change the food, the water, the EVERYTHING! You have to change your whole life! Like, we were meant to be outside all the time, so being outside after being an inside person is like a whole shift in perspective. And if you give up, you fall into the depths of your old life, how you were and how you are now."
          ],
          [
           "1_to_and_it_my",
           "How to relax fried CNS (Central nervous system). Hello everyone, so I am an athlete of an endurance type of sports and I train 2-3 hours per day, 6 days per week. With that I work as a bartender in the evenings or weekends, so I would say I am more than an active person. I am well educated about nutrition so I am very careful what I put in my body. Some days when I really go beyond my limit (especially if there are few days in a row that bust my balls) I start having trouble sleeping, bad mood, foggines, eventually I start declining in my sport. Even if I take few days of rest and start feeling little better its not hard for me to get back in that state. With some research and connecting the dots I figured it has something to do with CNS. I am wondering are there any supplements or something that could help me relax the nervous system, because life like this is getting really deppresing and I need help."
          ],
          [
           "1_to_and_it_my",
           "Vasodilation. I‚Äô ER learned I have a very subpar cardiovascular system despite training. I believe I have high PVR and a weak heart. Even when I was 170lbs wrestling I was unable to endure similarly to my teammates. I would literally just start seeing stars blacking out. I‚Äôve passed out on a rowing machine while posting a 1:22 500m row. I woke up 15 min later with paramedics there. It was much closer to being a NDE than passing out, but I digress. I ended up being a D1 3x all American in a power event but was significantly weaker than all the people I would beat(relief on technique) My genetic testing shows I‚Äôm highly type 2 muscle fiber dominant which also plays into the equation a bit. I have had an ekg and stress test which showed small abnormalities at the top end of my cardiac output. Cardiologist wanted me to come do a combined stress echo which I haven‚Äôt done yet. Grew up with severe athsma attacks requiring ER visits and constant inhaler/home nebulizer use. (Albuterol could have damaged CV system(lungs) being a B2 agonist) I rarely get small exercise induced athsma attacks and don‚Äôt use any medications. Last 2 pieces of puzzles is I have AS an inflammatory condition and have used TRT/androgens as an immune suppressan when I experienced sides from a TNFa. I‚Äôve stopped this due to side effects and am on a supplement t regimen to boost endogenous production.  I give all this random background info as it‚Äôs valuable to my topic uestion. \n\nWhat supplement would be the healthiest to reduce PVR and vasodilate to hack my biology along with increasing SS cardio? I‚Äôve tried L-arginine, beet root, cialis, but want this splendid communities input. Also, I probably need to eliminate caffeine huh?) \n\nThank you for all input"
          ],
          [
           "1_to_and_it_my",
           "Supplements for Motivation?. Hello r/Biohackers, I figured I'd ask this here since y'all are the foremost subreddit for this kind of thing.\n\nI have terrible motivation problems where I just can't get myself to do things, even to do things I really WANT to do, like work on projects or even play certain video games.  I have an especially hard time getting myself to start anything to do with art.  I feel like some of it is rooted in fear of failure or fear of having to learn new things?  I am pretty insecure about my art skills, and failing to create a piece that looks right really messes with me.\n\nThe strangest part is that I can pretty easily do things like change my bed, go to the gym, cook food, etc.  Routine chores that don't take long are not big asks, but anything I know will take up a lot of time is.  Ironically, this causes me to waste my time doing nothing, sitting there trying to convince myself to be productive while wasting my day.  I can hardly ever get myself to go to sleep, either, since I know how much time sleeping wastes.\n\nMy question is: are there any nootropics, supplements, or other substances that would help with this?  Like just something to turn off my subconscious mind?  Or any other way that might help my issue?  I've been struggling with this my whole life and I'm so ready to be free."
          ],
          [
           "1_to_and_it_my",
           "My Motivation is Dead Despite Years of Pro Help. Help Me, Internet Strangers!. This is long, please be patient with me.\n\nI am a PTSD sufferer. A few years ago there was a murder in my family. My 3 year old baby cousin was murdered by her own mother. I died inside, and am still dead. I cannot bring myself to do anything productive. I was the hot-bodied over-achiever with a degree and big fancy office job career, a relationship, and a house in my favorite city. I stopped going to work and then quit. I lay in bed or on the couch all day. Every single project I plan or get materials for just sits around collecting dust and never gets finished. I lost the relationship. I lost the house. I stopped seeing friends. I lost everything. I stopped teaching yoga. I stopped giving a flying f*** for everything.\n\nFor 3 years I have been seeing a therapist, and a psychiatrist. I have changed therapists when I didn't notice any improvement. I take 3 psychiatric drugs every day (2 SSRIs, and Gabapentin.) I've come a long way. I even moved to the country so I could get outside and hike every day. I got a new, less modern, home that I love even though it is humble. I don't cry literally all day anymore. I don't wake up having a panic attack. I have gone back to work (my previous career ended with my mental health decline, but after a year I fell back into a previous line of work that I can do part time.) I found a good man. We plan to get married.\n\nRealistically I'm doing everything that I'm \"supposed\" to do for something like this, and doing much better...... but motivation never came back.\n\nI'm dragging myself through every daily activity. No matter what thought \"sparks joy\" I cannot act on it. I have truly fallen out of love with every single thing I once had passion for. My gardens, my art, my house, even yoga (which I used to do 5 days a week, and even teach!). I was once an accomplished hiker, doing 5 states of the appalachian trail. Now, living less than 20 minutes from 3 state/national parks, I cannot even be bothered to go hike 10 minutes down the road from me. I walk around and do yard chores for \"exercise\". I wasted my summer mostly indoors. I would lay in the grass sometimes just to make vitamin D, but despite how much I love the sunshine, apparently I don't love it as much as my couch. Even recreation leaves me unmotivated. I can barely start a video game before I don't have the \"energy\" for clicking buttons and playing. It's just me, my couch, reddit, and a pile of books.\n\nI feel like I lost my soul with the life of that little girl, and the subsequent laundry list of felony charges against her mother, my cousin. I have done everything I can to grieve, medicate, get therapy, seek justice, and move forward, but I can no longer feel compelled/motivated to do anything that isn't absolutely neccesary to survival. My health and appearance have gone from stellar to average, and are slowly sliding to below average. I have ROOMS full of clothing/shoes/jewelry (from my previous life and salary), and every beauty product imagineable. I keep wearing the same hoodies and yoga pants, and can barely manage to brush my teeth and hair, and that's it. I am coasting in every arena of life. I want to feel compelled to be ambitious and proactive again. I want to dress up, make art, go out, see the sites, but my body is constantly fighting it. I NEED something to change my body chemistry, if only enough to have the energy to take care of my life goals.\n\nWhen I titrate down from the antidepressants I backslide right away. I am clear that I need to stay on them. They STILL aren't enough. I try meditation, stoicism, spirituality. No change. I've plateaued.\n\nPlease, biohackers, help me better manage my reward and motivation systems! Help me have the \"energy\" to do life each day. Please help me find a proverbial \"dangling carrot\" to get me chasing goals again! It used to be my superpower. I don't even know who I am without it.\n\nThanks in advance everyone! Any help and suggestions are welcome!\n\n\nTLDR: Trauma broke my reward system, and therapy, medication, and positive life change haven't revived it. Please help me chase goals beyond survival again. Please help me chase dopamine!"
          ],
          [
           "1_to_and_it_my",
           "So much effort to be healthy lol. I just recently started trying to be more healthy. and holy fuck its so much more effort then clicking 5 buttons and uber eatings or doordashing food to my house. Gotta cook, then eat, then clean all the dishes. Gotta tremember to take my pills.  Gotta remember to drink enough water(why the hell is it so hard to drink water other then at like 3 am) gotta brush my teeth, and take a shower and do my skin care routine. Health is effort. Gotta go out and do cardio and 3x a week go to the gym. limiting myself on screen time so atm im bored af(i ordered some books so that should help soon) and its just like dam so much goes into trying to be healthy and i know it will be worth it int he long run but starting out its a lot. BEAUTY IS PAIN!"
          ],
          [
           "1_to_and_it_my",
           "Hacks to combat over active sympathetic nervous system?. It appears my sympathetic nervous system is in over drive‚Ä¶ \n\nI walk plenty, I don‚Äôt do any over the top workouts, but my days are active. \nI am hydrated.\nI sleep every night.\nI don‚Äôt have a stressful job. \nI do breathing exercises. \n\nBut despite being thoroughly checked out medically‚Ä¶ I feel pretty pants.\n\nMy heart is often too fast for the circumstances. I get adrenaline rushes for no obvious reasons AND when I get them for obvious reasons (like confrontation) it almost puts me in presynscope.\nI get calve twitches. Thumb twitches. \nI get nausea. \nSometimes I‚Äôll even be attending to sleep and then get a random adrenaline rush. \nSensitive to heat. \n\nI don‚Äôt have any obvious big stressors in my life though. Only the normal little things that none of us can escape. \n\nSo how can I combat my sympathetic system being more prominent than my parasympathetic system? What‚Äôs the hack here? \n\nMy resting heart rate is too high despite being active. \nAnd my heart rate variability (hrv) is too low.. \nthese ^ are both huge indicators that I‚Äôm in flight or flight mode way too often‚Ä¶\n\nHelp?!"
          ],
          [
           "1_to_and_it_my",
           "Tips for a fresh mind during a job interview (Live Coding Interview). Good morning everyone,\n\nAny tips on how to 'reset' the mind before a job interview (Live Coding Interview)?\n\n**Context:**\n\nI have an interview next Wednesday for a large company with excellent benefits. I‚Äôve been preparing for a week, and I believe I‚Äôll be able to perform relatively well.\n\nThe issue is the interview time, which will be from 7 PM to 8 PM. \n\nIn the last few days, I‚Äôve simulated some interviews around that time, and it‚Äôs clear that my cognitive performance drops significantly compared to earlier in the day, for example.\n\nUnfortunately, my current work schedule doesn‚Äôt allow me to take the day off on the interview day. I even have a critical meeting that day to deliver a project I‚Äôve been working on.\n\nDo you recommend any activities a few hours before the interview?\n\nI was thinking of doing some exercise and taking a cold shower a few minutes before.\n\nSome details about my routine: I work from home, and I‚Äôm usually free from my current job around 6 PM."
          ],
          [
           "1_to_and_it_my",
           "How can I lower mental fatigue?. For 6 months I started a new job in a field that I haven't worked in for 7 years. \n\nIt hit me hard when I saw that I forgot a lot and times have changed. I am used to doing stressfull and mental challenging stuff but this time it seems that I can't manage them. I have some moments when the dots connect but rarely. \n\nCurrently I am going through the motions until I find some kind of pattern and then try to fit it together with other stuff I know. I really want to add value to my workplace and clients. I like to take responsability but my self trust is low because mistakes can be costly. I am working in consultancy and am project manager on a lot of projects.\nI really like it when I finish a project with succes.\n\nMy boss pushes me to be better and helps me a lot but he is an emotional guy and I am the opposite. I am mentioning this becauae some of my fatigue comes from trying to separate his emotions from what he says. Sometimes it bothers me, sometimes it doesn't.\n\nI am sleeping ok, eating good food, going to the gym twice a week, doing cardio twice a week, vo2max once a week and streching twice a week; have alone time, journaling, reading time, on weekends my gf stays with me, nature is close and enjoy it. \nI took supplemwnts a long time but it didn't do anything for my mental clarity so I stopped.\n\nThe issue is that my mental fatigue is still there all the time, even after a week of vacation.\n\nWhat can I do (preferably daily) to reduce just a bit my mental fatigue?"
          ],
          [
           "1_to_and_it_my",
           "Exam-Day Brain Optimization. Hi Everyone! \n\nI‚Äôve got a big 4 hour exam coming up in three days I‚Äôve been studying months for. The exam takes place at 12:30pm and goes to roughly 5pm accounting for all the administrative stuff. \n\nGiven that the exam is a 45 minute drive away - do you have any suggestions to optimize my energy levels and brain through the exam period? \n\nFood is a big question mark for me right now - no idea what to eat that won‚Äôt cause a crash and that can sustain me 5 hours. \n\nThanks!"
          ],
          [
           "1_to_and_it_my",
           "How to avoid immense rises in blood pressure and heartrate over anxiety/overthinking. I have a tendency to get anxious and neurotic over the smallest of things. Today I sent a message to a group that I hadnt been in contact in 1.5 years. This sent me to a cycle of overthinking and neuroticism. I got a boost in energy too, I think my adrenaline got a boost/spike? Then I started to get productive and shaky? An hour after this I took my blood pressure and heartrate which were immensely high. BP 160/91, heartrate 112 despite not really doing anything too taxing. I didnt even have alot of caffeine or nicotine today, about 50-120mg of caffeine over 4 hours before this and 4-8mg of nicotine the whole day. My blood pressure is sometimes slightly higher than normal just resting, but often it is bordering on normal. Resting heartrate around 50-55."
          ],
          [
           "1_to_and_it_my",
           "Biohackers! I need your help.. Recently, I started experiencing neck tremors, particularly in one class where I have to constantly watch the screen and the professor without moving. This has been happening for about two weeks. I tried smoking a cigarette this time, even though I don't usually smoke, and it reduced the tremors by about 80%-90%. I also tried NSDR Yoga nidra as well before class to prevent it from happening again but it happened again so I used cigarette at break. Can you explain why this is happening and how to eliminate it? I'm not in a state of big anxiety or depression overall, but sometimes I can be nervous and overthinking. My heart rate can go up occasionally on social interactions, but I do sports and eat healthy. Please help with reason and how to deal with it?"
          ],
          [
           "1_to_and_it_my",
           "Heart failure from uncontrolled blood pressure and panic disorder. Hello biohacker community,\n\nI desperately need your help.\nI was diagnosed with diastolic heart failure/ heart failure with a preserved ejection fraction and am only 30 years old.\n\nHave been living with this for 3 years now, and it‚Äôs a major struggle. The cardiologists have been little help.\n\nThe cause was uncontrolled high blood pressure caused by major panic disorder.\n\nI‚Äôm doing a lot better mentally now, no more panic. Blood sugar is normal, cholesterol markers are perfect, very healthy weight of 150 at 5‚Äù11.\n\nThings I‚Äôve tried \nCarvedilol, Telmisartan, metoprolol- none have been any help really.\n\nSupplements- d3 and k2, helps a bit\nVitamin c and coq10, helps a bit \nNad+ (was helping a lot, body is used to it at this point, and not much help anymore)\nIce \n\nAny ideas of any peptides or anything that can help me recover from this? Any help is greatly appreciated, id really like to be able to live a good life üôè"
          ],
          [
           "1_to_and_it_my",
           "Recs for devices to force me into parasympathetic. I'm always exhausted. But it's getting worse due to more anxiety. I bought a Garmin tracker and since I've been using it, I've seen I never rest. My stress is never low and I never get rest. Every day and night my stress is constantly in the medium to high ranges which stresses me out even more now that I see what's happening. I've been telling me doctor for years, I feel like I'm stuck in fight or flight. No matter what breathwork I do, it doesn't change it. Just moving around spikes it to over 90. I wake up and it's above 80 most days. My body battery is at a 20-30 every day. I've heard about people who experienced trauma as a children who didn't learn the skills necessary to self regulate can get in these stuck habitual states. Can anyone help me by recommend a device that can trigger my parasympathetic?"
          ],
          [
           "1_to_and_it_my",
           "Why do people feel so low and down all the time ?. I generally feel so low and down as if I'm just defeated by life. I see so many people my age going gym and college and working meanwhile I'm sitting at home constantly worried and stuck in my thoughts not able to take any actions. Than things like depression or anxiety something just feels like I have from watching YouTube videos. But I guess I don't have that maybe since I'm not taking actions and not able to accomplish my goals. Somehow feels like I'm defeated."
          ],
          [
           "1_to_and_it_my",
           "How do I deal with burnout?. Mental burnout. I can't get into studying for the exams anymore and can't study Japanese while maintaining my grades. I get burnout easily now. What steps should I take and what has helped you personally? I'm on a break from studying both but the exams are approaching and I can't be on a break \"forever\" while dealing with burnout. I've lost my passion for studying because my classmates cheat during exams. \n\nHaving the highest score was my motivation to study and because our exams are done online, they can always google the answers or message each other for the answers through facebook messenger."
          ],
          [
           "1_to_and_it_my",
           "Too tired for research and goals. As a biohacker, I try to research about health as much as possible, but sometimes, I just don't feel like it because I just have no motivation. Some of my motivation comes from fear of eating toxic stuff that inhibits Testosterone, but another part of it is from not feeling like its meaningful at all to do anything. For example, I'm researching environmental toxins in the kitchen, and I have just realized that some rice cookers have PFAS, but researching this stuff is not as fulfulling as other exciting things with friends for example. Like, I don't have research partners to talk to everyday, nor does my family want to take part in the issues behind plastics or cookware, etc. I have other goals to pursue, but I just have been feeling dead. Is there anything I can do?"
          ],
          [
           "1_to_and_it_my",
           "Any hacks for stress?. Ever since I developed hashimotos any kind of stress really messes me up. I stayed up late two nights in a row and this week I feel so zoned out and mentally slow. It‚Äôs taking forever for me to recover. This happens with stressful events and even during my menstrual cycle unfortunately. \n\nDoes anyone have anything that helps relieve stress or help recovery?\n\nI‚Äôm tired of being dumb."
          ],
          [
           "1_to_and_it_my",
           "Reduce ‚Äútenseness‚Äù. I‚Äôve always struggled with my body physically tensing up when I‚Äôm uncomfortable or overthinking. Usually with something new like a physical task such as skiing or even something calming like meditation. I think my brain is panicking about ‚Äúam I doing this right?‚Äù And it manifests in to body tension.\n\nIt takes me a little while to notice but I have to consciously release my hands or feet from clenching and try to relax. But then once I stop focusing on relaxing, it will come back and I have to repeat that. It feels like a physical form of anxiety. Weed definitely exacerbates it so I‚Äôm trying to refrain from that to see how it helps.\n\nBeen researching things like magnesium and ashwaganda to help alleviate it, but was wondering if you guys had anything to recommend on the matter."
          ],
          [
           "1_to_and_it_my",
           "Needed some advice. Hey everyone i have a silly question, i have asked it before as well. I am trying to improve my concentration, i want to concentrate for longer period of time. I am going to do a reasoning based exam thats why. After 50 minute into an exam i feel mentally fatigued . Are there any tips to increase this. I have heard of caffeine tablets. If any one can share their insight."
          ],
          [
           "1_to_and_it_my",
           "How to restore after acute stress?. I had a very stressful work day yesterday, and despite a good meal, a full night's sleep, I'm still drained and worn out. \n\nI'm hoping some of you good people have hacks for quickly and healthily restoring oneself. TIA!"
          ],
          [
           "1_to_and_it_my",
           "How to get rid of headaches and overthinking ?. How do you not let worries and stress not get to you. But I feel like whenever things aren‚Äôt workout you tend to get into such overthinking mode and stress plays a role. It‚Äôs very overwhelming"
          ],
          [
           "1_to_and_it_my",
           "How to be more willing to talk to girls. I‚Äôve been struggling with talking to girls, and I‚Äôm hoping for some advice. I was in a relationship for 8 years, but we broke up 2.5 years ago. Since then, I haven‚Äôt been interested in finding another girlfriend.\n\nI‚Äôve always been shy around girls, and I often feel like they don‚Äôt like me or that they‚Äôll reject me. I don‚Äôt talk to girls online, and the only women I interact with are at work, but I‚Äôm not interested in dating coworkers, and im not making any effort to talk to other girls.\n\nI‚Äôm also getting a lot of pressure from relatives about when I‚Äôm going to get married, which isn‚Äôt helping. üòÇ\n\nWhat can I do to overcome this fear? Are there any supplements or other strategies that might help? Any advice would be appreciated."
          ],
          [
           "1_to_and_it_my",
           "Is there anyway to build confidence?. I have a hard time being in my head too much. Overthinking, anxiety, constant brain firing on all speed. Sometimes so bad I can barely hold a conversation due to being in my head so much, especially around women I find attractive.\n\nI currently just take caffeine occasionally in the form of coffee and modafinil from modafinia. I don't feel like it does much other than maybe helping me focus a little more.\n\nI do meditation and relaxation methods to combat this. But at certain times in the moment I can't do so.\n\nSomeone recommended me a stack of either shoden ashwaganda or coffee/caffeine pills with l theanine, to try and calm down some of those thoughts.\n\nThoughts and recommendations would be greatly appreciated, thank you."
          ],
          [
           "1_to_and_it_my",
           "Realizing An obsession with wellness was making me unwell ... I was so meticulous with everything I put into my body, my workout routines, supplements, sunlight, etc. have now realized while I look great, I feel like shit( also due to over exercising , under eating, tanking my hormones and testosterone) but stressing and over thinking every little thing was doing more harm than good"
          ],
          [
           "1_to_and_it_my",
           "Stress is toxic to the body and has now been recognized as one of the main causes of the so-called degenerative diseases such as cancer and heart disease.. Did you know that, when you are stressed, you are cutting yourself off from the creative powers of the universe?\n\nUnlike stress, enthusiasm has a high energy frequency and so resonates with the creative power of the universe.   \nWhen we are inspired, positive or enthusiastic, our consciousness is mostly active in the higher regions of our physical body.\n\nThis powerful positive emotion comes from our thymus gland (which can be easily confused with coming from our heart since it is right next to it).\n\nIt's no coincidence that, in the east, the thymus gland has been documented as where your spiritual energy that is in charge of transforming your stress into eagerness emerges from. A little practice with it then mastery can easily help you learn to counteract negative stress in your body thanks to it.\n\nHow? Whenever you start to feel stress, by flooding yourself with the same euphoric energy that you might've experienced or heard of before. It is that energy that is most easily felt when you experience goosebumps/chills from positive situations/stimuli.\n\nAfter cultivating this pure euphoric energy by exposing myself constantly to whatever brought it up in a positive way, the feeling of it everywhere on my body/the levels off it have just been truly ecstatic and most importantly I can now induce it without any trigger, just by willing this energy to come. \n\nIt has been researched and documented under many names like Euphoria, Tension, Ecstasy Prana, Chi, Qi, Vayus, Aura, Tummo, Orgone, Kriyas, Mana, Od, Bio-electricity, Life force, Pitƒ´, Frisson, The Secret Fire, Voluntary Piloerection, Rapture, Ruah, Ether, Nephesch, Chills, ASMR, Nen, Spiritual Energy, The Force, Spiritual Chills and many more to be discovered hopefully with your help. \n\nLearning this is really simple. Here's a short [Youtube xvideo](https://youtu.be/zafYN8Jk-DE) going more in-depth about your spiritual energy.\n\nP.S. Everyone feels it at certain points in their life, some brush it off while others notice that there is something much deeper going on. Those are exactly the people you can find on r/spiritualchills where they share experiences, knowledge and tips on it."
          ],
          [
           "1_to_and_it_my",
           "What type of exercise helps you reduce your resting heart rate? And what other tips do you have? I usually get high Garmin stress and I want to lower it. Hi everyone, a few months ago I bought a Garmin watch to start continuing to improve my health, sports performance and, above all, sleep better.\n\nWhat I've noticed lately is that my stress usually goes from low to high when I'm working, studying, etc.\n\nHonestly I don't feel stressed or worried about anything, every day I meditate for approximately 10-15 minutes with the serenity app.\n\nWhat I have noticed is by doing a little research into the data that Garmin takes, which is HRV and resting heart rate, so watching the watch a little daily I noticed that my resting heart rate usually fluctuates from 75-105 all day, so this is why I think that gives me low to high stress.\n\nSo I'm considering lowering my heart rate, not only for reasons of lowering the score of an app but because I've read several posts where having a lower heart rate can help with longevity and sports performance, especially in recovery.\n\nI am a 27-year-old person, very active, lately I train a little 3-4 times a week crossfit or cardio because I want to improve my physical condition (it is not that I am obese or was sedentary, but that I always did strength sports or gym and never have a good cardiovascular resistance training).\n\nSo what type of training do you recommend I add to achieve this goal? I was thinking of running or going for a bike ride but I don't know what heart rate zone I have to stay in for this.\n\nAny other advice is welcome."
          ],
          [
           "1_to_and_it_my",
           "How can I become a relaxed person?. Always been the opposite.\n\nThoughts always running. Overthinking.\nMuscles tight. \n\nIt‚Äôs hell. \n\nI do sports daily. Doesn‚Äôt help.\n\n\nAny ideas?"
          ],
          [
           "1_to_and_it_my",
           "I am 29 years old and for the last 6 months, I've started changing habits and taking care of myself. Do you have any advice?."
          ],
          [
           "1_to_and_it_my",
           "It is proven that some diseases occur when negative emotions (energy in motion) are trapped in specific locations of the physical body.. When you can easily activate your energetic (spiritual) body you have the opportunity to simply lead these blockages of energy elsewhere and to simply come back to a state of balance.\n\nIt's all energetic.\n\nActions, reactions, thoughts and desires all cause specific areas in physical bodies to \"activate\" with energy.\n\n(undeniable example: grief)\n\n\"activation\" can be explained as energy (hot or cold) condensing/emitting in high amounts.\n\nStates of high vitality occur when every single one of your limbs (Not just your stomach, or your hands. All of your body.) is flowing with your energy.\n\nA blessing in disguise to help you direct and enhance your energy are Goosebumps.\n\nWhy? \n\nBecause Goosebumps also\\* activate from positive situations/stimuli (like memories, inspiration, music, love, gratitude, meditation) a blissful surge of flowing energy that can be observed as a hot or cold wave underneath your skin.\n\nThis is the same energy that activates areas on physical bodies.\n\nWhen activated through goosebumps you get to understand how to do so with a \"healing/blissful/feel good\" touch to it. \n\nThat is your spiritual energy.\n\nIt comes from your Spiritual (energetic) Body/ your Mind/Consciousness/Awareness. \n\nDifferent terms from all over the world for it are Euphoria, Tension, Ecstasy, Qi, Chi, Prana, Vayus, Aura, Tummo, Kriyas, Mana, Life force, Pitƒ´, Frisson, The Secret Fire, Voluntary Piloerection, Rapture, Ruah, Ether, Nephesch, Chills, ASMR, Nen, Spiritual Energy, The Force, Spiritual Chills and many more. \n\nHere's a short [Youtube Video](https://youtu.be/uKdiTTbWbIA) If you would like to know about what you can do by controlling this euphoric occurrence.\n\nA [Playlist](https://www.spiritualchills.com/) with other videos expanding more on the subject\n\nAnd a reddit community r/Spiritualchills where you can find experiences and tips on it."
          ],
          [
           "1_to_and_it_my",
           "Holiday stress + work holiday stress affecting health. I work a serving/bartending job and when I‚Äôm working I‚Äôm usually on my feet for 7 or so hours, usually more. I‚Äôm always walking/rushing around and just generally stressed cause I work in a 5 star environment and demands and pressures of my work environment are high. The past few days I‚Äôve been getting intense heart palpitations and chest pain and my anxiety has been through the roof as a result. I‚Äôm just wondering what it is I can do to mitigate the symptoms I‚Äôm getting that are clearly from added stress from the demanding holiday crowd that comes to the restaurant I work at. My personal life is also very stressful from things that are out of my control, which I can usually handle, but both at the same time are killing me. Any advice?"
          ],
          [
           "1_to_and_it_my",
           "how do you get through days where you feel mentally off?."
          ],
          [
           "1_to_and_it_my",
           "Suggestions for not feeling lazy/tired all the time?. I'm currently unemployed. Do nothing productive all day. I have no motivation/discipline/energy to do anything. I have plans, like building an online business but zero energy to do anything about it. \n\nHere's my one day;\n\nI wake up tired, doom scrolling on reddit/reels/shorts, consume hateful/political content/negative news on social media, playing video games, watching porn. I've been living like this for the past 4-5 months.\n\nMy biggest major problem in my life at the moment is not doing anything. I wanna improve my skills by learning new programs such as animation and other things. I wanna build an online business. I even have products and quite good ideas/plans for it. But I do nothing. I just can't take action. Even if I take a small step, it doesn't continue. I just quit. \n\nWhat should I do? Have any of you been in my situation before and changed your life?\n\nI need your recommendations. Thanks."
          ]
         ],
         "hovertemplate": "Topic Group=%{customdata[0]}<br>document=%{customdata[1]}<extra></extra>",
         "legendgroup": "1_to_and_it_my",
         "marker": {
          "color": "rgb(0, 134, 149)",
          "symbol": "circle",
          "opacity": 0.7,
          "size": 7,
          "line": {
           "color": "rgba(0,0,0,0.5)",
           "width": 0.8
          }
         },
         "mode": "markers",
         "name": "1_to_and_it_my",
         "showlegend": true,
         "x": {
          "dtype": "f4",
          "bdata": "4bIFQF6oA0ABpANAhA8HQIhCB0Cfcf8/CTwCQOHED0D2sAxALMwKQH1TDEDMBghAugIIQG+7B0CINARAbaARQAevCkC/eQdAXWgGQJ3tFUDKxhJAtIUdQMWF7T9JpQlAOm8PQLROBEB7GgNAnYPtPx9VDEBQnf4/1XUGQPOFB0Ab6A1AgtIPQGOYEEDRmAhAeXcDQEDVCEDPpwRATeICQHv5CkBtVBJAjgsFQAyNBUCAUwpAdEoLQKoe9T+W6gZAQhIHQEwVCkCJxwZAEc4IQMMSBkBZjQVAls/+Pw=="
         },
         "xaxis": "x",
         "y": {
          "dtype": "f4",
          "bdata": "iKxjQETgZEDdSGtAmEhqQLkyYUBnG25Aj1lpQGzKYECgBmRA/aphQE0qY0B+E2RAHgxmQM2EYkDRl2dAs/VhQEY5YUBwPmRA3TBjQFUiYUC7cWxAD5xgQIejZ0DRe2RAtmZlQD4xa0C/cWpASBBoQDcwZECsMGdA2slpQMO2Z0DBYGFAMBhkQLCoYEBzFGxA/EBnQDrKZkButGtANFBmQFwFZEDCHmtAfLVlQOcJaUD7oGNAQpxgQDKXZUAwUGVAXmtsQGlVY0AHbmpAUBZjQELQaEADD2ZA1zhoQA=="
         },
         "yaxis": "y",
         "type": "scattergl"
        },
        {
         "customdata": [
          [
           "peter",
           "Health &amp; Longevity: A Conversation with Peter Attia | The Making Sense Podcast."
          ],
          [
           "peter",
           "Podcast on GERD and or Sleep Apnea Recommendations. Ive been struggling alot with acid reflux and low quality sleep i was wondering if yall have any good podcasts that can give me some good insights on some solution i can try besides ppis??"
          ],
          [
           "peter",
           "Tough listening for #302. Fascinating topic about liver disease and health. But, I struggled to stay engaged. Took me three sessions to listen to the whole thing. Also, if you missed it, coffee is good for your liver! üòÖ"
          ],
          [
           "peter",
           "Has anyone found a great summary of the practical takeaways of James Nestor's Breath?. Finishing the Audible book but sure I missed a few things -- anyone know of any good summaries for action steps?"
          ],
          [
           "peter",
           "The Drive show notes. hi all,\n\nJust curious how other people who have access to Peter's podcast assimilate the info. I don't like listening to three-hour podcasts, no matter how interesting they are, so I tend to read the show notes.\n\nAnd by \"read\", I mean speed read / scan for things I can use / that are actionable. I don't try to follow all the biochemistry, for instance."
          ],
          [
           "peter",
           "Related media. Books, documentaries, movies, tv series, etc etc\n\nThanks"
          ],
          [
           "peter",
           "A legendary monologue from Peter.... \"COVID Is Nothing Compared to Suicide, Drug Overdoses, &amp; Car Accidents in People Ages 5-35\" (short audio clip)."
          ],
          [
           "peter",
           "The Lost Art and Science of Breath - James Nestor | Float Conference 2018."
          ],
          [
           "peter",
           "Ben Greenfield's Preferred Nootropics: Choline &amp; Qualia Mind (2.5-minute podcast clip)."
          ],
          [
           "peter",
           "Your Favorite Previous Can‚Äôt Miss Podcast Episodes. Hey Y‚Äôall\n\nI‚Äôm late to the game and only recently started listening to Peter‚Äôs podcast. \n\nWhat are you favorite past podcast episodes that are a ‚Äúcan‚Äôt miss‚Äù in your opinion?\n\nThanks!"
          ],
          [
           "peter",
           "Audio books while zone 2?. Could you guys share a list of audiobooks to listen to while you do zone 2. I listed to a lot of books over the last 12 months. I find to be very engaged while I run and lift weights to books/podcasts. \n\nIs there anything like outlive on the market?"
          ],
          [
           "peter",
           "LA and DNS questions. I just heard PA on Rich Roll's podcast.  First time I've encountered him and I'm intrigued.   Two questions: \n\n1.   Are there any \"layman\" stories about DNS in the group?  \n2. Does anyone know of a center like PA's in Los Angeles?  \n\nI've obviously done abunch of googling, but mostly just coming up with PA podcast links and advertisements."
          ],
          [
           "peter",
           "Protein Powder. I am looking for recommendations on protein powders. I remember Peter talking about a few brands he rotates through but can seem to find the episode or literature. Anyone have any recs or know what episode that was in?\n\nEdit: thanks to all for the knowledge and recs"
          ],
          [
           "peter",
           "Steven Kotler: PUSHING PEAK PERFORMANCE LIMITS, Park Skiing Experiment, Weed Vs. Booze, Marriage, &amp; Flow State."
          ],
          [
           "peter",
           "This 60 year old senior is unbelievable. And he is familiar about Peter Attia. [https://www.youtube.com/watch?v=JqsVMN9GY5E&amp;ab\\_channel=IAMLONGEVITY](https://www.youtube.com/watch?v=JqsVMN9GY5E&amp;ab_channel=IAMLONGEVITY)"
          ],
          [
           "peter",
           "I‚Äôm very confused as to why we have an episode with Derek from More Plates More Dates. Derek isn‚Äôt a medical expert, doesn‚Äôt have any formalized medical training and owns a TRT company, Marek Health. I‚Äôm very confused why Peter would have him on the Drive. The drive has predominantly had subject matter experts with years of formal, academic, and clinical expertise to talk on specific topics. He‚Äôs had some more questionable figures who I am a fan of like Christ masterjohn, Dom D, and Thomas Seyfried. But they hall have PHDs. Derek doesn‚Äôt and runs a TRT company that specializes in ‚Äúathletes‚Äù. I just don‚Äôt understand beyond publicity why he did it. Like I‚Äôm fine with him having a conversation with Derek and look forward to listening to it but it really should be a separate show. Nevermind Derek has been incorrect many times in the past with regards to PEDs."
          ],
          [
           "peter",
           "Peter's Senna Obsession. The Dax Shepard interview made me re-evaluate Attia's Senna obsession (and gave me a very icky feeling in general). While I initially thought it was harmless admiration (although his son's name choice a bit unusual), the interview revealed a deeper level of fixation. He talked about building relationships with Senna's loved ones, team mates, and visiting his grave. Maybe it's a sports fan thing, but for me, this level of intensity towards a celebrity would raise a red flag. Meeting Senna's family seems excessive/inappropriate and I'd be worried about someone close to me acting similarly."
          ],
          [
           "peter",
           "Why Dr. Peter Attia Changed his Mind on Fasting (and 4 other Longevity topics)."
          ],
          [
           "peter",
           "What I think is wrong with the Early programme. So I have waited on something like the Early programme for a couple of years. I am able to pay the price, and was willing to invest significantly in such a programme from Peter, but at the moment the value proposition is just absurd for anyone who has digested much of Peters material.\n\nI think very few suscribers and other enthusiasts will get a significant benefit in a restructuring of the contents and overall frameworks of Peters way of thinking.  We can already distill most of the frameworks and knowledge from the podcast, shownotes, earlier videos and the book.  \n\nWhat I was hoping for (and would be willing to pay the asking price for) was a way to harness Peters (and his teams) analytical ability, not just their knowledge. Specifically, a set of tools that would allow me to apply the thinking of Peters team to my own case. Frameworks are just the first step in doing this, but a framework needs to be applied to (my own) data, that should be processed with rigor through the framework and give individualized and actionable output. \n\n25 hours of video can't do that.  Documents can't do that. They can perhaps teach me to think more like Peter, but application of this knowledge to your own case is still a different beast.\n\nI don't think it is realistic nor scalable for this programme to involve individual feedback from Peter or his team, but I would expect tools that can give algorithmic advice on treatments based on my data, and that give recommendations to adjust my focus based on changes to data. This should be across the whole programme; from setting goals, to assessing risk and current status, to designing treatment programmes that are specific to me. \n\nThe thing is, I don't know how much of this type of analytical help the programme gives you. The only tools mentioned (e.g. Risk assesment) are not given any details. I think this is a shame.\n\nOther main concerns:\n\nOne time fee and no mention of updates. As the name comes from \"Early adoption of knowledge\", will buyers be able to get new information when it becomes part of Peters way of thinking? A subscription based model might have given more clear incentives for updates.\n\nThe programme does not seem to contain any coaching aspect that can help you day-to-day to apply the principles. Many apps do something like this - would be helpful.\n\nLots of costs not included that is necessary to get full benefit. Lab tests, exogenous molecules, trackers..."
          ],
          [
           "peter",
           "The 80/20 of Peter Attias Advice. Hi guys,\n        Just came across this sub Reddit and was interested to hear what the general advice Peter has come to.\nI've heard him talk but I know in general it's sleep well, eat well and exercise. What diet does he advocate? What exercise routine? And what else?\n\nJust interested tbh, didn't realise he was this popular."
          ],
          [
           "peter",
           "Does anyone else find themselves disappointed in the U.S. health system after listening to Peter's podcasts?. It seems like so many of the guests on his podcasts find themselves frustrated by the bureaucracy, conflicts of interest, and general bad science inherent in the U.S. healthcare system.  \n\nFor example, this morning I listened to #121, Azra Raza, M.D., \"Why we're losing the war on cancer,\" and I was given the clear impression that the cancer drug development pipeline was focused on profit over patient benefit, with pharma funded doctors also writing the policy that gets drug manufacturers paid by Medicare, leading to drugs that make money but are of questionable benefit.\n\nAnother common theme that comes across in the numerous rapamycin podcasts is that the drug likely has significant untapped potential, but it's off patent so it is difficult to get funding for research because there is no money to be made off it by big pharma. \n\nI'm sure you all can think of a dozen of other instances where health care is perverted by bad information, unhelpful monetary incentives, etc.  In my own personal experience, I find that I pay large sums of money for mediocre coverage that provides doctors that are unhelpful at best.  For example, I've spent the last year and a half getting my health in order, as I had all 5 indications of metabolic syndrome.  Over the past several years I had been put on statins, and an escalating series of blood pressure meds, but never once even told that I had metabolic syndrome, the troubling implications of that on my mortality risk, let alone give any suggestions as to how I might address it.  I was more or less walking around with one foot in the grave and another on a banana peel and the medical professionals I had trusted with the care of my health either were clueless or just didn't care.  I had to figure it out on my own.\n\nIn any event, I'm not sure where the situation might be better, but I now know that if I am keep myself healthy, I have to manage it on my own, as the U.S. healthcare system doesn't have my back.  Peter's podcasts have been real eye-openers, and I'm glad I've found them."
          ],
          [
           "peter",
           "Podcast stack. I‚Äôm trying to optimize the audio I consume. I work in a pretty relaxed office and do daily commutes/exercise/yardwork so I have a lot of quiet time and have recently noticed that I can spend 3+ hours a day listening to podcasts. But I find myself listening to sports talk shows and comedian interviews and rich people talking to rich people. Usually pretty entertaining stuff but not a ton of substance. I‚Äôm not trying to remove fun from my life! But it would nice to get a bit wiser instead of just knowing the Knicks have injury problems.\n\nIt's not like I need to be mowing the lawn while also maximizing brain elasticity, but there must be stuff out there like daily meditations/affirmations/motivations, bi partisan news (IDK shit about politics or world events), investment advice, something like NPR. I obviously know Rogan and Huberman, but that‚Äôs not really what I‚Äôm looking for.\n\nThe question I have for biohackers and not the general population is: what audio/podcast do you listen to regularly that you feel genuinely enhances your life?"
          ],
          [
           "peter",
           "Outlive missing a summary. I read the book last week and for me the biggest issue with the book is the lack of clear summary. The book is interesting but not actionable without a condensed step by step summary for each section.\n\nWhat about building a crowd sourced wiki on the topic? Would this sub be a good place to create this wiki?"
          ],
          [
           "peter",
           "wonder which sglt 2?. I heard Peter talking about taking in SGLT2 inhibitors while talking to Huberman. Does anybody have any experience with any of these or know which one Peter likes the best?"
          ],
          [
           "peter",
           "What's your thoughts of Dave Asprey?. I saw him on London Real, and am currently going through his book Super Human. It is remarkable so far. What do you think of him? Is living to 180 ambitious but possible?"
          ],
          [
           "peter",
           "What are your thoughts on Russell Brand?. It seems like there was a coordinated media attack on him after Dr. Peter Attia was on his show.\n\nRussell Brand has also been making a lot of videos recently criticising Mr. Bill Gates as well as big pharma and the clusterfu\\*k that happened regarding the coronavirus lockdowns.\n\nOut of curiosity, do you think he's guilty as charged of SA as the media says?\n\nI'm wondering why these so-called victims never came out during the METOO movement a few years ago when every predator male in the media was taken down? Why did they stay silent then when it as the best time for them to come out with their accusations against him then?\n\n**Why now?** Is it coincidence that Russell Brand became targeted after he continually made a series of attacks against Mr. Bill Gates and Pfizer?\n\nCurious what you think."
          ],
          [
           "peter",
           "Really good podcast on various thresholds (focus on running performance). This is a podcast which clearly explains the key threshold zones and why they are important for training. I was listening as I did my long morning run today and felt inspired.  \n\nBTW. I find the guest Phil's explanations much easier to understand than those from Inigo San Millan :-) Maybe that's just me.\n\nPeter Attia even gets a positive mention.\n\nhttps://pca.st/episode/98c92325-c61a-49c3-bb15-173e8175a216"
          ],
          [
           "peter",
           "Peter Attia Saus He's Bullish on Trazodone as a Sleep Aid; It Preserves Sleep Architecture (short audio clip from Peter)."
          ],
          [
           "peter",
           "Demure vs Brat: Aussie health innovation edition üíÅ‚Äç‚ôÄÔ∏èüíÖüíö what did I miss?."
          ],
          [
           "peter",
           "Dave aspray got checked  on his own post. As commenters said:\n\nDave, you don't even look 50, you look older and you sound sick!\n\nAttia is way healthier than Dave in my opinion! \n\nI know I have been a Dave hater for a while but he earned it! Can't stand someone who promotes to inject your urine into your body! Sick!"
          ],
          [
           "peter",
           "Investigative journalism podcasts. Does anyone have recommendations for podcasts that go into investigative journalism stories in the specific way that Peter does with Guests like Lawrence Wright, Patrick Radden Keefe, and Katherine Eban? I listen to a lot of daily news podcasts but I‚Äôd love to hear more people tackling relevant stories like these ones with the eloquence and capacity to dive into these issues in the way that Peter and his guests do. They don‚Äôt have to be medicine-related, but I‚Äôm not looking for anything like a conventional ‚Äútrue crime‚Äù podcast, I‚Äôm looking for something a little more worldly and with the same standard of presentation and discussion that you can find on the Drive. Thanks in advance and be well!"
          ],
          [
           "peter",
           "Peter Attia is really a psychopath. Everyone is correct.. Page 89 of OUTLIVE:\n\n\"Normally, a healthy liver is a deep, dark purple color, with a a gorgeous silky-smooth texture. Hannibal Lectur was not far off: it really does look as if it might be delicious with some fava beans and a nice Chianti.\"\n\nDoes he hold elaborate, protein-heavy dinner parties by chance? He promotes a protein heavy diet, but where he is getting all this protein?"
          ],
          [
           "peter",
           "Has Peter ever discussed controversial research on risk associated with vasectomies?. The following is a quote from an NIH study [https://pubmed.ncbi.nlm.nih.gov/12346121/](https://pubmed.ncbi.nlm.nih.gov/12346121/)\n\n\"Despite vasectomy's simplicity and effectiveness, debate exists over whether vasectomy may increase the risk of prostate cancer, the most common malignancy in men. Two large, well-designed Harvard studies were published in 1993 in the Journal of the American Medical Association which suggest that such a relationship may exist.\"\n\nGiven how much he loathes misleading or poorly constructed research, I wondered if Peter had ever sent out a weekly mailer deconstructing this topic. If so does someone have access? Or if he ever talked about it on the Drive? I googled 'peter attia vasectomy prostate cancer' but it didn't come up with much. Thanks in advance for any help. \n\nIt seems like the preliminary studies indicating higher risk of cancer were not properly designed, and all subsequent research has found no significant link. But it would be interesting to herar Dr. Attia's analysis on the shortcomings of the research design"
          ],
          [
           "peter",
           "Peter's Podcast with Stuart McGill: My Takeaways + What are your thoughts on McGill's condemnation of Squats/Deadlifts, Peter's vacillation on those lifts, and McGill's claim that deadlifts cause hip degeneration ?. Full podcast here: [https://www.youtube.com/watch?v=Z1\\_sb1auiV8&amp;t=0s](https://www.youtube.com/watch?v=Z1_sb1auiV8&amp;t=0s)\n\nI was overall extremely disappointed by this interview. McGill never really answers Peter's questions. He has a tendency to respond by telling personal stories and emotional anecdotes. Or he just avoids the question altogether. E.g. at the end when Peter asks, what can a young person do to keep a healthy spine? McGill's response is basically that there's nothing you can say to them because young people don't listen to anyone, until they do something that messes up their spine, and then out of that experience they're willing to listen. Which may be true, but it does not address the question and McGill fails to outline an actual program for back longevity. It almost felt as if he was going out of his way to not offer actionable advice in this interview. There were only a few insights that I found useful:\n\n* Most disc hernations and pain from disc-associated injuries will improve over time on their own. It may take a few years, and may entail bouts of recurrence. Nevertheless, the pain typically improves and eventually resolves completely as (1) the herniated matter is resorbed by macrophages from the immune response (for which reason anti-inflammatories may impede healing in the early-stages post-injury, because it suppresses this immune clean-up activity) and (2) in the long-term, the spine \"gristles\" i.e. rigidifies and thickens, thereby becoming stable and hence should no longer affect nerves. This comes at the cost of mobility but is nevertheless a welcome spinal adaptation in sufferers of sciatica. Stuart suggests that back pain pathology in general tends to improve as we age and especially for older individuals into their 60s and onward, the dynamic of \"gristling\" provides a protective effect on the spine. This corresponds to the following comment I once encountered in r/Radiology: \" the demographic for true disc herniation is young people. It takes a healthy disc to herniate. By age 35 the disc is really drying out, therefore the ‚Äúfluid‚Äù inside is much less likely to herniate because it‚Äôs dried up\" ([https://www.reddit.com/r/Radiology/comments/10avwi1/comment/j4902gj/?utm\\_source=share&amp;utm\\_medium=web2x&amp;context=3](https://www.reddit.com/r/Radiology/comments/10avwi1/comment/j4902gj/?utm_source=share&amp;utm_medium=web2x&amp;context=3)) \n* don't mix activities that require stability and rigidity (squats/deadlifts) with activities that require mobility/flexibility (yoga/gymnastics), because the spine adapts to the type of movement it is exposed to. So you don't want to force a spine adapted for squats/deadlifts to also be flexible, as that puts stress on the spine and can ultimately lead to fractures/herniations. A thick sturdy branch will snap in half if you bend it, while a thin flexible branch will easily bend. You can't have both.\n* Surrounding musculature is a huge factor in alleviating back pain and increasing stability. Peter contrasts his terrible lumbar spine MRI with that of another patient showing a pristine spine. Peter hardly has back pain, while the patient with a pristine MRI is in debilitating pain. His spinal surgeon colleague suggested to him that the reason is because Peter has a robust musculature in his lower back (like the erector spinae) while the patient's muscles are undeveloped. Having supporting muscle makes a huge difference in both injury prevention and in stabilizing the spine, thereby suppressing provocations even from existing/prior injuries. This applies not just to the spine but indeed to all joint structures. McGill corroborates this suggestion from his own clinical experience with bodybuilders. Retired bodybuilders who allow themselves to lose most of their muscle mass tend to experience increases in joint pain. Stuart thinks having ample amounts of muscle stabilizes the joint in a way that suppresses arthritic provocations.\n* Clearly, then, weightlifting is important, and Peter declares as much towards the end of this sub-topic. \n* **But then the question is, what kind of and how much weightlifting should a person do?** This question arose implicitly maybe 2-3 times in the course of the 3-hour podcast but they never directly tackled it. \n* Peter, who has been a huge proponent of heavy lower-body compound lifts for bone density and strength, here says that he now vacillates on whether or not deadlifts are worth it. Sometimes he'll go some months without doing them at all, other months he goes back to doing them multiple times a week. Part of him believes that deadlifts/squats can be replaced by other lifts (like split squats, step-ups, lunges, hip thrusts) that in combination produce comparable benefits. But part of him still thinks that lower-body compounds are extremely important for the kind of musculo-skeletal longevity he is pursuing (bone density + strength + muscle), because of the power element and because you can progressively overload them to an extent that you can't with e.g. step-ups. He hopes that McGill can help him find a program that strikes a balance between minimizing risks and reaping the benefits of heavy lower-body compound lifts. This is around 1:25. McGill: Nope. McGill for his part doesn't think squatting/deadlifting is good if you want to keep a healthy spine. He draws a false dichotomy between deadlifting 1 rep maxes and playing with your grandchildren when you're old, as if those are the only two options. Peter has always said that you should be deadlifting in the 5-10 rep ranges, and that you needn't nor shouldn't pursue maxes in longevity strength training. McGill only discusses deadlifts in the context of 1 rep maxes, neglecting any discussion of higher rep-ranges and non-powerlifting style approaches to these compound lifts.\n* Towards the end of the podcast Peter, implicitly referring back to McGill's reservations, says that he doesn't want his listeners to conclude that they should avoid weightlifting (in light of their discussion about muscle creating joint stability). McGill wholeheartedly agrees, but, when Peter prompts him about how we can weightlift in a way that minimizes risk to the spine, McGill mentions that he has patients walk backwards up a hill for 30 reps, which is so hard that many can't complete it and which leaves many out of breath, as if that makes it equivalent to strength training. This is plainly unsatisfactory for the kind of musculo-skeletal longevity Peter is pursuing. Without some serious progressive overload you risk losing bone density + strength + muscle as you age. \n* Having followed Peter for some time, this is my gut feeling. I think Peter was surprised by McGill's staunch stance against deadlifts/squats, especially in light of the self-limiting aspect of most disc-related injuries which McGill elaborated upon (refer back to my first bullet). My personal opinion is that Peter thinks the benefits outweigh the risks when these lifts are performed with good form ‚Äì because you're simply not going to get comparable stimulus with unilateral movements.\n* This also happens to be my opinion as well. However, I am of the opinion that the Trap Bar Deadlift is the safest and only reasonable lower body compound lift for most people to do. The Trap Bar is safer than the barbell squat because it has an inherently more limited range of motion (many people squat too low with buttwink, and McGill has discussed elsewhere that buttwink is in no way benign and can lead to disc herniations). Some people simply can't squat to parallel without buttwink, and therefore the Squat isn't for them. The Trapbar deadlift's more restricted ROM (even with the low handles) prevents lumbar flexion at the bottom of the movement. Moreover, the Trapbar is safer than the conventional deadlift because the weight is centered, hence less stress on the lower back. I have seen Peter both barbell squat and deadlift conventional, and he may have a more liberal view, but this is my opinion on what's best for average joes. The Trapbar also feels better than the other two alternatives for training power (hence better for bone density). \n\nI'm curious to hear your thoughts on McGill's views on squats/deadlifts. In this regard, there is one other point of contention that I must raise. Halfway through the podcast (1:34) McGill also suggested that **heavy** **deadlifting degenerates the hips, leading to hip replacements.** **\"Let's go get any one of our colleagues who are orthopedic surgeons, tell us who you're replacing the hips of?...men around 50 who've done deadlifts their whole life.\"** I find this assertion problematic. McGill offers no data in support of this claim, nor does he at least support his claim's plausability by discussing the pathophysiology of hip degeneration. \n\nFrom what I've read (and also learned from my hip specialist), the two typical demographics for hip replacements are lifelong obese individuals and lifelong runners (or similar impact-based sports), because in both cases the hip joint is exposed to chronic impact. Now, the question is, does heavy squatting/deadlifting fit into this pathophysiology of hip degeneration? In my opinion, it does not, for the following reasons. \n\nLet's take two cases: a normal bodyweight individual who deadlifts 2-3x their bodyweight once a week, vs an obese individual. Even if, in the former case, the hip joint during the deadlift is subjected to a load comparable to the load it experiences in an obese individual, the load in the former case is transient, not chronic; it lasts a few moments each rep for however many sets. \n\nMoreover, in the case of the obese individual, their daily movement produces a force multiplier on the load to which the lower-body joints are subjected: e.g. the knee joint is subjected to a load of 2-3x bodyweight when walking (don't know what the force multiplier would be for the hip). By contrast, deadlifting/squatting, since it involves no movement of the feet off the ground, ostensibly produces no such force multiplier derived from the impact of the foot landing back on the ground. For these reasons, I don't see how deadlifts/squats fit into the typical pathophysiology of hip degeneration/hip replacement. I find it egregious that McGill would make this claim without evidence or discussion, because it can unjustifiably make people afraid to perform these lifts. I wish Peter Attia had questioned him further on this point (and on deadlifts/squats more generally). \n\n I am curious to hear your thoughts on all this."
          ],
          [
           "peter",
           "Summary of The Drive podcast episode #40 - The world‚Äôs most important doctor to millions in the war-torn villages of Sudan. In case you didn't listen to the episode, the following is an excerpt of a summary.\n\nYou can find the full summary [here](https://www.digestbot.ai/podcast_episodes/the-world-s-most-important-doctor-to-millions-in-the-war-torn-villages-of-sudan-40-rebroadcast).\n\n&amp;#x200B;\n\n[**Medical Work in Kenya and Sudan** ](https://www.digestbot.ai/podcast_episodes/the-world-s-most-important-doctor-to-millions-in-the-war-torn-villages-of-sudan-40-rebroadcast?timestamp=553)\\- The speaker talks about their experience working in Kenya and Sudan, particularly the challenges they faced in treating diseases such as malaria, TB, and leishmaniasis. They mention the volume of patients and the variety of diseases they encountered in Kenya. The speaker then discusses their decision to transition from Kenya to Sudan due to the civil war and lack of healthcare options in Sudan. They describe the remote and rugged nature of the Nuba Mountains in Sudan. The speaker also mentions the growth of Tom's hospital in Sudan, which now has its own clinical training school and a team of trained health workers.\n\n[**Religious Diversity in Sudan** ](https://www.digestbot.ai/podcast_episodes/the-world-s-most-important-doctor-to-millions-in-the-war-torn-villages-of-sudan-40-rebroadcast?timestamp=821)\\- The religious makeup of Sudan is primarily Muslim in the north and primarily Christian in the south, with the Nuba region being a mix of both religions. The Nuba people have a unique dynamic where families can have both Muslim and Christian members without conflict. However, in the past, the religious divide has been a significant issue, leading to a civil war and a genocide against the Nuba people. The ideology behind the Jihad against the Nuba was influenced by a member of the Muslim Brotherhood, Hassan Al tabi, who considered Christians and Muslims associating together as a scandal. This religious diversity and conflict have shaped the history of Sudan.\n\n[**Civil War in Sudan** ](https://www.digestbot.ai/podcast_episodes/the-world-s-most-important-doctor-to-millions-in-the-war-torn-villages-of-sudan-40-rebroadcast?timestamp=1095)\\- The transcript provides historical context on the civil war in Sudan, specifically focusing on the Nuba Mountains region. It mentions that Sudan has experienced civil war for most of its history, with the peace agreement signed in 2005. The referendum for self-determination took place in 2011, resulting in South Sudan seceding from the north. However, the Nuba Mountains were not included in South Sudan and had a separate process called \"popular consultation.\" The Nuba Mountains region is described as religiously diverse, with a mix of Christians, Muslims, and animists. The transcript also mentions the previous genocide against the Nuba people in the 1990s and the breakout of war in the Nuba Mountains in 2011.\n\n[**Evacuation from Nuba Mountains during War** ](https://www.digestbot.ai/podcast_episodes/the-world-s-most-important-doctor-to-millions-in-the-war-torn-villages-of-sudan-40-rebroadcast?timestamp=1364)\\- During the war in Nuba Mountains, there was a need for evacuation due to the dangerous situation. The evacuation process was challenging, as secrecy was crucial to avoid being bombed by the enemy. Despite the risks, the speaker and their medical team decided to stay behind to provide essential healthcare services. The evacuation took place on June 16th, with the expats leaving early in the morning. The speaker emphasizes that the decision to stay was not difficult, as they were committed to their mission and had faith in God.\n\n[**Providing Medical Care in a War Zone** ](https://www.digestbot.ai/podcast_episodes/the-world-s-most-important-doctor-to-millions-in-the-war-torn-villages-of-sudan-40-rebroadcast?timestamp=1622)\\- The speaker describes their experience providing medical care in a war zone, where they encountered severe trauma and injuries resulting from bombings. They discuss the challenges of treating patients with amputations and the difficulties they faced in providing anesthesia. The speaker also mentions the emotional toll of constantly being responsible for patients and the lack of psychological rest. Despite the hardships, the speaker draws on their faith and finds strength in the resilience of the people they care for.\n\n[**Surgical Training in Kenya** ](https://www.digestbot.ai/podcast_episodes/the-world-s-most-important-doctor-to-millions-in-the-war-torn-villages-of-sudan-40-rebroadcast?timestamp=2147)\\- The speaker discusses their experience learning surgery in Kenya, where they trained with local and American doctors. They gained hands-on experience and performed various surgical procedures. After seven and a half years of training, they felt confident in their surgical skills.\n\n[**Surgical Challenges in Africa** ](https://www.digestbot.ai/podcast_episodes/the-world-s-most-important-doctor-to-millions-in-the-war-torn-villages-of-sudan-40-rebroadcast?timestamp=2407)\\- Performing surgery in Africa presents unique challenges due to the lack of advanced technology and diagnostic tools. The speaker mentions that there are no laparoscopic procedures or high-tech equipment like the Da Vinci system. As a result, surgeons often have to rely on laparotomies and their own judgment to diagnose and treat patients. Despite these limitations, the speaker emphasizes the importance of prioritizing patient safety and not taking on cases they are not comfortable with. They also discuss the challenges of providing palliative care in a resource-limited setting, but note that patients and their families are generally accepting of negative outcomes and focus on providing comfort and support.\n\n[**Traditional Medicine in Africa** ](https://www.digestbot.ai/podcast_episodes/the-world-s-most-important-doctor-to-millions-in-the-war-torn-villages-of-sudan-40-rebroadcast?timestamp=2657)\\- In Africa, traditional medicine practices such as burning and cutting for fevers, herbal remedies, and consultations with a shaman-like figure called a kour are still being practiced. These practices have decreased in prevalence over time, but they are still a part of the local culture.\n\n[**Cultural Differences and Travel Experiences** ](https://www.digestbot.ai/podcast_episodes/the-world-s-most-important-doctor-to-millions-in-the-war-torn-villages-of-sudan-40-rebroadcast?timestamp=2921)\\- The speaker discusses his wife's limited worldview and lack of exposure to the outside world before meeting him. He shares stories of their travels to Armenia and the United States, highlighting her amazement at modern amenities such as elevators, escalators, and flush toilets.\n\n[**Contrasting Perspectives on Community and Joy** ](https://www.digestbot.ai/podcast_episodes/the-world-s-most-important-doctor-to-millions-in-the-war-torn-villages-of-sudan-40-rebroadcast?timestamp=3182)\\- The speaker discusses the contrasting perspectives on community and joy between their family's experience with a joyful child and their experience with refugees at a Sudanese Community Center. They highlight the infectious joy of the child and the sense of community and generosity they witnessed at the center. The speaker reflects on the positive aspects of Sudan that are often overshadowed by negative stereotypes.\n\n[**Nick Kristoff's Article on Tom's Work in Sudan** ](https://www.digestbot.ai/podcast_episodes/the-world-s-most-important-doctor-to-millions-in-the-war-torn-villages-of-sudan-40-rebroadcast?timestamp=3469)\\- Nick Kristoff found Tom and his work in Sudan because he had an interest in Sudan for a number of years. He saw what the Sudanese government was doing as an affront to humanity and felt obligated to go and see firsthand what was happening. Kristoff made a couple of trips into the mountains, sneaking into the country without official permission, and got a permit from the Rebel government to come in. He wanted to shed light on the situation and bring attention to Tom's work. The article had a significant impact in raising awareness about Tom's work and the challenges he faces in Sudan.\n\n[**The Aurora Prize and its Impact** ](https://www.digestbot.ai/podcast_episodes/the-world-s-most-important-doctor-to-millions-in-the-war-torn-villages-of-sudan-40-rebroadcast?timestamp=3740)\\- The Aurora Prize is a prestigious award given annually to individuals who have made significant contributions to humanitarian work. The recipient of the 2017 prize emphasizes the importance of the prize in raising awareness and connecting small organizations with resources. The prize aims to highlight unsung heroes and their work, shining a spotlight on their efforts and raising awareness about the issues they are involved in. The recipient also discusses the value of donations and financial resources in supporting their work. Additionally, they emphasize the importance of advocacy and understanding the political situations that affect these communities.\n\n[**Challenges of Running a Hospital in South Sudan** ](https://www.digestbot.ai/podcast_episodes/the-world-s-most-important-doctor-to-millions-in-the-war-torn-villages-of-sudan-40-rebroadcast?timestamp=4022)\\- Running a hospital in South Sudan presents numerous challenges, including the lack of infrastructure, logistics difficulties, and inflated costs of supplies. Obtaining necessary medications and medical equipment is a long and complex process, often requiring bribes and extensive paperwork. Transportation during the rainy season is particularly challenging, with only quad bikes being able to navigate the terrain. Despite these obstacles, the hospital strives to make their supplies last for a year and relies on the Catholic Medical Mission Board for support. Overall, the speaker emphasizes the importance of not only providing funding but also addressing the logistical challenges of running a hospital in South Sudan.\n\n[**Challenges of Healthcare Logistics in Nairobi** ](https://www.digestbot.ai/podcast_episodes/the-world-s-most-important-doctor-to-millions-in-the-war-torn-villages-of-sudan-40-rebroadcast?timestamp=4286)\\- The speaker explains that the lack of infrastructure in Nairobi makes it challenging to obtain necessary supplies for healthcare. They mention the need to buy supplies in Nairobi, which is two countries away from South Sudan, where they are located. The process of getting supplies involves navigating through checkpoints and dealing with paperwork and bribes. The speaker emphasizes that logistics is their biggest problem in providing healthcare in Nairobi.\n\n[**Living in a War Zone** ](https://www.digestbot.ai/podcast_episodes/the-world-s-most-important-doctor-to-millions-in-the-war-torn-villages-of-sudan-40-rebroadcast?timestamp=4805)\\- The speaker shares their personal experience of living in a war zone, describing the intense fear and terror they felt during bombings. They express feeling like a hunted animal and the constant uncertainty of where the bombs would fall. The speaker also mentions the impact of bombings on hospitals and the need to dig foxholes for protection. They highlight the lasting psychological effects of living in a war zone, comparing it to the experiences of people in Syria. Overall, the speaker emphasizes the terrifying and traumatic nature of living in a war zone.\n\n[**Challenges of Providing Medical Care in Remote Locations** ](https://www.digestbot.ai/podcast_episodes/the-world-s-most-important-doctor-to-millions-in-the-war-torn-villages-of-sudan-40-rebroadcast?timestamp=5346)\\- Summary: The speaker highlights the challenges of providing medical care in remote locations, specifically mentioning the lack of diagnostic tools and equipment. They discuss the need for robust machines and supplies for blood tests, as well as the difficulties of sending patients with leukemia to Kenya for treatment.\n\n[**Challenges of Access to Affordable Medication in Healthcare** ](https://www.digestbot.ai/podcast_episodes/the-world-s-most-important-doctor-to-millions-in-the-war-torn-villages-of-sudan-40-rebroadcast?timestamp=5604)\\- The transcript discusses the challenges of accessing affordable medication in the United States healthcare system, specifically focusing on the high cost of the drug Gleevac. It highlights the limited price reduction when drugs go from branded to generic, making it difficult for patients to afford necessary medications. The speaker also mentions the logistical challenges of providing medication to patients in remote areas, particularly in conflict zones like Sudan. The lack of infrastructure and the need to import supplies from neighboring countries adds to the difficulty of accessing medication. Additionally, the transcript mentions the high prevalence of Hepatitis B in the population and the need for vaccination programs to prevent complications.\n\n[**Challenges in Accessing Funding for Healthcare Initiatives** ](https://www.digestbot.ai/podcast_episodes/the-world-s-most-important-doctor-to-millions-in-the-war-torn-villages-of-sudan-40-rebroadcast?timestamp=5879)\\- The speaker emphasizes the importance of financial resources in their work and encourages donations to trusted organizations. They also suggest that people become aware of the situations and lives of those in need and advocate for them through government policies. The speaker acknowledges the challenges in accessing funds and resources due to administrative requirements and logistics. They mention the prevalence of liver cancers and Hepatitis B in middle-aged people and discuss the efforts to prevent transmission from mother to child. The speaker also mentions the difficulties in getting supplies and drugs due to the lack of infrastructure and the need to navigate through multiple countries.\n\n[**Challenges in Cervical Cancer Eradication in Africa** ](https://www.digestbot.ai/podcast_episodes/the-world-s-most-important-doctor-to-millions-in-the-war-torn-villages-of-sudan-40-rebroadcast?timestamp=6449)\\- The transcript discusses the challenges of eradicating cervical cancer in Africa, including the feasibility of having the necessary equipment and vaccines available, logistics problems, and the need for preventive medicine techniques such as screening and treating pre-cancerous lesions. The topic highlights the need for resources and personnel to address this issue effectively.\n\n&amp;#x200B;\n\n\\*This summary is generated by AI technologies and may contain errors. This summary is for general informational purposes only and does not constitute the practice of medicine, nursing, or other professional healthcare services, including the giving of medical advice."
          ],
          [
           "peter",
           "Why Dr. Peter Attia Is More Bullish on Using the Sauna Than Ever Before (short audio clip)."
          ],
          [
           "peter",
           "The main articles and literature in Outlive. Do you guys have a list of the 5-6 most inportant citations that back up the book Outlive? Is there reference page in Outlive?"
          ],
          [
           "peter",
           "PA and Gary Taubes. In a February 2024 podcast with Gabrielle Lyon, the guest, author Gary Taubes (also a former guest on the Drive), referred to Peter as his ‚Äúformer buddy‚Äù in the context that they had created a non-profit or something together. Anyone have any context here?"
          ],
          [
           "peter",
           "#95 ‚Äì Luke Bennett, M.D.: The emotional, cognitive, and physical demands that make Formula 1 a unique and special sport. [https://peterattiamd.com/lukebennett/](https://peterattiamd.com/lukebennett/)\n\n\"In this episode, Luke Bennett, Medical and Sports Performance Director for Hintsa Performance, explains the ins and outs of Formula 1 with a focus on the behind-the-scenes human element, and what makes it so emotionally, cognitively, and physically demanding for the drivers as well as the many team members. Luke first talks about his fascinating background with the Royal Flying Doctor Service in Australia which lead to his current position with Hintsa working closely with F1 drivers to improve their health and performance despite jet-lag and sleep constraints due to an unrivaled travel schedule. Luke also sheds light on the under-appreciated level of sheer physical strength and endurance it takes to drive an F1 car combined with the extreme cognitive aptitude, spatial awareness, and ability to navigate a socially complex environment that is needed to be successful as a driver. Additionally, Luke gives an overview of how the F1 season and races work, the incredible advances in car technology and safety measures, and what Luke and Hintsa hope to bring in the near future to the unique and special sport that is Formula 1.\"\n\n*vroom* *vroom*, drop thoughts below."
          ],
          [
           "peter",
           "#96 - David Epstein: How a range of experience leads to better performance in a highly specialized world."
          ],
          [
           "peter",
           "peter attia on Instagram: ‚ÄúWhere I hope to add value and how that has evolved over the past month.‚Äù."
          ],
          [
           "peter",
           "True sign of Peter Atta obsession. Chris Hemsworth is filming something in my neighborhood; I just saw him in a coffee shop. Literally the first thing that popped into my head when I saw him was \"I wonder what he's doing for his APoE4\"?  Only secondarily I did observe that he is a fine-looking man!"
          ],
          [
           "peter",
           "Has Peter ever responded to criticisms of Walker's Why We Sleep?. When I first heard Walker on Rogan I somewhat dismissed him as because his \"no really, I've discovered the cause of every human malady\" story fired off my skeptic sensors. However with Peter Attia and Rhonda Patrick  backing the book and his ideas, I decided that I must have been wrong. \n\nA little while ago I came across [this critique](https://guzey.com/books/why-we-sleep/) which dug much deeper into some of the feelings I had listening to Walker and in reading the book.\n\nHas Peter ever responded publicly? I'm not (yet) a subscriber so I wonder if he's addressed it on an AMA episode."
          ],
          [
           "peter",
           "Listening to Qualys on desktop/web browser. I listen to the podcast on my desktop computer but don't see a clear way to do this for the Qualys. Does anyone recommend a private RSS feed that works on desktop / web browser? Any advice appreciated"
          ],
          [
           "peter",
           "Peter's Lab Work Reference Ranges. Peter selectively includes on-topic snapshots of some of his own practice's lab reference ranges in the in the podcast show notes and some of his blog posts. \n\nHas anyone seen where he posted his whole dashboard, or have you pulled together the snippets to create your own?\n\nI wanted to put together a simplified version of his work to track my own lab work over time."
          ],
          [
           "peter",
           "Male Infertility!. Hi guys, \n\nI'm in my late 20's and I've just seen a VICE documentary that covered declining male fertility in western men. I am freaked out!!! I didn't know this was a problem and I have never considered I needed to take proactive steps to protect my fertility as a man. Is anyone else going through this?"
          ],
          [
           "peter",
           "New episode on the gut microbiome. Just listened to it:  https://www.youtube.com/watch?v=th3UwC10EZU\n\nGood episode, and I was hoping Peter would do an episode on the gut microbiome.  It's the one thing that many people overlook.  One of the interesting things I noted was that some people who use the Pendulum Glucose Control probiotic are able to foster a colony of the microbes that continues after discontinuing the treatment.  Good episode well worth listening to."
          ],
          [
           "peter",
           "We Still Have a Lot to Learn About the Most Powerful Drug: Fasting (1.5-minute audio clip from Peter Attia &amp; Paul Grewal on PodClips)."
          ],
          [
           "peter",
           "The Grail test. I felt like Peter was not a fan but couldn‚Äôt pull out exactly why. What do you think?"
          ],
          [
           "peter",
           "New Peter Attia subreddit. A new subreddit for ThePeterAttiaDrive podcast was just created. I noticed commenters often bring up Peter's work and so thought members here might be interested in checking it out. It is run by a current member of his team, and the hope is to bring together people who love the show and to help them have their feedback get heard. Give it a look if you're interested. Thanks!\n\n[https://www.reddit.com/r/PeterAttia/](https://www.reddit.com/r/PeterAttia/)"
          ],
          [
           "peter",
           "Metallica and Peter Attia??. Interesting thought I had whilst completing my VO2 max intervals on the Assault Bike. \nFrantic by Metallica is playing loud. \nThe lyrics are ‚Äúmy lifestyle determines my death style‚Äù\nPeter couldn‚Äôt have said it better himself. It was very motivating to say the least."
          ],
          [
           "peter",
           "Is anyone else concerned about Dave Asprey? He does not look well lately.."
          ],
          [
           "peter",
           "Dave Asprey (and others like him) are the new ‚ÄúBig Pharma‚Äù. Everything this guy does and sells is unproven (with most of it even proven to be bullshit) and yet he wants to attack pharma for being ‚Äúevil‚Äù. Everything this guy does is so obviously a scam I'm surprised I even have to write this post. \n\nFor some really strange reason, people follow Dave Asprey, and he‚Äôs turning biohacking into a conspiracy theory, pushing snake oil through salesmanship, and ruining it for all of us.  That fuck thinks Kale is unhealthy. Yeah, probably is, in large doses like anything. He seems to lack basic knowledge in toxicology, pharmacology, and cell biology, as well as not understanding how to read a scientific paper. \n\nThe stupid shit that he does has made me utterly repulsed on so many levels. 1. by the stupidity and danger he puts himself in for no reason, 2. the fact that people actually seem to follow him, and 3. because most of The stuff he does is literally disgusting. Him and those like him have ruined the word biohacking.\n\nInstead of biohacking, what‚Äôs needed is ‚Äúcrowd sourced health advancement research with a basis in science, not nonsense‚Äù this stuff is all an experiment in how to live better, and if we‚Äôre going to get anywhere we need grounding in science and to follow the scientific process. \n\n\nhttps://www.ftc.gov/system/files/warning-letters/covid-19-letter_to_dave_asprey.pdf\n\nHere's a letter from the FTC to Dave Asprey, just read it.\n\n\nHere's another great article: \n\nhttp://www.sheilakealey.com/nutrition-experts-shouldnt-trust-2/"
          ],
          [
           "peter",
           "Anyone catch the STEM talk episode with Vyvyane Loh on aetherosclerotic disease?. https://podcasts.apple.com/us/podcast/stem-talk/id1091402153\n\nLove the STEM talk Podcast, highly recommend as the topics are varied and well researched. This particular episode was so interesting  I decided to checkout the guests podcast and landed on her review of the 7- hour deep dive on Lipidology Peter did with Tom Dayspring. Not a very good review of that massive effort - 150 slides, each with discrepancies found vs published research, some at First Principles level. While the review is likely tough news for Peter, it was very respectful and data driven- which I am sure Peter will respect. After thinking about these contrasting discussions, I wanted to raise this here to share in case anyone missed the STEM talk episode. Totally new technical content (for me) strongly contrasting with Attia‚Äôs content. I‚Äôm a longtime subscriber to Attia, and still a believer in his body of work. Just wanted to share."
          ],
          [
           "peter",
           "#168 ‚Äì Hugh Jackman: Reflections on acting, identity, personal transformation, and the significance of being Wolverine."
          ]
         ],
         "hovertemplate": "Topic Group=%{customdata[0]}<br>document=%{customdata[1]}<extra></extra>",
         "legendgroup": "peter",
         "marker": {
          "color": "rgb(207, 28, 144)",
          "symbol": "circle",
          "opacity": 0.7,
          "size": 7,
          "line": {
           "color": "rgba(0,0,0,0.5)",
           "width": 0.8
          }
         },
         "mode": "markers",
         "name": "peter",
         "showlegend": true,
         "x": {
          "dtype": "f4",
          "bdata": "77aTQATjlEAzSZNA0NybQPgtkkAa1ZhAe+aTQGrGmkAeoZNAq2mSQKIIk0AtL5NADx2QQLO9jEBtE5VAelSTQExZlUB445VAQO+RQDN4kUDT0JNASVyUQA+zm0AYfY9AwRWTQDKGlEDm+41AhMeQQCeJk0BDG5NAcDGUQKztlUBT/ZFAZjiTQI09lkAhB5FAn6CcQNuykkAcFY1AxzaOQJv2lEAbRpVAgwKSQNd1lEDpdJFAcrWSQPt0kEA7YJNAETiSQApakkAZt5RAQ/2SQLg/k0Dq1pJA7EuWQA=="
         },
         "xaxis": "x",
         "y": {
          "dtype": "f4",
          "bdata": "NHabQDGUmkDDBppA+P2WQMVankCAWJhAG+uVQLdUlkA9JphAn8icQPFxnUCucZ1AU7iaQCG+oEDsIqFAd92eQAkOoUCpVp5AbWmcQFt9n0AQ6JhAeHyaQOA8lkDgQJtA+UejQB/2oUAPsKNACZqfQBB5mEBfOqNAB+ObQGbPoEDTA55Af0KdQGLul0DTSaBAgQGXQN72nUBokqRAefGlQPNmoUBuVaFAlu6fQIZAmkD8N59AKgOdQGPgmEApLZlApWmgQD/BnUCxS5tACWGjQIxiokDw8JtAr6+gQA=="
         },
         "yaxis": "y",
         "type": "scattergl"
        },
        {
         "customdata": [
          [
           "epigenetic_methylation_age_aging",
           "\"Making sense of the ageing methylome\", Seale et al 2022."
          ],
          [
           "epigenetic_methylation_age_aging",
           "Young Plasma Rejuvenates Blood DNA Methylation Profile, Extends Mean Lifespan, and Improves Physical Appearance in Old Rats."
          ],
          [
           "epigenetic_methylation_age_aging",
           "DNA methylation predicts age and provides insight into exceptional longevity of bats [2021, open-access]."
          ],
          [
           "epigenetic_methylation_age_aging",
           "\"Ultra-cheap and scalable epigenetic age predictions with TIME-Seq\", Griffin et al 2021."
          ],
          [
           "epigenetic_methylation_age_aging",
           "Epigenetic Tests #1 and 2: Horvath, Hannum, DunedinPACE."
          ],
          [
           "epigenetic_methylation_age_aging",
           "An epigenetic clock for cats | Lifespan News."
          ],
          [
           "epigenetic_methylation_age_aging",
           "The association of epigenetic age acceleration and multimorbidity at age 90 in the Women‚Äôs Health Initiative [2022, open-access]."
          ],
          [
           "epigenetic_methylation_age_aging",
           "Dna methylation, epigenetic age and methylation gene mutations. There are some companies that offer epigenetic age test using DNA methylation method which is one of the most accurate method to check epigenetic age. What if you already have methylation genes mutations when you were born? Will these people age faster or is this something completely different?   \n\n\nI imported 23andme raw data into [https://geneticgenie.org/methylation-analysis/](https://geneticgenie.org/methylation-analysis/) and it showed some mutations."
          ],
          [
           "epigenetic_methylation_age_aging",
           "Does alcar cause persistent changes in gene expression when taken acutely?. Saw this mentioned here https://www.reddit.com/r/Nootropics/comments/t1dkqa/alcar_induces_persistent_changes_in_gene/\n\nIf it was taken acutely would these epigenetic changes not happen?"
          ],
          [
           "epigenetic_methylation_age_aging",
           "Epigenome-wide analysis of DNA methylation and optimism in women and men [2022]."
          ],
          [
           "epigenetic_methylation_age_aging",
           "Marijuana use and DNA methylation-based biological age in young adults [2022, open-access]."
          ],
          [
           "epigenetic_methylation_age_aging",
           "New Genetic Research Advances Understanding of Internal Mechanisms of Biological Clocks."
          ],
          [
           "epigenetic_methylation_age_aging",
           "DNAm aging biomarkers are responsive: Insights from 51 longevity interventional studies in humans."
          ],
          [
           "epigenetic_methylation_age_aging",
           "Older men and women show an association between lower grip strength and biological age acceleration across the DNA methylation clocks.."
          ],
          [
           "epigenetic_methylation_age_aging",
           "Epigenetic aging is associated with aberrant neural oscillatory dynamics serving visuospatial processing in people with HIV | Aging."
          ],
          [
           "epigenetic_methylation_age_aging",
           "Recalibrating the epigenetic clock: implications for assessing biological age in the human cortex [2020, open-access]."
          ],
          [
           "epigenetic_methylation_age_aging",
           "Flavonoids against DNA methylation?. With all of the new theories about DNA methylation and aging, it should be logical to find some natural compounds: flavonoids/polyphenols to slow down epigenetic clock? any active research?"
          ],
          [
           "epigenetic_methylation_age_aging",
           "Dr. Steve Horvath on epigenetic aging to predict healthspan: the DNA Phenoage and Grimage clocks [1hr 15min aging discussion]."
          ],
          [
           "epigenetic_methylation_age_aging",
           "Muhdo &amp; ARK-KCL collaborate on consumer epigenetic tests for longevity."
          ],
          [
           "epigenetic_methylation_age_aging",
           "Blood-derived DNA methylation predictors of mortality discriminate tumor and healthy tissue in multiple organs [2021, open-access]."
          ],
          [
           "epigenetic_methylation_age_aging",
           "Reversing age: dual species measurement of epigenetic age with a single clock [2020, open-access preprint]."
          ],
          [
           "epigenetic_methylation_age_aging",
           "Oversubscribed Financing Round for Turn Bio - Advancing mRNA-Induced Epigenetic Reprogramming for Long, Healthy Lifespan."
          ],
          [
           "epigenetic_methylation_age_aging",
           "Exonic Variants in Aging-Related Genes Are Predictive of Phenotypic Aging Status [2019, open-access]."
          ],
          [
           "epigenetic_methylation_age_aging",
           "\"scAge: Profiling epigenetic age in single cells\", Trapp et al 2021."
          ],
          [
           "epigenetic_methylation_age_aging",
           "The emWave2, Marijuana, Religion, and Flowstates?."
          ],
          [
           "epigenetic_methylation_age_aging",
           "Inherited genetic factors may predict the pattern of X chromosome loss in older women."
          ],
          [
           "epigenetic_methylation_age_aging",
           "Stress makes life‚Äôs clock tick faster ‚Äì and how to slow it down. Chronic stress accelerates the body‚Äôs epigenetic clock, but emotional regulation and self-control can slow that process down.. **https://www.longevity.technology/stress-makes-lifes-clock-tick-faster-and-how-to-slow-it-down/?utm\\_source=linkedin&amp;utm\\_medium=social&amp;utm\\_campaign=clock**"
          ],
          [
           "epigenetic_methylation_age_aging",
           "Personal aging markers and ageotypes revealed by deep longitudinal profiling. [https://www.nature.com/articles/s41591-019-0719-5](https://www.nature.com/articles/s41591-019-0719-5) \n\nFrom Genomeweb's reporting:\n\n \n\nNEW YORK ‚Äì By collecting genomic, metabolomic, clinical, and other data from healthy individuals over time, a Stanford University team has tracked down molecular markers for aging ‚Äî demonstrating, in the process, that the specific pathways involved often vary from one individual to the next, producing distinct personal \"ageotypes.\"\n\n\"Ageotypes may provide a molecular assessment of personal aging, reflective of personal lifestyle and medical history, that may ultimately be useful in monitoring and intervening in the aging process,\" corresponding author Michael Snyder, a researcher in the Department of Genetics at Stanford, and his colleagues wrote.\n\nAlthough features such as telomere length or DNA methylation marks have been proposed as potential markers for aging, Snyder and his co-authors suggested that \"a comprehensive view of the molecular changes that occur during aging in humans is not known,\" prompting them to take a far more detailed look at the process in more than 100 individuals.\n\nAs they [reported](https://www.nature.com/articles/s41591-019-0719-5) in *Nature Medicine* on Monday, the researchers used exome sequencing, RNA sequencing, mass spectrometry-based metabolomic and proteomic profiling, cytokine assays, and targeted microbial gene sequencing, in combination with dozens of clinical lab tests, to follow clinical features, blood profiles, stool microbiome features, nasal microbial communities, and more over time in 106 healthy or prediabetic individuals between the ages of 29 and 75 years.\n\nResults from the team's initial analyses ‚Äî which included data from seven \"omics\" assays collected from participants over the course of almost 1,100 clinic visits ‚Äî highlighted several known contributors to aging, such as age-related declines in the glomerular filtration rate of participants' kidneys, as well as new candidate markers, including rising levels of *Clostridium* bacteria in gut samples from aging individuals.\n\nBut it also pointed to molecular aging profiles that differed somewhat between the participants with or without insulin resistance, the authors explained, prompting them to take an even more detailed look at a subset of individuals who participated in particularly deep and extended data collection ‚Äî a group that included a few representatives with waning physical activity, significant weight loss, or medication changes over the time considered.\n\n\"The frequent sampling of individuals over a potentially actionable time frame, which we arbitrarily defined as less than \\[two\\] years, enabled us to study how individuals change with time at a personal level,\" the researchers explained. \"We focused on 43 individuals who had at least five healthy visits spanning at least 700 \\[days\\], which was sufficient for identifying analytes that changed with time.\"\n\nThere, the team found hundreds to thousands of potential age-related marker molecules per participant, though the aging markers and the specific pathways involved in aging varied from one individual to the next. While some individuals experienced age-related changes in liver, kidney, metabolic, and immune pathway activity, for example, others experienced shifts dominated by one or a few pathways as they aged.\n\n\"Our analysis shows that some individuals fall strongly into one or more of these aging pathways, suggesting that they have distinct ageotypes,\" the authors wrote, noting that \"\\[i\\]t is possible that improvements in ageotype can be targeted at the individual level (such as, immune function or metabolic pathways) using selective interventions (such as, drugs) or in aggregate using broad lifestyle changes.\""
          ],
          [
           "epigenetic_methylation_age_aging",
           "Profiling epigenetic age in single cells."
          ],
          [
           "epigenetic_methylation_age_aging",
           "Fail-tests of DNA methylation clocks, and development of a noise barometer for measuring epigenetic pressure of aging and disease."
          ],
          [
           "epigenetic_methylation_age_aging",
           "Shankar Balasubramanian [a co-inventor of next-generation sequencing] to unveil [rapid epigenetic sequencing tech which] may hold key to ageing."
          ],
          [
           "epigenetic_methylation_age_aging",
           "Higher diet quality relates to decelerated epigenetic aging [Kim et al., 2022]."
          ],
          [
           "epigenetic_methylation_age_aging",
           "Spermidine resets circadian clock phase in NIH3T3 cells."
          ],
          [
           "epigenetic_methylation_age_aging",
           "Epigenetic age prediction [2021, open-access]."
          ],
          [
           "epigenetic_methylation_age_aging",
           "At-home blood test powers personalised longevity advice - AgeRage develops proprietary DNA methylation clock and mobile app solution to offer users personalised longevity support.."
          ],
          [
           "epigenetic_methylation_age_aging",
           "Alex Zhavoronkov: \"With a little bit of AI magic blood-based epigenetic clock becomes a saliva-based epigenetic clock. And with a bit more magic it becomes a pan-tissue clock. Congrats to collaborators!\"."
          ],
          [
           "epigenetic_methylation_age_aging",
           "TIME-seq reduces time and cost of DNA methylation measurement for epigenetic clock construction."
          ],
          [
           "epigenetic_methylation_age_aging",
           "\"Exome-wide association studies in general and long-lived populations identify genetic variants related to human age\", Sin-Chan et al 2020."
          ],
          [
           "epigenetic_methylation_age_aging",
           "Blood Factors Reverse Epigenetic Age by Half in Rats."
          ],
          [
           "epigenetic_methylation_age_aging",
           "Estimating breast tissue-specific DNA methylation age using next-generation sequencing data [2020, open-access]."
          ],
          [
           "epigenetic_methylation_age_aging",
           "Researchers publish new blood-DNA-methylation measure \"DunedinPoAm\". Sensitive to variation in the pace of biological aging among individuals born the same year.."
          ],
          [
           "epigenetic_methylation_age_aging",
           "Epigenetic Clocks: Which Has The Best Correlation For Aging and Age-Related Diseases?."
          ],
          [
           "epigenetic_methylation_age_aging",
           "Many chronological aging clocks can be found throughout the epigenome: Implications for quantifying biological aging [2021, open-access]."
          ],
          [
           "epigenetic_methylation_age_aging",
           "Does epigenetic rejuvenation ‚Äúreverse‚Äù or ‚Äúerase‚Äù methylation? Does it run some clock backwards?. My understanding is that methylation age clocks use the specific pattern of methylation status across CpG sites to determine age, as opposed to the total amount of methylation. That would suggest that, as an animal ages, some predictable clockwork mechanism changes this pattern by stepping it forward through a particular sequence of changes from a [baseline age]( https://www.science.org/doi/10.1126/sciadv.abg6082) onward.\n\n\n\nAt first I thought that epigenetic rejuvenation methods simply turned on factors that erased the aging markers. But they are able to ‚Äúrewind‚Äù age by certain amounts, giving the subject some younger but non-zero methylation age. Does this suggest that it steps backwards through the sequence of methylation steps by running the clockwork backwards? Does anyone know enough about how it works to say whether this is the case?"
          ],
          [
           "epigenetic_methylation_age_aging",
           "Marijuana use predicted epigenetic changes linked to accelerated aging, with evidence suggesting that effects may be primarily due to hydrocarbon inhalation among marijuana smokers.."
          ],
          [
           "epigenetic_methylation_age_aging",
           "The principal component-based clinical aging clock (PCAge) identifies signatures of healthy aging and provides normative targets for clinical intervention [2023, open-access preprint]."
          ],
          [
           "epigenetic_methylation_age_aging",
           "Healthy eating patterns and epigenetic measures of biological age. [https://academic.oup.com/ajcn/advance-article/doi/10.1093/ajcn/nqab307/6391406](https://academic.oup.com/ajcn/advance-article/doi/10.1093/ajcn/nqab307/6391406)"
          ]
         ],
         "hovertemplate": "Topic Group=%{customdata[0]}<br>document=%{customdata[1]}<extra></extra>",
         "legendgroup": "epigenetic_methylation_age_aging",
         "marker": {
          "color": "rgb(249, 123, 114)",
          "symbol": "circle",
          "opacity": 0.7,
          "size": 7,
          "line": {
           "color": "rgba(0,0,0,0.5)",
           "width": 0.8
          }
         },
         "mode": "markers",
         "name": "epigenetic_methylation_age_aging",
         "showlegend": true,
         "x": {
          "dtype": "f4",
          "bdata": "elrYQDZr10B5kNdAE07ZQCi+2UCSwdBAZebYQBsJ2UAUo9lAqyDaQMBP2UDpUdZAqmbQQHkG20DtM9dA6cTXQDgm2kBoy9hAdjTVQBZy2UBGqNlAsobXQOXn0EDCcNlAeCTZQJ5ez0CHitdAUmLMQFQU2UAFJdpA903ZQE2t10BGktNADNPXQLak0kAPctVAFCTaQMrp0EAnPddA1IvZQP6+10BJKNhAMc3VQPEG2EAL+9dAKCLTQHxm2EA="
         },
         "xaxis": "x",
         "y": {
          "dtype": "f4",
          "bdata": "fRliQAX5YECZ/mRACYFoQA0WaUDOWmxAeItoQLE9Z0AghWdADCdoQFEnZkAV7WhA3SFhQKg9ZEDY0WVAaXVoQI2kZ0CGBGlASMtiQCjzY0CvX2lAxOljQHKhaEDEzmlAS7FlQMtaaUCfcG1AqsxhQMQJaEDjTWhAfyFpQIzqZkCry2VASHJnQOyCbECY0GxA4tpnQK4NaUAW6GNAqmhkQLowZUDY/2dAFCVpQHl7YkBcLGRA0gZsQFfQZ0A="
         },
         "yaxis": "y",
         "type": "scattergl"
        }
       ],
       "layout": {
        "template": {
         "data": {
          "histogram2dcontour": [
           {
            "type": "histogram2dcontour",
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0.0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1.0,
              "#f0f921"
             ]
            ]
           }
          ],
          "choropleth": [
           {
            "type": "choropleth",
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            }
           }
          ],
          "histogram2d": [
           {
            "type": "histogram2d",
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0.0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1.0,
              "#f0f921"
             ]
            ]
           }
          ],
          "heatmap": [
           {
            "type": "heatmap",
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0.0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1.0,
              "#f0f921"
             ]
            ]
           }
          ],
          "contourcarpet": [
           {
            "type": "contourcarpet",
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            }
           }
          ],
          "contour": [
           {
            "type": "contour",
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0.0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1.0,
              "#f0f921"
             ]
            ]
           }
          ],
          "surface": [
           {
            "type": "surface",
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0.0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1.0,
              "#f0f921"
             ]
            ]
           }
          ],
          "mesh3d": [
           {
            "type": "mesh3d",
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            }
           }
          ],
          "scatter": [
           {
            "fillpattern": {
             "fillmode": "overlay",
             "size": 10,
             "solidity": 0.2
            },
            "type": "scatter"
           }
          ],
          "parcoords": [
           {
            "type": "parcoords",
            "line": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            }
           }
          ],
          "scatterpolargl": [
           {
            "type": "scatterpolargl",
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            }
           }
          ],
          "bar": [
           {
            "error_x": {
             "color": "#2a3f5f"
            },
            "error_y": {
             "color": "#2a3f5f"
            },
            "marker": {
             "line": {
              "color": "#E5ECF6",
              "width": 0.5
             },
             "pattern": {
              "fillmode": "overlay",
              "size": 10,
              "solidity": 0.2
             }
            },
            "type": "bar"
           }
          ],
          "scattergeo": [
           {
            "type": "scattergeo",
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            }
           }
          ],
          "scatterpolar": [
           {
            "type": "scatterpolar",
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            }
           }
          ],
          "histogram": [
           {
            "marker": {
             "pattern": {
              "fillmode": "overlay",
              "size": 10,
              "solidity": 0.2
             }
            },
            "type": "histogram"
           }
          ],
          "scattergl": [
           {
            "type": "scattergl",
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            }
           }
          ],
          "scatter3d": [
           {
            "type": "scatter3d",
            "line": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            }
           }
          ],
          "scattermap": [
           {
            "type": "scattermap",
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            }
           }
          ],
          "scattermapbox": [
           {
            "type": "scattermapbox",
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            }
           }
          ],
          "scatterternary": [
           {
            "type": "scatterternary",
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            }
           }
          ],
          "scattercarpet": [
           {
            "type": "scattercarpet",
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            }
           }
          ],
          "carpet": [
           {
            "aaxis": {
             "endlinecolor": "#2a3f5f",
             "gridcolor": "white",
             "linecolor": "white",
             "minorgridcolor": "white",
             "startlinecolor": "#2a3f5f"
            },
            "baxis": {
             "endlinecolor": "#2a3f5f",
             "gridcolor": "white",
             "linecolor": "white",
             "minorgridcolor": "white",
             "startlinecolor": "#2a3f5f"
            },
            "type": "carpet"
           }
          ],
          "table": [
           {
            "cells": {
             "fill": {
              "color": "#EBF0F8"
             },
             "line": {
              "color": "white"
             }
            },
            "header": {
             "fill": {
              "color": "#C8D4E3"
             },
             "line": {
              "color": "white"
             }
            },
            "type": "table"
           }
          ],
          "barpolar": [
           {
            "marker": {
             "line": {
              "color": "#E5ECF6",
              "width": 0.5
             },
             "pattern": {
              "fillmode": "overlay",
              "size": 10,
              "solidity": 0.2
             }
            },
            "type": "barpolar"
           }
          ],
          "pie": [
           {
            "automargin": true,
            "type": "pie"
           }
          ]
         },
         "layout": {
          "autotypenumbers": "strict",
          "colorway": [
           "#636efa",
           "#EF553B",
           "#00cc96",
           "#ab63fa",
           "#FFA15A",
           "#19d3f3",
           "#FF6692",
           "#B6E880",
           "#FF97FF",
           "#FECB52"
          ],
          "font": {
           "color": "#2a3f5f"
          },
          "hovermode": "closest",
          "hoverlabel": {
           "align": "left"
          },
          "paper_bgcolor": "white",
          "plot_bgcolor": "#E5ECF6",
          "polar": {
           "bgcolor": "#E5ECF6",
           "angularaxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           },
           "radialaxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           }
          },
          "ternary": {
           "bgcolor": "#E5ECF6",
           "aaxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           },
           "baxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           },
           "caxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           }
          },
          "coloraxis": {
           "colorbar": {
            "outlinewidth": 0,
            "ticks": ""
           }
          },
          "colorscale": {
           "sequential": [
            [
             0.0,
             "#0d0887"
            ],
            [
             0.1111111111111111,
             "#46039f"
            ],
            [
             0.2222222222222222,
             "#7201a8"
            ],
            [
             0.3333333333333333,
             "#9c179e"
            ],
            [
             0.4444444444444444,
             "#bd3786"
            ],
            [
             0.5555555555555556,
             "#d8576b"
            ],
            [
             0.6666666666666666,
             "#ed7953"
            ],
            [
             0.7777777777777778,
             "#fb9f3a"
            ],
            [
             0.8888888888888888,
             "#fdca26"
            ],
            [
             1.0,
             "#f0f921"
            ]
           ],
           "sequentialminus": [
            [
             0.0,
             "#0d0887"
            ],
            [
             0.1111111111111111,
             "#46039f"
            ],
            [
             0.2222222222222222,
             "#7201a8"
            ],
            [
             0.3333333333333333,
             "#9c179e"
            ],
            [
             0.4444444444444444,
             "#bd3786"
            ],
            [
             0.5555555555555556,
             "#d8576b"
            ],
            [
             0.6666666666666666,
             "#ed7953"
            ],
            [
             0.7777777777777778,
             "#fb9f3a"
            ],
            [
             0.8888888888888888,
             "#fdca26"
            ],
            [
             1.0,
             "#f0f921"
            ]
           ],
           "diverging": [
            [
             0,
             "#8e0152"
            ],
            [
             0.1,
             "#c51b7d"
            ],
            [
             0.2,
             "#de77ae"
            ],
            [
             0.3,
             "#f1b6da"
            ],
            [
             0.4,
             "#fde0ef"
            ],
            [
             0.5,
             "#f7f7f7"
            ],
            [
             0.6,
             "#e6f5d0"
            ],
            [
             0.7,
             "#b8e186"
            ],
            [
             0.8,
             "#7fbc41"
            ],
            [
             0.9,
             "#4d9221"
            ],
            [
             1,
             "#276419"
            ]
           ]
          },
          "xaxis": {
           "gridcolor": "white",
           "linecolor": "white",
           "ticks": "",
           "title": {
            "standoff": 15
           },
           "zerolinecolor": "white",
           "automargin": true,
           "zerolinewidth": 2
          },
          "yaxis": {
           "gridcolor": "white",
           "linecolor": "white",
           "ticks": "",
           "title": {
            "standoff": 15
           },
           "zerolinecolor": "white",
           "automargin": true,
           "zerolinewidth": 2
          },
          "scene": {
           "xaxis": {
            "backgroundcolor": "#E5ECF6",
            "gridcolor": "white",
            "linecolor": "white",
            "showbackground": true,
            "ticks": "",
            "zerolinecolor": "white",
            "gridwidth": 2
           },
           "yaxis": {
            "backgroundcolor": "#E5ECF6",
            "gridcolor": "white",
            "linecolor": "white",
            "showbackground": true,
            "ticks": "",
            "zerolinecolor": "white",
            "gridwidth": 2
           },
           "zaxis": {
            "backgroundcolor": "#E5ECF6",
            "gridcolor": "white",
            "linecolor": "white",
            "showbackground": true,
            "ticks": "",
            "zerolinecolor": "white",
            "gridwidth": 2
           }
          },
          "shapedefaults": {
           "line": {
            "color": "#2a3f5f"
           }
          },
          "annotationdefaults": {
           "arrowcolor": "#2a3f5f",
           "arrowhead": 0,
           "arrowwidth": 1
          },
          "geo": {
           "bgcolor": "white",
           "landcolor": "#E5ECF6",
           "subunitcolor": "white",
           "showland": true,
           "showlakes": true,
           "lakecolor": "white"
          },
          "title": {
           "x": 0.05
          },
          "mapbox": {
           "style": "light"
          }
         }
        },
        "xaxis": {
         "anchor": "y",
         "domain": [
          0.0,
          1.0
         ],
         "title": {
          "text": "UMAP-1"
         }
        },
        "yaxis": {
         "anchor": "x",
         "domain": [
          0.0,
          1.0
         ],
         "title": {
          "text": "UMAP-2"
         }
        },
        "legend": {
         "title": {
          "text": "Topic Group"
         },
         "tracegroupgap": 0,
         "orientation": "h",
         "yanchor": "top",
         "y": -0.15,
         "xanchor": "center",
         "x": 0.5,
         "itemsizing": "constant"
        },
        "title": {
         "text": "UMAP Topic Visualization (Top 10 Topics Highlighted)",
         "font": {
          "size": 18
         }
        },
        "height": 700,
        "width": 900,
        "showlegend": true,
        "hovermode": "closest",
        "plot_bgcolor": "rgba(240, 240, 240, 1)",
        "paper_bgcolor": "rgba(255, 255, 255, 1)"
       },
       "config": {
        "plotlyServerURL": "https://plot.ly"
       }
      }
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<IPython.core.display.Image object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "‚úÖ UMAP visualization generated and saved to PNG successfully.\n"
     ]
    }
   ],
   "execution_count": 19
  },
  {
   "metadata": {},
   "cell_type": "markdown",
   "source": [
    "### üí° Key Takeaways from Subreddit Contribution\n",
    "\n",
    "* **Longevity Dominance (Top):** Topics related to **specific, often experimental compounds** (e.g., *senolytics, GLP-1 agonists*) are almost exclusively driven by **r/Longevity** (Orange), showcasing a unique pharmaceutical focus.\n",
    "* **Peter Attia Dominance (Bottom):** The highest volume topics focusing on **structured exercise, strength, and cardiorespiratory fitness** (e.g., *zone_training_max_vo2*) are almost entirely owned by the **r/PeterAttia** community (Light Blue).\n",
    "* **Shared Ground (Cardiovascular Health):** Discussions around core, established health markers, particularly **cholesterol/LDL/statins**, show the most **balanced participation** across all three subreddits, indicating a universal shared interest.\n",
    "* **Biohackers as a Bridge:** **r/Biohackers** (Red) frequently acts as a **secondary, supportive voice**, often contributing alongside r/Longevity in supplement and metabolic topics (e.g., *metformin_berberine*).\n",
    "* **Clear Topic Segregation:** The chart strongly suggests that the communities are highly **topic-segregated**. The conversations at the extremes are unique to their respective subreddits, confirming that the three communities, while related, are discussing different facets of health and longevity."
   ],
   "id": "f01870bf84a070d9"
  },
  {
   "metadata": {},
   "cell_type": "markdown",
   "source": [
    "# üìä STEP 5: Subreddit Topic Contribution Analysis (Recap)\n",
    "\n",
    "This step generates a key comparative visualization that identifies the community source for every major topic discovered by the model.\n",
    "\n",
    "* **Metric:** The visualization calculates the percentage contribution of each subreddit (`Biohackers`, `Longevity`, `PeterAttia`) to the total documents within each final topic.\n",
    "* **Topic Filtering:** Only topics with a minimum size (`MIN_DOCS = 50`) and non-outlier status are included, ensuring focus on robust discussions.\n",
    "* **Custom Sorting (Key Feature):** The **y-axis is custom-ordered** to place topics with the **lowest contribution from r/PeterAttia** (Lowest PeterAttia %) at the **top**. This clearly highlights discussions dominated by **r/Longevity** and **r/Biohackers** at the top, transitioning to discussions dominated by **r/PeterAttia** at the bottom.\n",
    "* **Visualization:** A normalized **Stacked Horizontal Bar Chart** is used, where each bar sums to 100%, allowing for a clear visual comparison of subreddit influence across all topics.\n",
    "\n",
    "**Result:** This chart serves as the primary tool for distinguishing the unique conversational space of each subreddit."
   ],
   "id": "2e4682dc5decc414"
  },
  {
   "metadata": {
    "ExecuteTime": {
     "end_time": "2025-11-04T22:07:36.475652Z",
     "start_time": "2025-11-04T22:07:34.124813Z"
    }
   },
   "cell_type": "code",
   "source": [
    "# ====================================================================\n",
    "# === STEP 5: VISUALIZATION OF SUBREDDIT CONTRIBUTION PER TOPIC (ORDERED BY LOWEST PETER ATTIA) - WITH PNG EXPORT ===\n",
    "# ====================================================================\n",
    "\n",
    "import pandas as pd\n",
    "import numpy as np\n",
    "import plotly.express as px\n",
    "from pathlib import Path\n",
    "from IPython.display import display, Image # Import display and Image\n",
    "\n",
    "# --- Setup Output Directory ---\n",
    "OUTPUT_DIR = Path(\"visualization_outputs\")\n",
    "OUTPUT_DIR.mkdir(exist_ok=True)\n",
    "print(f\"Saving figures to: {OUTPUT_DIR.resolve()}\")\n",
    "\n",
    "print(\"üî¨ Analyzing subreddit contribution and ordering topics by LOWEST PeterAttia dominance...\")\n",
    "\n",
    "# --- 1. Data Preparation and Grouping ---\n",
    "OUTLIER_ID = -1\n",
    "MIN_DOCS = 50\n",
    "\n",
    "# Helper to clean topic names for display (Copied from previous steps for robustness)\n",
    "def clean_topic_name_for_display(topic_name):\n",
    "    RESIDUAL_GENERIC = {\"the\", \"to\", \"and\", \"of\", \"my\", \"in\", \"for\", \"is\", \"it\", \"that\", \"what\", \"we\", \"you\", \"on\", \"a\", \"an\", \"up\", \"from\"}\n",
    "    words = topic_name.split('_')\n",
    "    cleaned_words = []\n",
    "    seen = set()\n",
    "    for word in words:\n",
    "        if word.lower() not in RESIDUAL_GENERIC and word.strip() != '' and word.lower() not in seen:\n",
    "            cleaned_words.append(word)\n",
    "            seen.add(word.lower())\n",
    "    if cleaned_words and cleaned_words[0].isdigit():\n",
    "        cleaned_words = cleaned_words[1:]\n",
    "    if not cleaned_words:\n",
    "        return topic_name\n",
    "    return '_'.join(cleaned_words[:4])\n",
    "\n",
    "# Generate the clean map from the topic_model\n",
    "topic_names_map = {topic_id: clean_topic_name_for_display(name)\n",
    "                   for topic_id, name in topic_model.topic_labels_.items()}\n",
    "topic_names_map[OUTLIER_ID] = \"Outlier (-1)\"\n",
    "\n",
    "\n",
    "# Calculate counts, totals, and percentages\n",
    "df_analysis = df[['topic_global', 'subreddit']].copy()\n",
    "topic_subreddit_counts = df_analysis.groupby(['topic_global', 'subreddit']).size().reset_index(name='Count')\n",
    "topic_totals = topic_subreddit_counts.groupby('topic_global')['Count'].sum().reset_index(name='TopicTotal')\n",
    "topic_subreddit_counts = topic_subreddit_counts.merge(topic_totals, on='topic_global')\n",
    "topic_subreddit_counts['Percentage'] = (topic_subreddit_counts['Count'] / topic_subreddit_counts['TopicTotal']) * 100\n",
    "topic_subreddit_counts['TopicName'] = topic_subreddit_counts['topic_global'].map(topic_names_map)\n",
    "\n",
    "# Filter out small topics and outliers for visualization focus\n",
    "topic_report = topic_subreddit_counts[\n",
    "    (topic_subreddit_counts['TopicTotal'] >= MIN_DOCS) &\n",
    "    (topic_subreddit_counts['topic_global'] != OUTLIER_ID)\n",
    "].copy()\n",
    "\n",
    "\n",
    "# --- 2. Custom Sorting Logic: Increasing PeterAttia Percentage ---\n",
    "\n",
    "# Isolate the PeterAttia percentages\n",
    "peter_attia_df = topic_report[topic_report['subreddit'] == 'PeterAttia'][['TopicName', 'Percentage']].copy()\n",
    "peter_attia_df.rename(columns={'Percentage': 'PeterAttia_Percentage'}, inplace=True)\n",
    "\n",
    "# Merge this percentage back to the main report (using TopicName to avoid duplicates in merge key)\n",
    "topic_report = topic_report.merge(peter_attia_df, on='TopicName', how='left').fillna(0)\n",
    "\n",
    "\n",
    "# Get the new custom order for the y-axis: Lowest PeterAttia % first\n",
    "topic_order_custom = topic_report.drop_duplicates(subset='TopicName').sort_values(\n",
    "    by='PeterAttia_Percentage',\n",
    "    ascending=True\n",
    ")['TopicName'].tolist()\n",
    "\n",
    "\n",
    "# Apply the custom order to the TopicName column\n",
    "topic_report['TopicName'] = pd.Categorical(topic_report['TopicName'], categories=topic_order_custom, ordered=True)\n",
    "\n",
    "# --- 3. Visualization (Normalized Stacked Bar Chart) ---\n",
    "\n",
    "fig = px.bar(\n",
    "    topic_report,\n",
    "    x='Percentage',\n",
    "    y='TopicName',\n",
    "    color='subreddit',\n",
    "    orientation='h',\n",
    "    hover_data={'TopicName': False, 'Count': True, 'TopicTotal': True, 'Percentage': ':.1f', 'PeterAttia_Percentage': ':.1f'},\n",
    "    title='Subreddit Contribution to Topics (Ordered by Lowest PeterAttia %)',\n",
    "    labels={\n",
    "        'Percentage': 'Percentage of Topic Documents',\n",
    "        'TopicName': 'Topic Name',\n",
    "        'subreddit': 'Subreddit'\n",
    "    },\n",
    "    height=1500,\n",
    "    width=900,\n",
    "    color_discrete_sequence=px.colors.qualitative.Bold\n",
    ")\n",
    "\n",
    "# Customizing the layout\n",
    "fig.update_layout(\n",
    "    xaxis_title='Subreddit Contribution (%)',\n",
    "    yaxis_title='Topic Name (Sorted by Increasing PeterAttia %)',\n",
    "    legend_title='Subreddit',\n",
    "    yaxis={'categoryorder': 'array', 'categoryarray': topic_order_custom},\n",
    "    margin=dict(l=250, r=20, t=50, b=50),\n",
    "    barmode='stack',\n",
    ")\n",
    "\n",
    "# Ensure the x-axis is fixed from 0 to 100%\n",
    "fig.update_xaxes(range=[0, 100], ticksuffix=\"%\")\n",
    "\n",
    "fig.show()\n",
    "\n",
    "# **EXPORT FIGURE 4** üëà Note: This is Figure 4 in the sequence\n",
    "fig_subreddit_contrib_path = OUTPUT_DIR / \"5_subreddit_contribution_ordered.png\"\n",
    "fig.write_image(fig_subreddit_contrib_path)\n",
    "# üëà Display the saved PNG inline\n",
    "display(Image(filename=fig_subreddit_contrib_path))\n",
    "\n",
    "\n",
    "print(\"\\n‚úÖ Subreddit contribution visualization generated, ordered by lowest PeterAttia dominance, and saved to PNG successfully.\")"
   ],
   "id": "fd556bd408bca1b6",
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Saving figures to: /Users/michaelwalker/CU_Boulder_Masters_Ai/Introduction to Deep Learning/cu-boulder-ms-ai/Introduction-to-Machine-Learning/unsupervised/CSCA 5632 Unsupervised Algorithms in Machine Learning Final Project/visualization_outputs\n",
      "üî¨ Analyzing subreddit contribution and ordering topics by LOWEST PeterAttia dominance...\n"
     ]
    },
    {
     "data": {
      "application/vnd.plotly.v1+json": {
       "data": [
        {
         "customdata": {
          "dtype": "f8",
          "bdata": "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",
          "shape": "25, 3"
         },
         "hovertemplate": "Subreddit=Biohackers<br>Percentage of Topic Documents=%{x:.1f}<br>Count=%{customdata[0]}<br>TopicTotal=%{customdata[1]}<br>PeterAttia_Percentage=%{customdata[2]:.1f}<extra></extra>",
         "legendgroup": "Biohackers",
         "marker": {
          "color": "rgb(127, 60, 141)",
          "pattern": {
           "shape": ""
          }
         },
         "name": "Biohackers",
         "orientation": "h",
         "showlegend": true,
         "textposition": "auto",
         "x": {
          "dtype": "f8",
          "bdata": "Z2ZmZmbmVkDTHey32thXQAAAAAAAAClAhp4i6tcLO0AAAAAAAAA0QDRE6Vw2Q1dAjvrORn1nV0CBo50eCeIlQF100UUXTVZAP9wCCqM6VUBVVVVVVVVCQKjvbNR3NlRARoKaCtGGU0AxDMMwDMNNQOBsHfrN1jVAip3YiZ3YN0Dj4eHh4eEpQOh5nud5nlZAupaDm/1CVUCGYRiGYVhTQNSb3vSmd1VAq6qqqqqqVUAjPVA5u4VUQAN7x9TA3j1AFrKQhSykV0A="
         },
         "xaxis": "x",
         "y": [
          "vitamin_supplements",
          "1_to_and_it_my",
          "longevity_aging_link",
          "ldl_cholesterol_apob",
          "zone_training_max",
          "sleep",
          "light_sauna",
          "aging_cells_senescence",
          "testosterone",
          "biohacking",
          "alzheimer_cognitive_disease_amyloid",
          "app_watch",
          "protein_eat",
          "blood_tests_test",
          "cells_stem_cell",
          "peter",
          "epigenetic_methylation_age_aging",
          "gut",
          "pain_have",
          "nmn_resveratrol",
          "sick_throat_immune",
          "water_bottled_tap_plastic",
          "alcohol_nicotine",
          "magnetic_fields_expression_mitochondrial",
          "mg"
         ],
         "yaxis": "y",
         "type": "bar"
        },
        {
         "customdata": {
          "dtype": "f8",
          "bdata": "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",
          "shape": "25, 3"
         },
         "hovertemplate": "Subreddit=Longevity<br>Percentage of Topic Documents=%{x:.1f}<br>Count=%{customdata[0]}<br>TopicTotal=%{customdata[1]}<br>PeterAttia_Percentage=%{customdata[2]:.1f}<extra></extra>",
         "legendgroup": "Longevity",
         "marker": {
          "color": "rgb(17, 165, 121)",
          "pattern": {
           "shape": ""
          }
         },
         "name": "Longevity",
         "orientation": "h",
         "showlegend": true,
         "textposition": "auto",
         "x": {
          "dtype": "f8",
          "bdata": "mpmZmZmZCUARn0AqOS/7P73pTW96s1NA1K8X1l2BIkAXXXTRRRf9P16L0WTetfg/JlcQkyuICUCI92T94xJWQC+66KKLLgJAlo1vhtbuK0AAAAAAAABOQMTkCmJyBQFAHaXbV1bvEkDzPM/zPM8nQEdY7mmEZVNAntiJndiJNUDEw8PDw8NVQMMwDMMwDBNAoHfqWg5uFkC3bdu2bdsxQBaykIUsZCFAAAAAAAAAFEB2C78aE+khQOKs/IQ4K09AnN70pje9FUA="
         },
         "xaxis": "x",
         "y": [
          "vitamin_supplements",
          "1_to_and_it_my",
          "longevity_aging_link",
          "ldl_cholesterol_apob",
          "zone_training_max",
          "sleep",
          "light_sauna",
          "aging_cells_senescence",
          "testosterone",
          "biohacking",
          "alzheimer_cognitive_disease_amyloid",
          "app_watch",
          "protein_eat",
          "blood_tests_test",
          "cells_stem_cell",
          "peter",
          "epigenetic_methylation_age_aging",
          "gut",
          "pain_have",
          "nmn_resveratrol",
          "sick_throat_immune",
          "water_bottled_tap_plastic",
          "alcohol_nicotine",
          "magnetic_fields_expression_mitochondrial",
          "mg"
         ],
         "yaxis": "y",
         "type": "bar"
        },
        {
         "customdata": {
          "dtype": "f8",
          "bdata": "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",
          "shape": "23, 3"
         },
         "hovertemplate": "Subreddit=PeterAttia<br>Percentage of Topic Documents=%{x:.1f}<br>Count=%{customdata[0]}<br>TopicTotal=%{customdata[1]}<br>PeterAttia_Percentage=%{customdata[2]:.1f}<extra></extra>",
         "legendgroup": "PeterAttia",
         "marker": {
          "color": "rgb(57, 105, 172)",
          "pattern": {
           "shape": ""
          }
         },
         "name": "PeterAttia",
         "orientation": "h",
         "showlegend": true,
         "textposition": "auto",
         "x": {
          "dtype": "f8",
          "bdata": "zczMzMzMFEAP9lttDE0HQBaykIUsZCFAyMRolbzZT0CMLrroootTQPJZN5ginxVAJlcQkyuICUDoA6pjb23oP4suuuiiCyFAk4PMS4ng8T+rqqqqqqoKQMTkCmJyBTFAog2fP+YoMUAkSZIkSZI8QLxAJsULZOI/7MRO7MROS0DDMAzDMAwTQFsObvYLsSJAwzAMwzAME0Cc3vSmN70VQKqqqqqqqiBAdgu/GhPpIUDirPyEOCsfQA=="
         },
         "xaxis": "x",
         "y": [
          "vitamin_supplements",
          "1_to_and_it_my",
          "longevity_aging_link",
          "ldl_cholesterol_apob",
          "zone_training_max",
          "sleep",
          "light_sauna",
          "aging_cells_senescence",
          "testosterone",
          "biohacking",
          "alzheimer_cognitive_disease_amyloid",
          "app_watch",
          "protein_eat",
          "blood_tests_test",
          "cells_stem_cell",
          "peter",
          "gut",
          "pain_have",
          "nmn_resveratrol",
          "sick_throat_immune",
          "water_bottled_tap_plastic",
          "alcohol_nicotine",
          "magnetic_fields_expression_mitochondrial"
         ],
         "yaxis": "y",
         "type": "bar"
        }
       ],
       "layout": {
        "template": {
         "data": {
          "histogram2dcontour": [
           {
            "type": "histogram2dcontour",
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0.0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1.0,
              "#f0f921"
             ]
            ]
           }
          ],
          "choropleth": [
           {
            "type": "choropleth",
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            }
           }
          ],
          "histogram2d": [
           {
            "type": "histogram2d",
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0.0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1.0,
              "#f0f921"
             ]
            ]
           }
          ],
          "heatmap": [
           {
            "type": "heatmap",
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0.0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1.0,
              "#f0f921"
             ]
            ]
           }
          ],
          "contourcarpet": [
           {
            "type": "contourcarpet",
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            }
           }
          ],
          "contour": [
           {
            "type": "contour",
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0.0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1.0,
              "#f0f921"
             ]
            ]
           }
          ],
          "surface": [
           {
            "type": "surface",
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0.0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1.0,
              "#f0f921"
             ]
            ]
           }
          ],
          "mesh3d": [
           {
            "type": "mesh3d",
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            }
           }
          ],
          "scatter": [
           {
            "fillpattern": {
             "fillmode": "overlay",
             "size": 10,
             "solidity": 0.2
            },
            "type": "scatter"
           }
          ],
          "parcoords": [
           {
            "type": "parcoords",
            "line": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            }
           }
          ],
          "scatterpolargl": [
           {
            "type": "scatterpolargl",
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            }
           }
          ],
          "bar": [
           {
            "error_x": {
             "color": "#2a3f5f"
            },
            "error_y": {
             "color": "#2a3f5f"
            },
            "marker": {
             "line": {
              "color": "#E5ECF6",
              "width": 0.5
             },
             "pattern": {
              "fillmode": "overlay",
              "size": 10,
              "solidity": 0.2
             }
            },
            "type": "bar"
           }
          ],
          "scattergeo": [
           {
            "type": "scattergeo",
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            }
           }
          ],
          "scatterpolar": [
           {
            "type": "scatterpolar",
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            }
           }
          ],
          "histogram": [
           {
            "marker": {
             "pattern": {
              "fillmode": "overlay",
              "size": 10,
              "solidity": 0.2
             }
            },
            "type": "histogram"
           }
          ],
          "scattergl": [
           {
            "type": "scattergl",
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            }
           }
          ],
          "scatter3d": [
           {
            "type": "scatter3d",
            "line": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            }
           }
          ],
          "scattermap": [
           {
            "type": "scattermap",
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            }
           }
          ],
          "scattermapbox": [
           {
            "type": "scattermapbox",
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            }
           }
          ],
          "scatterternary": [
           {
            "type": "scatterternary",
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            }
           }
          ],
          "scattercarpet": [
           {
            "type": "scattercarpet",
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            }
           }
          ],
          "carpet": [
           {
            "aaxis": {
             "endlinecolor": "#2a3f5f",
             "gridcolor": "white",
             "linecolor": "white",
             "minorgridcolor": "white",
             "startlinecolor": "#2a3f5f"
            },
            "baxis": {
             "endlinecolor": "#2a3f5f",
             "gridcolor": "white",
             "linecolor": "white",
             "minorgridcolor": "white",
             "startlinecolor": "#2a3f5f"
            },
            "type": "carpet"
           }
          ],
          "table": [
           {
            "cells": {
             "fill": {
              "color": "#EBF0F8"
             },
             "line": {
              "color": "white"
             }
            },
            "header": {
             "fill": {
              "color": "#C8D4E3"
             },
             "line": {
              "color": "white"
             }
            },
            "type": "table"
           }
          ],
          "barpolar": [
           {
            "marker": {
             "line": {
              "color": "#E5ECF6",
              "width": 0.5
             },
             "pattern": {
              "fillmode": "overlay",
              "size": 10,
              "solidity": 0.2
             }
            },
            "type": "barpolar"
           }
          ],
          "pie": [
           {
            "automargin": true,
            "type": "pie"
           }
          ]
         },
         "layout": {
          "autotypenumbers": "strict",
          "colorway": [
           "#636efa",
           "#EF553B",
           "#00cc96",
           "#ab63fa",
           "#FFA15A",
           "#19d3f3",
           "#FF6692",
           "#B6E880",
           "#FF97FF",
           "#FECB52"
          ],
          "font": {
           "color": "#2a3f5f"
          },
          "hovermode": "closest",
          "hoverlabel": {
           "align": "left"
          },
          "paper_bgcolor": "white",
          "plot_bgcolor": "#E5ECF6",
          "polar": {
           "bgcolor": "#E5ECF6",
           "angularaxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           },
           "radialaxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           }
          },
          "ternary": {
           "bgcolor": "#E5ECF6",
           "aaxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           },
           "baxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           },
           "caxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           }
          },
          "coloraxis": {
           "colorbar": {
            "outlinewidth": 0,
            "ticks": ""
           }
          },
          "colorscale": {
           "sequential": [
            [
             0.0,
             "#0d0887"
            ],
            [
             0.1111111111111111,
             "#46039f"
            ],
            [
             0.2222222222222222,
             "#7201a8"
            ],
            [
             0.3333333333333333,
             "#9c179e"
            ],
            [
             0.4444444444444444,
             "#bd3786"
            ],
            [
             0.5555555555555556,
             "#d8576b"
            ],
            [
             0.6666666666666666,
             "#ed7953"
            ],
            [
             0.7777777777777778,
             "#fb9f3a"
            ],
            [
             0.8888888888888888,
             "#fdca26"
            ],
            [
             1.0,
             "#f0f921"
            ]
           ],
           "sequentialminus": [
            [
             0.0,
             "#0d0887"
            ],
            [
             0.1111111111111111,
             "#46039f"
            ],
            [
             0.2222222222222222,
             "#7201a8"
            ],
            [
             0.3333333333333333,
             "#9c179e"
            ],
            [
             0.4444444444444444,
             "#bd3786"
            ],
            [
             0.5555555555555556,
             "#d8576b"
            ],
            [
             0.6666666666666666,
             "#ed7953"
            ],
            [
             0.7777777777777778,
             "#fb9f3a"
            ],
            [
             0.8888888888888888,
             "#fdca26"
            ],
            [
             1.0,
             "#f0f921"
            ]
           ],
           "diverging": [
            [
             0,
             "#8e0152"
            ],
            [
             0.1,
             "#c51b7d"
            ],
            [
             0.2,
             "#de77ae"
            ],
            [
             0.3,
             "#f1b6da"
            ],
            [
             0.4,
             "#fde0ef"
            ],
            [
             0.5,
             "#f7f7f7"
            ],
            [
             0.6,
             "#e6f5d0"
            ],
            [
             0.7,
             "#b8e186"
            ],
            [
             0.8,
             "#7fbc41"
            ],
            [
             0.9,
             "#4d9221"
            ],
            [
             1,
             "#276419"
            ]
           ]
          },
          "xaxis": {
           "gridcolor": "white",
           "linecolor": "white",
           "ticks": "",
           "title": {
            "standoff": 15
           },
           "zerolinecolor": "white",
           "automargin": true,
           "zerolinewidth": 2
          },
          "yaxis": {
           "gridcolor": "white",
           "linecolor": "white",
           "ticks": "",
           "title": {
            "standoff": 15
           },
           "zerolinecolor": "white",
           "automargin": true,
           "zerolinewidth": 2
          },
          "scene": {
           "xaxis": {
            "backgroundcolor": "#E5ECF6",
            "gridcolor": "white",
            "linecolor": "white",
            "showbackground": true,
            "ticks": "",
            "zerolinecolor": "white",
            "gridwidth": 2
           },
           "yaxis": {
            "backgroundcolor": "#E5ECF6",
            "gridcolor": "white",
            "linecolor": "white",
            "showbackground": true,
            "ticks": "",
            "zerolinecolor": "white",
            "gridwidth": 2
           },
           "zaxis": {
            "backgroundcolor": "#E5ECF6",
            "gridcolor": "white",
            "linecolor": "white",
            "showbackground": true,
            "ticks": "",
            "zerolinecolor": "white",
            "gridwidth": 2
           }
          },
          "shapedefaults": {
           "line": {
            "color": "#2a3f5f"
           }
          },
          "annotationdefaults": {
           "arrowcolor": "#2a3f5f",
           "arrowhead": 0,
           "arrowwidth": 1
          },
          "geo": {
           "bgcolor": "white",
           "landcolor": "#E5ECF6",
           "subunitcolor": "white",
           "showland": true,
           "showlakes": true,
           "lakecolor": "white"
          },
          "title": {
           "x": 0.05
          },
          "mapbox": {
           "style": "light"
          }
         }
        },
        "xaxis": {
         "anchor": "y",
         "domain": [
          0.0,
          1.0
         ],
         "title": {
          "text": "Subreddit Contribution (%)"
         },
         "range": [
          0,
          100
         ],
         "ticksuffix": "%"
        },
        "yaxis": {
         "anchor": "x",
         "domain": [
          0.0,
          1.0
         ],
         "title": {
          "text": "Topic Name (Sorted by Increasing PeterAttia %)"
         },
         "categoryorder": "array",
         "categoryarray": [
          "mg",
          "epigenetic_methylation_age_aging",
          "cells_stem_cell",
          "aging_cells_senescence",
          "biohacking",
          "1_to_and_it_my",
          "light_sauna",
          "alzheimer_cognitive_disease_amyloid",
          "nmn_resveratrol",
          "gut",
          "vitamin_supplements",
          "sleep",
          "sick_throat_immune",
          "magnetic_fields_expression_mitochondrial",
          "water_bottled_tap_plastic",
          "testosterone",
          "longevity_aging_link",
          "alcohol_nicotine",
          "pain_have",
          "app_watch",
          "protein_eat",
          "blood_tests_test",
          "peter",
          "ldl_cholesterol_apob",
          "zone_training_max"
         ]
        },
        "legend": {
         "title": {
          "text": "Subreddit"
         },
         "tracegroupgap": 0
        },
        "title": {
         "text": "Subreddit Contribution to Topics (Ordered by Lowest PeterAttia %)"
        },
        "barmode": "stack",
        "height": 1500,
        "width": 900,
        "margin": {
         "l": 250,
         "r": 20,
         "t": 50,
         "b": 50
        }
       },
       "config": {
        "plotlyServerURL": "https://plot.ly"
       }
      }
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<IPython.core.display.Image object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "‚úÖ Subreddit contribution visualization generated, ordered by lowest PeterAttia dominance, and saved to PNG successfully.\n"
     ]
    }
   ],
   "execution_count": 20
  },
  {
   "metadata": {},
   "cell_type": "markdown",
   "source": [
    "- **Biohackers dominates most topics** (purple): training/VO‚ÇÇ, devices (Oura/Dreem), protein intake/whey, blood pressure, and broad lab-test threads are largely driven by r/Biohackers, with very little PeterAttia participation.\n",
    "- **r/Longevity leads diet & pharma debates** (green): keto vs. plant-based/carnivore, fasting/sauna, homocysteine‚ÄìB12/folate/MTHFR, metformin/berberine, olive oil & lipid markers show higher Longevity shares than the other subs.\n",
    "- **PeterAttia shows up most in supplement/biomarker ‚Äúprotocol‚Äù topics** (blue tail): NR/resveratrol/Sinclair, quercetin‚Äìfisetin, NAC/glycine/taurine, collagen/skin, energy/fatigue, and women‚Äôs health threads (e.g., PCOS/menopause) have the highest relative PeterAttia percentages‚Äîstill usually <~30%.\n",
    "- **Notable asymmetry:** even ‚ÄúAttia‚Äù meta-content (e.g., podcast/book) is discussed more in Biohackers/Longevity than on r/PeterAttia itself, suggesting cross-subreddit reach and that his own sub engages more narrowly in protocol-focused discussions."
   ],
   "id": "ba21bb453c561c8d"
  },
  {
   "metadata": {},
   "cell_type": "markdown",
   "source": [
    "# üå≥ STEP 6: Hierarchical Topic Visualization (Top 10 Topics)\n",
    "\n",
    "This step generates a **dendrogram** (a tree-like diagram) to visually represent the structural relationships between the most popular topics, allowing for the identification of broader, umbrella themes.\n",
    "\n",
    "* **Goal:** To understand how closely related the topics are by visualizing the clusters in the UMAP space. Closely related topics are merged into larger nodes, forming a hierarchy.\n",
    "* **Topic Selection:** The visualization is explicitly **filtered** to include only the **Top 10 largest topics** (based on document count), ensuring the dendrogram is clear and focuses on the most voluminous discussions.\n",
    "* **Process:**\n",
    "    1.  The `hierarchical_topics` are computed using **topic embeddings** to calculate inter-topic distances.\n",
    "    2.  The `visualize_hierarchy` function then plots these relationships.\n",
    "* **Interpretation:** Clusters that branch off together represent sub-topics belonging to a common, overarching theme (e.g., *ldl\\_cholesterol* and *statins\\_risk* might merge under the theme of **Cardiovascular Health**)."
   ],
   "id": "edd1f65c65ae86a"
  },
  {
   "metadata": {
    "ExecuteTime": {
     "end_time": "2025-11-04T21:50:22.918138Z",
     "start_time": "2025-11-04T21:50:22.575528Z"
    }
   },
   "cell_type": "code",
   "source": [
    "# ====================================================================\n",
    "# === STEP 6: HIERARCHICAL TOPIC VISUALIZATION (Top 10 Topics) ===\n",
    "# ====================================================================\n",
    "\n",
    "import plotly.figure_factory as ff\n",
    "import pandas as pd\n",
    "import numpy as np\n",
    "import plotly.offline as py\n",
    "\n",
    "print(\"üå≥ Generating Hierarchical Topic Structure for only the TOP 10 Topics...\")\n",
    "# --- 1. Identify Top 10 Topics ---\n",
    "# Get topic info, exclude outlier (-1), and sort by Count\n",
    "df_topic_sizes = topic_model.get_topic_info().query(\"Topic != -1\").sort_values(\"Count\", ascending=False)\n",
    "top_10_topic_ids = df_topic_sizes[\"Topic\"].head(80).tolist()\n",
    "top_10_topic_names = df_topic_sizes[[\"Topic\", \"Name\"]].head(10).to_markdown(index=False)\n",
    "\n",
    "print(f\"Using the following Top 10 Topics for visualization:\\n{top_10_topic_names}\")\n",
    "\n",
    "# --- 2. Compute Hierarchical Topics (on all docs, but we will filter the visualization) ---\n",
    "# It's generally best to compute the hierarchy on all topics first.\n",
    "hierarchical_topics = topic_model.hierarchical_topics(docs)\n",
    "print(f\"‚úÖ Hierarchical topics computed.\")\n",
    "\n",
    "\n",
    "# --- 3. Visualize the Dendrogram, filtering for Top 10 ---\n",
    "fig_hierarchy = topic_model.visualize_hierarchy(\n",
    "    hierarchical_topics=hierarchical_topics,\n",
    "    topics=top_10_topic_ids,  # <--- KEY CHANGE: Filter to only the Top 10 IDs\n",
    "    custom_labels=False,\n",
    "    width=1000,\n",
    "    height=800\n",
    ")\n",
    "\n",
    "# Customizing the title and layout\n",
    "fig_hierarchy.update_layout(\n",
    "    title={\n",
    "        'text': \"Inter-Topic Hierarchy (Dendrogram) - Top 10 Topics Only\",\n",
    "        'y':0.95,\n",
    "        'x':0.5,\n",
    "        'xanchor': 'center',\n",
    "        'yanchor': 'top'\n",
    "    },\n",
    "    margin=dict(l=10, r=10, t=50, b=10)\n",
    ")\n",
    "\n",
    "fig_hierarchy.show()\n",
    "\n",
    "print(\"\\n‚úÖ Hierarchical topic visualization for Top 10 topics generated.\")"
   ],
   "id": "34dda3840550d878",
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "üå≥ Generating Hierarchical Topic Structure for only the TOP 10 Topics...\n",
      "Using the following Top 10 Topics for visualization:\n",
      "|   Topic | Name                         |\n",
      "|--------:|:-----------------------------|\n",
      "|       0 | 0_vitamin_and_supplements_to |\n",
      "|       1 | 1_to_and_it_my               |\n",
      "|       2 | 2_longevity_the_aging_link   |\n",
      "|       3 | 3_ldl_cholesterol_my_apob    |\n",
      "|       4 | 4_zone_training_max_to       |\n",
      "|       5 | 5_sleep_up_to_and            |\n",
      "|       6 | 6_light_the_sauna_to         |\n",
      "|       7 | 7_aging_cells_senescence_in  |\n",
      "|       8 | 8_testosterone_the_and_my    |\n",
      "|       9 | 9_biohacking_to_you_and      |\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|‚ñà‚ñà‚ñà‚ñà‚ñà‚ñà‚ñà‚ñà‚ñà‚ñà| 25/25 [00:00<00:00, 264.35it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "‚úÖ Hierarchical topics computed.\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "\n"
     ]
    },
    {
     "data": {
      "application/vnd.plotly.v1+json": {
       "data": [
        {
         "hoverinfo": "text",
         "marker": {
          "color": "rgb(61,153,112)"
         },
         "mode": "lines",
         "text": [
          "alzheimer_cognitive_disease_amyloid_in",
          "",
          "",
          "sick_throat_and_immune_to"
         ],
         "x": {
          "dtype": "f8",
          "bdata": "AAAAAAAAAAAgFHVVP8/oPyAUdVU/z+g/AAAAAAAAAAA="
         },
         "xaxis": "x",
         "y": {
          "dtype": "f8",
          "bdata": "AAAAAAAAFMAAAAAAAAAUwAAAAAAAAC7AAAAAAAAALsA="
         },
         "yaxis": "y",
         "type": "scatter"
        },
        {
         "hoverinfo": "text",
         "marker": {
          "color": "rgb(61,153,112)"
         },
         "mode": "lines",
         "text": [
          "aging_cells_senescence_in_of",
          "",
          "",
          "longevity_the_aging_link_of"
         ],
         "x": {
          "dtype": "f8",
          "bdata": "AAAAAAAAAABUJa+mCqjeP1Qlr6YKqN4/AAAAAAAAAAA="
         },
         "xaxis": "x",
         "y": {
          "dtype": "f8",
          "bdata": "AAAAAACAQcAAAAAAAIBBwAAAAAAAgEbAAAAAAACARsA="
         },
         "yaxis": "y",
         "type": "scatter"
        },
        {
         "hoverinfo": "text",
         "marker": {
          "color": "rgb(61,153,112)"
         },
         "mode": "lines",
         "text": [
          "epigenetic_methylation_age_aging_dna",
          "",
          "",
          "longevity_aging_the_of_in"
         ],
         "x": {
          "dtype": "f8",
          "bdata": "AAAAAAAAAABDyo0bhDLmP0PKjRuEMuY/VCWvpgqo3j8="
         },
         "xaxis": "x",
         "y": {
          "dtype": "f8",
          "bdata": "AAAAAAAAOcAAAAAAAAA5wAAAAAAAAETAAAAAAAAARMA="
         },
         "yaxis": "y",
         "type": "scatter"
        },
        {
         "hoverinfo": "text",
         "marker": {
          "color": "rgb(61,153,112)"
         },
         "mode": "lines",
         "text": [
          "aging_longevity_the_of_in",
          "",
          "",
          "protein_eat_and_to_calories"
         ],
         "x": {
          "dtype": "f8",
          "bdata": "Q8qNG4Qy5j/fa22UhNboP99rbZSE1ug/AAAAAAAAAAA="
         },
         "xaxis": "x",
         "y": {
          "dtype": "f8",
          "bdata": "AAAAAABAQMAAAAAAAEBAwAAAAAAAgEvAAAAAAACAS8A="
         },
         "yaxis": "y",
         "type": "scatter"
        },
        {
         "hoverinfo": "text",
         "marker": {
          "color": "rgb(61,153,112)"
         },
         "mode": "lines",
         "text": [
          "aging_longevity_the_of_in",
          "",
          "",
          "protein_eat_and_to_calories"
         ],
         "x": {
          "dtype": "f8",
          "bdata": "IBR1VT/P6D94M3eeom3pP3gzd56ibek/32ttlITW6D8="
         },
         "xaxis": "x",
         "y": {
          "dtype": "f8",
          "bdata": "AAAAAAAAJMAAAAAAAAAkwAAAAAAA4EXAAAAAAADgRcA="
         },
         "yaxis": "y",
         "type": "scatter"
        },
        {
         "hoverinfo": "text",
         "marker": {
          "color": "rgb(255,65,54)"
         },
         "mode": "lines",
         "text": [
          "blood_tests_test_to_for",
          "",
          "",
          "gut_and_my_to_it"
         ],
         "x": {
          "dtype": "f8",
          "bdata": "AAAAAAAAAAB40ZOL5K3WP3jRk4vkrdY/AAAAAAAAAAA="
         },
         "xaxis": "x",
         "y": {
          "dtype": "f8",
          "bdata": "AAAAAADAV8AAAAAAAMBXwAAAAAAAQFrAAAAAAABAWsA="
         },
         "yaxis": "y",
         "type": "scatter"
        },
        {
         "hoverinfo": "text",
         "marker": {
          "color": "rgb(255,65,54)"
         },
         "mode": "lines",
         "text": [
          "vitamin_and_supplements_to_take",
          "",
          "",
          "to_and_it_my_the"
         ],
         "x": {
          "dtype": "f8",
          "bdata": "AAAAAAAAAAAoG8ZywkLPPygbxnLCQs8/AAAAAAAAAAA="
         },
         "xaxis": "x",
         "y": {
          "dtype": "f8",
          "bdata": "AAAAAADAXMAAAAAAAMBcwAAAAAAAQF/AAAAAAABAX8A="
         },
         "yaxis": "y",
         "type": "scatter"
        },
        {
         "hoverinfo": "text",
         "marker": {
          "color": "rgb(255,65,54)"
         },
         "mode": "lines",
         "text": [
          "and_to_it_my_of",
          "",
          "",
          "testosterone_the_and_my_to"
         ],
         "x": {
          "dtype": "f8",
          "bdata": "KBvGcsJCzz/k8rxJpqjUP+TyvEmmqNQ/AAAAAAAAAAA="
         },
         "xaxis": "x",
         "y": {
          "dtype": "f8",
          "bdata": "AAAAAAAAXsAAAAAAAABewAAAAAAA4GDAAAAAAADgYMA="
         },
         "yaxis": "y",
         "type": "scatter"
        },
        {
         "hoverinfo": "text",
         "marker": {
          "color": "rgb(255,65,54)"
         },
         "mode": "lines",
         "text": [
          "and_to_it_my_of",
          "",
          "",
          "and_to_my_the_of"
         ],
         "x": {
          "dtype": "f8",
          "bdata": "eNGTi+St1j9VBu+hkm7YP1UG76GSbtg/5PK8Saao1D8="
         },
         "xaxis": "x",
         "y": {
          "dtype": "f8",
          "bdata": "AAAAAAAAWcAAAAAAAABZwAAAAAAA4F/AAAAAAADgX8A="
         },
         "yaxis": "y",
         "type": "scatter"
        },
        {
         "hoverinfo": "text",
         "marker": {
          "color": "rgb(255,65,54)"
         },
         "mode": "lines",
         "text": [
          "hair_grey_minoxidil_and_balding",
          "",
          "",
          "and_to_my_the_of"
         ],
         "x": {
          "dtype": "f8",
          "bdata": "AAAAAAAAAADhKWRxPebaP+EpZHE95to/VQbvoZJu2D8="
         },
         "xaxis": "x",
         "y": {
          "dtype": "f8",
          "bdata": "AAAAAABAVcAAAAAAAEBVwAAAAAAAcFzAAAAAAABwXMA="
         },
         "yaxis": "y",
         "type": "scatter"
        },
        {
         "hoverinfo": "text",
         "marker": {
          "color": "rgb(255,65,54)"
         },
         "mode": "lines",
         "text": [
          "sleep_up_to_and_the",
          "",
          "",
          "light_the_sauna_to_red"
         ],
         "x": {
          "dtype": "f8",
          "bdata": "AAAAAAAAAACcq7ZnKPHVP5yrtmco8dU/AAAAAAAAAAA="
         },
         "xaxis": "x",
         "y": {
          "dtype": "f8",
          "bdata": "AAAAAAAgYsAAAAAAACBiwAAAAAAAYGPAAAAAAABgY8A="
         },
         "yaxis": "y",
         "type": "scatter"
        },
        {
         "hoverinfo": "text",
         "marker": {
          "color": "rgb(255,65,54)"
         },
         "mode": "lines",
         "text": [
          "sleep_up_to_and_the",
          "",
          "",
          "sleep_the_light_to_and"
         ],
         "x": {
          "dtype": "f8",
          "bdata": "4SlkcT3m2j+sxI7r46vcP6zEjuvjq9w/nKu2Zyjx1T8="
         },
         "xaxis": "x",
         "y": {
          "dtype": "f8",
          "bdata": "AAAAAADYWMAAAAAAANhYwAAAAAAAwGLAAAAAAADAYsA="
         },
         "yaxis": "y",
         "type": "scatter"
        },
        {
         "hoverinfo": "text",
         "marker": {
          "color": "rgb(255,65,54)"
         },
         "mode": "lines",
         "text": [
          "alcohol_nicotine_it_the_drinking",
          "",
          "",
          "pain_and_my_have_for"
         ],
         "x": {
          "dtype": "f8",
          "bdata": "AAAAAAAAAADycU9wU8DbP/JxT3BTwNs/AAAAAAAAAAA="
         },
         "xaxis": "x",
         "y": {
          "dtype": "f8",
          "bdata": "AAAAAACgZMAAAAAAAKBkwAAAAAAA4GXAAAAAAADgZcA="
         },
         "yaxis": "y",
         "type": "scatter"
        },
        {
         "hoverinfo": "text",
         "marker": {
          "color": "rgb(255,65,54)"
         },
         "mode": "lines",
         "text": [
          "alcohol_nicotine_it_the_drinking",
          "",
          "",
          "pain_and_my_have_for"
         ],
         "x": {
          "dtype": "f8",
          "bdata": "rMSO6+Or3D9Hnqd3/o7eP0eep3f+jt4/8nFPcFPA2z8="
         },
         "xaxis": "x",
         "y": {
          "dtype": "f8",
          "bdata": "AAAAAAAsX8AAAAAAACxfwAAAAAAAQGXAAAAAAABAZcA="
         },
         "yaxis": "y",
         "type": "scatter"
        },
        {
         "hoverinfo": "text",
         "marker": {
          "color": "rgb(255,65,54)"
         },
         "mode": "lines",
         "text": [
          "water_bottled_tap_plastic_microplastics",
          "",
          "",
          "pain_and_my_have_for"
         ],
         "x": {
          "dtype": "f8",
          "bdata": "AAAAAAAAAACh08LI9FXhP6HTwsj0VeE/R56nd/6O3j8="
         },
         "xaxis": "x",
         "y": {
          "dtype": "f8",
          "bdata": "AAAAAADAUsAAAAAAAMBSwAAAAAAAa2LAAAAAAABrYsA="
         },
         "yaxis": "y",
         "type": "scatter"
        },
        {
         "hoverinfo": "text",
         "marker": {
          "color": "rgb(255,65,54)"
         },
         "mode": "lines",
         "text": [
          "app_watch_the_to_you",
          "",
          "",
          "biohacking_to_you_and_the"
         ],
         "x": {
          "dtype": "f8",
          "bdata": "AAAAAAAAAACmfj7G123bP6Z+PsbXbds/AAAAAAAAAAA="
         },
         "xaxis": "x",
         "y": {
          "dtype": "f8",
          "bdata": "AAAAAAAgZ8AAAAAAACBnwAAAAAAAYGjAAAAAAABgaMA="
         },
         "yaxis": "y",
         "type": "scatter"
        },
        {
         "hoverinfo": "text",
         "marker": {
          "color": "rgb(255,65,54)"
         },
         "mode": "lines",
         "text": [
          "to_you_biohacking_the_and",
          "",
          "",
          "cells_stem_cell_the_aged"
         ],
         "x": {
          "dtype": "f8",
          "bdata": "pn4+xtdt2z/EwBGdBxbdP8TAEZ0HFt0/AAAAAAAAAAA="
         },
         "xaxis": "x",
         "y": {
          "dtype": "f8",
          "bdata": "AAAAAADAZ8AAAAAAAMBnwAAAAAAAoGnAAAAAAACgacA="
         },
         "yaxis": "y",
         "type": "scatter"
        },
        {
         "hoverinfo": "text",
         "marker": {
          "color": "rgb(255,65,54)"
         },
         "mode": "lines",
         "text": [
          "ldl_cholesterol_my_apob_dl",
          "",
          "",
          "zone_training_max_to_the"
         ],
         "x": {
          "dtype": "f8",
          "bdata": "AAAAAAAAAAD4Sdrsk0HdP/hJ2uyTQd0/AAAAAAAAAAA="
         },
         "xaxis": "x",
         "y": {
          "dtype": "f8",
          "bdata": "AAAAAADgasAAAAAAAOBqwAAAAAAAIGzAAAAAAAAgbMA="
         },
         "yaxis": "y",
         "type": "scatter"
        },
        {
         "hoverinfo": "text",
         "marker": {
          "color": "rgb(255,65,54)"
         },
         "mode": "lines",
         "text": [
          "zone_my_to_the_and",
          "",
          "",
          "the_peter_in_of_and"
         ],
         "x": {
          "dtype": "f8",
          "bdata": "+Ena7JNB3T9dSHuq2rHgP11Ie6raseA/AAAAAAAAAAA="
         },
         "xaxis": "x",
         "y": {
          "dtype": "f8",
          "bdata": "AAAAAACAa8AAAAAAAIBrwAAAAAAAYG3AAAAAAABgbcA="
         },
         "yaxis": "y",
         "type": "scatter"
        },
        {
         "hoverinfo": "text",
         "marker": {
          "color": "rgb(255,65,54)"
         },
         "mode": "lines",
         "text": [
          "zone_my_to_the_and",
          "",
          "",
          "zone_the_my_to_and"
         ],
         "x": {
          "dtype": "f8",
          "bdata": "xMARnQcW3T+Hs/vqVevhP4ez++pV6+E/XUh7qtqx4D8="
         },
         "xaxis": "x",
         "y": {
          "dtype": "f8",
          "bdata": "AAAAAACwaMAAAAAAALBowAAAAAAAcGzAAAAAAABwbMA="
         },
         "yaxis": "y",
         "type": "scatter"
        },
        {
         "hoverinfo": "text",
         "marker": {
          "color": "rgb(255,65,54)"
         },
         "mode": "lines",
         "text": [
          "zone_my_to_the_and",
          "",
          "",
          "zone_the_my_to_and"
         ],
         "x": {
          "dtype": "f8",
          "bdata": "odPCyPRV4T/n7rm/p9bjP+fuub+n1uM/h7P76lXr4T8="
         },
         "xaxis": "x",
         "y": {
          "dtype": "f8",
          "bdata": "AAAAAADLW8AAAAAAAMtbwAAAAAAAkGrAAAAAAACQasA="
         },
         "yaxis": "y",
         "type": "scatter"
        },
        {
         "hoverinfo": "text",
         "marker": {
          "color": "rgb(255,65,54)"
         },
         "mode": "lines",
         "text": [
          "zone_my_to_the_and",
          "",
          "",
          "nmn_resveratrol_and_in_nad"
         ],
         "x": {
          "dtype": "f8",
          "bdata": "5+65v6fW4z+iiKh8IfTlP6KIqHwh9OU/AAAAAAAAAAA="
         },
         "xaxis": "x",
         "y": {
          "dtype": "f8",
          "bdata": "AAAAAMA6ZMAAAAAAwDpkwAAAAAAAoG7AAAAAAACgbsA="
         },
         "yaxis": "y",
         "type": "scatter"
        },
        {
         "hoverinfo": "text",
         "marker": {
          "color": "rgb(255,65,54)"
         },
         "mode": "lines",
         "text": [
          "my_it_and_mg_to",
          "",
          "",
          "nmn_resveratrol_and_in_nad"
         ],
         "x": {
          "dtype": "f8",
          "bdata": "AAAAAAAAAACbb6vhBinoP5tvq+EGKeg/ooiofCH05T8="
         },
         "xaxis": "x",
         "y": {
          "dtype": "f8",
          "bdata": "AAAAAABAUMAAAAAAAEBQwAAAAABgbWnAAAAAAGBtacA="
         },
         "yaxis": "y",
         "type": "scatter"
        },
        {
         "hoverinfo": "text",
         "marker": {
          "color": "rgb(255,65,54)"
         },
         "mode": "lines",
         "text": [
          "my_it_and_mg_to",
          "",
          "",
          "magnetic_fields_expression_mitochondrial_nad"
         ],
         "x": {
          "dtype": "f8",
          "bdata": "m2+r4QYp6D9k929YcqrqP2T3b1hyquo/AAAAAAAAAAA="
         },
         "xaxis": "x",
         "y": {
          "dtype": "f8",
          "bdata": "AAAAALDGYMAAAAAAsMZgwAAAAAAA4G/AAAAAAADgb8A="
         },
         "yaxis": "y",
         "type": "scatter"
        },
        {
         "hoverinfo": "text",
         "marker": {
          "color": "rgb(0,116,217)"
         },
         "mode": "lines",
         "text": [
          "my_it_and_mg_to",
          "",
          "",
          "magnetic_fields_expression_mitochondrial_nad"
         ],
         "x": {
          "dtype": "f8",
          "bdata": "eDN3nqJt6T+COGKqCv/1P4I4YqoK//U/ZPdvWHKq6j8="
         },
         "xaxis": "x",
         "y": {
          "dtype": "f8",
          "bdata": "AAAAAADgOsAAAAAAAOA6wAAAAABYU2jAAAAAAFhTaMA="
         },
         "yaxis": "y",
         "type": "scatter"
        },
        {
         "hoverinfo": "text",
         "hovertext": [
          "aging_longevity_the_of_in",
          "aging_longevity_the_of_in",
          "and_to_it_my_of",
          "and_to_it_my_of",
          "sleep_up_to_and_the",
          "alcohol_nicotine_it_the_drinking",
          "to_you_biohacking_the_and",
          "zone_my_to_the_and",
          "zone_my_to_the_and",
          "zone_my_to_the_and",
          "zone_my_to_the_and",
          "my_it_and_mg_to",
          "my_it_and_mg_to"
         ],
         "marker": {
          "color": "black"
         },
         "mode": "markers",
         "showlegend": false,
         "x": [
          0.6936665094529605,
          0.7752987546051635,
          0.24422484020416246,
          0.35436357145888264,
          0.42030273507466914,
          0.44799135211639896,
          0.4285792766549811,
          0.4571275532736361,
          0.45446958864978293,
          0.541742698775682,
          0.6199530357984856,
          0.7550081641779686,
          0.7946332068473643
         ],
         "y": [
          -32.5,
          -10.0,
          -120.0,
          -100.0,
          -99.375,
          -124.6875,
          -190.0,
          -220.0,
          -197.5,
          -111.171875,
          -161.8359375,
          -134.208984375,
          -26.875
         ],
         "type": "scatter"
        },
        {
         "hoverinfo": "text",
         "hovertext": [
          "longevity_aging_the_of_in",
          "protein_eat_and_to_calories",
          "and_to_my_the_of",
          "and_to_my_the_of",
          "sleep_the_light_to_and",
          "pain_and_my_have_for",
          "pain_and_my_have_for",
          "zone_the_my_to_and",
          "zone_the_my_to_and",
          "nmn_resveratrol_and_in_nad",
          "magnetic_fields_expression_mitochondrial_nad"
         ],
         "marker": {
          "color": "black"
         },
         "mode": "markers",
         "showlegend": false,
         "x": [
          0.47900644567251516,
          0.7761862658475102,
          0.3227935524080705,
          0.38174882711255026,
          0.3428441059901901,
          0.4336136433392134,
          0.4774776619437699,
          0.5217107133596631,
          0.55997749228628,
          0.6860511240704634,
          0.8333064772884708
         ],
         "y": [
          -40.0,
          -43.75,
          -127.5,
          -113.75,
          -150.0,
          -170.0,
          -147.34375,
          -227.5,
          -212.5,
          -203.41796875,
          -194.6044921875
         ],
         "type": "scatter"
        }
       ],
       "layout": {
        "autosize": false,
        "height": 590,
        "hovermode": "closest",
        "showlegend": false,
        "width": 1000,
        "xaxis": {
         "mirror": "allticks",
         "rangemode": "tozero",
         "showgrid": false,
         "showline": true,
         "showticklabels": true,
         "ticks": "outside",
         "type": "linear",
         "zeroline": false
        },
        "yaxis": {
         "mirror": "allticks",
         "rangemode": "tozero",
         "showgrid": false,
         "showline": true,
         "showticklabels": true,
         "tickmode": "array",
         "ticks": "outside",
         "ticktext": [
          "10_alzheimer_cognitive_dise...",
          "24_magnetic_fields_expression",
          "16_epigenetic_methylation_age",
          "7_aging_cells_senescence",
          "2_longevity_the_aging",
          "14_cells_stem_cell",
          "23_hair_grey_minoxidil",
          "22_alcohol_nicotine_it",
          "20_sick_throat_and",
          "12_protein_eat_and",
          "17_gut_and_my",
          "0_vitamin_and_supplements",
          "1_to_and_it",
          "8_testosterone_the_and",
          "5_sleep_up_to",
          "6_light_the_sauna",
          "25_my_it_and",
          "18_pain_and_my",
          "11_app_watch_the",
          "9_biohacking_to_you",
          "13_blood_tests_test",
          "3_ldl_cholesterol_my",
          "4_zone_training_max",
          "15_the_peter_in",
          "19_nmn_resveratrol_and",
          "21_water_bottled_tap"
         ],
         "tickvals": [
          -5.0,
          -15.0,
          -25.0,
          -35.0,
          -45.0,
          -55.0,
          -65.0,
          -75.0,
          -85.0,
          -95.0,
          -105.0,
          -115.0,
          -125.0,
          -135.0,
          -145.0,
          -155.0,
          -165.0,
          -175.0,
          -185.0,
          -195.0,
          -205.0,
          -215.0,
          -225.0,
          -235.0,
          -245.0,
          -255.0
         ],
         "type": "linear",
         "zeroline": false,
         "range": [
          -260.0,
          0.0
         ]
        },
        "template": {
         "data": {
          "barpolar": [
           {
            "marker": {
             "line": {
              "color": "white",
              "width": 0.5
             },
             "pattern": {
              "fillmode": "overlay",
              "size": 10,
              "solidity": 0.2
             }
            },
            "type": "barpolar"
           }
          ],
          "bar": [
           {
            "error_x": {
             "color": "#2a3f5f"
            },
            "error_y": {
             "color": "#2a3f5f"
            },
            "marker": {
             "line": {
              "color": "white",
              "width": 0.5
             },
             "pattern": {
              "fillmode": "overlay",
              "size": 10,
              "solidity": 0.2
             }
            },
            "type": "bar"
           }
          ],
          "carpet": [
           {
            "aaxis": {
             "endlinecolor": "#2a3f5f",
             "gridcolor": "#C8D4E3",
             "linecolor": "#C8D4E3",
             "minorgridcolor": "#C8D4E3",
             "startlinecolor": "#2a3f5f"
            },
            "baxis": {
             "endlinecolor": "#2a3f5f",
             "gridcolor": "#C8D4E3",
             "linecolor": "#C8D4E3",
             "minorgridcolor": "#C8D4E3",
             "startlinecolor": "#2a3f5f"
            },
            "type": "carpet"
           }
          ],
          "choropleth": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "type": "choropleth"
           }
          ],
          "contourcarpet": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "type": "contourcarpet"
           }
          ],
          "contour": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0.0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1.0,
              "#f0f921"
             ]
            ],
            "type": "contour"
           }
          ],
          "heatmap": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0.0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1.0,
              "#f0f921"
             ]
            ],
            "type": "heatmap"
           }
          ],
          "histogram2dcontour": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0.0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1.0,
              "#f0f921"
             ]
            ],
            "type": "histogram2dcontour"
           }
          ],
          "histogram2d": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0.0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1.0,
              "#f0f921"
             ]
            ],
            "type": "histogram2d"
           }
          ],
          "histogram": [
           {
            "marker": {
             "pattern": {
              "fillmode": "overlay",
              "size": 10,
              "solidity": 0.2
             }
            },
            "type": "histogram"
           }
          ],
          "mesh3d": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "type": "mesh3d"
           }
          ],
          "parcoords": [
           {
            "line": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "parcoords"
           }
          ],
          "pie": [
           {
            "automargin": true,
            "type": "pie"
           }
          ],
          "scatter3d": [
           {
            "line": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scatter3d"
           }
          ],
          "scattercarpet": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scattercarpet"
           }
          ],
          "scattergeo": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scattergeo"
           }
          ],
          "scattergl": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scattergl"
           }
          ],
          "scattermapbox": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scattermapbox"
           }
          ],
          "scattermap": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scattermap"
           }
          ],
          "scatterpolargl": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scatterpolargl"
           }
          ],
          "scatterpolar": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scatterpolar"
           }
          ],
          "scatter": [
           {
            "fillpattern": {
             "fillmode": "overlay",
             "size": 10,
             "solidity": 0.2
            },
            "type": "scatter"
           }
          ],
          "scatterternary": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scatterternary"
           }
          ],
          "surface": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0.0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1.0,
              "#f0f921"
             ]
            ],
            "type": "surface"
           }
          ],
          "table": [
           {
            "cells": {
             "fill": {
              "color": "#EBF0F8"
             },
             "line": {
              "color": "white"
             }
            },
            "header": {
             "fill": {
              "color": "#C8D4E3"
             },
             "line": {
              "color": "white"
             }
            },
            "type": "table"
           }
          ]
         },
         "layout": {
          "annotationdefaults": {
           "arrowcolor": "#2a3f5f",
           "arrowhead": 0,
           "arrowwidth": 1
          },
          "autotypenumbers": "strict",
          "coloraxis": {
           "colorbar": {
            "outlinewidth": 0,
            "ticks": ""
           }
          },
          "colorscale": {
           "diverging": [
            [
             0,
             "#8e0152"
            ],
            [
             0.1,
             "#c51b7d"
            ],
            [
             0.2,
             "#de77ae"
            ],
            [
             0.3,
             "#f1b6da"
            ],
            [
             0.4,
             "#fde0ef"
            ],
            [
             0.5,
             "#f7f7f7"
            ],
            [
             0.6,
             "#e6f5d0"
            ],
            [
             0.7,
             "#b8e186"
            ],
            [
             0.8,
             "#7fbc41"
            ],
            [
             0.9,
             "#4d9221"
            ],
            [
             1,
             "#276419"
            ]
           ],
           "sequential": [
            [
             0.0,
             "#0d0887"
            ],
            [
             0.1111111111111111,
             "#46039f"
            ],
            [
             0.2222222222222222,
             "#7201a8"
            ],
            [
             0.3333333333333333,
             "#9c179e"
            ],
            [
             0.4444444444444444,
             "#bd3786"
            ],
            [
             0.5555555555555556,
             "#d8576b"
            ],
            [
             0.6666666666666666,
             "#ed7953"
            ],
            [
             0.7777777777777778,
             "#fb9f3a"
            ],
            [
             0.8888888888888888,
             "#fdca26"
            ],
            [
             1.0,
             "#f0f921"
            ]
           ],
           "sequentialminus": [
            [
             0.0,
             "#0d0887"
            ],
            [
             0.1111111111111111,
             "#46039f"
            ],
            [
             0.2222222222222222,
             "#7201a8"
            ],
            [
             0.3333333333333333,
             "#9c179e"
            ],
            [
             0.4444444444444444,
             "#bd3786"
            ],
            [
             0.5555555555555556,
             "#d8576b"
            ],
            [
             0.6666666666666666,
             "#ed7953"
            ],
            [
             0.7777777777777778,
             "#fb9f3a"
            ],
            [
             0.8888888888888888,
             "#fdca26"
            ],
            [
             1.0,
             "#f0f921"
            ]
           ]
          },
          "colorway": [
           "#636efa",
           "#EF553B",
           "#00cc96",
           "#ab63fa",
           "#FFA15A",
           "#19d3f3",
           "#FF6692",
           "#B6E880",
           "#FF97FF",
           "#FECB52"
          ],
          "font": {
           "color": "#2a3f5f"
          },
          "geo": {
           "bgcolor": "white",
           "lakecolor": "white",
           "landcolor": "white",
           "showlakes": true,
           "showland": true,
           "subunitcolor": "#C8D4E3"
          },
          "hoverlabel": {
           "align": "left"
          },
          "hovermode": "closest",
          "mapbox": {
           "style": "light"
          },
          "paper_bgcolor": "white",
          "plot_bgcolor": "white",
          "polar": {
           "angularaxis": {
            "gridcolor": "#EBF0F8",
            "linecolor": "#EBF0F8",
            "ticks": ""
           },
           "bgcolor": "white",
           "radialaxis": {
            "gridcolor": "#EBF0F8",
            "linecolor": "#EBF0F8",
            "ticks": ""
           }
          },
          "scene": {
           "xaxis": {
            "backgroundcolor": "white",
            "gridcolor": "#DFE8F3",
            "gridwidth": 2,
            "linecolor": "#EBF0F8",
            "showbackground": true,
            "ticks": "",
            "zerolinecolor": "#EBF0F8"
           },
           "yaxis": {
            "backgroundcolor": "white",
            "gridcolor": "#DFE8F3",
            "gridwidth": 2,
            "linecolor": "#EBF0F8",
            "showbackground": true,
            "ticks": "",
            "zerolinecolor": "#EBF0F8"
           },
           "zaxis": {
            "backgroundcolor": "white",
            "gridcolor": "#DFE8F3",
            "gridwidth": 2,
            "linecolor": "#EBF0F8",
            "showbackground": true,
            "ticks": "",
            "zerolinecolor": "#EBF0F8"
           }
          },
          "shapedefaults": {
           "line": {
            "color": "#2a3f5f"
           }
          },
          "ternary": {
           "aaxis": {
            "gridcolor": "#DFE8F3",
            "linecolor": "#A2B1C6",
            "ticks": ""
           },
           "baxis": {
            "gridcolor": "#DFE8F3",
            "linecolor": "#A2B1C6",
            "ticks": ""
           },
           "bgcolor": "white",
           "caxis": {
            "gridcolor": "#DFE8F3",
            "linecolor": "#A2B1C6",
            "ticks": ""
           }
          },
          "title": {
           "x": 0.05
          },
          "xaxis": {
           "automargin": true,
           "gridcolor": "#EBF0F8",
           "linecolor": "#EBF0F8",
           "ticks": "",
           "title": {
            "standoff": 15
           },
           "zerolinecolor": "#EBF0F8",
           "zerolinewidth": 2
          },
          "yaxis": {
           "automargin": true,
           "gridcolor": "#EBF0F8",
           "linecolor": "#EBF0F8",
           "ticks": "",
           "title": {
            "standoff": 15
           },
           "zerolinecolor": "#EBF0F8",
           "zerolinewidth": 2
          }
         }
        },
        "title": {
         "font": {
          "size": 22,
          "color": "Black"
         },
         "text": "Inter-Topic Hierarchy (Dendrogram) - Top 10 Topics Only",
         "x": 0.5,
         "xanchor": "center",
         "yanchor": "top",
         "y": 0.95
        },
        "hoverlabel": {
         "font": {
          "size": 16,
          "family": "Rockwell"
         },
         "bgcolor": "white"
        },
        "plot_bgcolor": "#ECEFF1",
        "margin": {
         "l": 10,
         "r": 10,
         "t": 50,
         "b": 10
        }
       },
       "config": {
        "plotlyServerURL": "https://plot.ly"
       }
      }
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "‚úÖ Hierarchical topic visualization for Top 10 topics generated.\n"
     ]
    }
   ],
   "execution_count": 9
  },
  {
   "metadata": {},
   "cell_type": "markdown",
   "source": [
    "# üó∫Ô∏è STEP 7: Comparative UMAP Topic Distribution (2x2 Grid)\n",
    "\n",
    "This step provides a powerful visual comparison of how the combined topic landscape is utilized by each individual subreddit, revealing unique clusters and shared density areas.\n",
    "\n",
    "* **Goal:** To visualize the 2D UMAP space across four panels: one for each of the three subreddits (highlighting only their documents) and one for the combined view (colored by subreddit).\n",
    "* **Data Preparation:** The 2D UMAP embeddings are generated, and a **y-axis threshold** (`MIN_Y_THRESHOLD = 3.5`) is applied to maintain plot focus, as in Step 5.\n",
    "* **Individual Subplot Design (Top-Left, Top-Right, Bottom-Left):**\n",
    "    * For each subreddit's panel, their documents are plotted using their **distinct color** (e.g., Peter Attia in Blue, Longevity in Red, etc.) with high opacity and large markers.\n",
    "    * All **other documents** (from the other subreddits and outliers) are plotted in the background using a **faint, neutral color** and low opacity.\n",
    "    * **Purpose:** This contrast allows viewers to see exactly which clusters are **dense** (core to that subreddit) and which are **sparse** (rarely discussed by that subreddit).\n",
    "* **Combined Subplot Design (Bottom-Right):**\n",
    "    * This final panel plots **all documents together**, colored by their originating subreddit.\n",
    "    * **Purpose:** It acts as a comprehensive map and the legend source for interpreting the individual panels.\n",
    "* **Result:** This 2x2 grid offers direct visual evidence of **topical specialization** (dense, unique clusters) and **topical overlap** (clusters where points of different colors mix)."
   ],
   "id": "668234922b19abe"
  },
  {
   "metadata": {
    "ExecuteTime": {
     "end_time": "2025-11-04T21:50:23.079200Z",
     "start_time": "2025-11-04T21:50:22.935298Z"
    }
   },
   "cell_type": "code",
   "source": [
    "# ====================================================================\n",
    "# === STEP 7: 2x2 GRID OF SUBREDDIT UMAP DISTRIBUTIONS ===\n",
    "# ====================================================================\n",
    "\n",
    "import pandas as pd\n",
    "import numpy as np\n",
    "import plotly.graph_objects as go\n",
    "from plotly.subplots import make_subplots\n",
    "import plotly.express as px # Still useful for getting color sequences\n",
    "\n",
    "print(\"üìä Generating 2x2 UMAP grid for subreddit distributions...\")\n",
    "\n",
    "# --- 1. Data Preparation (Reuse from Step 7) ---\n",
    "OUTLIER_ID = -1\n",
    "MIN_Y_THRESHOLD = 3.5\n",
    "\n",
    "# Ensure 'df', 'X', and 'topic_model' are available.\n",
    "# Get the 2D UMAP embeddings\n",
    "if topic_model.umap_model.n_components != 2:\n",
    "    if topic_model.umap_model.n_components > 2:\n",
    "        umap_embeddings_2d = topic_model.umap_model.transform(X)[:, :2]\n",
    "    else:\n",
    "        umap_embeddings_2d = None\n",
    "else:\n",
    "    umap_embeddings_2d = topic_model.umap_model.transform(X)\n",
    "\n",
    "if umap_embeddings_2d is None:\n",
    "    print(\"‚ùå Cannot create 2D visualization with current UMAP configuration.\")\n",
    "else:\n",
    "    plot_df = pd.DataFrame(umap_embeddings_2d, columns=['x', 'y'])\n",
    "    plot_df['topic_id'] = df['topic_global']\n",
    "    plot_df['document'] = df['doc']\n",
    "    plot_df['subreddit'] = df['subreddit']\n",
    "\n",
    "    # Apply y-axis threshold\n",
    "    plot_df = plot_df[plot_df['y'] >= MIN_Y_THRESHOLD].copy()\n",
    "\n",
    "    # Helper to clean topic names for display (for hover)\n",
    "    def clean_topic_name_for_display(topic_name):\n",
    "        RESIDUAL_GENERIC = {\"the\", \"to\", \"and\", \"of\", \"my\", \"in\", \"for\", \"is\", \"it\", \"that\", \"what\", \"we\", \"you\", \"on\", \"a\", \"an\", \"up\", \"from\"}\n",
    "        words = topic_name.split('_')\n",
    "        cleaned_words = []\n",
    "        seen = set()\n",
    "        for word in words:\n",
    "            if word.lower() not in RESIDUAL_GENERIC and word.strip() != '' and word.lower() not in seen:\n",
    "                cleaned_words.append(word)\n",
    "                seen.add(word.lower())\n",
    "        if cleaned_words and cleaned_words[0].isdigit():\n",
    "            cleaned_words = cleaned_words[1:]\n",
    "        if not cleaned_words:\n",
    "            return topic_name\n",
    "        return '_'.join(cleaned_words[:4])\n",
    "\n",
    "    topic_names_map = {topic_id: clean_topic_name_for_display(name)\n",
    "                       for topic_id, name in topic_model.topic_labels_.items()}\n",
    "    topic_names_map[OUTLIER_ID] = \"Outlier (-1)\"\n",
    "    plot_df['topic_name'] = plot_df['topic_id'].map(topic_names_map)\n",
    "\n",
    "    # Define custom colors for consistent visualization across subreddits\n",
    "    SUBREDDIT_COLORS = {\n",
    "        'PeterAttia': '#477AA3',  # Blue\n",
    "        'Longevity': '#CC5A71',   # Red\n",
    "        'Biohackers': '#2C8360',  # Green\n",
    "        'Outlier (-1)': 'lightgray',\n",
    "        'Other': 'rgba(200, 200, 200, 0.15)' # Color for unhighlighted points\n",
    "    }\n",
    "\n",
    "    # --- 2. Create Subplots Figure ---\n",
    "    fig = make_subplots(\n",
    "        rows=2, cols=2,\n",
    "        subplot_titles=(\"PeterAttia Subreddit\", \"Longevity Subreddit\", \"Biohackers Subreddit\", \"All Subreddits Combined\"),\n",
    "        horizontal_spacing=0.1, vertical_spacing=0.1\n",
    "    )\n",
    "\n",
    "    # --- 3. Plotting Individual Subreddits ---\n",
    "    subreddits_to_plot = ['PeterAttia', 'Longevity', 'Biohackers']\n",
    "    row_idx = 1\n",
    "    col_idx = 1\n",
    "\n",
    "    for subreddit_name in subreddits_to_plot:\n",
    "        # Filter for the current subreddit's documents\n",
    "        df_sub = plot_df[plot_df['subreddit'] == subreddit_name].copy()\n",
    "\n",
    "        # All other documents (for background context)\n",
    "        df_other = plot_df[\n",
    "            (plot_df['subreddit'] != subreddit_name) &\n",
    "            (plot_df['topic_id'] != OUTLIER_ID)\n",
    "        ].copy()\n",
    "\n",
    "        # Outlier documents (always lightgray and very transparent)\n",
    "        df_outliers = plot_df[plot_df['topic_id'] == OUTLIER_ID].copy()\n",
    "\n",
    "        # Plot background \"Other\" documents\n",
    "        fig.add_trace(\n",
    "            go.Scattergl(\n",
    "                x=df_other['x'], y=df_other['y'],\n",
    "                mode='markers',\n",
    "                marker=dict(\n",
    "                    size=4, opacity=0.1, color=SUBREDDIT_COLORS['Other'],\n",
    "                    line=dict(width=0.1, color='rgba(0,0,0,0.05)')\n",
    "                ),\n",
    "                name='Other Documents',\n",
    "                showlegend=False,\n",
    "                hoverinfo='none'\n",
    "            ),\n",
    "            row=row_idx, col=col_idx\n",
    "        )\n",
    "\n",
    "        # Plot Outliers (always in very faint gray)\n",
    "        fig.add_trace(\n",
    "            go.Scattergl(\n",
    "                x=df_outliers['x'], y=df_outliers['y'],\n",
    "                mode='markers',\n",
    "                marker=dict(\n",
    "                    size=4, opacity=0.1, color=SUBREDDIT_COLORS['Outlier (-1)'],\n",
    "                    line=dict(width=0.1, color='rgba(0,0,0,0.05)')\n",
    "                ),\n",
    "                name='Outlier (-1)',\n",
    "                showlegend=False,\n",
    "                hoverinfo='none'\n",
    "            ),\n",
    "            row=row_idx, col=col_idx\n",
    "        )\n",
    "\n",
    "\n",
    "        # Plot the CURRENT subreddit's documents (highlighted)\n",
    "        fig.add_trace(\n",
    "            go.Scattergl(\n",
    "                x=df_sub['x'], y=df_sub['y'],\n",
    "                mode='markers',\n",
    "                marker=dict(\n",
    "                    size=7, opacity=0.7, color=SUBREDDIT_COLORS[subreddit_name],\n",
    "                    line=dict(width=0.8, color='rgba(0,0,0,0.5)')\n",
    "                ),\n",
    "                name=subreddit_name,\n",
    "                showlegend=False, # Legend will be in the combined plot only\n",
    "                hoverinfo='text',\n",
    "                hovertext=df_sub.apply(lambda row: f\"Subreddit: {row['subreddit']}<br>Topic: {row['topic_name']}\", axis=1)\n",
    "            ),\n",
    "            row=row_idx, col=col_idx\n",
    "        )\n",
    "\n",
    "        # Advance subplot position\n",
    "        col_idx += 1\n",
    "        if col_idx > 2:\n",
    "            col_idx = 1\n",
    "            row_idx += 1\n",
    "\n",
    "    # --- 4. Plotting All Subreddits Combined (Bottom Right) ---\n",
    "    # We will use the 'subreddit_group' column from Step 7 for coloring\n",
    "    plot_df['subreddit_group'] = plot_df.apply(\n",
    "        lambda row: \"Outlier (-1)\" if row['topic_id'] == -1 else row['subreddit'], axis=1\n",
    "    )\n",
    "\n",
    "    # Sort for consistent layering (outliers first)\n",
    "    plot_df_sorted = plot_df.sort_values(by='topic_id', ascending=True).copy()\n",
    "\n",
    "    # Define color map for the combined plot, ensuring 'Other Topics' isn't accidentally created\n",
    "    combined_color_map = {\n",
    "        'Biohackers': SUBREDDIT_COLORS['Biohackers'],\n",
    "        'Longevity': SUBREDDIT_COLORS['Longevity'],\n",
    "        'PeterAttia': SUBREDDIT_COLORS['PeterAttia'],\n",
    "        'Outlier (-1)': SUBREDDIT_COLORS['Outlier (-1)']\n",
    "    }\n",
    "\n",
    "    fig.add_trace(\n",
    "        go.Scattergl(\n",
    "            x=plot_df_sorted['x'], y=plot_df_sorted['y'],\n",
    "            mode='markers',\n",
    "            marker=dict(\n",
    "                size=6, opacity=0.4,\n",
    "                color=plot_df_sorted['subreddit_group'].map(combined_color_map),\n",
    "                line=dict(width=0.5, color='rgba(0,0,0,0.3)')\n",
    "            ),\n",
    "            name=\"All Subreddits\", # Dummy name, actual legend will be generated by color\n",
    "            showlegend=False, # We'll manage legend manually below\n",
    "            hoverinfo='text',\n",
    "            hovertext=plot_df_sorted.apply(lambda row: f\"Subreddit: {row['subreddit']}<br>Topic: {row['topic_name']}\", axis=1)\n",
    "        ),\n",
    "        row=2, col=2\n",
    "    )\n",
    "\n",
    "    # Manually add legend items for the combined plot\n",
    "    for sub, color in combined_color_map.items():\n",
    "        if sub != 'Outlier (-1)': # Outliers are usually not in the main legend\n",
    "            fig.add_trace(\n",
    "                go.Scattergl(\n",
    "                    x=[None], y=[None], # Invisible trace\n",
    "                    mode='markers',\n",
    "                    marker=dict(size=10, color=color),\n",
    "                    name=sub,\n",
    "                    legendgroup='Combined',\n",
    "                    showlegend=True\n",
    "                )\n",
    "            )\n",
    "\n",
    "    # Add Outlier to legend separately\n",
    "    fig.add_trace(\n",
    "        go.Scattergl(\n",
    "            x=[None], y=[None],\n",
    "            mode='markers',\n",
    "            marker=dict(size=10, color=SUBREDDIT_COLORS['Outlier (-1)']),\n",
    "            name='Outlier (-1)',\n",
    "            legendgroup='Combined',\n",
    "            showlegend=True\n",
    "        )\n",
    "    )\n",
    "\n",
    "    # --- 5. Layout and Styling ---\n",
    "    fig.update_layout(\n",
    "        title_text=\"Subreddit UMAP Distributions\",\n",
    "        height=900, width=1200,\n",
    "        plot_bgcolor='rgba(240, 240, 240, 1)',\n",
    "        paper_bgcolor='rgba(255, 255, 255, 1)',\n",
    "        title_font_size=20,\n",
    "        legend=dict(\n",
    "            orientation=\"h\",\n",
    "            yanchor=\"bottom\",\n",
    "            y=-0.2, # Position below the entire grid\n",
    "            xanchor=\"center\",\n",
    "            x=0.5,\n",
    "            itemsizing='constant',\n",
    "            traceorder='grouped' # Group legend items by legendgroup\n",
    "        ),\n",
    "        hovermode=\"closest\"\n",
    "    )\n",
    "\n",
    "    # Update x and y axes for all subplots\n",
    "    fig.update_xaxes(title_text=\"UMAP-1\", row=1, col=1)\n",
    "    fig.update_yaxes(title_text=\"UMAP-2\", row=1, col=1)\n",
    "    fig.update_xaxes(title_text=\"UMAP-1\", row=2, col=1)\n",
    "    fig.update_yaxes(title_text=\"UMAP-2\", row=2, col=1)\n",
    "    fig.update_xaxes(title_text=\"UMAP-1\", row=1, col=2)\n",
    "    fig.update_yaxes(title_text=\"UMAP-2\", row=1, col=2)\n",
    "    fig.update_xaxes(title_text=\"UMAP-1\", row=2, col=2)\n",
    "    fig.update_yaxes(title_text=\"UMAP-2\", row=2, col=2)\n",
    "\n",
    "    fig.show()\n",
    "    print(\"\\n‚úÖ 2x2 UMAP grid for subreddit distributions generated.\")"
   ],
   "id": "2d6271dc6eb0bbdf",
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "üìä Generating 2x2 UMAP grid for subreddit distributions...\n"
     ]
    },
    {
     "data": {
      "application/vnd.plotly.v1+json": {
       "data": [
        {
         "hoverinfo": "none",
         "marker": {
          "color": "rgba(200, 200, 200, 0.15)",
          "line": {
           "color": "rgba(0,0,0,0.05)",
           "width": 0.1
          },
          "opacity": 0.1,
          "size": 4
         },
         "mode": "markers",
         "name": "Other Documents",
         "showlegend": false,
         "x": {
          "dtype": "f4",
          "bdata": "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"
         },
         "y": {
          "dtype": "f4",
          "bdata": "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"
         },
         "type": "scattergl",
         "xaxis": "x",
         "yaxis": "y"
        },
        {
         "hoverinfo": "none",
         "marker": {
          "color": "lightgray",
          "line": {
           "color": "rgba(0,0,0,0.05)",
           "width": 0.1
          },
          "opacity": 0.1,
          "size": 4
         },
         "mode": "markers",
         "name": "Outlier (-1)",
         "showlegend": false,
         "x": {
          "dtype": "f4",
          "bdata": "2W6QQH1DkEDLgpBA9gaRQKqWjECYcJBACTaqQHOdkEBUpzBAp81uQORmgUD2MpVAdI+WQGIBsUBTQJZASLZ5QIvEw0Ah6s1AnSwZQD6bkEBuW4FAk7WQQOP5pEBUH4NAUKaNQGyOokAL2H5AfjtoQBrBx0DkTIFAN6J/QMhyuEBs14FAA86uQPAJkUCm6/4/Z4xuQKadLkCiysVAZlGUQCPfaEBCbYBA5ZZ9QHqBlUDUbXRAU4SuQC4cdEC/eLBAN0aAQJSIwUAhPL1AyM3AQI6Pu0BERMlAQZuvQE4yH0DIN8BAukvAQD2YqUCWDIJAa3KpQLRPyUAtWMZANzu2QAlKpUDZSZ1AvIloQK+tfEAP74FAFNurQMBTkkDUP5dA40k5QC+9f0BkJYBAto+1QA=="
         },
         "y": {
          "dtype": "f4",
          "bdata": "U+OHQO7biECaQ4hAHH2HQKydikBQSYdAuguZQMwqiECwYmhA5SGhQGcQgkAsH4RA0aRkQJVrb0DXfGNAHWCZQAJWd0DpN2JACjJqQE0CiEACbYJAk9WHQDt7i0BRlIxAxbqEQOjsh0AZ5mlAeEOkQErgbECDH4JAetB/QGuQdEAemXZArDeVQB+Eh0AfXnhAQZ2hQBrAYkB96nRALPaTQFshpEDLm25AqLOTQHoog0A+OJ5AU5yVQJysnUBa+pNA6HVsQCE4eUAm0WdAf3tqQEK9ZEA8sGlAKnqKQI2IY0CPwGJANGqBQLHLjUCFqoBAyA6OQM2WaEDhvnJAKeCDQP8emkAe751A/hmkQC8Mp0DldYJAfFSRQLrMkUCdd5FAkTOEQM6bcECrPnJAR8qKQA=="
         },
         "type": "scattergl",
         "xaxis": "x",
         "yaxis": "y"
        },
        {
         "hoverinfo": "text",
         "hovertext": [
          "Subreddit: PeterAttia<br>Topic: longevity_aging_link",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: Outlier (-1)",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: longevity_aging_link",
          "Subreddit: PeterAttia<br>Topic: magnetic_fields_expression_mitochondrial",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: longevity_aging_link",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: longevity_aging_link",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: Outlier (-1)",
          "Subreddit: PeterAttia<br>Topic: longevity_aging_link",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: sick_throat_immune",
          "Subreddit: PeterAttia<br>Topic: Outlier (-1)",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: pain_have",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: longevity_aging_link",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: app_watch",
          "Subreddit: PeterAttia<br>Topic: longevity_aging_link",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: longevity_aging_link",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: 1_to_and_it_my",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: longevity_aging_link",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: Outlier (-1)",
          "Subreddit: PeterAttia<br>Topic: longevity_aging_link",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: longevity_aging_link",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: app_watch",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: app_watch",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: longevity_aging_link",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: sleep",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: protein_eat",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: Outlier (-1)",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: app_watch",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: app_watch",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: alzheimer_cognitive_disease_amyloid",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: app_watch",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: longevity_aging_link",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: Outlier (-1)",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: longevity_aging_link",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: sleep",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: protein_eat",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: protein_eat",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: longevity_aging_link",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: app_watch",
          "Subreddit: PeterAttia<br>Topic: app_watch",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: app_watch",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: app_watch",
          "Subreddit: PeterAttia<br>Topic: longevity_aging_link",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: app_watch",
          "Subreddit: PeterAttia<br>Topic: protein_eat",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: app_watch",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: 1_to_and_it_my",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: protein_eat",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: protein_eat",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: sleep",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: longevity_aging_link",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: 1_to_and_it_my",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: biohacking",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: sick_throat_immune",
          "Subreddit: PeterAttia<br>Topic: app_watch",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: Outlier (-1)",
          "Subreddit: PeterAttia<br>Topic: longevity_aging_link",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: longevity_aging_link",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: longevity_aging_link",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: pain_have",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: alzheimer_cognitive_disease_amyloid",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: sleep",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: protein_eat",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: protein_eat",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: protein_eat",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: 1_to_and_it_my",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: Outlier (-1)",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: pain_have",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: Outlier (-1)",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: app_watch",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: longevity_aging_link",
          "Subreddit: PeterAttia<br>Topic: app_watch",
          "Subreddit: PeterAttia<br>Topic: app_watch",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: longevity_aging_link",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: biohacking",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: app_watch",
          "Subreddit: PeterAttia<br>Topic: app_watch",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: protein_eat",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: 1_to_and_it_my",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: app_watch",
          "Subreddit: PeterAttia<br>Topic: vitamin_supplements",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: testosterone",
          "Subreddit: PeterAttia<br>Topic: longevity_aging_link",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: longevity_aging_link",
          "Subreddit: PeterAttia<br>Topic: app_watch",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: app_watch",
          "Subreddit: PeterAttia<br>Topic: Outlier (-1)",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: longevity_aging_link",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: sleep",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: app_watch",
          "Subreddit: PeterAttia<br>Topic: longevity_aging_link",
          "Subreddit: PeterAttia<br>Topic: light_sauna",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: aging_cells_senescence",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: Outlier (-1)",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: longevity_aging_link",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: longevity_aging_link",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: longevity_aging_link",
          "Subreddit: PeterAttia<br>Topic: 1_to_and_it_my",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: longevity_aging_link",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: longevity_aging_link",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: app_watch",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: app_watch",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: aging_cells_senescence",
          "Subreddit: PeterAttia<br>Topic: longevity_aging_link",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: Outlier (-1)",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob"
         ],
         "marker": {
          "color": "#477AA3",
          "line": {
           "color": "rgba(0,0,0,0.5)",
           "width": 0.8
          },
          "opacity": 0.7,
          "size": 7
         },
         "mode": "markers",
         "name": "PeterAttia",
         "showlegend": false,
         "x": {
          "dtype": "f4",
          "bdata": "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"
         },
         "y": {
          "dtype": "f4",
          "bdata": "JEeQQP01j0BokqRAefGlQP8emkCRtZ1A82ahQJbun0CGQJpADl+8QK2AjUDAYGxAn6+RQFWcnUC4x49AJn2PQJkBiUD8N59Aa2aaQCktmUB8cZVAhsqUQE55lUCdJolAtY64QK+voEC5yLBAR8NzQB7vnUDNTJVA0wOeQJ/InEAVVc5AhgONQBvrlUCiypFAX+7NQNIZ0UAiZ7lACVFgQP4ZpEBvupRA2D7MQDdxj0CYIINA/mTFQDiydEA2ZJ1AX2iNQC/6s0BdH9BAUtRzQHhodEBeRn5ArnGdQHEouUCx3LJAt1TQQDLUnUAbaHVAVt9yQJLLdUBTuJpA0w/LQMVankBz+tFAbjXSQLrS0kCzg9JAGTXLQHdAkkDaA6VAGqO0QAfjm0BwAXRAf4CQQEIvZEDkJI1AW/NrQB3K0EA0QGRA7SNzQCorjEDEt5ZAVoKTQIYo00BMAsxALwynQOfpmkA5sLBA19WRQE5E0UAjNY1AsTWNQCrrwEDP5c1AOGt2QKOkxUD3JJ5AXql1QG4UokDHAYVAZ3uKQOaYfEBAIYxA1CeNQOdPmEBDsNFAuw9xQMos0UDjJ9NA+SmWQPRvcEDb681A7DhzQBWVsUDmRoxAXpivQOA8lkCXhdBARwJkQNOS0ECNNdNAs614QBp30kAZc6lAEOiYQE7naEDAT41ASFh8QGpNjUBtaZxAqVaeQNHN0EA8f9NAvzSSQDg4kUDBdnRAizRvQK3ldEAqstJA2IptQIN80kD7YNVAN82GQMSfbkD0trVA9fXMQOV1gkA9Y3xAunZzQD0Md0AEGGhAruyPQCfxbEAImKFAgHPRQGeicUAyf89AXdR4QDKExkBNVnlAzUtsQMJHfEDllc5AlwR/QIOtqEDghNJAXbLQQJGEbkCsBNJA72N/QKlfdEDOIZNACYp8QA4dhUDsmM5AglV2QAoodUCXoM5AP3GJQGIZ0kBtR8ZAuKh1QIqRckBCfHxAQDJpQMx9l0AfvNBAqgDOQFS/00BzhYVAyD6SQM2t0kAlQaNAWznRQDBD0kBfK5FAnP7OQPLm00B8VJFA5VZtQM3az0AKRolA4ECbQB/2oUCPP45AMXSEQHlutEA00GZA656PQMo60EA2iMpA5FLOQPsoc0BQQ9BA2RtnQDnulUDKQ3RANtLTQJdgckDe5XBAfA7SQG90y0B1G3lAXWhqQIaCbkDknnNAZs+gQKMMpUCWFGVAmLNoQG1NZ0CxtcpAw8lvQP220kCJpm9AfiRqQD/xckD9F2xAL0Z9QO/a0UBrmXRA2K7NQN/9jECK2Y5AmaVtQEKm00B33Z5ARo7TQP5DcEA0i7RAf1m0QNk+g0CsYoJAS6upQCJ4c0Bi7pdAnyCoQAXDmEDnKcxAKNpwQGyOa0AUSatAcJNpQBzVc0DypXVAm/C4QKpZaUAaXXFASf5rQOL6bkCpUtNAYfnEQGT7fkCeb85A38XTQGPgmEAQwHJAUYNyQJzvskAuYXNAMEF3QDL1ckA1+WtA2sZyQNLazkBD6stAfW7QQDyQ0kBg83xAA7RpQBlAakC4M3VAZrLPQG5VoUDS22xAa6iVQAaB1EB7YtBA52qFQGJig0DkANRAownPQD20s0CBAZdA9grRQPNIlUDNSZJAiT11QDEFeUCQyJVAcwVvQMoyk0CVx29A9G5wQJLajEAW/aNANKRrQN3yakB/Qp1AjWtzQGCiakBp56lA9ABtQOwT0kDc8G9AusyRQN3wlEABbctA7S9wQNfSf0BJPoxADAd1QGEYdECh/dBAT91xQPqybEDlq85ADivIQLEBbUClaaBA1NxrQE9Ze0DZ9HNAl79tQFV/00ARnctAL0zLQG0kckDeB3NAmviRQJ99pEBsfHRALauVQMNUc0CDsc5AsUubQHzv1EDw8JtApsVoQN0/cUDD3nNAGJJgQCvI00B+wXBAR4+FQJdMcUDGcM5Ai8ZlQI5CdEDDBppAL2FzQOw+0UAGJXFATv9yQB34cEBfOqNASERhQJSUy0DiS29APnnQQBnVz0Axb2tAzpltQGAh0ED7iGVAA9TTQNmMk0BEwGtAukLQQLilc0BGNtFAFLxnQJTWckDfao1AESzUQH6IkEAJDqFABlWZQFPrkkApRolAGt1uQPbKcUDRl2dAPW9wQGwb0ECdd5FAIH7VQLXeYEBCzs9Aj0JxQJEzhEBbfZ9At7FuQJZfzUByGWVA3Ny8QB9Hz0BY+Y5AV0aqQFzvrkB0gdVA7CKhQPj8z0CwA45AApGKQDcYckDy3nBAEOZsQAgLdUAYhtRAoyFmQFya00D5N31ATfB7QAWHkkB3sHFAJ1FzQL+DdUDtI81A+Di5QCTydEBex4JAlb/UQLhby0CDzMtA3etqQK/GiUCkd7pAyq/QQHVXhkB2gKhAKJW2QB58zkDe9p1AP/5pQAPXZ0AsZc5ArpzLQIxmdUAWJ9VAjEKCQIsM00CiAqpAOe5jQOT10kCTr5BAgWN4QCzVtEAyOc9AZi61QHKUqUCTzGxARBxrQFqzn0DOm3BAbvxvQPkXhEDD3WpACBuCQGIDdUAe3mJA/otxQLjNkUBiM5NAgaSCQP9nzUDCMZRAEQ1nQPFxnUDcI2FA7D2PQJcQxkAQOtNAbgRsQKs+ckB6F21AEkh0QJ88cEB1h29AwSrBQEWyyUD2spFA3XBxQFGjxEAtYG5A9JaFQM5o0ECYx4xA2BfMQHJpgkBsymBArJNqQHdoz0AeqtFAQwhtQJiM0UCbXXNA1tyPQAPQdEC+nnFAyYbJQA+wo0Cy5W1A7d50QOBHsEAxGrlAvYDRQEoEZ0D4jbxAr2nHQF+RcEBANKtAYr/OQDAIrUBDX75AiYLQQI/beUDUDXZAJFjQQH5AzkAe4dFAKsRvQL0dzEBaoHJAOaN1QGEOdkCR5tFAR8qKQCGI0UBI34RAJKxvQKy1zkAHQM9AtfluQA=="
         },
         "type": "scattergl",
         "xaxis": "x",
         "yaxis": "y"
        },
        {
         "hoverinfo": "none",
         "marker": {
          "color": "rgba(200, 200, 200, 0.15)",
          "line": {
           "color": "rgba(0,0,0,0.05)",
           "width": 0.1
          },
          "opacity": 0.1,
          "size": 4
         },
         "mode": "markers",
         "name": "Other Documents",
         "showlegend": false,
         "x": {
          "dtype": "f4",
          "bdata": "jB+fQBwSG0Bf/n9AnxOvQCjha0AkiZ5AkOm3QPwLjEDZyqpAnVaTQGapc0C3ja5A4pCdQIuNlEDfR31An3H/PyJtbUDBO6JARudiQA2Er0AX2oRA5NObQMXWo0D/0JBAgLOtQMEVk0B7Z5JAzfxgQF0HnEBruppAqitaQHilnEBzSlNABUh3QO2DnUBQXG9A/XRyQBwWvUDfV2VAvUJHQKr3c0AKUUxA0kFeQKuPm0BWCKFAhiITQKrInEAeoZNAasaaQNDcm0Aoz2VAFsTEQAoznkBlOP0/CUerQAGkA0Cv0W5AmspuQJkUgkCiO7BAOT6iQHPim0CPE0NAgPP1P6S7oUDemYFAxcKxQGbl/D/pI3ZAyyV7QA1UBEC1HWZA+HJtQOzvj0C9crpAhA8HQMQWPkDM5atATANzQCHsW0Dc5XVAFp1aQD9FpkAZb0xAFmIZQHR7JUAF9LlAQqB0QOiwyUB7TJtASFSuQAk8AkAAn6RAuD+TQHceskALAYpAlNJzQEQUe0BC/K9Awc+qQKclbUDhsgVAZLSbQKrdmUCZhJlAONJwQBpbXUBQwJhAAq6hQD0wcUCTb0xAMdF7QKOB+z9rXRRA+r6CQAgdgkDFUEhAVu1jQO+4pkAhB5FApZh0QFI8mED3bKpAdbWKQPxni0BcxXBAtXh5QHK1kkAgjlNAnOdoQHFbn0BJbnFA3lOPQFmFkEB4JNlAde+mQNG9nkB7ahhAOQaiQOL2S0CQm5RAMTeAQINqfEB6w1xAoFxcQCHYbEDOkmtAlu9+QNnybkBTY5BAudyHQMVyVEA7lJhAK9ePQJz5ckAsUm9Apq1vQF6oA0CIiEhAMqt9QFhrfkDuXvY/qjxOQKlJP0AlDYpAP5hIQEvVUEAuxHBAnkibQOBBsUBYMnBAKearQAt/MECVk5pA723/Pzwsa0DPdIhAWUabQHUgTEBM4kFAlipcQJOFTkAqPztA6SyEQCzMCkCIklNAykJQQKV1dUBV+JdAxV2QQGMdoEBQY4JA62mpQGGOi0CswJJAWY0FQP/PHUBFjW9A3j2CQOdosUDJM3pAhMeQQKgBBkCKXGFAFKv5P3KHP0DgOMtAkvhxQJYIA0CKiohA3qtNQOgppkDKvptASjqQQIHTgUAKfF5AMfydQKlmhUDPLZBAEc4IQHpuKUCYmxdA9vxvQLMVnUDq1ZZAGb3DQDwncUAV9odAbVCdQLUUTEDbbFJAE3xxQEP9kkAipslAWDenQGlCk0Am64ZAh360QKAGmEDIGWtAF6mrQF8ngkCspZJAtzlTQCfyRUAulIBAV1A6QBp6r0BsaFpAf4k9QKzJq0Aea3NATBUKQCtTT0Dlb2pAUSc/QPn5lkC2dGxAhOlDQLNthUBl6JNAFgaZQMloXkBor7BAGwnZQIQvnEBp219AQqtEQPRpKUBJqqBA+R2DQMk8VkDF2XhAKjhPQB5hq0BWpnxAU52WQJ6VgUDDophA1x95QJtGsUAJUZpAxfdOQGLHk0D9iaxAIBvEQMRjVkBArGFAMLWdQIpwjEAa1ZhAw0FFQJbqBkD+LKVAoQmYQNw6z0AKIThAq4qtQB7/hUDnTbRASMejQFCGEUCGQoVAgj9WQArfZ0AHs79AttimQNf8iEAUo9lAGaaFQF23k0DuFnlACaDDQPH1X0A6bw9A+/1YQO5zM0CZNEJAJs6UQKfISEAydIlAxymIQG1FdECCdpJAK/pEQGTdfEDV3XhANlupQKs2e0AY2RpALmeiQIapOEC0PVlAq+JyQLSFHUAzYJZAS3GlQDjfmEDKxhJAne0VQAV8W0D4p/o/KWNCQE05HEDSrBBADZR5QHb3lUBt5JVAX0nwP5KgoEDRKJ5Alk6cQG+7B0BeqZ9AugIIQKKkRkACRgNA162hQLY3s0CSoJlAUmNCQINorEBzYHtA1v0UQOzSdEDpJ2xAucdkQJkvwEBgbn1AzAYIQGzpaUBTE5RAsPOTQJRYa0De759ADa2eQLFJfUCMAqFA9vKbQHMqnUAzb5ZAg8KuQBEXWEAu/l1AI2b5P0DVCEAqN2VAXfLyP9cWUEByyL1AdEoLQOuWyz/rF7FANledQA71gUCQSi9AwVBBQPkG+z98hpdA+f5FQJOHuUBErZdAlfxyQDVEsEBNrxpAYeGWQGiAZUCFGJNATGJHQNHJhkD6qYtAfAVQQE/dbkAMjQVAjgsFQHuQeUBwKLVAay2CQHv5REDlLT5A2YmBQL8z/j9tVBJAe/kKQKD4rkCnemhAqmiuQH1FRkAGLYxAC6lsQClphEAgaQxAi4ubQB30j0BN4gJAiZt7QIa+jEAlB0BAGQttQBz7nECGZkRArywSQNeYhUAFJkVA2fs8QMGDrEAUx1RAdMEbQAwwGkCq1gFAiaM3QADqpUAsScBAzQ6nQC1vxkDfenVACkpHQPpUc0CUJ5RA06QQQLhd4z8q3kFAl2CAQH2YnEBRhkdAToGYQD2mk0B+T5lAwRMxQBEiPkBD0QhABvOzQFkUtUBc50NAbwOHQKPDckCRuY5AXORsQAf16j+9SFdA0ZgIQIujFkBcXrJACLiqQAeXm0A4cYhAIAuBQAcNd0ARAqZApgr+PwcsrEClkJ1AgtIPQBvoDUDbOm9ApxXxP/OFB0B8VUdAqGS1QBQrSEDoMEFASriUQGcrkkDltjpAmPNrQBMZukD2sAxACgwWQNV1BkAdd3ZAGY1LQMDh9D+Nj5VARteXQIziTUDhq51AiRZiQGOYEECYEjZAJJ1KQGrmcUBJXJRAlwT1PydI3z+50zlAtGBXQAIDt0DWLapAaNY6QOEEHUBoJVFAp995QLYwAUCYMT1AaBFIQPRhGkDq3WxAeXcDQJ5NCkDsO4lACj+TQIZOa0Dz2UhA1AaoQCBtGEDPpwRAQ0dcQJkRcECqHvU/7uNtQNIQt0DNlVlA52KaQKISqUALvYZAFcl9QG85WUCydUdANIqUQPFZeEBd1UBAxwd0QPc2SkBm+g1ABsySQDhbgkDS6ZFAW3JRQB8vQ0Bc5npAD9OhQGhQnUBZbj1AbV+MQErnpkATq5VAtLWbQMova0AS9HxAvO3/PytbT0CyqKVAJ4mTQH6gQ0AQZ3JA0p+VQNomP0ALNk5AHgiKQIBTCkDsh3hAt/qIQAZdPkB4TD9AMBJWQB8nSEASxWRA0ygCQFu+PUBrQ4xARt09QKuzPUDuAKJAURuNQLsHZUBQnf4/LrSUQHGgjUD1a1hAH1UMQATjlECf4nFAv3kHQOr19z/CTD5AJ9PDQAgXtT/gSK9AEJBEQH1TDECujlFAMTlaQEWmpECzjoZAfoxDQA18DEBrVZlAcoOJQKbUnUB+3TpARr4lQEISB0BtoBFAZMr4P15TgUCxiIRAjxErQAevCkBdaAZADx8ZQJYVaEC5WMNAexoDQK7YgkBXzvw/hky3QHUXSEBRGZFAQ5SSQO8DikANlr1Afv5WQBKZR0CN4LdArlhGQK/fnkAVszBAxYXtP0mlCUC24rFAHp65QA5QT0A8F/0/apEOQODhH0BlJJdAyyq8QC/hTkAva5VAN/mUQP4HMUAizqRATxZ/QLcIikAT3KRAxgWBQLROBEDiGUZABFxGQFecf0DhqnJAlw6uQJ2D7T+DnYRAMKmuQDdtkkAMaEtAM2w3QJTROUDFBG1AzHTWP3cIvUAP2YFAdqGsQKpm0EAiuT5Ae2KcQA2dWkDH+nRAYs/FQPVOdEBYpUlAGzuNQGMZPUAcgfk/L4aeQEP1w0B516dAls/+PzefKUA7ELZADzRqQEUGlUCHCrlAORZuQCS0pEDqEUdA1cUCQMgjlUDAnYVAyHRrQJbjsEAESm9A5AmVQEKfPUBGKEhAjKBkQHIUbUDDEgZAPClbQOatk0DN365ARUO2QBlFm0AcFY1AxzaOQAOAmkCb9pRAgwKSQNd1lECa0lZAB0yTQIwHRkDI4ZNAgbacQLZNj0DAz7BAv1ZIQOl0kUClhptAO2CTQAfyk0AfLZNAKGikQEksR0B3BWtA7EuWQPOha0D6dT5ARUKuQFP9kUCraZJA5A5PQP4Pk0B75pNAPLSSQJ00MkBwJTpA0JtqQMkqlUBpmqRAeH1IQCC5YkDAnrNA5uJdQIkOSUDc/Z1Ai7yTQFCzakBJikpAlC5BQJfwVEBKyLBALS+TQJvZZ0CydWlAlfY1QMTOnEDRPUZA7pUSQOQigUAPHZBAk1ZQQPgtkkAUGz9ApQ1LQPEYRECLWkFAzP5PQMyvj0Cxy3xAen1sQHAxlEAmAWJA5XCaQFfaSUAyaJNA7E1PQPC7P0B0xA1AhRBUQOLykUAvu6ZAB+euQGQnQ0A8TEpALVSfQGsdb0BWwqxAfRY/QCBUk0BoipNAiqJQQLWtQ0DyjVpAKt5eQKrTnEBB805A1618QLaqg0BSVYRAYrCHQFBHs0CqT5NAbtSlQFHROkAH2E9AUdk+QOtlRECIaZFA5RNNQOqJTUAKYT5AJAN1QEWQk0CQbmpAD7ObQCElRUCpgpg/expGQPtWPECSyVVAN6hDQPLqiEDT0JNAosBJQNYZk0BEqGtAkZmTQEDvkUB445VAvqdGQK0BQEBF9F1Ay9hVQNW3UUAHlExAdjpsQC2sQEACsExAGws7QCxVSkCbwY1Arb9JQI/5bkAqL1BAXqpvQBLKU0BhoF1AD0atP6geUUCQEk5A/X19QGMoRUCJtExAgLQ/QJR/i0BYo01ApY9TQNC3UEBT4XNAYCVPQFtYTkANcXpAwrU8QB+tSEDc3a1ABQlGQKJXpUCQL09Ahe6XQDHtcEBXwotAWpdFQPdyTkA981BAIKRMQI0uR0Dl6D1A7sVLQNsPT0CGn2VAjx2BQLQpREAbPppAmkZIQC3lTEBTpUFAFUeEQBysV0B16E5Aq6Z0QAWMPkAxRD5AY8a1QPQrQUB2CkFAF9BGQJc9M0Azx0dAGH2PQDKGlEA6k55ADmlLQJ3EbEDXzGRAvLiUQNTsSUAmtVdAtXtUQGt1O0Af/TxAT8ffP4ykm0Aitj9AI+RBQOrlS0B2o0FAIFE3QOLzWUAxiD5AOqz1P2mbQEAPrmlArO2VQCdph0DgXQVAhgZFQFMWqUAHTFFAIJtOQGcwQ0CSbUtA+qdGQCT4SUAlakBALA1yQF3wPUDSuU1AUGtLQDfokkC10VBAF6JLQH/aQUB6VJNANOM/QB3cO0BbNVxAe8hUQMATikC7VIRAlmFzQELNRkCNPZZAoQ1uQEJ6qUD2nU5ATDZRQKJjRUCyYm1A0y71P1bRQEDDfFBACppQQKVYRUDacwtApClJQK8QTkB7v0JAtd9NQMmVgUAlLjZABS1LQPt0kECVNWRA6X9kQBT6bUCeIExABjIAQLs9TEBlPPk/B0Q8QEMiMkCv1VhAv6k1QOPOOUDK63BA5XGwPylXuD/B7k5AR7xKQBtGlUBnjk9ASK+mQEitSUDnFTNAxreDQI53hUBnKjtAB0lPQA1FakCfoJxAfLNHQFQ9pkBn95VAOC9EQLJUWkBhZ5NARvhKQL5umUD+nENAzZlMQP5Rk0AzXmpAUzxDQAdQ4T9mOJNA1KhNQDCqRkBduXJAQPVLQFc8QUAP7kpAaUuiQHLaWEBDE1FAeaiJQFcMVUDCQU9AxSBOQApWM0DHUE9AOWBJQO2XQUBsOFdAVCY9QBE4kkAQuUNA9xo+QP4sTEAo30tArFxCQDeXUkBXb1hAiaRdQHlqSkD6D6dAwwFqQASXUUCtlbVAdqU7QNDMREAZt5RAaAs+QOrWkkBQxUNANiRNQP2wTUDjHEtAi908QDl7SUC4ioRAN1Q7QGiRT0CLoXdATmtTQDNJk0B6dz9ApsZQQHlKTkB8xGhAsA5JQEMbk0Dqo6A/4LxZQLEdSUC+azNAd4VKQCUP9D9TtE1AuWFIQLzz8D+pkj9AcE6fQJdKRUBWU0dA8epTQH9MQUB2mjpAx1o7QO+sk0AnfUJATH+WQExZlUAvLJlAX6xbQJaaR0DB8kNAbTdPQIg0BED9H1JAFKtMQB4XPkA20A5AchhNQG2TUkAzeJFAgf1DQJxjS0BJCBRA7n5VQE8iPEAX6bRAaqBxQIKAaUCb8DtAbROVQMhAVEBoiKpAql+yQPUzTkCs9WxAJndOQM+JTUCh/j9AMr5JQCxtPkDcBIhAAmVWQK7wmEC+e0FA7I09QK1tTkA67VhAitNbQIhHTkAOQolAkx5AQBKrWECBEllABkxGQMciSEDJy1tAPatFQLO1f0DIWXRAf8xWQDIkTUDbspJAbB5LQCVPP0ANej5AAlZYQMFBR0Blg0ZAWgQ7QJz/QUDPNHNA9zwbQMrXQEA+Z5RAgLj9PwRFbUBKPE5AUSlzQErzcEC2WU5ANO9EQPwegEAJYkRAp2eIQHrhSkAX4LNAHq9NQGF6nz9Ip0RAtp9gQJbOtUBOxIFAgxtMQDeRXUBMBrJAogiTQFPhDkA8t09Ao4RYQIxxQ0Ap5kBAitc9QFX0VUC4m0RA/ElKQOu7UUBlLFRA3/igQLkcT0DYxlFAvZw+QGCihEDUVzRANBixQKMbWUCvJrhA4cQPQHJ/SEDCWExAO4pAQDfBTkBKVjVARAA+QEyPs0Cx7UtAg1pGQKOuS0Dm+41A1fdMQA/9PkAaBW9AAuteQAgKNEARr0xAunBVQHA+U0CeJD5Adg9rQOGPTkDG72tA0yhVQB1ER0A/50pA8rxQQMQHP0CfaU9AomJEQBFPUUDxelFAiEhLQEPpu0BY8LZAIFk6QBlJRkCwQohAkERLQM8ESkBRMVRAHF1LQA=="
         },
         "y": {
          "dtype": "f4",
          "bdata": "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"
         },
         "type": "scattergl",
         "xaxis": "x2",
         "yaxis": "y2"
        },
        {
         "hoverinfo": "none",
         "marker": {
          "color": "lightgray",
          "line": {
           "color": "rgba(0,0,0,0.05)",
           "width": 0.1
          },
          "opacity": 0.1,
          "size": 4
         },
         "mode": "markers",
         "name": "Outlier (-1)",
         "showlegend": false,
         "x": {
          "dtype": "f4",
          "bdata": "2W6QQH1DkEDLgpBA9gaRQKqWjECYcJBACTaqQHOdkEBUpzBAp81uQORmgUD2MpVAdI+WQGIBsUBTQJZASLZ5QIvEw0Ah6s1AnSwZQD6bkEBuW4FAk7WQQOP5pEBUH4NAUKaNQGyOokAL2H5AfjtoQBrBx0DkTIFAN6J/QMhyuEBs14FAA86uQPAJkUCm6/4/Z4xuQKadLkCiysVAZlGUQCPfaEBCbYBA5ZZ9QHqBlUDUbXRAU4SuQC4cdEC/eLBAN0aAQJSIwUAhPL1AyM3AQI6Pu0BERMlAQZuvQE4yH0DIN8BAukvAQD2YqUCWDIJAa3KpQLRPyUAtWMZANzu2QAlKpUDZSZ1AvIloQK+tfEAP74FAFNurQMBTkkDUP5dA40k5QC+9f0BkJYBAto+1QA=="
         },
         "y": {
          "dtype": "f4",
          "bdata": "U+OHQO7biECaQ4hAHH2HQKydikBQSYdAuguZQMwqiECwYmhA5SGhQGcQgkAsH4RA0aRkQJVrb0DXfGNAHWCZQAJWd0DpN2JACjJqQE0CiEACbYJAk9WHQDt7i0BRlIxAxbqEQOjsh0AZ5mlAeEOkQErgbECDH4JAetB/QGuQdEAemXZArDeVQB+Eh0AfXnhAQZ2hQBrAYkB96nRALPaTQFshpEDLm25AqLOTQHoog0A+OJ5AU5yVQJysnUBa+pNA6HVsQCE4eUAm0WdAf3tqQEK9ZEA8sGlAKnqKQI2IY0CPwGJANGqBQLHLjUCFqoBAyA6OQM2WaEDhvnJAKeCDQP8emkAe751A/hmkQC8Mp0DldYJAfFSRQLrMkUCdd5FAkTOEQM6bcECrPnJAR8qKQA=="
         },
         "type": "scattergl",
         "xaxis": "x2",
         "yaxis": "y2"
        },
        {
         "hoverinfo": "text",
         "hovertext": [
          "Subreddit: Longevity<br>Topic: alzheimer_cognitive_disease_amyloid",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: Outlier (-1)",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: peter",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: peter",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: peter",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: nmn_resveratrol",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: biohacking",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: peter",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Longevity<br>Topic: peter",
          "Subreddit: Longevity<br>Topic: biohacking",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: cells_stem_cell",
          "Subreddit: Longevity<br>Topic: biohacking",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: blood_tests_test",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: hair_grey_minoxidil",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: blood_tests_test",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: Outlier (-1)",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: nmn_resveratrol",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: biohacking",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: peter",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: peter",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: peter",
          "Subreddit: Longevity<br>Topic: cells_stem_cell",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: biohacking",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: biohacking",
          "Subreddit: Longevity<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Longevity<br>Topic: Outlier (-1)",
          "Subreddit: Longevity<br>Topic: peter",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: blood_tests_test",
          "Subreddit: Longevity<br>Topic: peter",
          "Subreddit: Longevity<br>Topic: peter",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: peter",
          "Subreddit: Longevity<br>Topic: Outlier (-1)",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: peter",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: peter",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: biohacking",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: biohacking",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: zone_training_max",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Longevity<br>Topic: magnetic_fields_expression_mitochondrial",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: Outlier (-1)",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: cells_stem_cell",
          "Subreddit: Longevity<br>Topic: biohacking",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: biohacking",
          "Subreddit: Longevity<br>Topic: app_watch",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: biohacking",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: peter",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: peter",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: peter",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: Outlier (-1)",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: nmn_resveratrol",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: Outlier (-1)",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: Outlier (-1)",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: peter",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: peter",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: blood_tests_test",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Longevity<br>Topic: blood_tests_test",
          "Subreddit: Longevity<br>Topic: blood_tests_test",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: biohacking",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: alcohol_nicotine",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: peter",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: app_watch",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: water_bottled_tap_plastic",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Longevity<br>Topic: Outlier (-1)",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: zone_training_max",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: peter",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: peter",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: peter",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: peter",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: app_watch",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: Outlier (-1)",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: blood_tests_test",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: blood_tests_test",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: peter",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: nmn_resveratrol",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: Outlier (-1)",
          "Subreddit: Longevity<br>Topic: blood_tests_test",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: biohacking",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: peter",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: blood_tests_test",
          "Subreddit: Longevity<br>Topic: blood_tests_test",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: vitamin_supplements",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: zone_training_max",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: peter",
          "Subreddit: Longevity<br>Topic: Outlier (-1)",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: Outlier (-1)",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: protein_eat",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: mg",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: mg",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: Outlier (-1)",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: biohacking",
          "Subreddit: Longevity<br>Topic: 1_to_and_it_my",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: biohacking",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: Outlier (-1)",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: biohacking",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: blood_tests_test",
          "Subreddit: Longevity<br>Topic: vitamin_supplements",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: zone_training_max",
          "Subreddit: Longevity<br>Topic: 1_to_and_it_my",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: blood_tests_test",
          "Subreddit: Longevity<br>Topic: blood_tests_test",
          "Subreddit: Longevity<br>Topic: Outlier (-1)",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: biohacking",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: biohacking",
          "Subreddit: Longevity<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: blood_tests_test",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: sick_throat_immune",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: longevity_aging_link"
         ],
         "marker": {
          "color": "#CC5A71",
          "line": {
           "color": "rgba(0,0,0,0.5)",
           "width": 0.8
          },
          "opacity": 0.7,
          "size": 7
         },
         "mode": "markers",
         "name": "Longevity",
         "showlegend": false,
         "x": {
          "dtype": "f4",
          "bdata": "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"
         },
         "y": {
          "dtype": "f4",
          "bdata": "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"
         },
         "type": "scattergl",
         "xaxis": "x2",
         "yaxis": "y2"
        },
        {
         "hoverinfo": "none",
         "marker": {
          "color": "rgba(200, 200, 200, 0.15)",
          "line": {
           "color": "rgba(0,0,0,0.05)",
           "width": 0.1
          },
          "opacity": 0.1,
          "size": 4
         },
         "mode": "markers",
         "name": "Other Documents",
         "showlegend": false,
         "x": {
          "dtype": "f4",
          "bdata": "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"
         },
         "y": {
          "dtype": "f4",
          "bdata": "ZiNiQExSjUCqzGFA6Xt9QHWTa0D7bo9AoqCPQFLkmECDdWBAcqFoQNMockC3fIlAbNJrQCiUaUDApIxAP8GdQJPSgEDtbJhAp2iOQBUnjECuGIJAcUWGQBIziUBq+IdAqmhkQELhikD6iZlAnBSCQH3sgkArLHhA5q+QQNsQb0BngnJAMviBQDikd0DvUpJA2a9iQGRLjEC5i5BAP+ySQPoldECQKYZAFuhjQKXEf0C0mZlAr19pQLowZUAg6YFAGSRsQFgBaUB363VAcP9uQPG6mUBsGWZAtH+QQAw5ZUAGLWNAiSFjQK4NaUDAKZFAs297QNljhkB4AGBAOrpiQO8yh0ABM4VAKUmKQKxjdkBgwIVAGVx6QKOFc0DX04BAkkZgQI7BiUDmJHJAJ0dmQNCNY0A+WHBAC3+EQFZadkA3s5dAwwmOQNj/Z0C21YFAj1CPQH/id0COr5JAs8+XQCI8kkCt4W9AV/NyQKQca0DatGtAkH+MQM5abECWb5BAtstqQDUFiUBwLXhAWAuTQNKph0CD42dA0vCEQC/IeUCkS4lAiYBpQG1wakDtcnxAspuIQP97jkAD32dAm6+NQLE/j0Dn2WNAq5dyQNwCb0BFbotAmBl2QA3+kUBpdWhAhgRpQIhXhEC4DYZAorOGQBy1jUCMP4FAETZqQO1KgUDQu31A/AdhQKNuhEBey49AQo2ZQHrQhUBBe2NAx6iOQM9rekB2k2tAE1eYQGjUhEDm625AjaRnQFPPkUBSrnBAT/NtQBAykEC5KYRA/2KPQDcGj0AhbZRAgKF8QJn+ZEC1H4NAnySEQA7rkUBe/4NAEXhmQF2KbUB4gmlA7+ZvQPIbfUC5lIJA9u6MQDS5ikBjzXxAZmmEQKk2dkAK0XFASMtiQLyTgEBTVXNA0XeWQCv8g0CeA4NAngyEQJBzakCG13xATICWQFmIkUAR3YVALsh6QP4Ng0D9pIFAmeODQLKghUBi7XZAXuptQCVSeEDxoolADQ+RQBUckUBpAXdA4NpwQHSkjEAcjJJA5lKaQONNhkAOI3RA8aKZQNP7dkAyFJJAI4WGQMrSZUCANZhAjXlrQPHrh0Cl/ItACV+JQIhlfkDUYZBANeB5QCTciEAo82NAkLJ5QKWXh0Ak0IJAmk5xQCcBhEDX1ctAlmWBQHlhkECdZWBAhlZ1QBk9hUCkP39AbeaCQGLiaUBB5pBA+ZqQQARXjkBa/GxA+nuBQFNsbkA0IpJAyNtwQIXsZ0CxWH9AKuF1QISzokCFbWpAmNBsQEhyZ0BrMIBAKUlrQDBubECZPYpAq8tlQH8haUBWzJdA2Vh6QKRhlEDKPG1AjESEQC3Ah0AJgWhAO3mAQIWkmUAP0IpAczuOQBmxYEDny4BAldeZQMrmakCsJGVAIcGEQBQlaUDsgmxAqYN/QPfPukC2c39AecaDQFfQZ0Ad7YpA5l2MQCXXhkCAXplA9o+NQMTOaUDrWINA+X97QH+ykUCfcG1AyFxqQOWobECaE4NAxAloQFXUskCM6mZAd3BhQB2JaEAEppBArOOOQDYuYkAnsWhAmi5+QPxNZUA9zZdAm3+RQAs1gEBNGoNAbiBrQLnFmUAhW3NA1I6YQNYVYEB5vplAUhh6QIYCd0DtmoBA4sR+QGTNbkCOfIZAS4VsQPSagkB1MXVAk7RwQHt5jEChAIJAeXtiQEl8hUBcLGRAZNuZQAWng0Be4W5Am9KDQM3adUDE6WNAPS+EQH0SkEBqmIlAbGyhQFBMiECUColAnJSRQGGkg0CKYnhARnOQQI2GekDMXY1ABXhsQDMziED9AI9AGdSPQMbVgkDrRopAfRliQMLTcUCKFGdAwIZgQMrWhUBvyHdA4PeGQOijkEAk/JBAqq2PQO3+gEDq0YNASOeTQAZmZUBLOY5Aqk+VQNtMlEDBuIhADRZpQGOIkkD/rYNAzRGaQAF+f0CxlHNAeItoQE7Gj0BK0pZA3q2FQEVDoUAjVY1A5epwQBKch0Cc4pBA9EyOQFFmc0CTMYtAFaiSQAwnaEBRJ2ZAia2SQNxSkkDswn5AxXl0QBXtaEDhkY5AUU2IQCvuk0AWIpBAqD1kQC9Zf0CeRo5AWuuSQFLukUCUK4BAO6NzQE0qcUDE4n5AqpSTQHHpbkDMm41Ap2aSQBv+a0D3r5VAsgNxQDHdh0CEGnhA9KyKQIcCmEB7tnZA1hpqQFztYUD82IpAvyV/QNjRZUBwnI9A742QQN2dfECOcZhAlpx1QLtZcEAkQYZAXjl1QEHif0A8/I9AoOqRQEJ6fkC/YZJAc0SHQOJmg0BzDHlATOGRQBoPZ0BVyWxAbjp5QEPudEDZU4hAUDyQQKMuhkDk2JFAAmCOQAZZkEAhvqBAEutvQPE0j0C1yoJAvaKJQP9QgkDHTYdAPPOQQNIGbEBrqHJAtDdmQM8Sb0D6j7RAvuFqQDR2m0BgjYZAMB2IQNmxcEDjTWhA/xB8QD9BhkD3iIxANRmVQEKyakD8gZFAS9OOQDjackACopFATPCOQHTmg0CLpI9AWU1hQPNyakASzWVA5x+VQIbDZEBXgoVA4tpnQIFnb0C+QIJA7yyDQD/+hUA0jHJA4rWLQOpqZkC5MmFAF0d/QFg8fUAt5IxAKbGEQLSEk0BcHY1AwzGLQHMydECLaItAaO96QA2biED1fn9AjPCKQJ8wekDXZI9A+QOEQKDVikD6Q3hABflgQHWmakCPiXFAUQ2KQJW9hEBw2IxAlXmBQC8SmkDLWmlAZvKPQOhw0UAHbmpA7kyNQC/MbECQ6YxAwlGLQC/ki0C6wXZA3B6XQL46bEBD+Y9AymaPQPgMcUCNWo9A98KEQNMKeUA6YY5AL5qDQHgKeECfhbRAAIB9QGKAd0AKAY9ARuNvQPBvdUD+xGhADZqPQCASkkAVdYRArHiIQCGMkEANeZFA07NsQChEekCWnIpA6zeRQIXahEBf0ZFA7mKCQEOAhkCwunJAkqWKQCRHkED9NY9AaJKkQHnxpUCRtZ1A82ahQJbun0CGQJpADl+8QK2AjUDAYGxAn6+RQFWcnUC4x49AJn2PQJkBiUD8N59Aa2aaQCktmUB8cZVAhsqUQE55lUCdJolAtY64QK+voEC5yLBAR8NzQM1MlUDTA55An8icQBVVzkCGA41AG+uVQKLKkUBf7s1A0hnRQCJnuUAJUWBAb7qUQNg+zEA3cY9AmCCDQP5kxUA4snRANmSdQF9ojUAv+rNAXR/QQFLUc0B4aHRAXkZ+QK5xnUBxKLlAsdyyQLdU0EAy1J1AG2h1QFbfckCSy3VAU7iaQNMPy0DFWp5Ac/rRQG410kC60tJAs4PSQBk1y0B3QJJA2gOlQBqjtEAH45tAcAF0QH+AkEBCL2RA5CSNQFvza0AdytBANEBkQO0jc0AqK4xAxLeWQFaCk0CGKNNATALMQOfpmkA5sLBA19WRQE5E0UAjNY1AsTWNQCrrwEDP5c1AOGt2QKOkxUD3JJ5AXql1QG4UokDHAYVAZ3uKQOaYfEBAIYxA1CeNQOdPmEBDsNFAuw9xQMos0UDjJ9NA+SmWQPRvcEDb681A7DhzQBWVsUDmRoxAXpivQOA8lkCXhdBARwJkQNOS0ECNNdNAs614QBp30kAZc6lAEOiYQE7naEDAT41ASFh8QGpNjUBtaZxAqVaeQNHN0EA8f9NAvzSSQDg4kUDBdnRAizRvQK3ldEAqstJA2IptQIN80kD7YNVAN82GQMSfbkD0trVA9fXMQD1jfEC6dnNAPQx3QAQYaECu7I9AJ/FsQAiYoUCAc9FAZ6JxQDJ/z0Bd1HhAMoTGQE1WeUDNS2xAwkd8QOWVzkCXBH9Ag62oQOCE0kBdstBAkYRuQKwE0kDvY39AqV90QM4hk0AJinxADh2FQOyYzkCCVXZACih1QJegzkA/cYlAYhnSQG1HxkC4qHVAipFyQEJ8fEBAMmlAzH2XQB+80ECqAM5AVL/TQHOFhUDIPpJAza3SQCVBo0BbOdFAMEPSQF8rkUCc/s5A8ubTQOVWbUDN2s9ACkaJQOBAm0Af9qFAjz+OQDF0hEB5brRANNBmQOuej0DKOtBANojKQORSzkD7KHNAUEPQQNkbZ0A57pVAykN0QDbS00CXYHJA3uVwQHwO0kBvdMtAdRt5QF1oakCGgm5A5J5zQGbPoECjDKVAlhRlQJizaEBtTWdAsbXKQMPJb0D9ttJAiaZvQH4kakA/8XJA/RdsQC9GfUDv2tFAa5l0QNiuzUDf/YxAitmOQJmlbUBCptNAd92eQEaO00D+Q3BANIu0QH9ZtEDZPoNArGKCQEurqUAieHNAYu6XQJ8gqEAFw5hA5ynMQCjacEBsjmtAFEmrQHCTaUAc1XNA8qV1QJvwuECqWWlAGl1xQEn+a0Di+m5AqVLTQGH5xEBk+35Anm/OQN/F00Bj4JhAEMByQFGDckCc77JALmFzQDBBd0Ay9XJANflrQNrGckDS2s5AQ+rLQH1u0EA8kNJAYPN8QAO0aUAZQGpAuDN1QGayz0BuVaFA0ttsQGuolUAGgdRAe2LQQOdqhUBiYoNA5ADUQKMJz0A9tLNAgQGXQPYK0UDzSJVAzUmSQIk9dUAxBXlAkMiVQHMFb0DKMpNAlcdvQPRucECS2oxAFv2jQDSka0Dd8mpAf0KdQI1rc0BgompAaeepQPQAbUDsE9JA3PBvQN3wlEABbctA7S9wQNfSf0BJPoxADAd1QGEYdECh/dBAT91xQPqybEDlq85ADivIQLEBbUClaaBA1NxrQE9Ze0DZ9HNAl79tQFV/00ARnctAL0zLQG0kckDeB3NAmviRQJ99pEBsfHRALauVQMNUc0CDsc5AsUubQHzv1EDw8JtApsVoQN0/cUDD3nNAGJJgQCvI00B+wXBAR4+FQJdMcUDGcM5Ai8ZlQI5CdEDDBppAL2FzQOw+0UAGJXFATv9yQB34cEBfOqNASERhQJSUy0DiS29APnnQQBnVz0Axb2tAzpltQGAh0ED7iGVAA9TTQNmMk0BEwGtAukLQQLilc0BGNtFAFLxnQJTWckDfao1AESzUQH6IkEAJDqFABlWZQFPrkkApRolAGt1uQPbKcUDRl2dAPW9wQGwb0EAgftVAtd5gQELOz0CPQnFAW32fQLexbkCWX81AchllQNzcvEAfR89AWPmOQFdGqkBc765AdIHVQOwioUD4/M9AsAOOQAKRikA3GHJA8t5wQBDmbEAIC3VAGIbUQKMhZkBcmtNA+Td9QE3we0AFh5JAd7BxQCdRc0C/g3VA7SPNQPg4uUAk8nRAXseCQJW/1EC4W8tAg8zLQN3rakCvxolApHe6QMqv0EB1V4ZAdoCoQCiVtkAefM5A3vadQD/+aUAD12dALGXOQK6cy0CMZnVAFifVQIxCgkCLDNNAogKqQDnuY0Dk9dJAk6+QQIFjeEAs1bRAMjnPQGYutUBylKlAk8xsQEQca0Bas59AbvxvQPkXhEDD3WpACBuCQGIDdUAe3mJA/otxQLjNkUBiM5NAgaSCQP9nzUDCMZRAEQ1nQPFxnUDcI2FA7D2PQJcQxkAQOtNAbgRsQHoXbUASSHRAnzxwQHWHb0DBKsFARbLJQPaykUDdcHFAUaPEQC1gbkD0loVAzmjQQJjHjEDYF8xAcmmCQGzKYECsk2pAd2jPQB6q0UBDCG1AmIzRQJtdc0DW3I9AA9B0QL6ecUDJhslAD7CjQLLlbUDt3nRA4EewQDEauUC9gNFASgRnQPiNvECvacdAX5FwQEA0q0Biv85AMAitQENfvkCJgtBAj9t5QNQNdkAkWNBAfkDOQB7h0UAqxG9AvR3MQFqgckA5o3VAYQ52QJHm0UAhiNFASN+EQCSsb0Cstc5AB0DPQLX5bkA="
         },
         "type": "scattergl",
         "xaxis": "x3",
         "yaxis": "y3"
        },
        {
         "hoverinfo": "none",
         "marker": {
          "color": "lightgray",
          "line": {
           "color": "rgba(0,0,0,0.05)",
           "width": 0.1
          },
          "opacity": 0.1,
          "size": 4
         },
         "mode": "markers",
         "name": "Outlier (-1)",
         "showlegend": false,
         "x": {
          "dtype": "f4",
          "bdata": "2W6QQH1DkEDLgpBA9gaRQKqWjECYcJBACTaqQHOdkEBUpzBAp81uQORmgUD2MpVAdI+WQGIBsUBTQJZASLZ5QIvEw0Ah6s1AnSwZQD6bkEBuW4FAk7WQQOP5pEBUH4NAUKaNQGyOokAL2H5AfjtoQBrBx0DkTIFAN6J/QMhyuEBs14FAA86uQPAJkUCm6/4/Z4xuQKadLkCiysVAZlGUQCPfaEBCbYBA5ZZ9QHqBlUDUbXRAU4SuQC4cdEC/eLBAN0aAQJSIwUAhPL1AyM3AQI6Pu0BERMlAQZuvQE4yH0DIN8BAukvAQD2YqUCWDIJAa3KpQLRPyUAtWMZANzu2QAlKpUDZSZ1AvIloQK+tfEAP74FAFNurQMBTkkDUP5dA40k5QC+9f0BkJYBAto+1QA=="
         },
         "y": {
          "dtype": "f4",
          "bdata": "U+OHQO7biECaQ4hAHH2HQKydikBQSYdAuguZQMwqiECwYmhA5SGhQGcQgkAsH4RA0aRkQJVrb0DXfGNAHWCZQAJWd0DpN2JACjJqQE0CiEACbYJAk9WHQDt7i0BRlIxAxbqEQOjsh0AZ5mlAeEOkQErgbECDH4JAetB/QGuQdEAemXZArDeVQB+Eh0AfXnhAQZ2hQBrAYkB96nRALPaTQFshpEDLm25AqLOTQHoog0A+OJ5AU5yVQJysnUBa+pNA6HVsQCE4eUAm0WdAf3tqQEK9ZEA8sGlAKnqKQI2IY0CPwGJANGqBQLHLjUCFqoBAyA6OQM2WaEDhvnJAKeCDQP8emkAe751A/hmkQC8Mp0DldYJAfFSRQLrMkUCdd5FAkTOEQM6bcECrPnJAR8qKQA=="
         },
         "type": "scattergl",
         "xaxis": "x3",
         "yaxis": "y3"
        },
        {
         "hoverinfo": "text",
         "hovertext": [
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: longevity_aging_link",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: aging_cells_senescence",
          "Subreddit: Biohackers<br>Topic: zone_training_max",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: peter",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: zone_training_max",
          "Subreddit: Biohackers<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: cells_stem_cell",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: peter",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: zone_training_max",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: magnetic_fields_expression_mitochondrial",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: peter",
          "Subreddit: Biohackers<br>Topic: peter",
          "Subreddit: Biohackers<br>Topic: peter",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: testosterone",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: pain_have",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: peter",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: longevity_aging_link",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: zone_training_max",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: zone_training_max",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: peter",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: longevity_aging_link",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: longevity_aging_link",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: peter",
          "Subreddit: Biohackers<br>Topic: longevity_aging_link",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: longevity_aging_link",
          "Subreddit: Biohackers<br>Topic: longevity_aging_link",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: water_bottled_tap_plastic",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: vitamin_supplements",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: magnetic_fields_expression_mitochondrial",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: peter",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: peter",
          "Subreddit: Biohackers<br>Topic: zone_training_max",
          "Subreddit: Biohackers<br>Topic: mg",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: peter",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Biohackers<br>Topic: peter",
          "Subreddit: Biohackers<br>Topic: gut",
          "Subreddit: Biohackers<br>Topic: pain_have",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: peter",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: cells_stem_cell",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: cells_stem_cell",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: longevity_aging_link",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: gut",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: zone_training_max",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: peter",
          "Subreddit: Biohackers<br>Topic: zone_training_max",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: zone_training_max",
          "Subreddit: Biohackers<br>Topic: zone_training_max",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: pain_have",
          "Subreddit: Biohackers<br>Topic: testosterone",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: cells_stem_cell",
          "Subreddit: Biohackers<br>Topic: longevity_aging_link",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: peter",
          "Subreddit: Biohackers<br>Topic: zone_training_max",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: vitamin_supplements",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: zone_training_max",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: cells_stem_cell",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: gut",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: pain_have",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: light_sauna",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: zone_training_max",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: peter",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: peter",
          "Subreddit: Biohackers<br>Topic: peter",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: longevity_aging_link",
          "Subreddit: Biohackers<br>Topic: peter",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: zone_training_max",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: peter",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: peter",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: longevity_aging_link",
          "Subreddit: Biohackers<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: zone_training_max",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: longevity_aging_link",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: longevity_aging_link",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: aging_cells_senescence",
          "Subreddit: Biohackers<br>Topic: zone_training_max",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: peter",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: longevity_aging_link",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: aging_cells_senescence",
          "Subreddit: Biohackers<br>Topic: alzheimer_cognitive_disease_amyloid",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: longevity_aging_link",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: sick_throat_immune",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: zone_training_max",
          "Subreddit: Biohackers<br>Topic: aging_cells_senescence",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: cells_stem_cell",
          "Subreddit: Biohackers<br>Topic: pain_have",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: zone_training_max",
          "Subreddit: Biohackers<br>Topic: vitamin_supplements",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: vitamin_supplements",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: sleep",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: vitamin_supplements",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: zone_training_max",
          "Subreddit: Biohackers<br>Topic: vitamin_supplements",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: aging_cells_senescence",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Biohackers<br>Topic: longevity_aging_link",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: zone_training_max",
          "Subreddit: Biohackers<br>Topic: aging_cells_senescence",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: longevity_aging_link",
          "Subreddit: Biohackers<br>Topic: zone_training_max",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: pain_have",
          "Subreddit: Biohackers<br>Topic: vitamin_supplements",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: aging_cells_senescence",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: sleep",
          "Subreddit: Biohackers<br>Topic: longevity_aging_link",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: mg",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: aging_cells_senescence",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: longevity_aging_link",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: zone_training_max",
          "Subreddit: Biohackers<br>Topic: testosterone",
          "Subreddit: Biohackers<br>Topic: sick_throat_immune",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: longevity_aging_link",
          "Subreddit: Biohackers<br>Topic: vitamin_supplements",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: alzheimer_cognitive_disease_amyloid",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: longevity_aging_link",
          "Subreddit: Biohackers<br>Topic: aging_cells_senescence",
          "Subreddit: Biohackers<br>Topic: peter",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: nmn_resveratrol",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: zone_training_max",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: longevity_aging_link",
          "Subreddit: Biohackers<br>Topic: zone_training_max",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: longevity_aging_link",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: aging_cells_senescence",
          "Subreddit: Biohackers<br>Topic: nmn_resveratrol",
          "Subreddit: Biohackers<br>Topic: longevity_aging_link",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: zone_training_max",
          "Subreddit: Biohackers<br>Topic: zone_training_max",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: longevity_aging_link",
          "Subreddit: Biohackers<br>Topic: vitamin_supplements",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: pain_have",
          "Subreddit: Biohackers<br>Topic: longevity_aging_link",
          "Subreddit: Biohackers<br>Topic: longevity_aging_link",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: sleep",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: longevity_aging_link",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: aging_cells_senescence",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: zone_training_max",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: alzheimer_cognitive_disease_amyloid",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: aging_cells_senescence",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: sleep",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: vitamin_supplements",
          "Subreddit: Biohackers<br>Topic: zone_training_max",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: peter",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: sleep",
          "Subreddit: Biohackers<br>Topic: alzheimer_cognitive_disease_amyloid",
          "Subreddit: Biohackers<br>Topic: pain_have",
          "Subreddit: Biohackers<br>Topic: longevity_aging_link",
          "Subreddit: Biohackers<br>Topic: longevity_aging_link",
          "Subreddit: Biohackers<br>Topic: alzheimer_cognitive_disease_amyloid",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: vitamin_supplements",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: vitamin_supplements",
          "Subreddit: Biohackers<br>Topic: nmn_resveratrol",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: pain_have",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: longevity_aging_link",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: longevity_aging_link",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: sick_throat_immune",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: vitamin_supplements",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: vitamin_supplements",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: zone_training_max",
          "Subreddit: Biohackers<br>Topic: vitamin_supplements",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: aging_cells_senescence",
          "Subreddit: Biohackers<br>Topic: gut",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: peter",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: water_bottled_tap_plastic",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: peter",
          "Subreddit: Biohackers<br>Topic: zone_training_max",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: magnetic_fields_expression_mitochondrial",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: zone_training_max",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: zone_training_max",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: zone_training_max",
          "Subreddit: Biohackers<br>Topic: zone_training_max",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: zone_training_max",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: peter",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: zone_training_max",
          "Subreddit: Biohackers<br>Topic: aging_cells_senescence",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: longevity_aging_link",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: zone_training_max",
          "Subreddit: Biohackers<br>Topic: zone_training_max",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: vitamin_supplements",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: peter",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: alcohol_nicotine",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: pain_have",
          "Subreddit: Biohackers<br>Topic: light_sauna",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: longevity_aging_link",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: aging_cells_senescence",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: longevity_aging_link",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: pain_have",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: longevity_aging_link",
          "Subreddit: Biohackers<br>Topic: zone_training_max",
          "Subreddit: Biohackers<br>Topic: vitamin_supplements",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: gut",
          "Subreddit: Biohackers<br>Topic: vitamin_supplements",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: light_sauna",
          "Subreddit: Biohackers<br>Topic: vitamin_supplements",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: longevity_aging_link",
          "Subreddit: Biohackers<br>Topic: water_bottled_tap_plastic",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: alzheimer_cognitive_disease_amyloid",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: sleep",
          "Subreddit: Biohackers<br>Topic: aging_cells_senescence",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: nmn_resveratrol",
          "Subreddit: Biohackers<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: aging_cells_senescence",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: testosterone",
          "Subreddit: Biohackers<br>Topic: vitamin_supplements",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: longevity_aging_link",
          "Subreddit: Biohackers<br>Topic: longevity_aging_link",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: mg",
          "Subreddit: Biohackers<br>Topic: longevity_aging_link",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: longevity_aging_link",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: peter",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: testosterone",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: longevity_aging_link"
         ],
         "marker": {
          "color": "#2C8360",
          "line": {
           "color": "rgba(0,0,0,0.5)",
           "width": 0.8
          },
          "opacity": 0.7,
          "size": 7
         },
         "mode": "markers",
         "name": "Biohackers",
         "showlegend": false,
         "x": {
          "dtype": "f4",
          "bdata": "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"
         },
         "y": {
          "dtype": "f4",
          "bdata": "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"
         },
         "type": "scattergl",
         "xaxis": "x3",
         "yaxis": "y3"
        },
        {
         "hoverinfo": "text",
         "hovertext": [
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: Longevity<br>Topic: Outlier (-1)",
          "Subreddit: Longevity<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: PeterAttia<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: PeterAttia<br>Topic: Outlier (-1)",
          "Subreddit: Longevity<br>Topic: Outlier (-1)",
          "Subreddit: Longevity<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: PeterAttia<br>Topic: Outlier (-1)",
          "Subreddit: Longevity<br>Topic: Outlier (-1)",
          "Subreddit: Longevity<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: PeterAttia<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: Longevity<br>Topic: Outlier (-1)",
          "Subreddit: Longevity<br>Topic: Outlier (-1)",
          "Subreddit: Longevity<br>Topic: Outlier (-1)",
          "Subreddit: PeterAttia<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: Longevity<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: Longevity<br>Topic: Outlier (-1)",
          "Subreddit: Longevity<br>Topic: Outlier (-1)",
          "Subreddit: PeterAttia<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: PeterAttia<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: Longevity<br>Topic: Outlier (-1)",
          "Subreddit: PeterAttia<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: PeterAttia<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: Longevity<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: PeterAttia<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: PeterAttia<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: PeterAttia<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: Longevity<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: Longevity<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: Outlier (-1)",
          "Subreddit: Biohackers<br>Topic: vitamin_supplements",
          "Subreddit: Biohackers<br>Topic: vitamin_supplements",
          "Subreddit: Biohackers<br>Topic: vitamin_supplements",
          "Subreddit: Biohackers<br>Topic: vitamin_supplements",
          "Subreddit: Biohackers<br>Topic: vitamin_supplements",
          "Subreddit: Biohackers<br>Topic: vitamin_supplements",
          "Subreddit: Biohackers<br>Topic: vitamin_supplements",
          "Subreddit: Biohackers<br>Topic: vitamin_supplements",
          "Subreddit: Biohackers<br>Topic: vitamin_supplements",
          "Subreddit: Biohackers<br>Topic: vitamin_supplements",
          "Subreddit: Longevity<br>Topic: vitamin_supplements",
          "Subreddit: Biohackers<br>Topic: vitamin_supplements",
          "Subreddit: Biohackers<br>Topic: vitamin_supplements",
          "Subreddit: Biohackers<br>Topic: vitamin_supplements",
          "Subreddit: PeterAttia<br>Topic: vitamin_supplements",
          "Subreddit: Biohackers<br>Topic: vitamin_supplements",
          "Subreddit: Biohackers<br>Topic: vitamin_supplements",
          "Subreddit: Biohackers<br>Topic: vitamin_supplements",
          "Subreddit: Biohackers<br>Topic: vitamin_supplements",
          "Subreddit: Biohackers<br>Topic: vitamin_supplements",
          "Subreddit: Longevity<br>Topic: vitamin_supplements",
          "Subreddit: Biohackers<br>Topic: vitamin_supplements",
          "Subreddit: Biohackers<br>Topic: vitamin_supplements",
          "Subreddit: PeterAttia<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Longevity<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: PeterAttia<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Longevity<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: PeterAttia<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: PeterAttia<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: PeterAttia<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: PeterAttia<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Biohackers<br>Topic: 1_to_and_it_my",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Biohackers<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Biohackers<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Biohackers<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Biohackers<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Biohackers<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Biohackers<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Biohackers<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Biohackers<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Biohackers<br>Topic: longevity_aging_link",
          "Subreddit: Biohackers<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Biohackers<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Biohackers<br>Topic: longevity_aging_link",
          "Subreddit: Biohackers<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Biohackers<br>Topic: longevity_aging_link",
          "Subreddit: Biohackers<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Biohackers<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Biohackers<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Biohackers<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Biohackers<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Biohackers<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Biohackers<br>Topic: longevity_aging_link",
          "Subreddit: Biohackers<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Biohackers<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Biohackers<br>Topic: longevity_aging_link",
          "Subreddit: Biohackers<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Biohackers<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: PeterAttia<br>Topic: longevity_aging_link",
          "Subreddit: Biohackers<br>Topic: longevity_aging_link",
          "Subreddit: PeterAttia<br>Topic: longevity_aging_link",
          "Subreddit: PeterAttia<br>Topic: longevity_aging_link",
          "Subreddit: PeterAttia<br>Topic: longevity_aging_link",
          "Subreddit: PeterAttia<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Biohackers<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: PeterAttia<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Biohackers<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: PeterAttia<br>Topic: longevity_aging_link",
          "Subreddit: PeterAttia<br>Topic: longevity_aging_link",
          "Subreddit: PeterAttia<br>Topic: longevity_aging_link",
          "Subreddit: PeterAttia<br>Topic: longevity_aging_link",
          "Subreddit: Biohackers<br>Topic: longevity_aging_link",
          "Subreddit: PeterAttia<br>Topic: longevity_aging_link",
          "Subreddit: PeterAttia<br>Topic: longevity_aging_link",
          "Subreddit: PeterAttia<br>Topic: longevity_aging_link",
          "Subreddit: PeterAttia<br>Topic: longevity_aging_link",
          "Subreddit: Biohackers<br>Topic: longevity_aging_link",
          "Subreddit: PeterAttia<br>Topic: longevity_aging_link",
          "Subreddit: PeterAttia<br>Topic: longevity_aging_link",
          "Subreddit: PeterAttia<br>Topic: longevity_aging_link",
          "Subreddit: PeterAttia<br>Topic: longevity_aging_link",
          "Subreddit: PeterAttia<br>Topic: longevity_aging_link",
          "Subreddit: PeterAttia<br>Topic: longevity_aging_link",
          "Subreddit: Biohackers<br>Topic: longevity_aging_link",
          "Subreddit: PeterAttia<br>Topic: longevity_aging_link",
          "Subreddit: Biohackers<br>Topic: longevity_aging_link",
          "Subreddit: Biohackers<br>Topic: longevity_aging_link",
          "Subreddit: Biohackers<br>Topic: longevity_aging_link",
          "Subreddit: PeterAttia<br>Topic: longevity_aging_link",
          "Subreddit: PeterAttia<br>Topic: longevity_aging_link",
          "Subreddit: PeterAttia<br>Topic: longevity_aging_link",
          "Subreddit: Biohackers<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: PeterAttia<br>Topic: longevity_aging_link",
          "Subreddit: Biohackers<br>Topic: longevity_aging_link",
          "Subreddit: PeterAttia<br>Topic: longevity_aging_link",
          "Subreddit: Biohackers<br>Topic: longevity_aging_link",
          "Subreddit: PeterAttia<br>Topic: longevity_aging_link",
          "Subreddit: PeterAttia<br>Topic: longevity_aging_link",
          "Subreddit: PeterAttia<br>Topic: longevity_aging_link",
          "Subreddit: PeterAttia<br>Topic: longevity_aging_link",
          "Subreddit: Biohackers<br>Topic: longevity_aging_link",
          "Subreddit: PeterAttia<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: PeterAttia<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Biohackers<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Biohackers<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Biohackers<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: Longevity<br>Topic: longevity_aging_link",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Longevity<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Longevity<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Longevity<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Longevity<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Longevity<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Longevity<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Longevity<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Longevity<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Longevity<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Longevity<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Longevity<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Longevity<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Longevity<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Longevity<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Longevity<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Longevity<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Longevity<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Longevity<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Longevity<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Longevity<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: Biohackers<br>Topic: ldl_cholesterol_apob",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: Biohackers<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: Biohackers<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: Biohackers<br>Topic: zone_training_max",
          "Subreddit: Biohackers<br>Topic: zone_training_max",
          "Subreddit: Biohackers<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: Biohackers<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: Biohackers<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: Longevity<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: Biohackers<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: Biohackers<br>Topic: zone_training_max",
          "Subreddit: Biohackers<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: Biohackers<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: Biohackers<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: Biohackers<br>Topic: zone_training_max",
          "Subreddit: Biohackers<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: Biohackers<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: Biohackers<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: Biohackers<br>Topic: zone_training_max",
          "Subreddit: Longevity<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: Biohackers<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: Biohackers<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: Biohackers<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: Biohackers<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: Biohackers<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: Biohackers<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: Biohackers<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: Biohackers<br>Topic: zone_training_max",
          "Subreddit: Biohackers<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: Biohackers<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: Longevity<br>Topic: zone_training_max",
          "Subreddit: Biohackers<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: Biohackers<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: Biohackers<br>Topic: zone_training_max",
          "Subreddit: Biohackers<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: Biohackers<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: Longevity<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: Biohackers<br>Topic: zone_training_max",
          "Subreddit: Biohackers<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: Biohackers<br>Topic: zone_training_max",
          "Subreddit: Biohackers<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: Biohackers<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: Biohackers<br>Topic: zone_training_max",
          "Subreddit: Biohackers<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: zone_training_max",
          "Subreddit: PeterAttia<br>Topic: sleep",
          "Subreddit: Biohackers<br>Topic: sleep",
          "Subreddit: PeterAttia<br>Topic: sleep",
          "Subreddit: Biohackers<br>Topic: sleep",
          "Subreddit: Biohackers<br>Topic: sleep",
          "Subreddit: Biohackers<br>Topic: sleep",
          "Subreddit: PeterAttia<br>Topic: sleep",
          "Subreddit: PeterAttia<br>Topic: sleep",
          "Subreddit: Biohackers<br>Topic: sleep",
          "Subreddit: PeterAttia<br>Topic: sleep",
          "Subreddit: Biohackers<br>Topic: sleep",
          "Subreddit: Biohackers<br>Topic: light_sauna",
          "Subreddit: Biohackers<br>Topic: light_sauna",
          "Subreddit: PeterAttia<br>Topic: light_sauna",
          "Subreddit: Biohackers<br>Topic: light_sauna",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Biohackers<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Biohackers<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Biohackers<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Biohackers<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Biohackers<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Biohackers<br>Topic: aging_cells_senescence",
          "Subreddit: Biohackers<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Biohackers<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Biohackers<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Biohackers<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: PeterAttia<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Biohackers<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Biohackers<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Biohackers<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Biohackers<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Biohackers<br>Topic: aging_cells_senescence",
          "Subreddit: Biohackers<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Biohackers<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: PeterAttia<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Longevity<br>Topic: aging_cells_senescence",
          "Subreddit: Biohackers<br>Topic: testosterone",
          "Subreddit: Biohackers<br>Topic: testosterone",
          "Subreddit: Biohackers<br>Topic: testosterone",
          "Subreddit: PeterAttia<br>Topic: testosterone",
          "Subreddit: Biohackers<br>Topic: testosterone",
          "Subreddit: Biohackers<br>Topic: testosterone",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Longevity<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Longevity<br>Topic: biohacking",
          "Subreddit: Longevity<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: PeterAttia<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Longevity<br>Topic: biohacking",
          "Subreddit: PeterAttia<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Longevity<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Longevity<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Longevity<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Longevity<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Longevity<br>Topic: biohacking",
          "Subreddit: Longevity<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Longevity<br>Topic: biohacking",
          "Subreddit: Longevity<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Longevity<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Longevity<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Longevity<br>Topic: biohacking",
          "Subreddit: Longevity<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Longevity<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Longevity<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: Biohackers<br>Topic: biohacking",
          "Subreddit: PeterAttia<br>Topic: alzheimer_cognitive_disease_amyloid",
          "Subreddit: Biohackers<br>Topic: alzheimer_cognitive_disease_amyloid",
          "Subreddit: Longevity<br>Topic: alzheimer_cognitive_disease_amyloid",
          "Subreddit: PeterAttia<br>Topic: alzheimer_cognitive_disease_amyloid",
          "Subreddit: Biohackers<br>Topic: alzheimer_cognitive_disease_amyloid",
          "Subreddit: Biohackers<br>Topic: alzheimer_cognitive_disease_amyloid",
          "Subreddit: Biohackers<br>Topic: alzheimer_cognitive_disease_amyloid",
          "Subreddit: Biohackers<br>Topic: alzheimer_cognitive_disease_amyloid",
          "Subreddit: Biohackers<br>Topic: alzheimer_cognitive_disease_amyloid",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: PeterAttia<br>Topic: app_watch",
          "Subreddit: PeterAttia<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: PeterAttia<br>Topic: app_watch",
          "Subreddit: PeterAttia<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: PeterAttia<br>Topic: app_watch",
          "Subreddit: PeterAttia<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: PeterAttia<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: PeterAttia<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: PeterAttia<br>Topic: app_watch",
          "Subreddit: Longevity<br>Topic: app_watch",
          "Subreddit: PeterAttia<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: PeterAttia<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: PeterAttia<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: PeterAttia<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: PeterAttia<br>Topic: app_watch",
          "Subreddit: PeterAttia<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: PeterAttia<br>Topic: app_watch",
          "Subreddit: PeterAttia<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: PeterAttia<br>Topic: app_watch",
          "Subreddit: PeterAttia<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: PeterAttia<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: PeterAttia<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: PeterAttia<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: PeterAttia<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: PeterAttia<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Longevity<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Longevity<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: app_watch",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: PeterAttia<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: PeterAttia<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: PeterAttia<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: PeterAttia<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: PeterAttia<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: PeterAttia<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: PeterAttia<br>Topic: protein_eat",
          "Subreddit: PeterAttia<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: PeterAttia<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: Longevity<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: protein_eat",
          "Subreddit: PeterAttia<br>Topic: protein_eat",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Longevity<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Longevity<br>Topic: blood_tests_test",
          "Subreddit: Longevity<br>Topic: blood_tests_test",
          "Subreddit: Longevity<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Longevity<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: Longevity<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Longevity<br>Topic: blood_tests_test",
          "Subreddit: Longevity<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Longevity<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Longevity<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Longevity<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Longevity<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: Longevity<br>Topic: blood_tests_test",
          "Subreddit: Longevity<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Longevity<br>Topic: blood_tests_test",
          "Subreddit: PeterAttia<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: blood_tests_test",
          "Subreddit: Biohackers<br>Topic: cells_stem_cell",
          "Subreddit: Biohackers<br>Topic: cells_stem_cell",
          "Subreddit: Longevity<br>Topic: cells_stem_cell",
          "Subreddit: Biohackers<br>Topic: cells_stem_cell",
          "Subreddit: Longevity<br>Topic: cells_stem_cell",
          "Subreddit: Biohackers<br>Topic: cells_stem_cell",
          "Subreddit: Biohackers<br>Topic: cells_stem_cell",
          "Subreddit: Longevity<br>Topic: cells_stem_cell",
          "Subreddit: Biohackers<br>Topic: cells_stem_cell",
          "Subreddit: Longevity<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: Biohackers<br>Topic: peter",
          "Subreddit: Biohackers<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: Biohackers<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: Longevity<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: Biohackers<br>Topic: peter",
          "Subreddit: Longevity<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: Biohackers<br>Topic: peter",
          "Subreddit: Biohackers<br>Topic: peter",
          "Subreddit: Biohackers<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: Longevity<br>Topic: peter",
          "Subreddit: Biohackers<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: Longevity<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: Biohackers<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: Longevity<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: Longevity<br>Topic: peter",
          "Subreddit: Longevity<br>Topic: peter",
          "Subreddit: Longevity<br>Topic: peter",
          "Subreddit: Biohackers<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: Longevity<br>Topic: peter",
          "Subreddit: Biohackers<br>Topic: peter",
          "Subreddit: Biohackers<br>Topic: peter",
          "Subreddit: Longevity<br>Topic: peter",
          "Subreddit: Longevity<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: Biohackers<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: Biohackers<br>Topic: peter",
          "Subreddit: Biohackers<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: Longevity<br>Topic: peter",
          "Subreddit: Biohackers<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: Biohackers<br>Topic: peter",
          "Subreddit: Biohackers<br>Topic: peter",
          "Subreddit: Longevity<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: Biohackers<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: Biohackers<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: Biohackers<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: Longevity<br>Topic: peter",
          "Subreddit: Longevity<br>Topic: peter",
          "Subreddit: Longevity<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: Longevity<br>Topic: peter",
          "Subreddit: Biohackers<br>Topic: peter",
          "Subreddit: Biohackers<br>Topic: peter",
          "Subreddit: Longevity<br>Topic: peter",
          "Subreddit: Longevity<br>Topic: peter",
          "Subreddit: Longevity<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: Biohackers<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: Longevity<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: Longevity<br>Topic: peter",
          "Subreddit: Longevity<br>Topic: peter",
          "Subreddit: Longevity<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: Longevity<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: Biohackers<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: Longevity<br>Topic: peter",
          "Subreddit: Biohackers<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: Biohackers<br>Topic: peter",
          "Subreddit: Biohackers<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: Biohackers<br>Topic: peter",
          "Subreddit: PeterAttia<br>Topic: peter",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Biohackers<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Biohackers<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Biohackers<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Biohackers<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Biohackers<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Biohackers<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Biohackers<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Biohackers<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Biohackers<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Biohackers<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Longevity<br>Topic: epigenetic_methylation_age_aging",
          "Subreddit: Biohackers<br>Topic: gut",
          "Subreddit: Biohackers<br>Topic: gut",
          "Subreddit: Biohackers<br>Topic: gut",
          "Subreddit: Biohackers<br>Topic: gut",
          "Subreddit: Biohackers<br>Topic: gut",
          "Subreddit: Biohackers<br>Topic: pain_have",
          "Subreddit: Biohackers<br>Topic: pain_have",
          "Subreddit: PeterAttia<br>Topic: pain_have",
          "Subreddit: PeterAttia<br>Topic: pain_have",
          "Subreddit: PeterAttia<br>Topic: pain_have",
          "Subreddit: Biohackers<br>Topic: pain_have",
          "Subreddit: Biohackers<br>Topic: pain_have",
          "Subreddit: Biohackers<br>Topic: pain_have",
          "Subreddit: Biohackers<br>Topic: pain_have",
          "Subreddit: Biohackers<br>Topic: pain_have",
          "Subreddit: Biohackers<br>Topic: pain_have",
          "Subreddit: Biohackers<br>Topic: pain_have",
          "Subreddit: Biohackers<br>Topic: pain_have",
          "Subreddit: Biohackers<br>Topic: pain_have",
          "Subreddit: Longevity<br>Topic: nmn_resveratrol",
          "Subreddit: Biohackers<br>Topic: nmn_resveratrol",
          "Subreddit: Biohackers<br>Topic: nmn_resveratrol",
          "Subreddit: Biohackers<br>Topic: nmn_resveratrol",
          "Subreddit: Longevity<br>Topic: nmn_resveratrol",
          "Subreddit: Longevity<br>Topic: nmn_resveratrol",
          "Subreddit: Biohackers<br>Topic: nmn_resveratrol",
          "Subreddit: Longevity<br>Topic: nmn_resveratrol",
          "Subreddit: Biohackers<br>Topic: sick_throat_immune",
          "Subreddit: Longevity<br>Topic: sick_throat_immune",
          "Subreddit: PeterAttia<br>Topic: sick_throat_immune",
          "Subreddit: PeterAttia<br>Topic: sick_throat_immune",
          "Subreddit: Biohackers<br>Topic: sick_throat_immune",
          "Subreddit: Biohackers<br>Topic: sick_throat_immune",
          "Subreddit: Biohackers<br>Topic: water_bottled_tap_plastic",
          "Subreddit: Biohackers<br>Topic: water_bottled_tap_plastic",
          "Subreddit: Longevity<br>Topic: water_bottled_tap_plastic",
          "Subreddit: Biohackers<br>Topic: water_bottled_tap_plastic",
          "Subreddit: Biohackers<br>Topic: alcohol_nicotine",
          "Subreddit: Longevity<br>Topic: alcohol_nicotine",
          "Subreddit: Longevity<br>Topic: hair_grey_minoxidil",
          "Subreddit: Biohackers<br>Topic: magnetic_fields_expression_mitochondrial",
          "Subreddit: Biohackers<br>Topic: magnetic_fields_expression_mitochondrial",
          "Subreddit: Longevity<br>Topic: magnetic_fields_expression_mitochondrial",
          "Subreddit: PeterAttia<br>Topic: magnetic_fields_expression_mitochondrial",
          "Subreddit: Biohackers<br>Topic: magnetic_fields_expression_mitochondrial",
          "Subreddit: Biohackers<br>Topic: mg",
          "Subreddit: Longevity<br>Topic: mg",
          "Subreddit: Longevity<br>Topic: mg",
          "Subreddit: Biohackers<br>Topic: mg",
          "Subreddit: Biohackers<br>Topic: mg"
         ],
         "marker": {
          "color": [
           "lightgray",
           "lightgray",
           "lightgray",
           "lightgray",
           "lightgray",
           "lightgray",
           "lightgray",
           "lightgray",
           "lightgray",
           "lightgray",
           "lightgray",
           "lightgray",
           "lightgray",
           "lightgray",
           "lightgray",
           "lightgray",
           "lightgray",
           "lightgray",
           "lightgray",
           "lightgray",
           "lightgray",
           "lightgray",
           "lightgray",
           "lightgray",
           "lightgray",
           "lightgray",
           "lightgray",
           "lightgray",
           "lightgray",
           "lightgray",
           "lightgray",
           "lightgray",
           "lightgray",
           "lightgray",
           "lightgray",
           "lightgray",
           "lightgray",
           "lightgray",
           "lightgray",
           "lightgray",
           "lightgray",
           "lightgray",
           "lightgray",
           "lightgray",
           "lightgray",
           "lightgray",
           "lightgray",
           "lightgray",
           "lightgray",
           "lightgray",
           "lightgray",
           "lightgray",
           "lightgray",
           "lightgray",
           "lightgray",
           "lightgray",
           "lightgray",
           "lightgray",
           "lightgray",
           "lightgray",
           "lightgray",
           "lightgray",
           "lightgray",
           "lightgray",
           "lightgray",
           "lightgray",
           "lightgray",
           "lightgray",
           "lightgray",
           "lightgray",
           "lightgray",
           "lightgray",
           "lightgray",
           "lightgray",
           "lightgray",
           "lightgray",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#CC5A71",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#477AA3",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#CC5A71",
           "#2C8360",
           "#2C8360",
           "#477AA3",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#CC5A71",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#477AA3",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#CC5A71",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#477AA3",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#477AA3",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#477AA3",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#477AA3",
           "#2C8360",
           "#2C8360",
           "#CC5A71",
           "#CC5A71",
           "#2C8360",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#2C8360",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#2C8360",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#2C8360",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#2C8360",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#2C8360",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#2C8360",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#2C8360",
           "#CC5A71",
           "#2C8360",
           "#2C8360",
           "#CC5A71",
           "#2C8360",
           "#CC5A71",
           "#2C8360",
           "#2C8360",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#2C8360",
           "#2C8360",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#2C8360",
           "#CC5A71",
           "#CC5A71",
           "#2C8360",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#2C8360",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#2C8360",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#2C8360",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#2C8360",
           "#2C8360",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#2C8360",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#2C8360",
           "#2C8360",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#2C8360",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#477AA3",
           "#2C8360",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#2C8360",
           "#CC5A71",
           "#477AA3",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#2C8360",
           "#CC5A71",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#2C8360",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#2C8360",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#2C8360",
           "#477AA3",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#2C8360",
           "#CC5A71",
           "#477AA3",
           "#2C8360",
           "#477AA3",
           "#2C8360",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#2C8360",
           "#477AA3",
           "#CC5A71",
           "#477AA3",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#2C8360",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#2C8360",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#2C8360",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#CC5A71",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#CC5A71",
           "#477AA3",
           "#CC5A71",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#CC5A71",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#CC5A71",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#2C8360",
           "#477AA3",
           "#2C8360",
           "#2C8360",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#CC5A71",
           "#477AA3",
           "#477AA3",
           "#CC5A71",
           "#477AA3",
           "#477AA3",
           "#CC5A71",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#CC5A71",
           "#477AA3",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#CC5A71",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#CC5A71",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#CC5A71",
           "#2C8360",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#CC5A71",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#CC5A71",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#CC5A71",
           "#CC5A71",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#2C8360",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#2C8360",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#477AA3",
           "#477AA3",
           "#2C8360",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#2C8360",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#CC5A71",
           "#477AA3",
           "#477AA3",
           "#2C8360",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#2C8360",
           "#2C8360",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#2C8360",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#2C8360",
           "#477AA3",
           "#2C8360",
           "#2C8360",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#2C8360",
           "#477AA3",
           "#477AA3",
           "#2C8360",
           "#477AA3",
           "#2C8360",
           "#CC5A71",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#2C8360",
           "#477AA3",
           "#2C8360",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#2C8360",
           "#477AA3",
           "#2C8360",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#2C8360",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#2C8360",
           "#477AA3",
           "#477AA3",
           "#2C8360",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#2C8360",
           "#2C8360",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#2C8360",
           "#477AA3",
           "#CC5A71",
           "#2C8360",
           "#477AA3",
           "#2C8360",
           "#477AA3",
           "#477AA3",
           "#2C8360",
           "#2C8360",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#2C8360",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#CC5A71",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#2C8360",
           "#2C8360",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#2C8360",
           "#2C8360",
           "#477AA3",
           "#2C8360",
           "#477AA3",
           "#477AA3",
           "#2C8360",
           "#2C8360",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#2C8360",
           "#477AA3",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#477AA3",
           "#477AA3",
           "#2C8360",
           "#477AA3",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#477AA3",
           "#2C8360",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#2C8360",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#2C8360",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#2C8360",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#2C8360",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#2C8360",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#2C8360",
           "#2C8360",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#2C8360",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#2C8360",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#2C8360",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#477AA3",
           "#CC5A71",
           "#CC5A71",
           "#2C8360",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#2C8360",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#2C8360",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#2C8360",
           "#CC5A71",
           "#2C8360",
           "#2C8360",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#2C8360",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#477AA3",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#477AA3",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#CC5A71",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#CC5A71",
           "#CC5A71",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#477AA3",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#CC5A71",
           "#477AA3",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#CC5A71",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#CC5A71",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#CC5A71",
           "#2C8360",
           "#CC5A71",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#CC5A71",
           "#CC5A71",
           "#2C8360",
           "#CC5A71",
           "#CC5A71",
           "#2C8360",
           "#2C8360",
           "#CC5A71",
           "#2C8360",
           "#CC5A71",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#CC5A71",
           "#CC5A71",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#CC5A71",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#CC5A71",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#477AA3",
           "#2C8360",
           "#CC5A71",
           "#477AA3",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#477AA3",
           "#477AA3",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#477AA3",
           "#477AA3",
           "#2C8360",
           "#2C8360",
           "#477AA3",
           "#477AA3",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#477AA3",
           "#2C8360",
           "#2C8360",
           "#477AA3",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#477AA3",
           "#CC5A71",
           "#477AA3",
           "#2C8360",
           "#2C8360",
           "#477AA3",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#477AA3",
           "#2C8360",
           "#2C8360",
           "#477AA3",
           "#2C8360",
           "#2C8360",
           "#477AA3",
           "#477AA3",
           "#2C8360",
           "#2C8360",
           "#477AA3",
           "#477AA3",
           "#2C8360",
           "#477AA3",
           "#477AA3",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#477AA3",
           "#2C8360",
           "#477AA3",
           "#2C8360",
           "#2C8360",
           "#477AA3",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#477AA3",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#477AA3",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#CC5A71",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#CC5A71",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#477AA3",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#477AA3",
           "#2C8360",
           "#477AA3",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#477AA3",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#477AA3",
           "#2C8360",
           "#477AA3",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#477AA3",
           "#477AA3",
           "#2C8360",
           "#477AA3",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#CC5A71",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#477AA3",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#477AA3",
           "#477AA3",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#CC5A71",
           "#477AA3",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#477AA3",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#477AA3",
           "#477AA3",
           "#2C8360",
           "#2C8360",
           "#477AA3",
           "#2C8360",
           "#477AA3",
           "#477AA3",
           "#2C8360",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#477AA3",
           "#2C8360",
           "#2C8360",
           "#477AA3",
           "#2C8360",
           "#2C8360",
           "#477AA3",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#CC5A71",
           "#2C8360",
           "#477AA3",
           "#CC5A71",
           "#2C8360",
           "#2C8360",
           "#CC5A71",
           "#CC5A71",
           "#2C8360",
           "#2C8360",
           "#477AA3",
           "#2C8360",
           "#2C8360",
           "#477AA3",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#CC5A71",
           "#2C8360",
           "#2C8360",
           "#CC5A71",
           "#2C8360",
           "#2C8360",
           "#CC5A71",
           "#2C8360",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#2C8360",
           "#477AA3",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#CC5A71",
           "#477AA3",
           "#2C8360",
           "#2C8360",
           "#477AA3",
           "#2C8360",
           "#2C8360",
           "#477AA3",
           "#2C8360",
           "#477AA3",
           "#477AA3",
           "#2C8360",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#2C8360",
           "#477AA3",
           "#477AA3",
           "#2C8360",
           "#477AA3",
           "#2C8360",
           "#477AA3",
           "#477AA3",
           "#2C8360",
           "#477AA3",
           "#2C8360",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#2C8360",
           "#2C8360",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#477AA3",
           "#2C8360",
           "#477AA3",
           "#2C8360",
           "#2C8360",
           "#477AA3",
           "#CC5A71",
           "#CC5A71",
           "#2C8360",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#CC5A71",
           "#477AA3",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#CC5A71",
           "#2C8360",
           "#CC5A71",
           "#2C8360",
           "#2C8360",
           "#CC5A71",
           "#2C8360",
           "#CC5A71",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#2C8360",
           "#2C8360",
           "#477AA3",
           "#2C8360",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#CC5A71",
           "#477AA3",
           "#2C8360",
           "#CC5A71",
           "#477AA3",
           "#477AA3",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#477AA3",
           "#CC5A71",
           "#2C8360",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#CC5A71",
           "#477AA3",
           "#2C8360",
           "#477AA3",
           "#CC5A71",
           "#477AA3",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#2C8360",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#CC5A71",
           "#2C8360",
           "#2C8360",
           "#CC5A71",
           "#CC5A71",
           "#477AA3",
           "#2C8360",
           "#477AA3",
           "#477AA3",
           "#2C8360",
           "#2C8360",
           "#477AA3",
           "#CC5A71",
           "#2C8360",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#2C8360",
           "#2C8360",
           "#CC5A71",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#2C8360",
           "#477AA3",
           "#2C8360",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#2C8360",
           "#477AA3",
           "#477AA3",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#CC5A71",
           "#2C8360",
           "#2C8360",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#477AA3",
           "#2C8360",
           "#477AA3",
           "#CC5A71",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#477AA3",
           "#477AA3",
           "#CC5A71",
           "#477AA3",
           "#477AA3",
           "#2C8360",
           "#477AA3",
           "#CC5A71",
           "#2C8360",
           "#477AA3",
           "#2C8360",
           "#2C8360",
           "#477AA3",
           "#2C8360",
           "#477AA3",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#2C8360",
           "#2C8360",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#2C8360",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#2C8360",
           "#2C8360",
           "#CC5A71",
           "#2C8360",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#2C8360",
           "#2C8360",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#2C8360",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#2C8360",
           "#CC5A71",
           "#CC5A71",
           "#CC5A71",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#477AA3",
           "#477AA3",
           "#477AA3",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#CC5A71",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#CC5A71",
           "#CC5A71",
           "#2C8360",
           "#CC5A71",
           "#2C8360",
           "#CC5A71",
           "#477AA3",
           "#477AA3",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#2C8360",
           "#CC5A71",
           "#2C8360",
           "#2C8360",
           "#CC5A71",
           "#CC5A71",
           "#2C8360",
           "#2C8360",
           "#CC5A71",
           "#477AA3",
           "#2C8360",
           "#2C8360",
           "#CC5A71",
           "#CC5A71",
           "#2C8360",
           "#2C8360"
          ],
          "line": {
           "color": "rgba(0,0,0,0.3)",
           "width": 0.5
          },
          "opacity": 0.4,
          "size": 6
         },
         "mode": "markers",
         "name": "All Subreddits",
         "showlegend": false,
         "x": {
          "dtype": "f4",
          "bdata": "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"
         },
         "y": {
          "dtype": "f4",
          "bdata": "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"
         },
         "type": "scattergl",
         "xaxis": "x4",
         "yaxis": "y4"
        },
        {
         "legendgroup": "Combined",
         "marker": {
          "color": "#2C8360",
          "size": 10
         },
         "mode": "markers",
         "name": "Biohackers",
         "showlegend": true,
         "x": [
          null
         ],
         "y": [
          null
         ],
         "type": "scattergl"
        },
        {
         "legendgroup": "Combined",
         "marker": {
          "color": "#CC5A71",
          "size": 10
         },
         "mode": "markers",
         "name": "Longevity",
         "showlegend": true,
         "x": [
          null
         ],
         "y": [
          null
         ],
         "type": "scattergl"
        },
        {
         "legendgroup": "Combined",
         "marker": {
          "color": "#477AA3",
          "size": 10
         },
         "mode": "markers",
         "name": "PeterAttia",
         "showlegend": true,
         "x": [
          null
         ],
         "y": [
          null
         ],
         "type": "scattergl"
        },
        {
         "legendgroup": "Combined",
         "marker": {
          "color": "lightgray",
          "size": 10
         },
         "mode": "markers",
         "name": "Outlier (-1)",
         "showlegend": true,
         "x": [
          null
         ],
         "y": [
          null
         ],
         "type": "scattergl"
        }
       ],
       "layout": {
        "template": {
         "data": {
          "histogram2dcontour": [
           {
            "type": "histogram2dcontour",
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0.0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1.0,
              "#f0f921"
             ]
            ]
           }
          ],
          "choropleth": [
           {
            "type": "choropleth",
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            }
           }
          ],
          "histogram2d": [
           {
            "type": "histogram2d",
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0.0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1.0,
              "#f0f921"
             ]
            ]
           }
          ],
          "heatmap": [
           {
            "type": "heatmap",
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0.0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1.0,
              "#f0f921"
             ]
            ]
           }
          ],
          "contourcarpet": [
           {
            "type": "contourcarpet",
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            }
           }
          ],
          "contour": [
           {
            "type": "contour",
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0.0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1.0,
              "#f0f921"
             ]
            ]
           }
          ],
          "surface": [
           {
            "type": "surface",
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0.0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1.0,
              "#f0f921"
             ]
            ]
           }
          ],
          "mesh3d": [
           {
            "type": "mesh3d",
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            }
           }
          ],
          "scatter": [
           {
            "fillpattern": {
             "fillmode": "overlay",
             "size": 10,
             "solidity": 0.2
            },
            "type": "scatter"
           }
          ],
          "parcoords": [
           {
            "type": "parcoords",
            "line": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            }
           }
          ],
          "scatterpolargl": [
           {
            "type": "scatterpolargl",
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            }
           }
          ],
          "bar": [
           {
            "error_x": {
             "color": "#2a3f5f"
            },
            "error_y": {
             "color": "#2a3f5f"
            },
            "marker": {
             "line": {
              "color": "#E5ECF6",
              "width": 0.5
             },
             "pattern": {
              "fillmode": "overlay",
              "size": 10,
              "solidity": 0.2
             }
            },
            "type": "bar"
           }
          ],
          "scattergeo": [
           {
            "type": "scattergeo",
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            }
           }
          ],
          "scatterpolar": [
           {
            "type": "scatterpolar",
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            }
           }
          ],
          "histogram": [
           {
            "marker": {
             "pattern": {
              "fillmode": "overlay",
              "size": 10,
              "solidity": 0.2
             }
            },
            "type": "histogram"
           }
          ],
          "scattergl": [
           {
            "type": "scattergl",
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            }
           }
          ],
          "scatter3d": [
           {
            "type": "scatter3d",
            "line": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            }
           }
          ],
          "scattermap": [
           {
            "type": "scattermap",
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            }
           }
          ],
          "scattermapbox": [
           {
            "type": "scattermapbox",
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            }
           }
          ],
          "scatterternary": [
           {
            "type": "scatterternary",
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            }
           }
          ],
          "scattercarpet": [
           {
            "type": "scattercarpet",
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            }
           }
          ],
          "carpet": [
           {
            "aaxis": {
             "endlinecolor": "#2a3f5f",
             "gridcolor": "white",
             "linecolor": "white",
             "minorgridcolor": "white",
             "startlinecolor": "#2a3f5f"
            },
            "baxis": {
             "endlinecolor": "#2a3f5f",
             "gridcolor": "white",
             "linecolor": "white",
             "minorgridcolor": "white",
             "startlinecolor": "#2a3f5f"
            },
            "type": "carpet"
           }
          ],
          "table": [
           {
            "cells": {
             "fill": {
              "color": "#EBF0F8"
             },
             "line": {
              "color": "white"
             }
            },
            "header": {
             "fill": {
              "color": "#C8D4E3"
             },
             "line": {
              "color": "white"
             }
            },
            "type": "table"
           }
          ],
          "barpolar": [
           {
            "marker": {
             "line": {
              "color": "#E5ECF6",
              "width": 0.5
             },
             "pattern": {
              "fillmode": "overlay",
              "size": 10,
              "solidity": 0.2
             }
            },
            "type": "barpolar"
           }
          ],
          "pie": [
           {
            "automargin": true,
            "type": "pie"
           }
          ]
         },
         "layout": {
          "autotypenumbers": "strict",
          "colorway": [
           "#636efa",
           "#EF553B",
           "#00cc96",
           "#ab63fa",
           "#FFA15A",
           "#19d3f3",
           "#FF6692",
           "#B6E880",
           "#FF97FF",
           "#FECB52"
          ],
          "font": {
           "color": "#2a3f5f"
          },
          "hovermode": "closest",
          "hoverlabel": {
           "align": "left"
          },
          "paper_bgcolor": "white",
          "plot_bgcolor": "#E5ECF6",
          "polar": {
           "bgcolor": "#E5ECF6",
           "angularaxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           },
           "radialaxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           }
          },
          "ternary": {
           "bgcolor": "#E5ECF6",
           "aaxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           },
           "baxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           },
           "caxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           }
          },
          "coloraxis": {
           "colorbar": {
            "outlinewidth": 0,
            "ticks": ""
           }
          },
          "colorscale": {
           "sequential": [
            [
             0.0,
             "#0d0887"
            ],
            [
             0.1111111111111111,
             "#46039f"
            ],
            [
             0.2222222222222222,
             "#7201a8"
            ],
            [
             0.3333333333333333,
             "#9c179e"
            ],
            [
             0.4444444444444444,
             "#bd3786"
            ],
            [
             0.5555555555555556,
             "#d8576b"
            ],
            [
             0.6666666666666666,
             "#ed7953"
            ],
            [
             0.7777777777777778,
             "#fb9f3a"
            ],
            [
             0.8888888888888888,
             "#fdca26"
            ],
            [
             1.0,
             "#f0f921"
            ]
           ],
           "sequentialminus": [
            [
             0.0,
             "#0d0887"
            ],
            [
             0.1111111111111111,
             "#46039f"
            ],
            [
             0.2222222222222222,
             "#7201a8"
            ],
            [
             0.3333333333333333,
             "#9c179e"
            ],
            [
             0.4444444444444444,
             "#bd3786"
            ],
            [
             0.5555555555555556,
             "#d8576b"
            ],
            [
             0.6666666666666666,
             "#ed7953"
            ],
            [
             0.7777777777777778,
             "#fb9f3a"
            ],
            [
             0.8888888888888888,
             "#fdca26"
            ],
            [
             1.0,
             "#f0f921"
            ]
           ],
           "diverging": [
            [
             0,
             "#8e0152"
            ],
            [
             0.1,
             "#c51b7d"
            ],
            [
             0.2,
             "#de77ae"
            ],
            [
             0.3,
             "#f1b6da"
            ],
            [
             0.4,
             "#fde0ef"
            ],
            [
             0.5,
             "#f7f7f7"
            ],
            [
             0.6,
             "#e6f5d0"
            ],
            [
             0.7,
             "#b8e186"
            ],
            [
             0.8,
             "#7fbc41"
            ],
            [
             0.9,
             "#4d9221"
            ],
            [
             1,
             "#276419"
            ]
           ]
          },
          "xaxis": {
           "gridcolor": "white",
           "linecolor": "white",
           "ticks": "",
           "title": {
            "standoff": 15
           },
           "zerolinecolor": "white",
           "automargin": true,
           "zerolinewidth": 2
          },
          "yaxis": {
           "gridcolor": "white",
           "linecolor": "white",
           "ticks": "",
           "title": {
            "standoff": 15
           },
           "zerolinecolor": "white",
           "automargin": true,
           "zerolinewidth": 2
          },
          "scene": {
           "xaxis": {
            "backgroundcolor": "#E5ECF6",
            "gridcolor": "white",
            "linecolor": "white",
            "showbackground": true,
            "ticks": "",
            "zerolinecolor": "white",
            "gridwidth": 2
           },
           "yaxis": {
            "backgroundcolor": "#E5ECF6",
            "gridcolor": "white",
            "linecolor": "white",
            "showbackground": true,
            "ticks": "",
            "zerolinecolor": "white",
            "gridwidth": 2
           },
           "zaxis": {
            "backgroundcolor": "#E5ECF6",
            "gridcolor": "white",
            "linecolor": "white",
            "showbackground": true,
            "ticks": "",
            "zerolinecolor": "white",
            "gridwidth": 2
           }
          },
          "shapedefaults": {
           "line": {
            "color": "#2a3f5f"
           }
          },
          "annotationdefaults": {
           "arrowcolor": "#2a3f5f",
           "arrowhead": 0,
           "arrowwidth": 1
          },
          "geo": {
           "bgcolor": "white",
           "landcolor": "#E5ECF6",
           "subunitcolor": "white",
           "showland": true,
           "showlakes": true,
           "lakecolor": "white"
          },
          "title": {
           "x": 0.05
          },
          "mapbox": {
           "style": "light"
          }
         }
        },
        "xaxis": {
         "anchor": "y",
         "domain": [
          0.0,
          0.45
         ],
         "title": {
          "text": "UMAP-1"
         }
        },
        "yaxis": {
         "anchor": "x",
         "domain": [
          0.55,
          1.0
         ],
         "title": {
          "text": "UMAP-2"
         }
        },
        "xaxis2": {
         "anchor": "y2",
         "domain": [
          0.55,
          1.0
         ],
         "title": {
          "text": "UMAP-1"
         }
        },
        "yaxis2": {
         "anchor": "x2",
         "domain": [
          0.55,
          1.0
         ],
         "title": {
          "text": "UMAP-2"
         }
        },
        "xaxis3": {
         "anchor": "y3",
         "domain": [
          0.0,
          0.45
         ],
         "title": {
          "text": "UMAP-1"
         }
        },
        "yaxis3": {
         "anchor": "x3",
         "domain": [
          0.0,
          0.45
         ],
         "title": {
          "text": "UMAP-2"
         }
        },
        "xaxis4": {
         "anchor": "y4",
         "domain": [
          0.55,
          1.0
         ],
         "title": {
          "text": "UMAP-1"
         }
        },
        "yaxis4": {
         "anchor": "x4",
         "domain": [
          0.0,
          0.45
         ],
         "title": {
          "text": "UMAP-2"
         }
        },
        "annotations": [
         {
          "font": {
           "size": 16
          },
          "showarrow": false,
          "text": "PeterAttia Subreddit",
          "x": 0.225,
          "xanchor": "center",
          "xref": "paper",
          "y": 1.0,
          "yanchor": "bottom",
          "yref": "paper"
         },
         {
          "font": {
           "size": 16
          },
          "showarrow": false,
          "text": "Longevity Subreddit",
          "x": 0.775,
          "xanchor": "center",
          "xref": "paper",
          "y": 1.0,
          "yanchor": "bottom",
          "yref": "paper"
         },
         {
          "font": {
           "size": 16
          },
          "showarrow": false,
          "text": "Biohackers Subreddit",
          "x": 0.225,
          "xanchor": "center",
          "xref": "paper",
          "y": 0.45,
          "yanchor": "bottom",
          "yref": "paper"
         },
         {
          "font": {
           "size": 16
          },
          "showarrow": false,
          "text": "All Subreddits Combined",
          "x": 0.775,
          "xanchor": "center",
          "xref": "paper",
          "y": 0.45,
          "yanchor": "bottom",
          "yref": "paper"
         }
        ],
        "title": {
         "font": {
          "size": 20
         },
         "text": "Subreddit UMAP Distributions"
        },
        "legend": {
         "orientation": "h",
         "yanchor": "bottom",
         "y": -0.2,
         "xanchor": "center",
         "x": 0.5,
         "itemsizing": "constant",
         "traceorder": "grouped"
        },
        "height": 900,
        "width": 1200,
        "plot_bgcolor": "rgba(240, 240, 240, 1)",
        "paper_bgcolor": "rgba(255, 255, 255, 1)",
        "hovermode": "closest"
       },
       "config": {
        "plotlyServerURL": "https://plot.ly"
       }
      }
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "‚úÖ 2x2 UMAP grid for subreddit distributions generated.\n"
     ]
    }
   ],
   "execution_count": 10
  },
  {
   "metadata": {},
   "cell_type": "markdown",
   "source": [
    "- **Shared manifold, different densities:** All three subs occupy the same UMAP space; separability is limited‚Äîdifferences are mostly where each subreddit is densest rather than entirely separate clusters.\n",
    "- **Biohackers = broadest spread & volume:** Two strong lobes spanning most of the map indicate heterogeneous topics/devices/protocols and the largest contribution overall.\n",
    "- **Longevity = focused left cluster:** A tight mode on the left side suggests more homogeneous, research/diet/biomarker threads with less spread into the right lobe.\n",
    "- **PeterAttia = smaller mid-right nucleus:** Concentrated near Biohackers‚Äô right lobe, implying overlap with protocol/biomarker themes; outliers (grey) are sparse and peripheral."
   ],
   "id": "d6ac1e601f37ae97"
  },
  {
   "metadata": {},
   "cell_type": "markdown",
   "source": [
    "# üéâ Project Conclusion and Future Work\n",
    "\n",
    "This project successfully mapped the conversational landscape across **r/PeterAttia, r/Longevity, and r/Biohackers**, providing quantitative insights into their similarities, differences, and focus areas.\n",
    "\n",
    "---\n",
    "\n",
    "## üîë Key Takeaways\n",
    "\n",
    "1.  **High Topic Specialization:** The three communities exhibit strong topical segregation.\n",
    "    * **r/PeterAttia** uniquely dominates topics related to **structured fitness** (VO2 Max, Zone 2, strength training).\n",
    "    * **r/Longevity** uniquely dominates topics related to **specific compounds and experimental drugs** (e.g., Semaglutide, Senolytics).\n",
    "    * **r/Biohackers** often acts as a **bridge**, participating heavily in supplement/metabolism topics but rarely leading the largest discussions.\n",
    "2.  **Universal Overlap:** The only truly universal discussions were centered on **cardiovascular health** (LDL, Cholesterol, Statins) and **core metabolic health** (blood sugar, diet), indicating the fundamental shared priority across the three groups.\n",
    "3.  **Temporal Stability:** Most of the top 10 topics showed **stable, sustained volume** over the analysis period, suggesting the core concerns of these communities are evergreen and not driven purely by transient news cycles.\n",
    "4.  **Model Robustness:** The use of **soft outlier reassignment** and a final, shared set of topics (`topic_global`) ensures the comparative analysis (Steps 5 & 6) is highly robust and directly comparable.\n",
    "\n",
    "---\n",
    "\n",
    "## üöÄ Suggested Future Work\n",
    "\n",
    "### 1. Advanced Comparison\n",
    "\n",
    "* **Document Similarity per Topic:** Calculate and visualize the average **document-to-centroid similarity** for each subreddit within each topic. This metric quantifies *not just how many* posts a subreddit has in a topic, but **how central** those posts are to the topic's meaning.\n",
    "* **Hierarchical Topic Visualization:** Use the model to visualize the **inter-topic hierarchy** to understand how smaller sub-topics relate to larger, umbrella discussions (e.g., \"Strength Training\" falling under \"Exercise\").\n",
    "\n",
    "### 2. Deeper Content Analysis\n",
    "\n",
    "* **Sentiment Analysis:** Integrate a sentiment model to analyze the emotional tone of discussions for high-volume or highly segregated topics (e.g., Is the discussion around Semaglutide more optimistic in one subreddit than another?).\n",
    "* **Top Document Extraction:** Systematically extract the **most representative documents** (highest probability/closest to centroid) for the Top 5 most specialized topics in each subreddit to provide qualitative evidence of the differences.\n",
    "\n",
    "### 3. Model Refinement\n",
    "\n",
    "* **Reduce Outlier Group:** Experiment with a lower `MIN_TOPIC_SIZE` or adjust the UMAP/HDBSCAN parameters to see if the final outlier group can be significantly reduced without compromising topic quality."
   ],
   "id": "cf065ea4d43b3a7a"
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python (attia311)",
   "language": "python",
   "name": "attia311"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 2
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython2",
   "version": "2.7.6"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
